
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-16501-16800*
  '("!Online" ".217_218" "5AZA" "969-Bub1" "A-20" "A-GSK3β-KI" "A-activated"
    "A-binding" "A-mediated" "A1" "A1086S" "A11-A21" "A12-G20" "A187C" "A1c"
    "A2013" "A261K" "A4" "A4-B1" "A4-B2" "A4-B3" "A4-F" "A4-M" "A4-S" "A427S"
    "A5" "A549-Ad-shGFP" "A549-Ad-shGFP-injected" "A549-Ad-shRKIP" "A549-K0R0"
    "A549-K4R6" "A750P" "A871G" "AAA59924" "AAGA" "AAH65518.1" "AALE" "AATAAA"
    "AAZ521" "ABHD16A" "ABHD17" "ABHD17B" "ABHD17C" "ABSCs" "ABT-737-induced"
    "ABT-737-mediated" "ABT-737-treated" "ACCURI" "ACCX16" "ACCX2" "ACCX5M1"
    "ACE-R" "ACY1215" "ADAAD-G" "ADAAD-Myc_B" "ADAADiN" "ADR‐induced" "ADSC"
    "ADSCs" "ADZ9291" "AFB1-DNA" "AFB1-DNA-positive" "AFB1-K2" "AFIFAHEESEDNSC"
    "AFU" "AG14781" "AGC" "AH23848" "AHO-3" "AKI" "AKRA" "AKT-dependent"
    "AKT1-3" "AKT1-MUT" "ALGG" "ALGGEN" "ALGGs" "ALI-PBEC" "ALP-Luc"
    "AMPK‐related" "AMRESCO" "ANLN" "ANM" "ANMs" "AOC4P" "AP-MS" "APC-Cdh1"
    "APE-7" "API" "API-59" "APT1L" "APTs" "AR-42" "ARACNe" "ARE-BP" "ARE-like"
    "ARIC" "ARL67156" "ARMS-PCR" "ARN509" "AS-qPCR" "AS-qPCR-positive" "ASCIZ"
    "ASCO" "ASE" "ASH1" "ASUs" "AT-hook" "AT1R" "AT8-immunoreactive" "ATB-737"
    "ATF4-U2OS" "ATF4-U2OS-injected" "ATG7-null" "ATM-CHEK2-CDC25-CDC2"
    "ATM-CHEK2-CDC25-cdc2" "ATMi" "ATMis" "ATR-checkpoint" "ATTD91" "ATTDD"
    "ATTO" "ATTO-488" "AUBPs" "AVTKAQKKDGKK" "AZD" "AZD6244-AZD8055"
    "AZD6244-BE235" "AZD6244-BEZ235" "AZD6344" "AZD6344-BEZ235" "Ab1p" "Ab2p"
    "Ab2p-α1" "Abcam" "Abelson" "Ac" "Ac-DEVD-AMC" "Ac-YVAD-CMK" "Achaete"
    "Achaete-scute" "Achilles" "Ad-Egr1-zsGREEN" "Ad-GFP" "Ad-mRFP-GFP-LC3"
    "Ad-shGFP" "Ad-shRKIP" "Ad-shRKIP-expressing" "Adamus" "Addenbrooke"
    "Adeno-PDK1-Y9F" "Adenosyl" "Adham" "Adinolfi" "Adinolfi’s" "AdipoDiff"
    "Advansta" "Adzhubei" "Ad‐LacZ" "Ad‐p53" "Affymetrix" "Africa" "African"
    "African-American" "African–American" "AgelA" "Agelastatin" "Agendia"
    "Agircan" "Aglaia" "AhR-agonist" "Ahr" "Ai" "Akt#1" "Akt#2" "Akt-dependent"
    "AktATMDSBEGFREGFR" "AktEGFREgr1EMTHCCHGFPI3KSTAT3" "Akti-1" "Akusjärvi"
    "Alexa" "Alk" "Alkhaja" "Allanson" "Allis" "Alzheimer" "Alzheimer's"
    "Alzheimer’s" "Ambros" "America" "American" "Americans" "Ameziane"
    "Aminoethyl" "Amit" "Amplification" "Amsterdam" "Anaplasma" "Andersson"
    "Angiocentric" "Animals" "AnkA" "AnnV" "Anselmi" "AntimiR-21" "Antisense"
    "Antonsson" "Ap" "ApalI" "Apert" "Apoil" "AppTec" "Aquino" "Arbibe"
    "Arcyriarubin" "Arg2616X" "Arginase1" "Arginine-X-Leucine" "Arg→Gln"
    "Arg→His" "Arg→Trp" "Arnoult" "Ashcroft" "Ashkenazi" "Asian"
    "Asian-Pacific" "Asians" "Asp44-Arg290" "Asp49-His115" "Atg12-Atg5"
    "Atg7-knockout" "Atg7-null" "Atkins" "Atom-Weights" "Auer" "Austin"
    "Australia" "Australians" "Austria" "AutoDock" "AxK" "Ayabe" "A‐Raf"
    "A‐raf" "A–4C" "A–E" "A–J" "A–S1C" "A–S1D" "A–S4J" "A–S5G" "A–S6C"
    "A–positive" "A→G" "B-Cdk1" "B-DNA" "B-catenin" "B-form" "B-induced"
    "B-malignancy" "B-type" "B-value" "B1" "B1-induced" "B16F-10" "B2" "B5"
    "B6" "B7H4" "B8" "BAG1L" "BAHD1" "BARX1" "BAX-248GA" "BAY" "BAY11-7085"
    "BC-CUL2-VHL" "BC-p53WT" "BC3-p53KD" "BC3-p53WT" "BCA" "BCAS3" "BCL"
    "BCL2-938C" "BCL2-938CA" "BCMW1" "BCOR-RARA" "BCSS" "BF3" "BGC-823-shHOXA1"
    "BGJ398" "BGT226" "BH3-domain-only" "BH3-only" "BHQ" "BIBR" "BIBR-1532"
    "BIBR-532" "BIM-1" "BIM-I" "BIM-II" "BIM-III" "BIM-IV" "BIM-IX" "BIM-V"
    "BIM-VI" "BIM-X" "BIM-XI" "BIRB1532" "BJ-RASV12" "BJ-SV40T" "BJ-hTERT"
    "BLBCs" "BLM-DNA2-RPA-MRN" "BMjX" "BPEC" "BPECs" "BQ" "BRAC1" "BRACs"
    "BRAF-inhibitor-resistant" "BRAFandPIK3CAexon" "BRB" "BRCA-defective"
    "BRCA1-A" "BRCA1-BRCT" "BRCA2-proficient" "BRCAness" "BRCT-Ab1p"
    "BRCT-Ab1p_short" "BRCT-Ab2p" "BRCT-Ab2p_short" "BRCT-I" "BRCT-II" "BRCT7"
    "BRCT8" "BSP-Luc" "BSX" "BT474R" "BV" "BW" "BY-2" "Babinski" "Bach1"
    "Badve" "Bai" "Baines" "Balmain" "Banck" "Baradaran-Heravi" "Barcelona"
    "Barrett" "Barrett’s" "Bartel" "Basel" "Bax‐induced" "Bax‐positive"
    "Bcl-2-like-2" "Bcl-extra" "Bcl-xl" "Bcl2-to-Bax" "Bclx" "Bcl‐2"
    "Bcl‐2‐associated" "BeadChip" "Beas2-CAG-EGFR" "Begg" "Begg's" "Begg’s"
    "Behcet" "Behcet’s" "Belancio" "Benzene-induced" "Beppu" "Bertero" "Betz"
    "Beyotime" "Bhargava" "Bhaskara" "BiPAP" "Bio" "Biochem" "Biocoat" "Biol"
    "Biosystems" "Birth-weight" "Blackledge" "Bodymap2" "Boerkoel" "Bojang"
    "Bonferroni" "Bonferroni-Holm" "Bonferroni–Holm" "Bor" "Borneo" "Boston"
    "Boyden" "BrCSCs" "Brazilians" "BrdU-PI" "Breslow" "British" "Brower"
    "Browser" "Brucea" "Bryant" "BssHII" "Bub1-concentration-dependent" "Bub3"
    "Burdick" "Burkitt" "Burness" "Burnichon" "Bx" "Bx-PC3" "BxPC3-MYB"
    "BxPC3-Neo" "BxPc3AFR" "BxPc3GEM" "BxPc3GEMR" "BxPc3GMER" "BxPc3OSIR"
    "B‐cell" "B–1D" "C+T" "C+T+S" "C-GSF" "C-allele" "C-domain" "C-extremity"
    "C-lobe" "C-promoting" "C-protocol" "C-region" "C-repeats" "C-rich"
    "C-term" "C-terminally" "C1" "C1085fs" "C18AQ" "C19MC" "C2"
    "C2-independent" "C228Ts" "C250Ts" "C3" "C30" "C57BL6" "C6" "C8" "CA+AA"
    "CACGTG" "CAF-like" "CAFs-CM" "CAF " "CAGTT" "CAP" "CAPERα" "CASC4"
    "CASPASE3-attributable" "CAW" "CB17" "CBC" "CBR-luc" "CC10rtTA" "CC242"
    "CCAT" "CCD841" "CCDN1" "CCL-779" "CCNB1IP1" "CCTTC" "CD-227" "CD-melting"
    "CD151-α3β1" "CD276" "CD34‐negative" "CD44v" "CD90" "CDK-substrate"
    "CDK1-dependent" "CDK1B" "CDK2i" "CDK5signaling" "CECs" "CELF1" "CENP"
    "CENPJ" "CEP-3891" "CEP-peptide-treated" "CEP17" "CEP170-His" "CEP350"
    "CEP6" "CEU" "CFPAC" "CFSs" "CFU‐Fs" "CFinder" "CHE" "CHK1-axis"
    "CHK1-defective" "CHK1-inhibitors" "CHK2i" "CHKA" "CHPv2" "CHR" "CHR-3966"
    "CHROMASS" "CIC-DUX" "CIGB" "CIGB-300" "CIN612" "CK2β" "CKα" "CLBL"
    "CLINICAL" "CLPTM1" "CMVdel1" "CMVdel3–6" "CMVdel4" "CMVdel5" "CNBD1"
    "CNKI" "CNVs" "COAD" "COMFORT" "COMFORT-I" "COMFORT-II" "CONCLUSION"
    "COPD-like" "COPII" "COSM498" "COSMIC" "COSY" "CPD-photolyase" "CPN"
    "CREG1" "CREST" "CRISPR-Cas9" "CRL1-type" "CRL1790" "CRPC" "CS055"
    "CSNK2A1" "CSQT-2" "CT+TT" "CTA091" "CTCA" "CTCCT" "CTCs" "CTR-2" "CTT"
    "CUL1-RING" "CV‐1" "CWR" "CWR22Rv1-Luc" "CX-4945" "CXCL" "CXCLs" "CXCR"
    "CXCR2-CXCL" "CXCR2-antagonists" "CXXC5" "CYP1B1-genotype" "CYP450" "Ca"
    "CaCl" "Caesarean" "CalAM" "Calbiochem" "Calderon" "Calderon-Montano"
    "Calu‐6" "Cambridge" "Capillary" "Cara" "Carlier" "Carroll" "Cascón"
    "Caspse-3" "Castro" "Castro‐Vega" "Catts" "Caucasian" "Caucasians"
    "Cd-activated" "Cd-damaged" "Cd-induced" "Cd-treated" "Cdc42"
    "Cdc42-N17-induced" "Cdc6p" "Cejas" "Cel-I" "Celgene" "CellTiter"
    "Cellurale" "Centaurus" "Centratherum" "Cetrorelix" "Cg" "Cg17627898"
    "ChIP-qPCR" "ChIP–qPCR" "ChTx" "Chang" "Chansu" "Charbord" "Charles" "Chem"
    "ChemiDoc" "ChemiDoc-It" "Cheng" "Chi-Square" "Chi-square" "Child-Pugh"
    "Chk1" "Choi" "Chou" "Chou-Talalay" "Chua" "Chung" "Cic-Dam-ID"
    "Cincinnati" "Cip" "Cip1" "Cipolat" "Cl" "Clara" "Class-I" "CldU"
    "Clear-cell" "Clinical" "ClinicalTrials" "Clontech" "Clt" "CoPP" "Cochrane"
    "Cohen" "Coiled-Coil" "Col2.3" "Coleman" "Colley" "Colony-forming" "Comino"
    "Commonly-changed" "ConSurf" "Concannon" "Conclusions" "Conroy" "Consent"
    "Coomassie" "Cossart" "Cost-effective" "Costello" "Cowden" "Cp-value"
    "CpG14" "CpG34" "Crawford" "Cre-loxP" "Crevel" "Crohn" "Crona"
    "Cross-Sectional" "Cross-sections" "Cross-validation" "Crouzon" "Cruz"
    "CtIP-dependent" "Ctgf" "CuSO4" "Cubas" "Cufflinks" "Cui" "Curcuma"
    "Curley" "Cuzick" "CxxC" "CxxC2" "Cy" "Cy-motif" "Cyc" "Cyp1b" "Cα" "Cδ"
    "C‐A" "C‐A‐C" "C–5E" "C–S3F" "D-D-N" "D-E" "D-domain" "D-limonene" "D-loop"
    "D2" "D2a1" "D3" "D323" "D324" "D32H" "D32N" "D4D6" "D61G-MB231" "D891H"
    "D=0.76" "DBS" "DBS-repair" "DBSs" "DBeQ" "DCDC5" "DCFH" "DCHS2" "DCJ"
    "DE605" "DEXSeq" "DFBWCC" "DFCI024" "DFCI032" "DG" "DHHC" "DJ" "DJ1" "DJ2"
    "DL-Dithiothreitol" "DLD1" "DLD1ATR" "DLX1" "DMAG" "DMAT" "DMCpG" "DMCpGs"
    "DMEM" "DMRs" "DN-K-ras-expressing" "DN-K-ras-reconstituted"
    "DN-K-ras-transfected" "DN3" "DNA*p" "DNA*pF" "DNA-adduct"
    "DNA-damage-inducing" "DNA-protein" "DNAJ17" "DNAp" "DNApF" "DNA‐binding"
    "DNA–DNA" "DNA–PARP1" "DNA–PARP2" "DNA–RAD51" "DNA–SRF–YAP" "DNA–protein"
    "DNA–protein-binding" "DNN" "DNR" "DNp73" "DO-1" "DOE" "DOX" "DPP3" "DPPA2"
    "DR-GFP" "DR1044" "DR1121" "DR1122" "DR1123" "DR1124" "DR158" "DR189"
    "DR663" "DRE" "DSAPGS" "DSBs" "DSGIS" "DUX" "DXM" "Dabbs" "Daf-2A" "Dahia"
    "Dakhlallah" "Dako" "Dalbergia" "Dam-Cic" "Dam-alone" "Dam-only" "DamID"
    "DamID-Seq" "Dammann" "Danes" "Daniels" "Danish" "Darby" "Davidson"
    "Davies" "Day3" "Deeken" "Deelen" "Dekker" "Delcuve" "Deletion" "Denmark"
    "Despites" "Dharmacon" "Dichlorofluorescin" "Dick" "Diego" "Dinkova"
    "Dinkova-Kostova" "Distal-less" "Dl-Gal4" "Dlx" "Dlx1-Dlx6"
    "Dlx3-transcriptional" "Dlx6" "Dna2" "DnaQ" "Doege–Potter's" "Domain-1"
    "Dose-response" "Double-strand" "Double-thymidine" "Dox-treatment"
    "Drosha‐mediated" "Drp1‐induced" "DsbA" "DsbA‐L" "Du" "Duan" "Dulbecco"
    "Dulbecco's" "Dunlop" "Dunnett" "Duolink" "Dysplasia" "E-64d" "E-box"
    "E-boxes" "E-cadhern" "E-caherin" "E-prostanoid" "E12" "E17K" "E19del"
    "E1A" "E1b" "E20ins3" "E20ins3dup" "E2F-retinoblastoma" "E2F1-miR-34c-SCF"
    "E3-ligase" "E4" "E47" "E5" "E6-E7-st-KRAS" "E6-E7-st-KRAS-NSC"
    "E6-E7-st-KRAS-shCXCR2" "E6C" "E6E7" "E6N" "E745-A750" "E746-750"
    "EA-hy926" "EASY-nLC" "EBIO" "EBPα" "EBPδ" "EBUS" "EC50" "EC50 "
    "ECM-receptor" "EDHFs" "EGF-like" "EGF-receptor" "EGFR-ligands"
    "EGFR-pathway" "EGFR1–EGFR4" "EGFR‐TKI" "EGFR‐TKIs" "EGFR‐TKI‐dependent"
    "EGR" "EIF4EBP1s" "EJ5" "EJ5-GFP" "ELISA" "ELISAs" "ELR" "EM900" "EMAP"
    "EMAP-Like" "EMG" "EML" "EML1" "EML1-4" "EML5" "EML6" "EMT-like"
    "EMT-phenotypes" "EMX2" "ENAESEADFSIHF" "EOPE" "EP4-mediated" "EPKs"
    "EPO-HRE" "EQKLISEEDL" "ER-IHC" "ER-negativity" "ER-positivity"
    "ER-transcriptional" "ER-α-FL" "ERCC" "ERE-luciferase" "ERK-MAPK-pathway"
    "ERK-mediated" "ERK-siRNA-transfected" "ERT12" "ERneg" "ERpos"
    "ERα-ligands" "ERα-negativity" "ERαKO" "ERβ-1-specific" "ERβKO"
    "ER‐positive" "ESC-like" "ESE" "ESI-MS" "ESR1mRNA" "ETGE" "ETGF" "EU" "EUS"
    "EUS-FNA" "EV" "EV71" "EXDL2" "EXO1-BLM-RPA-MRN" "Ecadherin" "Edlich"
    "Edmondson" "Edmondson-Steiner" "Edwards" "Edwards-VENN" "Egberts"
    "Egfr-RNAi" "Egger" "Egger's" "Egger’s" "Eggington" "Egr" "Egr1-driven"
    "Egr1-zsGREEN" "Eight-week-old" "Eisenhofer" "Eitan" "El" "El-Hoss"
    "Element-1" "Eliasson" "Elk" "Elk-1-upstream" "Ellis" "Elmbrook" "Elston"
    "Elston-Ellis" "Emory" "EndMT" "Endonuclease" "Endothelia"
    "Endothelial-independent" "Endothelial-mesenchymal" "Engels" "England"
    "English" "Ensembl" "EpRE" "EpREs" "Epithelial-Mesenchymal"
    "Epithelial-mesenchymal" "Epithelial-to-mesenchymal"
    "Epithelial–mesenchymal" "ErbB" "ErbB2-dependent" "ErbB2-driven"
    "Erythropoeitin" "Eskes" "Estaquier" "Estonia" "Ets21c" "Euclidean" "Eun"
    "Euro" "Euro-Brazilians" "Europe" "European" "European-American"
    "Europeans" "Ewing-like" "ExAC" "Exon1–9" "Exonuclease" "Exon‐Specific"
    "Eμ-Myc" "Eμ-myc" "E‐boxes" "E–2G" "E–S2G" "F-actin" "F-fluorodeoxyglucose"
    "F1" "F1-4" "F12-K" "F1662S" "F877L" "FA-R" "FA-like" "FABGdCMP" "FAKi"
    "FANCR" "FBG " "FBLX11" "FBXL11" "FCD" "FDG-PET" "FF4" "FGF-FGFR-HSPG"
    "FGFR1gain" "FGFR1‐4" "FGFR3mRNAdata" "FGFR3mRNAwas" "FGFR3‐TACC3"
    "FGFR3‐directed" "FGFR3‐overexpressed" "FGFR‐inhibitors" "FIGO"
    "FIGO-grade" "FIGO-stage" "FIGO-stages" "FIGO-sub-stages" "FIH-V5" "FIP"
    "FISH" "FKTN" "FLAG" "FLAG-EXD2" "FLAG-PCNT-Myc-rescued" "FLAG-c-FOS-F"
    "FLT3-ITD" "FLT3-dependant" "FMD" "FNA" "FNAs" "FOLDX" "FOLFIRI"
    "FOLFIRINOX" "FOLFOX" "FOPFlash" "FOXOa" "FRA15A" "FRA16D" "FRA6E" "FRA8I"
    "FRAX" "FTL-ARE-A" "FTLD-FUS" "FTLD-MND" "FTLD-TDP" "FTLD-ni" "FTLD-tau"
    "FWD" "FYN3" "Faconi" "Fadri-Moskwik" "Fagerberg" "FancJ" "Fbw7" "FcεRI"
    "FdUMP" "Fe" "Fermentas" "Festa" "Feulgen" "Fifty-six" "Fifty-two"
    "Fifty‐four" "Fig. S1A" "Fig. S1B" "Fig. S2A" "Fig. S2B" "Fig. S2C"
    "Fig. S3B" "Finak" "Finland" "Fishbein" "Five-year" "Flachsbart" "Flag"
    "Flockhart" "Flow-mediated" "Fluka" "Fok" "Fok-I" "FokI" "Follow-up"
    "Follow‐up" "Fontanini" "ForkheadboxO" "Fra" "Fra-1-proficient" "Fragile-X"
    "Framingham" "France" "Franciscan" "Fraumeni" "French" "Frezza" "Frizzled"
    "Froedtert" "Fudan" "Fuhrman" "Fuhrman's" "Fujita" "Fukuyama" "FuncNet"
    "Function-3" "Furga" "Fuzz1" "Fyn-null" "F‐actin" "G-Protein-Receptor"
    "G-actin" "G-elements" "G-quadruplex" "G-quadruplexes" "G-quartet"
    "G-quartets" "G-rich" "G-tract" "G-tracts" "G0" "G0-G1" "G1" "G1-G3-G4"
    "G1-S" "G1-S-phase" "G1-arrest" "G1-cells" "G1-like" "G1-phases"
    "G1-to-S-phase" "G10" "G2" "G2-L3-G2-L1-G2-L2-G2" "G2-M" "G2-dependent"
    "G2-synchronous" "G22" "G22-C30" "G23" "G24" "G24-G28" "G24-G29"
    "G24-selectively" "G25" "G26" "G28" "G29" "G2M" "G3" "G4" "G4-seq" "G49A"
    "G719X" "G8" "G8-G10" "G9" "GA" "GA+AA" "GA-box" "GAAYDIpSQVFPFAKKK" "GAD"
    "GAP-domain-dead" "GATCs" "GATOR1" "GBE" "GBE-Gal80" "GC-element"
    "GC-elements" "GCS" "GC‐box" "GC‐rich" "GEF-induced" "GEGE" "GEMMs"
    "GETAWAY" "GFGEYSRpSPTF" "GFGEYpS" "GFGEYpSRpSPTF" "GFP-Cdc42-N17"
    "GFP-Cdc42-V12" "GFP-Shp2-E76G" "GFP-Shp2-WT" "GFP-lentivirus"
    "GFP‐encoding" "GG" "GG+GT" "GGGAGG" "GGTCAG" "GGTCGG" "GIMAP" "GKN1"
    "GLAM2" "GLGC" "GLS2-ΔC139" "GLS2-ΔN163" "GM-CSF-only" "GOG" "GOG213" "GOM"
    "GPR91-PI3K" "GRCh37" "GROMACS" "GRP91" "GSE15471" "GSE19004" "GSE19665"
    "GSE2127" "GSE28829" "GSE37589" "GSE6764" "GSE9012" "GSE9809" "GSF"
    "GSK3β-KI" "GSM1208659" "GST-Cdc42-G15A" "GST-PIN1-conjugated"
    "GST-WWOXK274R" "GST-WWOXWFPA" "GST–PHD1-S1301A" "GST–PHD1-S130D" "GT+TT"
    "GTEx" "GTF2IRD2" "GTG" "GTGAC" "GTGACTCAGCA" "GVGD" "GWA" "GWASs"
    "Gadolinium" "Gain-of-function" "Galán" "Gandofi" "Gandolfi" "Gap" "Garcia"
    "Garcia-Garcia" "Gartler" "Gastrokine" "Gearhart" "Geffitinib" "GenBank"
    "GenEx" "GenScript" "GeneChip" "Genechem" "Gene–gene" "Genome-wide"
    "Genomes" "Genotype-Tissue" "Genotype-phenotype" "Genotype–phenotype"
    "Georgi" "German" "Germany" "Geva" "Geva-Zatorsky" "Gi" "Gianti" "Gibco"
    "Gilford" "Glu290-Arg44" "Glu643del" "Glutamate" "Goel" "Goodwin" "Google"
    "Gram-negative" "Gram-positive" "Grecchi" "Greek" "Greenberg" "Gretschel"
    "Group2" "Gsk3b" "Guan" "Guerit" "Gutierrez" "GxGxxG" "Gy" "Gómez"
    "Gómez-Villafuertes" "Gö6976" "Gα" "Gβ" "Gβγ" "Gγ" "G‐A‐C" "H&E" "H-HG"
    "H-NG" "H-bond" "H-score" "H-scores" "H-scoring" "H1" "H1297fs" "H1975"
    "H1s" "H2" "H2013" "H2592del" "H2AK119Ub" "H2AK119ub" "H2BK119" "H3"
    "H3-H4" "H3-K36" "H3-acetylation" "H3-containing" "H3-nucleosomes" "H37Ra"
    "H37Rv" "H3K14" "H3K14-ac" "H3K27" "H3K27m2" "H3K36" "H3K36m3"
    "H3K4-specific" "H3K56" "H3K56Ac" "H3K56Q" "H3K56R" "H3K9" "H3K9-Ac"
    "H3K9Ac" "H3K9m2" "H3S10" "H3S10p" "H3k56Ac" "H3pS10" "H4" "H4K16Ac"
    "H4K20" "H4K5" "H4K5-Ac" "H4k16" "H4k16Ac" "H5" "H8" "H875Q" "H875Y"
    "HA-BRCA1-S1164" "HA-BRCA1-S1164mut" "HA-BRCA1wt" "HA-ER-α-FL"
    "HA-ER-α-ΔLBD" "HA-FLAG-tagged" "HA-GnRHR" "HA-Tuba" "HA-Ubi" "HA-mGnRHR"
    "HA-wtBRCA1" "HA1EB-GFP" "HA1EB-GFP-cMYC" "HACs" "HAECs" "HAER-α-FL"
    "HAVSEGTKAVTK" "HBI-8000" "HBSS" "HCCcells" "HCoV" "HCoV-229E"
    "HCoV-229E-induced" "HDA1" "HDAC1-associated" "HDAC3-Ser-424" "HDAC5s"
    "HDACs1" "HDFP" "HDFs" "HDL2-cholesterol" "HDL3-cholesterol" "HDPE"
    "HDPE-E6E7" "HEC50B" "HEG-5" "HEK-MOCK" "HELP-WD" "HER2-E" "HER2-OE"
    "HER2-postive" "HER2agents" "HER2neg" "HER2pos" "HER2‐negative"
    "HER2‐positive" "HER2‐targeted" "HFF" "HFFs" "HFK" "HFK-16" "HFK-18"
    "HFK-31" "HFKs" "HG-U133" "HGF‐induced" "HGF‐treated" "HIBECs" "HIF"
    "HIF-hydroxylase" "HIF1-α" "HIF1-α-dependent" "HIF1-α-mediated" "HIF‐2α"
    "HITS-CLIP" "HL-7702" "HL7702" "HLA-A26" "HLA-B51" "HLA-DRα" "HLA-DRβ"
    "HLECs" "HME" "HMGCR-mevalonate" "HMLE" "HMVECs" "HNSCCs" "HO-1-null"
    "HOTTIP" "HOX424" "HOXA1-and" "HOXA1-or" "HPAF-scram" "HPNE" "HPRT" "HPV8"
    "HPVE" "HPVE6E7-immortalized" "HPV‐negative" "HPV‐positive" "HQ"
    "HR-Defective" "HR-Mlu1" "HR-MluI" "HR-defective" "HR-proficient" "HR=0.24"
    "HR=2.3" "HR=3.8" "HRM-MS-qPCR" "HRs" "HS587-T" "HSCORE" "HSCOREs" "HSPB"
    "HSPB1-HSPB10" "HSPH" "HSQC" "HSQCs" "HSV-1" "HT1080" "HT256"
    "HT29-C25-injected" "HTRF" "Haenzel" "Hagelkruys" "Hagenbuchner" "Haigis"
    "Hamon" "Haokip" "HapMap" "HapMap-CEU" "HapMap3" "Haploview"
    "Hardy-Weinberg" "Hardy–Weinberg" "Harner" "Hartgrink" "Harvard" "Harvey"
    "Hayashi" "Hayes" "Hazza" "HdCDT" "HeLa-RhoA-N19" "HeLa-RhoA-V14" "Hebei"
    "Helsinki" "Henikoff" "Hepa1c1c7" "HepaRGcells" "Hepatocyte-derived" "Her2"
    "Heravi" "Hericium" "HhH" "HiB5" "HiSeq" "High-risk" "High‐order"
    "Hippo-YAP" "His-BRCA1" "His-CEP170" "His-Hdm2" "His-Plk1" "His-UBE4B"
    "His-pull" "His-sepharose" "His-ubiquitin" "Hispanic" "Hodgkin" "Hoechst"
    "Hoff" "Hohenberger" "Holliday" "Holm" "Homologene" "Hoogeveen"
    "Hoogeveen‐Westerveld" "Hoogsteen" "Hoppins" "Hoss" "Hossain" "Hotchkiss"
    "Hpv16E7" "Hs294" "Hsa-miR-145" "Hsu" "Hu" "Huang" "Huber" "Huebner"
    "Huh7cells" "Huh7‐soR" "Hui" "HumanHap550" "HumanMethylation450"
    "HumanMethylation450K" "HumanOmniExpress" "Huntington" "Huntington’s"
    "Hurley" "Hutchinson" "Hypoxyprobe" "H‐score" "I-DNA" "I-II" "I-IV"
    "I-Mutant" "I-PpoI" "I-Sce-I" "I-fold" "I-motif" "I-selective" "I16fs"
    "IAA" "IALT" "IALT-Bio" "IBECs" "IC1000" "IC50" "ICGC" "ICL-agents" "ICN1"
    "ICON7" "ICRF-187" "IFHIF-1α" "IFN-γ-pretreatment" "IFNλ2" "IFNλ3" "IFNλ3 "
    "IFNλs" "IHC-negative" "IHC-positive" "IHC4" "IHCs" "II-IIIA" "II-V"
    "II-p135" "IIA" "III-IV" "IIIA" "III‐driven" "III–IV" "IIc" "IIhad" "IIα"
    "IIβ" "IIβ-binding" "IKKs" "IKKɛ" "IL-10-dependent" "IL-13Rɑ1" "IL-17α"
    "IL-1receptor" "IL-1β-stimulated" "IL-32α" "IL-32β" "IL-32γ" "IL-32θ"
    "IL-32θ-His" "IL-4-mediated" "IL-4Rɑ" "IL-6-651" "IL-alpha" "IL-beta"
    "IL1F5" "IL2gamma" "ILGR5" "ILPR" "IL‐1β" "IL‐1β+PDTC" "IL‐1β‐stimulated"
    "IM3829" "INBHA" "IP-MS" "IPHC-CT" "IPI-504" "IPND" "IR-A" "IR-B" "IRB"
    "IRDye700DX" "IRES‐dependent" "IRES‐mediated" "IRS2-dependent" "ISG" "ISGs"
    "ITC" "IU" "IVIS" "IVR" "IVS" "IVS28-159A" "IX71" "IbTx" "Iceland"
    "Icelanders" "Icelandic" "IgE-antigen" "IgG-like" "Ijichi" "Illumina"
    "Image-Pro" "ImageJ" "Imager" "In-vitro" "Inc" "Ince" "Indians" "Infinium"
    "Inoki" "Inr" "Ins2Akita" "Insert" "Insertion" "Institute–National"
    "Insulin" "Invitrogen" "Iosub" "Iosub-Amir" "Iranians" "Ishii" "Iwamoto"
    "IĸBα" "IκBα-SR-cDNA" "IκBα-SR-cDNA-transfected" "IκΒ" "I–II" "I–III"
    "I–IV" "J-induced" "J-mediated" "J00277" "JAK2-independent"
    "JAK3-dependent" "JAKT2" "JHU" "JHUC-1" "JHU_Q1" "JHU_Q3" "JNJ"
    "JNJ-26481585" "JPT" "JQ" "JQ1" "JUN-D" "JUNB" "JUND" "JX" "JX682562-TT"
    "JZ" "Jackson" "Jacquemont" "Jakobs" "Jalouli" "Jamshid" "Jang" "Jans"
    "Jansen" "Janus-like" "Japanese" "Jeb" "Jenuwein" "Jewell" "Jewish" "Jiang"
    "Jiangsu" "Jiao" "Jolma" "Jong" "Jong-Eun" "Joseph" "Joseph’s"
    "Juglandaceae" "Juglans" "Juglanthraquinone" "Juhlin" "Jα" "Jβ1" "Jβ2"
    "K-M" "K0R0" "K9" "K954Qfs" "K954Qfs*6" "KAT11" "KAVTKAQK" "KCNN1-3"
    "KDM2B-1" "KDM2B-2" "KDMs" "KF" "KF848660-CC" "KG" "KI-H6" "KIF1Bb" "KKU"
    "KKU-213" "KKU-214" "KLM1-R" "KMTs" "KNK43" "KO-Ad-GFP-infected"
    "KO-Ad-WWOX" "KO-Ad-WWOX-infected" "KO-MEFs" "KP3" "KRAS-NSC" "KRAS-PDAC"
    "KRAS-shCXCR2" "KRAS4A" "KRAS4B" "KRASmutant" "KRC-00509" "KRC-00715"
    "KRCA" "KRCA-0080" "KRRAS4B" "KU55933‐mediated" "KU55993" "KU58948"
    "Kamohara" "Kanaya" "Kang" "Kaplan" "Kaplan-Meier" "Kaplan–Meier"
    "Kaplan–Meier–Plotter" "Karbowski" "Karin" "Karnoub" "Katsuhiro" "Kaunas"
    "Kawecki" "Kd" "Kelch" "Khare" "Ki-67" "Kilbride" "Kim" "Kimura" "Kinex"
    "Kip" "Kirsten" "Kluck" "Knock-down" "Knockdown-replacement"
    "Knocking-down" "Koga" "Kokichi" "Kolanczyk" "Koo" "Kopp" "Korea" "Korean"
    "Korsakoff" "Korsmeyer" "Kosaka" "Kossa" "Kostova" "Kotiadis" "Kralovicova"
    "Kras" "Kras-driven" "Krebs" "Kroemer" "Kruskal-Wallis" "Krüppel‐like"
    "Kumar" "Kunderfranco" "Kuorilehto" "Kupperwasser" "Kuwana" "Kv" "Kyoto"
    "Kühnisch" "L-AHA" "L-SFN" "L-X-X-Q-D-X-D-L-G" "L-azidohomoalanine"
    "L-dopa" "L-ferritin" "L-norvaline" "L-type" "L1" "L1-related" "L1RP" "L2"
    "L4" "L463–F468" "L51" "L52" "L858R" "L875A-N879A"
    "L875A-N879A-G1001A-Y1003A" "LA7" "LA7-induced" "LBD" "LC3-I" "LC3B-I"
    "LC3B-II" "LC3I" "LC3II" "LDK" "LDK-378" "LDL-cholesterol" "LI-03-0012"
    "LI-03-0155" "LI-03-0191" "LI-03-0257" "LIVE" "LKB1-deficent" "LKB1-null"
    "LKB1-shRNA-treated" "LM-P" "LMCs" "LNA-antimiR-21"
    "LNA-antimiR-21-induced" "LNA-antimiR-21-mediated" "LNM" "LOC100131726"
    "LOPE" "LOPE " "LOVD" "LOXtg" "LR" "LR-χ" "LSDB" "LTag" "LUAD" "LUM-A"
    "LUM-B" "LV+S" "LVEDV" "LVEF" "LVH" "LVI" "LVIDd" "LW" "LX142.3" "LX49.3"
    "LY29004" "LacZ" "Laemmli" "Laere" "Lag-1" "Lai" "Lamph" "Large-scale"
    "Lauren" "Lauren's" "Lauren’s" "Laurén" "Lebreton" "Lectin-like"
    "Leguminosae" "Leiden" "Letouzé" "Leukoencephalopathy" "Li" "Li-Fraumeni"
    "Life" "Limma" "LincRNA-p21" "Lineweaver" "Lineweaver-Burke" "Linqu"
    "Lipinski" "Lipinski’s" "Lipofectamine" "Liu" "Lize" "Lkb1" "Log-rank"
    "LogP3" "Lonati" "Long-lived" "Loss-of-function" "Loupakis" "Ltd" "Lu"
    "Luchetti" "Luke" "Luke’s" "Lum" "Luminex" "Luo" "Lutay" "Lutheran" "LxxLL"
    "Lyon" "M-FISH" "M-carboxycinnamic" "M-forming" "M-like" "M-phases"
    "M-specific" "M1663K" "M2-macrophages" "M5E1" "M6P" "M896V" "MAC"
    "MAC-specific" "MACs" "MAKP" "MAKP-activated" "MAPK-dependent"
    "MAPK-pathway" "MAPK→PNTP2" "MARCM" "MATE-2K" "MATE-mediated"
    "MATE-related" "MATLAB" "MC-MS" "MCC-HI" "MCC-HIs" "MCC-His" "MCC-LO"
    "MCDB" "MCDB-170" "MCF-10" "MCF10A-HER2" "MCF7-shEV" "MCF7-shWWOX" "MCL1L"
    "MCN" "MCW" "MDA-2131-4" "MDA-2131-5" "MDA-2131-8" "MDA-513"
    "MDA-MB231carcinoma" "MDA-MD-231" "MDA-MD-IBC-3" "MDCK-F-cells" "MDpocket"
    "MEK-RNAi" "MEK-siRNA-transfected" "MEK1-ΔN3EE" "MELD" "MELT" "MEM" "MEME"
    "MEMO-PCR" "MESA-RV" "MEpiCM" "MGA" "MGB" "MGC" "MGC80-3" "MGCD01030"
    "MGH006" "MHC" "MHC-β" "MIB" "MIB‐1" "MICOS" "MIFF" "MIFF1" "MIFF3" "MIFF4"
    "MINDACT" "MIZ‐1‐mediated" "MLJ1" "MLRA" "MM" "MMS417" "MMSE" "MMTV-NeuT"
    "MND" "MO-to-DC" "MO-to-MAC" "MO-to-OC" "MO-to-iDC" "MO-to-iDCs"
    "MO-to-iMAC" "MO-to-iMACs" "MODEL" "MOI" "MONETA" "MRD" "MRN-complex"
    "MRTFA" "MRTFB" "MRYIL" "MS" "MS-HPLC" "MSC-CM" "MSCcultures" "MSigDB"
    "MTIIA" "MTS" "MVs" "MV‐soR" "MX1D" "MX1M" "MX1P" "MYB-QKI5" "MYB-QKI6"
    "MYB-overexpressing" "MYB-promoter" "MYBtr" "MYCN‐amplified"
    "MYC‐dependent" "MYC‐driven" "MYC‐induced" "MYC‐mediated"
    "MYC‐overexpressing" "MYC‐regulated" "MYC‐specific" "MYND" "MYO3A"
    "MaSC-like" "Madin" "Madin–Darby" "Magdeburg" "Magombedze" "Malaysia"
    "Maloney" "Malpica" "Malsburg" "Maml" "MammaPrint" "Manon" "Mansha"
    "Mantel-Cox" "Mantel–Haenzel" "Manyam" "MapQuant" "MapQuant-negative"
    "MapQuant-positive" "MapQuant-test" "MapQuant-undetermined" "Maria" "Marr"
    "Martinez" "Martino" "Martinou" "Mary" "Mary-X" "Marzo" "Mas" "Masago"
    "Massachusetts" "Masson" "Masson's" "Material" "Matsunaga" "Matsuo"
    "Mattson" "MaxQuant" "Mayer" "McBride" "McClung" "Mdm2-null" "MeCP1"
    "MedCalc" "Medicines@Taiwan" "Mediterranean" "Mediterranean’s" "Meier"
    "Meigs" "Mel1011" "Meliaceae" "Menlo" "Menten" "Meprin" "Merck" "Merkel"
    "Messeguer" "Met-CCL5" "Metabochip" "Metavir" "Methodology" "Methods"
    "Methylanthraniloyl" "Met‐dependent" "Mfold" "Mi2" "Mi2-β" "Mi2β" "MiR-100"
    "MiR-148a" "MiR-214" "MiR-21expression" "MiR-24" "MiR-497" "MiR200"
    "MiRNA-21" "MiRStart" "MiSeq" "MiaPaCa" "MiaPaCa-NT-Scr" "MiaPaCa-shMYB"
    "MiaPaca-Scr" "Mic60" "Michael" "Michaelis" "Michaelis-Menten" "Michele"
    "Michrom" "MicroRNA-140" "MicroRNA-29" "MicroRNA-29b" "Middlebrook"
    "Midwest" "Miglietta" "Mig‐6" "Mihaylova" "Milford" "Millan" "Milli"
    "Milli-Q" "Millipore" "Milwaukee" "Mini-Mental" "Mir717" "Misaki"
    "Missiaglia" "MitoPY1" "Mitsuhashi" "Mitsuishi" "Mock-treated" "Mok"
    "Moldoveanu" "Monick" "Monocyte" "Montano" "Montessuit" "Morecroft"
    "Mori-Iwamoto" "Morrison" "Mortazavi" "Moskwik" "Mossevelde" "MslI" "Mu"
    "MuTect" "Munshi" "Murai" "Mut1091" "Mut845" "Myc-Rac1-G12V"
    "Myc-Rac1-T17N" "Myc-immunoprecipitation" "Myc-tag" "Myc_B" "Myc_C"
    "Mycobaterium" "Myc‐driven" "Müller" "Mφ" "N-CoRδ" "N-CoRω"
    "N-GlcNAcylation" "N-HG" "N-HTT" "N-NG" "N-SH2" "N-SH2-associated"
    "N-X-E-T" "N-X-S" "N-acetylglucosamine-6-sulfatase" "N-edited" "N-end"
    "N-extremity" "N-glycoprotein" "N-labeled" "N-linked" "N-lobe" "N-methyl-N"
    "N-myristoylation" "N-nitrosobutyl" "N0" "N0–1" "N0–2" "N2–3" "N3-11"
    "N4-11" "N4-3" "N=24" "N=27" "N=45" "NA07022" "NAB2ex2‐STAT6ex2" "NAB2ex4"
    "NAB2ex4‐STAT6ex2" "NAB2ex4‐STAT6ex3" "NAB2ex4‐STAT6ex5"
    "NAB2ex6‐STAT6ex16" "NAB2ex6‐STAT6ex17" "NAB2ex6‐STAT6ex18"
    "NAB2ex7‐STAT6ex3" "NAB2‐STAT6" "NAB2‐STAT6fusion" "NAGM" "NAP" "NCBI"
    "NCI" "NCI-H522" "NCID" "NCM-460" "NCSLC" "NCT01323751" "NCT02189343"
    "NDY1" "NEAT1" "NEAT1-1" "NEAT1-2" "NEAT1-miR-107-CDK6" "NESvSrc" "NF-κB1"
    "NF2-null" "NFAT-NF" "NFAT-RE" "NFAT5-deficient" "NFKBID" "NFkappaB1"
    "NF‐κB" "NF‐κΒ" "NGFI" "NGS‐based" "NH" "NHANES" "NHCH" "NHF1" "NHLBI"
    "NHPAs" "NICD2" "NIH3T3vSrc" "NIH‐3T3" "NKI" "NLSvSrc" "NM_002875"
    "NM_033358" "NNK" "NOESY" "NOXs" "NPVof" "NRF2-ARE" "NRF2-MAFG-DNA"
    "NRF2-Notch" "NRF2-dependent" "NRF2-homo-1498" "NRF2-small" "NRF2–DNA"
    "NSABP" "NSC0" "NSC5" "NSH2" "NT157" "NTHi" "NTUH" "NUTH" "NVP-AWE-541"
    "Nagelkerke" "Naito" "Nano-LC-MS" "Nava" "Nayler" "Nayler’s" "Nc" "Ndong"
    "Nechushtan" "Neh" "Neh3" "Neh4" "Neh4-5" "Neh5" "Neh6" "Neh7" "NetGestalt"
    "Netherlands" "Netrins" "Neu" "NeuT" "Newcastle" "Next-generation"
    "Nf1Col1" "Nf1Prx1" "Ni-NTA" "Nikzamir" "Ninety-four" "Nishida" "Nisoli"
    "Node-positive" "Nogueira" "Non‐small‐cell" "Noonan" "Norazmi" "Normal"
    "Northrup" "Notch" "Notch-driven" "Notch-induced" "Notch-mutant"
    "Nottingham" "Novartis" "Nox" "Nras" "Nrf2" "Nrf2-ARE" "Nrf2-ARE-driven"
    "Nrf2-Keap1" "Nrf2-sMaf" "NspI" "NuRD" "Nygaard" "N = 7" "Nückel"
    "O-GlcNAcylated" "O-GlcNAcylation" "O-GlcNAcyltransferase" "O-linked" "O15"
    "O2b" "O2b1" "O3" "O3-M122" "OA-like" "OC" "OCEANS" "OCT" "OCVAR-3" "OD1"
    "OD2" "ODN-1" "ODN-2" "ODN-3" "ODYA" "OGTT" "OMIM" "OMVs" "OPSCC" "OR=0.70"
    "OR=0.76" "OR=0.78" "OR=0.83" "OR=0.87" "ORF1p-GFP" "ORR" "ORs" "OSE7"
    "OSHazard" "OSI" "OSI-744" "OV1002" "OVCA3" "OVCAR" "OVCAR-429" "Objective"
    "Okazaki" "Oliviero" "Olsson" "Olympus" "Omics" "OmniExpress" "Omomyc"
    "OncoCarta" "Oncology" "Oncomine" "Oncopanel" "Oncotarget" "Oncotype"
    "OncotypeDX" "Onotology" "OptiPak" "Orantinib" "Organista" "Organista-Nava"
    "Ortega" "Osborne" "OsteoDiff" "Oudijk" "Owen" "Oxford" "Ozgo" "P+1" "P0"
    "P1" "P13K" "P2" "P278L" "P2X" "P2X7R" "P2X7Rs" "P2Y" "P7" "P9103-71"
    "P=0.000" "P=0.0003" "P=0.0005" "P=0.0006" "P=0.0008" "P=0.001" "P=0.002"
    "P=0.003" "P=0.004" "P=0.005" "P=0.0073" "P=0.008" "P=0.0081" "P=0.0087"
    "P=0.011" "P=0.015" "P=0.021" "P=0.025" "P=0.0258" "P=0.030" "P=0.034"
    "P=0.035" "P=0.038" "P=0.0454" "P=0.052" "P=0.078" "P=0.0817" "P=0.256"
    "P=0.265" "P=0.289" "P=0.851" "PAH-DNA" "PAH-DNA-positive" "PAH-adduct"
    "PAM50" "PANC" "PANC-1-R" "PAPR1" "PARP1–DNA" "PARP2–DNA" "PARPi" "PARPis"
    "PARP–DNA" "PBST" "PBuA" "PCA" "PCC-SUM1315" "PCCs" "PCFG1" "PCGF"
    "PCI-24781" "PCNA-like" "PCR-RFLP" "PCR–Sanger" "PC‐9" "PD18" "PD21" "PD25"
    "PD30" "PD41" "PD44" "PD47" "PD6" "PD8" "PDKs" "PDPSKSAPAPKKGSKKAVTKAQK"
    "PDS" "PDX4" "PDX7" "PEG-300" "PEG-catalase-inhibitable" "PEPAKSAPAPK"
    "PER-ARNT-SIM" "PETACC3" "PF-04217903" "PF-956980" "PGCC" "PGCCs" "PHA"
    "PHA-767491" "PHD1-S130A" "PHD1-S130A–GFP" "PHD1-S130A–GFP-transfected"
    "PHD1-S130D" "PHD1-S130D­–GFP" "PHD1-S130D–GFP" "PHD1–HIFα" "PI-negative"
    "PI3K-cascade" "PI3K-pathway" "PI3KCA" "PIK3R1-BT-474" "PIMO" "PIP-like"
    "PK59" "PKCβI" "PKCβII" "PKCη" "PKCθ" "PKCι" "PKCλ" "PKM1" "PKT" "PLC3"
    "PLEs" "PLGGs" "PLX4720-BEZ235" "PLX4720-BEZ25" "PMID" "PNAS" "PNTP1"
    "PNTP2" "POLD1-depletedATR" "PPARγ2" "PPGL" "PPGLs" "PR-IHC"
    "PRC1-mediated" "PRCKQ" "PRIDE" "PROMO" "PROVEAN" "PRR12" "PRpos" "PSE"
    "PT-45" "PTENP" "PTENP1-expressing" "PTENloss" "PTEN‐negative" "PTF" "PVTT"
    "PVTTs" "PX-12" "PXD001737" "PaTu2" "Pab1801" "Padmanabhan" "Pagano"
    "Paget" "Paget's" "Pahan" "Pakistan" "Pakistani" "PalmB" "Palmostatin"
    "Pan-Cancer" "Pan-nuclear" "Panc1-NT-Scr" "Panc1-shMYB" "Pandit" "Paola"
    "Papathomas" "Parikh" "Parker" "Parkinson" "Parone" "Patel"
    "Pathway-enrichment" "Pawlak" "Pawlikowska" "Pearson" "Pearson's" "Peng"
    "PeproTech" "Peptide-Spectrum" "Peptidyl-prolyl" "Per-Arnt-Sim" "Perego"
    "Pfizer" "PfpI" "Phe19A" "Phellinus" "PhenDC" "PhiX174" "Philadelphia"
    "Philips" "Phosphatase" "PhosphoNET" "PhosphoSitePlus"
    "Phosphosite-specific" "Photoimmunotherapy" "Phung" "Pickett" "Pillai"
    "Pittsburgh" "Pladeinolide" "Platz" "PluriTest" "Pollack" "Polo-box"
    "PolyPhen" "PolyPhen2" "Polyak" "Polyphen2" "Polysomy" "Pragnell" "Premix"
    "Primaria" "PrimeScript" "Principal" "Pro-angiogenic" "Pro-inflammatory"
    "Pro-malignant" "Procoagulant" "PrognoScan" "Proietti" "Promega" "Protein"
    "Protein-tyrosine" "ProteomeXchange" "Pten" "Pu" "PubChem" "Pugh" "Punga"
    "Purkinje" "Purohit" "PvuII" "PyVmT" "P = 0.001" "P = 0.005" "Q-statistic"
    "Q1SA" "Q3" "Q3E1" "Q3SA" "Q3SC" "Q3SE" "Q3SE1" "Q3SE2" "Q3SG" "Q3SI"
    "Q7L989" "QGRS" "QRT‐PCR" "QVD" "Qiagen" "Qiang" "Qiang’s" "Qiao" "Qk"
    "Quad610" "QuantiMORE" "Quecetin" "Quinn" "R-spine" "R0" "R1" "R1302fs"
    "R1670E" "R248W" "R2598X" "R367" "R370" "R371" "R53A" "R54A" "R618X"
    "R681X" "R7BP" "RAD51-ATP-DNA" "RAD51–DNA" "RAD6" "RAF-inhibitor-induced"
    "RAF-signalling" "RALDH" "RANKL-mediated" "RASGFR1" "RASS10" "RASSF1B"
    "RASSF1C" "RASSF1D" "RASSF1E" "RASSF1F" "RASSF1G" "RB-null" "RB-regulated"
    "RBE-siIRS2" "RBE-siTFDP1" "RBE-siTFDP1cells" "RC170N" "RCGTG" "RD-Gi"
    "RD-Sc" "RDF" "REACTOME" "REMBRANDT" "RFLP" "RHC-80267" "RHPS4" "RIPA" "RJ"
    "RKRL" "RL-34" "RLP26" "RMSD" "RMSDs" "RMSF" "RMSFs" "RNA" "RNA-dependent"
    "RNA-like" "RNA-protein" "RNA-seq" "RNAfast" "RNAi‐based" "RNA‐binding"
    "RNA‐seq" "ROIs" "RPL" "RPMI-1640" "RPMI2650" "RRMS" "RSEM" "RTV" "RT‐PCR"
    "RUNX1T1" "RUVL2B" "RVAWT" "RVDA" "RVFAC" "RVIDd" "RVSP" "Rab5"
    "Rab7-mediated" "Rac1-GDP" "Rac1-GTP" "Rac1-ΔC33" "Rac1-ΔN29"
    "Rac1-ΔSwitch" "Rad3" "Rad3-related" "Rad51-ssDNA" "Rad9A-dependend"
    "Radiation-induced" "Radkov" "Raf-transformed" "Rafiee" "Rag" "Ragulator"
    "Ragulator-Rag" "RanGDP" "Rane" "Rank" "Ras-Myc-CyclinD-Rb" "Ras-RNAi"
    "Ras-association" "Ras-down-stream" "Ras-like" "Ras-transformed" "Rb"
    "Re-analyzing" "Re-expression" "Re-introduction" "Re-replication" "RefSeq"
    "Regulus" "Reiman" "Reis" "RelA" "Renaud" "Renault" "Renna" "Results"
    "Rho-GDP" "Rho-GTP" "Rho-family" "RhoA-GTP" "RhoA-N19" "RhoA-V14" "Rhodes"
    "Rhodopsin" "Rhodopsin-like" "Rhus" "Ricciardiello" "Ricolinostat" "Ridley"
    "Riley" "Roche" "Rodgers" "Roepman" "Roh" "Rohde" "Romani" "Romania"
    "Roock" "Rosa26" "Rosell" "Roswell" "Roth" "Rotterdam" "Rountree" "Rous"
    "RpSPVF" "Rs9400239" "Rs9486902" "RsaI" "Rubinsztein" "Rushmore" "Russia"
    "Rutten" "RuvA" "Rv0386" "Rüschoff" "S-Adenosyl" "S-G-E" "S-labelled"
    "S-palmitoylation" "S-phases" "S1" "S1-S2" "S1-S36" "S1-S4" "S10H3" "S1164"
    "S1189" "S1191" "S127" "S1282_G1285delinsR" "S1282delins" "S1377"
    "S1377mut" "S1981" "S1C-D" "S1D" "S1E" "S1c" "S2259" "S2A-B" "S2B" "S2C"
    "S2C-D" "S2D" "S2E" "S2a" "S2a-e" "S2a–d" "S2b" "S2d" "S3" "S3B-C" "S3I"
    "S3c" "S3d" "S4" "S473" "S4A" "S4A-B" "S4B" "S4C" "S4D" "S4E" "S4F" "S5-S6"
    "S5A" "S5A–D" "S5C" "S5a" "S6" "S6-specific" "S6A-C" "S6K‐T389" "S6a-b"
    "S7" "S7-S8" "S7B" "S7C" "S7D" "S7a" "S8" "S8-S9" "S889G" "S8a-b" "S8b"
    "S9" "S969" "S969-Bub1" "SAPAPKKGSK" "SAS13.0" "SAhRM" "SAhRMs" "SB203508"
    "SB939" "SBR-EE" "SC-like" "SCDFinder" "SCFβ-TrCP" "SCH-479833"
    "SCH-900776" "SCM-like" "SCNV" "SCNVs" "SDHx" "SDS-polyacrylamide" "SEC31B"
    "SELEX" "SEQUEST" "SFT‐like" "SG4110-16" "SG4110-18" "SGC"
    "SGC-7901-shHOXA1" "SGC-7901cells" "SGC-803" "SGS6" "SH2-LD" "SHIFTX"
    "SHO-SCID" "SHP2-D61G-MB231" "SHP2SHP2-D61G-MB231" "SI27" "SI6" "SIFT"
    "SILAC-based" "SIMs" "SIOD" "SIRTs" "SIRTs1" "SK-Mel119" "SKBR"
    "SKBR3-ERB#3" "SKBR3R" "SM" "SMARTpool" "SN28" "SNP" "SNPin" "SNPinfo"
    "SNPs" "SNU" "SNU-620" "SNU1079-IRS2" "SNUI079" "SNVs" "SOS" "SPSS" "SPxF"
    "SR" "SR-3306" "SRC-family" "SRC251" "SRC251T175L" "SRCY" "SRCY527F-GFP"
    "SRCY527F-GFP-expressing" "SRCY527FΔSH2" "SRCY527FΔSH2-GFP"
    "SRCY527F∆SH2-GFP" "SRC∆SH2-GFP" "SRF–MRTF" "SRF–MRTF-binding"
    "SRF–MRTF-responsive" "SRF–YAP" "SRF–YAP-induced" "SRF–YAP–IL6" "SRs"
    "SSCs" "SSEA4" "SSLD" "SSLD-294" "SSLD294" "SSNV" "SSNVs" "SSO-PEBP" "SSc"
    "STA5b" "STAT-DNA" "STAT5s" "STAT6VT" "STE-1" "STE20-like" "STGE" "STUbLs"
    "SU1124" "SU1127" "SUD-DHL-4" "SUMO-KAP1" "SUMO-like"
    "SUMOylation‐dependent" "SUMO‐1" "SUN1079" "SVA-D" "SVA-E" "SVA-E-positive"
    "SW1080" "SW1900" "SYBR" "SYK-mediated" "Sabatini" "Sabatini's" "Sadaat"
    "Sadahiro" "Saengboonmee" "Sagi" "Saharan" "Sakai" "Sami" "Sampson"
    "Sancak" "Sanger" "Sanjiv" "Scandinavia" "Scarff-Bloom-Richardson" "Sce"
    "Schafer" "Schafranek" "Scheffler" "Schellenberg" "Schiebel" "Schiff"
    "Schimke" "Schinzel" "Schlisio" "Schwann" "Scientific" "Scorrano" "Scr"
    "Scr-peptide-treated" "Sean" "Seckel" "Second-generation"
    "Second‐generation" "Secord" "Secretin" "Segal" "Self-Renewal"
    "Self-renewal" "Selleckchem" "Selumetinib" "Semecarpus" "Sen" "Sendai"
    "Seo" "Seq" "Sequence-related" "Ser1164" "Ser1189" "Ser154residue" "Ser199"
    "Ser314" "Ser4" "Ser769" "Serdementan" "Serezani" "Serono" "Sertoli"
    "Serverand" "Seventy‐five" "Sf3b" "Shandong" "Sharma" "Shef5N" "Shelton"
    "Shen" "Short-130" "Shp2-E76G-expressing" "Shp2-E76G-induced"
    "Shp2-E76G-mediated" "Shukla" "SiSRSF2" "Sichuan" "Sidak" "Siena" "Siewert"
    "Sigma-Aldrich" "Significance" "Silwal-Pandit" "Simms" "Simplex" "Sina"
    "Single-allelic" "Single-cell" "Single-nucleotide" "Sinicrope" "Siravegna"
    "Sirius" "Sixty-one" "Sixty‐four" "Skopje" "Skp1-Cul1-F-box" "Slovenians"
    "Smad" "Smad2" "Smad3D407E" "Smads" "Small-animal" "Smoothened" "SnPP"
    "Snail" "Soerensen" "Solanum" "Soong" "Sowa" "Sp1" "Sp1‐binding"
    "Sp1‐dependent" "Sp1‐induced" "Sp1‐mediated" "Sp1‐specific" "SpIDA" "Spain"
    "Spanish" "Sparmann" "Spd" "Spearman" "SpeedVac"
    "Spt‐Ada‐Gcn5‐acetyltransferase" "Src" "Src-dependent" "Src-family"
    "Src-homology-2" "Src-kinase-dependent" "Stabel" "Steiner" "Stk11"
    "Stranges" "Stress-induced" "Stylonychia" "Sub-interface" "Sudemycin"
    "Sueda" "Sugano" "Sugie" "Super-enhancer" "Superdex" "Superdex-200"
    "Superose" "Superti" "Superti-Furga" "Superti-Furga's" "Sur" "SureFIND"
    "Suresh" "Suzuki" "Sweden" "Switzerland" "Szabo" "T-allele" "T-alleles"
    "T-dual" "T-helper" "T1" "T1-2N0M0" "T1-2N1M0" "T1-4N0-2M1" "T1-4N2M0"
    "T1-weighed" "T120-H2A" "T185" "T188" "T190" "T1D" "T1DM" "T2"
    "T2-weighted" "T207" "T2D" "T2DM" "T2N0M0" "T2WI-MRI" "T2w" "T3" "T3-11"
    "T308" "T3N0-1M0" "T4" "T4-11" "T4-3" "T4N0-2M0" "T4b" "T7" "T790M" "T7E1"
    "T878A" "T919S" "TAE" "TAE-684" "TALENs" "TALENs-mediated" "TATA"
    "TATA‐less" "TAZ-induced" "TAZ-miR-130" "TAp63γ" "TAp73" "TAp73's" "TAp73α"
    "TB32047" "TBK" "TBK1-1-294" "TBNC" "TBST" "TCAG" "TCAGCA" "TCG" "TCRα"
    "TCRβ-V" "TEAD-binding-deficient" "TEADs" "TEAD–YAP" "TEAD–YAP-mediated"
    "TEPP" "TEPP-46" "TF3" "TF3+DAPT" "TFII" "TFII-IΔNLS" "TF‐binding" "TGAATG"
    "TGAATGAA" "TGAC" "TGACDHDGC" "TGACTCAGCA" "TGAG" "TGCTGA" "TGFRB3" "TGG"
    "TIAM2L" "TIAM2S" "TIDM" "TKDs" "TKI‐dependent" "TKOμ" "TMDQ" "TMEM106B"
    "TMPS" "TMR-dextran" "TNF-ɑ" "TNF‐related" "TNF‐α" "TNF‐α+PDTC"
    "TNF‐α‐stimulated" "TOP" "TOPFlash" "TPA" "TR-FRET" "TRA-1-60" "TRA-1-81"
    "TRANS-AM" "TRBV" "TRBV13-2" "TRBV15" "TRBV16-Jβ1" "TRBV16-Jβ2" "TRBV19"
    "TSC‐causing" "TSS200" "TTCTT" "TUNEL‐positive" "TWI " "TXNRD" "TY"
    "TaKaRa" "Taba" "Tacke" "Tail" "Tait" "Taiwan" "Takamori" "Talalay" "Tamil"
    "Tapias" "Taq" "Taq-I" "TaqMan" "TaqMan-MGB" "TargertScan" "TargetPrint"
    "TargetScan" "Target‐based" "Tazawa" "Tca8113p160" "Tchernitsa" "TdR"
    "Teff" "Terry" "Tessoulin" "Tet-Off" "Tet-On" "TetO-wt-EGFR" "Tg" "Th17"
    "Th22" "Thailand" "TheFGFR3gene" "Theaflavin-3" "Thermo" "Thi" "Thirty‐one"
    "Thornton" "Thr180" "Thr183" "Thr202" "Three-phosphoinositede" "Tien"
    "Time-course" "Time-lapse" "Todt" "Tokyo" "Toll-like" "Tormo" "Toste"
    "Toyoshima" "Toyota" "Tra-IR700" "Trail" "Tramtrack" "Trang"
    "Trichostatin-A" "Triple-negative" "Tris-HCl" "Tris-acetate" "Tris–EDTA"
    "Tris–HCl" "TritonX" "TritonX-100" "Trks" "TruSeq" "Tscca" "Tscca8113"
    "Tsukamoto" "TuRC" "Tuba" "Tuba-Cdc42" "Tuba-mediated" "Tubastatin" "Tukey"
    "Tunisians" "Turkish" "Twenty-five" "Twenty-four" "Twenty-nine"
    "Twenty-seven" "Twenty-six" "Twenty-three" "Twenty-two" "Twenty‐one"
    "Twist" "Two‐tailed" "Tyr204" "Tyrs" "TÜF" "Tübingen" "T‐cell" "T–E–Y"
    "U*·mH" "U-rich" "U-shape" "U-test" "U1" "U133" "U2" "U251"
    "U2AF-proficient" "U2AF35-depleted" "U2AF35-sensitive" "U2AF35a" "U2AF35b"
    "U373" "U73122" "UAS-cic-RNAi" "UCA1" "UCSC" "UFBs" "UH" "UL" "UNC01"
    "UNC0638" "USC" "USCs" "USP72" "UT7" "UTRa" "UTRa1" "UTRa2" "UTRb"
    "UTR–luciferase" "UV-DNA" "UV-damage" "UV-irradiated" "UV-lesion"
    "UV-lesions" "UV-oligo" "UVA" "UVB" "UVC-irradiated" "UVC-irradiation"
    "UVP" "Uen" "Ullrich" "Ullrich’s" "Ultraviolet-A" "UniProtKB" "Uniprot"
    "Ural" "Uramoto" "Utsugi" "Uzawa" "V-ATPase" "V-C8" "V-DJ" "V-type"
    "V12S35" "V2" "V5" "V5-TSC2" "V5-tagged" "V600" "VAR" "VC-001" "VC-012"
    "VC-041" "VCAM" "VD3" "VE822" "VEGF-receptor" "VENN" "VGEF" "VGEF-A" "VH"
    "VH-10" "VHL-mediated" "VMRC" "VMRC‐LCD" "VPC-13566" "VPC-14449" "VSE"
    "VUSs" "Valdiglesias" "Valerio" "Valls" "Vaux" "Vavs" "Vegf-A" "Velos"
    "Vento" "Vento-Tormo" "Venus" "Vergne" "Verma" "Viale" "Vikhanskaya"
    "Villafuertes" "Vina" "Virmid" "Visvader" "Vivanco" "Volinia" "Vp" "VspI"
    "Vu" "Vα" "Vα–Jα" "Vβ" "W742C" "W742L" "WC" "WC1213" "WCLs" "WFPA" "WGA2"
    "WGA2-amplified" "WHI" "WHI-P154" "WHR" "WIT" "WP" "WRAP53β-γH2AX" "WT-AR"
    "WT-LBD" "WU-BC3" "WWL70" "WWOX-WFPA" "WWOXWFPA" "WWRT1" "WZ" "Wadt"
    "Waldenstrom" "Waldenstrom's" "Wallis" "Wals" "Walter" "Waltham" "Wanfang"
    "Waniczek" "Warburg" "Wardwell" "Wardwell-Ozgo" "Washington" "Watson"
    "Watson–Crick" "Wegiel" "Weinberg" "Weinstein" "Well-designed"
    "Well‐differentiated" "Weng" "Wenhao" "Wentink" "Werner" "Western-blot"
    "WesternBright" "Wheaton" "Whitney" "Whitsett" "Whole-genome" "Wilcoxon's"
    "Wilcoxon-rank" "Willcox" "Wisconsin" "Wolberg" "Wolter" "Wong" "Wu" "WuXi"
    "Wurm" "Wymann" "X-irradiated" "X-irradiation" "X-ray" "X-rays" "XGnRHR"
    "XRCC1Arg399Gln" "XTT" "XX+Xx" "XX-genotype" "XY" "XbaI" "Xiang" "Xiao"
    "Xiong" "Xodo" "Xq27.3" "Xu" "Xx+xx" "X‐ray" "Y182" "Y185" "Y187" "Y210"
    "Y403A_short" "Y430" "Y430F" "Y515" "Y515F" "Y694" "Y699" "YAP-TAZ-miR-130"
    "YFP-fusions" "YRI" "YSRpSPTF" "Yaffe" "Yalcin" "Yamaguchi" "Yang"
    "Yankner" "Yarmolinsky" "Yat" "Yat-Sen" "Yeh" "Yes-Associated"
    "Yes-associated" "Yonsei" "Yoshimoto" "Youle" "Yousin" "YpSRpSPTF"
    "Z-DEVD-FMK" "Z-score" "Z-scores" "Z045801-5" "ZER1" "ZF-like" "ZFN" "ZFNs"
    "ZG" "ZG-like" "ZINC08790006" "ZINC08792229" "ZINC08792355" "ZJ" "ZR75"
    "ZYG11" "ZYG11B" "ZZ" "Zablocki" "Zahrt" "Zan" "Zatorsky" "Zeng" "Zf"
    "Zf-CxxC" "Zhang" "Zhao" "Zheng" "Zhongshan" "Zhou" "Zhu" "Zimmer"
    "Zimmerman" "Ziptip" "ZnPPIX" "Zumla" "Zupkovitz" "Z‐VAD‐FMK" "a-synuclein"
    "aBRAF" "aCGH" "aFGFR3fluorescence" "aPKCs" "aSMA" "aa31-140" "aa502-862"
    "ab120224" "ab142088" "aberrantly-expressed" "abexinostat" "aboutand"
    "above-medium" "absorbance" "accordant" "accurrate"
    "acetylation-deacetylation" "acetylation-defective" "acetylation-mimic"
    "acetylcoline" "acid-sensitive" "acini-like" "actin-membrane"
    "activator-like" "activators" "active-site" "actives" "acyl" "acyl-biotin"
    "add-back" "adeno" "adeno-sine" "adenocarcinoid" "adenocarcinoma-like"
    "adenoid" "adenoma-initiating" "adenoma-to-carcinoma"
    "adenosine-tri-phosphate" "adenylate" "adenylyl" "adhesion-like"
    "adhesiveness" "adhesome" "adipogenic-differentiated" "adipose-derived"
    "adoloscents" "adrenaline" "advanced-stage" "advancedHCCpatients"
    "advancements" "adventitia" "affinity-purification" "aficionados"
    "afterBonferroni" "afterload" "againstESCCrisk" "againstNSCLCcells" "agar"
    "age-associated" "age-at-onset" "age-coefficient" "age-induced"
    "aggresome-autophagy" "aggresome-like" "aggresome-lysosome" "agonist-like"
    "air-liquid" "aldosteronism" "algorithm" "algorithms" "alkyl" "allKRAS"
    "alloantigen" "allograft" "allografts" "alpha-helix" "alpha2beta1"
    "already-metastatic" "amines" "amino-acid" "amino-terminally"
    "aminobenzamides" "aminos" "amitriptyline-inhibitable" "ammonium"
    "amplicon" "amplicons" "amplifications" "an7d" "anEGFR" "anEGFRdownstream"
    "anacardium" "analytes" "andAKT2" "andATR" "andDISH" "andFGFR3gene"
    "andFISHandDISHresults" "andI" "andJAK1" "andKRAS" "andLGR5" "andNAB2ex4"
    "andPIK3CA" "andPLC" "andother" "andp53" "androgen-depletion-induced"
    "androgen-deprivation-resistant" "aneuploid" "aneuploidy"
    "angiogenesis-associated" "angiotension-II-induced" "angitensin" "anisole"
    "ankyrin-repeat" "antagomir" "anterograde" "anthelminticum" "anthocyanin"
    "anthraquinone" "antibody-IR700" "antibody-specifically" "anticarcinogen"
    "antimiR" "antimiR-21" "antimiR-21-induced" "antimicrobial-mediated"
    "antiparallel" "antiplatelet" "antiredox" "antitumor-induced" "antitumour"
    "anti‐Bax" "anti‐HGF" "anti‐Sp1" "anti‐angiogenic" "anti‐inflammatory"
    "anti‐p53" "antrum" "aos" "aphthae" "apical-basal" "apical–basal"
    "apical–basolateral" "apoEKO" "apoenzyme" "apoptosis-regulatory"
    "apoptosisare" "apraxia" "arc‐shaped" "arginosuccinate" "arm-level"
    "aromatic-anomeric" "arrangement–remains" "arrow-head" "arteriole"
    "arterioles" "as-of-yet" "as-yet-unappreciated" "as-yet-uncharacterized"
    "asKRAS" "asON" "asignificant" "aspirin-induced" "aspirin-treated"
    "assessSTAT6" "associations" "astrong" "asymmetries" "atand"
    "atheroma-like" "ation" "atorva" "atorvastain" "atrium" "atypia" "aureus"
    "authophagy" "authors" "autistic-like" "auto-PARylated" "auto-PARylation"
    "auto-modification" "autoinactivate" "autophagy-lysosome" "avium" "axon"
    "azidohomoalanine" "a–c" "a–d" "a–g" "b1" "bHLH-PAS" "backbone-to-backbone"
    "bacterially-derived" "bafilomycin" "basal-A" "basal-B" "basal-enriched"
    "basal-like" "basal–apical" "basic-loop" "basidiomata" "bead-based"
    "bead-bound" "bearingJAK1" "becauseKRAS" "bed-ridden" "begun"
    "below-medium" "benzene-induced" "benzo" "benzoquinone" "benzotropolone"
    "beta-E1" "betaMEM" "between-study" "betweenATR" "betweenERand"
    "betweenFGFR1" "betweenFGFR1mRNAexpression" "betweenJAK2" "betweenKRAS"
    "bi-allelic" "bi-allelically" "bi-dentate" "bi-directional"
    "bi-orientation" "bilevel" "biliverdin" "bio-energetic" "bioactives"
    "bioassay" "biomembranes" "biomolecules" "bioproducts" "biorhythms"
    "biospecimens" "biotin" "biotin‐labeled" "bipyridium" "bishydroxamide"
    "bisindolylmaleimides" "bisphosphate" "bisulfate" "bivariate" "blastocytes"
    "bleed-through" "blocker" "blockers" "blockingKRAS" "blood-brain"
    "blood-vessel" "blood–brain" "bone-marrow" "bothLGR5" "bothTIAM2SmRNAand"
    "botulinum" "bound-like" "box-containing" "box–containing" "bp" "brachy"
    "brachyury" "bradykinesia" "brainstem" "brain‐specific" "branch-like"
    "break-apart" "break-repair" "breakpoint" "breakpoints" "brighter"
    "bright‐field" "broad-range" "broad-spectrum" "broader" "bromopalmitate"
    "browsers" "bufatin" "build-up" "burst-like" "buthionine"
    "butylhydroquinone" "butylhydroxy" "by-pass" "by-passing" "by-product"
    "by-products" "by14-3-3β-specific" "byIHC" "byJAK1" "byKRAS" "byRT" "b–c"
    "c-PTIO" "cABPP" "cNHEJ" "cPKCs" "cacodylate" "cadhern" "café-au-lait"
    "caherin" "calicheamicin" "caliper" "callosum" "calorimetry" "campthotecin"
    "cancer-cell-derived" "cancer-relevance" "cancer-relevant"
    "cancer-therapeutic" "cancerHRAS" "cancer‐related" "caner" "capase-3"
    "capillary-like" "cap‐dependent" "carbachole" "carboxyethyl"
    "carboxyfluorescein" "carboxyl" "carboxyl-terminal" "carboxy‐terminal"
    "carcinogen-DNA" "cardia" "cargos" "carotid" "cartilage-specific"
    "case-by-case" "case-control" "case–control" "caspase‐3"
    "castration-resistance" "catabolite" "catabolites" "catalases" "catalyse"
    "catarrhalis" "ccRCC" "ceRNA" "cecal" "cecum" "celiac" "cell-autonomous"
    "cell-by-cell" "cell-cycle-associated" "cell-cycle-regulated"
    "cell-cycle-specific" "cell-intrinsic" "cell-like" "cell-migratory"
    "cell-permeable" "cell-protective" "cell-to-cell" "cell-type-specific"
    "cells" "cellularSFTs" "cellulo" "cell‐based" "centriole" "centroid"
    "centromere" "cerebellum" "cerebrovasculature" "ceretinib" "cerevisiae"
    "cetin" "cfDNA" "chamomile" "characteristcs" "characterizedCD200"
    "charge-to-mass" "check-up" "chemically-distinct" "chemically-induced"
    "chemo" "chemo-radiotherapies" "chemo-radiotherapy" "chemo-therapeutic"
    "chemoattractant" "chemoresistance" "chemoresistant" "chemotherapy-naïve"
    "chi-square" "chiasm" "chidamide" "cholesterol-rich" "choline" "chr11"
    "chr15" "chr19" "chromatid" "chromatids" "chromo-ATPase" "chromosome-X"
    "cic-RNAi" "cinnamoyl" "cip1" "circuitry" "cis-elements" "cis-regulatory"
    "cisplatin-DNA" "class-1" "class-I" "class-IIb" "classifier" "classifiers"
    "clearer" "clearest" "clinic-pathologic" "clinic-pathological"
    "clinical-grade" "clinically-related" "clinically-relevant" "clinicians"
    "clinico" "clinico-pathological" "cluster‐type" "cnt-miR-transfected"
    "coauthors" "codominant" "codon" "codons" "coiled-coil" "coli" "collagens"
    "collision-induced" "colocalise" "colonoscopies" "colonoscopy"
    "colony-formation" "colony-forming" "colony‐forming" "colorectum"
    "combination-specific" "commonest" "communication-targeted" "comorbidities"
    "compartment-specific" "compassionate-use" "complex1" "complex‐dependent"
    "computed-tomography" "concatemer" "concentration-dependent-manner"
    "concentration-dependently" "concentration-response" "condensate"
    "conductance" "confounder" "confounders" "congenita" "connections-mediated"
    "contibutes" "continuum" "control+pHBLV-5" "control-DNA"
    "control-shRNA-treated" "controlJAK1" "controlsTIAM2Stranscription"
    "copy-number" "copy‐numbers" "core-containing" "core-needle" "coregulators"
    "corpus-predominant" "correlations" "cost-effective" "counter-examples"
    "counter-intuitive" "covariate" "covariates" "coworkers" "co‐expressing"
    "co‐factors" "co‐workers" "crescent-shaped" "cribriform" "crizotonib"
    "cross-activating" "cross-compared" "cross-complementation"
    "cross-contamination" "cross-inhibits" "cross-linker"
    "cross-linker-induced" "cross-linkers" "cross-modulation" "cross-peaks"
    "cross-referenced" "cross-resistance" "cross-section" "cross-sectional"
    "cross-species" "cross-strand" "cross-susceptible" "cross-validation"
    "crossing-over" "crossover" "cross‐talk" "cryo" "cryo‐electron"
    "crypt-villus" "ctDNA" "cubitus" "culturedBM" "culture‐expanded" "cut-off"
    "cut-offs" "cut-point" "cut‐off" "cyan" "cyanidin-3-glucose" "cyanins"
    "cyclehexamide" "cycler" "cyclin-B" "cyclobutane-pyrimidine"
    "cyclohexamide" "cyclohexene" "cyclohexylethoxy" "cyclopenta" "cyst-like"
    "cyto" "cyto-D" "cytochemistry" "cytochromes" "cytofluorograms" "cytology"
    "cytomembrane" "cytometer" "cytoplasm-to-nucleus" "c‐Met" "c‐Met‐mediated"
    "c‐Met‐targeted" "c–d" "dL" "dUTP-biotin" "damage-based" "damage-induced"
    "damage-inducing" "damage-response" "damage–induced" "data" "dataset"
    "datasets" "day-case" "dbSNP" "ddPCR" "de-acetyltransferases"
    "de-activation" "de-palmitoylation" "de-repressed" "de-repression"
    "deacetylase-activating" "deacetylase-dead" "death-receptor" "decidedin"
    "decorticate" "decreasedESCCrisk" "decreasedKRAS" "dectect"
    "dedifferentiate" "deeper" "deficientATR" "degron" "del746–750" "delGA"
    "deleteriousness" "deletions" "delex25" "delta-like"
    "dendritic-cell-specific" "deoxynucleotide"
    "deoxynucleotidyltransferase-mediated" "deoxyuridine" "dependend"
    "depleted-cells" "der" "desmoplasia" "determineNAB2" "detox"
    "deubiqutinates" "di-methylated" "di-methylation" "diabetes-induced"
    "diaminobenzidine" "diaminopyrimidine" "dibenzo" "dichloride"
    "dichlorodihydrofluorescein" "dichroism" "diet-derived" "diet-induced"
    "diet-switch" "dietary-mediated" "diethyl" "diethylaminobenzaldehyde"
    "difference=0.008" "difference=0.12" "difficult-to-fold"
    "difficult-to-replicate" "diffraction-quality" "digallate" "digoxin-like"
    "dihydrobenzocarbazole" "dihydroxy" "dihydroxyindeno" "diiron"
    "diiron-tyrosyl" "dimerises" "dimethyl-H3K9" "dimethylsulphoxide" "dimmers"
    "dimorphism" "dinucleotides" "diopter" "dioxanyl" "dioxopiperazine"
    "diphosphate" "diphosphate-ribose" "diphosphate " "diploid" "discoidin"
    "discrepant" "disease-free" "disease-relevance" "disease-relevant"
    "disease‐free" "disomy" "disphosphate" "distal-binding" "dithiocarbamate"
    "dithiolethione" "dl93–100" "dmPGE" "doi" "domain-motif"
    "dominant-negative" "dormancy" "dorsal-ventral" "dose-AZD9291"
    "dose-dependently" "dose-effect" "dose-kinetics" "dose-limiting"
    "dose-response" "double-label" "double-membrane" "double-mutant"
    "double-strand" "double-strand-break" "doublings" "down-expression"
    "down-modulation" "down-steam" "down-stream" "downfield" "down‐regulated"
    "down‐regulation" "dox" "drawn" "drivesSTAT6" "droplet" "droplets"
    "drug-drug" "drug-like" "dsDNA" "dual-agent" "dual-binder" "dual-chamber"
    "dual-click" "dual-phosphorylated" "dual‐color" "duct-derived" "duplexes"
    "dwarfism" "dysphagia" "dysplasias" "eLife" "eQTLs" "eSPAN" "eag-like"
    "earlier-stage" "early-onset" "early-passage" "early-stage" "early-stages"
    "echinoderm" "echocardiography" "echolalia" "ectoderm" "ectodomain" "edema"
    "edge-type" "effecter" "eighty-two" "elangiectasia" "electro"
    "electrospray" "elemene" "element-variable" "element–and" "elicitors"
    "elios" "eluate" "email" "emboli" "embryoid" "encephalomyelitis"
    "end-capture" "end-diastolic" "end-join" "end-labelled" "end-resection"
    "end-stage" "end-to-end" "endarterectomy" "endo-reduplicated" "endocardium"
    "endocytosis-mediated" "endoderm" "endogenousKRAS"
    "endogenousTIAM2SmRNAand" "endometrioid" "endometrium" "endoscopy"
    "endothelial-derived" "endothelial-mesenchymal" "endpoint" "endpoints"
    "enhancer" "enoate" "enrichment-analysis" "enteroblasts" "enteroendocrine"
    "enthalpy" "entire­ly" "entomophila" "entropy" "entry-exit"
    "environment–gene" "enzyme–DNA" "enzymopathy" "eosin" "eosinophils"
    "ependyma" "epidermal-growth-factor-induced" "epidermalgrowth" "epigenome"
    "epigenomes" "episomes" "epistaxis" "epithelia" "epithelial-cell"
    "epithelial-like" "epithelial-mesenchymal" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelioid" "equal-sized" "erbB-4" "erinaceus"
    "erinacines" "erythema" "erythematodes" "erythrocytes" "esg" "esg-Gal4"
    "esg-Gal4-UAS-2XEYFP" "esgGal4" "esophagus-associated" "estrogen-signaling"
    "estrogen-to-androgen" "et" "ethoxyphenyl" "etio" "etio-pathogenesis"
    "etio-physiology" "et " "eukemia" "ever-expanding" "ever-smokers" "ex"
    "ex-smokers" "ex19del" "exhibitedSTAT6" "exo" "exoenzyme" "exome"
    "exon-centric" "exon-intron" "exon14" "exon19" "exon5" "exon9indel" "exons"
    "exonuclease-endonuclease-phosphatase" "exosome" "expert-authored"
    "explane" "expre" "expressedKRAS" "expressers" "expressingJAK1"
    "expressionin" "extra-cerebral" "extra-ocular" "extra-renal" "extravasate"
    "extra‐cellular" "e–f" "f_BC" "factor-1" "factor-2" "factor‐2" "fall-down"
    "fallen" "false‐negative" "false‐positive" "fasciculations" "fast-acting"
    "fate-decision" "fat‐forming" "fed" "feed-back" "feedback-broken"
    "feedback-driven" "feedback-intact" "feedback-regulated" "fetU6" "ffluc"
    "fibrates" "fibroblast-like" "fibroblastoid" "fibroblast‐like"
    "fibrosis-relevant" "fide" "fifth-leading" "fifths" "fifty-seven"
    "fifty-six" "findin­­g" "fine-mapped" "fine-needle" "fine-tune"
    "fine-tuned" "fine-tuning" "first-degree" "first-in-human" "first-in-line"
    "first-line" "first-strand" "firstline" "five-membered" "five-residue"
    "five-residues" "five‐factor" "flavonoid" "flavonoids" "flexure"
    "flow-mediated" "fluorodeoxyglucose" "fluorodeoxyglucose-positron"
    "fluorophore" "fluorophores" "fluorophosphonate-rhodamine" "fluorouracile"
    "foam-cell" "foci‐positive" "fold-back" "folding-after-binding"
    "folding-before-binding" "follicular-like" "follow-up" "follow‐up"
    "forFGFR3" "forKRAS" "forKRASWTpatients" "forMOMP" "forTIAM2Sectopic"
    "forebrain" "fork-associated" "formaldehyde-Triton" "formaldehyde-methanol"
    "formalin‐fixed" "four-fifths" "four-helix" "four-stage" "four-stranded"
    "four-week-old" "fourth-most-common" "foveolata" "fraktalkine" "frameshift"
    "free-energy" "free-survival" "fromFGFR‐1" "fromHER2" "fromLGR5"
    "front-line" "frozen" "full-size" "full-text" "full‐length" "fumarate"
    "fun-tune" "functional-enrichment" "functionalSNPs" "functionally-related"
    "furan-2,7-diol" "fusiform" "fusion-gene" "fusion‐negative" "gDNA"
    "gain-of-function" "gallate" "gallbladder" "galvanotaxis" "gamma-H2Ax"
    "gamma-radiation" "gastrectomy" "gastrostomy" "gate-keeper" "gatekeeper"
    "gavage" "gefitinib-pulse" "gefitinib‐dependent" "gefitinib‐induced"
    "gefitinib‐mediated" "gefitinib‐sensitive" "gefitinib‐treated" "geldamycin"
    "gem-treated" "gemcitabine-chemotherapy" "gender‐related" "gene-ontology"
    "gene-therapy" "generalise" "generateEXD2" "genes" "genesRUNX2andDLX5were"
    "genetically-distinct" "gene–environment" "gene–environmental" "gene–gene"
    "genome" "genome-wide" "genotoxic-stress" "genotype-RV"
    "genotype-phenotype" "genotype–phenotype" "germline" "gestational–age"
    "givinostat" "gland-reconstituting" "glandular-like" "glatiramer"
    "glaucarubinone" "glia" "globus" "glomeruli" "glomerulosa"
    "glucose-lactate" "glutaminases" "glutamylcysteine" "glycaemia" "glycan"
    "glycemia" "glycoproteome" "glycosite" "glytazonas" "glĥucose" "go-go"
    "goes" "gofr" "grade-modified" "granulocyte-monocyte" "gravis" "greater"
    "greatest" "grey-level" "group1" "growth-regulatory" "growth-suppressive"
    "guanyl" "gvc" "g–l" "hADSC" "hADSCs" "hAha1–Y223E-only" "hAha1–Y223F-only"
    "hAha1–Y223F–FLAG" "hCD45" "hCD45 " "hCNT" "hCXCL" "hCXCL1" "hCXCL5"
    "hCXCL8-mediated" "hCXCR2" "hENT" "hENT1" "hESC" "hESCs" "hGnRHR" "hMSC"
    "hMSCs" "hNPCs" "hNT-2" "hPSC" "hPSCs" "hTERTm" "hVECs" "hadKRASWTlung"
    "hadLGR5" "half-life" "half-lives" "half-maximal" "haplo"
    "haplo-insufficiency" "haplo-insufficient" "haplotype" "haplotypes"
    "haploview4.2" "harboredKRAS" "havingKRAS" "head-and-neck" "head-to-head"
    "head-to-tail" "healthy-looking" "heartwood" "heartwoods" "heat-shock"
    "heatmap" "heatmaps" "heavier" "helices" "helix" "helix-hairpin-helix"
    "helix-loop-helix" "hematoxylin–eosin" "hemi" "hemicorpus"
    "hepatocyte-inducing" "hepatocyte-like" "heptamer" "hetero"
    "hetero-anamnesis" "hetero-aromatic" "hetero-atom" "hetero-dimer"
    "hetero-dimeric" "hetero-dimers" "hetero-tetramer" "heteroduplex"
    "heteroduplexes" "heterotetramer" "heterotrimer" "heterotrimers"
    "heterozygote" "heterozygousATR" "hexa-histidine-tagged" "hexamer" "hg19"
    "hiPS" "hidden" "high-affinity" "high-calcium" "high-capacity"
    "high-carbohydrate" "high-content" "high-density" "high-dose"
    "high-expression" "high-fat" "high-fidelity" "high-grade" "high-level"
    "high-mobility" "high-performance" "high-phosphate" "high-resolution"
    "high-resolution-melting" "high-risk" "high-salt" "high-susceptibility"
    "highFGFR1" "higher-salt" "highly-conserved" "highly-correlated"
    "highly-soluble" "high‐order" "high‐risk" "hilar" "hindbrain" "hippocampi"
    "hispolon" "histochemistry" "histologies" "histology" "histone-3"
    "histopathology" "histotype" "hnRNPA2B2" "hnRNPC" "hnRNPC1" "hnRNPR"
    "hnRNPs" "hnRPA1" "hoc" "homeodomain" "homeoprotein" "homo-oligomer"
    "homo-zygous" "homolog" "homologs" "homologue-1" "homologus" "homology-2"
    "honokiol-treated" "host-cell–microbe" "host-directed" "hot-spot" "hotspot"
    "hotspots" "hr" "hrm-HPV" "hrm-HPVs" "hsa-miR-1225-5p" "hsa-miR-145"
    "hsa-miR-145-3p" "hsa-miR-145-5p" "hsa-miR-148a" "hsa-miR-200b"
    "hsa-miR-200c" "hsa-miR-214" "hsa-miR-361-5p" "hsa-miR-429" "hsa-miR-638"
    "hsa-miRNA-145-5p" "htSNP" "htSNPs" "http" "huckebein"
    "human-patient-derived" "hundred-ninety" "hybridLGR5" "hydrazide"
    "hydrodynamics-based" "hydrogen-bond" "hydroxamides" "hydroxybutyl"
    "hydroxydeoxyguanosine" "hydroxyestrone" "hydroxyl-HIF-1α"
    "hydroxytryptamine" "hydroxyvitamin" "hyper" "hyper-inflammatory"
    "hyper-regenerative" "hyperaldosteronism" "hyperinsulinaemic-euglycaemic"
    "hyperinsulinemia" "hyperintense" "hyperintensities"
    "hyperosmolarity-induced" "hyperoxia" "hyperphosphatemia" "hyperreflexia"
    "hypertonia" "hypo-expression" "hypocalcemia" "hypokinesia"
    "hypometabolism" "hypothalamic-pituitary" "hypoxia-depend" "hypoxia-like"
    "hypoxia-mimetic" "hypoxic-activated" "hypoxic-inducible"
    "hypoxic-resistance" "h–i" "i-motif" "iDC" "iDCs" "iGLuc" "iMAC" "iMACs"
    "iPOND" "iTRAQ" "ice-cold" "ideally-suited" "identifier" "identifiers" "ie"
    "ii" "iii–vi" "ileum" "imino-aromatic" "imino-imino" "immediate-early"
    "immune-competent" "immune-compromised" "immune-deficient"
    "immune-histochemistry" "immune-mediated" "immune-modulatory"
    "immune-precipitation" "immune-reactivity" "immune-regulation"
    "immune-related" "immune‐modulatory" "immuno" "immuno-cytochemistry"
    "immuno-histochemical" "immuno-precipitation" "immunoassays"
    "immunochemistry" "immunocomplex" "immunocomplexes" "immunocytochemistry"
    "immunoglobulin" "immunoglobulin‐like" "immunohistochemistry"
    "immunoprecipitants" "immunoprecipitation-quantitative"
    "immunoprecipitation-sequence" "immunoprecipitations" "immunosurveillance"
    "immunotherapies" "immunotherapy" "impedance" "imperforate"
    "implicatedKRAS" "importin-α" "importin-α4" "in-depth" "in-frame" "in-gel"
    "in-house" "in-line" "in-situ" "in-solution" "in-source" "in-vitro"
    "in-vivo" "in14-3-3β-high" "inAKT1" "inATR" "inCD200" "inHCCcells"
    "inHCT116" "inHER2" "inJAK1" "inJAK2" "inKRAS" "inLGR5" "inNSCLCcell"
    "inPOLD1" "inTIAM2SmRNAand" "inTSC2" "inactivateKRAS" "incanum"
    "increasedCD200" "indel" "indels" "independent-ErbB2"
    "independently-generated" "indictors" "individualSNPs" "induced-cellular"
    "induced-pluripotency" "inducedCD200" "infection-induced"
    "inflammation-associated" "inflammation-induced" "inflammation-mediated"
    "inflammation–are" "inflammation–has" "inflammatory-related" "inhibitKRAS"
    "inhibiton" "inhibitor1" "inhibitorSU11274" "inhibitsKRAS" "inibitors"
    "inihibitors" "inmCRCpatients" "inner‐mitochondrial"
    "instability-independent" "insulae" "insulin-induced" "insulin-like"
    "insuline" "insulin‐like" "inter-alveolar" "inter-collaboration"
    "inter-correlation" "inter-dimer" "inter-domain" "inter-domains"
    "inter-individual" "inter-laboratory" "inter-lesional" "inter-method"
    "inter-observer" "inter-quartet" "inter-strand" "interactions"
    "interactome" "interactomes" "intercalates" "interchromatin" "interdomain"
    "intergrin" "interleukin‐1β" "intermediate-conductance" "intermediate-risk"
    "intermembrane" "internucleotide" "interquartile" "interstrand"
    "intestinal-type" "intestinal‐type" "intima" "intoKRAS" "intra-S-phase"
    "intra-axial" "intra-chromosomal" "intra-laboratory" "intra-peritoneal"
    "intra-protein" "intra-tumoral" "intranucleotide" "intraobserver"
    "intraplaque" "intrathoracicSFTs" "intratumour" "intravasate"
    "invaginations" "invasion-associated" "investigatedFGFR3" "in‐frame"
    "iodoacetamide" "ionic" "irinotecan+atova" "iron-regulatory" "isoenzymes"
    "isomer" "isomerise" "isomerizes" "isomorphs" "isopropanol" "isotope-coded"
    "isotype-Abs" "isozyme" "isozymes" "iv" "j105" "j212" "javanica" "jetPEI"
    "junction‐associated" "kJ" "kappa-light-chain-enhancer" "karyotype"
    "karyotypes" "kbp" "kcal" "kelch-like" "keren" "kg"
    "kinase-mediated-regulation" "kinase-peptide" "kinase‐targeted"
    "kininogens" "kinome" "kmplot" "knock-down" "knock-in" "knock-in–like"
    "knockdown-rescue" "knocked-down" "knockin" "knocking-down" "krn"
    "kruppel-like" "kw1" "kw2" "kw3" "lactone" "laevis" "lambda" "lamda"
    "landa" "lap-like" "large-conductance" "large-scale" "large‐scale"
    "laser-induced" "laser-injury" "laser-microirradiation" "late-evolved"
    "late-onset" "late-passage" "late-stage" "later-in-life" "later-stage"
    "lateral-loop" "layer–as" "leading-edge" "leakiness" "lecitihin"
    "lecitihin-cholesterol" "lectin-affinity" "lectin-like" "left-sided"
    "left‐sided" "lenti-KRAS" "lenti-Scramble" "lenti-miR-302s" "lenti-miR145"
    "lenti-pCCL" "lenti-viral" "lenti-virus" "lentiviral-mediated"
    "lentivirals" "lenvi" "lenvi-126" "let7c" "leucine-rich-repeat"
    "leucine-zipper" "leukemia-relevant" "levelmRNA" "life-expectancy"
    "life-or-death" "lifespan" "lifetime-never" "ligand-to-receptor"
    "ligonucleotides" "limit-cycle" "limonene" "lincRNA-p21" "lineage-specific"
    "linewidths" "linkKRAS" "lipopolysaccharide" "lipopolysaccharides"
    "lipoproteins" "liposome" "littermate" "liver-X" "lncRNA-AF085935" "lobar"
    "lobules" "lobulo" "lobulo-alveolar" "locally-advanced" "loci"
    "loco-regionally" "log-rank=25.072" "log2" "log2FC" "logit" "long-distance"
    "long-lasting" "long-lived" "long-range" "long-standing" "longa"
    "longer-term" "longevity-associated" "long‐term" "loss-of-function"
    "loss-of-function-CIC" "loss‐of‐function" "low-adherence" "low-affinity"
    "low-amplification" "low-capability" "low-capacity" "low-copy-number"
    "low-dose" "low-expression" "low-frequency" "low-grade" "low-level"
    "low-magnitude" "low-or" "low-risk" "low-set" "low-to-moderate" "low-toxic"
    "low-vegetable" "lower-grade" "lower-stomach" "lower-third" "low‐risk"
    "loxP" "lrm" "luc-5" "luciferase-gene" "luciferase-reporter" "lucitanib"
    "lumens" "luminal-A" "lumpectomy" "ly0" "lymph-node" "lymphoblastoid"
    "lysis" "lysozome" "m+n" "m5C" "mAb-IR700" "mCXCL1" "mCXCL2" "mCXCL3"
    "mCXCL5" "mCXCR2" "mL " "mMcl-1" "mNSC" "mNSCs" "mPanIN" "mRNA-associated"
    "mRNA-levels" "mRORC2" "mSH" "mTOR-mediated" "mTOR-specific" "mTORs" "mW"
    "macronuclei" "macroscopically-intact" "macules" "maculopathy" "main-chain"
    "majorNAB2ex4" "make-up" "maleate" "malignantSFTs" "mammalian-wide" "mammo"
    "mammo-sphere" "mammography" "mammoplasties" "mammoplasty" "mammosphere"
    "mammospheres" "mandshurica" "mannose-6-phosphate" "mant-ATP" "mant-ATPγS"
    "mass-action" "mast-cell" "mastectomy" "master-program" "master-regulators"
    "mastermind-like" "mastermind-like-1" "matrix-stiffness" "meaningfulness"
    "mechano" "mediastinum" "mediated-phosphorylation" "mediatingKRAS"
    "medium-basal" "medium-to-high" "medulla" "melanogaster" "melatonin"
    "mellitus" "melting-curve" "membrane-to-nucleus" "meniscus" "mesencephalon"
    "mesenchymal-epithelial" "mesenchymal-like" "mesenchyme" "mesh-work"
    "mesoderm" "meta-regression" "meta-static" "metal-responsive"
    "metaplasia-dysplasia-carcinoma" "metastasectomies" "metastasectomy"
    "metastaticCRC" "meta‐analysis" "metformine" "methionine-choline"
    "methoxydalbergione" "methoxyphenyl" "methyl-4-phenylpyridinium"
    "methyladenine" "methylase-fusion" "methylation-expression"
    "methylcytosine" "methylcytosines" "methylene" "methylethenyl" "methylome"
    "methylthiazole" "methyltransferase-1" "mevalonate-HMG-CoA" "miR-100"
    "miR-100's" "miR-100-corresponding" "miR-100-mediated" "miR-103"
    "miR-106b-25" "miR-107" "miR-122" "miR-1225" "miR-125a-3p"
    "miR-125b-mimic-treated" "miR-126–3p-containing" "miR-128" "miR-128a"
    "miR-128b" "miR-129" "miR-130" "miR-130a" "miR-140" "miR-144-3p" "miR-145"
    "miR-148" "miR-148a" "miR-15" "miR-155" "miR-15b-3p" "miR-17" "miR-17-92"
    "miR-18" "miR-181" "miR-185" "miR-18a" "miR-192" "miR-192-MDM2"
    "miR-192-mediated" "miR-193a" "miR-194" "miR-199" "miR-19a" "miR-200"
    "miR-200a-3p" "miR-208" "miR-208a" "miR-20a" "miR-21-5p" "miR-210"
    "miR-214" "miR-215" "miR-217" "miR-218" "miR-22" "miR-23b" "miR-23b-stably"
    "miR-24" "miR-24-BCL2L11" "miR-24-induced" "miR-24-overexpression"
    "miR-26a" "miR-26b-5p" "miR-27a" "miR-27b" "miR-29a-3p" "miR-29b-3p"
    "miR-29b1" "miR-302" "miR-302-binding" "miR-302-downregulated"
    "miR-302-overexpressing" "miR-302a" "miR-302c" "miR-302d" "miR-34"
    "miR-34-a" "miR-340" "miR-34b" "miR-34s" "miR-362" "miR-375" "miR-421"
    "miR-449a" "miR-449s" "miR-455" "miR-494" "miR-497" "miR-497-inhibited"
    "miR-497-inhibiting" "miR-497-overexpressing" "miR-497-suppressed"
    "miR-506" "miR-508-3p" "miR-519" "miR-519a-mut" "miR-519a-suppressive"
    "miR-584" "miR-584-3" "miR-584-3p" "miR-5p" "miR-610" "miR-610-in"
    "miR-610-in-transfected" "miR-610-transfected" "miR-637" "miR-658"
    "miR-663" "miR-675" "miR-711" "miR-711-inhibitor-transfected"
    "miR-711-inhibitors" "miR-711-mediated" "miR-711-mimic-transfected"
    "miR-711-mimics" "miR-NC" "miR125b" "miR141" "miR200" "miR200a" "miR200c"
    "miR200s" "miR205" "miR21" "miR429" "miRDB" "miRNA-138" "miRNA-155"
    "miRNA-208a" "miRNA-21" "miRNA-27a" "miRNA-27a-3p" "miRNA-29" "miRNA-29a"
    "miRNA-29a-based" "miRNA-29a-induced" "miRNA-29a-mice"
    "miRNA-29a-transfected" "miRNA-29a-treated" "miRNA-29b" "miRNA-34a"
    "miRNA-497" "miRNA-568" "miRNA-oncogene" "miRNA200" "miRNA29a-mediated"
    "miRNA–mRNA–Ago" "miRanda" "miScript" "mice" "micelles" "micro-environment"
    "micro-irradiated" "micro-metastases" "micro-porosity" "micro-vessel"
    "microM" "microRNA-130" "microRNA-143" "microRNA-27a" "microRNA-29"
    "microRNA-497" "microRNA-584-3p" "microRNA-feedback" "microRNA-mRNA"
    "microRNA-p53-MDM2" "microRNA-perturbation" "microRNA200" "microaneurysms"
    "microarray-negative" "microarray-positive" "microarray‐based"
    "microdialysis-proteomics" "microdomain" "microdomains" "microfoci-like"
    "microhomology" "microlaser" "micromass" "micrometastases" "micropipette"
    "microsatellite" "microtubule-to-kinetochore" "microvasculature"
    "microvessels" "mid-1980s" "mid-G1" "mid-adult" "mid-parental" "midbrain"
    "middle-passage" "middle-third" "midgut" "midguts" "midpoint" "midzone"
    "milk-producing" "miltiorrhiz" "min-h" "mini-chromosome" "mini-gene"
    "mini-signature" "minichromosome" "minigene" "minigenes" "minorNAB2ex6"
    "minus-end-directed" "mis-orientation" "mis-segregation" "mispairings"
    "missense" "mito-aggresome" "mitoPY1" "mitoTEMPOL" "mitochondrial-induced"
    "mitochondrial-specific" "mitochondrial‐mediated" "mitochondrial–nuclear"
    "mitoses" "mitotracker" "mixed-lineage" "mixed-type" "mock-depleted"
    "mock-treated" "moderate-risk" "moderate-to-high" "moderately-to-poorly"
    "modest-to-moderate" "modificatioins" "modulatesKRAS" "molecules"
    "mono-allelic" "mono-binding" "mono-flavones" "mono-flavonoid"
    "mono-methylated" "mono-oxygenases" "monoacylglyerol" "monoclonals"
    "monodisperse" "monoglutamate" "monolayer" "mononucleosomes"
    "monophophosphate" "monophosphate" "monophosphoisoform" "monosomy"
    "monotherapies" "monotherapy" "morbidities" "morpholino"
    "mortality-to-incidence" "mortem" "most-widely" "motif-containing" "motile"
    "mpk" "mt" "mtPLD1" "mucosa" "mucosae" "multi-cancer" "multi-central"
    "multi-component" "multi-drug" "multi-ethnic" "multi-experimental"
    "multi-factor" "multi-factorial" "multi-functional" "multi-gene"
    "multi-genes" "multi-lumen" "multi-modal" "multi-modality" "multi-organ"
    "multi-parametrical" "multi-protein" "multi-step" "multi-system"
    "multi-variable" "multicenter" "multidrug-resistance-associated"
    "multidrug-resistance-related" "multiforme" "multilineage" "multimer"
    "multinucleate" "multiple-monoubiquitination" "multiplrotein"
    "multiprotein" "multiscale" "multisite" "multistage" "multisubunit"
    "multisystem" "multitarget" "multivariate" "multivariate-gender"
    "multi‐targeted" "muscularis" "musculus" "mutation-identification"
    "mutation-unspecific" "mutations" "myasthenia" "myocardium" "myocytes"
    "myofibroblasts" "myristate" "myxoid" "myxovirus" "m²" "m–n" "n+m"
    "n-‘TGA’-n-‘TCA’-‘GC’-n" "n=15" "n=17" "n=18" "n=3" "n=3–4" "n=5" "n=52"
    "nL" "nLC" "nPKCs" "nTGAnTCAGCn" "nab-paclitaxel" "nano" "nano-TiO2"
    "nano-chromatography" "nano-electrospray" "nanocolumn" "nanodomain"
    "nanoscopy" "naphthoflavone" "naïve" "ncomms10072" "ncomms10076"
    "ncomms10077" "ncomms10186" "ncomms10420" "ncomms10530" "ncomms10553"
    "ncomms9829" "neaoplasia" "near-adult" "near-infrared" "near-physiological"
    "near-universal" "neck-of-femur" "necropsy" "necrosome" "neg"
    "negative-feedback" "negative-like" "neo-vascular" "neoadjuvant"
    "neoantigen" "neoantigens" "neocortex" "neocortices" "neoplasias"
    "neostriatum" "nephropathy" "net-work" "network-based" "neu-overexpressing"
    "neurite" "neurobiology" "neurocytes" "neuroendocrine" "neuroepithelium"
    "neuron-like" "neuron‐specific" "neuropathology" "neurosphere"
    "neurotrauma" "neutropenia" "never-smoker" "never-smokers" "newest"
    "next-generation" "next‐generation" "ni" "nick-end" "nick-sensor"
    "nine-stranded" "nitrosobutyl" "nl" "nod-like" "node-negative"
    "node-positive" "nolic" "nonadjuvant" "noncarriers" "nonchordate"
    "nonhistone" "nonmalignant" "nonmissense" "nonmisssense" "nonobese"
    "nonrandom" "nonredundant" "nonsense-mediated" "nonsense‐mediated"
    "nonsignificant" "nontargeting-siRNA-treated" "non‐apoptotic"
    "non‐canonical" "non‐carriers" "non‐coding" "non‐drinker" "non‐drinkers"
    "non‐protein‐coding" "non‐small" "non‐small‐cell" "non‐specific"
    "non‐transduced" "non‐treated" "normal-like" "normal-looking"
    "normal-sized" "norvaline" "nos" "not-otherwise-specified" "notKRAS"
    "notLGR5" "nsON" "nsSNP" "nt" "nt-1494" "nt-1599" "nuclear-mitochondrial"
    "nuclear‐factor" "nucleases" "nucleate" "nucleo" "nucleo-cytoplamic"
    "n = 3" "n = 7" "o166" "o253" "o35" "obesity-associated" "obesity‐induced"
    "oblongata" "observedin" "occludes" "occupancy-response" "octamers"
    "odorifera" "oestrogen" "ofAKT1SNPs" "ofAKT1variant" "ofATR" "ofCD200"
    "ofEGFRand" "ofEGFR‐TKIs" "ofER‐positive" "ofFGFR1" "ofFGFR1at" "ofFGFR3"
    "ofHER2" "ofHGF" "ofHNSCCfrom" "ofJAK1" "ofJAK2" "ofK" "ofK-Ras4B" "ofKRAS"
    "ofKRASmutations" "ofLGR5" "ofNAB2" "ofTIAM2" "ofTIAM2Sectopic"
    "ofTIAM2Sin" "off-target" "off-targets" "offs" "ofhad" "ofp35" "ofvariants"
    "oldest-old" "olignucleotide" "oligoadenylate" "oligopyrimidine" "on-going"
    "on-line" "on1" "onATR" "onCD200" "onco-miR-24" "oncogene‐induced"
    "oncomiR" "oncomiRNAs" "oncovirus" "one-electron" "one-hour" "one-third"
    "one-time" "one-way" "one-year" "one‐factor" "one‐way" "onlyJAK1" "onsense"
    "ontogeny" "oocytes" "oophorectomy" "open-conformation" "open-label"
    "orBMP7" "orKRAS" "orLGR5" "organelle" "organelles" "organoids"
    "organosulfur" "organs" "oriens" "orientation-specific" "ornithine"
    "oroidin" "ortho" "ortho-dihydroxy" "ortholog" "orthologues"
    "orthotopically-injected" "osmolarity-sensitive" "osteoblasts"
    "osteochondrodysplasias" "osteoid" "osteomalacia" "osteophyte"
    "osteosar-coma" "ought" "outside-to-inside" "over-activation"
    "over-parameterization" "over-proliferation" "over-replicated"
    "over-representation" "over-stimulated" "over-stimulation" "overabundance"
    "overgrew" "overridden" "overview" "oxPAPC" "oxidases" "oxodG"
    "oxoglutarate" "oxygen-dependence" "oxygen-sensitivity" "oxygenase-1"
    "oxygenases" "ozone-challenged" "p21-luc" "p21Cip" "p21Cter" "p21p23"
    "p300-dependency" "p300-dependent" "p38MAPK" "p52SchA" "p52ShcA" "p53-2A"
    "p53-2S" "p53-TAZ2" "p53-double" "p53-null" "p53BS" "p53R2-positive"
    "p53RE1" "p53RE2" "p53S392" "p53TAD" "p53WT" "p53core" "p53‐dependent"
    "p65-dependent" "p65-independent" "p65NFκB" "p66SchA" "p66ShcA" "p73DD"
    "p85α" "p=0.0001" "p=0.0003" "p=0.0005" "p=0.001" "p=0.0011" "p=0.003"
    "p=0.012" "p=0.03" "p=0.05" "p=0.084" "p=0.41" "p=0.76" "pATK" "pBR"
    "pBRCA1" "pCDNA3-N-3HA" "pCHK2" "pCL-G" "pCL-T" "pCMV"
    "pCMV-G-NR-U6-shHSP27" "pCMV-G-NR-U6-shRNA" "pCMV6-HIF-1α" "pE2F1" "pEGFP"
    "pEGFP-C2" "pENTER" "pEZX" "pEZX-MT01" "pGFP-C1" "pGFP-SH2" "pGFP-SHP1"
    "pGFP-SHP2" "pGFP-SRC" "pGFP‐Sp1" "pGL-3" "pGL3-1118" "pGL3-1118-Mut-1"
    "pGL3-1118-Mut-2" "pGL3-1118-Mut-3" "pGL3-1118-Mut-4" "pGL3-1118-Mut-5"
    "pGL3-1181" "pGL3-1381" "pGL3-883" "pGL3-UTR-MUT" "pGL3-UTR-WT"
    "pGL3-basic" "pGL3b" "pH" "pH3S10" "pHIVLacZ" "pJAK2" "pLL3.7-shMTA1"
    "pLVX-IRES-Neo-JAK1" "pMAPK" "pMIR" "pMIR-REPORT" "pN" "pN0" "pNRF2"
    "pNSun2" "pNSun2+pHBLV-5" "pQCXIH-N-FLAG" "pRK" "pRK7-N-FLAG" "pRK7-N-MYC"
    "pRL-SV40" "pRelA" "pS" "pS-172" "pS1241" "pS1241PCNT" "pS172" "pS1981-ATM"
    "pS2259" "pS2259PCNT" "pS404" "pS404pS406" "pS406" "pS824-KAP1"
    "pS824-SUMO-KAP1" "pS969" "pSPTF" "pSPxF" "pSPxF-motif" "pSTAT1" "pSTAT3"
    "pSVOA" "pSVOAΔ5" "pSer-Pro" "pStage" "pSxxF" "pT" "pT2-4" "pTBK1" "pTERT"
    "pTERT-G" "pTERT-T" "pTERTm" "pTERTms" "pY+0" "pY+3" "pY118-paxillin"
    "pY31-paxillin" "pY416" "pY577-FAK" "pY705" "pack-year" "pack-years"
    "pair-wise" "paired-end" "pairedHCCsamples" "pairwise" "palate-associated"
    "pallidum" "pallidus" "palmitoyl-CoA" "palmitoyl-proteins"
    "palmitoyl-proteome" "palmitoyl-proteomics" "palmitoylthioesterases"
    "pan-ErbB" "pan-European" "pan-hydroxylase" "pan-nuclear" "panAKT"
    "pancreatitis" "pantoprazole" "papaverine" "para-carcinoma" "paracrine"
    "paraganglia" "paraspeckle" "parenchyma" "parenchymal-mesenchymal"
    "parentalKRAS" "paricipates" "parkinsonism" "partum" "pathergy"
    "pathobiology" "pathogenicity-prediction" "pathologies–auto-immune"
    "pathomechanism" "pathophenotypes" "pathophysiology" "pathway-enrichment"
    "patient-derived-MM" "patients-only" "patternless" "pcDNA" "pcDNA3"
    "pcDNA3-Flag-FGFR1" "pcDNA3-Foxo3a" "pcDNA3.1" "pcDNA3.1SHP2SHP2" "pcDNA4"
    "peaks–one" "peculiarities" "peduncles" "penetrance" "penile" "pentimidine"
    "peonidins" "peptide-N-glycosidase" "peptide–penetratin" "peptidoglycan"
    "per-exome" "per-risk" "perhaps" "peri-arteriolar" "perilla" "perimortem"
    "periosteum" "peritoneum" "permeabilization-fixation" "peroxidases"
    "perseverations" "phagocytophilum" "phagophore" "pharma" "phase-contrast"
    "phase-dependent" "phase-to-mitosis" "phenyl" "phenylarsine" "phonotype"
    "phosopho-HDAC3-Ser-424" "phosphate-treated" "phosphate‐containing"
    "phosphatidylinositide" "phosphatidylinositide-3-kinase"
    "phosphatidylinositol-3-OH" "phosphatome" "phosphine" "phospho-H1"
    "phospho-H3S10" "phospho-HDAC3-Ser-424" "phospho-PHD1" "phospho-Tyr-9"
    "phosphoSerine" "phosphoThreonine" "phosphoTyr" "phosphoadenosine"
    "phosphoatases" "phosphoinositede" "phosphoinositide-3,4"
    "phosphoinositides" "phosphopeptide" "phosphopeptides" "phosphopetide"
    "phosphoproteome" "phosphor-SPxF" "phosphorimage" "phosphorimager"
    "phosphorothioate" "phosphorylation-mimetic" "phosphorylation-mimicking"
    "phosphosite" "phosphosite-mimetic" "phosphosites" "phosphostain"
    "phosphosulfate" "phosphotyrosine-agarose" "phosphotyrosyl"
    "photoimmunochemotherapy" "photolesions" "photomicrographs" "photoproducts"
    "phototherapy" "physico" "physiological-like" "physiopathology"
    "phytoconstituents" "piwi-like" "pixel" "pixels" "platin" "pleomorphism"
    "pleura" "pleura‐based" "plexiform" "plice" "ploidy" "ployphenols" "pluri"
    "pluri-raw" "pluripotency-associated" "podophyllotoxin" "poliploidy"
    "polo-boxes" "poly-A" "poly-histidine" "poly-phenol" "polyA" "polycomblike"
    "polygonal-shaped" "polymerase-1" "polymerase-2" "polymorphism"
    "polymorphisms" "polyphe" "polyphe-nolic" "polyphenols" "polyploid"
    "polypyrimidine" "polysomy" "polyubquitin" "polη" "pons" "poor-survival"
    "poor-surviving" "poorer" "population‐based" "pos" "positive-cells"
    "positron" "post-DMM" "post-co-culture" "post-diagnosis" "post-engraftment"
    "post-enzalutamide" "post-explantation" "post-genome" "post-hoc"
    "post-hydrodynamic" "post-imatinib" "post-implantation" "post-infection"
    "post-injection" "post-inoculation" "post-irradiation" "post-menopausal"
    "post-mitotic" "post-mortem" "post-natal" "post-ovulatory"
    "post-replication" "post-stasis" "post-sunitinib" "post-surgery"
    "post-surgical" "post-therapy" "post-transcriptional"
    "post-transcriptionally" "post-transduction" "post-transfection"
    "post-translational" "post-translationally" "post-treatment" "post-tumor"
    "postload" "postmastectomy" "postmortem" "post‐transcriptional"
    "post‐translational" "ppERK" "prHER2" "prHER3" "pracinostat" "predicators"
    "predisposition-syndrome" "premarin" "presenilin‐associated"
    "prethoracotomy" "pre‐mRNA" "pri-miR-29a" "pri-miR-29b2" "primagraft"
    "primagrafts" "primay" "priori" "prioritise" "pro-EMT" "pro-IL-1alpha"
    "pro-IL-1apha" "pro-IL-1beta" "pro-IL1beta" "pro-angiogenic"
    "pro-anigogenic" "pro-antigenic" "pro-cancer" "pro-ceramide" "pro-growth"
    "pro-inflammatory" "pro-invasive" "pro-malignant" "pro-metastasis"
    "pro-metastatic" "pro-migratory" "pro-myelocytic" "pro-oncogene"
    "pro-oxidative" "pro-proliferation" "pro-proliferative" "pro-regenerative"
    "pro-renin" "pro-survival" "pro-tumor" "pro-tumorigenic" "proband"
    "procaspase-3" "proctos" "progeny" "progeroid" "progestin"
    "progression-free" "progression‐free" "prokaryotes"
    "proliferation-advantage" "proliferator-activated" "prolyl-4-hydroxylases"
    "promoter-less" "promoter-reporter" "promoter-specificity" "promoterless"
    "promoter–reporter" "proof-of-concept" "proof-of-principle" "properties"
    "propria" "propyl" "prostaglandins" "prostatectomy" "protease-like"
    "proteasomal-mediated" "proteasome‐dependent" "protein-DNA"
    "protein-centric" "protein-interaction" "protein-like" "protein-serine"
    "protein-tyrosine" "proteinGroups" "proteinopathies" "proteinopathy"
    "proteins" "proteins–should" "proteins–systematically" "protein‐coding"
    "protein–ATP" "protein–DNA" "protein–interaction" "protein–ssDNA"
    "proteome" "proteomes" "proteosome" "protomer" "protomers" "protooncogenes"
    "proven" "pro‐apoptotic" "pro‐inflammatory" "pro‐osteogenic" "pseudo-3"
    "pseudo-gel" "pseudo-kinase" "pseudo-overhang" "pseudo-sites"
    "pseudo-substrate" "pseudoexon" "pseudoexons" "pseudogene"
    "pseudosubstrate" "psiCHECK2" "publicly-available" "pull-down" "pull-downs"
    "pulldown" "pulled-down" "pulse-chase" "punctum" "puromycin-specific"
    "pyramidale" "pyrazole" "pyrene-7,8-diol-9,10-epoxide" "pyridopyrimidinone"
    "pyridostatin" "pyridoxazine" "p‐Met‐expressing" "p‐Met‐positive"
    "q-values" "qRT‐PCR" "quadruplex" "quality-control" "quasi" "quer"
    "quer-cetin" "quinoline" "quintuple" "quisinostat" "rHDAC" "rHDAC3-SMRT"
    "rMFI" "rSNP" "rSNP-617" "rSNPs" "race-specific" "rad3-related"
    "radiation-induced" "radiation-treated" "radiatum" "radicals"
    "radio-resistance" "radio-sensitization" "radio-sensitize" "radioligand"
    "radioresistance" "radioresistant" "radiosurgery" "random-effects"
    "rapamicyn" "rare-cutting" "rarer" "rat-derived" "ratio=0.003" "raw-files"
    "re-addition" "re-analysis" "re-analyzed" "re-assessed" "re-association"
    "re-biopsy" "re-classification" "re-classified" "re-classifying"
    "re-conceptualization" "re-conceptualizing" "re-confirmed" "re-define"
    "re-distribution" "re-enforcing" "re-entered" "re-epithelialization"
    "re-equilibrated" "re-established" "re-establishing" "re-establishment"
    "re-evaluated" "re-evaluation" "re-expressed" "re-expression" "re-firing"
    "re-identification" "re-incubated" "re-initiates" "re-initiation"
    "re-introduced" "re-introduction" "re-licensing" "re-localization"
    "re-localized" "re-order" "re-organization" "re-organize" "re-oxygenation"
    "re-palmitoylation" "re-plotted" "re-refinement" "re-replicated"
    "re-replication" "re-sensitize" "re-sequenced" "re-suspended" "re-tested"
    "reactants" "reaction-restriction" "readout" "readouts" "realms"
    "rearrangedreceptors" "receiver-operating" "receptor-1" "receptor-2"
    "receptor-tyrosine" "receptor-α" "receptor‐type" "receptor–ligand"
    "recombination-mediated" "recto-sigmoid" "rectosigmoid" "reemphasizes"
    "reenter" "reestablish" "regions" "regrowth" "regular-sized"
    "regulatingCD200" "regulatingKRAS" "regulators" "regulon" "regulons"
    "relapse‐free" "related-mortality" "relaxant" "remodeler" "renila"
    "renilla" "repeat-containing" "replication-associated" "replication-fork"
    "replication-induced" "replicon" "repopulate" "representativeness"
    "repressors" "reprogramme" "requireda" "resectable-stage" "resp"
    "responder" "responders" "restitution–the" "retrotransposon"
    "retrotransposons" "retrovirus" "revealedLGR5" "reverse-transcription"
    "revertant" "revertants" "rhBMP2" "rhCD200" "rhSCF" "rhomboid‐like"
    "riboproteins" "ribose" "ridden" "right-sided" "ring‐like" "ring‐mediated"
    "risen" "risk-associated" "ro" "roadmap" "rocaglate" "round-shape"
    "rs1005165" "rs10138277" "rs10216210" "rs1035140" "rs1035142" "rs1045485"
    "rs1056836" "rs11258747" "rs1129293" "rs1130214" "rs1130233" "rs113067944"
    "rs11615" "rs116697954" "rs11820062" "rs11899004" "rs12045585" "rs1219515"
    "rs12509403" "rs12693932" "rs12778366" "rs12778366-C" "rs13006529"
    "rs13031237" "rs13217795" "rs1327795" "rs1337080" "rs162561" "rs17468277"
    "rs1799768" "rs1799782" "rs1800440" "rs1830298" "rs1861270" "rs1935949"
    "rs1969821" "rs2037718" "rs2066734" "rs2227631" "rs2227674" "rs2228001"
    "rs2279017" "rs2279115" "rs2293554" "rs2294750" "rs2304186" "rs2494731"
    "rs2494732" "rs2494738" "rs2494750" "rs2494752" "rs2498796" "rs25487"
    "rs25489" "rs2736100" "rs2736100G" "rs2762520" "rs2764264" "rs2802292"
    "rs2853691" "rs2935713" "rs2949750" "rs2994329" "rs3212986" "rs34171066"
    "rs36043647" "rs3730358" "rs3740051" "rs3769823" "rs3769825" "rs3803300"
    "rs3803304" "rs3823963" "rs4014195" "rs4150441" "rs4288294" "rs45136"
    "rs451360" "rs4645878" "rs4646994" "rs4746720" "rs4750316" "rs4781560"
    "rs479744" "rs4946936" "rs4988000" "rs5918764" "rs609261" "rs609621"
    "rs6465787" "rs6723097" "rs6736233" "rs6745051" "rs700635" "rs702873"
    "rs7254616" "rs7254617" "rs7762395" "rs791885" "rs791888" "rs8027411"
    "rs842647" "rs920778" "rs920778T" "rs9274490" "rs9400239" "rs9456497"
    "rs947474" "rs9486902" "rs967591" "rs967591G" "rsIDs" "rxn" "s-related"
    "s00109-015-1374-z" "s12881-015-0257-z" "s12885-015-1977-3"
    "s12885-015-1983-5" "s12885-015-1988-0" "s12885-015-2001-7"
    "s12885-015-2036-9" "s12885-016-2048-0" "s12885-016-2051-5"
    "s12885-016-2057-z" "s12885-016-2058-y" "s12885-016-2061-3"
    "s12885-016-2072-0" "s12885-016-2078-7" "s12943-015-0487-x"
    "s12943-015-0488-9" "s12943-015-0490-2" "s12943-016-0493-7"
    "s12967-015-0753-0" "s13000-015-0449-z" "s13045-016-0233-x"
    "s13046-015-0266-y" "s13046-015-0269-8" "s13046-015-0277-8"
    "s13046-016-0285-3" "s13058-015-0658-0" "s13058-015-0659-z"
    "s13058-015-0667-z" "s13058-016-0673-9" "s13058-016-0674-8"
    "s13059-015-0863-2" "s13059-015-0864-1" "s13229-015-0066-4"
    "s40478-015-0267-2" "s40478-015-0268-1" "sENG" "same-length"
    "sample-collection" "sanguilutine" "sapiens" "sarcomatoid" "sc-52"
    "sc-7392" "sc-81485" "scatterplot" "scatter‐type" "scotomas" "screenings"
    "scute" "second-generation" "second-leading" "second-line" "second-most"
    "secondaries" "secondary-type" "second‐line" "secretome" "self-association"
    "self-defence" "self-destructive" "self-esteem" "self-interaction"
    "self-protection" "self-renew" "self-renewal" "self-report"
    "self-sufficient" "semi" "semi-dominant-negative" "semi-quantitative"
    "semi-transition" "semi-transitions" "senescence-like" "sense-strand"
    "sensitizer" "separase-null" "sequenc" "sequence-complementary"
    "sequence-related" "sequence-specific" "sequence-unrelated"
    "sequence-verified" "ser-63" "serine-proline-x-phenylalanine" "serine‐rich"
    "serologies" "serosa" "serous-type" "serum-and" "set-up" "setting-up"
    "seven-WD40" "seven-gene" "seventy-four" "seven‐factor" "sex-age"
    "sex-based" "sex-biases" "sex-mediated" "sex-specific" "sex‐related" "sh-1"
    "sh-PIN1virus" "sh-mock" "shCXCR2" "shControl" "shEV" "shGFP" "shHO-1"
    "shHSP27" "shHSP27-3" "shHSP7" "shIRS2" "shKAP1" "shKDM2B#1" "shKDM2B#2"
    "shLacZ" "shLuc" "shMYB" "shNrf2" "shPKM2" "shREV7" "shRKIP" "shRNAi"
    "shRNA‐based" "shRNF4" "shSp1‐1" "shSp1‐2" "shTBK" "shTBK1-transfected"
    "shTiam1" "short-distance" "short-hairpin" "short-range" "short-term"
    "shortmer" "shortmers" "showedHER2" "showedthe" "show–to" "shp53"
    "si-BANCR" "si-NC" "si-ZYG11A" "si-mock" "siAKT" "siAKT1-transfected"
    "siBRCA2" "siCTRL" "siCystC" "siFIH" "siFOXO" "siFOXO3a-transfected"
    "siGENOME" "siKAP1" "siNFKB1" "siNT" "siPOLD" "siPOLD1" "siPlk1"
    "siR-EIF4EBP1-treated" "siRELA" "siRNA-1" "siRNA-Lentivirus"
    "siRNA-transfection-mediated" "siRNA1" "siRNA2" "siSETD" "siSETD2-003"
    "siSLC38A9" "siSRSF2" "siScr" "siScramble" "side-chain" "side-chains"
    "side-effects" "sigmoid" "signal-to-noise-ratio" "signallingin"
    "signature-gene" "signature-level" "signficant" "signicant"
    "significantly-enriched" "silensced-cells" "silico" "silmitasertib"
    "simpler" "simplest" "single-analysis" "single-cell" "single-center"
    "single-dose" "single-gene" "single-molecule" "single-nucleotide"
    "single-photon" "single-span" "single-strand" "single-track" "single‐locus"
    "singly-palmitoylated" "sion" "sip53" "sirtuin" "sister-chromatid" "sites"
    "situ" "situsignals" "sixty-six" "size-exclusion" "skeletal-restricted"
    "small-cell" "small-cell-lung-cancer" "small-conductance" "small-hairpin"
    "small-interfering" "small-molecule" "small-scale" "small-study" "smokers"
    "snap-frozen" "soR‐HCC" "soft-agar" "solamargine" "solid-phase" "solider"
    "solute" "somaticEGFRgene" "son-of-sevenless" "sorafenib‐induced"
    "sorafenib‐resistant" "so‐called" "spacer" "specifically-defined"
    "specificities" "speck-like" "spectrometer" "sphere-cultured"
    "sphere-forming" "sphere-inducing" "spinal-cord" "spindle-cell"
    "spindle-like" "spindle‐shaped" "spitz" "spitzoid" "splice-site" "srIκΒ"
    "srep17714" "srep17766" "srep17869" "srep17873" "srep17879" "srep17910"
    "srep18097" "srep18277" "srep18388" "srep18417" "srep18454" "srep18476"
    "srep18528" "srep18678" "srep18709" "srep18741" "srep18764" "srep18792"
    "srep18949" "srep18995" "srep19020" "srep19050" "srep19312" "srep19546"
    "srep20010" "ss" "st" "stable-dimer" "stage‐specific" "staghorn"
    "stainings" "standard-of-care" "state-of-the-art" "status-specific"
    "steady-state" "steady‐state" "stefins" "stellate" "stem-bark" "stem-cell"
    "stem-cell-based" "stem-like" "stem-loop" "stemloop" "stemness" "stents"
    "step-down" "step-wise" "stepwise" "stg" "stimulators" "storiform"
    "strand-exchange" "strand-invasion" "stress-activated" "stress-associated"
    "stress-induced" "stress-inducible" "stress-mediated" "stress-response"
    "stress-responsive" "stressful" "stressors" "stress–induced" "stromal-like"
    "structurally-divergent" "structure-activity" "structure-based"
    "structure-specific" "structure–activity" "study-wide" "sub-G1"
    "sub-Saharan" "sub-cellular" "sub-clinical" "sub-clones" "sub-cluster"
    "sub-cohort" "sub-cohorts" "sub-domains" "sub-functionalization"
    "sub-functionalizations" "sub-group" "sub-groups" "sub-interface"
    "sub-interfaces" "sub-lethal" "sub-location" "sub-millimolar"
    "sub-nanomolar" "sub-network" "sub-pocket" "sub-population" "sub-region"
    "sub-set" "sub-stages" "sub-stoichiometric" "sub-tests" "sub-toxic"
    "sub-type" "sub-types" "sub-ventricular" "subG1" "subclass" "subclasses"
    "subdomain" "subfamilies" "subfamily-E" "subfractions" "sublines"
    "sublocations" "submotifs" "submucosa" "subserosa" "subset" "subsets"
    "subspecies" "substrain" "substrate‐binding" "substrate–phosphatase"
    "subtype" "succinate-GPR91" "succinate-GPR91-mediated" "succinimidyl"
    "succinyl" "succinyl-CoA" "sulfatase-1" "sulfhydryl" "sulfobetaine"
    "sulfonyl" "sulphoximine" "sun-exposure" "super-enhancer"
    "super-resolution" "superactivate" "supernatant" "supernatants"
    "supershift" "super‐resolution" "suppresser" "suppresson" "supra-molecular"
    "supress" "symptomatology" "synapse" "synapses" "synergises" "synergism"
    "synergisms" "systems-wide" "tail-peptide" "target–the" "taxia"
    "techniques–classical" "telangiectasia‐mutated" "telatinib"
    "telomerase-depleted" "telomerase-expressing" "telomerase-negative"
    "telomerase-positive" "tenovins" "termedATR" "terpene" "tertiles"
    "testosterone–RV" "tet-on" "tetrachloride" "tetrahydroxychalcone"
    "tetrahydroxyflavone" "tetraploid" "tetrapolyploid" "tetrazolium" "tgN3"
    "thanKRASwild‐type" "that14-3-3β" "thatAKT1rs2294750SNPwas" "thatCD200"
    "thatHRAS" "thatJAK1" "thatKRAS" "thatKU55933" "thatLGR5" "thatwas"
    "theCD200" "theDNAdamage" "theEGFRpathway" "theEGFRpathways" "theGCbox"
    "theHER2" "theKRAS" "theNAB2‐STAT6fusion" "theTIAM2Score" "theirKRAS"
    "theta" "thetime" "thge" "thiamine" "thioamide" "thioamides"
    "third-generation" "thirty-fifth" "thirty-five" "thirty-two" "thoraco"
    "thoraco-lumbar" "three-component" "three-dimensional"
    "three-dimensionally" "three-group" "three-marker" "three-step"
    "three-year" "threeAKT1SNPs" "thrombi" "thrombocythemia" "thrombus"
    "thymocytes" "tibialis" "tick-borne" "tight-binding" "tightly-packed"
    "time-course" "time-courses" "time-dependence" "time-dependently"
    "time-lapse" "time-point" "time-points" "time-scale" "time-scales"
    "time-series" "time-window" "timecourse" "timeframe" "timepoint"
    "time–that" "tissues" "tissue‐specific" "titre" "toCD200" "toDNAdamage"
    "toKRAS" "toKRASmutant" "toLGR5" "toWTgroup" "toassess" "toexamine"
    "togeather" "topologies" "topology" "total-p73-knockout" "toto"
    "tower-like" "toxicant" "toxicants" "trans-activator" "trans-membrane"
    "trans-well" "transcatheter" "transcription-PCR"
    "transcription-quantitative" "transcriptome" "transcriptomes" "transducer"
    "transfected-A549" "transfectedATR" "transfections" "transgenes"
    "transheterozygote" "transheterozygotes" "transient-transfection"
    "transposon" "transposons" "transrepress" "transwell" "transwells"
    "trastuzumab-IR700" "treatment-naïve" "treatment-predictive"
    "treatment-use" "triazolopyrazine" "tributyrin" "trichrome" "tricuspid"
    "trihydroxy" "triloop" "trimester" "trimesters" "trimethoxyldalbergiquinol"
    "trimethyl" "trinucleotide" "triphosphate" "triphosphate "
    "triple-knockout" "triple-negative" "triploid" "trisphosphate" "trithorax"
    "tryosine" "ts" "tub-Gal80" "tubGal80" "tube-like" "tubule" "tubules"
    "tubuli" "tumor-adjacent" "tumor-affected" "tumor-cell-autonomous"
    "tumor-node-metastasis" "tumor-normal" "tumor-specificity"
    "tumor-suppressive" "tumor-to-background" "tumorsphere" "tumorspheres"
    "tumor‐suppressive" "tumor‐type" "tumour-induced" "tumour-initiating"
    "tumour-promoting" "tumour-suppressing" "tumour-suppressor" "tumoursphere"
    "twenty-four" "twenty-seven" "two-anchor" "two-cell" "two-group" "two-log"
    "two-month" "two-sided" "two-state" "two-step" "two-tailed" "two-thirds"
    "two-three" "two-three-fold" "two-way" "two-way-ANOVA" "type-1" "type-2"
    "tyrosine-protein" "tyrosine‐protein" "tyrosyl" "ubiquitin-E3"
    "ubiquitin‐dependent" "ubiquitin–proteasome-dependent"
    "ultra-centrifugation" "ultra-fine" "ultrafast" "ultrastructure"
    "ultrastructures" "un" "under-appreciated" "under-expressed"
    "under-expressing" "under-expression" "under-powered" "under-studied"
    "under-treatment" "undergoes" "undergone" "understream" "undertaken"
    "unfound" "unirradiatedlymphoblasts" "univariate" "unmet"
    "untransfectedATR" "untreatedATR" "up-stream" "upto" "up‐regulated"
    "up‐regulates" "up‐regulation" "uracil-tegafur" "urea" "usedp53" "ustin"
    "utero" "v3a" "v3b" "v5" "v5a" "vPRC1" "vacs1" "vacuolar-type" "vacuole"
    "vacuoles" "valgus" "vector-MB231" "vector-U2OS" "vector-only"
    "vehicle-treated" "vera" "verapamil-inhibitable" "verniciflua" "versusKRAS"
    "vesicle-Golgi" "vessels" "vic" "vic-trihydroxy" "vide" "villi" "villus"
    "vitro" "vitrotrans" "vitrotrans-well" "viverrini" "vivo" "viz" "vn"
    "waist-hip" "water-soluble" "wavelet" "weakest" "web-like" "website"
    "websites" "weight-ratio" "well-acknowledged" "well-connected"
    "well-conserved" "well-consolidated" "well-controlled" "well-defined"
    "well-designed" "well-developed" "well-differentiated" "well-documented"
    "well-matched" "well-recognized" "well-separated" "well-studied"
    "well-superimposed" "well-tolerated" "well‐documented" "well‐established"
    "well‐known" "whetherKRAS" "whole-body" "whole-cell" "whole-exome"
    "whole-genome" "wholeBM" "wide-array" "wide-ranging" "wide-reaching"
    "wide-spread" "wildtype" "wild‐type" "with14-3-3γ" "withEGFR‐TKIs"
    "withESCCrisk" "withHGFand" "withKRAS" "withLGR5" "withp53" "wks" "work-up"
    "workers" "workflow" "workflows" "workup" "world-wide" "written"
    "wt-EGFR-driven" "wt-EGFR-overexpressing" "wtBRCA" "wtBRCA1-transfected"
    "wtEGFR" "wtGSK3" "wtPLD1" "wtih" "x-axis" "x-ray" "xl" "xon" "y-axis"
    "yan" "yan-RNAi" "yorkie" "yp1b1" "yr" "z-FA-fmk" "z-score" "z-stack"
    "zinc-coordination" "zona" "zymography" "×10" "×90%" "×FLAG-tagged" "× 10"
    "× 10" "êB" "ĸB" "Δ33" "Δ5" "Δ78" "Δ88" "ΔAAD" "ΔC139" "ΔC2" "ΔCt" "ΔF-box"
    "ΔF23" "ΔF48" "ΔG" "ΔG " "ΔLBD" "ΔLRF" "ΔLRR" "ΔMBII" "ΔN" "ΔN149" "ΔN29"
    "ΔNLS" "ΔNp63" "ΔPIP" "ΔRING" "ΔS" "ΔSH2" "ΔSH2-GFP" "ΔSTAT3" "ΔSwitch"
    "ΔWW" "Δcentral" "ΔΔG" "ΙL‐1β" "ΝF" "ΝF‐κΒ" "ΤΝFα" "α-KG" "α-NF" "α-PCGF1"
    "α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic" "α-defensins" "α-helical"
    "α-helices" "α-helix" "α-mediated" "α-negative" "α1-α1" "α2-α3" "α2β5" "α3"
    "α4" "α5" "α5β3" "α6" "α7" "α8" "α9" "αA" "αA-αD" "αB" "αB-αD" "αC" "αC1"
    "αC3" "αD" "αEGFR" "αF" "αL" "αNF" "αSM" "αSM‐actin" "β-1" "β-COPI"
    "β-N-acetylglucosamine" "β-NAP" "β-barrel" "β-bridges" "β-chain"
    "β-elemene" "β-pol" "β-propeller" "β-propellers" "β-rearrangement"
    "β-sandwich" "β-sheet" "β-sheeted" "β-sheets" "β-small" "β-stands"
    "β-strand" "β-strands" "β-unsaturated" "β1" "β10" "βA-βC" "βa" "βb" "βc"
    "βe" "βf" "βg" "γ-GCS" "γ-GCSh" "γ-TuRC" "γ-glutamylcysteine"
    "γ-irradiation" "γ-phosphate" "γH2A" "γH2AXIGFRIRNSCLCTKI" "κB" "κB-luc"
    "λTOP" "λtop" "μM-DAC" "μM-SN38" "μg" "μg " "μl" "μl " "μmol" "π-π"
    "‘OMIM’" "‘b’" "‘cribriform’" "⁄M" "∆LR-χ" "∆N" "∆SH2" "∆SH2-GFP" "∆β"
    "∆β " "−NESvSrc" "−NLSvSrc" "△716"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-16501-16800*
  '("histologies" "Mir717" "shLacZ" "Qk" "mNSC" "cytologic atypia" "Q3E1-"
    "Q3E1" "M5E1" "100–500kb" "p=0.0003" "p=0.003" "Exon1–9" "MYBtr" "mNSCs"
    "QKI6" "QKI5" "HTH" "non-Angiocentric" "PLGG" "PLGGs" "Q3SE" "=0.0011"
    "p=0.001" "19/19" "MYB driven enhancer" "ΔNp63" "ICN1" "‘cribriform’"
    "co-binds" "MSigDB" "CAGTT" "Enhancer" "primagrafts" "Adenoid"
    "a strong enhancer" "primagraft" "adenoid" "300bp" "JQ1" "3C" "Tormo"
    "Vento" "NSABP" "explane" "around/below" "Dabbs" "OncotypeDX" "Badve"
    "Roepman" "Amsterdam" "BV" "Agendia" "Mammaprint" "PRpos" "HER2pos"
    "re-classified" "HER2neg" "IHC/genomic" "ERneg" "ERpos"
    "the equivocal MapQuant" "histochemistry" "Viale" "Rhodes" "the Cohen’s"
    "Cohen" "MapQuant" "HER2 +" "re-assessed" "pN0" "= 0.78" "AKI" "10‐factor"
    "transcription factor‐binding" "SNPinfo" "‐ AKT" "single‐locus" "rs2949750"
    "high‐risk" "rs1130233" "rs1130214" "rs3803300" "rs12045585" "rs2994329"
    "the mini meta‐analysis" "meta‐analysis" "‐locus" "SNPS"
    "a mini meta‐analysis" "‐analysis" "rs7254617" "JPT" "YRI" "‐way" "‐order"
    "C‐A‐C" "C‐A" "‐C" "= 0.37–0.83" "non‐drinkers" "rs2294750"
    "only three AKT1 SNPs" "‐carriers" "rs2304186" "rs10138277" "rs2494752"
    "rs2494750" "‐environmental" "againstESCCrisk" "‐AKT1SNPhaplotype"
    "threeAKT1SNPs" "ofAKT1SNPs" "‐drinker" "‐drinkers"
    "Further stratified analysis found thatAKT1rs2294750SNPwas"
    "analysis found thatAKT1rs2294750SNPwas" "thatAKT1rs2294750SNPwas"
    "decreasedESCCrisk" "individualSNPs" "andAKT2" "inAKT1" "withESCCrisk"
    "functionalSNPs" "rs2494732" "P = 0.0001" "P = 0.0006" "= 0.46" "OR = 0.70"
    "P = 0.012" "= 0.94" "‐cancer" "3‐kinases" "5‐year" "= 0.70" "ceRNA"
    "competitively binding miR-193a" "miR-193a" "Material/Methods"
    "disease-associated SNPs" "Enhancers" "Clinical/LSDB" "rsIDs"
    "the clinically relevant SNPs" "clinically relevant SNPs"
    "49 065 potentially clinically relevant non-exonic SNPs" "dbSNP" "‘OMIM’"
    "clinically significant putative NRF2 regulatory SNPs" "rs113067944"
    "oxPAPC" "TGACDHDGC" "GTGAC" "GTGACTCAGCA" "TCAG" "TCG" "submotifs"
    "ATGACTCAGCA" "nTGAnTCAGCn" "GSE37589"
    "publicly available NRF2 ChIP-seq datasets" "SELEX" "TGACTCAGCA" "TGAG"
    "TCAGCA" "TGCTGA" "unfound" "disease-associated sequence polymorphisms"
    "disease-associated regulatory SNPs" "rSNPs" "G / A" "non‐small‐cell"
    "‐strand" "γH2AXIGFRIRNSCLCTKI" "AktATMDSBEGFREGFR" "gefitinib‐treated"
    "anti‐caspase 3" "sub‐G 1" "KU55993" "‐G 1" "Gefitinib‐induced" "‐lobe"
    "Mig‐6" "gefitinib‐induced" "EGFR‐TKI" "VMRC‐LCD" "Calu‐6" "PC‐9" "VMRC"
    "‐6" "‐LCD" "‐9" "telangiectasia‐mutated" "the traditional EGFR‐TKIs"
    "‐effects" "EGFR‐TKIs" "Non‐small‐cell" "againstNSCLCcells"
    "gefitinib‐dependent" "thatKU55933" "ofEGFRand/or" "‐TKI" "inNSCLCcell"
    "anEGFRdownstream" "theDNAdamage" "ATMis" "cross‐talk" "ofEGFR‐TKIs"
    "theEGFRpathways" "withEGFR‐TKIs" "‐TKIs" "somaticEGFRgene"
    "theEGFRpathway" "‐sensitive" "‐independent" "Non‐small" "‐talk"
    "non‐small" "GVGD" "possible deleterious VUSs" "VUSs"
    "MUTYH mutation underwent colonoscopy" "colonoscopy" "Fraumeni"
    "an annual mammography" "prophylactic oophorectomy"
    "one received prophylactic contralateral mastectomy" "mammography"
    "oophorectomy" "bilateral mastectomy" "_41251919delGTAAAGAACA" "195X" "£"
    "illumina" "prophylactic mastectomy" "insertion/deletions" "GRP91" "LVH"
    "non-hypertrophic" "atrium" "RV/tibia" "LV+S" "LVEF" "LVEDV" "LVIDd"
    "RVFAC" "RVDA" "RVAWT" "RVIDd" "RV/" "RVSP" "the formerly orphan Gi-" "Gi-"
    "succinyl" "the right ventricular (RV) afterload" "afterload" "adventitia"
    "RVH" "active UC" "Hazza" "Simms" "Ayabe" "signal-to-noise-ratio"
    "galvanotaxis" "ß1-integrin" "KCNN1-3" "cytochromes" "Ba 2+"
    "endoscopic biopsies" "-5-" "methylene" "ethoxyphenyl" "Aminoethyl"
    "a Pearson's" "120min" "EBIO" "ChTx" "conductance" "Clt" "IbTx" "UC" "= 8"
    "+44" "3 +" "1 +/-" "Thr202/ Tyr204" "5c" "& Methods" "IL-32γ" "IL-32β"
    "IL-32θ" "= 0.041" "unirradiatedlymphoblasts" "signallingin" "Catts"
    "Serverand" "Consurf" "apoptosisare" "~35nm" "fallen" "thetime" "~0.15"
    "toexamine" "60 ns" "using Bayesian classifier" "PolyPhen2"
    "afterBonferroni" "KF" "JX" "GenBank" "Tamil" "VAR" "Sadaat"
    "Polymorphism (SNP)" "etio" "astrong" "asignificant" "showedthe" "GROMACS"
    "deleteriousness" "toassess" "PROVEAN" "nsSNP" "= 0.05"
    "TNF α -stimulated HAECs" "SnPP" "CECs" "McClung" "Biliverdin" "biliverdin"
    "shNrf2" "shHO-1" "antiplatelet" "INN" "6 h" "Anti-inflammation"
    "polyphenols" "erinacines" "Zan" "EA-hy926" "adhesiveness"
    "adhesion molecule-1" "absolute lack/inhibition" "DCFH"
    "TNF- α -induced MMP and adhesion molecule activation/expression"
    "activation/expression" "only 100  μ g/mL" "zymography" "basidiomata"
    "sMaf" "proliferation/migration" "-glutamylcysteine" "erinaceus (HE)"
    "erinaceus" "Hericium" "P13K" "1/2 " "8 h" "κ B" "capillary-like"
    "autoinactivate" "Phosphosite-specific" "OD2" "OD1"
    "Supplemental Table S4A" "NZ" "These included 477 activatory phosphosites"
    "UniProt" "phenylarsine" "T207/T190" "GGSFPLSPGKKGG" "Kinex" "MEK1-ΔN3EE"
    "AxK" "phosphosite" "GxGxxG" "PhosphoNET" "PhosphoSitePlus" "yr" "TEY"
    "EPKs" "subdomains" "subdomain" "phosphosites" "4 h" "ΔN"
    "10.1038/srep20010" "Carlier" "Hoss" "El" "Ndong" "Kuorilehto" "Kolanczyk"
    "Nf1Col1" "Nf1Prx1" "Kühnisch" "Apoil" "Crawford" "DOE" "f_BC" "_bc" "gvc"
    "3cb" "_BC" "multiscale" "an ubiquitous protein expressed in osteoblasts"
    "periosteum" "state-of-the-art" "closely mimic diabetic pathophysiology"
    "chemoattractant" "tubuli" "highly proliferating microvessels" "ASMA"
    "tubule" "AQP" "VCAM" "HMVECs" "HAECs" "IX71" "N = 7" "Non-viral"
    "10 μg/mL" "= 21" "Paraspeckle" "interchromatin" "Paraspeckles" "MEN"
    "targetscan" "NEAT1-2" "NEAT1-1" "paraspeckles" "LSCC" "NEAT1"
    "paraspeckle" "siRNA-1" "10.1038/ncomms10553" "Thornton" "DJ" "mMcl-1"
    "necrosome" "Mitotracker" "Vβ" "TRBV" "Jβ1" "Jβ2" "TRBV19" "TCRα" "Jα" "Vα"
    "J-induced" "DN3" "J-mediated" "active p38 MAPK" "/Ser 389" "/Thr 390"
    "knockin" "6 p" "36 h" "X-irradiation"
    "the stroma around particular breast cancer subsets" "1.06E-4" "Finak"
    "Karnoub" "PyVmT" "co-implantation" "Agelastatin" "S7b" "S4c" "oroidin"
    "AgelA" "Co-culture" "tumorspheres" "tumorsphere" "nucleate" "co-evolution"
    "three-dimensional mixed cell co-cultures" "n  = 15" "3 × 10" "siAKT"
    "self-renewal marker SSEA4" "Agar" "Patel" "Miranda" "-hNT-2" "AP"
    "immunodeficient nonobese diabetic/severe" "miR-302a" "hNT-2" "miR-302s"
    "hPSC" "hPSCs" "meaningfulness" "Grecchi" "Valdiglesias" "Wallis"
    "glatiramer" "T2w" "CIS/early" "EDSS" "Immunocytochemistry" "= 0.025"
    "= 0.06" "= 0.20" "p = 0.05" "n = 18" "n = 15" "= 10" "= 0.12" "= 0.17"
    "= 0.62" "= 12" "co-immunostaining" "= 27" "a unique comparative dataset"
    "NPVof" "IHC/FISH" "TargetPrint" "MINDACT" "= 0.65" "= 0.76" "= 0.87"
    "10.1038/ncomms10530" "Walter" "H3S10p" "re-licensing" "AKRA" "RKRL"
    "Cdc6p" "35S-labelled" "dl93–100" "MR/AA" "Arginine-X-Leucine"
    "the amino-acid sequence MRYIL" "Cy" "MRYIL" "minichromosome"
    "re-replication" "Anti-Flag" "2 h" "H3S10" "co-staining" "5-ethynyl-2"
    "=10" "Oxford" "NKI" "Diego" "Datasets" "CTC" "nonadherent mammospheres"
    "caliper" "BC3-p53KD" "BC3-p53WT" "KD" "retroviruses" "WU" "CTCs" "≤0.05"
    "S2D" "4 h" "EGR" "ALGG" "co-amplified" "ALGGs" "17/18" "H2592del"
    "R1302fs" "_ splice" "OncoPanel" "Histology" "29-year-old"
    "immunochemistry" "non-SFT" "aCGH" "_splice" "Oncopanel" "DFBWCC" "6/7"
    "co-deletion" "1p" "Rountree" "fibrotic EndMT" "Ser154residue"
    "3mM inorganic phosphate causes EndMT" "hyperphosphatemia"
    "pathological EndMT" "endocardium" "EFE" "tricuspid" "monophophosphate"
    "prokaryotes" "EndMT" "HCAEC" "Co- Immunoprecipitation" "4×10"
    "10.1038/srep19546" "Åkerström" "CYP11B2/B1" "Perhaps" "ZG-like" "11/24"
    "NHPAs, CPAs" "NHPAs" "hyperaldosteronism" "glomerulosa (ZG)" "ZG"
    "glomerulosa" "zona" "aldosteronism (PA)" "aldosteronism" "+ 1" "≥50"
    "H-score" "= 8" "NHCH" "agonist-like" "O15" "sulfonyl" "T878A/S"
    "H875Q/T919S" "W742L/C" "VPC-14449" "BAG1L" "Function-3" "ARN509"
    "H875Y/T878A" "F877L/T878A" "EC50" "T878A/S889G" "T878A/D891H" "EC50 "
    "VC-001" "VC-012" "MiSeq" "14/62" "WGA2" "VPC-13566" "BF3" "17A1" "CRPC"
    "90 min" "n = 3" "co-regulators" "= 25" "= 0.030" "n = 7" "co-chaperones"
    "10.1038/srep17714" "Yarmolinsky" "functionally relevant SNPs"
    "nephropathy" "Eliasson" "Davidson" "Kanaya" "incident T2D" "WC" "WHR"
    "Festa" "tertiles" "1.60–2.96" "glycemia" "=0.12" "-sub-group"
    "non-significance" "Meigs" "Stranges" "1.28–2.18" "OGTT" "postload"
    "980 incident T2D" "IGT" "Procoagulant" "T2D" "non-diabetic" "n=15" "=0.23"
    "=0.02" "=6" "co-morbidities" "epigenetic/transcription" "mortem" "synapse"
    "GAD" "neurites" "perimortem" "hippocampi"
    "the neighboring hippocampal cell layers stratum pyramidale or stratum radiatum"
    "radiatum" "pyramidale" "HiB5" "shRNAi" "postmortem" "CA3/2" "oriens" "SZ"
    "Co-localization" "1 h" "4 h" "2-day" "~30%"
    "the BRCT domains 7/8–targeting CalAM" "CalAM" "ΔAAD" "A–positive" "WCLs"
    "siBRCA2" "IIβ" "PARPis" "PARPi" "7/8" "n = 17" "pH3 S10" "IIβ-binding"
    "transcription factor p65NFκB" "p65 NFκB" "non-steroidal"
    "both active p65NFκB" "MEK-siRNA-" "D-domain" "NCI" "Huber" "sion"
    "p65NFκB" "non-toxic" "N0–2" "the bacterial genome"
    "Western and Northern Europe" "alkyl" "antrum" "cardia" "Kaunas" "n  = 7"
    "gastric neoplastic mucosa" "one-time" "J/cm 2" "Tra" "MFI" "IRDye700DX"
    "photoimmunochemotherapy" "IR700" "epidermal growth factor-2"
    "molecular optical imaging-guided cancer phototherapy" "phototherapy"
    "Photoimmunotherapy" "= 0.0414" "= 0.0024" "n  = 3" "2 h" "Mi2β" "Belancio"
    "multiplrotein" "Bojang" "methylated H3K27" "methyltransferase-1"
    "non-target" "L1 RP" "HDACs1" "MBD2/3" "L1RP" "ORF1p" "Mi2" "Element-1"
    "1 h" "Gö6976" "Shef5N" "histone 2AX" "MIFF1" "MIFF4" "MIFF3" "TdR" "HFF"
    "brachyury" "embryoid" "SSEA4" "MIFF" "HFFs" "peptidoglycan"
    "herpes simplex virus-1" "HSV-1" "A strong synergism" "non-silencing"
    "speck-like" "iGLuc" "Ac-YVAD-CMK"
    "The Gram-positive bacterium Staphylococcus aureus" "aureus" "≤ 0.05" "2–3"
    "NOD-like" "0.6kbp" "anti-phospho" "0.6 kbp" "ΔSTAT3" "-Prom-Luc" "pGL-3"
    "renila" "choline" "biomembranes" "NAFLD" "1 X" "non-alcoholic" "300 bp"
    "supress" "S4/S8" "exo-" "exo" "DnaQ" "campthotecin" "DBS-repair" "DBS"
    "EXD2" "6P" "BLM-DNA2-RPA-MRN" "Matsunaga" "SW1900/GEM" "Taba" "EUS"
    "Iwamoto" "HSPH" "HSPB" "B7H4" "Hoff" "febrile neutropenia" "neutropenia"
    "Conroy" "hENT1" "Olympus" "Zhongshan" "-diaminobenzidine"
    "diaminobenzidine" "WesternBright" "UVP" "ChemiDoc" "Menlo" "Advansta"
    "Sirius" "PBST" "electro" "Tokyo" "RNAfast" "Milford" "UniProtKB" "uniprot"
    "SEQUEST" "MS/MS" "CID" "Velos" "·min −1" "Milli" "nLC" "micropipette"
    "Ziptip" "coomassie" "SpeedVac" "IAA" "ammonium" "BCA" "aliquots"
    "Switzerland" "Basel" "Roche" "Waltham" "RIPA" "hnRNPC1/C2" "hnRNPA2B2"
    "HnRNPs" "β-1" "FASP" "Qiao" "Uen" "Aquino" "collagens" "hnRNPC" "hnRNPR"
    "hnRNPs" "Reactome" "gene/protein" "Proteome" "iTRAQ" "biospecimens"
    "omics" "endoscopy" "2 h" "10.1038/srep19312" "prioritise" "Lipinski’s"
    "Lipinski" "ZINC08792355" "ZINC08792229" "ZINC08790006" "Medicines@Taiwan"
    "‘b’" "thioamides" "generalise" "thioamide" "RMSE" "implausible IC 50"
    "PubChem" "Vina" "QSAR" "tenovins" "AutoDock" "non-biased" "= 0.87" "≥ 50"
    "IC 50  " "kcal/mol" "PrognoScan" "lucitanib" "ER‐positive" "‐lank" "‐rank"
    "ER‐positive/HER2‐negative" "gain/amplification" "‐score"
    "FGFR1 gain/amplification" "307 ER‐positive/HER2‐negative"
    "90 (29.3%) patients underwent total mastectomy" "3‐kinase"
    "Fibroblast growth factor receptor‐1" "‐HER2"
    "epidermal growth factor receptor‐2" "ofFGFR1" "betweenFGFR1"
    "a comprehensive analysis ofFGFR1at" "ofFGFR1at"
    "fibroblast growth factor receptor‐1" "betweenERand" "BGJ398" "= 0.032"
    "= 0.019" "= 0.70" "P  = 0.015" "MIB‐1" "60 min" "‐Actin"
    "‐activated protein kinase" "= 0.039" "the scirrhous histological subtype"
    "mpk" "SNU-620" "SNU" "quinoline" "PF-04217903" "Cui" "mTor" "Weinstein"
    "HTRF" "pyridoxazine" "triazolopyrazine" "IC 50 s" "in 1 X" "1 h"
    "several bioinformatic websites" "Gastrokine" "6-day" "pMIR" "siScramble"
    "siNFKB1" "Monolayer" "siRELA" "Lauren’s" "miR-508-3p" "36 h" "=25 " "=10 "
    "= 0.033" "= 0.155" "28-day" "P  = 0.052" "P  = 0.012" "NF-κB1" "hTERTm"
    "Papathomas" "landa" "Gandofi" "The recurrent pTERTm" "Egberts" "HRs"
    "Sweden" "Austria" "pTERTms" "Gandolfi" "noncarriers" "pTERTm" "p = 0.0005"
    "= 25" "non-Asian" "chr5:1,295,228" "immature ileal explants"
    "the immature cecum" "Explants" "SB203508" "the immature ileal explants"
    "mature ileal explants" "immature ileal and cecal explants" "cecal"
    "human fetal intestinal explants" "60 min" "4h" "1h" "2h" "60min" "villi"
    "observedin" "villus" "ontogeny" "hyperoxia" "NFĸB" "the neonatal ileum"
    "ileum" "NEC" "partum" "IEC" "# 1" "2-3" "N = 3" "6h" "2/5" "Hodgkin" "XTT"
    "aBRAF" "bead-based ELISAs" "Luminex" "inibitors" "insuline"
    "a bead-based ELISA" "KRAS4A/4B" "weight/body" "LW/BW" "transposon"
    "Haigis" "Millan" "KRAS4B" "LW" "transposons" "=15" "oxygenase-1"
    "SCFβ-TrCP" "oxygenases" "proteosome" "Tg" "MTA1+/+" "MTA1−/−" "×90%" "**p"
    "anti-sense" "10 μg/ml" "MTA1 expression" "Ozgo" "Wardwell"
    "underwent radical gastrectomy" "LNM" "ΔCt" "≥2-fold" "mucosae" "Seo"
    "1900s" "5-Ethynyl-2" "G1-S" "pyrazole" "propyl" "Karin"
    "encephalomyelitis" "anti-inflammation" "Laere" "Marzo" "Platz" "Daniels"
    "loxP" "Yeh" "PCa:CAF" ":1 × 10" "co-injected" "PCa:CAF "
    "infiltration/accumulation" "CWR" "migration/infiltration" "/22Rv1"
    "co-implanted" "co-implants" "IVIS" "/RAW264.7" "Mφ" "non-ERE" "TME" "= 10"
    "≥2 " "acini-like" "non-genomic" "‐kinase" "HGF/c‐Met‐mediated" "Jiang"
    "p‐Met‐positive" "Xiang" "‐angiogenic" "anti‐HGF" "‐HGF" "‐HCC" "‐catenin"
    "‐MET" "sorafenib‐induced" "MV‐soR" "Huh7‐soR" "F‐actin" "‐soR"
    "‐differentiated" "HGF/c‐Met" "sorafenib‐resistant" "‐blind"
    "cancer‐related" "withHGFand" "c‐Met" "inhibitorSU11274" "‐Met" "HCCcells"
    "‐resistantHCCcells" "advancedHCCpatients" "annexin V/propidium" "** P"
    "* P" "‐linked" "bright‐field" "mg/mL" "long‐term" "‐resistant" "‐line"
    "oncovirus" "LTag" "lrm" "intercalates" "heterotrimer" "E6C" "E6N"
    "heterotrimers" "p53core" "isothermal titration calorimetry"
    "the mucosal and cutaneous epithelia" "LxxLL" "3×10" "=78" "1:1:1" "TBNA"
    "EBUS" "Proietti" "3-months" "Maria" "ADC histologic subtype" "12/91"
    "PLEs" "FNAs" "adenocarcinoma (ADC) histologic subtype" "FNA" "kirsten"
    "P = 0.41" "= 0.87" "Non-small-cell" "Orantinib" "disomy" "Egger's"
    "Begg's" "1.06–1.58" "1.22–2.60" "1.07–1.78" "1.92–3.60" "1.57–2.63"
    "264/3178" "SQCC" "= 2.0%" "pack-years" "pack-year" "Denmark" "Sugie"
    "Kopp" "NF- κ B1" "1.48–2.92" "1.15–2.18" "del/del"
    "COX-1 (50C>T) polymorphism, and COX-2 (-1195G>A) polymorphism" "-826C"
    "ins/del" "= 0.76" "= 0.85" "= 0.23" "= 0.13" "= 18" "Jang" "Goel"
    "Waniczek" "pseudogene" "= 0.014" "6H" "P  = 0.011"
    "aggressive histologic subtype" "co-mutation" "15∼21" "co-alteration"
    "Kosaka" "E20ins3dup" "the histologic subtype" "pStage" "E19del" "18∼21"
    "G719X" "_Y764insFQEA" "Breslow" "and 2 nd" "P = 0.015" "P = 0.002" "n = 3"
    "∼10%" "∼40%" "∼45%" "SNP polymorphisms" "T1D" "British"
    "intronic SNP rs13031237 and rs702873 SNP"
    "The intronic rs842647 GG polymorphism" "PRCKQ" "Turkish" "GIMAP" "HLA-A26"
    "aphthae" "multisystem" "pathergy" "rs947474" "rs11258747" "rs4750316"
    "rs13031237" "rs702873" "rs842647" "RFLP" "Behcet’s" "Behcet" "Th17"
    "= 0.011" "Lonati" "/Ser 643" "Jalouli" "sh-PIN1 virus" "sh-PIN1virus"
    "ROIs" "HCT116/5xHRE-ODD-luc" "5xHRE-ODD-luc"
    "The subcellular co-localization" "lamda" "pSer/Thr-Pro" "isomerizes"
    "Ser/Thr-Pro" "-1α" "Peptidyl" "1 x 10" "8 h" "tube-like" "Scheffler"
    "deletion/monosomy" "1O1G" "commonest" "cytology" "squamous histology"
    "D4D6" "CEP6" "non-rearranged" "LCC" "Spanish" "rearrangedreceptors"
    "monosomy" "gains/amplifications" "=0.028" "non-small cell lung carcinoma"
    "blockers" "siRNA1" "melanogaster" "Kv" "à" "10  μ L" "DCJ" "CAW"
    "‐oligomerize" "‐terminus" "Schinzel" "cryo‐electron" "cryo" "‐electron"
    "OMVs" "Antonsson" "‐organization" "inner‐mitochondrial" "Yamaguchi"
    "Frezza" "Cipolat" "‐mitochondrial" "‐homogeneously" "Jans" "Mic60"
    "Alkhaja" "Malsburg" "Hoppins" "Harner" "multisubunit" "Scorrano" "MICOS"
    "Montessuit" "Arnoult" "Estaquier" "Parone" "Z‐VAD‐FMK" "‐VAD" "‐axis"
    "‐SY5Y" "arc‐shaped" "Wurm" "Jakobs" "‐shaped" "‐Bax"
    "almost all Bax‐positive" "Bax‐positive" "super‐resolution" "nanoscopy"
    "‐resolution" "TOM" "‐point" "‐FMK" "Karbowski" "ring‐like" "Schafer"
    "Manon" "Renault" "Kuwana" "Baines" "Bax‐induced" "so‐called" "Nechushtan"
    "Eskes" "Wolter" "Todt" "Schellenberg" "Edlich" "Moldoveanu" "Youle"
    "Martinou" "Bcl‐2" "Kluck" "intermembrane" "pro‐apoptotic" "Tait" "Kroemer"
    "Yankner" "Mattson" "Korsmeyer" "Vaux" "Hotchkiss" "et " "‐delineated"
    "forMOMP" "Dual‐color" "dual‐color" "‐associated" "‐called" "‐apoptotic"
    "10.1038/ncomms10420" "Tien" "vacuole" "midpoint" "centroid" "Y430F/Y515F"
    "phosphatome" "co-suppression" "Darby" "Madin" "homology-2" "p44/42 MAPK"
    "Re-introduction" "re-introduced" "Adham" "VGEF" "Secord" "ICON7" "OCEANS"
    "GOG" "Engels" "=0.237" "=1.40" "=0.025" "=0.015" "=52" "P=0.011" "P=0.021"
    "serous/non-serous" "P=0.030" "serous/non-serous histological subtype"
    "=0.030" "=0.034" "=25" "=0.0006" "=0.0003" "=0.008" "7 +" "=0.24" "=0.021"
    "=0.011" "bioinformatic algorithms" "anti-oncogenic" "G 1 /S"
    "re-sensitize" "SNVs" "CHPv2" "BxPc3GEMR" "OSI" "BxPc3OSIR" "BxPc3AFR"
    "BxPc3GEM" "blocker" "non-small" "=0.012" "RNA/Protein" "mg/ml"
    "characteristcs" "histological subtype" "adeno-" "3q25-27" "hsa-miR-145-5p"
    "using nonparametric Mann–Whitney" "non-smoking" "p  = 0.001" "10 μL"
    "non-small cell lung carcinomas" "stem cell-like" "Virmid" "MuTect" "HME"
    "ILAE" "Focal cortical dysplasia (FCD)" "utero" "FCD" "FCDII" "‐redundant"
    "pharma" "Pladeinolide" "Sudemycin" "cap‐dependent" "‐03814735" "‐RAS"
    "‐overexpression" "Toyoshima" "MYC‐induced" "‐oncogene"
    "MYC‐overexpressing" "‐201" "Schiff" "MYC‐dependent" "‐repression" "Omomyc"
    "Antisense/ASO" "‐translational" "CELF1" "turnover/stability" "‐quadruplex"
    "MYC‐specific" "‐150" "‐loops" "‐suppressive" "non‐coding" "‐coding" "RPL"
    "‐rRNA" "MYC‐regulated" "‐transcriptionally" "MYC‐driven" "AUBPs"
    "‐overexpressing" "‐Gcn5" "‐Ada" "A‐Raf" "‐Raf" "‐raf" "‐mRNA" "‐driven"
    "MYC transcriptionally up‐regulates S‐Adenyl" "‐Adenyl" "CBC"
    "‐methylguanosine" "post‐transcriptional" "‐transcriptional" "‐wide"
    "E‐boxes" "CACGTG" "co‐factors" "‐MYC" "‐Myc" "‐acetyltransferase"
    "‐keeping" "‐of" "‐amplified" "DNA‐binding" "S3I" "‐ dependent"
    "well‐established" "full‐length" "up‐regulates" "‐terminal" "non‐canonical"
    "‐boxes" "‐factors" "RpSPVF" "dimerizes/oligomerizes"
    "interaction/dimerization" "C–5E" "IRIF" "-Ab2p" "GEGE" "pS 404" "SAXS"
    "BRCT/CtIP" "a 2:2" "electrospray" "ASUs" "ASU" "pSxxF" "GAAYDIpSQVFPFAKKK"
    "BRCT/Bach1" "pS404" "pS406" "BRCT-Ab1p_short" "carboxyl" "αL" "Helices"
    "BRCT-Ab2p_short" "YpSRpSPTF" "Ab2p" "GFGEYpSRpSPTF" "2p" "_short"
    "YSRpSPTF" "BRCT-Ab1p" "GFGE" "GFGEYSRpSPTF" "pS404pS406" "PTF" "GFGEYpS"
    "pSPTF" "phosphopetide" "phosphopeptides" "Bach1/FancJ" "HBOC" "SPxF"
    "BRCT/Abraxas" "serine-proline-x-phenylalanine" "pSPxF" "4 Gy"
    "non-catalytic" "Neoadjuvant" "Pairwise" "lumpectomy" "=27" "=24" "=45"
    "phosphatidylinositide" "basal/mesenchymal" "Ecadherin" "LABC" "NOAH"
    "NeOAdjuvant" "emboli" "erythema" "pJAK2" "IDC" "=0.0001" "≥50%" "JAK 1/2"
    "non-adherent" "Austin" "FRAX" "hCNT" "hENT" "synergises"
    "pyridopyrimidinone" "glaucarubinone" "FOLFIRINOX" "Group 2" "‐canonical"
    "‐regulates" "‐modulatory" "‐known" "‐derived" "αSM‐actin"
    "commitment/differentiation" "‐expanded" "‐established" "NF‐κΒ"
    "GFP‐encoding" "‐encoding" "‐srIkB" "non‐transduced" "‐srIκB" "‐transduced"
    "ΝF‐κΒ" "TNF‐α‐stimulated" "co‐ expressed" "‐ expressed" "NF‐κB" "‐κΒ" "ΝF"
    "A similar significant down‐regulation" "‐stimulated" "up‐regulation"
    "IL‐1β" "TNF‐α" "‐regulation" "‐α" "‐day" "‐γ" "‐8" "DXM" "non‐treated"
    "‐state" "‐cellular" "‐sorting" "‐inducer" "PPARγ2" "αSM" "‐actin" "WB"
    "cells/cm 2" "rMFI" "‐factor" "pro‐osteogenic" "‐grading" "‐F" "CFU‐Fs"
    "‐Fs" "‐renew" "‐fibroblasts" "Charbord" "Fs" "pathway:NF‐κB" "culturedBM"
    "‐κB" "‐osteogenic" "pro‐inflammatory" "ofCD200" "down‐regulated"
    "‐inflammatory" "orBMP7" "MSCcultures" "wholeBM"
    "bone marrow mesenchymal stem/stromal cells" "± 16" "‐treated"
    "‐containing" "P = 0.004" "‐expressing" "QRT‐PCR" "−7" "benign PPGLs"
    "48/548" "49/950" "Müller" "up‐regulated" "‐regulated" "screenings"
    "Eisenhofer" "Pragnell" "Balmain" "Andersson" "penile" "Castro‐Vega"
    "microarray‐based" "HRAS‐ mutated" "‐test" "‐tailed" "‐ mutated"
    "11 mutated PPGLs" "apparently sporadic PPGL" "‐occurrence" "Costello"
    "Cubas" "‐mutated" "sporadic PPGL" "Castro" "‐Vega" "sporadic PCCs"
    "‐workers" "Oudijk" "3 mutated PCCs" "active kinase‐signaling pathways"
    "SDHx" "Burnichon" "Crona" "Yoshimoto" "Luchetti" "Juhlin" "Fishbein"
    "Cascón" "Wadt" "KIF1Bb" "Schlisio" "Letouzé" "Dahia" "paraganglia" "PGLs"
    "PCCs" "‐signaling pathways" "benign PPGL" "sporadic PPGLs"
    "the Harvey rat sarcoma viral oncogene homolog ( HRAS )" "homolog ( HRAS )"
    "Harvey" "PPGLs" "PPGL" "PGL" "PCC" "‐protein" "= 0.37" "P  = 0.76"
    "‐related" "Pfizer" "only one biopsy" "No mutational subsets"
    "a significantly higher ORR" "≥59" "≥2" "approximately 5–7" "4-week-on"
    "mg/day" "non-interventional" "ORR" "+1" "re-evaluation" "atorvastain"
    "atorva" "T/C" "RTV" "LAST1" "pCMV" "dichloride" "PIMO" "Hypoxyprobe"
    "LATS1/2" "MST1/2" "molecules/signaling pathways" "mevalonate" "5SA"
    "Martino" "Trang" "oncomiRNAs" "pEZX" "heptamer" "8h" "re-analysis"
    "miScript" "approximately 22 bp" "Tessoulin" "anti-myeloma" "±SD"
    "Co-treatment" "anti-MM" "34a" "MRD" "nos" "=26" "-TKD" "TKD" "⩾10"
    "=0.019" "=0.0252" "3-year" "n =18" "=2" "=5" "=0.03" "P =0.005" "miRs"
    "MiR-23b" "chr" "Clara" "BCMW1" "SureFIND" "pathobiology" "miR-23b"
    "Waldenstrom's" "Waldenstrom" "μl " "SpIDA" "CHKA" "BMjX" "E2/S1P" "1–7"
    "angitensin-" "angitensin" "Mas" "Osteoblasts"
    "formyl peptide receptor-like" "PKT" "EGF-like" "carbachole"
    "hydroxytryptamine" "TMPS" "Ullrich’s" "Ullrich" "Sos" "re-association"
    "Gγ" "Gβ" "Gα" "acetylcoline" "Metabotropic glutamate/pheromone"
    "biorhythms" "Trks" "AT 1 R" "ZYG11B" "Pawlak" "ZYG11" "data/dots"
    "immunohistochemistry (IHC)" "Google" "ZYG11A" "=0.016"
    "a gastric cancer cell line AAZ521" "AAZ521" "Cheng" "ofKras" "mPanIN"
    "Ijichi" "ofK" "HPNE" "decreasedKRAS" "Kamohara" "Takamori"
    "implicatedKRAS (G12D) -induced CXCLs" "implicatedKRAS"
    "thatKRAS (G12D) -induced CXCLs" "cancerHRAS" "hCXCL" "thatHRAS" "Sagi"
    "Sparmann" "togeather" "just CXCLs" "CXCLs"
    "the human pancreatic duct-derived HPNE/-KRAS cell model havingKRAS"
    "havingKRAS" "linkKRAS" "cre/+" "CXCL" "CXCR" "mediatingKRAS" "shCXCR2"
    "Masson's" "trichrome" "Masson" "E6-E7-st" "IHCs" "E6-E7-st-KRAS-NSC"
    "E6-E7-st-KRAS-shCXCR2" "modulatesKRAS" "inhibitsKRAS" "hCXCR2" "hCXCL1"
    "exogenous expression ofKRAS" "whetherKRAS" "mCXCL2" "mCXCL5" "mCXCL1"
    "mCXCR2" "theKras" "regulatingKRAS" "Matsuo" "ELR"
    "the most frequent (90%) histological subtype" "U -test" "IRB" "Cincinnati"
    "Emory" "neurobiology" "non-neuronal cells" "Sidak" "pS6/S6" "Tukey"
    "CTR-2" "S1d" "Dunnett" "simplex" "SSCs" "SSC" "CNVs" "Simplex" "AGRE"
    "pathomechanism" "1p36" "= 0.005" "p  = 0.76" "= 0.011" "= 0.017" "= 0.021"
    "= 0.0006" "= 0.0002" "= 0.0001" "= 0.0144" "= 0.66" "= 0.013" "= 2"
    "* p  " "–7" "HER2 / HER3" "pNRF2" "-Dichlorofluorescin"
    "Dichlorofluorescin" "prHER3" "prHER2" "Pearson's" "cytofluorograms" "pATK"
    "HER2/HER3" "elicitors" "HER2 /" "6-Diamidino-2-Phenylindole" "nmol/L" "ZJ"
    "JZ" "GY" "WZ" "TY" "JQ" "DG" "XL" "transrepress" "SIRT6 -depleted hMSCs"
    "physical stressors" "H3K56" "UAS" "hVECs" "oxodG" "PX-12" "tibialis"
    "karyotypes" "progeroid" "Gilford" "Hutchinson" "hMSC" "3 × 10"
    "co-localizes" "anti-oxidative" "H3K56Ac" "activator-like" "cytometer"
    "midbrain" "Omics" "ac" "complex 1" "H3K14" "methyl-4-phenylpyridinium"
    "non-histones" "1-Methyl-4-phenyl-1" "oocytes"
    "phosphorylation/de-phosphorylation" "pS824-SUMO-KAP1" "MCF7/shKAP1"
    "timepoint" "co-existence" "DBeQ" "MCF7/shRNF4" "co-opts" "G1-cells"
    "re-entered" "G1-" "re-initiation" "Faconi" "SIMs" "STUbLs" "pS824-KAP1"
    "pCDNA3" "DsbA" "‐L" "CCAT" "‐rich" "‐less" "qRT‐PCR" "3.6‐fold" "‐ to"
    "shLuc" "Sp1‐specific" "1.5‐fold" "and 2‐fold" "_−1211" "_−87" "pGL3b"
    "+82" "‐DNA" "‐linking" "‐Sp1" "biotin‐labeled" "‐labeled" "GC‐box" "‐box"
    "eosinophils" "promoterless" "TF‐binding" "Sp1‐mediated" "TIAM2L" "TIAM2S"
    "6q25.2" "T‐cell" "pairedHCCsamples" "HepaRGcells" "theGCbox" "inHCCcells"
    "ofTIAM2" "1‐2" "P  =   0.001" "=   0.25" "5 × 10" "‐cell" "logit" "cyan"
    "spitzoid" "GCN" "GRCh37/hg19" "sanguilutine" "bafilomycin" "phagophore"
    "Representative photomicrographs" "the acidic vesicular organelles" "3MA"
    "methyladenine" "acidic vesicular organelles" "Caspase-3/7" "caspase-3/7"
    "AnnV" "the tropical tree Aglaia foveolata" "dioxanyl" "rocaglate"
    "Malaysia" "Meliaceae" "Borneo" "foveolata" "Aglaia" "cyclopenta" "-7"
    "μg/mL " "- O -" "gavage" "Immuno" "non-honokiol-treated"
    "representative photomicrographs" "Hs294" "cell migration/image" "Mel1011"
    "photomicrographs" "Mel 119" "NHM" "Nox" "these internal organs/tissues"
    "migration/extravasation" "perpetual aberrant epigenomes" "PEPAKSAPAPK"
    "SAPAPKKGSK" "HAVSEGTKAVTK" "PDPSKSAPAPKKGSKKAVTKAQK" "di-methylated"
    "AVTKAQKKDGKK" "KAVTKAQK" "/MS" "RC170N/h" "non-malignant" "PTENP" "UCA1"
    "RJ" "Flockhart" "HOTTIP" "BANCR" "P  = 0.001" "10 μg/ml" "E-caherin"
    "Mortazavi" "Nishida" "caherin" "cadhern" "Subset" "Group 1" "= 0.041"
    "= 0.018" "= 0.047" "rs3769823" "rs13006529" "Washington" "rs1035140"
    "rs1861270" "email" "1.34–2.92" "non-Hispanic" "pairwise" "HapMap"
    "1.34-2.92" "rs2293554" "rs11899004" "rs6723097" "rs3769825" "rs6736233"
    "rs1045485" "BCAC" "= 5" "95 % CI " "95 % CIs" "≥30 " "p  = 0.0005"
    "95 % CI" "Colley" "Arg2616X" "cm/year" "mg/kg/week"
    "the cerebral peduncles and globus pallidus" "pallidus" "globus"
    "peduncles" "hyperintense" "celiac" "Karyotype" "echocardiography"
    "brachy-" "brachy" "valgus" "cubitus" "13-year-old" "co-occurrence"
    "Allanson" "GHD" "L-dopa" "Fudan" "Sertoli" "nonmalignant" "Montano"
    "Calderon" "α2β5/FAK" "heavier" "firstline" "Sina" "bufatin" "intergrin"
    "α5β3" "the traditional Chinese medicine Chansu" "Chansu" "waf/cip1"
    "anti-metastatic" "Manyam" "McBride" "Amit" "onco-miR-24" "suppresser"
    "Tsukamoto" "Tchernitsa" "Rubinsztein" "Hagenbuchner" "Volinia" "Nava"
    "Organista" "Naito" "MVs" "Bartel" "Ambros" "Huang" "Mansha" "Kilbride"
    "Concannon" "Xiong" "Gretschel" "Hohenberger" "Hartgrink" "Fujita" "TET2"
    "ɑ" "OC" "titre" "STAT6VT" "PF-956980" "differentiation/maturation"
    "TSS200" "DC/MAC" "beadchip" "iMAC" "iDC" "MO-to-iMACs" "MO-to-iDCs"
    "MO-to-iDC" "MO-to-iMAC" "the three biological replicates" "immature MACs"
    "iMACs" "iDCs" "lipopolysaccharide (LPS)" "non-redundant" "MACs" "MAC"
    "methylcytosines" "methylcytosine" "methylome" "epigenomes" "μG/ml" "5hmC"
    "Toll-like" "normal mammary gland explants" "non-transduced"
    "non-endo-reduplicated" "PD21" "immortal BPECs" "05BPEC" "04BPEC"
    "tetraploid" "6p" "11p" "12BPECs" "S2d" "tetrapolyploid" "PD44" "PD6" "ANM"
    "ANMs" "PD30" "PD18" "PD25" "CD-227" "BPEC" "Ince" "14BPEC" "12BPEC"
    "mammoplasties" "transformed BPECs" "LT/st" "BPECs"
    "mammary epithelial growth medium MCDB-170" "MCDB-170" "doublings" "MCDB"
    "MEpiCM" "MEGM" "organoids" "Primaria" "WIT" "senescence-like" "S5a" "20q"
    "17q" "S2b" "on 1 " "10.1038/srep18528" "IFNλ3 " "IFNλs" "MLRA" "IFNλ2"
    "MELD" "CHE" "-Syndrome-Test" "PSE" "PHES" "IL-17α" "IFNλ3" "MHE"
    "non-viral" "P = 0.005" "= 0.019" "‐ray" "‐binding" "‐caspase 3"
    "ADR‐induced" "sip53" "‐induced" "‐b" "‐a" "TAp63γ" "Ad‐p53" "/p53BS"
    "p53BS" "‐rays" "‐LacZ" "‐p53" "kininogens" "stefins" "toDNAdamage" "‐fold"
    "wild‐type" "36 h" "μg /mL" "‐small" "‐mediated" "‐A" "Murai" "CD8 +"
    "NTHi" "diethylaminobenzaldehyde" "RALDH" "Foxp3+" "/Foxp3 +" "Foxp3 +"
    "liposomes" "liposome" "succinimidyl" "carboxyfluorescein" "Teff"
    "COPD-like" "arginase-1+/CD68+" "alveolar size/appearance" "Dox" "dox"
    "littermate" "ĸB" "IKTA" "-κB" "= 0.24" "= 0.21" "κB" "SABER" "Sakai"
    "repeated invasive biopsies" "Mok" "serial biopsies"
    "at least three non-zero" "non-zero" "26/34" "17/24" "ex19del+" "L858R+"
    "copies/mL" "fifths" "cfDNA" "ex19del" "ddPCR" "two-month" "JAK2/STAT3"
    "JAK2/" "procaspase-3" "VCT" "heartwoods" "TMDQ"
    "trimethoxyldalbergiquinol" "traditional Korean" "methoxydalbergione"
    "Leguminosae" "= 5" "1X" "in 1X" "= 6" "untransfectedATR" "-transfectedATR"
    "transfectedATR" "non-ICL-agents" "XRCC6-" "XRCC" "DLD1ATR"
    "proliferation inhibition selectively ofATR s/s" "betweenATR" "termedATR"
    "the bi-allelic hypomorphic ATR splice site mutation 2101 A→G" "A→G"
    "depletedATR" "foci/cell"
    "the fluorogenic CASPASE3-specific substrate Ac-DEVD-AMC 96 h" "siPOLD1-"
    "siPOLD" "fluorouracile" "siPOLD1" "heterozygousATR" "untreatedATR" "onATR"
    "inATR" "andATR" "ofATR" "-deficientATR" "deficientATR" "-Seckel"
    "the classical chemo-" "6 h" "1 -3" "= 2" "4 Gy" "s/s" "HR+/HER2+" "HR+"
    "postmastectomy" "mastectomy" "Schafranek" "Duan" "UT7" "Erythropoeitin"
    "#7" "#6" "NT157" "tetrazolium" "methylthiazole" "shIRS2" "shControl"
    "non-hematological" "10μL" "crizotonib" "inihibitors" "LDK" "MGH006" "DMAG"
    "newest" "Ceretinib" "1151Tins" "ceretinib"
    "the unusual dihydrobenzocarbazole" "dihydrobenzocarbazole" "KRCA"
    "diaminopyrimidine" "WHI" "STE-1" "v3a" "TAE-684" "TAE" "‐3" "3a/b" "fide"
    "Alk" "Jeb" "Mu" "Meprin" "EML1" "TD" "EMAP" "EML" "echinoderm"
    "non-smokers" "protein-like" "three bioinformatic algorithms" "miR-200a-3p"
    "GenEx" "Exosomes" "radiation-induced radioresistance" "SABR" "exosomes"
    "exosome" "miR-208a" "Radioresistance" "co-culture" "G 0 /G 1" "poliploidy"
    "3p21" "Dammann" "the peculiar subtype" "2/8" "CFPAC" "RASSF1G" "RASSF1E"
    "RASSF1D" "PDX4" "PANC" "ploidy" "0/1+" "insulae" "RASSF1F" "RASSF1B"
    "clinico" "2/14" "8/14" "= 0.010" "5/8" "3 + " "2 + " "1 + " "= 6" "nu/nu"
    "10.1038/srep19020" "Purohit" "co-exist" "24mer" "40mer" "6–4PP" "60mer"
    "+9nt" "+11" "+9" "RsaI" "40 mer" "oligos" "9nt" "ApalI" "2nt" "MslI"
    "NspI" "2.1−2.2" "VspI" "Ts" "C-protocol" "expressers" "C+T+S" "C+T"
    "photolesions" "N+" "N +" ": C" "J/m 2" "Curley" "synergisms" "ELISAs"
    "CCDN1" "extracellular signal-regulated kinase 1/2" "mesenchyme" "MSC-CM"
    "PBEC" "= 0.06" "blastocytes" "Sugano" "Kokichi" "telatinib" "Chung"
    "6-hour" "apoenzyme" "its physical interactome" "Sowa" "Interactome"
    "succinate" "oxoglutarate" "siFIH" "siNT" "re-oxygenation"
    "subsequent re-oxygenation" "oxidation/hydroxylation" "non-HIF" "FIH"
    "ANTI-FLAG" "co-activator" "scatter‐type" "cluster‐type" "‐targeted"
    "intestinal‐type" "Rüschoff" "discrepant" "HER2‐positive" "‐1" "Lauren's"
    "Lauren" "NPV" "1+" "or 2+" "‐field" "ISH (DISH)" "ISH" "‐color"
    "andFISHandDISHresults" "andDISH" "byIHC" "inHER2" "ofHER2" "P = 0.0817"
    "cut‐off" "10 μL" "Coronary stents" "stents" "intima"
    "dithiocarbamate (PDTC)" "dithiocarbamate" "Rafiee" "at least 2 h" "SRs"
    "lipoproteins" "low-density lipoprotein-1" "Taqman" "cycler" "vitrotrans"
    "Oncotarget" "PNAS" "cell migration/metastasis"
    "migration/invasion/metastasis" "cell proliferation/viability"
    "migration/metastasis" "Michael" "Charles" "ΔSwitch" "ΔN29" "ΔC33"
    "GLS2-ΔC139" "Ser199/204" "ΔN163" "ΔC139" "anti-Flag" "co-transduced"
    "-triphosphate " "-diphosphate " "triphosphate " "diphosphate "
    "glutaminases" "migration/invasion" "* p" "** p" "1 × 10" "4 × 10" "× 10"
    "2 × 10" "understream" "Cd-treated" "cyclehexamide" "cyclohexamide" "MTIIA"
    "GCS" "glutamylcysteine" "Cd-induced" "Cd" "5 x" "10.1038/srep18949"
    "Sueda" "approximately 6 h" "the regulatory associated protein mTOR"
    "respective monotherapies" "monotherapies" "lysosome/vacuole" "A/A" "10 μL"
    "Thr202/Tyr204" "#10" "Brca1/2" "the G4-stabilizing drug RHPS4"
    "mitotic DSBs" "approximately fifteen DSBs" "S7B" "TWI " "TWI" "RHPS4"
    "replication-associated DSBs" "CldU" "DBSs" "PhenDC" "and 2E" "F/F"
    "CO-FISH" "TTACGC" "remodeler" "macronuclei" "Stylonychia" "seq" "Zimmer"
    "PDS" "pyridostatin" "S4C" "DLD1" "G-Rich" "Ltd" "PHA-767491" "PHA" "0–3"
    "Seckel" "CCD841" "BJ" "HA1EB-GFP" "HA1EB-GFP-cMYC" "UVA" "VH-10" "VH"
    "homologus" "Sanjiv" "5B" "24 hr" "Lai" "Mihaylova"
    "bacterial lipopolysaccharides (LPS)" "lipopolysaccharides" "bisphosphate"
    "JNJ-26481585" "CS055" "Celgene" "MERCK" "Novartis" "sublocations" "scr"
    "levelmRNA" "de-acetyltransferases" "factor-2" "CHR-3966" "abexinostat"
    "JNJ" "quisinostat" "hydroxamides" "chidamide" "CHR" "pracinostat"
    "givinostat" "Beppu" "tributyrin" "phenyl" "Munshi" "12 h" "*p " "± SD"
    "anti-cleaved" "Polyphen" "Polymorphism" "phosphopeptide" "wtBRCA1"
    "S1164/S1377" "wtBRCA" "phosphorimager" "/S1377" "HA-BRCA1wt" "VSE" "WCE"
    "-X-" "S1189/S1191" "siPlk1" "cellulo" "calicheamicin"
    "more residual γH2AX foci 24 h" "MRN-" "40X" "5X" "pcDNA 3" "S / T"
    "Non-Homologous" "Stellate" "NNK" "Condensate" "analytes" "Bx" "Arginase1"
    "MCN" "CPN" "acute and chronic pancreatitis" "neaoplasia" "reprogramme"
    "Dakhlallah" "COX-2/PGE 2" "+54" "non-5AZA" "sites/regions" "5AZA"
    "anti-fibrotic" "fibroblast/myofibroblast" "2–3 " "SSc" "1×10" "≥1 "
    "5-Aza-2" "β 1" "±6 " "n =7" "blockingKRAS" "inactivateKRAS" "becauseKRAS"
    "multilineage" "the colonic submucosa" "Crohn" "theirKRAS" "asKRAS"
    "dedifferentiate" "withLGR5" "orKRAS" "fromLGR5" "thatLGR5" "inLGR5"
    "ILGR5" "hadLGR5" "situsignals" "orLGR5" "ofLGR5" "hybridLGR5"
    "stochastic LGR5 re-expression" "andLGR5" "theKRAS" "endoderm" "ectoderm"
    "mesoderm" "intoKRAS" "parentalKRAS" "miR145" "endogenousKRAS"
    "lentiviral re-expression" "toKRAS" "harboredKRAS" "pCCL" "expressedKRAS"
    "allKRAS" "versusKRAS" "betweenKRAS" "non-colorectal" "withKRAS" "n = 7"
    "notKRAS" "findin­­g" "forKRAS" "SC-like" "colonoscopies" "inhibitKRAS"
    "byKRAS" "embryonic stem cell-like" "inKRAS" "thatKRAS" "andKRAS" "G1-like"
    "further confirmed mTOR" "the noncancerous lines and 3 basal-like" "PR+"
    "ER+" "6-diamidino-2-phenylindole" "1 x" "10.1038/srep19050" "Cara"
    "Purkinje" "axon" "Netrins" "ASCIZ" "neuron-like" "NAP" "forebrain" "BSX"
    "COPII" "phosphoproteome" "CENPJ" "Werner" "Homologene" "SCDFinder"
    "proteomes" "whose homologs" "S/TQ" "non-differentiated"
    "10.1038/srep18995" "Saengboonmee" "Warburg" "glĥucose" "non-DM" "mg/dL"
    "FBG " "FBG" "REACTOME" "KKU-214" "KKU-213" "H-NG" "KKU" "viverrini"
    "Thailand" "Mellitus (DM)" "Mellitus" "mellitus (DM)" "1 × 10" "12 h"
    "± 6 " "non-communicable" "10.1038/srep18764"
    "previously published dataset"
    "the microarray analysis underwent carotid endarterectomy" "Lyon"
    "endarterectomy" "French" "NetGestalt" "GSE28829" "dectect" "Vavs"
    "occlusive thrombi" "thrombi" "carotid" "biogenic amines" "FcεRI" "amines"
    "overabundance" "CFinder" "proteins/genes" "PPI" "symptomatology"
    "intraplaque" "vascular pathophysiology" "Kd" "gofr" "Bai" "FoldX" "ΔΔG"
    "SHIFTX" "30ns" "20pSer" "18pThr" "15pSer" "enthalpy" "FOLDX" "p53TAD:TAZ2"
    "ZZ" "biomolecules" "TAZ2" "ΔG" "co-transcription" "Jewell" "Guan" "Furga"
    "siSLC38A9" "Newcastle" "Owen" "At least major organelles" "Sabatini's"
    "Superti" "Sabatini" "siScr" "Morrison" "Sean" "amino acid/Rag"
    "arginosuccinate" "ornithine" "re-addition" "L-norvaline" "norvaline"
    "GATOR1" "Carroll" "re-suspended" "5 × 10" "2 × 10" "1x" "24 hr" "~40%"
    "panAKT" "necropsy" "SCR" "240/244" "Phung" "intravasate"
    "gynecological oncology" "Non-specific" "1x10" "PI3KCA" "Fukuyama" "FKTN"
    "retrotransposons" "∼0.05%" "droplet" "NM_033358" "pos" "Centaurus"
    "non-Icelandic" "chr19" "AATAAA" "polyA" "TSD" "_033358"
    "a polymorphic insertion/deletion" "SINE-VNTR-" "HiSeq" "TruSeq" "Nano"
    "rs1830298" "Romania" "Spain" "Netherlands" "rs 700635" "Iceland"
    "Icelanders" "rs1035142" "retrotransposon" "rs700635" "∼2.8" "4 × 10"
    "S6A-C" "PaTu2" "TEPP-46" "TEPP" "RCGTG" "extratumoral origin/vessels"
    "Luo" "PKM1" "isoenzymes" "disphosphate (ADP)" "disphosphate" "S5A"
    "1 × 10" "SGC-7901 cells" "SGC-7901cells" "miR-711-inhibitor-transfected"
    "miR-711-mimic-transfected" "-RASSF1A-transfected" "-vector-transfected"
    "\\b" "3p21.3" "co-treanfected" "Ubi" "co-cultured" "co-cultures"
    "non-cytotoxic" "the active mono-flavones" "Georgi"
    "an incurable monoclonal B-malignancy" "an active mono-flavonoid" "2 × 10"
    "12h" "∼4.5" "ATMi" "Missense" "interactions/associations" "congenita"
    "´-deoxyuridine" "WRAP53β" "g/mL" "co-precipitates" "non-irradiated"
    "10.1038/srep18741" "Kralovicova" "morpholino" "intronic or exonic SSOs"
    "efficient intronic SSOs" "browsers" "DEXSeq" "global transcriptome"
    "1467 coding nonsynonymous SNPs" "U2AF1/U2AF2" "intronic haplotypes"
    "hexamer" "U2AF35a" "Cufflinks" "genes/exons" "isomerise" "eukemia" "ro"
    "SR" "ATM-CHEK2-CDC25-CDC2" "minigenes" "rs4988000" "A longer oligo"
    "oligo" "ie" "Intronic SSOs" "triloop" "exonic splicing enhancers" "MIR"
    "stemloop" "PPT/3" "minigene" "BPS/PPT"
    "a previously reported A-T mutation IVS28-159A" "IVS28-159A" "IVS"
    "phosphorothioate" "a common intronic polymorphism" "rs609261-"
    "-activated exons" "rs609621" "SSO-" "SSO" "ATM-CHEK2-CDC25-cdc2"
    "pseudoexon" "a common intronic variant rs609261" "rs609261"
    "elangiectasia" "taxia-" "taxia" "Transcriptome" "dinucleotides"
    "polypyrimidine" "hoc" "pseudo-3" "intronic SSOs" "pseudoexons" "SSOs"
    "ligonucleotides" "o" "plice-" "plice" "xon (NSE)" "xon" "onsense" "~20%"
    "24 hrs" "S1981" "~90%" "~75%" "DNAp" "DNApF" "p21Cter" "DNA*p" "*p"
    "DNA*pF" "*pF" "FABGdCMP" "BTNE" "apurinic/apyrimidinic"
    "our study supports Liu’s" "14-3-3ε" "that14-3-3β" "that 14-3-3β"
    "in14-3-3β-high" "HL-7702" "Portal vein tumour thrombus (PVTT)"
    "expressionin" "solider" "andother" "cell adhesion/motility"
    "transcatheter" "PVTTs" "14-3-3β" "β as" "to 14-3-3" "= 0.034" "= 49"
    "2×10" "pcDNA3" "HMLE" "S4b" "S4a" "and 2+" "S2c" "superactivate" "BTBC"
    "co-overexpressed" "S3c" "2 × 10" "Biosystems" "TaKaRa" "Premix" "SYBR"
    "Ex" "Dharmacon" "SMARTpool" "siGENOME" "Biochem" "Beyotime" "YPYDVPDYA"
    "EQKLISEEDL" "Immunocomplexes" "in 1x" "5x" "Imager" "TBST" "Laemmli"
    "lysis" "Phospho-ERK1/2" "Dako" "Millipore" "Cruz" "GenScript" "ACCURI"
    "Alexa" "TritonX" "Countstar IC1000" "Amresco" "Dulbecco's" "Gibco"
    "Dulbecco" "NHF1" "Selleckchem" "PeproTech" "AMRESCO" "Genechem" "pCDNA"
    "pQCXIH-N-FLAG" "pRK" "Pagano" "Michele" "degron" "KDM2A/FBLX11"
    "KDM2A/FBXL11" "the only two KDMs" "KDMs" "*4" "*14" "ΔF-box"
    "immunocomplex" "ΔF48" "shKDM2B#2" "shKDM2B#1" "KDM2B-2" "KDM2B-1" "UL"
    "2B" "Non-phosphorylatable" "the electrical impedance" "impedance"
    "suggesting CREG1" "A549-K4R6" "K0R0" "CLPTM1" "TMEM106B" "glycan"
    "glycosite" "CD276" "H/L" "the three technical replicates" "|0.94" "|H/M"
    "QuantiMORE" "SPEG"
    "a Triple SILAC-based/N-linked glycopeptide enrichment workflow" "CREG1"
    "glycoproteome" "N-linked" "BATTLE"
    "Kirsten rat sarcoma viral oncogene homolog (KRAS)" "homolog (KRAS)"
    "hydrazide" "SILAC" "non-overlapping" "sensitizer" "CCL-779" "Paget's"
    "Paget" "autophagic vacuoles" "vacuoles" "V-type" "non-tuberculous" "Renna"
    "with/without" "EM900" "ERL" "multisite" "mTORs" "cargos" "GEF-induced"
    "AZM" "Non-apoptotic" "=0.038" "non-apoptotic" "poses" "hMSCs" "CD90"
    "OsteoDiff" "Kossa" "the adipogenic-differentiated hADSCs" "droplets"
    "AdipoDiff" "ADSC" "hADSC" "ADSCs" "allografts" "hepatocyte-like"
    "cytochemistry" "immuno" "hADSCs" "anti-correlations" "Gianti" "α A" "α 7"
    "α 6" "MDpocket" "pY705" "-α5" "lap-like" "Y694/699" "αA"
    "their sequence-related peculiarities/specificities" "α7" "α3" "…N" "LFA"
    "characteristics/properties" "MONETA" "correlated/anti-correlated" "STAT5s"
    "non-phosphorylated" "the proximal CCD anti-correlates" "anti-correlates"
    "N-extremity" "-helix (CCD)" "-helices (CCD)" "-helices"
    "a sequence-dependent structural rearrangement/adjustment" "αB-αD" "-helix"
    "quasi" "display huge RMSF" "musculus" "RMSF" "RMSFs" "RMSD" "RMSDs" "α9"
    "α8" "α6" "α5" "α4" "694/699" "the crystallographic structures 1Y1U"
    "isomorphs" "1BG1" "1Y1U" "CESAT" "C-extremity" "LGL" "C-term"
    "import/export" "C α" "C  α" "αC" "folding/unfolding" "anti-correlated"
    "5b" "αD" "EU" "LMCs" "pMAPK" "ADZ9291" "H1975/luc" "HCC827/luc"
    "PC-9/ffluc" "gefitinib/erlotinib" "L858R/T790M" "ICGC" "jetPEI" "TB32047"
    "inhibition/apoptosis" "SGS6" "multitarget" "MCL1L" "E6E7" "HDPE-" "HDPE"
    "SGS" "Bclx" "allograft" "1/6" "subG1" "Caspase 3/7" "rs2736100 G" "=49"
    "=18" "rs920778T" "rs2736100G" "pTERT" "Hebei" "rs45136" "rs2853691"
    "Jiangsu" "htSNP" "5p15.33" "rs451360" "rs2736100" "htSNPs" "48h"
    "Haploview 4.2" "=17" "P = 0.005" "= 0.016" "= 0.012" "= 0.013" "= 0.017"
    "P =0.003" "= 0.010" "= 0.41" "= 0.018" "= 0.007" "= 0.69" "polyubquitin"
    "geldamycin" "rapamicyn" "authophagy" "re-establishment" "HBSS" "NeuT"
    "24 hrs" "Morecroft" "invasion/migration" "NCID" "desmoplasia" "Korea"
    "Yonsei" "shGFP" "shRKIP" "/Suppressor" "Maml" "non-treated" "non-tumorous"
    "hairless/Lag-1" "re-organization" "the highly aggressive GBM subtype"
    "the novel tumor-suppressive miR-584-3p" "miR-221/222" "eosin (HE)" "Segal"
    "cytoskeletal re-organization" "anti-migratory" "approximately 24 h" "U251"
    "mispairings" "miR-584-3p" "microRNA-584-3p" "H & E" "co-transfections"
    "anti-invasive" "and 3-methoxy-4-naphthoflavone" "anticarcinogen" "4OH-E2"
    "4-hydroxy-E2" "TBNC" "~6.0-" "~3.0-" "~5.0" "yp1b1" "~2.7-fold"
    "~4.5-fold" "~1.0-fold" "SAhRM" "overridden" "photoproducts" "BRCAness"
    "lobulo" "triple-negative (TNBC) basal-like" "SAhRMs" "αNF" "Ahr" "hyper-"
    "~1.5" "~2.7" "~75 %" "~65 %" "Renaud" "Cejas" "nonadjuvant"
    "pulmonary stereotactic radiosurgery" "radiosurgery" "‐fluorouracil"
    "FOLFIRI" "FOLFOX" "‐sided" "pulmonary metastasectomy" "prethoracotomy"
    "hilar" "secondaries" "a negative prognostic factor inmCRCpatients"
    "inmCRCpatients" "metastasectomy (LM)" "metastasectomy" "toWTgroup"
    "ofKRASmutations" "OSHazard" "LDFS" "toKRASmutant" "forKRASWTpatients"
    "‐function" "hadKRASWTlung" "metastasectomies" "metastaticCRC" "andPIK3CA"
    "the prognostic role ofKRAS" "ofKRAS" "KRASmutant" "= 0.010" "P  = 0.005"
    "Progression‐free" "μ mol/L" "‐embedded" "= 0.012" "progression‐free"
    "P  = 0.035" "cerebrovasculature" "non-transgenic" "callosum"
    "hyperintensities" "the extra-cerebral arterioles" "non-transgenic mice"
    "tgN3" "a typical trial-timeframe" "Rutten" "GOM" "Leukoencephalopathy"
    "on 1 " "C57BL/6 " "colocalise" "endothelia" "co-stainings" "thinner"
    "inhibiton" "epistaxis" "Endothelia" "ought" "monolayers" "hindbrain" "2 +"
    "eSPAN" "ΔPIP" "ΔRING" "IDCL" "interdomain" "protomer" "protomers" "ITC"
    "calorimetry" "orthologues" "microlaser" "polη" "CHROMASS" "reestablish"
    "= 1.00" "100-mM" "4 B" "3 C" "the tumor-suppressive TAp73" "aficionados"
    "circuitry" "Eμ-Myc" "E1a/Ras" "Vikhanskaya" "TAp73α" "mirror TAp73's"
    "distinct temporal realms" "realms" "–7,12-dimethylbenz" "TAp73's" "DNp73"
    "OVERVIEW" "overview" "TAp73" "‐off" "FGFR‐inhibitors" "‐inhibitors"
    "‐TACC3" "tumor‐type" "Uzawa" "‐overexpressed" "HPV‐positive" "0.79–1.77"
    "0.81–1.80" "0.65–1.36" "0.64–1.39" "1/179" "18/522" "124/211" "89/185"
    "‐five" "all OPSCC's" "‐irradiation" "HPV‐negative" "‐positive"
    "copy‐numbers" "OPSCC" "‐documented" "ClinicalTrials" "Identifier"
    "FGFR3‐directed" "‐directed" "‐activated protein kinase (MAPK)"
    "ofHNSCCfrom" "‐numbers" "‐type" "= 0.034" "‐four" "= 0.77" "HER2+"
    "SKBR3-ERB#3" "7-day" "SKBR" "#3" "one-hour"
    "triple negative breast cancer subtypes" "ZR75" "PR+/-" "kg/m 2" "HER2/"
    "24-hour" "around 1~8%" "nod-like" "Limma" "P=0.005"
    "cyclin-dependent kinase inhibitor 1A" "Steiner" "Edmondson" "miR-519a"
    "P=0.0005" "=0.005" "adenomatous polyposis coli" "IBECs" "fusiform"
    "HIBECs" "HIBEC" "ABT-737-mediated" "ABT-737-treated" "ABT-737-induced"
    "Bcl-2-like-2" "xL" "repopulate" "lentivirals" "MFE" "mammo" "Abcam"
    "BrCSCs" "andp53" "miR-449a/b" "miR-449a" "miR-34a/c" "Lize"
    "anti-proliferation" "Tazawa" "exogenous rhSCF" "rhSCF" "pGL3-1118-Mut-5"
    "pE2F1" "pENTER" "supershift" "withp53" "brighter" "Brower" "UCSC"
    "the publicly accessible algorithm MiRStart" "MiRStart" "Toyota"
    "miR-34b/c" "miR-34s" "miR-34b" "miR-34c" "cell survival/proliferation"
    "DMAT" "Ortega" "dihydroxyindeno" "1,3-Dichloro-6-" "furan-2,7-diol"
    "dibenzo" "methoxyphenyl" "CIGB-300" "silmitasertib" "CIGB" "ERE" "kmplot"
    "CSNK2A1" "Written" "‐exome" "‐W" "Inoki" "Yaffe" "S1282_G1285delinsR"
    "K954Qfs" "‐occurs" "TSC‐causing" "_3855delinsG" "tissue‐specific"
    "‐specific" "the only two exons" "automatically associating stop codons"
    "*6" "‐causing" "‐T389" "delex25" "complex‐dependent" "_G1285delinsR"
    "‐dependent" "+ex31" "‐length" "‐Specific" "GTEx" "RNA‐seq" "25/31"
    "Fagerberg" "BodyMap2" "‐seq" "Bodymap2" "‐sequencing" "atand" "Browser"
    "Ensembl" "+ex25:−ex25" "+ex25" "Kimura"
    "two other comparatively more conserved exons" "indel" "Exons" "Olsson"
    "Xiao" "Leiden" "Eggington" "Hoogeveen‐Westerveld"
    "Several computational algorithms" "Adzhubei" "Henikoff" "SIFT" "PolyPhen"
    "Dunlop" "Hoogeveen" "‐Westerveld" "VUS" "large‐scale" "ExAC" "EVS" "NHLBI"
    "Exome" "Northrup" "Wentink" "Jansen" "Mayer" "Khare" "Sancak" "Osborne"
    "Sampson" "hypomelanotic macules" "macules" "exon 5" "11/83" "BRCA1/2"
    "‐scale" "in‐frame" "alloantigen" "Wolberg" "Polyak" "Malpica" "-b" "-h"
    "-g" "g" "–f" "f" "-d" "d" "–b" "-e" "e" "cytomembrane" "Feulgen"
    "Greenberg" "erythrocytes" "PGCC" "at least three times greater"
    "colorectum" "IIhad" "PGCCs" "polyploid" "= 0.012" "= 0.006" "P  = 0.004"
    "1–3 " "5 × 10" "P  = 0.000" "P =0.000" "de-palmitoylation"
    "the most significant PalmB" "microdomain" "Biol" "Misaki" "ABHD17A/B/C"
    "quintuple" ":449-56" "biotin" "acyl" "Chem" "Dekker" "palmostatin"
    "the previously reported PalmB" "monoacylglyerol" "AHO-3" "nanodomain" "hr"
    "ABHD17C" "ABHD17B" "internal organelles" "bromopalmitate" "ABHD17A"
    "ABHD16A" "WWL70" "synapses" "cABPP" "APT1L" "R7BP" "APT1/2" "Huntington’s"
    "Huntington" "L-azidohomoalanine" "azidohomoalanine" "ODYA"
    "re-palmitoylation" "palmitoylthioesterases" "HDFP" "fluorophosphonate"
    "PalmB" "mSH" "APTs" "DHHC" "palmitoyl" "eLife" "DOI" "ABHD17"
    "Palmostatin" "S-palmitoylation" "Non-targeting" "+3" "+ 3" "24 hr"
    "Non-Targeting" "=0.084" "30-minutes" "cyto" "negligible/undetected"
    "non-tyrosine kinase receptor" "predicators" "GSF" "≥ 0.05" "RASS10"
    "Huh7 cells" "AFB1" "5-aza-2" "Pugh"
    "Barcelona Clinic Liver Cancer (BCLC) stage and tumor thrombus" "11p15.2"
    "xl" "Bcl" "5×10" "= 0.020" "= 0.002" "non-cancerous" "Wnt/β-catenin"
    "retrovirus" "the normal colorectal mucosa" "GI" "SATB1/2" "5 × 10"
    "Vivanco" "rarer" "non-hotspot" "re-tested" "microM" "Parikh" "AKT1-3"
    "G49A:E17K" "simplest" "oncology" "non-linear" "bearingJAK1 S" "JAK1/2"
    "inJAK1 S" "controlJAK1 S729C" "controlJAK1 S" "ofJAK1 S703I" "ofJAK1 S"
    "andJAK1 S" "AppTec" "WuXi" "ofJAK2" "COMFORT"
    "essential thrombocythemia (ET)" "vera (PV)" "thrombocythemia" "vera"
    "Western Europe" "Africa" "Saharan" "Monotherapy" "thatJAK1 S" "Transducer"
    "REMBRANDT" "NICD2" "transwells" "isozyme" "atypical PKC isozymes"
    "classical or conventional PKC isozymes"
    "surrounding healthy brain parenchyma" "multiforme (GBM)" "multiforme"
    "Anti-Human" "non-receptor tyrosine kinase" "PMID" "MCW" "Luke’s"
    "Joseph’s" "Joseph" "Elmbrook" "Franciscan" "Wheaton" "Luke" "Lutheran"
    "Froedtert" "Zablocki" "Midwest" "Milwaukee" "Wisconsin" "EDHFs"
    "arteriolar FMD" "Nisoli" "Valerio" "Kotiadis" "mechano" "timeframe"
    "mitoPY1" "Daf-2A" "IIc" "IIa" "499+vehicle" "PTIO" "Zhou" "mitotracker"
    "the mitochondrial-specific antioxidant mitoTEMPOL" "mitoTEMPOL" "non-CAD"
    "papaverine" "incubating atrial or adipose arterioles" "Eitan" "FMD"
    "microvessels" "BIBR-1532" "BIBR" "Human coronary and adipose arterioles"
    "non-nuclear" "co-authors" "Zumla" "Choi" "Utsugi" "CTT" "TGAC" "Tacke"
    "Du" "Quinn" "adenylate" "Serezani" "Verma" "Pahan" "Lu" "Szabo"
    "Zupkovitz" "Galán" "Bryant" "Magombedze" "avium" "Mycobaterium"
    "Hagelkruys" "catarrhalis" "BAHD1" "Lebreton" "AnkA" "phagocytophilum"
    "Anaplasma" "non-virulent" "Koo" "nonpathogenic MTB H37Ra" "Zahrt" "Rohde"
    "live virulent MTB H37Rv" "Middlebrook" "Messeguer" "PROMO" "ALGGEN"
    "Lutay" "Zheng" "Lamph" "Davies" "Kawecki" "Pollack" "Wymann" "Chua"
    "Vergne" "lysozome" "Monick" "Parker" "Stabel" "Kumar" "Delcuve"
    "supernatants" "Romani" "elios" "Roh" "live MTB H37Rv" "H37Ra" "Roth"
    "Allis" "Jenuwein" "Norazmi" "Hossain" "Crevel" "Marr" "Cossart" "Hamon"
    "Arbibe" "Valls" "Akusjärvi" "Punga" "Radkov" "Garcia" "Philips"
    "virulent MTB H37Rv" "H37Rv" "12 h" "Non-adherent" "sensitise" "chamomile"
    "perilla" "tetrahydroxyflavone" "Northern Australia" "javanica" "Brucea"
    "antitumour" "ZnPPIX" "garlic organosulfur" "organosulfur" "cinnamoyl"
    "coauthors" "Wegiel" "sensitises" "IM3829" "cyclohexylethoxy"
    "radioresistance" "mammary MCF-7/DOX" "ETGF" "Thi/PfpI" "Shelton" "chemo-"
    "rSNP" "Suzuki" "N-nitrosobutyl" "hydroxybutyl" "nitrosobutyl" "TPA" "Neh4"
    "Neh6" "STGE" "DGR" "Tramtrack" "dimerises" "DSAPGS" "DSGIS" "ARE/EpRE"
    "Neh" "Moi" "concatemer" "HPV8" "cutaneous HPV8" "complete viral genomes"
    "^E4" "UNC01" "viral episomes" "CHK2i" "viral genomes"
    "stable viral genomes" "VE822" "CIN612" "HFKs" "HFK" "Rad3" "reenter"
    "episomes" "S/G 2" "IP-MS" "tryosine" "NIH3T3vSrc" "NESvSrc" "NLSvSrc"
    "SYF+/+" "SYF−/−" "subfractions"
    "a ubiquitous non-receptor tyrosine kinase" "SMYD" "MYND" "C-terminally"
    "fraktalkine" "acute neurotrauma" "neurotrauma" "co-localised" "Subsets"
    "NAGM" "isotype" "non-neurological" "co-stimulus" "NAWM" "CNS" "WM"
    "pancreatitis" "phosphorylation/degradation" "êB" "MX1M" "MX1D" "MX1P"
    "BAY" "MOI" "Gi" "which increases cellular NADPH/NADP +" "EV71"
    "NADPH/NADP +" "-oligoadenylate" "oligoadenylate" "ISG" "ISGs"
    "enzymopathy" "HCoV" "myxovirus" "w / v" "Δ C" "PXD001737" "identifier"
    "PRIDE" "two technical replicates" "each biological replicate"
    "Complete three biological replicates" "proteinGroups" "MaxQuant" "nl/min"
    "C18AQ" "nanocolumn" "Michrom" "OptiPak" "sulfobetaine" "Calbiochem"
    "Fluka" "Jackson" "Burdick" "FWD" "Cambridge" "μl/sample" "rxn" "Clontech"
    "CaCl" "iodoacetamide" "phosphine" "carboxyethyl" "NH" "Invitrogen"
    "ProteomeXchange" "interactomes" "an important co-chaperone" "co-chaperone"
    "LC–MS/MS" "10.1038/srep18678" "clearer" "hotspot"
    "the geographical representativeness" "representativeness" "Greek" "Shen"
    "the tubular subtype" "France" "Roock" "the mucinous subtype" "cecum"
    "flexure" "multicenter" "non-responsiveness" "risen" "hotspots" "= 0.007"
    "P = 0.001" "= 0.002" "H&E" "homologue-1" "scute" "Achaete"
    "These results not only support co-regulation" "Tca8113p160" "WP1066-" "WP"
    "S2C" "nsON" "asON" "Tscca" "MiR-21expression" "=0.002"
    "the representative IHC" "AJCC" "S1C" "S2A" "=0.007" "S2B" "bio" "QVD"
    "glytazonas" "platin" "chemo/radiosensitivity" "radio/chemosensitivity"
    "PCDNA3.1" "non-functional" "Non-small cell lung carcinoma" "reemphasizes"
    "the traditional Chinese herb Solanum incanum" "incanum" "Solanum"
    "Solamargine" "receptor-2" "epidermalgrowth"
    "non-small cell lung carcinoma (NSCLC)" "solamargine" "PI3K/ mammalian"
    "Kunderfranco" "phosphorylation/activation" "P=0.000" "=0.000" "Germany"
    "Qiagen" "ºC" "dimmers" "amplicons" "P=0.001" "requireda" "MTA1expression"
    "aSMA" "Weng" "Wenhao" "a dual function co-regulator" "epithelioid"
    "intraobserver" "decidedin" "Suresh" "pLL3.7-shMTA1" "NuRD" "co-regulator"
    "nonsignificant" "XX+Xx" "heterozygotes" "XX homozygotes" "Xx+xx" "Xx" "xx"
    "Hui" "Fok" "Taq" "XX" "PvuII" "XbaI" "Wanfang" "CNKI" "= 0.90" "= 0.005"
    "≥ 50%" "95% CIs" "10.1038/srep18709" "polycomblike" "H3K36m3"
    "a public dataset" "Oncomine" "di-methylation" "UNC0638" "trimethyl" "KMTs"
    "H3K27" "10.1038/srep18417" "Villafuertes" "Gómez" "Adinolfi’s" "Adinolfi"
    "PDKs" "Atypical isotypes" "U73122" "aPKCs" "nPKCs" "cPKCs" "AG14781"
    "LY29004" "even more evident 48 h" "wtGSK3" "ARL67156" "BBG" "DMEM"
    "P2X7Rs" "neurite" "the adrenal medulla" "P2Y" "P2X" "P2X7R" "co-treated"
    "miR125b" "~51.5%" "~46.4%" "=0.0000" "~PDL" "~2.0" "non-polysomal"
    "=0.0005" "Renilla" "bisulfate" "m5C" "Adenosyl" "UTRa1" "UTRb" "UTRa"
    "pNSun2" "IRES" "HDFs" "diploid" "pcDNA 3.1" "2BS" "5C" "10.1038/srep18388"
    "Oliviero" "at least one other PCGF ortholog" "hESCs" "DPPA2"
    "the physical interactome" "global H2AK119ub" "co-purified"
    "immunoprecipitation/MS" "eluate" "co-precipitate" "co-purifies"
    "a Q Exactive mass spectrometer" "spectrometer" "nano" "glia" "Blackledge"
    "CxxC" "Zf" "vPRC1" "coworkers" "Gearhart" "orthologs" "offs" "PCGF"
    "homologs" "anti- FLAG" "4C" "and 3B" "HACs" "Guerit" "FOPFlash"
    "Smad 2/3/4" "κB-luc" "TOPFlash" "-luc" "pri-" "pri" "miR-29a/b1"
    "the mature miR-29a-3p" "miR-29b1" "micromass" "miR-29a-3p" "h" "un"
    "the medial meniscus" "meniscus" "osteophyte" "miR-29b-3p" "OA" "Smad 2/3"
    "48 h" "3p" "29a" "10.1038/ncomms10077" "microRNA-27a" "=0.06"
    "a previously described oncomiR" "miRNA–mRNA–Ago" "oncoMiR" "miR-26b"
    "125b" "renilla" "Serdementan" "MTS" "dimethylsulphoxide" "66Cl4" "GEMMs"
    "miRNA-27a-3p" "miR-106b-25" "homeodomain" "suppresson" "alpha-helix"
    "occludes" "miR-27a" "homeoprotein" "72 h" "48 h" "5p" "24 h"
    "re-expressed" "∼50%" "‐frame" "NAB2 ‐ STAT6 fusion" "NAB2ex6‐STAT6ex16"
    "NAB2ex4‐STAT6ex3" "next‐generation" "RT‐PCR" "‐generation"
    "NAB2 ‐ STAT6 gene" "‐term" "Tapias" "atypia" "‐risk" "the visceral pleura"
    "pleura‐based" "NAB2ex4‐STAT6ex2/3" "4/10 HPFs" "disease‐free" "‐year"
    "‐free" "the last follow‐up" "follow‐up" "‐up" "NAB2 ex4 ‐STAT6 ex2/3"
    "NAB2ex6‐STAT6ex16/17" "NAB2ex4‐STAT6ex2" "NAB2ex6‐STAT6ex17" "‐ends"
    "‐fixed" "NAB2‐STAT6" "NAB2‐STAT6 gene" "‐negative" "‐STAT6" "‐2"
    "pleomorphism" "lobules" "fat‐forming" "storiform"
    "the pulmonary parenchyma" "pleura" "‐one"
    "one mediastinal cellular SFT‐like" "sarcomatoid" "‐like"
    "NAB2ex4‐STAT6ex2/3 variant" "‐STAT6ex2/3 variant" "NAB2ex4"
    "highly variable breakpoints" "breakpoints" "NAB2‐STAT6 fusion"
    "‐STAT6 gene" "12q13" "‐4" "myxoid" "staghorn" "patternless" "mediastinum"
    "atypical/malignant" "‐STAT6ex2/3was" "4/10HPFs" "malignantSFTs"
    "‐STAT6ex2was" "‐STAT6ex16/17" "‐STAT6ex2/3variant" "‐nine" "‐STAT6fusion"
    "‐likeSFTs" "‐forming" "mediastinal/pericardial" "‐based" "cellularSFTs"
    "‐relevant" "‐PCR" "intrathoracicSFTs" "‐STAT6in" "P  = 0.001" "16/17"
    "10.1038/srep18792" "osteochondrodysplasias" "-phosphosulfate"
    "phosphosulfate" "-phosphoadenosine" "phosphoadenosine" "Apert" "Crouzon"
    "rs791885" "rs2762520" "Rotterdam" "ARIC" "rs1219515" "rs791888"
    "rs2935713" "HumanOmniExpress" "Quad610" "HumanHap550" "GWA" "OmniExpress"
    "protooncogenes" "adenylyl" "Adeno" "AH23848" "dmPGE" "AGC"
    "prostaglandins (PG)" "prostaglandins" "phosphoinositede" "72 h" "± SD"
    "24 h" "4 c" "an adverse DFS" "SNU1079"
    "Kirsten rat sarcoma viral oncogene homolog ( KRAS )" "homolog ( KRAS )"
    "Kirsten" "13q34" "= 17" "non-tumor" "Targetscan" "MiRanda" "caner"
    "MiR-148a" "361-5p" "IRS1/2" "SGC7901-1225+" "KeGG" "micrometastases"
    "MGC803-1225+" "SGC" "MGC" "hsa-miR-148a" "_1_3" "_2_3/" "_4" "_1" "_4/"
    "_2" "Eastern Europe" "miR-1225-5p" "re-expression" "MiR-361-5p" "Banck"
    "fs" "an exceptional responder" "Korean" "adenocarcinoid" "non-responder"
    "CNBD1" "MGA" "BCOR" "anti-angiogenesis" "miR141" "miR200s" "12p13"
    "miR200c" "miR429" "miR200a" "peritoneum" "web-like" "miR200" "microRNA200"
    "OSE7" "Day 3" "cyst-like" "lumens" "HPVE" "invaginations" "and 3D"
    "the cell tightly control all nucleases" "theta" "Ku" "S/G2" "Okazaki"
    "iPOND" "Co-depletion" "co-depletion" "heteroduplex" "responder" "MRN"
    "gamma-H2Ax" "ss" "co-depleted" "MluI" "BssHII" "microhomology" "replicon"
    "RuvA" "HhH" "Uniprot" "catastrophic mitoses" "Holliday" "heteroduplexes"
    "Domain-1" "classical non-homologous" "cNHEJ" "MMEJ" "48 h"
    "Non-homologous" "non-conservative" "EJ5" "PntP1" "DUX" "drawn" "Ets21C"
    "non-protein" "InR" "de-repressed" "de-repression" "yan" "ortholog"
    "overgrew" "Δ88" "Δ78" "Δ33" "pntP2" "pntP1" "PNTP2" "PNTP1" "octamers"
    "G/A" "TGAATGAA" "TGAATG" "the dominant active Cic ΔC2" "co-overexpresssed"
    "its previously characterized direct target gene- aos" "gDNA"
    "only methylated GATCs" "GATCs" "aos" "huckebein" "nucleo"
    "re-localization" "V12S35" "λtop" "F/O" "progeny" "ΔC2" "GFP +"
    "transheterozygote" "transheterozygotes" "fetU6" "MARCM" "UAS-cic-RNAi"
    "GFP+" "PH3+" "YFP+" "midguts" "mitoses" "esg-Gal4-UAS-2XEYFP" "esg" "ts"
    "GBE" "importin-α4" "Despites" "entomophila" "VM" "krn" "keren" "vn"
    "spitz" "enteroendocrine" "enteroblasts" "MAKP" "stg" "ISCs" "DamID"
    "midgut" "ISC" "log2" "co-repressor" "Mi-2/NuRD" "+120%" "72 h" "72h"
    "pBRCA1" "HOX424" "platinum-sensitive OV1002" "24 h" "coverslips" "24h"
    "ROI" "Entropy" "IDM" "entropy" "SIRTs" "sirtuins" "OV1002"
    "non-homologous" "locus/gene" "Rs3803304" "rs 3803304" "2.3×10" "j"
    "Deelen" "D2a1" "YCC" "ethnic Japanese" "willcox" "rs1327795"
    "eastern Europe" "Sami" "Estonia" "Finland" "Russia" "Scandinavia" "Ural"
    "rs9400239" "rs1935949" "rs2764264" "rs13217795" "HWE" "0.05/" "Rs9400239"
    "bonferroni" "Rs9486902" "A1c" "Sichuan" "rs9486902" "Danes" "rs9456497"
    "Yousin" "Danish" "rs3803304" "Jewish" "Ashkenazi" "Zeng" "Pawlikowska"
    "Nygaard" "Flachsbart" "Soerensen" "Anselmi" "rs 2764264" "rs2802292"
    "Willcox" "insulin/IGF-1" "gene/loci" "Terry" "GGTCAG" "GGTCGG" "CTCCT"
    "CCTTC" "TTCTT" "2b" "P = 0.05" "P = 0.003" "P = 0.001" "=0.006"
    "D-Limonene" "1-methyl-4-" "isomer" "cyclohexene" "methylethenyl"
    "Limonene" "ultrastructure" "ultrastructures" "HLECs" "D-limonene"
    "terpene" "limonene" "podophyllotoxin" "Nogueira" "pcDNA" "Akt#2" "#1" "Nc"
    "kappa-light-chain-enhancer" "peroxidases" "Juglandaceae"
    "a naturally occurring anthraquinone" "mandshurica" "Juglans"
    "anthraquinone" "Juglanthraquinone" "Riley" "Ad-mRFP-GFP-LC3" "CQ" "mol/L"
    "weakest" "FIP200-" "FIP" "EpREs" "catabolites" "μ L" "PBuA-" "neoplasias"
    "pS10p27 Kip1" "monophosphoisoform" "16-hour" "nuclear/cytosol" "toto"
    "CLBL" "bishydroxamide" "aminobenzamides" "antiredox" "PBuA" "sirtuin"
    "nonhistone" "ubiquitination/degradation" "μ g" "Cip/Kip"
    "aldehyde dehydrogenase-1" "secretome" "non-SP" "condensate" "neurosphere"
    "GPX1/2" "adrenaline" "melatonin" "CoPP" "myocardium" "ABSCs" "Fumarate"
    "fumarate" "Mitsuishi" "chemo/radioresistance" "Padmanabhan" "toxicants"
    "ARE-like" "sulfhydryl" "ETGE" "Kelch/DGR" "IVR" "MRP2/3" "maleate"
    "diethyl" "Kostova" "Dinkova" "Hayes" "TXNRD" "dithiolethione" "anisole"
    "-butylhydroxy" "butylhydroxy" "MRE" "quinone oxidoreductase-1" "-BHQ"
    "BHQ" "butylhydroquinone" "-naphthoflavone" "naphthoflavone" "Pickett"
    "Rushmore" "radioresistant" "HNSCC" "sulphoximine (BSO)" "sulphoximine"
    "buthionine" "Wnt/" "− / −HSCs" "Yalcin" "catalases"
    "-dichlorodihydrofluorescein" "dichlorodihydrofluorescein"
    "fluorogenic dye Hoechst" "Hoechst" "Chang" "non-CSCs" "diabetic/severe"
    "nonobese" "Dick" "factor-erythroid 2-" "NOXs" "oxidases" "CD133 +"
    "10.1038/srep18476" "Wu" "adhesome" "SHP2_C-SH2 domain" "N-myristoylation"
    "SRC251T175L" "SRC251" "phosphoatases" "∆SH2" "SRCY527FΔSH2" "ΔSH2"
    "SRCY527FΔSH2-GFP" "pY577-FAK" "pY118-paxillin" "pY31-paxillin"
    "a shorter FRAP t  1/2" "∆SH2-GFP" "SRCY527F" "ΔSH2-GFP" "SRCY" "/YES"
    "FAKi" "SHP2_N-SH2 domain" "TIRFM" "NSH2" "pGFP" "formation/maturation"
    "non-receptor protein" "organelles" "SHP2_N-SH2 domains" "_N-SH2 domains"
    "SRC_SH2 domain" "_N-SH2 domain" "_SH2 domain" "co-localize"
    "10.1038/ncomms9829" "Ameziane" "LOVD" "FANCR" "catalyses" "3.9-kb" "kbp"
    "SFM" "D-loop" "RAD51 A293T" "revertant" "DCHS2" "revertants"
    "Subsequent Sanger" "_002875" "workflows" "interaction/repair" "PRR12"
    "FuncNet" "workflow" "proteome" "proband" "WGS" "-exome" "fibroblastoid"
    "KU58948" "-ribose" "imperforate" "FA-like" "DEB" "interstrand"
    "an atypical subtype" "non-synonymous" "pyrene-7,8-diol-9,10-epoxide"
    "NCSLC" "Cl" "adduct" "-to-S phase" "benzo" "= 0.008" "= 0.0003"
    "P  = 0.003" "non-receptor tyrosine kinases" "rs2228001" "rs2279017"
    "19q13" "rs4150441" "repairing bulky DNA adducts" "HQ" "BQ" "rs967591G"
    "non-small-cell" "rs4781560" "rs25489" "Haploview" "Haplotypes"
    "benzoquinone" "the large benzene-induced DNA adducts" "rs25487" "rs967591"
    "rs1005165" "rs1799782" "MGB" "TaqMan" "deeper" "rs11615" "19q13.2–3"
    "GA +AA" "CT+TT" "= 0.162" "P = 0.035" "lipase inactive mtPLD1" "mtPLD1"
    "mt" "hypoxia-inducible factor-1α" "P- value" "μg " "2 /5" "Zhao"
    "Bhargava" "Polysomy" "Ellis" "Elston" "EE" "cribriform" "LOE"
    "physiopathology" "Burness" "polysomy" "a more aggressive subset" "p52SchA"
    "phosphoTyr" "epithelia" "p66ShcA" "non-Smad" "caveolar microdomains"
    "microdomains" "lambda" "monolayer" "motile" "coregulators" "Tyrs"
    "nonchordate" "Smad2/3" "p52ShcA" "4B" "pg/ml" "EMT-like" "p38 MAPK" "Seq"
    "Pittsburgh" "ANLN" "RSEM" "premarin" "progestin" "PCA" "ERβ IHC" "CXXC5"
    "+ 3" "+ 2" "primay" "Superdex" "deubiqutinates" "3×FLAG-tagged"
    "anti-FLAG" "×FLAG-tagged" "the putative post-translational modificatioins"
    "modificatioins" "Ni" "paricipates" "contibutes" "7q22" "trithorax"
    "Co-Immunoprecipitation" "non-essential" "ubiquitin/proteasome"
    "a large public dataset" "eQTLs" "rs12509403" "rs4014195"
    "an intergenic SNP" "rs11820062" "co-vary" "myofibroblasts" "NFKBID"
    "a larger subset" "pSTAT3" "pSTAT1" "pRelA" "lipopolysaccharide"
    "lymphoblastoid" "re-analyzed" "arteriole" "parenchyma" "histopathology"
    "log 2" "9/13" "hg19" "= 0.83" "= 0.77" "= 0.66" "co-regulated" "= 0.02"
    "= 0.008" "= 0.006" "caspase 3/7" "dual pathway co-targeting"
    "anti-melanoma" "Co-targeting" "∼20%" "VENN" "Edwards" "BRB"
    "three independent biological replicates" "AZD6344" "stainings" "O/N"
    "group 1" "group1" "AZD" "strong synergism" "synergism" "Talalay" "Chou"
    "_cc128" "16/49" "mTORC1/2" "vitro" "mTOR-" "mTOR" "Selumetinib/AZD6244"
    "co-targeting" "mg/Kg" "= 21" "∼30%" "clearest" "stressful" "Gartler"
    "Atkins" "∼24-fold" "Nayler’s" "Nayler"
    "7,402 unique RefSeq transcript identifiers" "identifiers" "RefSeq"
    "aneuploid" "punctum" "∼1.5" "rs2066734" "Only one SNP" "chr11"
    "any heterozygous SNPs" "XY" "karyotype" "_CAR3" "_Q1" "Euclidean"
    ".217_218" "JHU_Q3" "JHU" "_218" "delGA" "γH2A" "pCHK2" "KU" "Q3SC" "Q3SA"
    "_Q3" "Q1SA" "pluri" "PluriTest" "non-A-T" "hESC" "Sendai" "Rb" "11q22"
    "+2" "≤ 5%" "TargertScan" "websites" "lenvi" "prostatectomy" "miR-361-5p"
    "miR-26a" "Transwell" "T1/2" "Loupakis" "Missiaglia" "Sinicrope"
    "Ricciardiello" "Sadahiro" "CIMP" "≥1" "T3/4" "well/moderately" "sigmoid"
    "proctos" "I/II" "≥T3" "serosa" "subserosa" "SI" "≤T2" "propria (MP)"
    "UICC" "propria" "muscularis" "SM" "submucosa" "mucosa" "adducts"
    "monoglutamate" "Soong" "-deoxyuridine" "5-fluoro-dUMP" "FdUMP"
    "5,10-methylene-THF" "5-fluo-rouracil" "rectosigmoid" "=0.001" "Phellinus"
    "hispolon" "g/ml" "odorifera" "Dalbergia" "heartwood" "anacardium"
    "Semecarpus" "verniciflua" "Rhus" "-tetrahydroxychalcone"
    "tetrahydroxychalcone" "22q11.2" "9q34" "breakpoint" "Abelson"
    "Philadelphia" "actives" "=0.052" "Toste" "AntimiR-21/" "phenocopies"
    "P=0.004" "MedCalc" "strong IHC" "antimiR-21/" "LNA-antimiR-21-mediated"
    "AntimiR" "non-metastatic" "mRNA target-predicting algorithms" "miRDB"
    "Biocoat" "BD" "miR-21-5p" "shorter 5-year DFS" "antimiR" "p85α"
    "target-predicting algorithms" "oncomiR" "=0.035" "=0.004"
    "expression/function" "Huebner" "hemi-" "hemi" "UH" "WWOXWFPA" "WFPA" "KO"
    "anti-phospho-histone 3" "WWOXK274R" "lenti" "shWWOX" "shEV" "UVC" "24hr"
    "FRA16D" "16q23.3-q24.1" "CFSs" "deoxynucleotide" "mutated genome" "LBD"
    "EREs" "A/B" "C/EBPδ" "Smads" "DRE" "ER-α-ΔLBD" "ΔLBD" "osteoblasts" "Dlx"
    "Various osteogenic stimulators" "C/EBP" "SG/mild"
    "the transcriptional starting codon" "introns" "1.02–2.36" "0.23–2.18"
    "0.18–1.42" "0.70–1.88" "ORs" "QMSP"
    "their relevant intestinal metaplasia (IM)/dysplasia (DYS)"
    "/dysplasia (DYS)" "pre-" "Shandong" "Linqu" "= 21" "= 0.80" "μg" "95 % CI"
    "neuropathology" "cerebellum" "Parkinsonism" "proteinopathies"
    "clinically diagnosed Alzheimer’s" "MND" "co-segregated" "non-fluent"
    "non-mutation" "the frontal and temporal neocortex" "thoraco" "oblongata"
    "medulla" "pons" "mesencephalon" "Betz" "proteinopathy" "iv"
    "the frontal and temporal neocortices" "pallidum" "neostriatum"
    "neocortices" "the temporal neocortex" "neocortex" "EMG"
    "parietal hypometabolism" "hypometabolism" "SPECT" "brainstem"
    "bradykinesia" "Babinski" "hemicorpus" "hypertonia" "hypokinesia" "gravis"
    "myasthenia" "dysphagia" "bilevel" "BiPAP" "DR1123" "gastrostomy"
    "decorticate" "ridden" "hyperreflexia" "no further diagnostic workup"
    "workup" "DR1124" "MMSE" "Korsakoff" "mild visuoconstructive apraxia"
    "anterograde" "DR1122" "apraxia" "Addenbrooke" "hetero" "DR1121"
    "perseverations" "echolalia" "DR189" "co-segregates" "Glu643del" "DR663"
    "DR1044" "DR158" "continuum" "fasciculations" "ni" "subclasses"
    "atypical Alzheimer" "Alzheimer’s" "FTLD" "lobar" "positron"
    "fluorodeoxyglucose" "Mossevelde" "= 7" "ESE" "exon5" "SiSRSF2" "siSETD"
    "1054del83" "H4K16Ac" "MGC80-3" "1054 del 83"
    "a premature termination codon (PTC)" "codon (PTC)" "aminos" "H3K36"
    "10.1038/srep18097" "Miglietta" "co-workers" "UNA" "HPRT" "•iM"
    "antiparallel" "co-crystal" "TTAGGG" "fluorophores" "C-repeats" "Hurley"
    "riboproteins" "kJ/mol" "Rodgers" "ILPR" "C:C" ":C " "ATTO-488" "ATTO"
    "folded/unfolded" "cacodylate" "Typical CD-melting" "M-like" "neutral pH"
    "bps" "urea" "ODN-3" "ODN-1" "ODN-2" "n+m" "U*·mH" ":C" "*·mH" "·mH" "-pH"
    "w/v" "G-quadruplex/" "G-elements" "J00277" "ase" "C-rich" "ΔS" "Δ S" "Δ G"
    "= 7" "4 C" "~6-" "Δ G  " "Δ S  " "1/3" "i- motif" "i -motif"
    "adhesion/spreading" "transwell" "non-transfected" "Noonan"
    "catalytically inactive SHP2SHP2" "SHP2SHP2" "phosphotyrosyl" "p53-2S"
    "wt-p53-" "and 2A" "luc" "p53-2A" "DO-1" "phospho-p53S15" "co-IP" "USA"
    "Fermentas" "non-stressed" "non-tumorigenic" "SSB/DSB" "ssDNA" "PAPR1"
    "ation" "undertaken" "S1D" "S4B" "crossover" "S4A" "nicked circular pBR"
    "pBR" "dsDNA" "3+" "Spd" "Pu" "duplexes" "catalyse" "polymerase-2"
    "non-specific" "± SD" "Immunohistochemistry (IHC)" "FACS" "or/and" "μL"
    "co-transfected" "the aggressive subset" "CNH" "non-luminal" "neg" "LVI"
    "TNBC" "particularly luminal B subtype" "Basal-like" "& E" "= 0.001"
    "= 0.038" "nonrandom" "DSB" "FFPE" "triploid" "co-amplification"
    "co-amplifications" "LI" "the largest subset" "pN" "pT" "situ" "10q23"
    "10.1038/ncomms10186" "B-type" "co-overexpression" "Kupperwasser" "BLBCs"
    "MRTFA" "MRTFB" "MaSC/progenitor" "TEADs" "tumoursphere" "co-activators"
    "MRTF" "E12/E47" "ΔWW" "mammosphere" "mammospheres" "Visvader"
    "transcriptome" "cells/tissues" "yorkie" "MaSC-like" "amplicon" "BLBC"
    "stem/progenitor" "#2" "Co-immunoprecipitation" "=3" "non-cell"
    "10.1038/srep17879" "specific mutated codons" "recurrently mutated codons"
    "nonmissense" "significantly inferior BCSS" "Pandit" "normal-like"
    "mammoplasty" "Nottingham" "LR-χ" "≥10%" "shorter BCSS" "BCSS" "Univariate"
    "basal-like" "NUTH" "Some recurrently mutated codons" "codons"
    "nonmisssense" "Cuzick" "Oncotype" "MammaPrint" "LR" "PAM50" "NTUH"
    "Taiwan" "IHC4" "= 0.21" "95% CI " "10.1038/srep18454" "easier"
    "Allelic asymmetries" "asymmetries"
    "the TALEN-introduced premature termination codon" "o253" "o166" "o35"
    "kw1" "mono-allelic" "hCD45 " "TALENs-mediated"
    "the premature termination codon" "a premature termination codon"
    "frameshift" "exon 14" "indels" "Sanger" "ITD" "T7E1" "spacer"
    "a premature stop codon" "TKDs" "TALEN" "exon14" "DSBs" "FokI" "TALENs"
    "TALE" "overexpression/knockdown" "classification/stratification"
    "cytogenetic/gene" "many genetically high-risk AL subtypes" "haplo" "μl"
    "protein phosphatase 2A" "NOD/SCID" "10.1038/srep18277" "Bertero"
    "expression/histologic" "Massachusetts" "explants" "explant" "England"
    "Boston" "Harvard" "mg/kg/dose" "Lipofectamine" "Thermo" "Eight-week-old"
    "Shortmer" "Regulus" "shortmer" "Aldrich" "C57Bl6" "C57BL/6" "substrain"
    "hidden" "roadmap" "re-define" "shortmers" "re-classification"
    "pathophenotypes" "IPF" "Ctgf" "Ashcroft" "Metavir" "+miR-control" "kg"
    "YAP/TAZ-miR-130/301" "stellate" "tetrachloride" "YAP/TAZ-miR-130" "#19"
    "#11" "miR-130a" "interactome" "transcriptomic datasets"
    "re-conceptualization" "YAP/TAZ" "non-identical" "#4" "Skopje" "written"
    "scotomas" "genotype/phenotype" "Gadolinium" "IU/dl" "café-au-lait"
    "Caesarean" "Schwann" "plexiform" "skeletal dysplasias" "dysplasias"
    "R681X" "the optic chiasm" "chiasm" "the largest NSCLC microarray dataset"
    "intratumour" "obtained using IHC" "naïve" "Rosell" "monophosphate"
    "deoxyuridine" "0.95–3.56" "ERCC1-" "ERCC" "≤ 140" "p53R2-positive"
    "histotype" "Reiman" "isotypes" "Hsu" "Uramoto" "tyrosyl" "diiron" "IALT"
    "a large publicly available NSCLC microarray dataset" "unmet"
    "an available NSCLC microarray dataset" "using IHC" "= 2.93" "H-scoring"
    "multiprotein" "·N-CoR" "·SMRT" "Ishii" "Li" "Bhaskara" "CK2β" "cerevisiae"
    "Co-immunoprecipitations" "non-immune" "immunocomplexes" "midzone"
    "mitotic CK2 α/α" "CK2 α/α" "CK2α/α" "Ac" "The resultant phosphorimage"
    "phosphorimage" "anti-phospho-H1" "anti-H1" "rHDAC" "aliquot"
    "Mononucleosomes" "H4K5" "the mitotic marker phospho-H3S10"
    "anti-phospho-H3S10" "Coomassie" "pulldown" "30-nm" "Moskwik" "non-histone"
    "ionic" "co-precipitated" "Jacquemont" "CO-IP" "Cδ" "IPND" "transducers"
    "dependend" "~ 50%" "100-mm" "non-phosphorylatable" "Pakistan"
    "Mediterranean’s" "Slovenians" "Tunisians" "Brazilians" "Euro"
    "retinal microvasculature" "microvasculature" "Iranians" "Nikzamir"
    "Mediterranean" "Gutierrez" "healthy non-diabetic" "TIDM" "T1DM"
    "Worldwide different ACE and PAI-1 SNP" "rs1799768" "rs4646994" "Indians"
    "T2DM" "Macular edema" "edema" "non-proliferative" "microaneurysms" "PDR"
    "NPDR" "4G/5G" "DNR" "Pakistani" "the HDL-raising minor T-alleles"
    "anti-atherosclerotic" "cardiovascular endpoints" "endpoints" "subspecies"
    "uptake/clearance" "confounder" "the HDL-associated PIK3CG SNPs"
    "enhancers" "non-coding" "metabolism/turnover" "lecitihin" "T-allele"
    "covariates" "presence/absence" "the two significantly HDL-associated SNPs"
    "Framingham" "GLGC" "Metabochip" "rs1129293" "rs3823963" "rs10216210"
    "rs2037718" "anti-hyperlipidaemic" "T-alleles" "fibrates" "CEU" "≥0.05"
    "non-linked" "kg/m²" "glycaemia" "TÜF" "Tübingen" "erythematodes" "Gβγ"
    "trisphosphate" "phosphoinositides" "rs116697954" "rs4288294" "German"
    "content/distribution" "= 0.0209" "A/C" "10-year" "mmol/L" "type-2"
    "centromeres" "an intact R-spine"
    "a tight ~300 kDa Bub1:Bub3/BubR1:Bub3 heterotetramer" "heterotetramer"
    "Superose" "DNN" "L875A-N879A" "ConSurf" "T/S" "LC-MS/MS" "phosphostain"
    "helices" "Cα" "4QPM" "P-S969" "re-refinement" "4R8Q" "mononucleosomes"
    "CENP-A-" "CENP" "/K" "Menten" "Michaelis" "Bor:Sur" "Promega"
    "the fluorophore’s" "-O-" "fluorophore" "mant" "-Methylanthraniloyl"
    "Methylanthraniloyl" "monodisperse" "Intra" "bi" "P+1" "complex/cyclosome"
    "gallbladder" "thymocytes" "vivo" "ex" "MiaPaCa-" "shMyb" "MiaPaca"
    "sublines" "shMYB" "a Boyden's" "non-expressing" "MiaPaCa" "∼2.6"
    "non-invasive" "10.1038/srep17873" "Kang" "4b" "Silico" "3c" "ΔC"
    "Chromatid" "CREST" "centromere" "two topoisomerase II isozymes"
    "dioxopiperazine" "chromatids" "triphosphate" "Cowden" "UFBs" "~ 80%"
    "~ 30%" "co-localization" "S1c" "Deeken" "Siena" "Siravegna" "#5"
    "chemiluminescent immunoassays" "immunoassays" "biopsies" "ectodomain"
    "ctDNA" "stimulators" "pantoprazole" "pentimidine" "Wals"
    "and 3D-geometrical" "immunocytochemistry" "-fold-factor" "Ai" "Vp" "Ap"
    "der" "Vu" "|r" "GETAWAY" "RDF" "Topology" "using Pearson’s" "Arcyriarubin"
    "x" "1/" "Lineweaver" "re-incubated" "thiamine" "metformine" "Gö" "XI"
    "physico" "WHIM" "solute" "bisindolylmaleimides" "Non-linear" "β1" "IC 50"
    "micelles" "Jamshid" "anti-atherogenic" "clinicians" "Co-IP" "multimer"
    "API" "Boyden" "longa" "Curcuma" "anti-inflammatory" "Rous" "LTR"
    "at least co-localize" "TFII" "promoter/enhancer"
    "The major immediate-early enhancer/promoter" "transgenes" "pEGFP"
    "pcDNA4/LacZ" "pHIVLacZ" "pSVOAΔ5" "pSVOA" "Δ5" "-Luc" "Luc" "pcDNA3.1"
    "CMVdel1" "TFII-IΔNLS" "ΔNLS" "eight confluent 100-mm" "co-repressors"
    "Inr" "E-box" "I-fold" "7q11.23" "intra-" "intra" "stem-like"
    "co-transfection" "non-targeting" "a monomeric topology"
    "the dimeric G-quadruplex" "GGGAGG" "Dimeric 32R-3n" "_3" "simpler"
    "the last G-tract" "AAGA" "both monomeric and dimeric G-quadruplex" "Xodo"
    "G-tracts" "characteristic CD"
    "mostly anti-parallel dimeric G-quadruplexes" "1/2" "around 33°C"
    "G24:G29:G24:G29" "G24:G24" "G26:G26" "G25:G25" "G:G" "G24:G28:G24:G28"
    "an anti-parallel dimeric head-to-head fold-back topology"
    "G23:G29:G23:G29" "G:C" "non-hydrogen" "Watson" "trinucleotide"
    "an anti-parallel dimeric fold-back head-to-head topology"
    "internucleotide" "intranucleotide" "in 1D" "NOESY" "COSY"
    "-end G-quadruplex units feature symmetric head-to-head topologies"
    "Hoogsteen" "downfield" "and 3q" "HSQCs" "N-edited" "vide" "G-tract" "HSQC"
    "linewidths" "broader" "TGG" "GTG" "topologies" "TINA" "G-quartet"
    "G-quartets" "subsequently G-quadruplex topology" "G-rich"
    "a symmetric head-to-head topology" "topology" "32R-3n" "anti-parallel"
    "G-quadruplexes" "10.1038/srep17766" "Peng" "Polymorphisms" "0–1" "Perego"
    "Paola" "canonical E-boxes" "TATA" "19q13.3" "Fontanini" "Masago"
    "Katsuhiro" "BCL2-938C" "Nückel" "-938C"
    "all significant prognostic indictors" "indictors" "Holm" "univariate"
    "3/4" "ECOG" "IIIA" "rs4645878" "rs2279115" "CA+AA" "BCL2-938CA" "GA+AA"
    "BAX-248GA" "BCL" "polymorphisms (SNP)" "= 0.035" "= 0.001" "= 0.004"
    "= 0.038" "10.1038/ncomms10072" "non-kinase" "IKKs" "genomes"
    "AFIFAHEESEDNSC" "Scr" "ENAESEADFSIHF" "shTBK" "subsequent regrowth"
    "regrowth" "TBK" "S-labelled" "Duolink" "immunoglobulins"
    "mitotic U937 myeloid leukaemia and Daudi Burkitt's"
    "mitotic U937 myeloid leukaemia and Daudi Burkitt" "co-localized" "HU"
    "multinucleate" "phospho-H3S10" "bivariate" "pH3S10" "IKKɛ" "pTBK1"
    "Burkitt" "AALE" "dormancy" "Pillai" "G0/G1" "3pS" "non-canonical" "TFBS"
    "CC" "Hu" "homozygotes" "Adamus" "Subtype" "NCBI" "classic CNV"
    "Three well-studied SNPs" "Maloney" "lifespan" "SIRT" "pathophysiology"
    "Weinberg" "rs4746720" "rs3740051" "rs12778366" "codominant" "= 3"
    "stemness" "compensatory hyperinsulinemia" "hyperinsulinemia" "endometrium"
    "paracrine/autocrine" "cardiac myocytes" "Rane" "antagomir" "NVP-AWE-541"
    "the most statistically relevant MEM" "MEM" "U133" "betaMEM" "GeneChip"
    "Affymetrix" "autocrine/paracrine" "CAFs-CM" "anti-miR-199a-5p"
    "mTOR/p70S6K" "pseudosubstrate" "inhibitor1/2" "Src-homology-2" "discoidin"
    "homolog" "non-significant" "neoantigen" "viral antigens" "immunotherapy"
    "haplotypes" "non-self" "neuroendocrine" "sporadic SSNVs"
    "only 12 non-synonymous SSNVs" "phenocopy" "missense" "SCNV" "subclass"
    "a recently developed algorithm" "algorithm" "SSNV" "UV" "HNSCCs"
    "serologies" "LO" "SCNVs" "the viral genome"
    "the presumptive tumor antigens" "antigens" "immunosurveillance"
    "immunotherapies" "neoantigens" "SSNVs" "exome" "Merkel" "= 0.0003"
    "= 0.03" "= 3" "advancements" "non-surviving" "IU/kg"
    "significantly less 1,25D3" "nearly 200 pg/mL" "CTA091" "24,25D3" "2D3"
    "the active metabolite 1,25D3" "OH" "catabolite" "in 1αOHase" "si" "-ZFN"
    "ZFN" "ZFNs" "received low dietary VD3" "received high dietary VD3"
    "less variable and averaged 56.3 pg/mL" "pg/mL" "VD3/kg" "siCTRL" "Greater"
    "CAMP" "gatekeeper" "H-scores" "Roswell" "osteomalacia" "hypocalcemia"
    "the CYP27B1 -encoded 1αOHase" "NHANES" "H1975" "VD3" "UVB" "vitamin D3/kg"
    "IU" "nucleases" "1,25D3" "1αOHase" "1,25-dihydroxyvitamin D3" "25D3"
    "hydroxyvitamin" "epithelial-like" "= 0.004" "Exon 19" "μg/g" "Koga"
    "Geffitinib" "effecter" "IC50" "hyperthermic monotherapy" "wtih" "CFDA"
    "_2249del15" "_A750del" "IPHC" "exon 19" "non-smoker" "Auer"
    "subsequently developed EOPE" "trimesters" "GA" "LOPE " "trimester (INHA)"
    "∆β " "INBHA" "sENG" "LOPE" "EOPE" "wks" "trimester" "enhancer" "= 0.85"
    "= 0.24" "= 0.03" "p  = 0.05" "chosen" "correlation analysis Spearman’s"
    "Wilcoxon's" "U-test" "Wilcoxon" "Whitney" "Inc" "SPSS" "Helsinki" "Laurén"
    "Barrett’s" "Siewert" "Barrett" "underwent gastrectomy" "Magdeburg"
    "gastrectomy" "z" "= 0.02" "= 0.003" "S2a" "p-P70S6K" "Cellurale" "Eun"
    "Jong" "anthocyanin" "peonidins" "cyanins" "flavonoids" "BRACs"
    "transducer" "S/T"
    "the parkinsonism-inducing neurotoxic agent 1-methyl-4-phenyl-1"
    "1-methyl-4-phenyl-1" "parkinsonism" "accordant" "Nrf2/ARE"
    "other exogenous toxicant" "toxicant" "neurocytes" "hNPCs" "Parkinson"
    "-bipyridium" "bipyridium" "Cyc" "PQ" "Ridley" "EV" "Sce" "botulinum"
    "exoenzyme" "resp" "a constitutively active RhoA" "Gy"
    "the bacterial toxin HdCDT" "HdCDT" "monotherapy" "active RhoA"
    "overexpression/hyperactivation" "RhoA" "μ g/mL" "Shukla"
    "apoptotic/survival" "perhaps" "p38MAPK" "hydroxydeoxyguanosine"
    "neuroepithelium" "2E1" "Alzheimer's" "Alzheimer" "cetin" "quer" "~80%"
    "Quecetin" "shHSP7" "~10%" "shHSP27-3" "relaxant" "nolic" "polyphe"
    "shHSP27" "recombinant lentiviral vector pCMV-G-NR-U6-shHSP27"
    "pCMV-G-NR-U6-shHSP27" "the more homogeneous histology" "and 3/12" "10/58"
    "non-methylated" "3+4" "TNM 3+4" "Fuhrman's" "higher Fuhrman's" "Fuhrman"
    "semi" "RASSF1C" "ccRCC" "29 as" "10.1038/srep17910" "Sharma" "Coleman"
    "Zimmerman" "viz" "the potential G-quadruplex" "a potential G-quadruplex"
    "upto" "ADAADiN" "°C" "peaks–one" "CD" "Circular dichroism" "dichroism"
    "ΔG " "Mfold" "olignucleotide" "sequenc" "nt" "G2-L3-G2-L1-G2-L2-G2" "QGRS"
    "VI" "approximately 150 bp" "serum starvation around Myc_C" "Myc_C" "_C"
    "Haokip" "monoclonals-" "monoclonals" "G-quadruplex" "Baradaran-Heravi"
    "expre" "myristate" "Myc_B" "_B" "FUSE" "quadruplex" "skeletal dysplasia"
    "Boerkoel" "dysplasia" "SIOD" "Dysplasia" "Schimke" "Heravi" "ADAAD"
    "RNAPII" "a transcriptional co-regulator" "× 10" "= 3" "H3K9" "mid-1980s"
    "neoadjuvant" "absorbance" "pcDNA3-Flag-FGFR1" "Kyoto" "Genomes" "~4.5"
    "non-union" "immunoglobulin" "osteoid" "re-distribution" "~70%" "dihydroxy"
    "ortho" "trihydroxy" "vic" "benzotropolone" "nonredundant" "TF3+DAPT"
    "elemene" "CBF-1/suppressor" "miltiorrhiz" "IIA" "flavonoid"
    "oligopyrimidine" "hydroxyl" "pH" "bioactives" "~50%" "p-p70S6K"
    "TF3-treated OVCAR-3 cell culture supernatant" "ELISA" "supernatant"
    "CellTiter" "Theaflavin-3" "helix" "TF3" "gallate" "ployphenols"
    "-digallate" "digallate" "co-treatment" "anti-proliferative" "Liu"
    "Immunohistochemistry" "portal vein tumor thrombus (PVTT)"
    "thrombus (PVTT)" "thrombus" "Barcelona" "BCLC" "PVTT" "GSE2127" "GSE9012"
    "GSE9809" "website" "GSE19004" "GSE19665" "P-values" "anti-human" "1–3"
    "Mitsuhashi" "chemoresistant" "Bio"
    "negative FBXW7 immunohistochemical HSCORE"
    "the FBXW7 immunohistochemical HSCORE"
    "The CCNE1 immunohistochemical HSCORE" "=0.0454" "HSCOREs" "=0.0073"
    "=0.0008" "high-grade histological subtype" "P=0.0081" "=0.0081"
    "the negative FBXW7 immunohistochemical HSCORE" "HSCORE" "=0.289" "=0.256"
    "=0.265" "=0.0817" "=0.078" "=0.851" "=0.0258" "=0.0087"
    "amplification/expression" "USC" "USCs" "transcriptomes" "microsatellite"
    "Endometrioid" "Multivariate" "FIGO" "immunohistochemistry" "endometrioid"
    "&E" "10.1038/ncomms10076" "N-end" "APC/C" "-Myc-rescued"
    "phospho-mimetic FLAG-PCNT 9D -Myc" "pS1241PCNT" "immunoprecipitants"
    "pS2259PCNT" "pS" "Schiebel" "Agircan" "9D -Myc" "Centriole" "chromatid"
    "primordial dwarfism" "dwarfism" "TuRC" "aneuploidy" "Centrioles"
    "organelle" "centrioles" "Kim" "centriole" "× 10" "ustin" "priori"
    "Smaller subsets" "covariate" "subsets" "human cardiac myocytes" "myocytes"
    "mono-oxygenases" "oestrogen" "subfamilies" "potential confounders"
    "haplotype" "mellitus" "race/ethnicity" "rs5918764" "rs1337080"
    "multiple potential confounders" "confounders" "16α-OHE"
    "16α-hydroxyestrone" "Americans" "=0.05" "×10" "rs1800440" "rs1056836"
    "Bonferroni" "African–" "available SNP genotypes" "genotypes"
    "hydroxyestrone" "RVEDV" "animal and human pulmonary arterioles"
    "arterioles" "sexual dimorphism" "dimorphism" "rs162561" "RVEF"
    "comorbidities" "accurrate" "adoloscents" "antigen" "begun" "intron" "DMRs"
    "signficant" "guanyl" "Onotology" "bp" "signicant" "MEME" "Nagelkerke"
    "Spearman" "scatterplot" "SNPs" "Cg17627898" "interquartile" "Cg" "hyper"
    "iii" "ii" "Z-scores" "Z-score" "Illumina" "HumanMethylation450"
    "epigenome" "DMCpGs" "DMCpG" "BeadChip" "Infinium" "BMI" "= 0.003"
    "P -value" "paracrine" "Sen" "Yat" "IHC" "endpoint" "TUNEL" "histology"
    "frozen" "exon19" "penetrance" "CC10rtTA" "WC1213" "wtEGFR"
    "mature respiratory epithelium" "Whitsett" "Rosa26" "goes"
    "a typical readout" "leakiness" "kinome" "biopsy" "non-responders"
    "responders" "PFS" "Oncology (ASCO)" "ASCO" "Oncology" "erbB" "wildtype"
    "μg/mL" "KEGG" "other prognostic classifiers" "classifiers"
    "mesenchymal-like" "proven" "stepwise" "TOP/FOP" "Meier" "Kaplan"
    "a prognostic classifier" "56-times" "Fra-1-" "Fra"
    "adenomatous polyposis coli (APC)" "coli (APC)" "coli" "JUND" "JUNB"
    "extravasate" "soft agar" "agar" "classifier" "codon" "Iosub" "sapiens"
    "SSLD" "∼62%" "∼38%" "anti-V5" "SSLD294" "ATTDD" "RanGDP" "C57BL6"
    "co-regulation" "∼70%" "∼65%" "miR-125a-3p" "chemoresistance"
    "Co-transfection" "the mutated UTR" "OVCAR-429" "poorer"
    "normal ovarian surface epithelium" "EOC" "Genome" "Pearson" "-UTR" "UTR"
    "the biocomputational prediction algorithms" "TargetScan" "miRanda"
    "algorithms" "HOSE" "subset" "OVCAR" "SNPin" "ofvariants" "genotype"
    "=0.78" "=0.70" "ofhad" "OR=0.83" "thatwas" "polymorphism (SNP)" "SNP"
    "Ras protein-specific guanine nucleotide-releasing factor-1" "exons"
    "=0.25" "p=0.41" "=0.21" "=0.62" "=0.85" "=0.41" "OR=0.87" "Qiang’s"
    "Qiang" "=0.72–1.05" "=0.87" "andI" "=0.003" "=0.72–0.93" "=0.69–0.85"
    "=0.70–0.88" "=0.61–0.82" "polymorphism" "GT+TT" "=0.76" "GG+GT" "=0.83"
    "Haenzel" "Hayashi" "Jiao" "Zhu" "aboutand" "Asian" "American" "European"
    "GWAS" "Europeans" "GWASs" "OMIM" "maculopathy" "axial" "diopter"
    "heterozygote" "homozygote" "=0.77" "=0.80" "GG" "Begg’s" "Begg"
    "Q-statistic" "Cochrane" "rs8027411" "Japanese" "polymorphisms" "95% CI"
    "non-mammalian" "sites/cell" "∼25–75" "Serono" "Merck" "Cetrorelix" "A261K"
    "HA" "CHX" "R53A/R54A" "pre" "ASE" "p" "ErbB" "titer" "pfu/nl"
    "radioligand" "titers" "readouts" "AFU" "readout" "zsGREEN" "ppERK"
    "XGnRHR" "hGnRHR" "mGnRHR" "laevis" "ultrafast" "undergone" "isozymes"
    "SOS" "Egr" "S130A" "timecourse" "S130D" "PHD1-S130D–GFP" "PHD1-S130A–GFP"
    "ΔMBII" "mis" "Krebs" "2+" "co-substrate" "Fe" "KG" "Per-Arnt-Sim" "HIFα"
    "P -values" "on 1" "stressors" "detox" "multi" "multivariate" "non-IBCs"
    "lung (TCGA LUAD)-specific and colorectal cancer (TCGA COAD-READ)-specific HDAC6 regulons"
    "thge" "COAD" "LUAD" "datasets" "regulons" "regulon" "ARACNe" "TCGA" "CNV"
    "mg/kg/day" "Mary" "Tubastatin" "MDA-MD-IBC-3" "DAVID" "heatmap" "log2FC"
    "subtypes" "subtype" "biological replicates" "replicates" "dataset"
    "non-transformed" "non-IBC" "HTP" "ACY1215" "toxic bioproducts"
    "bioproducts" "epidermal growth factor receptor-2" "5-year" "Ricolinostat"
    "Achilles" "doi:10.1186" "mg/kg" "anti-apoptotic" "multistage" "Anti-tumor"
    "G1/S" "glomeruli" "tubules" "eosin" "siFOXO" "μg/ml" "anti-cancer"
    "anti-tumor" "enoate" "lactone" "genome" "replicate" "ForkheadboxO"
    "phytoconstituents" "chemo" "Australia" "Europe" "America" "y" "doi" "LA7"
    "bioassay" "anthelminticum" "Centratherum" "10.1038/srep17869" "Zhang"
    "English" "African" "DFS" "Xu" "polymerase-1" "ribose" "diphosphate"
    "adeno" "Wong" "P-value" "greater" "Egger’s" "Egger" "0.98–1.50"
    "Australians" "Caucasians" "Asians" "95%CI" "epithelium" "Germline"
    "chromosome 17q12-21" "germline" "non-cancer" "greatest" "Goodwin" "pixel"
    "pixels" "heatmaps" "the stationary wavelet" "MATLAB" "SWT" "wavelet"
    "ImageJ" "Venus" "phonotype" "non-oscillating" "Jolma" "Zatorsky" "Geva"
    "reactants" "et" "miR-29a" "Yang" "c" "b" "undergoes" "silico"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-16501-16800*
  '(("MYB-NFIB" . SPARSER::COLLECTION)
    ("BET-bromodomain" . SPARSER::COLLECTION)
    ("KIT or CDK6" . SPARSER::COLLECTION) ("Ink4a/Arf" . SPARSER::COLLECTION)
    ("IDH" . SPARSER::PROTEIN) ("eGFP or MYBtr" . SPARSER::COLLECTION)
    ("Ink4a/ARF:EGFRvIII" . SPARSER::BIO-COMPLEX)
    ("Similarly both isoforms" . SPARSER::ISOFORM)
    ("OLIG2 and GFAP" . SPARSER::COLLECTION)
    ("the proximal QKI" . SPARSER::PROTEIN) ("MYB-luc" . SPARSER::COLLECTION)
    ("BRAF or FGFR" . SPARSER::COLLECTION) ("mim-1" . SPARSER::PROTEIN)
    ("mim" . SPARSER::PROTEIN)
    ("downregulated genes overlapped enhancers" . SPARSER::PROTEIN)
    ("MYB and another antibody" . SPARSER::COLLECTION)
    ("KIT and CDK6" . SPARSER::COLLECTION) ("QKI6" . SPARSER::PROTEIN)
    ("QKI5" . SPARSER::PROTEIN) ("MYB-QKI6" . SPARSER::COLLECTION)
    ("MYB-QKI5" . SPARSER::COLLECTION) ("KH" . SPARSER::MOLECULE)
    ("STAR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYB and QKI" . SPARSER::COLLECTION)
    ("MYB or MYBL1" . SPARSER::COLLECTION) ("MYB-ESR1" . SPARSER::COLLECTION)
    ("ere" . SPARSER::PROTEIN) ("ten histologic subtypes" . SPARSER::PROTEIN)
    ("rare histologic subtypes" . SPARSER::PROTEIN)
    ("the temporal lobe" . SPARSER::PROTEIN)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("MYB-QKI" . SPARSER::COLLECTION) ("QKI" . SPARSER::PROTEIN)
    ("p 4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Gene 2" . SPARSER::PROTEIN)
    ("U87 MG" . SPARSER::PROTEIN) ("HRP 1" . SPARSER::PROTEIN)
    ("MYC-tagged" . SPARSER::PROTEIN) ("k 2" . SPARSER::PROTEIN)
    ("l 32" . SPARSER::PROTEIN) ("CDK7" . SPARSER::PROTEIN)
    ("isoform 7" . SPARSER::PROTEIN) ("micro-RNAs" . SPARSER::MICRO-RNA)
    ("Ink4a" . SPARSER::PROTEIN) ("v- myb" . SPARSER::PROTEIN)
    ("MYBL1" . SPARSER::PROTEIN) ("MYB and MYB" . SPARSER::COLLECTION)
    ("BET and Notch inhibitors target" . SPARSER::COLLECTION)
    ("transcriptional activator, and ΔNp63" . SPARSER::COLLECTION)
    ("RBPJ" . SPARSER::PROTEIN)
    ("the myoepithelial component" . SPARSER::COMPONENT)
    ("These more aggressive specimens lack TP63" . SPARSER::PROTEIN)
    ("TP63 and NOTCH1" . SPARSER::COLLECTION)
    ("a smaller fraction" . SPARSER::COMPONENT)
    ("JAG1 and JAG2" . SPARSER::COLLECTION)
    ("TP53/TP63/TP73" . SPARSER::COLLECTION)
    ("CDK6 and GMNN" . SPARSER::COLLECTION) ("GMNN" . SPARSER::PROTEIN)
    ("Conformation" . SPARSER::BIO-CONFORMATION)
    ("NFIB, TGFBR3 and RAD51B" . SPARSER::COLLECTION)
    ("smaller enhancers" . SPARSER::PROTEIN)
    ("NFIB and TGFRB3" . SPARSER::COLLECTION)
    ("NFIB , TGFBR3 and RAD51B" . SPARSER::COLLECTION)
    ("the enhancer-associated BET bromodomain protein BRD4" . SPARSER::PROTEIN)
    ("canonical NFIB" . SPARSER::PROTEIN)
    ("NFIB and TGFBR3" . SPARSER::COLLECTION)
    ("transcription factor (TF)" . SPARSER::PROTEIN)
    ("NFIB" . SPARSER::PROTEIN) ("loco" . SPARSER::PROTEIN)
    ("a highly active promoter" . SPARSER::PROMOTER)
    ("GFI1 or GFI1B" . SPARSER::COLLECTION) ("Bromodomain" . SPARSER::PROTEIN)
    ("ACC" . SPARSER::PROTEIN) ("pGL 4" . SPARSER::PROTEIN)
    ("TAF13" . SPARSER::PROTEIN) ("CDH18" . SPARSER::PROTEIN)
    ("1 – 2" . SPARSER::PROTEIN) ("Epidermal Growth Factor" . SPARSER::PROTEIN)
    ("beta-cyclodextrin" . SPARSER::MOLECULE) ("X11" . SPARSER::PROTEIN)
    ("EN1" . SPARSER::PROTEIN) ("TP73" . SPARSER::PROTEIN)
    ("RAD51B" . SPARSER::PROTEIN) ("TGFBR3" . SPARSER::PROTEIN)
    ("TMPRSS2" . SPARSER::PROTEIN) ("GFI1B" . SPARSER::PROTEIN)
    ("GFI1" . SPARSER::PROTEIN) ("BCR-ABL fusion gene" . SPARSER::PROTEIN)
    ("TP63" . SPARSER::PROTEIN) ("STAT6, and regulators" . SPARSER::COLLECTION)
    ("DNMT3A , TET2 , IDH1 and IDH2" . SPARSER::COLLECTION)
    ("TET2 and DNMT3A" . SPARSER::COLLECTION)
    ("the methylated cytosines" . SPARSER::NUCLEOBASE)
    ("lymphoid and myeloid" . SPARSER::COLLECTION)
    ("TET1, based on data from mouse embryonic stem cells (ESCs)"
     . SPARSER::PROTEIN)
    ("methylated cytosine" . SPARSER::NUCLEOBASE)
    ("partial and non-overlapping" . SPARSER::COLLECTION)
    ("GM-SCF" . SPARSER::COLLECTION) ("JAK3–STAT6" . SPARSER::COLLECTION)
    ("Tet2" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("Interleukin-4" . SPARSER::PROTEIN)
    ("receptor and HER2" . SPARSER::COLLECTION)
    ("ESR1 and ERBB2" . SPARSER::COLLECTION)
    ("the prognostic and predictive markers ER , PR and HER2"
     . SPARSER::COLLECTION)
    ("ER , PR and HER2" . SPARSER::COLLECTION) ("GGI" . SPARSER::MOLECULE)
    ("Estrogen Receptor (ER)" . SPARSER::PROTEIN)
    ("Estrogen receptor, Progesterone receptor and HER2" . SPARSER::COLLECTION)
    ("estrogen receptor, progesterone receptor and HER2" . SPARSER::COLLECTION)
    ("PR 5" . SPARSER::PROTEIN) ("Progesterone Receptor" . SPARSER::PROTEIN)
    ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("Progesterone receptor" . SPARSER::PROTEIN) ("Alcohol" . SPARSER::DRUG)
    ("Cao" . SPARSER::MOLECULE) ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("genotypes and AKT1" . SPARSER::COLLECTION)
    ("carried at least one risk genotype" . SPARSER::PROTEIN)
    ("at least one variant genotype" . SPARSER::PROTEIN)
    ("AKT3/PKB γ" . SPARSER::COLLECTION) ("AKT2/PKB" . SPARSER::COLLECTION)
    ("AKT1/PKB α" . SPARSER::COLLECTION)
    ("the viral oncogene" . SPARSER::ONCOGENE) ("PtdIns" . SPARSER::PROTEIN)
    ("phosphatidylinositols" . SPARSER::PROTEIN)
    ("some other oncogenes and tumour‐suppressor genes xref"
     . SPARSER::COLLECTION)
    ("five potentially functionalSNPs inAKT1(rs2494750, rs2494752 and rs10138277) andAKT2(rs7254617 and rs2304186) genes"
     . SPARSER::GENE)
    ("etc ." . SPARSER::PROTEIN) ("beta 8" . SPARSER::PROTEIN)
    ("PKB γ" . SPARSER::PROTEIN) ("PKB α" . SPARSER::PROTEIN)
    ("PIP2" . SPARSER::PIP2) ("PI3K–AKT" . SPARSER::PROTEIN)
    ("subunits and isoforms" . SPARSER::COLLECTION)
    ("HOTAIR, and PIK3R3" . SPARSER::COLLECTION)
    ("HOTAIR/PIK3R3" . SPARSER::COLLECTION) ("dicer" . SPARSER::PROTEIN)
    ("PIK3R3 and HOTAIR" . SPARSER::COLLECTION)
    ("/AKT/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("lincRNA" . SPARSER::RNA) ("LincRNA" . SPARSER::RNA)
    ("HOTAIR or PIK3R3" . SPARSER::COLLECTION)
    ("HOTAIR and PIK3R3" . SPARSER::COLLECTION)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-KIT" . SPARSER::PROTEIN) ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("hnRNP-K" . SPARSER::PROTEIN) ("PIK3R3" . SPARSER::PROTEIN)
    ("multiple weak AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("the cell-type-specific super-enhancers" . SPARSER::PROTEIN)
    ("typical enhancers" . SPARSER::PROTEIN)
    ("super-enhancers" . SPARSER::PROTEIN) ("Enhancers" . SPARSER::PROTEIN)
    ("double helix grooves and surface amino acids of the transcription factor"
     . SPARSER::PROTEIN)
    ("a given transcription factor" . SPARSER::PROTEIN)
    ("the ancestral alleles" . SPARSER::ALLELE)
    ("explicit 11 nt oligonucleotides" . SPARSER::MOLECULE)
    ("a ubiquitous cellular protein" . SPARSER::PROTEIN)
    ("the exosomal fraction" . SPARSER::COMPONENT)
    ("palmitoyl" . SPARSER::PROTEIN) ("miR-126–5p" . SPARSER::COLLECTION)
    ("GCA" . SPARSER::PROTEIN) ("‘GC’" . SPARSER::PROTEIN)
    ("NRF2-MAFG" . SPARSER::COLLECTION)
    ("nearly 1000 unique ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("‘TGA’" . SPARSER::PROTEIN) ("TGA" . SPARSER::PROTEIN)
    ("Maf-Nrf2" . SPARSER::COLLECTION)
    ("the homodimeric NRF2–DNA complex" . SPARSER::BIO-COMPLEX)
    ("homodimeric MAF proteins" . SPARSER::PROTEIN) ("tilt" . SPARSER::DRUG)
    ("which positions NRF2" . SPARSER::PROTEIN)
    ("A’ and MAFG" . SPARSER::COLLECTION)
    ("MAFF, MAFG and MAFK" . SPARSER::COLLECTION) ("MAFK" . SPARSER::PROTEIN)
    ("MAFF" . SPARSER::PROTEIN) ("A’ and NRF2" . SPARSER::COLLECTION)
    ("the NRF2-small MAF heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("Nrf2-MafG" . SPARSER::COLLECTION) ("MafG" . SPARSER::PROTEIN)
    ("TRE and MARE" . SPARSER::COLLECTION) ("MARE" . SPARSER::PROTEIN)
    ("MAFG" . SPARSER::PROTEIN)
    ("previously identified NRF2 target gene (Ferritin, light polypeptide, FTL ) promoter"
     . SPARSER::PROMOTER)
    ("PWM" . SPARSER::DRUG)
    ("the actual disease-causing variant" . SPARSER::VARIANT)
    ("alleles and haplotypes" . SPARSER::COLLECTION)
    ("antioxidant and detoxification genes" . SPARSER::COLLECTION)
    ("a ubiquitously expressed transcription factor and a key regulator"
     . SPARSER::COLLECTION)
    ("E2-" . SPARSER::MOLECULE) ("-5p" . SPARSER::COLLECTION)
    ("miR-126–3p" . SPARSER::COLLECTION) ("FTL" . SPARSER::PROTEIN)
    ("Ferritin" . SPARSER::PROTEIN) ("NRF2 and DNA" . SPARSER::COLLECTION)
    ("NRF2 and disease-associated regulatory SNPs (rSNPs)"
     . SPARSER::COLLECTION)
    ("a ubiquitous redox-activated transcription factor" . SPARSER::PROTEIN)
    ("oxidant and electrophile" . SPARSER::COLLECTION)
    ("H3K27ac" . SPARSER::MOLECULE) ("H3K27Ac" . SPARSER::MOLECULE)
    ("subunit A" . SPARSER::PROTEIN)
    ("12- o -tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("SNP-A" . SPARSER::PROTEIN) ("EGFL7" . SPARSER::PROTEIN)
    ("KLF2" . SPARSER::PROTEIN) ("Proteinase-K" . SPARSER::PROTEIN)
    ("p 5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("k 1" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma oncogene" . SPARSER::PROTEIN)
    ("light polypeptide" . SPARSER::PROTEIN)
    ("EGFR and downstream factors Akt and ERK" . SPARSER::COLLECTION)
    ("the ATM inhibitor KU55933 and the EGFR‐TKI gefitinib"
     . SPARSER::COLLECTION)
    ("those expressing exogenous wild‐type EGFR" . SPARSER::PROTEIN)
    ("‐MAPK/ERK" . SPARSER::COLLECTION)
    ("KU55933 and gefitinib" . SPARSER::COLLECTION)
    ("EGFR and/or its downstream molecules" . SPARSER::COLLECTION)
    ("gefitinib and KU55933" . SPARSER::COLLECTION)
    ("the EGFR‐TKI gefitinib or the ATM kinase inhibitor KU55933 (Table xref )"
     . SPARSER::COLLECTION)
    ("Calu" . SPARSER::PROTEIN) ("IGFR and EGFR" . SPARSER::COLLECTION)
    ("H2AX, Chk2, BRCA1, and p53" . SPARSER::COLLECTION)
    ("Erb" . SPARSER::PROTEIN)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("16 pathogenic variants" . SPARSER::VARIANT)
    ("TP53 and PTEN" . SPARSER::COLLECTION)
    ("MSH2 (mismatch DNA repair) and XRCC1 (base excision repair)"
     . SPARSER::COLLECTION)
    ("30 (22.6%) pathogenic variants" . SPARSER::VARIANT)
    ("ATM , BRIP1 , FANCI , RAD50 , and RAD51C" . SPARSER::COLLECTION)
    ("MSH2 and MUTYH" . SPARSER::COLLECTION)
    ("the pathogenic variants" . SPARSER::VARIANT)
    ("BRIP1 , MSH2 , MUTYH , and RAD51C" . SPARSER::COLLECTION)
    ("RAD50 , ATM , and TP53" . SPARSER::COLLECTION)
    ("BRCA2 or RAD50" . SPARSER::COLLECTION)
    ("complex and inability" . SPARSER::COLLECTION)
    ("FANCI-FANCD2" . SPARSER::COLLECTION)
    ("benign variants" . SPARSER::VARIANT)
    ("the heterozygous TP53 p" . SPARSER::PROTEIN)
    ("ATM , BRIP1 , FANCI , MSH2 , MUTYH , and RAD51C" . SPARSER::COLLECTION)
    ("gene and tumor" . SPARSER::COLLECTION)
    ("Comprehensive multiple gene" . SPARSER::GENE)
    ("medium-to-high penetrance genes" . SPARSER::GENE)
    ("ATM , BRIP1 , PALB2 , PTEN and CHEK2" . SPARSER::COLLECTION)
    ("BRCA and RAD51C" . SPARSER::COLLECTION)
    ("receptor (HR)" . SPARSER::RECEPTOR)
    ("BRIP1 , MSH2, MUTYH , and RAD51C" . SPARSER::COLLECTION)
    ("RAD50, ATM , and TP53" . SPARSER::COLLECTION)
    ("ATM, BRIP1, FANCI, MSH2, MUTYH , and RAD51C" . SPARSER::COLLECTION)
    ("MUTYH" . SPARSER::PROTEIN) ("xeroderma pigmentosum" . SPARSER::PROTEIN)
    ("PMS1" . SPARSER::PROTEIN) ("MSH3" . SPARSER::PROTEIN)
    ("MLH3" . SPARSER::PROTEIN) ("CA-125" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("PMS2" . SPARSER::PROTEIN)
    ("GPR91-PI3K" . SPARSER::PROTEIN-PAIR)
    ("VEGF and cAMP" . SPARSER::COLLECTION)
    ("Succinate-GPR91" . SPARSER::COLLECTION)
    ("the mitochondrial ROS" . SPARSER::PROTEIN) ("GRP" . SPARSER::PROTEIN)
    ("at least one metabolite" . SPARSER::MOLECULE)
    ("aequorin" . SPARSER::PROTEIN)
    ("succinate dehydrogenase or other enzymes" . SPARSER::COLLECTION)
    ("MCT" . SPARSER::PROTEIN) ("monocrotaline" . SPARSER::MOLECULE)
    ("succinate-GPR91-PI3K/Akt" . SPARSER::COLLECTION)
    ("siRNA-GPR91" . SPARSER::COLLECTION)
    ("the RVH-associated gene anp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RVH-associated genes and PI3K/Akt signaling in the cardiac muscle cells in vitro"
     . SPARSER::COLLECTION)
    ("Wortmannin" . SPARSER::PROTEIN) ("p-Akt/Akt" . SPARSER::COLLECTION)
    ("PAB and sham" . SPARSER::COLLECTION)
    ("atrial natriuretic peptide (ANP) and vascular endothelial growth factor (VEGF)"
     . SPARSER::COLLECTION)
    ("atrial natriuretic peptide (ANP)" . SPARSER::PROTEIN)
    ("RVH-associated genes" . SPARSER::GENE) ("ANP" . SPARSER::PROTEIN)
    ("succinate and its receptor" . SPARSER::COLLECTION) ("Gq" . SPARSER::DRUG)
    ("amino acids, peptides, lipids, nucleotides and photons"
     . SPARSER::COLLECTION)
    ("Succinate" . SPARSER::PROTEIN)
    ("an insufficient oxygen" . SPARSER::MOLECULE) ("HF" . SPARSER::PROTEIN)
    ("GPR91-PI3K/Akt" . SPARSER::COLLECTION)
    ("the hypertrophic gene marker anp and p-Akt/t-Akt in cardiomyocytes"
     . SPARSER::COLLECTION)
    ("the hypertrophic gene marker anp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("up-regulated RVH-associated genes" . SPARSER::GENE)
    ("sham and PAB" . SPARSER::COLLECTION)
    ("p-Akt/t-Akt" . SPARSER::COLLECTION) ("succinate" . SPARSER::PROTEIN)
    ("succinate-GPR91" . SPARSER::COLLECTION) ("PAB" . SPARSER::PROTEIN)
    ("a formerly orphan G-protein-coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("succinate dehydrogenase complex" . SPARSER::PROTEIN)
    ("β-blockers" . SPARSER::DRUG) ("natriuretic peptide" . SPARSER::PROTEIN)
    ("G-Protein" . SPARSER::PROTEIN) ("GPR91" . SPARSER::PROTEIN)
    ("salt and water" . SPARSER::COLLECTION)
    ("KCNN4 and ileal" . SPARSER::COLLECTION) ("defensins" . SPARSER::PROTEIN)
    ("CRC and SD" . SPARSER::COLLECTION)
    ("VEGFR and ß1-integrin" . SPARSER::COLLECTION)
    ("especially growth factor receptors" . SPARSER::RECEPTOR)
    ("CFTR" . SPARSER::PROTEIN)
    ("an intact intestinal barrier" . SPARSER::PROTEIN)
    ("CRC or SD" . SPARSER::COLLECTION)
    ("the PI3K inhibitor Ly294002 or the ERK inhibitor 3-(2-Aminoethyl)-5-"
     . SPARSER::COLLECTION)
    ("thiazolidinedione" . SPARSER::DRUG)
    ("Akt and ERK-1/2" . SPARSER::COLLECTION)
    ("PI3K- and MAPK-pathway" . SPARSER::COLLECTION) ("WB" . SPARSER::PROTEIN)
    ("KCNN4 and Ca 2+" . SPARSER::COLLECTION)
    ("KCNMA1 and KCNN4" . SPARSER::COLLECTION)
    ("possible downstream targets" . SPARSER::TARGET-PROTEIN)
    ("IFN-γ, TNF-α and IL-12" . SPARSER::COLLECTION)
    ("NF-κB-, PI3K- and ERK-cascades" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NF-κB-" . SPARSER::PROTEIN)
    ("ions and water" . SPARSER::COLLECTION) ("IBD" . SPARSER::PROTEIN)
    ("PI3K and ERK" . SPARSER::COLLECTION) ("interferon-γ" . SPARSER::PROTEIN)
    ("KCNA3" . SPARSER::PROTEIN) ("KCNH2" . SPARSER::PROTEIN)
    ("KCNN1" . SPARSER::PROTEIN) ("P450" . SPARSER::PROTEIN-FAMILY)
    ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IFN γ" . SPARSER::PROTEIN)
    ("Ba 2" . SPARSER::PROTEIN) ("KCNMA1" . SPARSER::PROTEIN)
    ("KCNQ1" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("tight junction" . SPARSER::PROTEIN)
    ("chemokine receptor" . SPARSER::PROTEIN) ("KCNN4" . SPARSER::PROTEIN)
    ("potassium channel" . SPARSER::PROTEIN)
    ("ZEB1, Sox2 and Bmi1" . SPARSER::COLLECTION)
    ("EMT and the stemness" . SPARSER::COLLECTION)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("IL-32 and its isoforms" . SPARSER::COLLECTION)
    ("Bmi1, Sox2 and ZEB1" . SPARSER::COLLECTION)
    ("EMT and stemness" . SPARSER::COLLECTION)
    ("Nanog , Oct4 and Sox2" . SPARSER::COLLECTION)
    ("Oct4, Bmi1, Sox2, c-myc and Nanog" . SPARSER::COLLECTION)
    ("ZEB1 and E-cadherin" . SPARSER::COLLECTION)
    ("a recombinant hexa-histidine-tagged IL-32θ protein" . SPARSER::PROTEIN)
    ("hexa" . SPARSER::PROTEIN) ("sphere-inducing media" . SPARSER::PROTEIN)
    ("STAT3-ZEB1" . SPARSER::COLLECTION)
    ("Bmi1 and ZEB1" . SPARSER::COLLECTION) ("Interleukin" . SPARSER::PROTEIN)
    ("D-1" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("IL-32" . SPARSER::PROTEIN)
    ("399Gln" . SPARSER::PROTEIN) ("the aberrant XRCC1" . SPARSER::PROTEIN)
    ("Solvent-" . SPARSER::MOLECULE) ("Solvent" . SPARSER::MOLECULE)
    ("molecules or residues" . SPARSER::COLLECTION)
    ("the free energy change DDG value –2.23" . SPARSER::PROTEIN)
    ("DDG" . SPARSER::PROTEIN)
    ("SNAP, PolyPhen2, and PROVEAN" . SPARSER::COLLECTION)
    ("Nicotine" . SPARSER::DRUG) ("/Arg" . SPARSER::COLLECTION)
    ("/Gln" . SPARSER::COLLECTION)
    ("susceptibilityprotein-2" . SPARSER::COLLECTION)
    ("susceptibilityprotein-1" . SPARSER::COLLECTION)
    ("SNAP" . SPARSER::PROTEIN) ("5 ps" . SPARSER::PROTEIN)
    ("e-5" . SPARSER::PROTEIN)
    ("HO-1 and glutathione S-transferase" . SPARSER::COLLECTION)
    ("AMPK, Nrf2, and HO-1" . SPARSER::COLLECTION)
    ("vascular cell adhesion molecule-1 (VCAM-1) and P-selectin"
     . SPARSER::COLLECTION)
    ("oxLDL" . SPARSER::MOLECULE) ("hydroperoxides" . SPARSER::MOLECULE)
    ("a stress-inducible enzyme" . SPARSER::ENZYME)
    ("oxygenase (HO)" . SPARSER::PROTEIN)
    ("oxygenase or haem" . SPARSER::COLLECTION) ("haem" . SPARSER::MOLECULE)
    ("Heme" . SPARSER::PROTEIN)
    ("proinflammatory cytokines and adhesion molecules" . SPARSER::COLLECTION)
    ("IL-6 and VCAM-1" . SPARSER::COLLECTION)
    ("a powerful proinflammatory cytokine" . SPARSER::PROTEIN)
    ("/AMPK/Nrf2" . SPARSER::COLLECTION) ("Akt and AMPK" . SPARSER::COLLECTION)
    ("nitric oxide (NO) and prostacyclin production in endothelial cells [ xref ]"
     . SPARSER::COLLECTION)
    ("prostacyclin" . SPARSER::MOLECULE)
    ("Compound C and shNrf2 abolished TNF α -triggered VCAM-1 expression"
     . SPARSER::COLLECTION)
    ("AMPK and Nrf2" . SPARSER::COLLECTION)
    ("AMPK and shNrf2" . SPARSER::COLLECTION)
    ("STO-609 and Compound C" . SPARSER::COLLECTION)
    ("manganese superoxide dismutase, catalase, and thioredoxin"
     . SPARSER::COLLECTION)
    ("AMPK and HO-1" . SPARSER::COLLECTION)
    ("activator protein 1 (AP-1) and NF-E2-related factor-2 (Nrf2)"
     . SPARSER::COLLECTION)
    ("Proinflammatory cytokines" . SPARSER::PROTEIN)
    ("superoxide anions, hydrogen peroxide, peroxynitrite, and hydroxyl radicals"
     . SPARSER::COLLECTION)
    ("peroxynitrite" . SPARSER::MOLECULE) ("/AMPK" . SPARSER::COLLECTION)
    ("CaMKK" . SPARSER::PROTEIN) ("INN" . SPARSER::DRUG)
    ("Clopidogrel (INN)" . SPARSER::DRUG) ("Clopidogrel" . SPARSER::DRUG)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("P-selectin" . SPARSER::PROTEIN) ("NF κ B" . SPARSER::PROTEIN)
    ("CD40 ligand" . SPARSER::PROTEIN) ("N-Acetylcysteine" . SPARSER::DRUG)
    ("SP2" . SPARSER::PROTEIN) ("DCF-DA" . SPARSER::DRUG)
    ("STO-609" . SPARSER::DRUG) ("l-glutamine" . SPARSER::MOLECULE)
    ("NF-E2-related factor-2" . SPARSER::PROTEIN)
    ("superoxide anions" . SPARSER::MOLECULE)
    ("Compound C" . SPARSER::MOLECULE) ("TNF α" . SPARSER::PROTEIN)
    ("proteins, and flavonoids" . SPARSER::COLLECTION)
    ("pentose, and hexose" . SPARSER::COLLECTION)
    ("hexose" . SPARSER::MOLECULE) ("diterpenoid" . SPARSER::MOLECULE)
    ("Crude or purified polysaccharides" . SPARSER::POLYSACCHARIDE)
    ("Nrf2/NF- κ B" . SPARSER::COLLECTION)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("Nrf2 and NF- κ B" . SPARSER::COLLECTION)
    ("a nonenzymatic antioxidant" . SPARSER::PROTEIN)
    ("cofactor or coenzyme" . SPARSER::COLLECTION)
    ("coenzyme" . SPARSER::MOLECULE)
    ("a well-studied thiol-based antioxidant" . SPARSER::DRUG)
    ("thiol" . SPARSER::MOLECULE)
    ("HO-1 and γ -GCLC genes" . SPARSER::COLLECTION)
    ("a basic leucine-zipper (bZIP) transcription factor" . SPARSER::PROTEIN)
    ("the toxic ROS" . SPARSER::PROTEIN)
    ("a potent antiangiogenic substance" . SPARSER::SUBSTANCE)
    ("Salicylates" . SPARSER::MOLECULE) ("at least part" . SPARSER::COMPONENT)
    ("MMP-9 and ICAM-1" . SPARSER::COLLECTION)
    ("HO-1 and γ -GCLC antioxidant genes" . SPARSER::COLLECTION)
    ("the TNF- α -induced excessive ROS" . SPARSER::PROTEIN)
    ("DCF" . SPARSER::PROTEIN) ("-DA" . SPARSER::MOLECULE)
    ("MMP and adhesion molecule" . SPARSER::COLLECTION)
    ("collagenase" . SPARSER::PROTEIN) ("MMP-9/NF- κ B" . SPARSER::COLLECTION)
    ("HEG" . SPARSER::PROTEIN)
    ("lectins, proteins, sterols, fatty acid, and esters"
     . SPARSER::COLLECTION)
    ("esters" . SPARSER::MOLECULE) ("sterols" . SPARSER::MOLECULE)
    ("lectins" . SPARSER::PROTEIN)
    ("polysaccharides" . SPARSER::POLYSACCHARIDE)
    ("essential amino acids" . SPARSER::AMINO-ACID)
    ("antioxidant and cytoprotective property" . SPARSER::COLLECTION)
    ("glutamate-cysteine ligase (GCLC)" . SPARSER::PROTEIN)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("enzymes and antioxidants" . SPARSER::COLLECTION)
    ("Nrf2-sMaf" . SPARSER::PROTEIN-PAIR)
    ("NF- κ B and nuclear factor (erythroid-2) related factor-2 (Nrf2)"
     . SPARSER::COLLECTION)
    ("erythroid-2" . SPARSER::COLLECTION)
    ("MMPs and adhesion molecules [ xref , xref ]" . SPARSER::COLLECTION)
    ("MMPs and adhesion molecules" . SPARSER::COLLECTION)
    ("tumor necrosis factor-" . SPARSER::PROTEIN)
    ("antiangiogenic molecules" . SPARSER::MOLECULE)
    ("NF- κ B and Nrf2" . SPARSER::COLLECTION) ("-GCLC" . SPARSER::COLLECTION)
    ("inhibitor-" . SPARSER::INHIBITOR)
    ("matrix metalloproteinase-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1)"
     . SPARSER::COLLECTION)
    ("hy" . SPARSER::MOLECULE) ("A–I" . SPARSER::PROTEIN)
    ("coenzyme Q" . SPARSER::PROTEIN) ("N-acetylcysteine" . SPARSER::DRUG)
    ("ELAM-1" . SPARSER::PROTEIN) ("1–8 " . SPARSER::PROTEIN)
    ("R-250" . SPARSER::PROTEIN) ("I- κ B α" . SPARSER::PROTEIN)
    ("Keap-1" . SPARSER::PROTEIN) ("NF-E 2" . SPARSER::PROTEIN)
    ("I- κ B" . SPARSER::PROTEIN) ("factor- κ B" . SPARSER::PROTEIN)
    ("TrkA" . SPARSER::PROTEIN) ("threonine and serine" . SPARSER::COLLECTION)
    ("T185/Y187 dual-phosphorylated forms" . SPARSER::FORM)
    ("Supplemental Figure S3B" . SPARSER::PROTEIN) ("VI" . SPARSER::PROTEIN)
    ("nitrogen atom (NZ)" . SPARSER::MOLECULE) ("OG" . SPARSER::PROTEIN)
    ("x-ray" . SPARSER::PROTEIN-PAIR)
    ("exogenous substrates" . SPARSER::SUBSTRATE)
    ("apparently ERK2 T190D mutants" . SPARSER::MUTANT)
    ("Supplemental Table S3A" . SPARSER::PROTEIN)
    ("serine, threonine, or tyrosine" . SPARSER::COLLECTION)
    ("Supplemental Table S3B" . SPARSER::PROTEIN)
    ("protein-tyrosine phosphatases and dual-specificity phosphatases/MAPK phosphatases"
     . SPARSER::COLLECTION)
    ("phosphatases/MAPK" . SPARSER::COLLECTION) ("PAO" . SPARSER::PROTEIN)
    ("oxide" . SPARSER::MOLECULE)
    ("protein-tyrosine phosphatase (PTP) or serine/threonine phosphatase (STP) inhibitors ( xref )"
     . SPARSER::COLLECTION)
    ("phosphatase (PTP)" . SPARSER::PHOSPHATASE) ("STP" . SPARSER::PROTEIN)
    ("Flag-ERK1" . SPARSER::COLLECTION)
    ("Recombinant ERK1 and its mutants" . SPARSER::COLLECTION)
    ("Phe or Glu" . SPARSER::COLLECTION)
    ("an exogenous substrate" . SPARSER::SUBSTRATE)
    ("The T207E phosphosite-mimetic mutant" . SPARSER::MUTANT)
    ("the resultant fragment" . SPARSER::FRAGMENT)
    ("ERK1-KD" . SPARSER::COLLECTION)
    ("The nonphosphospecific antibodies" . SPARSER::ANTIBODY)
    ("generic phosphotyrosine-specific antibodies" . SPARSER::ANTIBODY)
    ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("alanine and leucine" . SPARSER::COLLECTION)
    ("human typical protein-serine/threonine kinases" . SPARSER::PROTEIN)
    ("protein kinase B/AKTs" . SPARSER::COLLECTION)
    ("AKTs" . SPARSER::PROTEIN-FAMILY) ("the second largest class" . CLASS)
    ("the human typical protein-serine/threonine kinases" . SPARSER::PROTEIN)
    ("MAPK/ERK-1" . SPARSER::COLLECTION)
    ("threonine–glutamic acid–tyrosine" . SPARSER::COLLECTION)
    ("–ERK" . SPARSER::COLLECTION)
    ("Ras-Raf–MAPK/extracellular signal–regulated kinase"
     . SPARSER::COLLECTION)
    ("macromolecule" . SPARSER::MOLECULE) ("DFG" . SPARSER::PROTEIN)
    ("484 typical protein kinases" . SPARSER::PROTEIN)
    ("at least 536 protein kinases" . SPARSER::PROTEIN)
    ("Eukaryotic protein kinases" . SPARSER::PROTEIN)
    ("serine, threonine, and tyrosine" . SPARSER::COLLECTION)
    ("VII and VIII" . SPARSER::COLLECTION) ("subdomains" . SPARSER::PROTEIN)
    ("most eukaryotic protein kinases" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("MARK4" . SPARSER::PROTEIN)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nitrogen atom" . SPARSER::MOLECULE) ("oxygen atom" . SPARSER::MOLECULE)
    ("UO126" . SPARSER::DRUG) ("myelin basic protein" . SPARSER::PROTEIN)
    ("G protein–coupled" . SPARSER::PROTEIN) ("ERK-1" . SPARSER::PROTEIN)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Extracellular signal–regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-MAPK" . SPARSER::COLLECTION) ("osx" . SPARSER::PROTEIN)
    ("chondrocytes and osteoblasts" . SPARSER::COLLECTION)
    ("f" . SPARSER::PROTEIN) ("the lesionous chondrocytes" . SPARSER::PROTEIN)
    ("Nf1" . SPARSER::PROTEIN) ("Prx1" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN)
    ("the sensing molecule AQP1 and the effector molecule COX-2"
     . SPARSER::COLLECTION)
    ("TonEBP/NFAT" . SPARSER::COLLECTION) ("NFAT-MMP-2" . SPARSER::COLLECTION)
    ("TNF-α and monocyte chemoattractant protein (MCP)-1 [ xref , xref – xref ]"
     . SPARSER::COLLECTION)
    ("aldose reductase and protein kinase C delta" . SPARSER::COLLECTION)
    ("rel/NF-κB" . SPARSER::COLLECTION) ("MCP" . SPARSER::PROTEIN)
    ("the hyperosmolar component" . SPARSER::COMPONENT)
    ("monosaccharides" . SPARSER::MOLECULE)
    ("our findings detail part of the molecular signaling"
     . SPARSER::COMPONENT)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("retinal COX-2 and AQP1" . SPARSER::COLLECTION)
    ("e–f" . SPARSER::PROTEIN-PAIR) ("e" . SPARSER::PROTEIN)
    ("d–e" . SPARSER::PROTEIN-PAIR) ("OPL" . SPARSER::PROTEIN)
    ("IPL" . SPARSER::PROTEIN)
    ("CD31 (Fig.  xref b) and ASMA (Fig.  xref g–l)" . SPARSER::COLLECTION)
    ("b" . SPARSER::PROTEIN)
    ("CD31 (a marker of angiogenesis) and α-smooth muscle actin (ASMA, a marker of arteriogenesis)"
     . SPARSER::COLLECTION)
    ("COX-2 and AQP1" . SPARSER::COLLECTION)
    ("mannitol or sodium chloride" . SPARSER::COLLECTION)
    ("b–c" . SPARSER::PROTEIN-PAIR)
    ("glucose and mannitol" . SPARSER::COLLECTION) ("d" . SPARSER::PROTEIN)
    ("AQP1 or the COX-2 inhibitor NS-398" . SPARSER::COLLECTION)
    ("TonEBP/NFAT5" . SPARSER::COLLECTION) ("c–d" . SPARSER::PROTEIN-PAIR)
    ("glucose-" . SPARSER::PROTEIN) ("-glucose" . SPARSER::COLLECTION)
    ("Endothelial COX-2" . SPARSER::PROTEIN)
    ("mitogens and endotoxin [ xref ]" . SPARSER::COLLECTION)
    ("matrix metalloproteinase (MMP)" . SPARSER::PROTEIN)
    ("endotoxin" . SPARSER::MOLECULE)
    ("VCAM-1 and ICAM-1" . SPARSER::COLLECTION)
    ("the proinflammatory proteins intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1"
     . SPARSER::COLLECTION)
    ("aquaporin (AQP)" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule (VCAM)-1" . SPARSER::PROTEIN)
    ("the proinflammatory proteins intercellular adhesion molecule (ICAM)-1"
     . SPARSER::PROTEIN)
    ("aquaporin" . SPARSER::PROTEIN) ("ICAM" . SPARSER::PROTEIN-FAMILY)
    ("polyol and hexosamine" . SPARSER::COLLECTION)
    ("polyol" . SPARSER::MOLECULE) ("sorbitol" . SPARSER::PROTEIN)
    ("AQP1 and COX-2" . SPARSER::COLLECTION) ("Retinas" . SPARSER::DRUG)
    ("the osmolarity-sensitive transcription factor Tonicity enhancer binding protein"
     . SPARSER::PROTEIN)
    ("AQP1 and TonEBP" . SPARSER::COLLECTION) ("TonEBP" . SPARSER::PROTEIN)
    ("the water channel aquaporin-1 (AQP1) and cyclooxygenase (COX)-2"
     . SPARSER::COLLECTION)
    ("cyclooxygenase" . SPARSER::PROTEIN)
    ("glucose or mannitol" . SPARSER::COLLECTION)
    ("mannitol" . SPARSER::PROTEIN)
    ("diabetic hyperglycemia" . SPARSER::PROTEIN)
    ("protein kinase C delta" . SPARSER::PROTEIN)
    ("aldose reductase" . SPARSER::PROTEIN) ("AQP4" . SPARSER::PROTEIN)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("NS-398" . SPARSER::DRUG)
    ("d -glucose" . SPARSER::MOLECULE) ("adhesion molecule" . SPARSER::PROTEIN)
    ("AQP1" . SPARSER::PROTEIN) ("aquaporin-1" . SPARSER::PROTEIN)
    ("an architectural component" . SPARSER::COMPONENT)
    ("UTR-MU" . SPARSER::COLLECTION) ("UTR-NC" . SPARSER::COLLECTION)
    ("MU" . SPARSER::PROTEIN) ("edu" . SPARSER::DRUG)
    ("homogeneous condensation" . SPARSER::PROTEIN-FAMILY)
    ("short noncoding RNAs and long noncoding RNAs (lncRNAs)"
     . SPARSER::COLLECTION)
    ("Cdk6" . SPARSER::PROTEIN) ("HIF-2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 6" . SPARSER::PROTEIN)
    ("only Ser 140 Ala mutant Mcl-1" . SPARSER::PROTEIN)
    ("the chemotherapeutic drug doxorubicin" . SPARSER::PROTEIN)
    ("a previously described mutant form" . SPARSER::FORM)
    ("mMcl-1" . SPARSER::COLLECTION) ("RIPK3, and RIPK3" . SPARSER::COLLECTION)
    ("MLKL" . SPARSER::PROTEIN) ("ripoptosome" . SPARSER::BIO-COMPLEX)
    ("mitochondria and caspase-3" . SPARSER::COLLECTION)
    ("dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("TMRE" . SPARSER::MOLECULE)
    ("BclX (anti-apoptotic) as well as Bid, Bax and Bad (pro-apoptotic)"
     . SPARSER::COLLECTION)
    ("Bid, Bax and Bad" . SPARSER::COLLECTION) ("BclX" . SPARSER::PROTEIN)
    ("ester (CFSE)" . SPARSER::MOLECULE)
    ("two major cytokines" . SPARSER::PROTEIN)
    ("IL-4 and IFNγ" . SPARSER::COLLECTION)
    ("reduced OVA-specific IgG1 ( xref ) and OVA-specific IgG2c ( xref )"
     . SPARSER::COLLECTION)
    ("isotype" . SPARSER::PROTEIN) ("isotype-Abs" . SPARSER::PROTEIN-PAIR)
    ("ovalbumin" . SPARSER::PROTEIN) ("IgM or IgG1" . SPARSER::COLLECTION)
    ("IgM" . SPARSER::PROTEIN)
    ("DP and single positive (SP) thymocytes ( xref )" . SPARSER::COLLECTION)
    ("cytidine deaminase (AID)" . SPARSER::PROTEIN) ("AID" . SPARSER::PROTEIN)
    ("γH2AX and phospho-Ser 389" . SPARSER::COLLECTION)
    ("ATM and p38 MAPK" . SPARSER::COLLECTION)
    ("a functional TCRβ" . SPARSER::PROTEIN)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION) ("Abs" . SPARSER::PROTEIN)
    ("GSK3β and phospho-Ser 9" . SPARSER::COLLECTION)
    ("CD4 and CD8" . SPARSER::COLLECTION) ("DP" . SPARSER::PROTEIN)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("an intrinsic competitive inhibitor" . SPARSER::INHIBITOR)
    ("GSK3β/GSK3α" . SPARSER::COLLECTION)
    ("both GSK3β and its closely related kinase GSK3α" . SPARSER::COLLECTION)
    ("MAPK14" . SPARSER::PROTEIN) ("Tcr β" . SPARSER::PROTEIN)
    ("Topro-3" . SPARSER::MOLECULE) ("Fas Ligand" . SPARSER::PROTEIN)
    ("L -glutamine" . SPARSER::MOLECULE) ("P81" . SPARSER::PROTEIN)
    ("N-C" . SPARSER::PROTEIN) ("anti-phospho" . SPARSER::PROTEIN)
    ("BA1" . SPARSER::PROTEIN) ("T-G" . SPARSER::PROTEIN)
    ("RIPK3" . SPARSER::PROTEIN) ("Necrostatin-1s" . SPARSER::MOLECULE)
    ("necrostatin-1s" . SPARSER::MOLECULE) ("IgG2c" . SPARSER::BIO-COMPLEX)
    ("cytidine deaminase" . SPARSER::PROTEIN)
    ("heavy chain" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("DN4" . SPARSER::PROTEIN) ("p38c" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("anti-CD28" . SPARSER::PROTEIN)
    ("GSK3α" . SPARSER::PROTEIN) ("Tcrβ" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("both novel therapeutic targets as well as novel biomarkers"
     . SPARSER::COLLECTION)
    ("ER and/or PR" . SPARSER::COLLECTION)
    ("estrogen or progesterone" . SPARSER::COLLECTION)
    ("autocrine OPN" . SPARSER::PROTEIN)
    ("the fourth mammary fat" . SPARSER::PROTEIN) ("MeOH" . SPARSER::MOLECULE)
    ("CD24-" . SPARSER::PROTEIN)
    ("doxorubicin, docetaxel, and cyclophosphamide" . SPARSER::COLLECTION)
    ("cyclophosphamide" . SPARSER::DRUG)
    ("a concise enantioselective solution" . SPARSER::MOLECULE)
    ("fibroblast-derived OPN or SUM1315-derived OPN" . SPARSER::COLLECTION)
    ("Tiam1 and OPN" . SPARSER::COLLECTION)
    ("control RMF or Tiam1-deficient RMF" . SPARSER::COLLECTION)
    ("RMF" . SPARSER::PROTEIN-FAMILY) ("/ESA" . SPARSER::COLLECTION)
    ("ESA" . SPARSER::PROTEIN) ("Snail and Fibronectin" . SPARSER::COLLECTION)
    ("Fibronectin and N-cadherin" . SPARSER::COLLECTION)
    ("Tiam1-" . SPARSER::PROTEIN) ("RMFs" . SPARSER::PROTEIN-FAMILY)
    ("Tiam1-OPN" . SPARSER::COLLECTION)
    ("osteopontin (OPN)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OPN" . SPARSER::PROTEIN) ("a ubiquitous protein" . SPARSER::PROTEIN)
    ("Tiam1 and osteopontin" . SPARSER::COLLECTION)
    ("Tiam1-osteopontin" . SPARSER::COLLECTION) ("SPP1" . SPARSER::PROTEIN)
    ("Ras-binding" . SPARSER::PROTEIN)
    ("AKT1 and subsequently avoiding OCT4" . SPARSER::COLLECTION)
    ("OCT4 and KLF4" . SPARSER::COLLECTION)
    ("facilitated OCT4's" . SPARSER::PROTEIN)
    ("directly targeting cell cycle-associated genes" . SPARSER::GENE)
    ("AKT1 and phospho-AKT" . SPARSER::COLLECTION) ("NPCs" . SPARSER::MOLECULE)
    ("E2F-1 and cyclin D1" . SPARSER::COLLECTION)
    ("AKT1 and OCT4" . SPARSER::COLLECTION) ("AP" . SPARSER::PROTEIN-FAMILY)
    ("CCND1 and CDK2" . SPARSER::COLLECTION)
    ("CDKN1A, RB1, RBL1, RBL2, LATS2 and TGFBR2" . SPARSER::COLLECTION)
    ("CCND1, CDK4, CDK6, CDKN1A and TGF β" . SPARSER::COLLECTION)
    ("S transition-associated regulators" . SPARSER::REGULATOR)
    ("Cyclin D1 and P21" . SPARSER::COLLECTION)
    ("Alkaline phosphatase (AP)" . SPARSER::PROTEIN-FAMILY)
    ("miR-302s" . SPARSER::PROTEIN) ("lenti-miR-302s" . SPARSER::PROTEIN-PAIR)
    ("gene, protein and miRNA" . SPARSER::COLLECTION)
    ("ECCs" . SPARSER::MOLECULE) ("CDK2 and CCND1" . SPARSER::COLLECTION)
    ("OCT4 and SOX2" . SPARSER::COLLECTION)
    ("the pluripotent factor OCT4" . SPARSER::PROTEIN)
    ("β -mercaptoethanol" . SPARSER::MOLECULE) ("Brg1" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::PROTEIN) ("Retinoic acid" . SPARSER::MOLECULE)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGFBR2" . SPARSER::PROTEIN)
    ("RBL2" . SPARSER::PROTEIN) ("RBL1" . SPARSER::PROTEIN)
    ("miR-302b" . SPARSER::MOLECULE) ("cranial MRI" . SPARSER::PROTEIN)
    ("DNA-damage related" . SPARSER::DNA)
    ("a promising diagnostic biomarker" . SPARSER::MOLECULE)
    ("a pan-nuclear γ-H2AX" . SPARSER::PROTEIN)
    ("further DNA damage response proteins" . SPARSER::PROTEIN)
    ("lymphocytic DNA damage foci" . SPARSER::PROTEIN)
    ("gamma-H2AX or 53BP1" . SPARSER::COLLECTION)
    ("γ-H2AX or 53BP1" . SPARSER::COLLECTION)
    ("Intranuclear γ-H2AX foci" . SPARSER::PROTEIN)
    ("lymphocytic γ-H2AX and 53BP1 foci" . SPARSER::PROTEIN)
    ("γH2AX and 53BP1" . SPARSER::COLLECTION)
    ("γ-H2AX (0.04 [0–0.5]) and 53BP1 (0.005 [0–0.2]) foci"
     . SPARSER::COLLECTION)
    ("CEL" . SPARSER::PROTEIN) ("γ-H2AX and 53BP1" . SPARSER::COLLECTION)
    ("CIS" . SPARSER::PROTEIN) ("TR 4" . SPARSER::PROTEIN)
    ("receptors and HER-2" . SPARSER::COLLECTION)
    ("discordant mRNA and IHC/FISH" . SPARSER::COLLECTION)
    ("mRNA and IHC/FISH" . SPARSER::COLLECTION)
    ("ER and PgR" . SPARSER::COLLECTION)
    ("receptors and HER2" . SPARSER::COLLECTION)
    ("PgR and HER-2" . SPARSER::COLLECTION)
    ("ER, PgR, and HER-2" . SPARSER::COLLECTION)
    ("NUSAP1, RRM2, CP110 and B-Myb" . SPARSER::COLLECTION)
    ("Cullin" . SPARSER::PROTEIN-FAMILY) ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("Cyclin A or Cyclin" . SPARSER::COLLECTION)
    ("Cyclin F-CDC6" . SPARSER::COLLECTION)
    ("CDT1 and ORC1" . SPARSER::COLLECTION)
    ("CDK and CDC7" . SPARSER::COLLECTION)
    ("LacZ and WT CDC6" . SPARSER::COLLECTION)
    ("WT CDC6 or the stable dl93–100 mutant CDC6" . SPARSER::COLLECTION)
    ("V5-tagged LacZ, WT CDC6 or the stable dl93–100 mutant CDC6"
     . SPARSER::COLLECTION)
    ("V5-tagged LacZ" . SPARSER::PROTEIN)
    ("Cyclin F and control siRNA" . SPARSER::COLLECTION)
    ("Geminin and control siRNA" . SPARSER::COLLECTION)
    ("Geminin and Cyclin F" . SPARSER::COLLECTION)
    ("Cyclin F or Geminin" . SPARSER::COLLECTION)
    ("Cyclin F and/or Geminin ( xref )" . SPARSER::COLLECTION)
    ("Cyclin F and Geminin" . SPARSER::COLLECTION)
    ("both Cyclin F and the CDT1 inhibitor Geminin" . SPARSER::COLLECTION)
    ("HA-CDC6" . SPARSER::COLLECTION)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KEN" . SPARSER::PROTEIN) ("TIG-3" . SPARSER::PROTEIN)
    ("state or aspartic acid (DDD)" . SPARSER::COLLECTION)
    ("alanine (AAA)" . SPARSER::AMINO-ACID)
    ("state or aspartic acid" . SPARSER::COLLECTION)
    ("DDD" . SPARSER::MOLECULE)
    ("an active SCF ubiquitin ligase complex" . SPARSER::BIO-COMPLEX)
    ("anaphase-promoting complex (APC)" . SPARSER::PROTEIN)
    ("GST-CDC6" . SPARSER::COLLECTION) ("MR/AA" . SPARSER::PROTEIN)
    ("CDC6 and its known interaction partner CDH1 (refs xref , xref ; xref )"
     . SPARSER::COLLECTION)
    ("Cyclin F MR/AA" . SPARSER::PROTEIN)
    ("Met-Arg-Tyr-Ile-Leu" . SPARSER::COLLECTION)
    ("Cyclin F- and V5-tagged" . SPARSER::COLLECTION)
    ("Cyclin F-" . SPARSER::PROTEIN) ("V5-tagged CDC6" . SPARSER::PROTEIN)
    ("Skp1 and Cul1" . SPARSER::COLLECTION)
    ("NUSAP1, RRM2 and CP110" . SPARSER::COLLECTION)
    ("deoxyribonucleotide" . SPARSER::MOLECULE)
    ("Cyclin F and CDC6" . SPARSER::COLLECTION)
    ("CDC6 and cyclin F" . SPARSER::COLLECTION)
    ("exogenous CDC6" . SPARSER::PROTEIN)
    ("cell division cycle 7 (CDC7) and the S phase cyclin-dependent kinases (CDKs)"
     . SPARSER::COLLECTION)
    ("protein kinases, cell division cycle 7 (CDC7) and the S phase cyclin-dependent kinases (CDKs)"
     . SPARSER::COLLECTION)
    ("bidirectional replisomes" . SPARSER::BIO-COMPLEX)
    ("replisomes" . SPARSER::BIO-COMPLEX)
    ("CDC6 and CDT1" . SPARSER::COLLECTION) ("Geminin" . SPARSER::PROTEIN)
    ("CDC6 and Cyclin F" . SPARSER::COLLECTION)
    ("β-Galactosidase" . SPARSER::PROTEIN) ("Ubch5c" . SPARSER::PROTEIN)
    ("Calyculin A" . SPARSER::MOLECULE) ("Anti-phospho" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("Orc2" . SPARSER::PROTEIN)
    ("ORC1" . SPARSER::PROTEIN) ("pre-RC" . SPARSER::BIO-COMPLEX)
    ("Cdc6" . SPARSER::PROTEIN) ("MLN4924" . SPARSER::DRUG)
    ("glutathione S- transferase" . SPARSER::PROTEIN)
    ("B-Myb" . SPARSER::PROTEIN) ("CP110" . SPARSER::PROTEIN)
    ("NUSAP1" . SPARSER::PROTEIN) ("cyclin F" . SPARSER::PROTEIN)
    ("cell division cycle 7" . SPARSER::PROTEIN)
    ("pre-RCs" . SPARSER::BIO-COMPLEX) ("Cyclin F" . SPARSER::PROTEIN)
    ("CDC6" . SPARSER::PROTEIN) ("Ding" . SPARSER::PROTEIN)
    ("lysyl oxidase ( LOX )" . SPARSER::PROTEIN)
    ("a clinically relevant suppressor" . SPARSER::SUPPRESSOR)
    ("San" . SPARSER::PROTEIN)
    ("109 significantly upregulated genes and 51 significantly downregulated genes"
     . SPARSER::COLLECTION)
    ("BLI and caliper" . SPARSER::COLLECTION)
    ("mammary fat" . SPARSER::PROTEIN) ("BLI" . SPARSER::PROTEIN)
    ("the humanized mammary fat" . SPARSER::PROTEIN)
    ("CBR-luc" . SPARSER::PROTEIN-PAIR) ("CBR" . SPARSER::PROTEIN)
    ("paired isogenic PDX" . SPARSER::PROTEIN)
    ("orthotopic PDX" . SPARSER::PROTEIN)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("a candidate prognostic biomarker" . SPARSER::MOLECULE)
    ("more aggressive forms" . SPARSER::FORM) ("PAK6" . SPARSER::PROTEIN)
    ("p21 protein (Cdc42/Rac)-activated kinase 6" . SPARSER::PROTEIN)
    ("INPP5D" . SPARSER::PROTEIN)
    ("inositol polyphosphate-5-phosphatase" . SPARSER::PROTEIN)
    ("CK18" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("G2a" . SPARSER::PROTEIN) ("GD2" . SPARSER::MOLECULE)
    ("H-2K" . SPARSER::PROTEIN) ("CK-18" . SPARSER::PROTEIN)
    ("cytokeratin 18" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("gene 2" . SPARSER::PROTEIN)
    ("CDK4 , MDM2 , and HMGA2" . SPARSER::COLLECTION)
    ("The strong nuclear STAT6" . SPARSER::PROTEIN)
    ("STAT6 and each co-amplified" . SPARSER::COLLECTION)
    ("two unique STAT6 fusion events STAT6" . SPARSER::PROTEIN)
    ("CPM and HIPK2" . SPARSER::COLLECTION)
    ("CDK4 and MDM2" . SPARSER::COLLECTION) ("CPM" . SPARSER::PROTEIN)
    ("IDH1 , TP53 and ATRX" . SPARSER::COLLECTION)
    ("300 cancer-associated genes" . SPARSER::GENE)
    ("a symptomatic intra-axial" . SPARSER::COLLECTION)
    ("axial" . SPARSER::PROTEIN) ("temozolomide" . SPARSER::DRUG)
    ("GFAP, OLIG2 and SOX2" . SPARSER::COLLECTION)
    ("the right parietal lobe" . SPARSER::PROTEIN)
    ("intra-axial" . SPARSER::COLLECTION) ("HIPK2" . SPARSER::PROTEIN)
    ("MIB1" . SPARSER::PROTEIN) ("OLIG2" . SPARSER::PROTEIN)
    ("an inorganic anion" . SPARSER::MOLECULE) ("anion" . SPARSER::MOLECULE)
    ("RASAL1 or BMP7" . SPARSER::COLLECTION)
    ("growth factors TGFβ [ xref , xref ] and CTGF [ xref ]"
     . SPARSER::COLLECTION)
    ("dimethylarginine (ADMA)" . SPARSER::DRUG) ("ADMA" . SPARSER::MOLECULE)
    ("dimethylarginine" . SPARSER::DRUG)
    ("the RASAL1 CpG island promoter and subsequent transcriptional silencing"
     . SPARSER::COLLECTION)
    ("HDAC2 or DNMT1" . SPARSER::COLLECTION)
    ("RASAL1 or exon" . SPARSER::COLLECTION)
    ("the commonly bound proteins" . SPARSER::PROTEIN)
    ("inorganic polyphosphate" . SPARSER::MOLECULE)
    ("endothelial cell marker CD31 and fibroblast cell marker S100A4 and EndMT transcriptional markers SNAIL"
     . SPARSER::COLLECTION)
    ("FTS and PFA" . SPARSER::COLLECTION)
    ("S100A4 and EndMT" . SPARSER::COLLECTION) ("FTS" . SPARSER::PROTEIN)
    ("the proximal RASAL1 promoter" . SPARSER::PROMOTER)
    ("fibroblast cell marker S100A4 and the three transcription factors SNAIL"
     . SPARSER::COLLECTION)
    ("CD31 and α-smooth muscle" . SPARSER::COLLECTION)
    ("pathological form" . SPARSER::FORM)
    ("smooth muscle actin (α-SMA) or fibroblast-specific protein-1 (FSP1)"
     . SPARSER::COLLECTION)
    ("mesenchymal marker proteins" . SPARSER::PROTEIN)
    ("Pecam-1" . SPARSER::COLLECTION) ("Klotho or FGF23" . SPARSER::COLLECTION)
    ("phospho-regulatory hormones FGF23 and Klotho" . SPARSER::COLLECTION)
    ("FGF23 and Klotho" . SPARSER::COLLECTION) ("FGF23-" . SPARSER::PROTEIN)
    ("fibroblast growth factor 23 (FGF23) and Klotho" . SPARSER::COLLECTION)
    ("Principal mediators" . SPARSER::PROTEIN) ("Klotho" . SPARSER::PROTEIN)
    ("PTH" . SPARSER::PROTEIN) ("sphingolipids" . SPARSER::MOLECULE)
    ("cGMP" . SPARSER::PROTEIN)
    ("extracellular inorganic orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("orthophosphate" . SPARSER::ORTHOPHOSPHATE) ("TLR5" . SPARSER::PROTEIN)
    ("DNA-methyltransferases" . SPARSER::PROTEIN)
    ("Ras-GAP" . SPARSER::PROTEIN) ("Vascular Endothelial" . SPARSER::PROTEIN)
    ("FGF23" . SPARSER::PROTEIN) ("parathyroid hormone" . SPARSER::PROTEIN)
    ("Ras-GTP" . SPARSER::PROTEIN) ("RASAL1" . SPARSER::PROTEIN)
    ("PRKACA" . SPARSER::PROTEIN) ("functional aldosterone" . SPARSER::PROTEIN)
    ("The investigated mutants contained aldosterone" . SPARSER::PROTEIN)
    ("corticosterone" . SPARSER::MOLECULE)
    ("deoxycorticosterone" . SPARSER::MOLECULE) ("cortisol" . SPARSER::PROTEIN)
    ("deoxycortisol" . SPARSER::MOLECULE)
    ("highly homologous enzymes" . SPARSER::ENZYME)
    ("CYP11B2 and CYP11B1" . SPARSER::COLLECTION)
    ("ZF and ZG" . SPARSER::COLLECTION) ("ZF" . SPARSER::PROTEIN)
    ("KCNJ5 , ATP1A1 , ATP2B3 and CACNA1D" . SPARSER::COLLECTION)
    ("receptor and CYP11B2" . SPARSER::COLLECTION)
    ("TCF/LEF-1" . SPARSER::COLLECTION) ("LRP" . SPARSER::PROTEIN)
    ("AXIN, APC, CKI and GSK3β" . SPARSER::COLLECTION)
    ("AXIN" . SPARSER::PROTEIN) ("CTNNB1 and KCNJ5" . SPARSER::COLLECTION)
    ("constitutional DNA" . SPARSER::DNA)
    ("different national cohorts" . SPARSER::MOLECULE)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("unilateral aldosterone" . SPARSER::PROTEIN)
    ("aldosterone" . SPARSER::PROTEIN)
    ("KCNJ5, ATP1A1, ATP2B3 and CACNA1D" . SPARSER::COLLECTION)
    ("a surgically correctable form" . SPARSER::FORM)
    ("Aldosterone" . SPARSER::PROTEIN) ("CYP21" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN) ("CYP11B1" . SPARSER::PROTEIN)
    ("SFRP2" . SPARSER::PROTEIN)
    ("Frizzled-related protein" . SPARSER::PROTEIN)
    ("mineralocorticoid receptor" . SPARSER::PROTEIN)
    ("CYP11B2" . SPARSER::PROTEIN) ("AXIN2" . SPARSER::PROTEIN)
    ("CACNA1D" . SPARSER::PROTEIN) ("ATP2B3" . SPARSER::PROTEIN)
    ("ATP1A1" . SPARSER::PROTEIN) ("KCNJ5" . SPARSER::PROTEIN)
    ("F877L/T878A and T878A/S889G" . SPARSER::COLLECTION)
    ("the inbound ligand" . SPARSER::LIGAND)
    ("the most flexible amino acid" . SPARSER::AMINO-ACID)
    ("hydroxyl" . SPARSER::PROTEIN)
    ("F877L/T878A, and T878A/S889G" . SPARSER::COLLECTION)
    ("the receptor’s" . SPARSER::RECEPTOR)
    ("bicalutamide and enzalutamide" . SPARSER::COLLECTION)
    ("two double mutants F877L/T878A (21.4 %) and T878A/S889G (5.3 %)"
     . SPARSER::COLLECTION)
    ("these 24 CRPC-associated AR mutants" . SPARSER::MUTANT)
    ("strong bicalutamide" . SPARSER::DRUG)
    ("strong agonist" . SPARSER::AGONIST)
    ("F877L/T878A, T878A/D891H, and T878A/S889G" . SPARSER::COLLECTION)
    ("four additional CRPC-associated variants" . SPARSER::VARIANT)
    ("bicalutamide-resistant AR variants T878A and W742L/C"
     . SPARSER::COLLECTION)
    ("hydroxyflutamide-" . SPARSER::DRUG)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("- 2-" . SPARSER::PROTEIN)
    ("FKBP52 and Bag-1 " . SPARSER::COLLECTION)
    ("F877L/T878A" . SPARSER::PROTEIN)
    ("the well-documented enzalutamide- and ARN509-resistant mutant"
     . SPARSER::COLLECTION)
    ("the well-documented enzalutamide-" . SPARSER::DRUG)
    ("anti-androgens, bicalutamide and hydroxyflutamide" . SPARSER::COLLECTION)
    ("enzalutamide-" . SPARSER::DRUG) ("T878A/S889G" . SPARSER::PROTEIN)
    ("estradiol or hydrocortisone" . SPARSER::COLLECTION)
    ("estradiol, progesterone, and hydrocortisone" . SPARSER::COLLECTION)
    ("A noteworthy mutant" . SPARSER::MUTANT) ("VC" . SPARSER::MOLECULE)
    ("all 24 CRPC-associated AR mutants" . SPARSER::MUTANT)
    ("our recently developed class" . CLASS) ("quinolone" . SPARSER::MOLECULE)
    ("DHT, progesterone, estradiol, and hydrocortisone" . SPARSER::COLLECTION)
    ("hydrocortisone" . SPARSER::DRUG) ("PCa and CRPC" . SPARSER::COLLECTION)
    ("the anti-androgens bicalutamide [ xref – xref ] and enzalutamide [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("progesterone and 17β-estradiol" . SPARSER::COLLECTION)
    ("weak adrenal androgens" . SPARSER::DRUG)
    ("CYP17, or AR" . SPARSER::COLLECTION) ("Enzalutamide" . SPARSER::DRUG)
    ("ABS" . SPARSER::PROTEIN) ("DHT" . SPARSER::PROTEIN)
    ("dihydrotestosterone" . SPARSER::DRUG) ("Abiraterone" . SPARSER::DRUG)
    ("two recent drugs abiraterone [ xref , xref ] and enzalutamide [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("abiraterone" . SPARSER::DRUG)
    ("CRPC-associated AR mutants" . SPARSER::MUTANT)
    ("hydroxyflutamide, bicalutamide, and enzalutamide" . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG) ("bicalutamide" . SPARSER::DRUG)
    ("hydroxyflutamide" . SPARSER::DRUG)
    ("a pivotal drug target" . SPARSER::TARGET-PROTEIN)
    ("androgen receptor (AR)" . SPARSER::PROTEIN) ("SO4" . SPARSER::PROTEIN)
    ("BAG1" . SPARSER::PROTEIN) ("- 2" . SPARSER::PROTEIN)
    ("Bag-1 " . SPARSER::PROTEIN) ("FKBP52" . SPARSER::PROTEIN)
    ("CYP17" . SPARSER::PROTEIN) ("anti-androgen" . SPARSER::DRUG)
    ("CYP17A1" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1 and type 2" . SPARSER::COLLECTION)
    ("CRP, TNF-α, leptin, or fibrinogen" . SPARSER::COLLECTION)
    ("fibrinogen" . SPARSER::PROTEIN) ("MCR" . SPARSER::PROTEIN)
    ("incident hyperglycemia" . SPARSER::PROTEIN)
    ("HOMA-IR" . SPARSER::COLLECTION) ("triglycerides" . SPARSER::MOLECULE)
    ("bi" . SPARSER::PROTEIN) ("leptin and adiponectin" . SPARSER::COLLECTION)
    ("various pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("Visceral fat" . SPARSER::PROTEIN) ("PAI-1/tPA" . SPARSER::COLLECTION)
    ("coagulation factor VIII, E-selectin, intercellular adhesion molecule-1, and tPA"
     . SPARSER::COLLECTION)
    ("the diabetic state" . SPARSER::BIO-STATE)
    ("triglyceride" . SPARSER::MOLECULE)
    ("prospective cohort" . SPARSER::MOLECULE)
    ("plasminogen activator inhibitor-1 and type 2" . SPARSER::COLLECTION)
    ("IRAS" . SPARSER::PROTEIN) ("carbohydrate" . SPARSER::MOLECULE)
    ("PAI-1 and T2D" . SPARSER::COLLECTION) ("E-selectin" . SPARSER::PROTEIN)
    ("coagulation factor VIII" . SPARSER::PROTEIN) ("RR 1" . SPARSER::PROTEIN)
    ("serine-protease" . SPARSER::PROTEIN)
    ("an HDAC1 and DAXX-containing protein complex" . SPARSER::COLLECTION)
    ("The unspecific HDAC inhibitor valproate" . SPARSER::DRUG)
    ("clozapine" . SPARSER::DRUG) ("antipsychotic" . SPARSER::DRUG)
    ("either DAXX mRNA or -protein" . SPARSER::COLLECTION)
    ("ubiquitous regulator" . SPARSER::REGULATOR)
    ("a developmental regulator" . SPARSER::REGULATOR)
    ("the GABA transporter GAT1 nor PV" . SPARSER::COLLECTION)
    ("the key GABAergic enzyme" . SPARSER::ENZYME)
    ("key histones" . SPARSER::PROTEIN)
    ("GAD1 mRNA and its corresponding protein" . SPARSER::COLLECTION)
    ("GABA and release" . SPARSER::COLLECTION) ("BDNF" . SPARSER::PROTEIN)
    ("risk-associated genes" . SPARSER::GENE)
    ("hippocampal sector CA1" . SPARSER::PROTEIN)
    ("epigenetic regulators and transcription factors" . SPARSER::COLLECTION)
    ("HDAC1 or Daxx" . SPARSER::COLLECTION) ("Daxx" . SPARSER::PROTEIN)
    ("GAT1 and PV" . SPARSER::COLLECTION) ("HDAC1/DAXX" . SPARSER::COLLECTION)
    ("LV and LV" . SPARSER::COLLECTION) ("-protein" . SPARSER::COLLECTION)
    ("DAXX/GAD67" . SPARSER::COLLECTION) ("HDAC/GAD67" . SPARSER::COLLECTION)
    ("HDAC1 or DAXX" . SPARSER::COLLECTION) ("HiB" . SPARSER::PROTEIN)
    ("HDAC1 and DAXX" . SPARSER::COLLECTION) ("GAD 65" . SPARSER::PROTEIN)
    ("Egr-1" . SPARSER::PROTEIN) ("GAD67" . SPARSER::PROTEIN)
    ("β2M" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("β-2-microglobulin" . SPARSER::PROTEIN)
    ("carboxy-fluorescein" . SPARSER::DRUG) ("GAT1" . SPARSER::PROTEIN)
    ("egr-1" . SPARSER::PROTEIN) ("GAD1" . SPARSER::PROTEIN)
    ("GAD 67" . SPARSER::PROTEIN) ("CA3" . SPARSER::PROTEIN)
    ("RPA, and BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("TOPBP1 and PLK1" . SPARSER::COLLECTION)
    ("TOPBP1-PLK1" . SPARSER::COLLECTION) ("PLK1–BRCA2" . SPARSER::COLLECTION)
    ("PLK1 and TOPBP1" . SPARSER::COLLECTION)
    ("PLK1 and CK2" . SPARSER::COLLECTION)
    ("CK2 or PLK1" . SPARSER::COLLECTION)
    ("a nonphosphorylatable mutant RAD51 protein" . SPARSER::PROTEIN)
    ("available antibodies" . SPARSER::ANTIBODY)
    ("RPA70 and RAD51" . SPARSER::COLLECTION)
    ("RPA, BRCA1, and RAD51" . SPARSER::COLLECTION)
    ("RPA and RAD51" . SPARSER::COLLECTION)
    ("endogenous TOPBP1 and the DNA repair protein BACH1 (Fig. S3 D)"
     . SPARSER::COLLECTION)
    ("coexpressed GFP- and mCherry-tagged wild-type TOPBP1"
     . SPARSER::COLLECTION)
    ("combined olaparib and CalAM showed a more pronounced effect ( xref )"
     . SPARSER::COLLECTION)
    ("foci, and 16-h" . SPARSER::COLLECTION) ("calcein" . SPARSER::MOLECULE)
    ("full-length and TOPBP1" . SPARSER::COLLECTION)
    ("defective HR" . SPARSER::PROTEIN)
    ("activated CHK2 kinase (pCHK2 T68) and RPA32" . SPARSER::COLLECTION)
    ("BRCA1–PALB2–BRCA2" . SPARSER::COLLECTION)
    ("several DDR kinases and repair proteins" . SPARSER::COLLECTION)
    ("BRCA1/2 genes and PARPi" . SPARSER::COLLECTION)
    ("trap" . SPARSER::PROTEIN)
    ("TOPBP1 physically binds PLK1" . SPARSER::PROTEIN)
    ("chemotherapeutic agent olaparib" . SPARSER::DRUG)
    ("S33" . SPARSER::PROTEIN) ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("LRRK1" . SPARSER::PROTEIN) ("RPA70" . SPARSER::PROTEIN)
    ("BACH1" . SPARSER::PROTEIN) ("TOPBP1" . SPARSER::PROTEIN)
    ("K-ras and NFκB" . SPARSER::COLLECTION)
    ("molecules and nitric oxides" . SPARSER::COLLECTION)
    ("mutational Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ–SMAD" . SPARSER::COLLECTION) ("K-ras/NFκB" . SPARSER::COLLECTION)
    ("the Elk-1-associated complex" . SPARSER::BIO-COMPLEX)
    ("a strong histone acetyltransferase activity" . SPARSER::PROTEIN)
    ("Ras/Raf" . SPARSER::COLLECTION) ("Ras-ERK" . SPARSER::COLLECTION)
    ("NSAID" . SPARSER::PROTEIN)
    ("various soluble pro-inflammatory mediators and leukocyte adhesion molecules"
     . SPARSER::COLLECTION)
    ("various soluble pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("both E-cadherin mRNA (Fig.  xref , left panel) and protein (Fig.  xref , right panel)"
     . SPARSER::COLLECTION)
    ("E-cadherin and Slug" . SPARSER::COLLECTION)
    ("p300 and p300" . SPARSER::COLLECTION) ("Elk1" . SPARSER::PROTEIN)
    ("DN-K-ras or IκBα-SR-cDNA" . SPARSER::COLLECTION)
    ("K-ras and p65NFκB" . SPARSER::COLLECTION)
    ("Elk-1 and p65NFκB" . SPARSER::COLLECTION)
    ("p-Elk-1" . SPARSER::COLLECTION)
    ("neither MEK nor ERK" . SPARSER::COLLECTION)
    ("ERK-siRNA" . SPARSER::COLLECTION) ("MEK-siRNA" . SPARSER::COLLECTION)
    ("E-cadherin-siRNA" . SPARSER::COLLECTION)
    ("K-ras and p53" . SPARSER::COLLECTION)
    ("dominant negative (DN) mutant form" . SPARSER::FORM)
    ("Elk-1-p300" . SPARSER::COLLECTION)
    ("activated Ras induced EMT" . SPARSER::PROTEIN)
    ("classical NFκB" . SPARSER::PROTEIN)
    ("the proximal E-cadherin promoter" . SPARSER::PROMOTER)
    ("Slug " . SPARSER::PROTEIN) ("p-Elk-1-p300" . SPARSER::COLLECTION)
    ("Ras/ERK" . SPARSER::COLLECTION) ("Slug/E-cadherin" . SPARSER::COLLECTION)
    ("α-actin" . SPARSER::PROTEIN) ("nitric oxides" . SPARSER::MOLECULE)
    ("transcription factor p65" . SPARSER::PROTEIN)
    ("ETS family" . SPARSER::PROTEIN) ("Cox-2" . SPARSER::PROTEIN)
    ("MLH1 and DAPK-1" . SPARSER::COLLECTION)
    ("MGMT and MLH1" . SPARSER::COLLECTION)
    ("the pro-apoptotic gene DAPK-1" . SPARSER::PROTEIN)
    ("the histological type" . TYPE) ("DAPK and MLH1" . SPARSER::COLLECTION)
    ("these genes and the tumor stage" . SPARSER::COLLECTION)
    ("MLH1 or MGMT" . SPARSER::COLLECTION)
    ("the more aggressive diffuse form" . SPARSER::FORM)
    ("DAPK-1 , MLH1 , and MGMT" . SPARSER::COLLECTION)
    ("intestinal and diffuse types" . TYPE)
    ("serine–threonine" . SPARSER::COLLECTION) ("DAPK" . SPARSER::PROTEIN)
    ("the intestinal form" . SPARSER::FORM) ("mutL" . SPARSER::PROTEIN)
    ("–CH 3" . SPARSER::MOLECULE) ("more aggressive form" . SPARSER::FORM)
    ("its histological type" . TYPE) ("the intestinal type" . TYPE)
    ("These two histological types" . TYPE)
    ("DAPK-1 and MLH1" . SPARSER::COLLECTION)
    ("MLH1 and MGMT" . SPARSER::COLLECTION)
    ("MLH1 , MGMT , and DAPK-1" . SPARSER::COLLECTION)
    ("death-associated protein kinase 1" . SPARSER::PROTEIN)
    ("O 6" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA-methyltransferase" . SPARSER::PROTEIN)
    ("nonpolyposis type 2 ( E. coli )" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN) ("CH 3" . SPARSER::MOLECULE)
    ("DAPK-1" . SPARSER::PROTEIN)
    ("the traditional photosensitizers" . SPARSER::DRUG)
    ("photosensitizers" . SPARSER::DRUG)
    ("5-FU and/or Tra-IR700" . SPARSER::COLLECTION) ("Tra" . SPARSER::PROTEIN)
    ("Tra-IR700" . SPARSER::COLLECTION) ("IR700" . SPARSER::PROTEIN)
    ("antibody-IR700" . SPARSER::PROTEIN-PAIR)
    ("5-FU or Tra-IR700" . SPARSER::COLLECTION)
    ("monoclonal antibodies and tyrosine kinase inhibitors"
     . SPARSER::INHIBITOR)
    ("antibodies and tyrosine kinase" . SPARSER::COLLECTION)
    ("5-FU and trastuzumab" . SPARSER::COLLECTION)
    ("both 5-FU and/or trastuzumab-IR700" . SPARSER::COLLECTION)
    ("5-FU and/or trastuzumab-IR700" . SPARSER::COLLECTION)
    ("near-infrared (NIR) light" . SPARSER::PROTEIN) ("NIR" . SPARSER::PROTEIN)
    ("photosensitizer" . SPARSER::DRUG) ("PIT 2 " . SPARSER::PROTEIN)
    ("PIT 1 " . SPARSER::PROTEIN) ("Foxn1 " . SPARSER::PROTEIN)
    ("RNAs and repressors" . SPARSER::COLLECTION)
    ("a histone deacetylase macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("cellular DNMT1" . SPARSER::PROTEIN)
    ("BaP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ORF1p" . SPARSER::PROTEIN)
    ("the repressive state" . SPARSER::BIO-STATE)
    ("proteins and HDAC1" . SPARSER::COLLECTION)
    ("target and non-target" . SPARSER::COLLECTION)
    ("ORF1p-GFP" . SPARSER::COLLECTION) ("stabilizers" . SPARSER::MOLECULE)
    ("the multimeric complex" . SPARSER::BIO-COMPLEX)
    ("repressive chromatin" . SPARSER::PROTEIN)
    ("MBD3, MTA2 and MTA3" . SPARSER::COLLECTION)
    ("Snail and glucose" . SPARSER::COLLECTION)
    ("using soluble chromatin" . SPARSER::PROTEIN)
    ("RB-associated proteins" . SPARSER::PROTEIN)
    ("RbAp46 and RbAp48" . SPARSER::COLLECTION)
    ("MBD2 and MBD3" . SPARSER::COLLECTION)
    ("MTA2 and MTA3" . SPARSER::COLLECTION) ("autoantigen" . SPARSER::DRUG)
    ("triple knockout (TKO) MEFs" . SPARSER::PROTEIN)
    ("pRb, p107, and p130" . SPARSER::COLLECTION) ("TKO" . SPARSER::PROTEIN)
    ("E2F/RB" . SPARSER::COLLECTION)
    ("an internal bidirectional promoter" . SPARSER::PROMOTER)
    ("reverse transcriptase and endonuclease" . SPARSER::COLLECTION)
    ("the NuRD macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("Mi2β" . SPARSER::PROTEIN) ("MTA 2" . SPARSER::PROTEIN)
    ("MTA-2" . SPARSER::PROTEIN) ("MBD3" . SPARSER::PROTEIN)
    ("RbAp48" . SPARSER::PROTEIN) ("RbAp46" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("MeCP2" . SPARSER::PROTEIN)
    ("CpG binding protein" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("ORF2p" . SPARSER::PROTEIN)
    ("ORF1" . SPARSER::PROTEIN) ("RbAP46" . SPARSER::PROTEIN)
    ("L1s" . SPARSER::PROTEIN) ("ATR–CHK1" . SPARSER::COLLECTION)
    ("RPA and γH2AX" . SPARSER::COLLECTION) ("annexinV" . SPARSER::PROTEIN)
    ("SSEA" . SPARSER::PROTEIN)
    ("OCT4, SOX2, KLF4, C-MYC, and LIN28" . SPARSER::COLLECTION)
    ("iPS" . SPARSER::PROTEIN) ("hiPS" . SPARSER::PROTEIN)
    ("histone 2" . SPARSER::PROTEIN) ("SSEA1" . SPARSER::DRUG)
    ("P53S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("paired box 6" . SPARSER::PROTEIN)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("beta-mercaptoethanol" . SPARSER::MOLECULE) ("B18" . SPARSER::PROTEIN)
    ("LIN28" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("octamer-binding transcription factor 3" . SPARSER::PROTEIN)
    ("lysozyme" . SPARSER::PROTEIN)
    ("alpha- and beta-hemolysins" . SPARSER::COLLECTION)
    ("hemolysins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-derived factor" . SPARSER::COLLECTION)
    ("EGFR or ADAM17" . SPARSER::COLLECTION)
    ("TGF-alpha, amphiregulin and HB-EGF" . SPARSER::COLLECTION)
    ("caspase-8 and probably other proteases" . SPARSER::COLLECTION)
    ("caspase- 4, caspase-8 and probably other proteases"
     . SPARSER::COLLECTION)
    ("probably other proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nanoparticles (nano-TiO2) and the ionophore nigericin"
     . SPARSER::COLLECTION)
    ("nigericin" . SPARSER::MOLECULE) ("ionophore" . SPARSER::MOLECULE)
    ("calpain and granzyme B" . SPARSER::COLLECTION)
    ("calpain" . SPARSER::PROTEIN)
    ("IL-1beta as well as IL-1alpha" . SPARSER::COLLECTION)
    ("mature IL-1beta" . SPARSER::PROTEIN) ("caspase-1-" . SPARSER::PROTEIN)
    ("keratinocytes and keratinocytes-derived IL-1" . SPARSER::COLLECTION)
    ("ADAM17-siRNA" . SPARSER::COLLECTION)
    ("an ADAM17 specific siRNA or a non-silencing control siRNA"
     . SPARSER::COLLECTION)
    ("an ASC specific siRNA or a non-silencing control siRNA"
     . SPARSER::COLLECTION)
    ("a caspase-1 specific siRNA or a non-silencing control siRNA"
     . SPARSER::COLLECTION)
    ("CMK" . SPARSER::PROTEIN)
    ("the central protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the principal protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-alpha and HB-EGF" . SPARSER::COLLECTION)
    ("Metalloproteinase" . SPARSER::PROTEIN)
    ("IL-1 and EGFR" . SPARSER::COLLECTION)
    ("particular IL-1alpha and IL-1beta" . SPARSER::COLLECTION)
    ("cytokines/chemokines" . SPARSER::COLLECTION)
    ("neutrophil" . SPARSER::PROTEIN) ("Cytokines" . SPARSER::PROTEIN)
    ("Antimicrobial peptides" . SPARSER::PEPTIDE)
    ("Toll-like receptors (TLRs) and intracellular NOD-like receptors (NLRs)"
     . SPARSER::COLLECTION)
    ("Metalloprotease" . SPARSER::PROTEIN) ("Disintegrin" . SPARSER::PROTEIN)
    ("IL-1alpha and IL-beta" . SPARSER::COLLECTION)
    ("caspase-1 and ASC" . SPARSER::COLLECTION)
    ("ASC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-1alpha and IL-1beta" . SPARSER::COLLECTION)
    ("antimicrobial peptides" . SPARSER::PEPTIDE)
    ("Keratinocytes" . SPARSER::PROTEIN) ("alpha-hemolysin" . SPARSER::PROTEIN)
    ("alpha-toxin" . SPARSER::PROTEIN) ("derived factor" . SPARSER::PROTEIN)
    ("TSST-1" . SPARSER::PROTEIN)
    ("toxic shock syndrome toxin-1" . SPARSER::PROTEIN)
    ("caspase- 4" . SPARSER::PROTEIN) ("poly I:C" . SPARSER::MOLECULE)
    ("TLR-3" . SPARSER::PROTEIN) ("caspase-4" . SPARSER::PROTEIN)
    ("TiO2" . SPARSER::MOLECULE) ("granzyme B" . SPARSER::PROTEIN)
    ("IL-1R1" . SPARSER::PROTEIN) ("IL1beta" . SPARSER::PROTEIN)
    ("Caspase-1" . SPARSER::PROTEIN) ("p20" . SPARSER::PROTEIN)
    ("NLRP3" . SPARSER::PROTEIN) ("RPL38" . SPARSER::PROTEIN)
    ("ribosomal protein L38" . SPARSER::PROTEIN) ("ml -1" . SPARSER::PROTEIN)
    ("TGF-alpha" . SPARSER::PROTEIN) ("caspase-1" . SPARSER::PROTEIN)
    ("IL-1beta" . SPARSER::PROTEIN) ("IL-1alpha" . SPARSER::PROTEIN)
    ("ceramide and hepcidin" . SPARSER::COLLECTION)
    ("macrophages or cytokines" . SPARSER::COLLECTION)
    ("NF-κB and JNK" . SPARSER::COLLECTION)
    ("iron-regulatory protein" . SPARSER::PROTEIN)
    ("Tunicamycin" . SPARSER::MOLECULE)
    ("ER stress-activated inositol-requiring enzyme" . SPARSER::ENZYME)
    ("anti-phospho-JNK" . SPARSER::PROTEIN-PAIR)
    ("SP600125 or DMSO" . SPARSER::COLLECTION)
    ("JNK and ER" . SPARSER::COLLECTION)
    ("ceramide or DMSO" . SPARSER::COLLECTION)
    ("siRNA and DMSO" . SPARSER::COLLECTION)
    ("siRNA and JAK" . SPARSER::COLLECTION)
    ("STAT3 siRNA and a chemical pan-JAK kinase inhibitor"
     . SPARSER::COLLECTION)
    ("a classical transcription factor" . SPARSER::PROTEIN)
    ("Specific commercial antibodies" . SPARSER::ANTIBODY)
    ("STAT3, NF-κB and c-Jun" . SPARSER::COLLECTION)
    ("P65 and JNK" . SPARSER::COLLECTION)
    ("ceramide or IL-6" . SPARSER::COLLECTION)
    ("JNK/c-Jun" . SPARSER::COLLECTION) ("JAK/STAT3" . SPARSER::COLLECTION)
    ("pRL" . SPARSER::PROTEIN) ("pGL" . SPARSER::PROTEIN)
    ("actinomycin D and ceramide" . SPARSER::COLLECTION)
    ("ceramide or solvent" . SPARSER::COLLECTION)
    ("actinomycin D or DMSO" . SPARSER::COLLECTION)
    ("synthetic cell-permeable ceramide analogs" . SPARSER::ANALOG)
    ("sphingomyelinase" . SPARSER::PROTEIN)
    ("sphingolipid" . SPARSER::MOLECULE) ("Fat" . SPARSER::PROTEIN)
    ("cytokines and adipokines" . SPARSER::COLLECTION)
    ("kinases (JAK)" . SPARSER::PROTEIN)
    ("the inflammatory cytokines, IL-1 and IL-6" . SPARSER::COLLECTION)
    ("cytokines, IL-1 and IL-6" . SPARSER::COLLECTION)
    ("an acute phase protein" . SPARSER::PROTEIN)
    ("ferroportin" . SPARSER::PROTEIN)
    ("both an acute phase protein and a pivotal regulator"
     . SPARSER::COLLECTION)
    ("a pivotal regulator" . SPARSER::REGULATOR)
    ("both an acute phase protein" . SPARSER::PROTEIN)
    ("Hepcidin" . SPARSER::PROTEIN) ("NF-κB or c-Jun" . SPARSER::COLLECTION)
    ("STAT3, JNK, and NF-κB" . SPARSER::COLLECTION)
    ("cell-permeable ceramide analogs" . SPARSER::ANALOG)
    ("HAMP" . SPARSER::PROTEIN) ("acute phase protein" . SPARSER::PROTEIN)
    ("hepcidin" . SPARSER::PROTEIN) ("IRE1" . SPARSER::PROTEIN)
    ("an 1" . SPARSER::DRUG) ("Phospho-JNK" . SPARSER::PROTEIN)
    ("X-box binding protein 1" . SPARSER::PROTEIN)
    ("IR or CPT" . SPARSER::COLLECTION) ("productive HR" . SPARSER::PROTEIN)
    ("BLM–DNA2" . SPARSER::COLLECTION) ("γH2AX and CHK2" . SPARSER::COLLECTION)
    ("an inhibitor targeting MRE11’s" . SPARSER::INHIBITOR)
    ("the recently developed small molecule inhibitors" . SPARSER::INHIBITOR)
    ("robust exonuclease activity" . SPARSER::PROTEIN)
    ("a gapped duplex substrate" . SPARSER::SUBSTRATE)
    ("Purified EXD2 and the MRN complex (MRE11, RAD50, NBS1)"
     . SPARSER::COLLECTION)
    ("circular single-stranded PhiX174 DNA" . SPARSER::DNA)
    ("EXD2 and MRE11" . SPARSER::COLLECTION)
    ("a robust exonuclease activity" . SPARSER::PROTEIN)
    ("ssDNA or dsDNA" . SPARSER::COLLECTION)
    ("a highly-soluble truncated form" . SPARSER::FORM)
    ("a robust nuclease activity" . SPARSER::PROTEIN)
    ("the full length GST-tagged EXD2 and the D108A and E110A mutant protein"
     . SPARSER::COLLECTION)
    ("EXD2 and WRN" . SPARSER::COLLECTION) ("protein (WRN)" . SPARSER::PROTEIN)
    ("an integrated homologous recombination reporter transgene"
     . SPARSER::PROTEIN)
    ("RAD51-ssDNA" . SPARSER::COLLECTION)
    ("cytologically discernible foci" . SPARSER::PROTEIN)
    ("Ku70, Ku80 or DNA2" . SPARSER::COLLECTION)
    ("essential components" . SPARSER::COMPONENT)
    ("MRE11 or CtIP" . SPARSER::COLLECTION)
    ("H2AX and CHK2" . SPARSER::COLLECTION)
    ("CPT and IR" . SPARSER::COLLECTION) ("phleomycin" . SPARSER::MOLECULE)
    ("EXD2" . SPARSER::PROTEIN) ("MRE11 and BRCA1" . SPARSER::COLLECTION)
    ("FLAG-EXD2" . SPARSER::PROTEIN-PAIR) ("GFP-CtIP" . SPARSER::COLLECTION)
    ("MRN complex" . SPARSER::BIO-COMPLEX) ("MRN" . SPARSER::BIO-COMPLEX)
    ("exonucleases" . SPARSER::PROTEIN) ("BLM-EXO1" . SPARSER::COLLECTION)
    ("BLM-DNA2" . SPARSER::COLLECTION)
    ("a weak endo- and exonuclease activity" . SPARSER::COLLECTION)
    ("endo- and exonuclease activity" . SPARSER::COLLECTION)
    ("endo-" . SPARSER::PROTEIN) ("ssDNA-RAD51" . SPARSER::COLLECTION)
    ("helicase (BLM)" . SPARSER::PROTEIN)
    ("EXO1 or DNA2" . SPARSER::COLLECTION)
    ("complex (MRN)" . SPARSER::BIO-COMPLEX)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("efficiently processes dsDNA substrates" . SPARSER::SUBSTRATE)
    ("efficient HR" . SPARSER::PROTEIN) ("guide RNA" . SPARSER::RNA)
    ("Chr 1" . SPARSER::PROTEIN) ("P2A" . SPARSER::PROTEIN)
    ("Sae2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KP" . SPARSER::PROTEIN)
    ("gemcitabine or paclitaxel" . SPARSER::COLLECTION)
    ("paclitaxel or cisplatin" . SPARSER::COLLECTION)
    ("Guo" . SPARSER::MOLECULE)
    ("HSP27 and the phosphorylated HSP27 state" . SPARSER::COLLECTION)
    ("MAP" . SPARSER::PROTEIN)
    ("HSPA (HSP70) and HSPC (HSP90)" . SPARSER::COLLECTION)
    ("HSPC" . SPARSER::PROTEIN) ("HSPA" . SPARSER::PROTEIN-FAMILY)
    ("stress-inducible proteins" . SPARSER::PROTEIN)
    ("oxaliplatin, irinotecan, fluorouracil, and leucovorin"
     . SPARSER::COLLECTION)
    ("most aggressive forms" . SPARSER::FORM) ("MAPKAPK-2" . SPARSER::PROTEIN)
    ("HSP110" . SPARSER::PROTEIN) ("HSP70" . SPARSER::PROTEIN)
    ("equilibrative nucleoside transporter 1" . SPARSER::PROTEIN)
    ("four possible key carcinogenesis molecules" . SPARSER::MOLECULE)
    ("chromogen" . SPARSER::MOLECULE) ("DAB" . SPARSER::MOLECULE)
    ("tetra" . SPARSER::MOLECULE) ("hydrated" . SPARSER::MOLECULE)
    ("Sirius Highest sensitivity chemiluminescent HRP Substrate (Advansta, Menlo Park, CA, USA) and intensities"
     . SPARSER::COLLECTION)
    ("Sirius Highest sensitivity chemiluminescent HRP Substrate"
     . SPARSER::SUBSTRATE)
    ("Substrate" . SPARSER::SUBSTRATE)
    ("the respective HRP-conjugated secondary antibody" . SPARSER::PROTEIN)
    ("PVDF" . SPARSER::DRUG) ("mortar and total RNA" . SPARSER::RNA)
    ("Reagent" . SPARSER::MOLECULE) ("Xi" . SPARSER::PROTEIN)
    ("the unique peptides" . SPARSER::PEPTIDE)
    ("at least one peptide and the p -value" . SPARSER::COLLECTION)
    ("at least one peptide" . SPARSER::PEPTIDE) ("LTQ" . SPARSER::MOLECULE)
    ("dodecyl" . SPARSER::MOLECULE) ("spin" . SPARSER::PROTEIN)
    ("Dithiothreitol" . SPARSER::PROTEIN) ("DL" . SPARSER::MOLECULE)
    ("ice-cold PBS" . SPARSER::PROTEIN)
    ("protein or peptide" . SPARSER::COLLECTION)
    ("a potential biomarker and target molecule" . SPARSER::COLLECTION)
    ("a versatile oncoprotein" . SPARSER::PROTEIN)
    ("c-myc , c-fos and c-jun" . SPARSER::COLLECTION)
    ("HnRNPD" . SPARSER::PROTEIN) ("HnRNPA2B1" . SPARSER::PROTEIN)
    ("c-myc , c-fos , p53 , and Rb" . SPARSER::COLLECTION)
    ("hnRNPA2B1 and hnRNPD" . SPARSER::COLLECTION)
    ("proteins, hnRNPD and hnRNPR" . SPARSER::COLLECTION)
    ("hnRNPA2B1, hnRNPD, hnRNPL and hnRNPR" . SPARSER::COLLECTION)
    ("other nucleic acid binding proteins" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("hnRNPD, hnRNPR, ATP5D and EMILIN1" . SPARSER::COLLECTION)
    ("EMILIN" . SPARSER::PROTEIN) ("diagnostic biomarkers" . SPARSER::MOLECULE)
    ("filamin" . SPARSER::PROTEIN-FAMILY)
    ("only 11, 22, and 29 proteins" . SPARSER::PROTEIN)
    ("shotgun" . SPARSER::PROTEIN) ("HnRNPL" . SPARSER::PROTEIN)
    ("hnRNPA2B1, hnRNPD and YBX-1" . SPARSER::COLLECTION)
    ("hnRNPA2B1, hnRNPD, hnRNPL and YBX-1" . SPARSER::COLLECTION)
    ("activated nucleic acid binding proteins" . SPARSER::PROTEIN)
    ("sigma (SFN)" . SPARSER::PROTEIN-FAMILY)
    ("sigma" . SPARSER::PROTEIN-FAMILY) ("SNRPF" . SPARSER::PROTEIN)
    ("RAN" . SPARSER::PROTEIN)
    ("desmin (DES) and vimentin (VIM) ( xref A)" . SPARSER::COLLECTION)
    ("vimentin (VIM)" . SPARSER::PROTEIN) ("ubiquinone" . SPARSER::DRUG)
    ("Y-box binding protein 1 (YBX-1) and nucleophosmin (NPM1)"
     . SPARSER::COLLECTION)
    ("heterogeneous nuclear ribonucleoproteins" . SPARSER::PROTEIN)
    ("hnRNPL, hnRNPR, hnRNPA2B1, hnRNPD and hnRNPC" . SPARSER::COLLECTION)
    ("further shed light" . SPARSER::PROTEIN)
    ("nucleic acid binding proteins" . SPARSER::PROTEIN)
    ("were run" . SPARSER::PROTEIN-FAMILY)
    ("a complex and multi-factorial process disease" . SPARSER::COLLECTION)
    ("four upregulated nucleic acid binding proteins" . SPARSER::PROTEIN)
    ("hnRNPA2B1, hnRNPD, hnRNPL and Y-box binding protein 1"
     . SPARSER::COLLECTION)
    ("hnRNPA2B1" . SPARSER::PROTEIN) ("hnRNPL" . SPARSER::PROTEIN)
    ("hnRNPD" . SPARSER::PROTEIN) ("HnRNPA2" . SPARSER::PROTEIN)
    ("hnRNPM4" . SPARSER::PROTEIN) ("hnRNPB1" . SPARSER::PROTEIN)
    ("calponin-1" . SPARSER::PROTEIN) ("CBX3" . SPARSER::PROTEIN)
    ("chromobox protein homolog 3" . SPARSER::PROTEIN)
    ("PFN1" . SPARSER::PROTEIN) ("profilin 1" . SPARSER::PROTEIN)
    ("TPM4" . SPARSER::PROTEIN)
    ("tropomyosin alpha-4 chain" . SPARSER::PROTEIN)
    ("EEF1B2" . SPARSER::PROTEIN) ("carbonic anhydrase 2" . SPARSER::PROTEIN)
    ("ATP5A1" . SPARSER::PROTEIN) ("Con-A" . SPARSER::PROTEIN)
    ("tissue-type" . SPARSER::PROTEIN)
    ("small nuclear ribonucleoprotein" . SPARSER::PROTEIN)
    ("GTP-binding nuclear protein Ran" . SPARSER::PROTEIN)
    ("FBN1" . SPARSER::PROTEIN) ("fibrillin-1" . SPARSER::PROTEIN)
    ("COL14A1" . SPARSER::PROTEIN) ("COL15A1" . SPARSER::PROTEIN)
    ("COL12A1" . SPARSER::PROTEIN) ("COL1A2" . SPARSER::PROTEIN)
    ("COL6A1" . SPARSER::PROTEIN) ("NADH dehydrogenase" . SPARSER::PROTEIN)
    ("citrate synthase" . SPARSER::PROTEIN) ("MT-ATP6" . SPARSER::PROTEIN)
    ("ATP5I" . SPARSER::PROTEIN) ("ATP5D" . SPARSER::PROTEIN)
    ("ATP5A" . SPARSER::PROTEIN) ("ATP5L" . SPARSER::PROTEIN)
    ("ATP5H" . SPARSER::PROTEIN) ("ATP synthase" . SPARSER::PROTEIN)
    ("YBX-1" . SPARSER::PROTEIN) ("Y-box binding protein 1" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein" . SPARSER::PROTEIN)
    ("DCA" . SPARSER::PROTEIN) ("NAD + and SIRT1" . SPARSER::COLLECTION)
    ("the available activators" . SPARSER::ACTIVATOR)
    ("inhibitors and activators" . SPARSER::COLLECTION)
    ("54 activators and 179 inhibitors (reference to xref and xref )"
     . SPARSER::COLLECTION)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION) ("SI" . SPARSER::PROTEIN)
    ("activators and inhibitors" . SPARSER::COLLECTION)
    ("Traditional Chinese Medicine" . SPARSER::DRUG)
    ("Medicines" . SPARSER::DRUG) ("HTS" . SPARSER::PROTEIN)
    ("Further SIRT1 ligands" . SPARSER::LIGAND)
    ("SRT1720, SRT2183, and SRT1460" . SPARSER::COLLECTION)
    ("DMax" . SPARSER::PROTEIN) ("ILP" . SPARSER::PROTEIN)
    ("− 3" . SPARSER::PROTEIN) ("SRT1460" . SPARSER::DRUG)
    ("SRT2183" . SPARSER::DRUG) ("SRT1720" . SPARSER::DRUG)
    ("EX-527" . SPARSER::DRUG) ("AZD4547 and BGJ398" . SPARSER::COLLECTION)
    ("significantly worse RFS" . SPARSER::PROTEIN)
    ("RFS or BCSS" . SPARSER::COLLECTION) ("CNA" . SPARSER::PROTEIN)
    ("AZD4547" . SPARSER::DRUG) ("TKI258" . SPARSER::DRUG)
    ("SU5402" . SPARSER::DRUG) ("PUM1" . SPARSER::PROTEIN)
    ("P 20" . SPARSER::PROTEIN)
    ("imatinib, sorafenib and gefitinib" . SPARSER::COLLECTION)
    ("Akt, and Erk" . SPARSER::COLLECTION)
    ("siRNA or small molecule inhibitor" . SPARSER::COLLECTION)
    ("Our western blot" . SPARSER::PROTEIN)
    ("a potent inhibitor of c-Met and its excellent cytotoxic effect on c-Met"
     . SPARSER::COLLECTION)
    ("c-Met-" . SPARSER::PROTEIN) ("Erk and Akt" . SPARSER::COLLECTION)
    ("-Met" . SPARSER::COLLECTION) ("phospho form" . SPARSER::FORM)
    ("the amplified c - met gene and a splice site mutation"
     . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE)
    ("HGF antibodies as well as small molecule inhibitors [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("biologics" . SPARSER::DRUG) ("PI3K/Akt/mTor" . SPARSER::COLLECTION)
    ("mTor" . SPARSER::PROTEIN) ("Molecules" . SPARSER::MOLECULE)
    ("c-Met and HGF" . SPARSER::COLLECTION)
    ("an extracellular α-chain and a membrane-spanning β-chain [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("an extracellular α-chain" . SPARSER::PROTEIN)
    ("imatinib and erlotinib" . SPARSER::COLLECTION)
    ("excellent c-Met inhibitors" . SPARSER::INHIBITOR)
    ("KRC" . SPARSER::PROTEIN) ("P30" . SPARSER::DRUG)
    ("c - met" . SPARSER::PROTEIN)
    ("phosphatase and tensin homologue (PTEN) and inositol polyphosphate 4-phosphatase type I (INPP4A)"
     . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("polyphosphate" . SPARSER::MOLECULE) ("inositol" . SPARSER::PROTEIN)
    ("FOXP3 [ xref ] and Gastrokine" . SPARSER::COLLECTION)
    ("Connective tissue growth factor (CTGF)" . SPARSER::PROTEIN)
    ("MMP9 and VEGF" . SPARSER::COLLECTION)
    ("NF-κB and COX-2" . SPARSER::COLLECTION)
    ("IL-1β/IL-6" . SPARSER::COLLECTION)
    ("siRNA, siNFKB1 or siRELA" . SPARSER::COLLECTION)
    ("The associated cell cycle regulators" . SPARSER::REGULATOR)
    ("Propidium" . SPARSER::MOLECULE) ("lacZ" . SPARSER::PROTEIN)
    ("form various dimeric complexes" . SPARSER::BIO-COMPLEX)
    ("p50, and NF-κB2" . SPARSER::COLLECTION) ("RELB" . SPARSER::PROTEIN)
    ("normal gastric epithelium" . SPARSER::PROTEIN)
    ("NFKB1 or RELA" . SPARSER::COLLECTION)
    ("NFKB1 and RELA" . SPARSER::COLLECTION) ("INPP4A" . SPARSER::PROTEIN)
    ("INPP5J" . SPARSER::PROTEIN)
    ("inositol polyphosphate-5-phosphatase J" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN) ("MT2A" . SPARSER::PROTEIN)
    ("Metallothionein 2A" . SPARSER::PROTEIN) ("ING4" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("high mobility group box 1" . SPARSER::PROTEIN)
    ("IL-17A" . SPARSER::PROTEIN) ("interleukin 17A" . SPARSER::PROTEIN)
    ("Connective tissue growth factor" . SPARSER::PROTEIN)
    ("p-Rb" . SPARSER::PROTEIN) ("6.3 " . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("Sonic Hedgehog" . SPARSER::PROTEIN)
    ("BRAF/NRAS" . SPARSER::COLLECTION) ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("dehydrogenase (SDH)" . SPARSER::PROTEIN)
    ("1 other histologic type" . TYPE) ("ETS/TCF" . SPARSER::COLLECTION)
    ("Thyroid" . SPARSER::PROTEIN) ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GC3" . SPARSER::PROTEIN) ("CEBP" . SPARSER::PROTEIN)
    ("JunB or FRA1" . SPARSER::COLLECTION)
    ("the intact ileal" . SPARSER::PROTEIN)
    ("cJun:cJun" . SPARSER::BIO-COMPLEX) ("cJun:JunB" . SPARSER::BIO-COMPLEX)
    ("a transcriptional repressor or a poor activator" . SPARSER::COLLECTION)
    ("IL-2, IL-4, VEGF and cyclin" . SPARSER::COLLECTION)
    ("cJun/JunD" . SPARSER::COLLECTION) ("JunD/JNK" . SPARSER::COLLECTION)
    ("chemokines and pro-inflammatory" . SPARSER::COLLECTION)
    ("cJun/p65" . SPARSER::COLLECTION) ("‘enhanceosome’" . SPARSER::PROTEIN)
    ("enhanceosome" . SPARSER::PROTEIN)
    ("the pleiotropic cytokine IL-6" . SPARSER::PROTEIN)
    ("cJun homodimer or cJun/cFos heterodimer" . SPARSER::COLLECTION)
    ("the pro-inflammatory IL-1β" . SPARSER::PROTEIN)
    ("JunD/cFos" . SPARSER::COLLECTION) ("cJun/cFos" . SPARSER::COLLECTION)
    ("AP-1 and NFκB" . SPARSER::COLLECTION)
    ("AP-1 and NFĸB" . SPARSER::COLLECTION) ("Wedelolactone" . SPARSER::DRUG)
    ("postnatal ileal" . SPARSER::PROTEIN) ("39kDa" . SPARSER::PROTEIN)
    ("immature and mature ileal" . SPARSER::PROTEIN)
    ("immature ileal" . SPARSER::PROTEIN)
    ("cFos and cJun" . SPARSER::COLLECTION)
    ("both immature and mature ileal" . SPARSER::PROTEIN)
    ("ileal and cecal" . SPARSER::COLLECTION)
    ("SAPKs, SB203508 and SP600125" . SPARSER::COLLECTION)
    ("SAPK/AP-1" . SPARSER::COLLECTION)
    ("immature human ileal" . SPARSER::PROTEIN)
    ("JunB and JunD" . SPARSER::COLLECTION)
    ("the canonical cJun" . SPARSER::PROTEIN)
    ("Fra1 and FosB" . SPARSER::COLLECTION)
    ("cJun and JunD" . SPARSER::COLLECTION)
    ("JunB and cFos" . SPARSER::COLLECTION) ("TRANS" . SPARSER::PROTEIN-FAMILY)
    ("cJun and cfos" . SPARSER::COLLECTION) ("SAPKs" . SPARSER::PROTEIN)
    ("cfos" . SPARSER::PROTEIN) ("JNK and p38 SAPK" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokine IL-1β" . SPARSER::PROTEIN)
    ("immature intestinal epithelium" . SPARSER::PROTEIN)
    ("the immature ileal" . SPARSER::PROTEIN)
    ("mature (23, 28 week) ileal" . SPARSER::PROTEIN)
    ("ileal" . SPARSER::PROTEIN) ("intestinal epithelium" . SPARSER::PROTEIN)
    ("JNK/cJun" . SPARSER::COLLECTION) ("NCM" . SPARSER::PROTEIN)
    ("Stress activated protein kinase/AP-1" . SPARSER::COLLECTION)
    ("TLR2, TLR4, MyD88, TRAF-6, NFkappaB1 and IL-8" . SPARSER::COLLECTION)
    ("SIGIRR, IRAK-M, A-20 and TOLLIP" . SPARSER::COLLECTION)
    ("TOLLIP" . SPARSER::PROTEIN) ("SIGIRR" . SPARSER::PROTEIN)
    ("NFkappaB" . SPARSER::PROTEIN) ("TLR2" . SPARSER::PROTEIN)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("lactase" . SPARSER::PROTEIN) ("cJun and JunB" . SPARSER::COLLECTION)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Map" . SPARSER::PROTEIN)
    ("-TGAG/CTCA-3" . SPARSER::COLLECTION)
    ("c-Jun, JunB, and JunD" . SPARSER::COLLECTION)
    ("c-Fos, FosB, Fra1, and Fra2" . SPARSER::COLLECTION)
    ("JunB" . SPARSER::PROTEIN) ("Jun, Fos and ATF" . SPARSER::COLLECTION)
    ("many pro-inflammatory cytokine genes" . SPARSER::GENE)
    ("TLR4 and IL-1R" . SPARSER::COLLECTION)
    ("receptors and signaling molecules" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokines interleukin 6 (IL-6) and interleukin"
     . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokines interleukin 6" . SPARSER::PROTEIN)
    ("the cFos/cJun heterodimer and the more potent cJun homodimer"
     . SPARSER::COLLECTION)
    ("less efficient JunD" . SPARSER::PROTEIN)
    ("cFos/cJun" . SPARSER::COLLECTION) ("cJun and cFos" . SPARSER::COLLECTION)
    ("cFos" . SPARSER::PROTEIN)
    ("multiple pro-inflammatory cytokine genes" . SPARSER::GENE)
    ("the pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("interleukin 1β and interleukin 6" . SPARSER::COLLECTION)
    ("FRA-1" . SPARSER::PROTEIN) ("FRA1" . SPARSER::PROTEIN)
    ("cIAP-2" . SPARSER::PROTEIN)
    ("immediate early response" . SPARSER::PROTEIN)
    ("Interleukin 1" . SPARSER::PROTEIN) ("IL-1 b" . SPARSER::PROTEIN)
    ("p38 SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SP-600125" . SPARSER::DRUG)
    ("Stress Activated Protein Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Interleukin 1β" . SPARSER::PROTEIN) ("Tam67" . SPARSER::PROTEIN)
    ("pIL-6" . SPARSER::PROTEIN) ("Interleukin 6" . SPARSER::PROTEIN)
    ("IRAK-M" . SPARSER::PROTEIN) ("TRAF-6" . SPARSER::PROTEIN)
    ("MyD88" . SPARSER::PROTEIN) ("hydrolase activity" . SPARSER::PROTEIN)
    ("Stress activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fra2" . SPARSER::PROTEIN) ("Activator-Protein 1" . SPARSER::PROTEIN)
    ("activator protein 1" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("interleukin 1 receptor" . SPARSER::PROTEIN)
    ("interleukin 1β" . SPARSER::PROTEIN) ("SUD" . SPARSER::PROTEIN)
    ("OCI/AML3" . SPARSER::COLLECTION) ("OCI" . SPARSER::PROTEIN)
    ("caspase 3 and the nuclear protein PARP" . SPARSER::COLLECTION)
    ("KRAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("ligand and the cellular background" . SPARSER::COLLECTION)
    ("attractive pharmacological targets" . SPARSER::TARGET-PROTEIN)
    ("pro-apoptotic proteins and direct target" . SPARSER::COLLECTION)
    ("PUMA" . SPARSER::PROTEIN)
    ("those expressing BRAF V600E or KRAS G12V (See Figure xref )"
     . SPARSER::COLLECTION)
    ("phycoerythrin (PE)" . SPARSER::PROTEIN-FAMILY)
    ("Annexin V and 7-Amino-actinomycin D" . SPARSER::COLLECTION)
    ("phycoerythrin" . SPARSER::PROTEIN-FAMILY)
    ("Sorafenib or AZD6244" . SPARSER::COLLECTION)
    ("BRAF V600E or KRAS G12V" . SPARSER::COLLECTION)
    ("RAS/RAF/ERK" . SPARSER::COLLECTION) ("MEK and ERK" . SPARSER::COLLECTION)
    ("RTCA" . SPARSER::PROTEIN) ("external cues" . SPARSER::PROTEIN-FAMILY)
    ("BRAF, and mutant" . SPARSER::COLLECTION)
    ("AKT, ERK and MEK" . SPARSER::COLLECTION)
    ("Sorafenib and AZD6244" . SPARSER::COLLECTION)
    ("IGF/PI3K/AKT" . SPARSER::COLLECTION) ("BRAF/KRAS" . SPARSER::COLLECTION)
    ("RAF and MAPK" . SPARSER::COLLECTION) ("RAF or MEK" . SPARSER::COLLECTION)
    ("BRAF V600E and KRAS G12V" . SPARSER::COLLECTION)
    ("overexpressing wildtype BRAF" . SPARSER::PROTEIN)
    ("growth factors, FGF2 and IGF1" . SPARSER::COLLECTION)
    ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("KRAS G12V or BRAF V600E" . SPARSER::COLLECTION)
    ("mutant BRAF V600E or KRAS G12V" . SPARSER::COLLECTION)
    ("ELK" . SPARSER::PROTEIN) ("ELK1 and FOXO3a" . SPARSER::COLLECTION)
    ("phospho-AKT, phospho-MEK and phospho-ERK" . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION)
    ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("RAF and AKT" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("BRAF or KRAS" . SPARSER::COLLECTION)
    ("MEK and RAF" . SPARSER::COLLECTION) ("RAF and MEK" . SPARSER::COLLECTION)
    ("PGK1" . SPARSER::PROTEIN) ("phospho-protein" . SPARSER::PROTEIN)
    ("AML3" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("AZ628" . SPARSER::DRUG) ("ELK1" . SPARSER::PROTEIN)
    ("HRAS , KRAS and NRAS" . SPARSER::COLLECTION)
    ("KRAS4A and KRAS4B" . SPARSER::COLLECTION)
    ("KRAS4A and 4B" . SPARSER::COLLECTION)
    ("p21 Cip1 and P27 Kip1" . SPARSER::COLLECTION)
    ("p16 INK4A and p21 Cip1" . SPARSER::COLLECTION)
    ("AKT, MEK, and ERK" . SPARSER::COLLECTION) ("dUTP" . SPARSER::MOLECULE)
    ("valine and aspartic acid" . SPARSER::COLLECTION)
    ("KRAS G12D and KRAS G12V" . SPARSER::COLLECTION)
    ("NRAS or KRAS" . SPARSER::COLLECTION)
    ("HRAS , NRAS and KRAS" . SPARSER::COLLECTION)
    ("HRAS Q61L and NRAS Q61K (Figure xref )" . SPARSER::COLLECTION)
    ("HRAS Q61L and NRAS Q61K" . SPARSER::COLLECTION)
    ("HRAS and NRAS" . SPARSER::COLLECTION)
    ("HRAS, KRAS4B and NRAS" . SPARSER::COLLECTION) ("PHI" . SPARSER::PROTEIN)
    ("isoform and transposons" . SPARSER::COLLECTION)
    ("transposase" . SPARSER::PROTEIN) ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("enhanced green fluorescent protein (EGFP)" . SPARSER::PROTEIN)
    ("AKT, MEK and ERK—were" . SPARSER::COLLECTION)
    ("Isoform" . SPARSER::ISOFORM) ("NRAS and HRAS" . SPARSER::COLLECTION)
    ("activator and effector" . SPARSER::COLLECTION)
    ("four highly homologous RAS proteins" . SPARSER::PROTEIN)
    ("HRAS, NRAS, KRAS4A and KRAS4B" . SPARSER::COLLECTION)
    ("the latter oncogene" . SPARSER::ONCOGENE)
    ("p53 and an activated RAS isoform" . SPARSER::COLLECTION)
    ("HRAS, KRAS , and NRAS" . SPARSER::COLLECTION) ("DcR2" . SPARSER::PROTEIN)
    ("DCR2" . SPARSER::PROTEIN) ("decoy receptor 2" . SPARSER::PROTEIN)
    ("P27 Kip1" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("HDAC1, ATF4 and MTA1" . SPARSER::COLLECTION)
    ("ATF4/MTA1/HDAC1" . SPARSER::COLLECTION)
    ("Gadd153, VEGF, TRB3, osteocalcin, TFIIB and RAP30" . SPARSER::COLLECTION)
    ("TFIIB" . SPARSER::PROTEIN) ("osteocalcin" . SPARSER::PROTEIN)
    ("ATF4/β-TrCP" . SPARSER::COLLECTION)
    ("HDAC1, and ATF4" . SPARSER::COLLECTION)
    ("ATF4, MTA1 and HDAC1" . SPARSER::COLLECTION)
    ("-acetyl" . SPARSER::MOLECULE) ("Flag-HDAC1" . SPARSER::COLLECTION)
    ("GST–MTA1" . SPARSER::COLLECTION) ("PHD3 or β-TrCP" . SPARSER::COLLECTION)
    ("ATF4 and PHD1" . SPARSER::COLLECTION)
    ("PHD3 and β-TrCP" . SPARSER::COLLECTION)
    ("MTA1, HDAC1, PHD1, PHD3 and β-TrCP" . SPARSER::COLLECTION)
    ("proteins, PHD1 and PHD3" . SPARSER::COLLECTION)
    ("PHD1, PHD3 and β-TrCP" . SPARSER::COLLECTION)
    ("MTA1, HDAC1 and ATF4" . SPARSER::COLLECTION)
    ("ATF4, MTA1, and HDAC1" . SPARSER::COLLECTION)
    ("MTA1 and MG132" . SPARSER::COLLECTION)
    ("MG132 and Thapsigargin or MTA1" . SPARSER::COLLECTION)
    ("Thapsigargin or MTA1" . SPARSER::COLLECTION)
    ("MTA1 or Thapsigargin" . SPARSER::COLLECTION)
    ("Thapsigargin or MTA1 expression" . SPARSER::COLLECTION)
    ("MTA1 expression" . SPARSER::PROTEIN) ("Thapsigargin" . SPARSER::MOLECULE)
    ("HIF-1α and p53" . SPARSER::COLLECTION)
    ("Myc-MTA1 expression" . SPARSER::PROTEIN-PAIR)
    ("ODDD and β-TrCP" . SPARSER::COLLECTION) ("ODDD" . SPARSER::PROTEIN)
    ("MTA1 or ATF4" . SPARSER::COLLECTION) ("Flag-ATF4" . SPARSER::COLLECTION)
    ("Myc-MTA1" . SPARSER::COLLECTION) ("MTA1 and ATF4" . SPARSER::COLLECTION)
    ("ATF4 and MTA1/HDAC1" . SPARSER::COLLECTION)
    ("ATF4 and MTA1" . SPARSER::COLLECTION)
    ("Metastasis-associated protein (MTA)" . SPARSER::PROTEIN)
    ("MTA1, MTA2, and MTA3" . SPARSER::COLLECTION)
    ("a global regulator" . SPARSER::REGULATOR)
    ("MTA1 and HDAC1" . SPARSER::COLLECTION)
    ("MTA1/HDAC1" . SPARSER::COLLECTION) ("LB3" . SPARSER::PROTEIN)
    ("LB1" . SPARSER::PROTEIN) ("gamma-tubulin" . SPARSER::PROTEIN)
    ("RAP30" . SPARSER::PROTEIN) ("TRB3" . SPARSER::PROTEIN)
    ("Gadd153" . SPARSER::PROTEIN) ("2-OG" . SPARSER::PROTEIN)
    ("MTA3" . SPARSER::PROTEIN)
    ("Activating transcription factor 4" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("activating transcription factor 4" . SPARSER::PROTEIN)
    ("a pivotal transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("HOXA1 or cyclin D1" . SPARSER::COLLECTION)
    ("cyclin D1-" . SPARSER::PROTEIN) ("HOXA1-" . SPARSER::PROTEIN)
    ("HOXA1 and/or cyclin D1" . SPARSER::COLLECTION)
    ("sh-HOXA1" . SPARSER::COLLECTION) ("HOXA" . SPARSER::PROTEIN)
    ("HOXA1 and cyclin D1" . SPARSER::COLLECTION) ("HOXA1" . SPARSER::PROTEIN)
    ("estrogen and propyl pyrazole triol (PPT, ERα specific agonist)"
     . SPARSER::COLLECTION)
    ("triol" . SPARSER::MOLECULE) ("IL6 and LIF" . SPARSER::COLLECTION)
    ("IL6 and leukemia inhibitory factor" . SPARSER::COLLECTION)
    ("Diethylstilbestrol" . SPARSER::DRUG) ("DES" . SPARSER::PROTEIN)
    ("epithelial ERα" . SPARSER::PROTEIN) ("PIN" . SPARSER::PROTEIN)
    ("IL-4 and IL-13" . SPARSER::COLLECTION)
    ("IL6 and MCP-1" . SPARSER::COLLECTION)
    ("Thbs2 and MMP3" . SPARSER::COLLECTION) ("Thbs2" . SPARSER::PROTEIN)
    ("LNCaP" . SPARSER::PROTEIN) ("CAFs " . SPARSER::PROTEIN)
    ("oxidants" . SPARSER::MOLECULE)
    ("chemokines, cytokines and prostaglandins" . SPARSER::COLLECTION)
    ("macrophages, CCL5 and IL-6" . SPARSER::COLLECTION)
    ("ERα, CD206, CCL5 and IL6" . SPARSER::COLLECTION)
    ("macrophage, CCL5 and IL6" . SPARSER::COLLECTION)
    ("IL6 and ERα" . SPARSER::COLLECTION)
    ("orthotopically xenografted mouse PCa" . SPARSER::PROTEIN)
    ("antibody or IgG" . SPARSER::COLLECTION)
    ("/macrophage" . SPARSER::COLLECTION)
    ("TGF-β3 and Wnt 5α" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION) ("SP1/KLF" . SPARSER::COLLECTION)
    ("ligand (CCL)" . SPARSER::MOLECULE)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("this metastatic PCa" . SPARSER::PROTEIN)
    ("/macrophages" . SPARSER::COLLECTION)
    ("E2 and ICI182,780" . SPARSER::COLLECTION)
    ("C4-2, or PC-3" . SPARSER::COLLECTION) ("media (CM)" . SPARSER::PROTEIN)
    ("E2 and ERα" . SPARSER::COLLECTION) ("TRAMP" . SPARSER::PROTEIN)
    ("the benign component" . SPARSER::COMPONENT)
    ("CCL5 and macrophages" . SPARSER::COLLECTION)
    ("CCL2 and CCL5" . SPARSER::COLLECTION)
    ("ESR1 and ESR2" . SPARSER::COLLECTION)
    ("the estrogen response element (ERE) or non-ERE mediated transactivation"
     . SPARSER::COLLECTION)
    ("response element (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("estrogens" . SPARSER::MOLECULE)
    ("growth factors, cytokines and chemokines" . SPARSER::COLLECTION)
    ("CCL5 and IL6" . SPARSER::COLLECTION)
    ("macrophages and PCa" . SPARSER::COLLECTION)
    ("CCL5 and IL-6" . SPARSER::COLLECTION) ("stromal ERα" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("ERα " . SPARSER::PROTEIN) ("CCL1" . SPARSER::PROTEIN)
    ("Wnt 5" . SPARSER::PROTEIN) ("C-C motif" . SPARSER::PROTEIN)
    ("laminin 5" . SPARSER::PROTEIN) ("ICI 182,780" . SPARSER::DRUG)
    ("C4-2" . SPARSER::PROTEIN) ("ICI182,780" . SPARSER::DRUG)
    ("large T-antigen" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("HGF and c‐Met" . SPARSER::COLLECTION)
    ("exogenous HGF" . SPARSER::PROTEIN)
    ("antibody and SU11274" . SPARSER::COLLECTION)
    ("Egr1 and its target MMP9" . SPARSER::COLLECTION)
    ("Egr1 and MMP9" . SPARSER::COLLECTION)
    ("cadherin and CK19" . SPARSER::COLLECTION) ("zeb" . SPARSER::PROTEIN)
    ("MV" . SPARSER::PROTEIN)
    ("EGFR and vascular endothelial" . SPARSER::COLLECTION)
    ("EMT and drug" . SPARSER::COLLECTION)
    ("ERK and PI3K" . SPARSER::COLLECTION)
    ("Akt and STAT3" . SPARSER::COLLECTION) ("SHARP" . SPARSER::PROTEIN)
    ("c‐Met kinase and its active phosphorylated form" . SPARSER::COLLECTION)
    ("ofHGF/c" . SPARSER::COLLECTION)
    ("early growth response" . SPARSER::PROTEIN) ("CK19" . SPARSER::PROTEIN)
    ("SU11274" . SPARSER::DRUG) ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("p53 as well as p53" . SPARSER::COLLECTION)
    ("low-risk mucosal (lrm) HPV E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("D44R E6 and R290E p53 mutants" . SPARSER::COLLECTION)
    ("bi-dentate" . SPARSER::PROTEIN-PAIR)
    ("the N-terminal arm and α1 helix" . SPARSER::COLLECTION)
    ("arm, β1 and β10" . SPARSER::COLLECTION)
    ("the e6ap peptide’s" . SPARSER::PEPTIDE)
    ("the adjacent MBP" . SPARSER::PROTEIN)
    ("The E6/e6ap/p53core ternary complex" . SPARSER::BIO-COMPLEX)
    ("E6/e6ap" . SPARSER::COLLECTION) ("E6/MBP-e6ap" . SPARSER::COLLECTION)
    ("maltose" . SPARSER::MOLECULE)
    ("a minimal E6/E6AP/p53 ternary complex" . SPARSER::BIO-COMPLEX)
    ("e6ap" . SPARSER::PROTEIN) ("zinc-binding" . SPARSER::PROTEIN)
    ("most mucosal and cutaneous E6 proteins" . SPARSER::PROTEIN)
    ("E6/E6AP/p53" . SPARSER::COLLECTION)
    ("previously described DNA-" . SPARSER::DNA) ("DNA-" . SPARSER::DNA)
    ("E6-p53" . SPARSER::COLLECTION)
    ("Neither E6 nor E6AP" . SPARSER::COLLECTION)
    ("E6, E6AP and p53" . SPARSER::COLLECTION)
    ("E6/E6AP" . SPARSER::COLLECTION) ("hrm" . SPARSER::PROTEIN-FAMILY)
    ("MRC 2" . SPARSER::PROTEIN) ("1–8" . SPARSER::PROTEIN)
    ("E 6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E 1" . SPARSER::MOLECULE)
    ("E6AP" . SPARSER::PROTEIN) ("EGFR/KRAS" . SPARSER::COLLECTION)
    ("male and 83 (60.6%, of 137)" . SPARSER::COLLECTION)
    ("PLE" . SPARSER::PROTEIN) ("TFG" . SPARSER::PROTEIN)
    ("FISH and EGFR" . SPARSER::COLLECTION) ("ALK 5" . SPARSER::PROTEIN)
    ("P 53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKN2A" . SPARSER::PROTEIN)
    ("KLC1" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("BIRC6" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nintedanib" . SPARSER::DRUG) ("Dovitinib" . SPARSER::DRUG)
    ("Brivanib" . SPARSER::DRUG)
    ("PIK3CA [ xref ] and DDR2 [ xref ]" . SPARSER::COLLECTION)
    ("Males" . SPARSER::MOLECULE)
    ("The ternary FGF-FGFR-HSPG (heparin sulfate proteoglycan) complex"
     . SPARSER::BIO-COMPLEX)
    ("HSPG" . SPARSER::PROTEIN) ("P13" . SPARSER::PROTEIN)
    ("the constitutively expressed cyclooxygenase-1 and inducibly expressed cyclooxygenase-2"
     . SPARSER::COLLECTION)
    ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFKB1 and -826C/T polymorphism" . SPARSER::COLLECTION)
    ("the respective genes" . SPARSER::GENE) ("receptor-" . SPARSER::RECEPTOR)
    ("COX-2 and COX-1" . SPARSER::COLLECTION) ("Ala/Ala" . SPARSER::COLLECTION)
    ("Pro/Ala" . SPARSER::COLLECTION) ("Pro/Pro" . SPARSER::COLLECTION)
    ("ins/ins" . SPARSER::COLLECTION) ("MR/IR" . SPARSER::COLLECTION)
    ("MR" . SPARSER::PROTEIN) ("PPARG" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("cyclooxygenase-1" . SPARSER::PROTEIN)
    ("I κ B α" . SPARSER::PROTEIN) ("PPAR- γ" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("COX-1" . SPARSER::PROTEIN)
    ("antiviral drugs" . SPARSER::DRUG)
    ("the methylated sporadic CRC" . SPARSER::PROTEIN)
    ("miR-21 and PTEN" . SPARSER::COLLECTION)
    ("sporadic CRC" . SPARSER::PROTEIN) ("IGFR" . SPARSER::PROTEIN)
    ("miR-21 and promoter" . SPARSER::COLLECTION)
    ("Hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("BCL2L11, ALK, PIK3CA , and KRAS" . SPARSER::COLLECTION)
    ("EGFR and ALK" . SPARSER::COLLECTION) ("ins" . SPARSER::PROTEIN)
    ("PNA" . SPARSER::PROTEIN) ("PI3K-TKIs" . SPARSER::COLLECTION)
    ("AKT1, BRAF, DDR2, ERBB2, FGFR, KRAS, MAPK2K1, MET1, NRAS, PIK3CA, PTEN, RET , and ROS1"
     . SPARSER::COLLECTION)
    ("papillary/micropapillary predominant types" . TYPE)
    ("the lepidic predominant types" . TYPE)
    ("male and 44 (72.1%)" . SPARSER::COLLECTION)
    ("PI3K-tyrosine kinase" . SPARSER::COLLECTION) ("MET1" . SPARSER::PROTEIN)
    ("MAPK2K1" . SPARSER::PROTEIN) ("f3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E19" . SPARSER::PROTEIN)
    ("their respective cytokines" . SPARSER::PROTEIN)
    ("IFN-γ, TNF-α, IL-17, IL22, and IL-23" . SPARSER::COLLECTION)
    ("The rs842647 GG genotype and G allele" . SPARSER::COLLECTION)
    ("RA and T1D" . SPARSER::COLLECTION)
    ("cohorts and SLE" . SPARSER::COLLECTION)
    ("REL and PRCKQ" . SPARSER::COLLECTION)
    ("the GG genotype and G allele" . SPARSER::COLLECTION)
    ("GG genotype and G allele" . SPARSER::COLLECTION)
    ("genotype and allele" . SPARSER::COLLECTION)
    ("genotype and rs842647" . SPARSER::COLLECTION)
    ("PRKCQ and CD40" . SPARSER::COLLECTION) ("Rel" . SPARSER::PROTEIN)
    ("NFKB1 and NFKBIA" . SPARSER::COLLECTION)
    ("STAT4 , and GIMAP genes and BD [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("STAT4 , and GIMAP" . SPARSER::COLLECTION)
    ("IL23R-IL12RB2" . SPARSER::COLLECTION)
    ("genotypes and rs842647" . SPARSER::COLLECTION)
    ("REL and PRKCQ" . SPARSER::COLLECTION) ("PRKCQ" . SPARSER::PROTEIN)
    ("REL" . SPARSER::PROTEIN) ("IL23" . SPARSER::PROTEIN)
    ("IL22" . SPARSER::PROTEIN) ("c-REL" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("IL12RB2" . SPARSER::PROTEIN)
    ("IL23R" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("Ser-Pro" . SPARSER::COLLECTION)
    ("promyelocytic leukemia (PML)" . SPARSER::PROTEIN)
    ("Oxygen" . SPARSER::MOLECULE) ("retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("VEGF and other angiogenic cytokines" . SPARSER::COLLECTION)
    ("other angiogenic cytokines" . SPARSER::PROTEIN)
    ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("peptidyl" . SPARSER::PROTEIN) ("VEGF and CD31" . SPARSER::COLLECTION)
    ("luciferin" . SPARSER::MOLECULE) ("sh-PIN1" . SPARSER::COLLECTION)
    ("complete media" . SPARSER::PROTEIN) ("DFO" . SPARSER::MOLECULE)
    ("EPO" . SPARSER::PROTEIN) ("GFP-PIN1" . SPARSER::COLLECTION)
    ("chymotrypsin" . SPARSER::PROTEIN) ("si-PIN1" . SPARSER::COLLECTION)
    ("anti-HIF-1α and anti-PIN1" . SPARSER::COLLECTION)
    ("a nonspecific protein phosphatase" . SPARSER::PROTEIN)
    ("HA-HIF-1α" . SPARSER::COLLECTION)
    ("intestinal alkaline phosphatase (CIP)" . SPARSER::PROTEIN)
    ("CIP" . SPARSER::PROTEIN) ("exogenous HIF-1α" . SPARSER::PROTEIN)
    ("PiB" . SPARSER::PROTEIN) ("HIF-1α and PIN1" . SPARSER::COLLECTION)
    ("antibody or anti-PIN1" . SPARSER::COLLECTION)
    ("exogenous PIN1" . SPARSER::PROTEIN)
    ("Flag epitope-tagged HIF-1α and HA-tagged PIN1" . SPARSER::COLLECTION)
    ("GST-PIN1" . SPARSER::COLLECTION) ("pThr-Pro" . SPARSER::COLLECTION)
    ("PIN1 and HIF-1α" . SPARSER::COLLECTION)
    ("Peptidyl-prolyl" . SPARSER::PROTEIN-PAIR)
    ("-isomerase" . SPARSER::ISOMERASE) ("PPIase" . SPARSER::PROTEIN)
    ("pVHL" . SPARSER::PROTEIN) ("a heterodimeric protein" . SPARSER::PROTEIN)
    ("HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 [ xref ]"
     . SPARSER::COLLECTION)
    ("angiogenic cytokines" . SPARSER::PROTEIN)
    ("VEGFR1 and VEGFR2" . SPARSER::COLLECTION)
    ("many hypoxic-inducible genes" . SPARSER::GENE)
    ("KLHL20" . SPARSER::PROTEIN)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("trans isomerase" . SPARSER::PROTEIN)
    ("intestinal alkaline phosphatase" . SPARSER::PROTEIN)
    ("pLP2" . SPARSER::PROTEIN) ("si-RNA" . SPARSER::RNA)
    ("cyclin-dependent kinase1" . SPARSER::PROTEIN)
    ("von Hippel Lindau" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("Kappa" . SPARSER::PROTEIN-FAMILY)
    ("negative IHC ROS1" . SPARSER::PROTEIN)
    ("Other histological subtypes" . SPARSER::PROTEIN)
    ("ALK and ROS1" . SPARSER::COLLECTION)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("ROS1-" . SPARSER::PROTEIN) ("Xalkori" . SPARSER::DRUG)
    ("ADC" . SPARSER::PROTEIN)
    ("the last years new predictive biomarkers" . SPARSER::MOLECULE)
    ("oncogene-driven subtypes" . SPARSER::PROTEIN)
    ("CD74 and SLC34A2" . SPARSER::COLLECTION)
    ("CD74 , EZR , SLC34A2 and SDC3" . SPARSER::COLLECTION)
    ("EZR" . SPARSER::PROTEIN) ("CNAs" . SPARSER::PROTEIN)
    ("SDC4" . SPARSER::PROTEIN) ("split 5" . SPARSER::PROTEIN)
    ("SDC3" . SPARSER::PROTEIN) ("SLC34A2" . SPARSER::PROTEIN)
    ("CD74" . SPARSER::PROTEIN) ("STAT3, and Eag1" . SPARSER::COLLECTION)
    ("Eag1 and STAT3" . SPARSER::COLLECTION)
    ("STAT3/VEGF" . SPARSER::COLLECTION)
    ("annexin V and PI" . SPARSER::COLLECTION)
    ("Some chemotherapeutic drugs" . SPARSER::DRUG)
    ("imipramine and astemizole" . SPARSER::COLLECTION)
    ("astemizole" . SPARSER::DRUG) ("imipramine" . SPARSER::DRUG)
    ("STAT3 and VEGF" . SPARSER::COLLECTION)
    ("siRNA or Eag1" . SPARSER::COLLECTION)
    ("Eag1 siRNA1, or Eag1 siRNA2" . SPARSER::PROTEIN)
    ("Eag1 and Eag2" . SPARSER::COLLECTION) ("eag" . SPARSER::PROTEIN)
    ("Eag" . SPARSER::PROTEIN) ("EAG" . SPARSER::PROTEIN)
    ("STAT3-VEGF" . SPARSER::COLLECTION)
    ("siRNA and Eag1" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor (VEGF) and signal transducer and activator of transcription 3 (STAT3)"
     . SPARSER::COLLECTION)
    ("Ether" . SPARSER::MOLECULE) ("P40)" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("KCNH5" . SPARSER::PROTEIN)
    ("Kv10.2" . SPARSER::PROTEIN) ("Eag2" . SPARSER::PROTEIN)
    ("KCNH1" . SPARSER::PROTEIN) ("Kv10.1" . SPARSER::PROTEIN)
    ("voltage-gated" . SPARSER::PROTEIN) ("Eag1" . SPARSER::PROTEIN)
    ("LG" . SPARSER::MOLECULE) ("Salvador" . SPARSER::PROTEIN)
    ("Bax and Tom22" . SPARSER::COLLECTION)
    ("Tom20, Tom22, or Sam50" . SPARSER::COLLECTION)
    ("antisera" . SPARSER::PROTEIN)
    ("only proteinaceous Bax" . SPARSER::PROTEIN)
    ("the intermembrane space proteins optic atrophy protein 1 (OPA1) and presenilin‐associated rhomboid‐like protein (PARL)"
     . SPARSER::COLLECTION)
    ("protein (PARL)" . SPARSER::PROTEIN) ("PARL" . SPARSER::PROTEIN)
    ("rhomboid" . SPARSER::PROTEIN-FAMILY) ("presenilin" . SPARSER::PROTEIN)
    ("potentially other proteins" . SPARSER::PROTEIN)
    ("Bax " . SPARSER::PROTEIN)
    ("discernible Mic27 and Mic60" . SPARSER::COLLECTION)
    ("Mic27 and Mic60" . SPARSER::COLLECTION) ("mitofilin" . SPARSER::PROTEIN)
    ("Mic" . SPARSER::PROTEIN-FAMILY) ("von" . SPARSER::PROTEIN)
    ("the tubular mitochondria" . SPARSER::PROTEIN)
    ("cytochrome c and Bax" . SPARSER::COLLECTION)
    ("Tom22, Bax, and cytochrome c" . SPARSER::COLLECTION)
    ("Bax and Sam50" . SPARSER::COLLECTION)
    ("SAM or TOB" . SPARSER::COLLECTION) ("TOB" . SPARSER::PROTEIN)
    ("Tom20 and Tom22" . SPARSER::COLLECTION)
    ("Tom20 and Bax" . SPARSER::COLLECTION)
    ("occasional elongated Bax" . SPARSER::PROTEIN)
    ("dim" . SPARSER::PROTEIN-FAMILY) ("arc" . SPARSER::PROTEIN)
    ("the apoptotic mitochondria" . SPARSER::PROTEIN)
    ("Bax and Tom20 or Tom22" . SPARSER::COLLECTION)
    ("Tom20 or Tom22" . SPARSER::COLLECTION)
    ("apoptotic mitochondria" . SPARSER::PROTEIN)
    ("VDAC, ANT, and CypD" . SPARSER::COLLECTION) ("CypD" . SPARSER::PROTEIN)
    ("ANT" . SPARSER::PROTEIN) ("VDAC" . SPARSER::PROTEIN)
    ("complex (PTPC)" . SPARSER::BIO-COMPLEX) ("PTPC" . SPARSER::BIO-COMPLEX)
    ("the Bcl‐2 proteins Bax (Bcl‐2‐associated X protein) and Bak (Bcl‐2‐antagonistic killer)"
     . SPARSER::COLLECTION)
    ("cytochrome c and Smac/DIABLO" . SPARSER::COLLECTION)
    ("MOMP" . SPARSER::PROTEIN)
    ("Tom20, Tom22, and Sam50" . SPARSER::COLLECTION)
    ("Sam50" . SPARSER::PROTEIN) ("Sam" . SPARSER::MOLECULE)
    ("Bax and Bak" . SPARSER::COLLECTION) ("OPA1" . SPARSER::PROTEIN)
    ("optic atrophy protein 1" . SPARSER::PROTEIN) ("Mic27" . SPARSER::PROTEIN)
    ("B–E" . SPARSER::PROTEIN) ("Smac/DIABLO" . SPARSER::PROTEIN)
    ("Drp1" . SPARSER::PROTEIN) ("Tom22" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tom20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdc42 or aPKC" . SPARSER::COLLECTION)
    ("aPKC or Cdc42" . SPARSER::COLLECTION)
    ("ROCK and ERK" . SPARSER::COLLECTION)
    ("the proper mitotic spindle positioning" . SPARSER::PROTEIN)
    ("Cdc42/Par6/Par3/aPKC" . SPARSER::COLLECTION)
    ("Par3-aPKC" . SPARSER::COLLECTION) ("Par6/Crb3" . SPARSER::COLLECTION)
    ("Rab11a/Rab8" . SPARSER::COLLECTION) ("GEF's" . SPARSER::GEF)
    ("MEK/ROCK" . SPARSER::COLLECTION) ("MEK and ROCK" . SPARSER::COLLECTION)
    ("ERK1/2 and myosin" . SPARSER::COLLECTION)
    ("U0126 and Y27632" . SPARSER::COLLECTION)
    ("MEK1/2 and ROCK" . SPARSER::COLLECTION)
    ("ERK and ROCK" . SPARSER::COLLECTION)
    ("Cdc42 and aPKC" . SPARSER::COLLECTION) ("Tubacin" . SPARSER::DRUG)
    ("Par3/aPKC" . SPARSER::COLLECTION)
    ("Cdc42/Par6/aPKC" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("Par3" . SPARSER::PROTEIN)
    ("cell-permeable inhibitor" . SPARSER::INHIBITOR)
    ("tubacin" . SPARSER::DRUG)
    ("unacetylable tubulin K40R mutant" . SPARSER::MUTANT)
    ("YF" . SPARSER::MOLECULE)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an essential guanine exchange factor (GEF)" . SPARSER::EXCHANGE-FACTOR)
    ("exchange factor (GEF)" . SPARSER::EXCHANGE-FACTOR)
    ("ERK and myosin" . SPARSER::COLLECTION) ("aPKC" . SPARSER::PROTEIN)
    ("CagA" . SPARSER::PROTEIN) ("Ras/Raf/ERK" . SPARSER::COLLECTION)
    ("HER2 or BCR-ABL" . SPARSER::COLLECTION)
    ("disease-associated tyrosine kinases" . SPARSER::PROTEIN)
    ("ERK/myosin" . SPARSER::COLLECTION) ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("MLC2" . SPARSER::PROTEIN) ("SH-PTP2" . SPARSER::PROTEIN)
    ("mitotic spindle positioning" . SPARSER::PROTEIN)
    ("Pin1" . SPARSER::PROTEIN) ("Crb3" . SPARSER::PROTEIN)
    ("Rab8" . SPARSER::PROTEIN) ("Rab11a" . SPARSER::PROTEIN)
    ("G15" . SPARSER::PROTEIN) ("GP135" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN)
    ("myosin phosphatase" . SPARSER::PROTEIN)
    ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rho GTPase" . SPARSER::PROTEIN)
    ("cdc42" . SPARSER::PROTEIN) ("Shp2" . SPARSER::PROTEIN)
    ("NRP-1:VEGF-R2" . SPARSER::BIO-COMPLEX)
    ("VEGF or its receptor" . SPARSER::COLLECTION)
    ("new predictive and prognostic biomarkers" . SPARSER::MOLECULE)
    ("p53 and VEGF" . SPARSER::COLLECTION)
    ("cediranib, pazopanib and sorafenib" . SPARSER::COLLECTION)
    ("VEGF-Trap" . SPARSER::COLLECTION) ("cediranib" . SPARSER::DRUG)
    ("ranibizumab" . SPARSER::DRUG) ("Trap" . SPARSER::PROTEIN)
    ("VEGF-A, VEGF-R2 and p53" . SPARSER::COLLECTION)
    ("VEGF-R1 (P=0.724) or VEGF-R2 (P=0.210)" . SPARSER::COLLECTION)
    ("VEGF-A (P=0.805), VEGF-R1 (P=0.724) or VEGF-R2 (P=0.210)"
     . SPARSER::COLLECTION)
    ("VEGF-R1 and VEGF-A" . SPARSER::COLLECTION)
    ("VEGF-A and VEGF-R2" . SPARSER::COLLECTION)
    ("type or FIGO-stage" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("VEGF-A, VEGF-R1 and VEGF-R2" . SPARSER::COLLECTION)
    ("p53 and VEGF-A" . SPARSER::COLLECTION)
    ("angiogenic inhibitors" . SPARSER::INHIBITOR)
    ("other pro-antigenic cytokines and their cognate receptors"
     . SPARSER::COLLECTION)
    ("other pro-antigenic cytokines" . SPARSER::PROTEIN)
    ("neo" . SPARSER::PROTEIN) ("VEGF-R1 and VEGF-R2" . SPARSER::COLLECTION)
    ("predictive and prognostic biomarkers" . SPARSER::MOLECULE)
    ("VEGF-R2 and VEGF-A and p53" . SPARSER::COLLECTION)
    ("VEGF-A and p53" . SPARSER::COLLECTION)
    ("VEGF-R2 and p53" . SPARSER::COLLECTION)
    ("VEGF-R2 (P=0.011) and p53 (P=0.015)" . SPARSER::COLLECTION)
    ("VEGF-A (P=0.030), VEGF-R2 (P=0.011) and p53 (P=0.015)"
     . SPARSER::COLLECTION)
    ("VEGF-R2 and VEGF-A" . SPARSER::COLLECTION)
    ("VEGF-R1, VEGF-R2 and VEGF-A" . SPARSER::COLLECTION)
    ("Flk-1" . SPARSER::PROTEIN) ("Flt-1" . SPARSER::PROTEIN)
    ("VEGF-R2" . SPARSER::PROTEIN) ("VEGF-R1" . SPARSER::PROTEIN)
    ("CCND1 and p-pRb" . SPARSER::COLLECTION)
    ("CCND1/CDK4" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("CCND1 and CCND2" . SPARSER::COLLECTION)
    ("a cyclin and a cyclin-dependent kinase (CDK)" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT3 and CCND2" . SPARSER::COLLECTION)
    ("anti-onco-miR" . SPARSER::COLLECTION) ("p-pRb" . SPARSER::COLLECTION)
    ("miR-610 directly targets CCND2 and AKT3" . SPARSER::COLLECTION)
    ("LN18" . SPARSER::PROTEIN) ("Akt3 and CCND2" . SPARSER::COLLECTION)
    ("anti-onco-miRNA" . SPARSER::COLLECTION)
    ("CCND2 and AKT3" . SPARSER::COLLECTION)
    ("cyclin D2 (CCND2) and AKT3" . SPARSER::COLLECTION)
    ("single-stranded RNAs" . SPARSER::RNA)
    ("small nuclear RNA" . SPARSER::RNA) ("CCN2" . SPARSER::PROTEIN)
    ("recombinant human epidermal growth factor" . SPARSER::DRUG)
    ("Cyclin D2" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("kinases and JAK" . SPARSER::COLLECTION)
    ("IL-6R/JAK1" . SPARSER::COLLECTION)
    ("HER inhibitors or cytotoxics" . SPARSER::COLLECTION)
    ("STAT3, MAPK or AKT" . SPARSER::COLLECTION)
    ("c-MET/HGF" . SPARSER::COLLECTION)
    ("EGFR, HER2, KRAS, p53, PIK3CA, PTEN and c-MET" . SPARSER::COLLECTION)
    ("P-gp, MRP-2 and ABCG2" . SPARSER::COLLECTION)
    ("the developed drug-resistant variants" . SPARSER::VARIANT)
    ("CD133, CD24 and CD44" . SPARSER::COLLECTION)
    ("afatinib, and erlotinib" . SPARSER::COLLECTION)
    ("transporter-1" . SPARSER::COLLECTION) ("dCK" . SPARSER::PROTEIN)
    ("afatinib or gemcitabine" . SPARSER::COLLECTION)
    ("KDR" . SPARSER::PROTEIN) ("STAT3, or c-MET" . SPARSER::COLLECTION)
    ("c-MET and HER" . SPARSER::COLLECTION)
    ("EGFR (Y1068) and HER3 ( xref )" . SPARSER::COLLECTION)
    ("STAT3 or HER" . SPARSER::COLLECTION)
    ("afatinib and crizotinib" . SPARSER::COLLECTION)
    ("STAT3, AKT and MAPK" . SPARSER::COLLECTION)
    ("total and phosphorylated SRC" . SPARSER::PROTEIN)
    ("SRC, MAPK, AKT and STAT3" . SPARSER::COLLECTION)
    ("major RTKs" . SPARSER::PROTEIN) ("c-MET and STAT3" . SPARSER::COLLECTION)
    ("CD44, CD24 and CD133" . SPARSER::COLLECTION)
    ("IGF-IR and c-MET" . SPARSER::COLLECTION)
    ("STAT3 and AKT" . SPARSER::COLLECTION)
    ("amphiregulin (AR)" . SPARSER::PROTEIN)
    ("afatinib and gemcitabine" . SPARSER::COLLECTION)
    ("gemcitabine, afatinib, erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("gefitinib (3.55-fold change, p<0.05) and gemcitabine (51.46-fold change, p<0.05)"
     . SPARSER::COLLECTION)
    ("erlotinib (2.96-fold change, p<0.05), gefitinib (3.55-fold change, p<0.05) and gemcitabine (51.46-fold change, p<0.05)"
     . SPARSER::COLLECTION)
    ("parental and drug-resistant pancreatic cancer cell variants"
     . SPARSER::VARIANT)
    ("vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("afatinib (BxPc3AFR) and erlotinib (BxPc3OSIR)" . SPARSER::COLLECTION)
    ("gemcitabine (BxPc3GEMR), afatinib (BxPc3AFR) and erlotinib (BxPc3OSIR)"
     . SPARSER::COLLECTION)
    ("EGFR ligands, putative cancer stem cells (CSCs) and epithelial mesenchymal transition (EMT) markers, as well as the expression levels"
     . SPARSER::COLLECTION)
    ("receptors and several downstream cell signalling molecules"
     . SPARSER::COLLECTION)
    ("afatinib, erlotinib and gemcitabine" . SPARSER::COLLECTION)
    ("afatinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib (OSI-774) or gefitinib ( xref , xref )" . SPARSER::COLLECTION)
    ("fluorouracil, irinotecan and oxaliplatin" . SPARSER::COLLECTION)
    ("-paclitaxel" . SPARSER::DRUG) ("nanoparticle" . SPARSER::MOLECULE)
    ("gemcitabine and HER" . SPARSER::COLLECTION)
    ("Crizotinib or Stattic" . SPARSER::COLLECTION)
    ("STAT3 or c-MET" . SPARSER::COLLECTION) ("p-c-MET" . SPARSER::COLLECTION)
    ("various growth factor receptors and downstream cell signaling molecules"
     . SPARSER::COLLECTION)
    ("phopsho-RTK" . SPARSER::COLLECTION)
    ("afatinib (BxPc3AFR) or erlotinib (BxPc3OSIR)" . SPARSER::COLLECTION)
    ("gemcitabine (BxPc3GEM), afatinib (BxPc3AFR) or erlotinib (BxPc3OSIR)"
     . SPARSER::COLLECTION)
    ("AFR" . SPARSER::PROTEIN)
    ("gemcitabine, afatinib, or erlotinib" . SPARSER::COLLECTION)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("MRP-2" . SPARSER::PROTEIN)
    ("deoxycytidine kinase" . SPARSER::PROTEIN) ("Stat-3" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("VEGFR3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VEGFR1" . SPARSER::PROTEIN)
    ("Tie-2" . SPARSER::PROTEIN) ("INS-R" . SPARSER::PROTEIN)
    ("HGF-R" . SPARSER::PROTEIN) ("beta-cellulin" . SPARSER::PROTEIN)
    ("insulin like growth factor" . SPARSER::PROTEIN)
    ("HER-4" . SPARSER::PROTEIN) ("HER-3" . SPARSER::PROTEIN)
    ("HM43" . SPARSER::PROTEIN) ("OSI-774" . SPARSER::DRUG)
    ("ICR62" . SPARSER::DRUG) ("SOX2 and hsa-miR-145" . SPARSER::COLLECTION)
    ("Hsa" . SPARSER::PROTEIN) ("far more complex" . SPARSER::BIO-COMPLEX)
    ("several stem cell-associated genes" . SPARSER::GENE)
    ("driving gene" . SPARSER::GENE) ("PAH-adduct" . SPARSER::PROTEIN-PAIR)
    ("SOX2 and TP53" . SPARSER::COLLECTION)
    ("TP53, SOX2 and subset" . SPARSER::COLLECTION)
    ("TP53 and SOX2" . SPARSER::COLLECTION)
    ("many stem cell-associated genes" . SPARSER::GENE)
    ("miR-200c" . SPARSER::MOLECULE) ("Beta-Actin" . SPARSER::PROTEIN)
    ("FTH1" . SPARSER::PROTEIN)
    ("the genetically validated target and a clinically available drug"
     . SPARSER::COLLECTION)
    ("a clinically available drug" . SPARSER::DRUG)
    ("the spontaneous convulsive seizures" . SPARSER::PROTEIN)
    ("focal cortical dysplasia type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epilepsy" . SPARSER::PROTEIN)
    ("symptomatic focal epilepsy" . SPARSER::PROTEIN)
    ("available antiepileptic drugs" . SPARSER::DRUG)
    ("MCD" . SPARSER::PROTEIN) ("FCDII" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MTOR" . SPARSER::PROTEIN) ("intractable epilepsy" . SPARSER::PROTEIN)
    ("Focal cortical dysplasia type II (FCDII)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type II (FCDII)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN)
    ("the undruggable MYC" . SPARSER::PROTEIN)
    ("ribosome and spliceosome" . SPARSER::COLLECTION)
    ("this key transcription factor" . SPARSER::PROTEIN)
    ("Prmt5" . SPARSER::PROTEIN) ("A unique molecule" . SPARSER::MOLECULE)
    ("Prmt" . SPARSER::PROTEIN)
    ("a core spliceosomal component" . SPARSER::COMPONENT)
    ("Bud31" . SPARSER::PROTEIN) ("Srsf1 or hnRNPA1" . SPARSER::COLLECTION)
    ("Erbb2 or Hpv16E7" . SPARSER::COLLECTION) ("Erbb2" . SPARSER::PROTEIN)
    ("eIF6" . SPARSER::PROTEIN)
    ("Additional essential components" . SPARSER::COMPONENT)
    ("Chk2 and Parp" . SPARSER::COLLECTION) ("Parp" . SPARSER::PROTEIN)
    ("hyperactive MYC" . SPARSER::PROTEIN)
    ("Atr and Chk1" . SPARSER::COLLECTION) ("Atr" . SPARSER::PROTEIN)
    ("CSNK1e" . SPARSER::PROTEIN)
    ("siRNA or shRNA‐based" . SPARSER::COLLECTION)
    ("How to indirectly target MYC (non‐oncogene addiction)"
     . SPARSER::WH-QUESTION)
    ("directly or indirectly preventing protein:protein or protein:DNA interactions"
     . SPARSER::COLLECTION)
    ("the monomeric form" . SPARSER::FORM)
    ("MYC and MAX" . SPARSER::COLLECTION) ("MYC/MAX" . SPARSER::COLLECTION)
    ("promoters and trans" . SPARSER::COLLECTION) ("MIZ" . SPARSER::PROTEIN)
    ("MAX and DNA" . SPARSER::COLLECTION)
    ("MAD or other HLH proteins" . SPARSER::COLLECTION)
    ("MAD" . SPARSER::PROTEIN) ("mRNA and trigger" . SPARSER::COLLECTION)
    ("Antisense" . SPARSER::PROTEIN) ("eIf4a" . SPARSER::PROTEIN)
    ("eIf" . SPARSER::PROTEIN) ("Rps" . SPARSER::PROTEIN)
    ("polyamine" . SPARSER::MOLECULE)
    ("the predominant regulator" . SPARSER::REGULATOR)
    ("bromodomain" . SPARSER::PROTEIN) ("BET" . SPARSER::PROTEIN)
    ("let7 and miR‐150" . SPARSER::COLLECTION) ("lin28B" . SPARSER::PROTEIN)
    ("Drosha" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("HOTAIR" . SPARSER::PROTEIN)
    ("microRNAs and long non‐coding RNAs" . SPARSER::COLLECTION)
    ("ribosomal components" . SPARSER::COMPONENT) ("RPS" . SPARSER::PROTEIN)
    ("snoRNAs" . SPARSER::RNA) ("snoRNPs" . SPARSER::BIO-COMPLEX)
    ("Nucleolin, nucleophosmin, fibrillarin, Nop56, and Bop1"
     . SPARSER::COLLECTION)
    ("Nop56" . SPARSER::PROTEIN) ("fibrillarin" . SPARSER::PROTEIN)
    ("mature rRNAs" . SPARSER::RNA)
    ("acetyltransferases, GCN5 and TRRAP" . SPARSER::COLLECTION)
    ("TFIIIB" . SPARSER::PROTEIN) ("UBF" . SPARSER::PROTEIN)
    ("SL1" . SPARSER::PROTEIN) ("ribosomal RNAs" . SPARSER::RNA)
    ("TRRAP" . SPARSER::PROTEIN) ("snRNP" . SPARSER::BIO-COMPLEX)
    ("MYC and EMT" . SPARSER::COLLECTION) ("EMT/MET" . SPARSER::COLLECTION)
    ("MYC and SAGA" . SPARSER::COLLECTION)
    ("the established pluripotent stem cell state" . SPARSER::BIO-STATE)
    ("SAGA" . SPARSER::PROTEIN) ("Srsf1 and MYC" . SPARSER::COLLECTION)
    ("Srsf1" . SPARSER::PROTEIN) ("MYC and hnRNPH" . SPARSER::COLLECTION)
    ("hnRNPH" . SPARSER::PROTEIN) ("kinase (PKM)" . SPARSER::KINASE)
    ("hnRNPA2, and PTB" . SPARSER::COLLECTION)
    ("4EBP1 and eIF4G" . SPARSER::COLLECTION)
    ("hydrolase (SAHH)" . SPARSER::PROTEIN) ("SAH" . SPARSER::MOLECULE)
    ("SAHH" . SPARSER::PROTEIN) ("homocysteine" . SPARSER::MOLECULE)
    ("even more complex" . SPARSER::BIO-COMPLEX)
    ("MYC not only binds every active promoter" . SPARSER::PROMOTER)
    ("the basic helix loop helix leucine zipper (bHLH‐LZ) family"
     . SPARSER::PROTEIN-FAMILY)
    ("LZ" . SPARSER::PROTEIN) ("Spt" . SPARSER::PROTEIN)
    ("Ada" . SPARSER::PROTEIN) ("elongation, and mRNA" . SPARSER::COLLECTION)
    ("L38" . SPARSER::PROTEIN) ("ARK5" . SPARSER::PROTEIN)
    ("Pim1" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AZD1152" . SPARSER::DRUG) ("Aurora kinase B" . SPARSER::PROTEIN)
    ("Aurora kinase A" . SPARSER::PROTEIN) ("GSK3beta" . SPARSER::PROTEIN)
    ("SAE2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ornithine decarboxylase" . SPARSER::PROTEIN) ("Brd4" . SPARSER::PROTEIN)
    ("lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bop1" . SPARSER::PROTEIN)
    ("GCN5" . SPARSER::PROTEIN) ("BUD31" . SPARSER::PROTEIN)
    ("PRMT5" . SPARSER::PROTEIN) ("splicing factor" . SPARSER::PROTEIN)
    ("polypyrimidine tract binding protein" . SPARSER::PROTEIN)
    ("hnRNPA2" . SPARSER::PROTEIN) ("MYC protein" . SPARSER::PROTEIN)
    ("Gcn5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Polymerase II" . SPARSER::PROTEIN)
    ("BRCA1-Abraxas" . SPARSER::COLLECTION)
    ("BRCA1 and Abraxas" . SPARSER::COLLECTION)
    ("Abraxas and BRCC36" . SPARSER::COLLECTION)
    ("the Abraxas/BRCA1-A complex and accumulation of BRCA1"
     . SPARSER::COLLECTION)
    ("Abraxas and HA-FLAG-tagged" . SPARSER::COLLECTION)
    ("HA-" . SPARSER::PROTEIN)
    ("a Myc-tagged full-length BRCA1 and a HA-tagged wild-type BRCT fragment"
     . SPARSER::COLLECTION)
    ("BRCA1 and a mutant BRCA1 BRCT fragment" . SPARSER::COLLECTION)
    ("FLAG-BRCA1" . SPARSER::COLLECTION)
    ("differentially Myc- or FLAG-tagged BRCA1 full-length protein"
     . SPARSER::COLLECTION)
    ("Myc-" . SPARSER::PROTEIN) ("IRIF" . SPARSER::PROTEIN)
    ("foci (IRIF)" . SPARSER::PROTEIN)
    ("the dimer and the peak" . SPARSER::COLLECTION)
    ("BRCT(P1659G)-Abraxas(Y403A)_short complex" . SPARSER::BIO-COMPLEX)
    ("-Abraxas" . SPARSER::COLLECTION)
    ("peptide and Ab2p" . SPARSER::COLLECTION)
    ("proline or aspartic acid" . SPARSER::COLLECTION)
    ("β2-β2" . SPARSER::COLLECTION)
    ("BRCT-Bach1 and BRCT-CtIP" . SPARSER::COLLECTION)
    ("peptide or phosphopeptide" . SPARSER::COLLECTION)
    ("a possible higher order BRCT-Ab2p complex" . SPARSER::BIO-COMPLEX)
    ("Dimer" . SPARSER::DIMER) ("Forms" . SPARSER::FORM)
    ("the monomeric BRCT/Abraxas complex" . SPARSER::BIO-COMPLEX)
    ("BRCA1/Abraxas" . SPARSER::COLLECTION)
    ("Bach1 and CtIP" . SPARSER::COLLECTION)
    ("form and collision" . SPARSER::COLLECTION) ("fix" . SPARSER::PROTEIN)
    ("tetrapeptides" . SPARSER::MOLECULE)
    ("ATR, DNA-PK, Chk1, or Chk2" . SPARSER::COLLECTION)
    ("Abraxas and the BRCA1-A complex ( xref )" . SPARSER::COLLECTION)
    ("RpS" . SPARSER::PROTEIN) ("chromatin and BRCA1" . SPARSER::COLLECTION)
    ("Abraxas and BRCA1" . SPARSER::COLLECTION)
    ("Abraxas-BRCA1" . SPARSER::COLLECTION)
    ("Abraxas and the BRCA1-A complex" . SPARSER::COLLECTION)
    ("RNF8/RNF168" . SPARSER::COLLECTION) ("lys" . SPARSER::PROTEIN)
    ("BRCT/Abraxas" . SPARSER::PROTEIN)
    ("BRE, and Rap80" . SPARSER::COLLECTION)
    ("NBA1/MERIT40" . SPARSER::COLLECTION) ("BRE" . SPARSER::PROTEIN)
    ("serine and phenylalanine" . SPARSER::COLLECTION)
    ("mediators, and effector" . SPARSER::COLLECTION)
    ("BRCA1-BRCT/Abraxas" . SPARSER::PROTEIN-PAIR)
    ("Abraxas, Bach1/FancJ, and CtIP" . SPARSER::COLLECTION)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phenylalanine" . SPARSER::AMINO-ACID) ("A–3D" . SPARSER::PROTEIN)
    ("glutamic acid" . SPARSER::AMINO-ACID) ("E–2" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN) ("Ubc13" . SPARSER::PROTEIN)
    ("Pad1" . SPARSER::PROTEIN) ("Mpr1" . SPARSER::PROTEIN)
    ("Rap80" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MERIT40" . SPARSER::PROTEIN)
    ("NBA1" . SPARSER::PROTEIN) ("BRCC36" . SPARSER::PROTEIN)
    ("Bach1" . SPARSER::PROTEIN) ("ER/HER2" . SPARSER::COLLECTION)
    ("JAK2 inhibitors and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("Cyclophosphamide" . SPARSER::DRUG)
    ("mTOR, JAK2, and STAT3" . SPARSER::COLLECTION)
    ("anthracycline and taxane-based chemotherapy" . SPARSER::COLLECTION)
    ("the pro-invasive cytokine IL-6" . SPARSER::PROTEIN)
    ("representative inflammatory cytokines" . SPARSER::PROTEIN)
    ("pS6 (55.6%) and pSTAT3 (71.4%)" . SPARSER::COLLECTION)
    ("pS6 (81.3%), pJAK2 (63.6%) and IL6 (53.1%)" . SPARSER::COLLECTION)
    ("pS6, pJAK2, pSTAT3, IL6 and CD163" . SPARSER::COLLECTION)
    ("pS6, pJAK2, STAT3, IL6, CD68 and CD163" . SPARSER::COLLECTION)
    ("endocrine and anti-HER2" . SPARSER::COLLECTION)
    ("anthracycline" . SPARSER::MOLECULE)
    ("pS6, pJAK2, pSTAT3, CD68, CD163 and IL-6" . SPARSER::COLLECTION)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("mTOR inhibitors in IDC and/or IBC" . SPARSER::COLLECTION)
    ("/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("IL-6/IL-8" . SPARSER::COLLECTION) ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("a regulator of cytokines interleukin-6 (IL-6) and IL-8 xref"
     . SPARSER::COLLECTION)
    ("E-cadherin and RhoC" . SPARSER::COLLECTION) ("eIF4GI" . SPARSER::PROTEIN)
    ("a dual HER2 and epidermal growth factor receptor (EGFR) inhibitor"
     . SPARSER::INHIBITOR)
    ("HER2 and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("Lapatinib" . SPARSER::DRUG)
    ("the monoclonal anti-HER2 antibody trastuzumab" . SPARSER::DRUG)
    ("an uncommon and aggressive form" . SPARSER::FORM)
    ("pS6 and pJAK2" . SPARSER::COLLECTION)
    ("pS6, pJAK2, pSTAT3 and IL6" . SPARSER::COLLECTION)
    ("CD68 (monocytes, macrophages) and CD163 (TAMs)" . SPARSER::COLLECTION)
    ("WISP3" . SPARSER::PROTEIN) ("MUC-1" . SPARSER::PROTEIN)
    ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("a drug’s" . SPARSER::DRUG)
    ("AKT and HIF1α" . SPARSER::COLLECTION) ("nucleoside" . SPARSER::MOLECULE)
    ("AKT and ERK" . SPARSER::COLLECTION) ("ERK and AKT" . SPARSER::COLLECTION)
    ("using western blot" . SPARSER::PROTEIN)
    ("FRAX597 or gemcitabine" . SPARSER::COLLECTION)
    ("FRAX597 and gemcitabine" . SPARSER::COLLECTION)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("PAK2 and PAK3" . SPARSER::COLLECTION)
    ("preferentially target group 1 PAKs" . SPARSER::PROTEIN-FAMILY)
    ("RET, YES1, TEK, and CSF1R" . SPARSER::COLLECTION)
    ("TEK" . SPARSER::PROTEIN) ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("a transmembrane mucin" . SPARSER::PROTEIN) ("mucin" . SPARSER::PROTEIN)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("Cdc42 and Rac" . SPARSER::COLLECTION)
    ("Gemcitabine" . SPARSER::DRUG) ("a 37 " . SPARSER::PROTEIN)
    ("NF2" . SPARSER::PROTEIN) ("PAK3" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("YES1" . SPARSER::PROTEIN)
    ("MUC13" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("FRAX597" . SPARSER::DRUG) ("moAbs" . SPARSER::DRUG)
    ("Alk2" . SPARSER::PROTEIN) ("BMP" . SPARSER::PROTEIN)
    ("RUNX2 and OSX" . SPARSER::COLLECTION) ("OSX" . SPARSER::PROTEIN)
    ("RUNX2 , DLX5 and BGLAP" . SPARSER::COLLECTION)
    ("NFkB" . SPARSER::PROTEIN) ("BMP4 and BMP7" . SPARSER::COLLECTION)
    ("osteogenic differentiation cues" . SPARSER::PROTEIN-FAMILY)
    ("the respective cytokines" . SPARSER::PROTEIN)
    ("RUNX2, DLX5 , BGLAP and ALPL" . SPARSER::COLLECTION)
    ("CD200 and ALPL" . SPARSER::COLLECTION)
    ("their osteoblastic state" . SPARSER::BIO-STATE)
    ("nearly all CD200 pos cells co‐expressed ALPL" . SPARSER::PROTEIN)
    ("ALPL" . SPARSER::PROTEIN)
    ("the respective molecules" . SPARSER::MOLECULE)
    ("BMPs" . SPARSER::PROTEIN)
    ("Bone morphogenetic proteins" . SPARSER::PROTEIN)
    ("BGLAP" . SPARSER::PROTEIN) ("RUNX2 and DLX5" . SPARSER::COLLECTION)
    ("osteogenic cues" . SPARSER::PROTEIN-FAMILY) ("inCD" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN) ("Fra1" . SPARSER::PROTEIN)
    ("CD200 molecule" . SPARSER::PROTEIN) ("CD200 antigen" . SPARSER::PROTEIN)
    ("DLX5" . SPARSER::PROTEIN) ("RUNX2" . SPARSER::PROTEIN)
    ("CD146" . SPARSER::PROTEIN) ("CD49c" . SPARSER::PROTEIN)
    ("CD49a" . SPARSER::PROTEIN) ("BMP7" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 2" . SPARSER::PROTEIN)
    ("CD200R" . SPARSER::PROTEIN)
    ("bone morphogenetic protein 4" . SPARSER::PROTEIN)
    ("CD200" . SPARSER::PROTEIN)
    ("norepinephrine and epinephrine" . SPARSER::COLLECTION)
    ("epinephrine" . SPARSER::DRUG) ("norepinephrine" . SPARSER::DRUG)
    ("NF1, MAX, RET and TMEM127" . SPARSER::COLLECTION)
    ("the receptor‐type tyrosine‐protein phosphatase zeta (PTPRZ1) and the transmembrane protein 195 (TMEM195)"
     . SPARSER::COLLECTION)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HRAS , VEGFA , and PNMT" . SPARSER::COLLECTION)
    ("HRAS and VEGFA" . SPARSER::COLLECTION) ("PNMT" . SPARSER::PROTEIN)
    ("NF1 and RET" . SPARSER::COLLECTION) ("RAS/RAF" . SPARSER::COLLECTION)
    ("PIK3/AKT/mTOR" . SPARSER::COLLECTION)
    ("NRAS and KRAS" . SPARSER::COLLECTION)
    ("the Harvey rat sarcoma viral oncogene homolog (HRAS) gene"
     . SPARSER::GENE)
    ("VHL , SDHx and EPAS1" . SPARSER::COLLECTION)
    ("MAX, NF1, RET , and TMEM127" . SPARSER::COLLECTION)
    ("Vega" . SPARSER::PROTEIN)
    ("the genes BAP1 (Wadt et al., xref ) and MDH2 (Cascón et al., xref )"
     . SPARSER::COLLECTION)
    ("The currently known susceptibility genes" . SPARSER::GENE)
    ("Bb" . SPARSER::MOLECULE) ("FH" . SPARSER::PROTEIN)
    ("SDHD" . SPARSER::PROTEIN) ("SDHC" . SPARSER::PROTEIN)
    ("SDHA" . SPARSER::PROTEIN) ("SDHB" . SPARSER::PROTEIN)
    ("PGLs" . SPARSER::PROTEIN) ("RET" . SPARSER::PROTEIN)
    ("TMEM195" . SPARSER::PROTEIN)
    ("transmembrane protein 195" . SPARSER::PROTEIN)
    ("PTPRZ1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("KIF1B" . SPARSER::PROTEIN) ("KMT2D" . SPARSER::PROTEIN)
    ("MDH2" . SPARSER::PROTEIN) ("BAP1" . SPARSER::PROTEIN)
    ("TMEM127" . SPARSER::PROTEIN) ("SDHAF2" . SPARSER::PROTEIN)
    ("theranostic biomarkers" . SPARSER::MOLECULE)
    ("extensive intra-" . SPARSER::PROTEIN)
    ("different mutational subtypes" . SPARSER::PROTEIN)
    ("a much larger cohort" . SPARSER::MOLECULE)
    ("very rare mutational subtypes" . SPARSER::PROTEIN)
    ("KIT and other receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("Serious treatment-related AEs" . SPARSER::PROTEIN)
    ("AEs" . SPARSER::PROTEIN) ("PRs" . SPARSER::PROTEIN)
    ("CR " . SPARSER::PROTEIN) ("CR or PR" . SPARSER::COLLECTION)
    ("KIT, PDGFRs, vascular endothelial growth factor (VEGF) receptors (VEGFRs), and several other receptor tyrosine kinases [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("VEGFRs" . SPARSER::PROTEIN) ("PDGFRs" . SPARSER::PROTEIN)
    ("gene and allele" . SPARSER::COLLECTION)
    ("KIT/PDGFRA" . SPARSER::COLLECTION) ("SDH" . SPARSER::PROTEIN)
    ("KIT or PDGFRA" . SPARSER::COLLECTION)
    ("pre-imatinib, post-imatinib/pre-sunitinib, or post-sunitinib"
     . SPARSER::COLLECTION)
    ("imatinib" . SPARSER::DRUG) ("KIT and PDGFRA" . SPARSER::COLLECTION)
    ("KIT or platelet-derived growth factor" . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("pre-imatinib" . SPARSER::DRUG)
    ("statins or YAP" . SPARSER::COLLECTION)
    ("SIAH2 or the other hypoxia-responsive E3 ligase(s)"
     . SPARSER::COLLECTION)
    ("LATS1 and LATS2" . SPARSER::COLLECTION) ("statin" . SPARSER::MOLECULE)
    ("LAST1" . SPARSER::PROTEIN) ("RAF-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("atorvastatin-" . SPARSER::DRUG)
    ("irinotecan and/or atorvastatin" . SPARSER::COLLECTION)
    ("Atorvastatin" . SPARSER::DRUG)
    ("either atorvastatin (5 μM, 48 h) or pravastatin (10 μM, 48 h)"
     . SPARSER::COLLECTION)
    ("AREG and CTGF" . SPARSER::COLLECTION) ("Statins" . SPARSER::MOLECULE)
    ("p-LAST1" . SPARSER::COLLECTION) ("t-LATS1" . SPARSER::COLLECTION)
    ("p-LATS1" . SPARSER::COLLECTION)
    ("the LATS and MST kinases" . SPARSER::COLLECTION)
    ("MST" . SPARSER::PROTEIN)
    ("atorvastatin or pravastatin" . SPARSER::COLLECTION)
    ("pravastatin" . SPARSER::DRUG) ("atorvastatin" . SPARSER::DRUG)
    ("mevalonate" . SPARSER::PROTEIN)
    ("HMGCR-mevalonate" . SPARSER::COLLECTION) ("Cobalt" . SPARSER::MOLECULE)
    ("the exogenous mutant" . SPARSER::MUTANT)
    ("Hydrochloride" . SPARSER::MOLECULE) ("Pimonidazole" . SPARSER::DRUG)
    ("SN38 and apoptosis in HCC cells" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG) ("hypoxia and normoxia" . SPARSER::COLLECTION)
    ("-normoxia" . SPARSER::COLLECTION)
    ("normoxia (20% O 2 ) and hypoxia (1% O 2 )" . SPARSER::COLLECTION)
    ("hypoxic HCC" . SPARSER::PROTEIN) ("CTGF and AREG" . SPARSER::COLLECTION)
    ("a transcriptional co-factor" . SPARSER::MOLECULE)
    ("the Yes-Associated Protein (YAP)" . SPARSER::PROTEIN)
    ("SN38 and TPT" . SPARSER::COLLECTION) ("TPT" . SPARSER::PROTEIN)
    ("sorafenib [ xref , xref ] and irinotecan [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("statins and irinotecan" . SPARSER::COLLECTION)
    ("prodrug" . SPARSER::DRUG)
    ("either siRNA or the HMGCR inhibitor statins" . SPARSER::COLLECTION)
    ("HMGCR" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("SIAH2" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("large tumor suppressor" . SPARSER::PROTEIN)
    ("MST1" . SPARSER::PROTEIN) ("STE20" . SPARSER::PROTEIN)
    ("HMG-CoA" . SPARSER::DRUG) ("CoCl2" . SPARSER::MOLECULE)
    ("NLE-miRNAs" . SPARSER::COLLECTION)
    ("Mcl-1 and c-Myc" . SPARSER::COLLECTION)
    ("Bcl-2 and Mcl-1" . SPARSER::COLLECTION)
    ("c-Myc and Mcl-1" . SPARSER::COLLECTION)
    ("c-Myc and some Bcl-2 family-related proteins" . SPARSER::COLLECTION)
    ("a strong promoter" . SPARSER::PROMOTER)
    ("miRNA-29a-Myc" . SPARSER::COLLECTION)
    ("a possible tumor suppressor" . SPARSER::SUPPRESSOR)
    ("miRNA and PBS" . SPARSER::COLLECTION)
    ("c-Myc, or co-transfected" . SPARSER::COLLECTION)
    ("AMO-29a" . SPARSER::COLLECTION) ("AMO" . SPARSER::PROTEIN)
    ("dexamethasone, and doxorubicin" . SPARSER::COLLECTION)
    ("MIRA-1" . SPARSER::COLLECTION) ("dexamethasone" . SPARSER::PROTEIN)
    ("MIRA" . SPARSER::PROTEIN) ("34a" . SPARSER::PROTEIN)
    ("miRNA-34a" . SPARSER::COLLECTION)
    ("molecule and drug" . SPARSER::COLLECTION)
    ("particularly PRIMA-1 Met /APR246" . SPARSER::COLLECTION)
    ("/APR246" . SPARSER::COLLECTION) ("APR" . SPARSER::PROTEIN)
    ("miRNA-29a/c-Myc" . SPARSER::COLLECTION)
    ("which targets c-Myc" . SPARSER::PROTEIN) ("29a" . SPARSER::PROTEIN)
    ("miRNA-29a" . SPARSER::COLLECTION) ("CDK9" . SPARSER::PROTEIN)
    ("Myc 3" . SPARSER::PROTEIN) ("PRIMA-1" . SPARSER::PROTEIN)
    ("proto-oncogene c-Myc" . SPARSER::PROTEIN)
    ("adequate reference genes" . SPARSER::GENE)
    ("the dominant KIT -negative leukemia" . SPARSER::PROTEIN)
    ("had achieved hematologic CR" . SPARSER::PROTEIN)
    ("shorter EFS" . SPARSER::PROTEIN) ("EFS" . SPARSER::PROTEIN)
    ("ITD and -TKD and NPM1" . SPARSER::COLLECTION)
    ("ITD and -TKD" . SPARSER::COLLECTION) ("FLT3-" . SPARSER::PROTEIN)
    ("MEMO" . SPARSER::PROTEIN) ("CBFB" . SPARSER::PROTEIN)
    ("CBF" . SPARSER::PROTEIN) ("N-ras" . SPARSER::PROTEIN)
    ("CBFβ" . SPARSER::PROTEIN) ("cytosine arabinoside" . SPARSER::DRUG)
    ("MYH11" . SPARSER::PROTEIN) ("RUNX1" . SPARSER::PROTEIN)
    ("Sp1 and NF-κB" . SPARSER::COLLECTION)
    ("Transcriptional regulators and miRs" . SPARSER::COLLECTION)
    ("suppressor or tumor" . SPARSER::COLLECTION)
    ("c-myc and miR-23b" . SPARSER::COLLECTION)
    ("overexpressing c-myc" . SPARSER::PROTEIN)
    ("c-myc or Sp1" . SPARSER::COLLECTION)
    ("miR-23a and miR-23b in human prostate cancer cells"
     . SPARSER::COLLECTION)
    ("c-myc, NF-kB and Sp1" . SPARSER::COLLECTION)
    ("c-myc/Sp1" . SPARSER::COLLECTION)
    ("IL-6 or supernatant" . SPARSER::COLLECTION)
    ("normal PCs" . SPARSER::PROTEIN)
    ("phosphorylated p65 (RELA) and MAPK (ERK1/2)" . SPARSER::COLLECTION)
    ("p65 (RELA)" . SPARSER::PROTEIN)
    ("Sp1 or a deletion mutant" . SPARSER::COLLECTION)
    ("NC or miR-23b" . SPARSER::COLLECTION)
    ("onco-miRNAs" . SPARSER::COLLECTION)
    ("/transcription factor (TF)" . SPARSER::COLLECTION)
    ("/transcription factor" . SPARSER::COLLECTION)
    ("Transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("b–27" . SPARSER::PROTEIN) ("miR-23a" . SPARSER::MOLECULE)
    ("a  2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD19" . SPARSER::PROTEIN)
    ("CD138" . SPARSER::PROTEIN)
    ("both EGFR and certain GPCR" . SPARSER::COLLECTION)
    ("EGFR and GPCR" . SPARSER::COLLECTION)
    ("ERK, PLC-γ1 and PI3K-Akt" . SPARSER::COLLECTION) ("LPA" . SPARSER::LPA)
    ("EGFR or other RTK" . SPARSER::COLLECTION)
    ("EGFR and TrkB" . SPARSER::COLLECTION) ("TrkB" . SPARSER::PROTEIN)
    ("EGFR and other RTKs" . SPARSER::COLLECTION)
    ("TRIO, BMjX and CHKA" . SPARSER::COLLECTION) ("TRIO" . SPARSER::PROTEIN)
    ("both GABA receptor and its effectors" . SPARSER::COLLECTION)
    ("GABA" . SPARSER::MOLECULE) ("EGFR and ErbB3" . SPARSER::COLLECTION)
    ("TGR5 and EGFR" . SPARSER::COLLECTION)
    ("SSTR1 and SSTR5" . SPARSER::COLLECTION)
    ("GPCR and EGFR" . SPARSER::COLLECTION)
    ("GPRC5A and EGFR" . SPARSER::COLLECTION)
    ("EGFR-STAT3" . SPARSER::COLLECTION) ("GPCR/Src" . SPARSER::COLLECTION)
    ("Ang-" . SPARSER::PROTEIN) ("Ang" . SPARSER::PROTEIN)
    ("angiotensin-" . SPARSER::PROTEIN)
    ("EGFR or other RTKs" . SPARSER::COLLECTION) ("-AR" . SPARSER::COLLECTION)
    ("-adrenoceptors" . SPARSER::COLLECTION)
    ("GPR30/GPER-1" . SPARSER::COLLECTION) ("adrenoceptors" . SPARSER::PROTEIN)
    ("GPER" . SPARSER::PROTEIN) ("GPCR-associated proteins" . SPARSER::PROTEIN)
    ("subunits and β-arrestins" . SPARSER::COLLECTION)
    ("PTPs" . SPARSER::PROTEIN) ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phenylephrine" . SPARSER::DRUG) ("bradykinin" . SPARSER::BRADYKININ)
    ("bombesin" . SPARSER::PROTEIN)
    ("neuregulin, transforming growth factor-α, and amphiregulin"
     . SPARSER::COLLECTION)
    ("disintegrin and metalloprotease" . SPARSER::COLLECTION)
    ("disintegrin" . SPARSER::PROTEIN) ("Trk" . SPARSER::PROTEIN)
    ("dominant-negative EGFR" . SPARSER::PROTEIN)
    ("EGFR and ErbB2" . SPARSER::COLLECTION)
    ("thrombin, and endothelin-1" . SPARSER::COLLECTION)
    ("thrombin" . SPARSER::PROTEIN) ("c-fos and SRF" . SPARSER::COLLECTION)
    ("Raf and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("Shc/Grb2" . SPARSER::COLLECTION)
    ("a short α-helical peptide" . SPARSER::PEPTIDE)
    ("transmembrane RTKs" . SPARSER::PROTEIN)
    ("GPCR and β-arrestins" . SPARSER::COLLECTION)
    ("scaffolds and activator" . SPARSER::COLLECTION)
    ("GPCR kinases (GRKs) and β-arrestins [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("currently only two protein families" . SPARSER::PROTEIN-FAMILY)
    ("GRKs" . SPARSER::PROTEIN)
    ("kinases, phospholipase C, and adenylate" . SPARSER::COLLECTION)
    ("The heterotrimeric G protein" . SPARSER::PROTEIN)
    ("the coupled heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("disulfide" . SPARSER::MOLECULE)
    ("receptors activated by amino acids and ions [ xref ]"
     . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN) ("Secretin" . SPARSER::DRUG)
    ("M2 and M3" . SPARSER::COLLECTION) ("opioid" . SPARSER::PROTEIN)
    ("serotonin" . SPARSER::MOLECULE)
    ("Fungal mating pheromone receptors" . SPARSER::RECEPTOR)
    ("receptors, and Frizzled/Smoothened" . SPARSER::COLLECTION)
    ("pheromone" . SPARSER::MOLECULE) ("Rhodopsin" . SPARSER::PROTEIN)
    ("approximately 800 GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("GPCR and RTKs" . SPARSER::COLLECTION)
    ("G protein-coupled receptors (GPCRs) and receptor-tyrosine kinases (RTKs)"
     . SPARSER::COLLECTION)
    ("GPCR, EGFR and EGFR" . SPARSER::COLLECTION)
    ("GPCRs and RTKs" . SPARSER::COLLECTION)
    ("Both G protein-coupled receptors (GPCRs) and receptor-tyrosine kinases (RTKs)"
     . SPARSER::COLLECTION)
    ("DRD2" . SPARSER::PROTEIN) ("dopamine receptor D2" . SPARSER::PROTEIN)
    ("Cos-7" . SPARSER::PROTEIN) ("P2Y 2" . SPARSER::PROTEIN)
    ("TGR5" . SPARSER::PROTEIN) ("S1P3" . SPARSER::PROTEIN)
    ("S1P" . SPARSER::PROTEIN) ("SSTR5" . SPARSER::PROTEIN)
    ("SSTR1" . SPARSER::PROTEIN) ("kisspeptin-10" . SPARSER::PROTEIN)
    ("GPRC5A" . SPARSER::PROTEIN) ("urotensin-II" . SPARSER::MOLECULE)
    ("GPR87" . SPARSER::PROTEIN) ("GPR48" . SPARSER::PROTEIN)
    ("GPR109A" . SPARSER::PROTEIN) ("GPR101" . SPARSER::PROTEIN)
    ("BRS-3" . SPARSER::PROTEIN)
    ("bombesin receptor subtype-3" . SPARSER::PROTEIN)
    ("B2R" . SPARSER::PROTEIN) ("FPRL1" . SPARSER::PROTEIN)
    ("formyl peptide receptor" . SPARSER::PROTEIN)
    ("p47phox" . SPARSER::PROTEIN) ("endothelin 1" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("Rat-1" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("Elk-1" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLC-γ1" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("ErbB3" . SPARSER::PROTEIN)
    ("ErbB1" . SPARSER::PROTEIN) ("β-arrestins" . SPARSER::PROTEIN)
    ("class C" . SPARSER::PROTEIN) ("class B" . SPARSER::PROTEIN)
    ("5-HT2B" . SPARSER::PROTEIN) ("Secretin receptor" . SPARSER::PROTEIN)
    ("a classic G1/S cell cycle-related protein" . SPARSER::PROTEIN)
    ("CCK8 and transwell" . SPARSER::COLLECTION)
    ("CDKN1A , CDKN1B , or CCND1" . SPARSER::COLLECTION)
    ("sh-" . SPARSER::PROTEIN-FAMILY) ("ZYG11A" . SPARSER::PROTEIN)
    ("si-ZYG11A" . SPARSER::PROTEIN-PAIR) ("si-" . SPARSER::PROTEIN)
    ("siRNA-2" . SPARSER::COLLECTION) ("SPC-A-1" . SPARSER::COLLECTION)
    ("SPC" . SPARSER::PROTEIN)
    ("PITX2 , HOXC13 , and BARX1" . SPARSER::COLLECTION)
    ("homologues, ZYG11A , ZYG11B and ZER1" . SPARSER::COLLECTION)
    ("cullin-2" . SPARSER::PROTEIN) ("A-1" . SPARSER::PROTEIN)
    ("interleukin 1" . SPARSER::PROTEIN) ("DLL3" . SPARSER::PROTEIN)
    ("HOXC13" . SPARSER::PROTEIN) ("PITX2" . SPARSER::PROTEIN)
    ("p-ERK and KRAS" . SPARSER::COLLECTION) ("Oxaliplatin" . SPARSER::DRUG)
    ("Ning" . SPARSER::PROTEIN-FAMILY) ("E6-E7-st" . SPARSER::PROTEIN)
    ("CXCR2 receptor as well as its ligands inKRAS (G12D)"
     . SPARSER::COLLECTION)
    ("CXCR2 macromolecular signaling complex" . SPARSER::BIO-COMPLEX)
    ("anti-CXCL8 or anti-CXCL1" . SPARSER::COLLECTION)
    ("CXCR2 and its ligands CXCL1" . SPARSER::COLLECTION)
    ("PDAC, and iii" . SPARSER::COLLECTION)
    ("polymorphonuclear leukocytes" . SPARSER::PROTEIN)
    ("KRAS and p-ERK" . SPARSER::COLLECTION)
    ("Monoclonal neutralizing antibody" . SPARSER::ANTIBODY)
    ("E6-E7-st-KRAS" . SPARSER::COLLECTION) ("HPNE-KRAS" . SPARSER::COLLECTION)
    ("E6-E7-st/-KRAS" . SPARSER::COLLECTION)
    ("HPNE/-KRAS" . SPARSER::COLLECTION)
    ("Cxcr2 and Cxcl1" . SPARSER::COLLECTION) ("Cxcl1" . SPARSER::PROTEIN)
    ("Cxcr2" . SPARSER::PROTEIN)
    ("cytokeratin and mCXCR2" . SPARSER::COLLECTION)
    ("CXCR2 and its ligands" . SPARSER::COLLECTION)
    ("the CXCR2 macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("CXCL1 and CXCL8" . SPARSER::COLLECTION)
    ("both CXCR2 and its ligands" . SPARSER::COLLECTION)
    ("CXCL5 and CXCL8" . SPARSER::COLLECTION)
    ("a seven transmembrane G-protein coupled receptor (GPCR)"
     . SPARSER::PROTEIN)
    ("Chemokines" . SPARSER::PROTEIN)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("the aberrant RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glycine" . SPARSER::AMINO-ACID) ("KRAS-CXCR2" . SPARSER::COLLECTION)
    ("Pdx1-cre" . SPARSER::COLLECTION) ("cre" . SPARSER::PROTEIN)
    ("A’" . SPARSER::PROTEIN) ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("Ptf1a" . SPARSER::PROTEIN) ("SCH-527123" . SPARSER::DRUG)
    ("CD18" . SPARSER::PROTEIN) ("CXCL8" . SPARSER::PROTEIN)
    ("CXCL5" . SPARSER::PROTEIN) ("CXCR1" . SPARSER::PROTEIN)
    ("CXCL6" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("CXCL1-3" . SPARSER::PROTEIN) ("Interleukin 4" . SPARSER::PROTEIN)
    ("Aspartic acid" . SPARSER::AMINO-ACID) ("CXCR2" . SPARSER::PROTEIN)
    ("our Western blot" . SPARSER::PROTEIN)
    ("a multiplex autism family" . SPARSER::PROTEIN-FAMILY)
    ("ErbB4 or other neurotransmitter receptors" . SPARSER::COLLECTION)
    ("ErbB4" . SPARSER::PROTEIN)
    ("group 1 metabotropic glutamate receptors" . SPARSER::RECEPTOR)
    ("p110β or p110δ" . SPARSER::COLLECTION) ("p110β-" . SPARSER::PROTEIN)
    ("p110δ and p110β" . SPARSER::COLLECTION)
    ("an attractive potential treatment target" . SPARSER::TARGET-PROTEIN)
    ("p110α, p110β, p110γ, and p110δ" . SPARSER::COLLECTION)
    ("NF-1" . SPARSER::PROTEIN)
    ("monogenic and idiopathic forms" . SPARSER::FORM)
    ("target, and biomarker" . SPARSER::COLLECTION)
    ("Easily assessable biomarkers" . SPARSER::MOLECULE)
    ("p110α, p110β, or p110δ" . SPARSER::COLLECTION)
    ("CTR and CTR-2" . SPARSER::COLLECTION) ("CTR" . SPARSER::PROTEIN)
    ("cortical malformations" . SPARSER::PROTEIN) ("p110γ" . SPARSER::PROTEIN)
    ("A-4" . SPARSER::PROTEIN) ("diC8" . SPARSER::DRUG)
    ("TGX-221" . SPARSER::DRUG) ("A1-A" . SPARSER::PROTEIN)
    ("p110β" . SPARSER::PROTEIN) ("IC87114" . SPARSER::MOLECULE)
    ("p110δ" . SPARSER::PROTEIN)
    ("a very attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("AR and RTK" . SPARSER::COLLECTION)
    ("NRF2 and HER2" . SPARSER::COLLECTION)
    ("HO-1 and pNRF2" . SPARSER::COLLECTION)
    ("their proximal promoter" . SPARSER::PROMOTER)
    ("individually both NRF2 and KEAP1 genes" . SPARSER::GENE)
    ("NRF2 and KEAP1" . SPARSER::COLLECTION)
    ("immunotherapeutic agents Pertuzumab and Trastuzumab"
     . SPARSER::COLLECTION)
    ("HER2, HER3, and pAKT" . SPARSER::COLLECTION)
    ("NRF-AR" . SPARSER::COLLECTION) ("NRF" . SPARSER::PROTEIN)
    ("NRF2 and ROS" . SPARSER::COLLECTION)
    ("the receptors and their downstream substrate" . SPARSER::COLLECTION)
    ("cis-" . SPARSER::PROTEIN) ("total basal ROS" . SPARSER::PROTEIN)
    ("phospho-NRF2 and HO-1" . SPARSER::COLLECTION)
    ("these monoclonal antibodies" . SPARSER::ANTIBODY)
    ("HER2-targeted monoclonal antibodies" . SPARSER::ANTIBODY)
    ("BID" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("p44/p22" . SPARSER::COLLECTION) ("p22" . SPARSER::PROTEIN)
    ("HER2 and pAKT" . SPARSER::COLLECTION)
    ("5% charcoal stripped FBS and 1 nmol/L Heregulin (HRG)"
     . SPARSER::COLLECTION)
    ("Heregulin (HRG)" . SPARSER::PROTEIN)
    ("5% charcoal stripped FBS" . SPARSER::PROTEIN) ("HRG" . SPARSER::PROTEIN)
    ("Heregulin" . SPARSER::PROTEIN)
    ("HER2-targeted immunotherapeutic agents Pertuzumab and Trastuzumab"
     . SPARSER::COLLECTION)
    ("Pertuzumab and Trastuzumab" . SPARSER::COLLECTION)
    ("inhibitory monoclonal antibodies" . SPARSER::ANTIBODY)
    ("AR and HER2/HER3" . SPARSER::COLLECTION)
    ("NRF2-AR" . SPARSER::COLLECTION) ("PI3K and MAPK" . SPARSER::COLLECTION)
    ("trigger both the AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a very robust antioxidant" . SPARSER::PROTEIN)
    ("antioxidant response elements (ARE) or electrophile response elements (EpREs)"
     . SPARSER::COLLECTION)
    ("response elements (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("detoxification enzymes and cytoprotective genes [ xref – xref ] as well as other genes"
     . SPARSER::COLLECTION)
    ("cytoprotective genes [ xref – xref ] as well as other genes"
     . SPARSER::COLLECTION)
    ("a leucine zipper transcription factor and the master regulator"
     . SPARSER::COLLECTION)
    ("HER2/HER3 receptors and their ligands" . SPARSER::COLLECTION)
    ("HER2-HER3" . SPARSER::COLLECTION)
    ("these heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("EGFR, HER3, and HER4" . SPARSER::COLLECTION)
    ("coreceptor" . SPARSER::PROTEIN)
    ("active homodimer and heterodimer" . SPARSER::COLLECTION)
    ("homodimer and heterodimer" . SPARSER::COLLECTION)
    ("HER1, HER2, HER3, and HER4" . SPARSER::COLLECTION)
    ("EGFR or HER" . SPARSER::COLLECTION)
    ("MAPK, and STAT" . SPARSER::COLLECTION)
    ("the intrinsic tyrosine kinase" . SPARSER::PROTEIN)
    ("a relevant anticancer target" . SPARSER::TARGET-PROTEIN)
    ("monoclonal antibodies, Pertuzumab and Trastuzumab" . SPARSER::COLLECTION)
    ("antibodies, Pertuzumab and Trastuzumab" . SPARSER::COLLECTION)
    ("Pertuzumab" . SPARSER::DRUG)
    ("receptors, HER2 and HER3" . SPARSER::COLLECTION) ("tBHQ" . SPARSER::DRUG)
    ("NRF2 and growth factor" . SPARSER::COLLECTION)
    ("an essential transcription factor" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN) ("Beta-actin" . SPARSER::PROTEIN)
    ("1-2 " . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide"
     . SPARSER::MOLECULE)
    ("Tert-butylhydroquinone" . SPARSER::DRUG)
    ("tert -butylhydroquinone" . SPARSER::DRUG) ("GHL" . SPARSER::PROTEIN)
    ("YL" . SPARSER::PROTEIN) ("HP and JZ" . SPARSER::COLLECTION)
    ("HP, DG, and XL" . SPARSER::COLLECTION)
    ("SNF2H, a chromatin remodeler, and other DNA repair factors"
     . SPARSER::COLLECTION)
    ("RNAP II complex and the depletion of SIRT6" . SPARSER::COLLECTION)
    ("HIF1α, c-JUN, and NF-κB" . SPARSER::COLLECTION)
    ("the NRF2-SIRT6-RNAP II complex" . SPARSER::BIO-COMPLEX)
    ("NRF2-SIRT6-RNAP" . SPARSER::COLLECTION)
    ("SIRT6-NRF2" . SPARSER::COLLECTION)
    ("chemical or physical stressors" . SPARSER::COLLECTION)
    ("toxins" . SPARSER::MOLECULE) ("SIRT6-NRF2-HO-1" . SPARSER::COLLECTION)
    ("WT SIRT6 instead of the H133Y mutant" . SPARSER::COLLECTION)
    ("HO-1, AKR1C1, and PTGS2" . SPARSER::COLLECTION)
    ("NRF2-RNAP II transcription complex" . SPARSER::BIO-COMPLEX)
    ("NRF2-RNAP" . SPARSER::COLLECTION)
    ("SIRT6 and RNAP" . SPARSER::COLLECTION)
    ("RNA polymerase II (RNAP II) and TAF II-p135" . SPARSER::COLLECTION)
    ("RNAP II complex" . SPARSER::BIO-COMPLEX) ("RNAP" . SPARSER::PROTEIN)
    ("-NRF2" . SPARSER::PROTEIN)
    ("the classic ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("HIF1α, c-MYC, c-JUN, and NF-κB" . SPARSER::COLLECTION)
    ("119 upregulated genes and 246 downregulated genes" . SPARSER::COLLECTION)
    ("genome-wide RNA" . SPARSER::RNA) ("ROS and DNA" . SPARSER::COLLECTION)
    ("-deoxyguanosine" . SPARSER::MOLECULE)
    ("deoxyguanosine" . SPARSER::MOLECULE) ("paraquat" . SPARSER::MOLECULE)
    ("thioredoxin and inducer" . SPARSER::COLLECTION)
    ("exogenous SIRT6" . SPARSER::PROTEIN)
    ("P16 and P21 proteins" . SPARSER::COLLECTION)
    ("-β-Gal" . SPARSER::COLLECTION) ("SIRT6 and hMSC" . SPARSER::COLLECTION)
    ("CD73, CD90, and CD105" . SPARSER::COLLECTION)
    ("CD45, CD34 and CD43" . SPARSER::COLLECTION)
    ("antigens" . SPARSER::PROTEIN) ("nuclease (TALEN)" . SPARSER::PROTEIN)
    ("NRF2-HO-1" . SPARSER::COLLECTION)
    ("NF-κB, HIF1α, and c-JUN" . SPARSER::COLLECTION)
    ("homologues" . SPARSER::PROTEIN)
    ("both nuclear factor erythroid 2-related factor 2 (NRF2) and RNA polymerase II"
     . SPARSER::COLLECTION)
    ("H2DCFDA" . SPARSER::DRUG) ("FOXA2" . SPARSER::PROTEIN)
    ("AAT2" . SPARSER::PROTEIN) ("β-GAL" . SPARSER::PROTEIN)
    ("Mitomycin C" . SPARSER::DRUG) ("SNF2H" . SPARSER::PROTEIN)
    ("AKR1C1" . SPARSER::PROTEIN) ("HMOX1" . SPARSER::PROTEIN)
    ("P21 proteins" . SPARSER::PROTEIN) ("β-Gal" . SPARSER::PROTEIN)
    ("CD43" . SPARSER::PROTEIN) ("K56" . SPARSER::PROTEIN)
    ("Sirt6" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SIRT6" . SPARSER::PROTEIN)
    ("HIF-1α and SIRT1" . SPARSER::COLLECTION)
    ("neurotoxicant" . SPARSER::MOLECULE)
    ("LPS or MPP +" . SPARSER::COLLECTION) ("DA" . SPARSER::MOLECULE)
    ("valproate" . SPARSER::DRUG) ("normal oxygen" . SPARSER::MOLECULE)
    ("normoxic state" . SPARSER::BIO-STATE)
    ("HIF-1α and its downstream target genes" . SPARSER::COLLECTION)
    ("si-SIRT1" . SPARSER::COLLECTION) ("siRNA-SIRT1" . SPARSER::COLLECTION)
    ("siRNA and MPP +" . SPARSER::COLLECTION)
    ("siRNA or MPP +" . SPARSER::COLLECTION)
    ("HIF-1α and HIF-1 β" . SPARSER::COLLECTION)
    ("genes, pathways and proteins" . SPARSER::COLLECTION)
    ("acetyltransferases (HAT)" . SPARSER::PROTEIN)
    ("histones and many non-histones" . SPARSER::COLLECTION)
    ("PPARs" . SPARSER::PROTEIN) ("synuclein" . SPARSER::PROTEIN)
    ("neurotoxin" . SPARSER::PROTEIN) ("SIRT1/HIF-1α" . SPARSER::COLLECTION)
    ("phenformin" . SPARSER::DRUG)
    ("HIF-1α and its target genes VEGFA and LDHA" . SPARSER::COLLECTION)
    ("VEGFA and LDHA" . SPARSER::COLLECTION) ("LDHA" . SPARSER::PROTEIN)
    ("SIRT1 and HIF-1α" . SPARSER::COLLECTION) ("HIF-1 β" . SPARSER::PROTEIN)
    ("Hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("Nrf-2" . SPARSER::PROTEIN) ("HIF-1a" . SPARSER::PROTEIN)
    ("MPP +" . SPARSER::MOLECULE)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("defective DDR" . SPARSER::PROTEIN) ("p97 or RNF4" . SPARSER::COLLECTION)
    ("proper DDR" . SPARSER::PROTEIN) ("KAP1 and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1 and RAD51" . SPARSER::COLLECTION)
    ("BRCA1/RAD51" . SPARSER::COLLECTION)
    ("RPA2 and the other 2 RPA subunits form complex" . SPARSER::COLLECTION)
    ("KAP1 or RNF4" . SPARSER::COLLECTION)
    ("RNF4 or KAP1" . SPARSER::COLLECTION)
    ("KAP1 and RNF4" . SPARSER::COLLECTION)
    ("53BP1 or BRCA1" . SPARSER::COLLECTION)
    ("DNA damage-induced pS824-KAP1 and BRCA1 foci" . SPARSER::PROTEIN)
    ("RNF4 and p97" . SPARSER::COLLECTION) ("DVC1-p97" . SPARSER::COLLECTION)
    ("-SIM-ARM" . SPARSER::COLLECTION) ("opts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK2 or CDK4" . SPARSER::COLLECTION)
    ("the complete media" . SPARSER::PROTEIN)
    ("iii and iv" . SPARSER::COLLECTION) ("ARM" . SPARSER::PROTEIN)
    ("DDR-protein" . SPARSER::COLLECTION)
    ("KRAB domain-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAB" . SPARSER::PROTEIN-FAMILY)
    ("SUMO or SUMO-like" . SPARSER::COLLECTION)
    ("SUMO and ubiquitin" . SPARSER::COLLECTION)
    ("RNF4-KAP1" . SPARSER::COLLECTION) ("foci and RNF4" . SPARSER::COLLECTION)
    ("RNF4 and KAP1" . SPARSER::COLLECTION) ("DR5" . SPARSER::PROTEIN)
    ("Phenol red" . SPARSER::DRUG) ("Npl4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ufd1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DVC1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("RING finger protein" . SPARSER::PROTEIN)
    ("CD151 and P2X7" . SPARSER::COLLECTION)
    ("MTA2 and midkine" . SPARSER::COLLECTION) ("MDK" . SPARSER::PROTEIN)
    ("GC/GT" . SPARSER::COLLECTION) ("a unique first exon" . SPARSER::PROTEIN)
    ("Sp1 and TIAM2S" . SPARSER::COLLECTION)
    ("a Western blot" . SPARSER::PROTEIN)
    ("DNA and input" . SPARSER::COLLECTION)
    ("the anti‐Sp1 antibody or rabbit IgG" . SPARSER::COLLECTION)
    ("the minimal core promoter" . SPARSER::PROMOTER)
    ("CCAAT" . SPARSER::PROTEIN) ("EPD" . SPARSER::PROTEIN)
    ("TGF" . SPARSER::DRUG) ("KLF" . SPARSER::PROTEIN)
    ("androgen receptor ( AR )" . SPARSER::PROTEIN)
    ("about approximately 626 amino acids" . SPARSER::AMINO-ACID)
    ("Rac1 and EMT" . SPARSER::COLLECTION) ("PRF" . SPARSER::PROTEIN)
    ("MTA2" . SPARSER::PROTEIN) ("Gata1" . SPARSER::PROTEIN)
    ("pGL3B" . SPARSER::MOLECULE) ("pSp1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Transcription Factor" . SPARSER::PROTEIN) ("RNF4" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("TIAM1" . SPARSER::PROTEIN)
    ("TIAM2" . SPARSER::PROTEIN) ("SIN3A, or MAZ" . SPARSER::COLLECTION)
    ("CTCF" . SPARSER::PROTEIN) ("Cs" . SPARSER::PROTEIN)
    ("ATG" . SPARSER::DRUG) ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("an aggressive form" . SPARSER::FORM)
    ("the multimeric GA-binding protein transcription factor"
     . SPARSER::PROTEIN)
    ("whose catalytic subunit" . SPARSER::PROTEIN) ("SIN3A" . SPARSER::PROTEIN)
    ("(Beta" . SPARSER::PROTEIN) ("chr5" . SPARSER::PROTEIN)
    ("GA-binding protein transcription factor" . SPARSER::PROTEIN)
    ("an unusual rocaglate derivative" . SPARSER::DERIVATIVE)
    ("the specific translational inhibitor" . SPARSER::INHIBITOR)
    ("another translational inhibitor" . SPARSER::INHIBITOR)
    ("a strong autophagy inducer" . SPARSER::MOLECULE)
    ("condensation and caspase-3" . SPARSER::COLLECTION)
    ("the early autophagy pathway components as well as caspase-mediated apoptosis"
     . SPARSER::COLLECTION)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("-ATPase" . SPARSER::COLLECTION)
    ("silvestrol or SAHA" . SPARSER::COLLECTION)
    ("EGFP-LC3" . SPARSER::COLLECTION) ("MDC" . SPARSER::PROTEIN)
    ("monodansylcadaverine" . SPARSER::DRUG)
    ("LC3 and p62" . SPARSER::COLLECTION)
    ("Autophagic mRNA LC3B and p62" . SPARSER::COLLECTION)
    ("LC3B and p62" . SPARSER::COLLECTION)
    ("silvestrol and HHT" . SPARSER::COLLECTION)
    ("caspase 3 or PARP" . SPARSER::COLLECTION)
    ("a luminogenic substrate" . SPARSER::SUBSTRATE)
    ("caspase-3, -6, and -7 [ xref ]" . SPARSER::COLLECTION)
    ("the identified major caspases" . SPARSER::PROTEIN)
    ("vinblastine" . SPARSER::DRUG)
    ("cyclin B1 and cyclin D1" . SPARSER::COLLECTION)
    ("homoharringtonine" . SPARSER::DRUG)
    ("cyclin D and Mcl-1" . SPARSER::COLLECTION) ("Atg5" . SPARSER::PROTEIN)
    ("proteins or organelles" . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN)
    ("proteins or intracellular organelles [ xref ]" . SPARSER::COLLECTION)
    ("Therapeutics" . SPARSER::THERAPEUTICS)
    ("paclitaxel or camptothecin" . SPARSER::COLLECTION)
    ("rocaglamide" . SPARSER::DRUG) ("benzofurans" . SPARSER::DRUG)
    ("rain" . SPARSER::PROTEIN) ("secondary metabolites" . SPARSER::PROTEIN)
    ("fungi" . SPARSER::PROTEIN)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("epidermal growth factor receptor (EGFR) and MET" . SPARSER::COLLECTION)
    ("BRAF and small G proteins" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION)
    ("silvestrol and SAHA" . SPARSER::COLLECTION)
    ("nucleosomal fragments" . SPARSER::FRAGMENT)
    ("silvestrol" . SPARSER::DRUG) ("benzofuran" . SPARSER::DRUG)
    ("Silvestrol" . SPARSER::DRUG) ("TRAF6" . SPARSER::PROTEIN)
    ("Bafilomycin A1" . SPARSER::DRUG) ("acridine orange" . SPARSER::MOLECULE)
    ("Suberoylanilide hydroxamic acid" . SPARSER::MOLECULE)
    ("Atg12" . SPARSER::PROTEIN) ("Atg6" . SPARSER::PROTEIN)
    ("Beclin 1" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("honokiol, NAC and DPI" . SPARSER::COLLECTION)
    ("honokiol, NAC or DPI" . SPARSER::COLLECTION)
    ("particular MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("membrane-bound and cytosolic proteins" . SPARSER::COLLECTION)
    ("p22 phox (membrane-bound) and p47 phox (cytosolic protein)"
     . SPARSER::COLLECTION)
    ("p47 phox , p40 phox and p67 phox" . SPARSER::COLLECTION)
    ("cytosolic protein (i.e., p47 phox ) and membrane-bound protein (i. e. , p22 phox )"
     . SPARSER::COLLECTION)
    ("p47 phox and p22 phox" . SPARSER::COLLECTION)
    ("honokiol and NAC" . SPARSER::COLLECTION)
    ("Nox1, MMP-2 and MMP-9" . SPARSER::COLLECTION) ("DPI" . SPARSER::PROTEIN)
    ("a well-known antioxidant and scavenger" . SPARSER::COLLECTION)
    ("The major gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SK-Mel119" . SPARSER::COLLECTION) ("Mel119" . SPARSER::PROTEIN)
    ("SK-Mel 119" . SPARSER::PROTEIN-PAIR) ("Honokiol" . SPARSER::DRUG)
    ("Bioactive phytochemicals" . SPARSER::DRUG)
    ("superoxide or hydrogen peroxide" . SPARSER::COLLECTION)
    ("p22 phox and p47 phox" . SPARSER::COLLECTION)
    ("diphenyleneiodonium" . SPARSER::DRUG) ("Mel" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("phytochemical" . SPARSER::DRUG)
    ("honokiol" . SPARSER::DRUG) ("Nox1" . SPARSER::PROTEIN)
    ("FL-1" . SPARSER::PROTEIN) ("N-Acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("gp91 phox" . SPARSER::PROTEIN) ("p67 phox" . SPARSER::PROTEIN)
    ("p40 phox" . SPARSER::PROTEIN) ("Nox-1" . SPARSER::PROTEIN)
    ("p47 phox" . SPARSER::PROTEIN) ("p22 phox" . SPARSER::PROTEIN)
    ("N-acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("HDACs and DNA" . SPARSER::COLLECTION)
    ("HDACs and serine/threonine kinases" . SPARSER::COLLECTION)
    ("K23, and mono-methylated" . SPARSER::COLLECTION)
    ("the tryptic peptides" . SPARSER::PEPTIDE)
    ("methyltransferases and acetyltransferases" . SPARSER::COLLECTION)
    ("the nucleosomal DNA" . SPARSER::DNA)
    ("H2A and H2B" . SPARSER::COLLECTION) ("H2A-H2B" . SPARSER::COLLECTION)
    ("Histones" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("K11" . SPARSER::PROTEIN) ("lncRNAs and tumors" . SPARSER::COLLECTION)
    ("si" . SPARSER::PROTEIN) ("si-NC" . SPARSER::COLLECTION)
    ("a potential oncogene or a candidate tumor suppressor"
     . SPARSER::COLLECTION)
    ("VLDLR, PVT1, and GAS5" . SPARSER::COLLECTION)
    ("VLDLR" . SPARSER::PROTEIN) ("LincRNAs" . SPARSER::RNA)
    ("LncRNA" . SPARSER::RNA) ("reliable biomarkers" . SPARSER::MOLECULE)
    ("many HCC-associated deregulated genes and signaling pathways"
     . SPARSER::COLLECTION)
    ("genes and signaling pathways" . SPARSER::COLLECTION)
    ("cytometry, and transwell" . SPARSER::COLLECTION)
    ("diphenyl" . SPARSER::DRUG) ("BANCR" . SPARSER::RNA)
    ("RNA (BANCR)" . SPARSER::RNA) ("RR 2" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("GAS5" . SPARSER::PROTEIN) ("PVT1" . SPARSER::PROTEIN)
    ("MALAT1" . SPARSER::PROTEIN) ("FoxC2 and E-caherin" . SPARSER::COLLECTION)
    ("the two histological subtypes" . SPARSER::PROTEIN)
    ("a strong repressor" . SPARSER::REPRESSOR) ("Foxc2" . SPARSER::PROTEIN)
    ("a shorter RFS" . SPARSER::PROTEIN) ("pN1-2" . SPARSER::COLLECTION)
    ("pT1 and pT2-4" . SPARSER::COLLECTION) ("Nodal" . SPARSER::PROTEIN)
    ("the histologic type" . TYPE)
    ("the forkhead transcription factor family and an important regulator"
     . SPARSER::COLLECTION)
    ("the E-box-binding protein ZEB1 and the forkhead box protein FoxC2"
     . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION)
    ("FoxC2 and E-cadherin" . SPARSER::COLLECTION)
    ("an epithelial–mesenchymal transition (EMT) regulator"
     . SPARSER::REGULATOR)
    ("p120ctn" . SPARSER::PROTEIN) ("pN1" . SPARSER::PROTEIN)
    ("2-4" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("FoxC2" . SPARSER::PROTEIN) ("protein or RNA" . SPARSER::COLLECTION)
    ("well-characterized prospective cohort" . SPARSER::MOLECULE)
    ("fine-mapping" . SPARSER::PROTEIN) ("Drugs" . SPARSER::DRUG)
    ("SERMs" . SPARSER::DRUG)
    ("tamoxifen and raloxifene" . SPARSER::COLLECTION)
    ("raloxifene" . SPARSER::PROTEIN) ("GH and IGF-1" . SPARSER::COLLECTION)
    ("mutations cause classic NF1" . SPARSER::PROTEIN)
    ("classical NF1" . SPARSER::PROTEIN) ("classic NF1" . SPARSER::PROTEIN)
    ("intravenous contrast substance" . SPARSER::SUBSTANCE)
    ("Cranial MRI" . SPARSER::PROTEIN) ("clonidine" . SPARSER::DRUG)
    ("XX" . SPARSER::PROTEIN) ("RAS-MAPK" . SPARSER::COLLECTION)
    ("NF1 and PTPN11" . SPARSER::COLLECTION)
    ("NF1 or PTPN11" . SPARSER::COLLECTION) ("IGF-BP3" . SPARSER::PROTEIN)
    ("IGF binding protein 3" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("Growth hormone" . SPARSER::PROTEIN) ("ATK" . SPARSER::PROTEIN)
    ("Bufalin and other clinical chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("other clinical chemotherapeutic drugs" . SPARSER::DRUG)
    ("gemcitabine and Bufalin" . SPARSER::COLLECTION)
    ("bufalin" . SPARSER::DRUG) ("Bufalin and rescue" . SPARSER::COLLECTION)
    ("AKT/GSK3β" . SPARSER::COLLECTION) ("/FAK" . SPARSER::COLLECTION)
    ("integrain/FAK" . SPARSER::COLLECTION)
    ("Bufalin (46.8%) or dinaciclib (41.3%)" . SPARSER::COLLECTION)
    ("dinaciclib" . SPARSER::DRUG)
    ("Bufalin or cisplatin" . SPARSER::COLLECTION)
    ("/β5" . SPARSER::COLLECTION)
    ("Bufalin or Paclitaxel" . SPARSER::COLLECTION)
    ("Bufalin and Paclitaxel" . SPARSER::COLLECTION)
    ("platinum or paclitaxel and Bufalin" . SPARSER::COLLECTION)
    ("paclitaxel and Bufalin" . SPARSER::COLLECTION)
    ("the firstline chemotherapeutic drug" . SPARSER::DRUG)
    ("Platinum and paclitaxel" . SPARSER::COLLECTION)
    ("MMP9 and Snail 1" . SPARSER::COLLECTION)
    ("Bax, cyclin B1 and E-cadherin" . SPARSER::COLLECTION)
    ("p-AKT1" . SPARSER::COLLECTION) ("p-GSK3β" . SPARSER::COLLECTION)
    ("p-FAK" . SPARSER::COLLECTION) ("MMP9 and Snail1" . SPARSER::COLLECTION)
    ("MMP 9 and Snail" . SPARSER::COLLECTION)
    ("Epithelial-Mesenchymal Transition (EMT) -related proteins"
     . SPARSER::PROTEIN)
    ("E-cadherin, and Snail1" . SPARSER::COLLECTION)
    ("cyclinA/CDK2" . SPARSER::COLLECTION) ("cyclinA" . SPARSER::PROTEIN)
    ("the essential negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("p21 and P27" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("Annexin V and PI" . SPARSER::COLLECTION)
    ("integrin/FAK" . SPARSER::COLLECTION)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("Integrin/FAK" . SPARSER::COLLECTION) ("Integrin" . SPARSER::PROTEIN)
    ("Kinase (FAK)" . SPARSER::KINASE)
    ("heterodimeric cell adhesion receptors" . SPARSER::RECEPTOR)
    ("Integrins" . SPARSER::PROTEIN) ("Bcl-2 and livin" . SPARSER::COLLECTION)
    ("akt" . SPARSER::PROTEIN) ("digoxin" . SPARSER::DRUG)
    ("paclitaxel-" . SPARSER::DRUG)
    ("Bufalin and paclitaxel" . SPARSER::COLLECTION)
    ("cyclin B1, CDK2, Bcl-2, Bcl-xl, MMP9 and SNAIL1" . SPARSER::COLLECTION)
    ("waf" . SPARSER::PROTEIN) ("Bufalin" . SPARSER::DRUG)
    ("ITGB5" . SPARSER::PROTEIN) ("CUB domain" . SPARSER::PROTEIN)
    ("ITGA2" . SPARSER::PROTEIN) ("Snail 1" . SPARSER::PROTEIN)
    ("snail1" . SPARSER::PROTEIN) ("MMP 9" . SPARSER::PROTEIN)
    ("P27" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNAIL1" . SPARSER::PROTEIN)
    ("miRNAs and other small RNAs" . SPARSER::COLLECTION)
    ("miRNAs and the down-stream target proteins" . SPARSER::COLLECTION)
    ("group, and BCL2L11" . SPARSER::COLLECTION)
    ("para" . SPARSER::PROTEIN-FAMILY) ("dys" . SPARSER::PROTEIN)
    ("secretory signaling molecules" . SPARSER::MOLECULE)
    ("Dai" . SPARSER::PROTEIN) ("C–E" . SPARSER::PROTEIN)
    ("E–G" . SPARSER::PROTEIN)
    ("down-regulated in gastric cancer" . SPARSER::PROTEIN)
    ("BCL2L11" . SPARSER::PROTEIN) ("TET" . SPARSER::PROTEIN)
    ("a constitutively activated/nuclear form" . SPARSER::FORM)
    ("either Type I (with γc chain) or Type II receptors (with IL-13Rɑ1)"
     . SPARSER::COLLECTION)
    ("membrane-bound dimeric IL-4R" . SPARSER::PROTEIN)
    ("IL-1a, IL-1b and TNF" . SPARSER::COLLECTION)
    ("IL-1 and prostaglandin E2" . SPARSER::COLLECTION)
    ("a bacterial antigen" . SPARSER::PROTEIN) ("RANKL" . SPARSER::PROTEIN)
    ("TLR4 and CD14" . SPARSER::COLLECTION)
    ("CCL22 and CSF1R" . SPARSER::COLLECTION)
    ("CCL20 and ARSB" . SPARSER::COLLECTION) ("pCDH-MIG" . SPARSER::COLLECTION)
    ("MIG" . SPARSER::PROTEIN)
    ("the monomeric and dimeric protein" . SPARSER::PROTEIN)
    ("STAT6 and TET2" . SPARSER::COLLECTION)
    ("IL-4 and JAK3" . SPARSER::COLLECTION)
    ("DUOX1 and SLAMF1" . SPARSER::COLLECTION)
    ("STAT6 and JAK3" . SPARSER::COLLECTION)
    ("a western blot" . SPARSER::PROTEIN)
    ("JAK3 and STAT6" . SPARSER::COLLECTION)
    ("the previously studied genes" . SPARSER::GENE)
    ("H3K27me3 and H" . SPARSER::COLLECTION)
    ("IL1B and CCL20" . SPARSER::COLLECTION)
    ("PYCARD , IL1B and IL1A" . SPARSER::COLLECTION)
    ("PYCARD" . SPARSER::PROTEIN)
    ("whereby 927 and 1,461 genes" . SPARSER::GENE)
    ("CD209 and CD83" . SPARSER::COLLECTION) ("PFAS" . SPARSER::PROTEIN)
    ("ARSB" . SPARSER::PROTEIN) ("chemokine, and IL1B" . SPARSER::COLLECTION)
    ("CD209 and CD206" . SPARSER::COLLECTION)
    ("CD83 and CD86" . SPARSER::COLLECTION) ("mDCs" . SPARSER::PROTEIN)
    ("IL-4-JAK3-STAT6" . SPARSER::COLLECTION)
    ("DCs and MACs in vitro and in vivo" . SPARSER::COLLECTION)
    ("DCs and MACs" . SPARSER::COLLECTION) ("-STAT6" . SPARSER::COLLECTION)
    ("JAK2 and downstream mediators" . SPARSER::COLLECTION)
    ("GM-CSF/IL-4" . SPARSER::COLLECTION)
    ("/interleukin 4" . SPARSER::COLLECTION) ("OCs" . SPARSER::PROTEIN)
    ("JAK3-STAT6" . SPARSER::COLLECTION) ("SAMHD1" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("CXCL13" . SPARSER::PROTEIN)
    ("MSR1" . SPARSER::PROTEIN) ("C/EBPα" . SPARSER::PROTEIN)
    ("GATA1" . SPARSER::PROTEIN) ("IL-13" . SPARSER::PROTEIN)
    ("c chain" . SPARSER::PROTEIN) ("IL-1b" . SPARSER::PROTEIN)
    ("IL-1a" . SPARSER::PROTEIN) ("Membrane-bound" . SPARSER::PROTEIN)
    ("AIM2" . SPARSER::PROTEIN) ("IL1A" . SPARSER::PROTEIN)
    ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SLAMF1" . SPARSER::PROTEIN)
    ("DUOX1" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("CCL22" . SPARSER::PROTEIN) ("CSF1" . SPARSER::PROTEIN)
    ("CSF1R" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("CD206" . SPARSER::PROTEIN) ("CD83" . SPARSER::PROTEIN)
    ("CD209" . SPARSER::PROTEIN) ("Janus kinase 3" . SPARSER::PROTEIN)
    ("IL-4R" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("interleukin 4" . SPARSER::PROTEIN)
    ("undetectable hTERT" . SPARSER::PROTEIN)
    ("isogenic 12BPEC" . SPARSER::PROTEIN) ("12BPECs" . SPARSER::PROTEIN)
    ("12BPEC and 14BPEC" . SPARSER::COLLECTION) ("12BPEC" . SPARSER::PROTEIN)
    ("05BPEC" . SPARSER::PROTEIN) ("04BPEC" . SPARSER::PROTEIN)
    ("12BPEC-hTERT, 04BPEC-hTERT and 05BPEC-hTERT" . SPARSER::COLLECTION)
    ("05BPEC-hTERT" . SPARSER::COLLECTION)
    ("04BPEC-hTERT" . SPARSER::COLLECTION)
    ("12BPEC-hTERT" . SPARSER::COLLECTION) ("endo" . SPARSER::PROTEIN)
    ("centromeric specific DNA" . SPARSER::DNA)
    ("cytokeratin K14, a myoepithelial marker, and K19, a luminal marker, which were not checked"
     . SPARSER::COLLECTION)
    ("This stress-associated barrier" . SPARSER::PROTEIN)
    ("hTERT and SV40 LT/st" . SPARSER::COLLECTION)
    ("H-RAS, hTERT and SV40 LT/st" . SPARSER::COLLECTION)
    ("LT" . SPARSER::PROTEIN) ("p16 protein" . SPARSER::PROTEIN)
    ("βGal" . SPARSER::PROTEIN) ("P16  INK4a" . SPARSER::PROTEIN)
    ("PBS-3 " . SPARSER::PROTEIN) ("K19" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("K-19" . SPARSER::PROTEIN)
    ("K-14" . SPARSER::PROTEIN) ("CD-10" . SPARSER::PROTEIN)
    ("Claudin-4" . SPARSER::PROTEIN) ("Cytokine" . SPARSER::PROTEIN)
    ("IL-1β, IL-6, IFNγ, IFNλ3, and IL-17a, and mRNA" . SPARSER::COLLECTION)
    ("IL-17a and IL-6" . SPARSER::COLLECTION)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("IL-1β, IL-6, IFNγ, IFNλ3 and IL-17a, and mRNA" . SPARSER::COLLECTION)
    ("IL-17a, and mRNA" . SPARSER::COLLECTION)
    ("IFNγ (100 ng/ml) and IL-17a (1 ng/ml)" . SPARSER::COLLECTION)
    ("key cytokines" . SPARSER::PROTEIN)
    ("IL-17a and IFNλ3" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, IFNλ3, IFNγ and IL-17a" . SPARSER::COLLECTION)
    ("IL-6, IL-17a, and IFNλ3" . SPARSER::COLLECTION)
    ("IL-1β (P = 0.283) or IFNγ (P = 0.178)" . SPARSER::COLLECTION)
    ("IL-6, IL-17a and IFNλ3" . SPARSER::COLLECTION)
    ("IL-6 and other cytokines" . SPARSER::COLLECTION)
    ("IFNλ1, IFNλ2 and IFNλ4" . SPARSER::COLLECTION)
    ("IL-17a, IFNλ3 and IFNγ" . SPARSER::COLLECTION)
    ("IL-1β and IL-6" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, IFNγ, IL-17a and IFNλ3" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, IFNγ, IL-17a, IFNλ2 and IFNλ3" . SPARSER::COLLECTION)
    ("cytokines and ammonia" . SPARSER::COLLECTION)
    ("HCC and CHE" . SPARSER::COLLECTION)
    ("cytokine and ammonia" . SPARSER::COLLECTION)
    ("ammonia" . SPARSER::MOLECULE)
    ("IL-1β, IL-1Ra, IL-2, IL-4, IL-6, IL-8, IL-10, IFNγ, IL-17a, IL-23, IFNλ1, IFNλ2, IFNλ3 and IFNλ4"
     . SPARSER::COLLECTION)
    ("male and 60 (33.1%) female patients" . SPARSER::COLLECTION)
    ("IL-1β, IL-1Ra, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IFNγ, IL-17a and IL-18"
     . SPARSER::COLLECTION)
    ("IL-17a" . SPARSER::PROTEIN)
    ("cytokines and their receptors" . SPARSER::COLLECTION)
    ("IL-6 and IFNγ" . SPARSER::COLLECTION)
    ("IL-6, IFNλ3 and IL-17α" . SPARSER::COLLECTION)
    ("IL-1β, IL-6, IFNγ, IL-17α, IFNλ2 and IFNλ3" . SPARSER::COLLECTION)
    ("IL-23" . SPARSER::PROTEIN) ("IFNλ1" . SPARSER::PROTEIN)
    ("IL1Ra" . SPARSER::PROTEIN) ("IL-18" . SPARSER::PROTEIN)
    ("IL-1Ra" . SPARSER::PROTEIN) ("IFNλ" . SPARSER::PROTEIN)
    ("IL-17" . SPARSER::PROTEIN) ("the essential enzymes" . SPARSER::ENZYME)
    ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p63 and p73" . SPARSER::COLLECTION) ("p63 or p73" . SPARSER::COLLECTION)
    ("the minimal promoter" . SPARSER::PROMOTER) ("BS" . SPARSER::PROTEIN)
    ("Cathepsins" . SPARSER::PROTEIN)
    ("acute phase proteins" . SPARSER::PROTEIN)
    ("multifunctional glycoproteins" . SPARSER::PROTEIN)
    ("cystatin" . SPARSER::PROTEIN) ("cystatins" . SPARSER::PROTEIN)
    ("tight‐binding inhibitors" . SPARSER::INHIBITOR)
    ("Cystatins" . SPARSER::PROTEIN)
    ("p53RDL1 , XEDAR , and PADI4" . SPARSER::COLLECTION)
    ("XEDAR" . SPARSER::PROTEIN) ("p53–cystatin C" . SPARSER::COLLECTION)
    ("cathepsins" . SPARSER::PROTEIN) ("3–1" . SPARSER::PROTEIN)
    ("TAp63" . SPARSER::PROTEIN) ("cystatin family" . SPARSER::PROTEIN)
    ("Cathepsin L" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("type 3" . SPARSER::PROTEIN) ("Type 3" . SPARSER::PROTEIN)
    ("Type 1" . SPARSER::PROTEIN) ("Cystatin family" . SPARSER::PROTEIN)
    ("PADI4" . SPARSER::PROTEIN) ("p53RDL1" . SPARSER::PROTEIN)
    ("p53AIP1" . SPARSER::PROTEIN) ("Cystatin C" . SPARSER::PROTEIN)
    ("cathepsin L" . SPARSER::PROTEIN) ("cystatin C" . SPARSER::PROTEIN)
    ("TGFβ, IL-10, and retinoic acids" . SPARSER::COLLECTION)
    ("IL-10 or retinoic acids" . SPARSER::COLLECTION)
    ("mutagen" . SPARSER::MOLECULE) ("profound emphysema" . SPARSER::PROTEIN)
    ("the bronchial epithelium and macrophages" . SPARSER::COLLECTION)
    ("epithelium and macrophages" . SPARSER::COLLECTION)
    ("DEAB" . SPARSER::MOLECULE) ("RALDH1 and RALDH2" . SPARSER::COLLECTION)
    ("antibodies or specific isotype control antibodies" . SPARSER::COLLECTION)
    ("CD3 and CD28 and co-cultured" . SPARSER::COLLECTION)
    ("CD28 and co-cultured" . SPARSER::COLLECTION)
    ("TGFβ or IL-10" . SPARSER::COLLECTION)
    ("significantly more CD4 + /CD25" . SPARSER::COLLECTION)
    ("antibodies and co-cultured" . SPARSER::COLLECTION)
    ("CD3/CD28" . SPARSER::COLLECTION)
    ("control (PBS) liposomes" . SPARSER::PROTEIN)
    ("/Foxp3" . SPARSER::COLLECTION)
    ("PBS and clodronate" . SPARSER::COLLECTION)
    ("clodronate or control (PBS) liposome-treated IKTA mice"
     . SPARSER::COLLECTION)
    ("PBS- or clodronate-liposomes" . SPARSER::COLLECTION)
    ("PBS-" . SPARSER::PROTEIN) ("liposomal clodronate" . SPARSER::DRUG)
    ("clodronate" . SPARSER::DRUG) ("DCs" . SPARSER::MOLECULE)
    ("MLR" . SPARSER::PROTEIN)
    ("Fizz1, Arginase-1, TGFβ, and IL-10" . SPARSER::COLLECTION)
    ("Fizz1" . SPARSER::PROTEIN) ("iNOS" . SPARSER::PROTEIN)
    ("TNFα and CCL3" . SPARSER::COLLECTION)
    ("anti-arginase-1 and anti-CD68" . SPARSER::COLLECTION)
    ("BAL" . SPARSER::PROTEIN) ("elastin" . SPARSER::PROTEIN)
    ("TGFβ and IL-10" . SPARSER::COLLECTION) ("urethane" . SPARSER::MOLECULE)
    ("/FoxP3" . SPARSER::COLLECTION) ("/CD25" . SPARSER::COLLECTION)
    ("IKTA" . SPARSER::PROTEIN) ("epithelium (IKTA)" . SPARSER::PROTEIN)
    ("tetracycline" . SPARSER::DRUG) ("5-2" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("Gr1" . SPARSER::PROTEIN)
    ("p84" . SPARSER::PROTEIN) ("RALDH 2" . SPARSER::PROTEIN)
    ("RALDH 1" . SPARSER::PROTEIN) ("vitamin A" . SPARSER::MOLECULE)
    ("RALDH2" . SPARSER::PROTEIN) ("RALDH1" . SPARSER::PROTEIN)
    ("retinoic acids" . SPARSER::MOLECULE)
    ("Retinoic acids" . SPARSER::MOLECULE) ("CD28" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("Arginase-1" . SPARSER::PROTEIN)
    ("CCL3" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("arginase-1" . SPARSER::PROTEIN) ("Foxp3" . SPARSER::PROTEIN)
    ("FoxP3" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("a good predictive biomarker" . SPARSER::MOLECULE)
    ("SH" . SPARSER::PROTEIN-FAMILY) ("HY" . SPARSER::MOLECULE)
    ("undetectable EGFR and detectable EGFR" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib or afatinib" . SPARSER::COLLECTION)
    ("undetectable EGFR" . SPARSER::PROTEIN)
    ("CREB and MAPK" . SPARSER::COLLECTION)
    ("ERK, JNK, and p38" . SPARSER::COLLECTION)
    ("PI3-K/AKT" . SPARSER::COLLECTION)
    ("proteins, Bcl-xL, and Survivin" . SPARSER::COLLECTION)
    ("ant-apoptotic molecule" . SPARSER::MOLECULE)
    ("ant" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK and CREB" . SPARSER::COLLECTION)
    ("ERK1/2, JNK and p38 MAPK" . SPARSER::COLLECTION)
    ("Bcl-xL and Survivin" . SPARSER::COLLECTION)
    ("procaspase-2 and PARP" . SPARSER::COLLECTION)
    ("various apoptotic and antiapoptotic proteins" . SPARSER::PROTEIN)
    ("Vincristine (VCT)" . SPARSER::DRUG) ("Vincristine" . SPARSER::DRUG)
    ("apoptosis inhibitors (Bcl-xl, Bcl-2, and Survivin) and cell cycle regulators [ xref ]"
     . SPARSER::COLLECTION)
    ("kinase (JAK)" . SPARSER::KINASE)
    ("a latent transcription factor" . SPARSER::PROTEIN)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("Bax, Bid, and Bak" . SPARSER::COLLECTION)
    ("Bcl2 and Bcl-xL, and Survivin" . SPARSER::COLLECTION)
    ("Bcl-xL, and Survivin" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinases (MAPKs) and CREB"
     . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and Survivin" . SPARSER::COLLECTION)
    ("C-1" . SPARSER::PROTEIN) ("C-9" . SPARSER::PROTEIN)
    ("C-8" . SPARSER::PROTEIN) ("C-7" . SPARSER::PROTEIN)
    ("C-6" . SPARSER::PROTEIN) ("C-5" . SPARSER::PROTEIN)
    ("C-4" . SPARSER::PROTEIN) ("C-2" . SPARSER::PROTEIN)
    ("H-6" . SPARSER::PROTEIN) ("H-5" . SPARSER::PROTEIN)
    ("H-4" . SPARSER::PROTEIN) ("H-3" . SPARSER::PROTEIN)
    ("H-2b" . SPARSER::PROTEIN) ("H-2" . SPARSER::PROTEIN)
    ("Cl 2" . SPARSER::PROTEIN) ("CH 2" . SPARSER::MOLECULE)
    ("procaspase-2" . SPARSER::PROTEIN) ("Val" . SPARSER::AMINO-ACID)
    ("Asn" . SPARSER::AMINO-ACID)
    ("increased DNA-damage [ xref ]" . SPARSER::DNA)
    ("increased DNA-damage" . SPARSER::DNA)
    ("POLD1 and ATR" . SPARSER::COLLECTION)
    ("the initiator CASPASE9 and the executioner CASPASE3 [ xref ]"
     . SPARSER::COLLECTION)
    ("the heterogeneous genotype" . SPARSER::PROTEIN)
    ("both ATR and its downstream major effector kinase CHK1"
     . SPARSER::COLLECTION)
    ("ATR and the genes" . SPARSER::COLLECTION)
    ("XRCC6 and XRCC5" . SPARSER::COLLECTION)
    ("the essential factors MCM [ xref ] and ORC [ xref ]"
     . SPARSER::COLLECTION)
    ("the essential factors MCM" . SPARSER::PROTEIN)
    ("XRCC5 and XRCC6" . SPARSER::COLLECTION)
    ("XRCC5/XRCC6" . SPARSER::COLLECTION) ("ORC" . SPARSER::BIO-COMPLEX)
    ("PRIM1 or POLD1" . SPARSER::COLLECTION)
    ("proteins, PRIM1 and POLD1" . SPARSER::COLLECTION)
    ("elongation and DNA" . SPARSER::COLLECTION)
    ("POLD1 and PRIM1" . SPARSER::COLLECTION)
    ("XRCC1 or PRIM1" . SPARSER::COLLECTION)
    ("an essential gene" . SPARSER::GENE)
    ("ATR and 20 genes" . SPARSER::COLLECTION)
    ("central checkpoint regulator and mediator" . SPARSER::COLLECTION)
    ("POLD1-depletedATR" . SPARSER::PROTEIN-PAIR)
    ("an even higher fraction" . SPARSER::COMPONENT)
    ("intranuclear γ-H2AX foci" . SPARSER::PROTEIN)
    ("pan-nuclear γ-H2AX" . SPARSER::PROTEIN) ("POLD1-" . SPARSER::PROTEIN)
    ("PARP, CASPASE3 and CASPASE9" . SPARSER::COLLECTION)
    ("cleaved Poly (ADP-ribose) polymerase (PARP) as well as the initiator caspases CASPASE8"
     . SPARSER::COLLECTION)
    ("CASPASE9 and the central effector CASPASE3" . SPARSER::COLLECTION)
    ("MMC, oxaliplatin or 5-FU" . SPARSER::COLLECTION)
    ("NU6027 (IC50 ratio 3) and VE-822 (IC50 ratio 2)" . SPARSER::COLLECTION)
    ("NU6027 (IC50 ratio 2) and UCN-01 (IC50 ratio 2)" . SPARSER::COLLECTION)
    ("NU6027, VE-822 or UCN-01" . SPARSER::COLLECTION)
    ("ICL- and non-ICL-agents" . SPARSER::COLLECTION)
    ("ICL-" . SPARSER::PROTEIN)
    ("VE-822 (IC50 ratio 5) and UCN-01 (IC50 ratio 8)" . SPARSER::COLLECTION)
    ("ATR or its major downstream effector kinase CHK1" . SPARSER::COLLECTION)
    ("only currently FDA-approved CHK1-inhibitor UCN-01" . SPARSER::DRUG)
    ("NU6027 and VE-822" . SPARSER::COLLECTION)
    ("ATR- and CHK1-inhibitors" . SPARSER::COLLECTION)
    ("XAB2 and PLK1" . SPARSER::COLLECTION) ("-genotype" . SPARSER::COLLECTION)
    ("mitomycin C (MMC)" . SPARSER::DRUG) ("ICL" . SPARSER::PROTEIN)
    ("ATR and DNA-repair" . SPARSER::COLLECTION)
    ("ATR and certain DNA-repair genes" . SPARSER::COLLECTION)
    ("ATM , XRCC1 and ERCC1" . SPARSER::COLLECTION)
    ("homologous recombination-mediated DNA-repair [ xref , xref ]"
     . SPARSER::DNA)
    ("homologous recombination-mediated DNA-repair" . SPARSER::DNA)
    ("PIK" . SPARSER::BIO-COMPLEX)
    ("ATR- or CHK1-inhibitors" . SPARSER::COLLECTION)
    ("ATR-" . SPARSER::PROTEIN) ("impaired DNA-repair" . SPARSER::DNA)
    ("ATR or its major effector kinase CHK1" . SPARSER::COLLECTION)
    ("ATR and POLD1" . SPARSER::COLLECTION)
    ("a central checkpoint regulator and mediator" . SPARSER::COLLECTION)
    ("Asp-Glu" . SPARSER::MOLECULE) ("β GAL" . SPARSER::PROTEIN)
    ("1 -2" . SPARSER::PROTEIN) ("1 -1" . SPARSER::PROTEIN)
    ("βGAL" . SPARSER::PROTEIN) ("LY2603618" . SPARSER::DRUG)
    ("XRCC6" . SPARSER::PROTEIN) ("XRCC5" . SPARSER::PROTEIN)
    ("DNA primase" . SPARSER::PROTEIN) ("PRIM1" . SPARSER::PROTEIN)
    ("CASPASE3" . SPARSER::PROTEIN) ("CASPASE9" . SPARSER::PROTEIN)
    ("CASPASE8" . SPARSER::PROTEIN) ("NU6027" . SPARSER::DRUG)
    ("XAB2" . SPARSER::PROTEIN) ("CYCLIN E" . SPARSER::PROTEIN)
    ("POLD1" . SPARSER::PROTEIN)
    ("trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("HSP90 and AIF" . SPARSER::COLLECTION) ("AIF" . SPARSER::PROTEIN)
    ("HER2-STAT3" . SPARSER::COLLECTION)
    ("STAT3-survivin" . SPARSER::COLLECTION)
    ("STAT3, and survivin" . SPARSER::COLLECTION)
    ("lapatinib or S3I-201" . SPARSER::COLLECTION)
    ("lapatinib and S3I-201" . SPARSER::COLLECTION)
    ("HER2 and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and survivin" . SPARSER::COLLECTION)
    ("HR (estrogen receptor [ER] and/or progesterone receptor [PR]) and HER2"
     . SPARSER::COLLECTION)
    ("HER2−" . SPARSER::PROTEIN) ("HR−" . SPARSER::PROTEIN)
    ("STAT3 and its target genes" . SPARSER::COLLECTION)
    ("HER2 and hormone" . SPARSER::COLLECTION)
    ("STAT3, STAT3, and survivin" . SPARSER::COLLECTION)
    ("HER2-STAT3-survivin" . SPARSER::COLLECTION)
    ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("IRS and JAK1/2" . SPARSER::COLLECTION)
    ("IRS2/JAK2" . SPARSER::COLLECTION) ("Kym-1" . SPARSER::COLLECTION)
    ("a classical downstream protein" . SPARSER::PROTEIN)
    ("SH2B, and leptin" . SPARSER::COLLECTION) ("Leptin" . SPARSER::PROTEIN)
    ("a JAK2/SH2B/IRS2 tertiary complex" . SPARSER::BIO-COMPLEX)
    ("JAK2/SH2B/IRS2" . SPARSER::COLLECTION)
    ("both EPOR [ xref ] and JAK2 [ xref ]" . SPARSER::COLLECTION)
    ("UT" . SPARSER::PROTEIN-FAMILY) ("EPOR and MPL" . SPARSER::COLLECTION)
    ("PMF and PV" . SPARSER::COLLECTION) ("MPL and CALR" . SPARSER::COLLECTION)
    ("IRS2 and JAK1/2" . SPARSER::COLLECTION)
    ("IRS/IGF1R" . SPARSER::COLLECTION) ("/PI" . SPARSER::COLLECTION)
    ("phospho-STAT5 and phospho-ERK" . SPARSER::COLLECTION)
    ("JAK2, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("ERK and P70S6K" . SPARSER::COLLECTION)
    ("DMSO or ruxolitinib" . SPARSER::COLLECTION)
    ("IRS2 (shIRS2) or a shRNA" . SPARSER::COLLECTION)
    ("IRS2 and STAT3" . SPARSER::COLLECTION)
    ("JAK2, STAT5, ERK and P70S6K" . SPARSER::COLLECTION)
    ("IRS2, JAK2, STAT3, STAT5, ERK and P70S6K" . SPARSER::COLLECTION)
    ("JAK2 and IRS2" . SPARSER::COLLECTION)
    ("anti-IRS2 and anti-JAK2" . SPARSER::COLLECTION)
    ("HL60" . SPARSER::PROTEIN) ("JAK2 and CALR" . SPARSER::COLLECTION)
    ("CALR" . SPARSER::PROTEIN) ("IRS1 and IRS2" . SPARSER::COLLECTION)
    ("interleukins" . SPARSER::PROTEIN) ("MPL" . SPARSER::PROTEIN)
    ("EPOR" . SPARSER::PROTEIN)
    ("the IL4 receptor-associated tyrosine kinase" . SPARSER::PROTEIN)
    ("180kDa" . SPARSER::PROTEIN)
    ("receptors and substrates" . SPARSER::COLLECTION)
    ("IRS2 and JAK2" . SPARSER::COLLECTION) ("JAK2/IRS2" . SPARSER::COLLECTION)
    ("leptin receptor" . SPARSER::PROTEIN) ("SH2B" . SPARSER::PROTEIN)
    ("NB4" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("IFNα" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("IL4" . SPARSER::PROTEIN) ("4PS" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN)
    ("Hsp90 inhibitors and the exposure" . SPARSER::COLLECTION)
    ("inhibitors and inhibitors" . SPARSER::COLLECTION)
    ("MET, AXL and RON" . SPARSER::COLLECTION)
    ("ALK or ALK" . SPARSER::COLLECTION)
    ("further ALK inhibitors" . SPARSER::INHIBITOR)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-RAS, H-RAS and K-RAS" . SPARSER::COLLECTION)
    ("K-RAS or BRAF" . SPARSER::COLLECTION)
    ("ALK or MEK" . SPARSER::COLLECTION) ("AKT or PI3 K" . SPARSER::COLLECTION)
    ("ALK and MEK" . SPARSER::COLLECTION)
    ("crizotinib and IGF-1R" . SPARSER::COLLECTION)
    ("erlotinib and an in-depth study of EML4-ALK cell lines [ xref ]"
     . SPARSER::COLLECTION)
    ("mAb" . SPARSER::DRUG) ("crizotinib and ganetespib" . SPARSER::COLLECTION)
    ("ALK and Hsp90" . SPARSER::COLLECTION)
    ("ALK and inhibitors" . SPARSER::COLLECTION)
    ("RTKs or Hsp90" . SPARSER::COLLECTION)
    ("EGFR and MET" . SPARSER::COLLECTION)
    ("NVP-AUY922 and ganetespib" . SPARSER::COLLECTION)
    ("ganetespib" . SPARSER::DRUG) ("IPI" . SPARSER::PROTEIN)
    ("geldanamycin" . SPARSER::DRUG)
    ("Geldanamycin and radicicol" . SPARSER::COLLECTION)
    ("radicicol" . SPARSER::DRUG) ("Geldanamycin" . SPARSER::DRUG)
    ("The macrocylic inhibitor PF-06463922" . SPARSER::DRUG)
    ("ALK and ALK" . SPARSER::COLLECTION)
    ("the second-generation ALK inhibitors alectinib and ceretinib (Table  xref )"
     . SPARSER::COLLECTION)
    ("P2 purinergic receptors" . SPARSER::PROTEIN)
    ("scaffolding proteins and DNA-associated proteins" . SPARSER::COLLECTION)
    ("DNA-associated proteins" . SPARSER::PROTEIN)
    ("crizotinib or TAE684" . SPARSER::COLLECTION)
    ("EGFR, KIT, IGF-1R and SRC" . SPARSER::COLLECTION)
    ("ALK/ROS1" . SPARSER::COLLECTION)
    ("the available ATP competitive ALK inhibitors" . SPARSER::INHIBITOR)
    ("crizotinib and PF-06463922" . SPARSER::COLLECTION)
    ("—aminopyridine" . SPARSER::MOLECULE) ("alectinib" . SPARSER::DRUG)
    ("brigatinib" . SPARSER::DRUG) ("ceritinib" . SPARSER::DRUG)
    ("aminopyridine" . SPARSER::MOLECULE) ("Crizotinib" . SPARSER::DRUG)
    ("docetaxel or pemetrexed" . SPARSER::COLLECTION)
    ("ALK/MET/ROS" . SPARSER::COLLECTION)
    ("two chemically-distinct inhibitors" . SPARSER::INHIBITOR)
    ("TAE684 and crizotinib" . SPARSER::COLLECTION)
    ("crizotinib" . SPARSER::DRUG) ("PC-9—EGFR" . SPARSER::COLLECTION)
    ("Akt and ERK" . SPARSER::COLLECTION)
    ("At least fifteen variants" . SPARSER::VARIANT)
    ("PI3 K/AKT" . SPARSER::COLLECTION) ("RAS/ERK" . SPARSER::COLLECTION)
    ("NPM-ALK" . SPARSER::COLLECTION)
    ("pleiotrophin (PTN) and midkine (MK)" . SPARSER::COLLECTION)
    ("MK" . SPARSER::PROTEIN) ("midkine" . SPARSER::PROTEIN)
    ("PTN" . SPARSER::PROTEIN) ("pleiotrophin" . SPARSER::PROTEIN)
    ("protein and protein tyrosine phosphatase" . SPARSER::COLLECTION)
    ("LDLa" . SPARSER::PROTEIN) ("NPM" . SPARSER::PROTEIN)
    ("nucleophosmin" . SPARSER::PROTEIN) ("MET and RON" . SPARSER::COLLECTION)
    ("RON" . SPARSER::PROTEIN) ("soluble tubulin" . SPARSER::PROTEIN)
    ("soluble tubulin and microtubules" . SPARSER::COLLECTION)
    ("tubulin and microtubules" . SPARSER::COLLECTION)
    ("Propeller" . SPARSER::PROTEIN-FAMILY)
    ("propellers" . SPARSER::PROTEIN-FAMILY)
    ("a presumably monomeric protein isoform" . SPARSER::ISOFORM)
    ("EML2 and EML4" . SPARSER::COLLECTION)
    ("Thr and basic residues" . SPARSER::COLLECTION)
    ("Trp-Asp" . SPARSER::COLLECTION)
    ("further EML proteins" . SPARSER::PROTEIN)
    ("Sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EML4 (echinoderm microtubule associated protein-like 4) and ALK (anaplastic lymphoma kinase)"
     . SPARSER::COLLECTION)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR)
    ("etoposide or an anti-mitotic" . SPARSER::COLLECTION)
    ("kinases or Hsp90" . SPARSER::COLLECTION)
    ("EML4 and ALK" . SPARSER::COLLECTION) ("EML4-ALK" . SPARSER::COLLECTION)
    ("the EML4 (echinoderm microtubule-associated protein-like) and ALK (anaplastic lymphoma kinase) genes"
     . SPARSER::COLLECTION)
    ("ALK" . SPARSER::PROTEIN) ("N-RAS" . SPARSER::PROTEIN)
    ("Insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("NVP-AUY922" . SPARSER::MOLECULE) ("ROS1" . SPARSER::PROTEIN)
    ("PF-06463922" . SPARSER::DRUG) ("TAE684" . SPARSER::DRUG)
    ("p23" . SPARSER::PROTEIN) ("PI3 K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY)
    ("Low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("EML2" . SPARSER::PROTEIN) ("anti-mitotic" . SPARSER::MOLECULE)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("EML4" . SPARSER::PROTEIN) ("Exosomal miRNAs" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("minimally invasive, novel and sensitive biomarkers" . SPARSER::MOLECULE)
    ("p21/AKT/mTOR" . SPARSER::COLLECTION)
    ("a relevant PDK2" . SPARSER::PROTEIN)
    ("cyclinD1-CDK4/6" . SPARSER::COLLECTION) ("AMI" . SPARSER::MOLECULE)
    ("endoglin" . SPARSER::PROTEIN) ("onco-miRNA" . SPARSER::COLLECTION)
    ("the pro-apoptotic PRKCD gene" . SPARSER::GENE)
    ("PRKCD" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein (XIAP) and survivin"
     . SPARSER::COLLECTION)
    ("the ubiquitous miR-16" . SPARSER::PROTEIN) ("SER " . SPARSER::AMINO-ACID)
    ("PARP1 and Bax" . SPARSER::COLLECTION)
    ("PARP1, Bcl2 and Bax" . SPARSER::COLLECTION)
    ("miRNA-NC" . SPARSER::COLLECTION) ("S3A and S3B" . SPARSER::COLLECTION)
    ("four representative differentially" . SPARSER::PROTEIN)
    ("miR-26b-5p" . SPARSER::PROTEIN-PAIR)
    ("only one miRNA" . SPARSER::PROTEIN)
    ("transporting radiation-induced serum miRNAs" . SPARSER::PROTEIN)
    ("mRNAs and various microRNAs" . SPARSER::COLLECTION)
    ("proteins, mRNAs and various microRNAs" . SPARSER::COLLECTION)
    ("either oncogenes or tumor suppressors [ xref ]" . SPARSER::COLLECTION)
    ("morphologic type" . TYPE) ("miR-126-3p" . SPARSER::COLLECTION)
    ("PDK2" . SPARSER::PROTEIN) ("SOX6" . SPARSER::PROTEIN)
    ("miR-181a" . SPARSER::MOLECULE) ("let7" . SPARSER::RNA)
    ("miR-15b" . SPARSER::MOLECULE) ("membrane component" . SPARSER::PROTEIN)
    ("CD63" . SPARSER::PROTEIN) ("miR-16" . SPARSER::PROTEIN)
    ("miR-1" . SPARSER::PROTEIN)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("miR-200a" . SPARSER::MOLECULE)
    ("RASSF1A and RASSF1B" . SPARSER::COLLECTION)
    ("RASSF1A, RASSF1B and RASSF1C" . SPARSER::COLLECTION)
    ("PDX1 and PDX4" . SPARSER::COLLECTION)
    ("PDX1, PDX4 and PDX5" . SPARSER::COLLECTION) ("PSN" . SPARSER::PROTEIN)
    ("disomic CEP3" . SPARSER::PROTEIN)
    ("both disomic CEP3 and RASSF1" . SPARSER::COLLECTION)
    ("CEP3 and RASSF1" . SPARSER::COLLECTION)
    ("PDAC and PDAC" . SPARSER::COLLECTION)
    ("14 primary PDACs" . SPARSER::MOLECULE) ("PDACs" . SPARSER::MOLECULE)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("RAS/PI3K/AKT" . SPARSER::COLLECTION)
    ("RASSF1A, RASSF1B, and RASSF1C" . SPARSER::COLLECTION)
    ("primary PDAC" . SPARSER::MOLECULE)
    ("14 xenografted primary PDAC" . SPARSER::MOLECULE)
    ("96 primary PDAC" . SPARSER::MOLECULE) ("PDX1" . SPARSER::PROTEIN)
    ("Messenger RNA" . SPARSER::RNA) ("DNAse I" . SPARSER::PROTEIN)
    ("CEP3" . SPARSER::PROTEIN) ("MTA-1" . SPARSER::PROTEIN)
    ("RASSF1 A" . SPARSER::PROTEIN)
    ("Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rassf1" . SPARSER::PROTEIN)
    ("Rassf1a" . SPARSER::PROTEIN)
    ("Ras Association Domain Family Member 1" . SPARSER::PROTEIN)
    ("ethidium" . SPARSER::MOLECULE) ("T-T or 6–4PP" . SPARSER::COLLECTION)
    ("oligo" . SPARSER::PROTEIN) ("UV-oligo" . SPARSER::PROTEIN-PAIR)
    ("immunodot-blot" . SPARSER::COLLECTION)
    ("DDB2 or PARP-1" . SPARSER::COLLECTION)
    ("adjacent pyrimidines" . SPARSER::DRUG)
    ("both UV and control oligos" . SPARSER::COLLECTION)
    ("Bsp" . SPARSER::PROTEIN) ("-fragments" . SPARSER::FRAGMENT)
    ("bead-bound DNA" . SPARSER::DNA) ("streptavidin" . SPARSER::PROTEIN)
    ("no other adjacent pyrimidines" . SPARSER::DRUG) ("PP" . SPARSER::PROTEIN)
    ("pyrimidines" . SPARSER::DRUG)
    ("neither GFP nor Rad51" . SPARSER::COLLECTION)
    ("protein GFP ( xref ) or the cellular DNA double strand break-repair protein Rad51 ( xref )"
     . SPARSER::COLLECTION)
    ("the endogenous cellular PARP-1" . SPARSER::PROTEIN)
    ("GFP-" . SPARSER::PROTEIN) ("GFP-PARP-1" . SPARSER::COLLECTION)
    ("exogenous PARP-1" . SPARSER::PROTEIN)
    ("exogenous GFP-tagged PARP-1" . SPARSER::PROTEIN)
    ("GFP-tagged exogenous PARP-1" . SPARSER::PROTEIN)
    ("detergent and salt" . SPARSER::COLLECTION)
    ("residual PARP-1" . SPARSER::PROTEIN)
    ("almost all PARP-1" . SPARSER::PROTEIN)
    ("NER and other repair proteins" . SPARSER::COLLECTION)
    ("Triton" . SPARSER::MOLECULE) ("subnuclear UV-damaged DNA" . SPARSER::DNA)
    ("methanol" . SPARSER::MOLECULE) ("formaldehyde" . SPARSER::MOLECULE)
    ("PARP-1 and DDB2" . SPARSER::COLLECTION)
    ("downstream NER proteins XPA 8,9 and XPC" . SPARSER::COLLECTION)
    ("XPA" . SPARSER::PROTEIN) ("dimers (CPD)" . SPARSER::DIMER)
    ("CPD" . SPARSER::PROTEIN) ("just altered DNA" . SPARSER::DNA)
    ("ADP-ribose (PAR)" . SPARSER::MOLECULE)
    ("DDB2 and PARP-1" . SPARSER::COLLECTION) ("PARP-1 " . SPARSER::PROTEIN)
    ("1−2" . SPARSER::PROTEIN) ("T-T" . SPARSER::PROTEIN)
    ("PAR 2" . SPARSER::PROTEIN) ("DDB2 " . SPARSER::PROTEIN)
    ("DDB2" . SPARSER::PROTEIN)
    ("growth factors and chemokines" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN) ("HGF and EGFR" . SPARSER::COLLECTION)
    ("TGF-α and HGF" . SPARSER::COLLECTION)
    ("AREG and HBEGF" . SPARSER::COLLECTION)
    ("STIM and gene" . SPARSER::COLLECTION) ("TAPI-1" . SPARSER::COLLECTION)
    ("TACE/ADAM17" . SPARSER::COLLECTION)
    ("inhibitor (PF)" . SPARSER::INHIBITOR)
    ("inhibitor (AG)" . SPARSER::INHIBITOR)
    ("both c-Met (HGF) and EGFR (TGF-α)" . SPARSER::COLLECTION)
    ("the respective inhibitors" . SPARSER::INHIBITOR)
    ("c-Met (HGF)" . SPARSER::PROTEIN)
    ("c-Met (HGF-receptor) and Epidermal Growth Factor Receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("PBEC" . SPARSER::PROTEIN) ("ALI-PBEC" . SPARSER::COLLECTION)
    ("STIM" . SPARSER::PROTEIN)
    ("Heparin-binding EGF-like growth factor ( HBEGF ) and Interleukin-6 ( IL6 )"
     . SPARSER::COLLECTION)
    ("amphiregulin ( AREG )" . SPARSER::PROTEIN) ("AREG" . SPARSER::PROTEIN)
    ("HBEGF" . SPARSER::PROTEIN) ("c-Met and EGFR" . SPARSER::COLLECTION)
    ("damaged pulmonary epithelium" . SPARSER::PROTEIN)
    ("HGF or EGFR" . SPARSER::COLLECTION)
    ("mitogen activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factors, c-Met and EGFR" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF) and epidermal growth factor receptor (EGFR) ligands"
     . SPARSER::COLLECTION)
    ("elastase" . SPARSER::PROTEIN) ("severe emphysema" . SPARSER::PROTEIN)
    ("emphysema" . SPARSER::PROTEIN) ("ADAM" . SPARSER::PROTEIN)
    ("MCSs" . SPARSER::PROTEIN) ("EGFR and c-Met" . SPARSER::COLLECTION)
    ("TNF-α/IL-1β" . SPARSER::COLLECTION) ("ALI" . SPARSER::PROTEIN)
    ("the pro-inflammatory cytokines TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION) ("COPD" . SPARSER::PROTEIN)
    ("HGF receptor" . SPARSER::PROTEIN) ("HGF-receptor" . SPARSER::PROTEIN)
    ("Extracellular signal-Regulated Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Interleukin-6" . SPARSER::PROTEIN)
    ("Heparin-binding EGF-like growth factor" . SPARSER::PROTEIN)
    ("Fibroblast Growth Factor 2" . SPARSER::PROTEIN)
    ("ATP5B" . SPARSER::PROTEIN) ("RPL13A" . SPARSER::PROTEIN)
    ("beta-Mercaptoethanol" . SPARSER::MOLECULE) ("ADAM17" . SPARSER::PROTEIN)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN) ("AG1478" . SPARSER::DRUG)
    ("PF04217903" . SPARSER::DRUG)
    ("Epidermal Growth Factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-α" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("CD105" . SPARSER::PROTEIN) ("CD80" . SPARSER::PROTEIN)
    ("CD73" . SPARSER::PROTEIN) ("Interleukin-1β" . SPARSER::PROTEIN)
    ("Tumour Necrosis Factor" . SPARSER::PROTEIN)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rad51 inhibitor and genotoxic agents" . SPARSER::COLLECTION)
    ("a key DNA repair protein" . SPARSER::PROTEIN)
    ("the gefitinib or cotreatment group, and Rad51 plasmid overexpression"
     . SPARSER::COLLECTION)
    ("group, and Rad51" . SPARSER::COLLECTION)
    ("SN-38 and gefitinib" . SPARSER::COLLECTION)
    ("SN-38 or gefitinib" . SPARSER::COLLECTION)
    ("the classic DNA damage marker γ-H2AX and p53" . SPARSER::COLLECTION)
    ("γ-H2AX and p53" . SPARSER::COLLECTION)
    ("quinazoline" . SPARSER::MOLECULE)
    ("gefitinib or irinotecan" . SPARSER::COLLECTION)
    ("gefitinib and irinotecan" . SPARSER::COLLECTION)
    ("lysosomal inhibitors chloroquine (CQ) and proteasome inhibitors MG132"
     . SPARSER::COLLECTION)
    ("chloroquine (CQ)" . SPARSER::PROTEIN)
    ("CHK-1 and CHK-2" . SPARSER::COLLECTION) ("Ko" . SPARSER::PROTEIN)
    ("using Western blot" . SPARSER::PROTEIN)
    ("SN-38 or Gefitinib" . SPARSER::COLLECTION)
    ("PARP, and caspase-3 and gefitinib" . SPARSER::COLLECTION)
    ("caspase-3 and gefitinib" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("gefitinib and/or SN-38" . SPARSER::COLLECTION)
    ("Annexin V-PI" . SPARSER::COLLECTION)
    ("gefitinib or SN-38" . SPARSER::COLLECTION)
    ("SN-38 and combination therapy" . SPARSER::COLLECTION)
    ("gefitinib and SN-38" . SPARSER::COLLECTION)
    ("SRB" . SPARSER::PROTEIN-FAMILY) ("synergizes" . SPARSER::PROTEIN)
    ("GEFI" . SPARSER::PROTEIN)
    ("cleavable topoisomerase I-DNA complex" . SPARSER::BIO-COMPLEX)
    ("Irinotecan or SN-38" . SPARSER::COLLECTION)
    ("Irinotecan" . SPARSER::DRUG)
    ("the standard systemic drug" . SPARSER::DRUG)
    ("inhibitors and gefitinib" . SPARSER::COLLECTION)
    ("irinotecan and gefitinib" . SPARSER::COLLECTION)
    ("MG-132" . SPARSER::DRUG) ("DNA repair protein" . SPARSER::PROTEIN)
    ("SN38" . SPARSER::DRUG) ("CHK-2" . SPARSER::PROTEIN)
    ("CHK-1" . SPARSER::PROTEIN) ("NaVO 3" . SPARSER::MOLECULE)
    ("SN-38" . SPARSER::DRUG) ("protein:protein" . SPARSER::BIO-COMPLEX)
    ("CBP/p300" . SPARSER::COLLECTION)
    ("both distal ubiquitin and an E2 ubiquitin-conjugating enzyme"
     . SPARSER::COLLECTION)
    ("both distal ubiquitin" . SPARSER::PROTEIN)
    ("OTU" . SPARSER::PROTEIN-FAMILY)
    ("K63 and K48 ubiquitin" . SPARSER::COLLECTION)
    ("specifically K48 ubiquitin" . SPARSER::PROTEIN)
    ("PHDs and FIH" . SPARSER::COLLECTION) ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("tankyrase, notch-1, and IκBα" . SPARSER::COLLECTION)
    ("FOXO3a, CyclinD1, ATF-4, and IKKβ" . SPARSER::COLLECTION)
    ("a ubiquitous master regulator" . SPARSER::REGULATOR)
    ("the FIH" . SPARSER::PROTEIN-FAMILY)
    ("Simultaneous glucose" . SPARSER::PROTEIN)
    ("OTUB1 and multiple proteins" . SPARSER::COLLECTION)
    ("metabolism-associated proteins" . SPARSER::PROTEIN)
    ("just 13 proteins" . SPARSER::PROTEIN)
    ("six previously described OTUB1" . SPARSER::PROTEIN)
    ("FLAG-OTUB1" . SPARSER::COLLECTION)
    ("purified FIH and either wild-type OTUB1 peptides" . SPARSER::COLLECTION)
    ("purified FIH" . SPARSER::PROTEIN-FAMILY)
    ("non-targeting siRNA (siNT) or siRNA" . SPARSER::COLLECTION)
    ("endogenous FIH" . SPARSER::PROTEIN-FAMILY)
    ("FLAG-HA-OTUB1" . SPARSER::COLLECTION) ("Nutrient" . SPARSER::MOLECULE)
    ("OTUB1 and FIH" . SPARSER::COLLECTION)
    ("Methionine" . SPARSER::AMINO-ACID)
    ("Endogenous FIH" . SPARSER::PROTEIN-FAMILY)
    ("the prototypic FIH substrate HIF" . SPARSER::PROTEIN-FAMILY)
    ("FIH and OTUB1" . SPARSER::COLLECTION)
    ("deubiquitinase (DUB)" . SPARSER::DEUBIQUITINASE)
    ("DUB" . SPARSER::PROTEIN)
    ("pharmacologic hydroxylase inhibitors" . SPARSER::INHIBITOR)
    ("tankyrase, notch-1, ASPP2, and IκBα" . SPARSER::COLLECTION)
    ("tankyrase" . SPARSER::PROTEIN) ("ARD" . SPARSER::PROTEIN)
    ("FIH" . SPARSER::PROTEIN-FAMILY) ("HIF (FIH)" . SPARSER::PROTEIN-FAMILY)
    ("asparaginyl" . SPARSER::PROTEIN)
    ("von Hippel-Lindau (VHL)" . SPARSER::PROTEIN)
    ("PHD1–3" . SPARSER::COLLECTION) ("Fe(II)-" . SPARSER::MOLECULE)
    ("proline and asparagine" . SPARSER::COLLECTION)
    ("aldehyde" . SPARSER::MOLECULE)
    ("hypoxia-inducible factor (HIF)" . SPARSER::PROTEIN)
    ("L-Arabinose" . SPARSER::MOLECULE) ("bis-tris" . SPARSER::MOLECULE)
    ("UBCH5B" . SPARSER::PROTEIN) ("ATF-4" . SPARSER::PROTEIN)
    ("CyclinD1" . SPARSER::PROTEIN) ("M31" . SPARSER::PROTEIN)
    ("Q96FW1" . SPARSER::PROTEIN) ("TRPV3" . SPARSER::PROTEIN)
    ("ion channel" . SPARSER::PROTEIN-FAMILY) ("notch-1" . SPARSER::PROTEIN)
    ("Q9NWT6" . SPARSER::PROTEIN) ("P40337" . SPARSER::PROTEIN)
    ("Q9H6Z9" . SPARSER::PROTEIN) ("Q9GZT9" . SPARSER::PROTEIN)
    ("Q96KS0" . SPARSER::PROTEIN) ("Fe(II)" . SPARSER::MOLECULE)
    ("asparagine residue" . SPARSER::MOLECULE) ("OTUB1" . SPARSER::PROTEIN)
    ("MIB" . SPARSER::PROTEIN) ("p53 and HER2" . SPARSER::COLLECTION)
    ("intestinal type" . TYPE) ("PPV" . SPARSER::MOLECULE)
    ("FISH, and HER2" . SPARSER::COLLECTION) ("bright" . SPARSER::PROTEIN)
    ("FISH, or dual‐color" . SPARSER::COLLECTION)
    ("Trastuzumab" . SPARSER::DRUG) ("mTOR/NF-κB/LOX-1" . SPARSER::COLLECTION)
    ("mTOR, NF-κB and LOX-1" . SPARSER::COLLECTION)
    ("vasoconstrictive molecules" . SPARSER::MOLECULE)
    ("siRNAs or rapamycin" . SPARSER::COLLECTION)
    ("inﬂammatory cytokines" . SPARSER::PROTEIN) ("sirolimus" . SPARSER::DRUG)
    ("ser/thr" . SPARSER::COLLECTION) ("thr" . SPARSER::AMINO-ACID)
    ("/LDL-R" . SPARSER::COLLECTION) ("LDLR" . SPARSER::PROTEIN)
    ("ox-LDL and inflammatory cytokines" . SPARSER::COLLECTION)
    ("lipoprotein" . SPARSER::PROTEIN) ("pyrrolidine" . SPARSER::DRUG)
    ("P70s6k" . SPARSER::PROTEIN)
    ("the selective autophagic target p62" . SPARSER::PROTEIN)
    ("at least 20 nM rapamycin" . SPARSER::DRUG)
    ("immunosuppressant" . SPARSER::DRUG)
    ("p70s6k and IκBα" . SPARSER::COLLECTION) ("p70s6k" . SPARSER::PROTEIN)
    ("Dil-ox-LDL" . SPARSER::COLLECTION)
    ("Lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ICAM-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("VCAM-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("P-selectins" . SPARSER::PROTEIN) ("LDL-R" . SPARSER::PROTEIN)
    ("P70" . SPARSER::PROTEIN) ("bafilomycin A1" . SPARSER::DRUG)
    ("Ox-LDL" . SPARSER::PROTEIN)
    ("Mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("s6k" . SPARSER::PROTEIN)
    ("ox-LDL" . SPARSER::PROTEIN)
    ("low density lipoprotein" . SPARSER::PROTEIN) ("LOX-1" . SPARSER::PROTEIN)
    ("the exogenous GLS2" . SPARSER::PROTEIN)
    ("endogenous GLS2 and exogenous GLS2" . SPARSER::COLLECTION)
    ("exogenous GLS2" . SPARSER::PROTEIN) ("western-blot" . SPARSER::PROTEIN)
    ("Rac1 or p53" . SPARSER::COLLECTION)
    ("GLS2 or GLS2" . SPARSER::COLLECTION) ("Tiam1/Vav1" . SPARSER::COLLECTION)
    ("p53 and GLS2" . SPARSER::COLLECTION)
    ("p53/GLS2/Rac1" . SPARSER::COLLECTION)
    ("ties" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GLS2/Rac1" . SPARSER::COLLECTION)
    ("protein and negative regulator" . SPARSER::COLLECTION)
    ("Rac1 and its GEFs Tiam1 and VAV1" . SPARSER::COLLECTION)
    ("GLS2 or p53" . SPARSER::COLLECTION)
    ("GLS2 and p53" . SPARSER::COLLECTION) ("HCCs" . SPARSER::PROTEIN)
    ("Tiam1 and VAV-1" . SPARSER::COLLECTION) ("VAV1-HA" . SPARSER::COLLECTION)
    ("Tiam1-HA" . SPARSER::COLLECTION)
    ("Rac1-ΔC33 and Rac1-ΔN29" . SPARSER::COLLECTION)
    ("Rac1-ΔC33" . SPARSER::PROTEIN-PAIR)
    ("GDP or GTPγS" . SPARSER::COLLECTION) ("Rac1-Myc" . SPARSER::COLLECTION)
    ("GLS2-ΔN163" . SPARSER::PROTEIN-PAIR) ("GLS1-Flag" . SPARSER::COLLECTION)
    ("anit" . SPARSER::MOLECULE) ("GLS2 and Rac1" . SPARSER::COLLECTION)
    ("Myc-Rac1" . SPARSER::COLLECTION) ("GLS2-Flag" . SPARSER::COLLECTION)
    ("pLPCX-GLS2-Flag" . SPARSER::COLLECTION)
    ("Tiam1 and VAV1" . SPARSER::COLLECTION) ("guanosine " . SPARSER::MOLECULE)
    ("proteins, lipids, and nucleotides" . SPARSER::COLLECTION)
    ("Glutamine" . SPARSER::AMINO-ACID) ("the enzyme’s" . SPARSER::ENZYME)
    ("glutaminase" . SPARSER::PROTEIN) ("GLS1 and GLS2" . SPARSER::COLLECTION)
    ("GLS" . SPARSER::PROTEIN) ("Glutaminase" . SPARSER::PROTEIN)
    ("Glutaminase 2" . SPARSER::PROTEIN)
    ("Glutaminase activity" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("VAV-1" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTPase-activating" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("glutaminase activity" . SPARSER::PROTEIN)
    ("nucleotide exchange factors" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("GLS2" . SPARSER::PROTEIN) ("GLS1" . SPARSER::PROTEIN)
    ("Akt/Foxo1" . SPARSER::COLLECTION) ("GCSh" . SPARSER::PROTEIN)
    ("HuR, CRD-BP and TTP" . SPARSER::COLLECTION)
    ("PI3K, Akt, mTORC2 and p38" . SPARSER::COLLECTION)
    ("siRNA and p38" . SPARSER::COLLECTION)
    ("PI3K and p38" . SPARSER::COLLECTION)
    ("TSC2 and GSK3" . SPARSER::COLLECTION)
    ("p38 or p38" . SPARSER::COLLECTION)
    ("p38/mTORC2/Akt" . SPARSER::COLLECTION)
    ("cellular c-Myc" . SPARSER::PROTEIN)
    ("The functional Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38, JNK or PI3K" . SPARSER::COLLECTION)
    ("wild type Foxo1 or a mutant" . SPARSER::COLLECTION)
    ("alanines" . SPARSER::AMINO-ACID) ("p38 or JNK" . SPARSER::COLLECTION)
    ("phospho-Akt and c-Myc" . SPARSER::COLLECTION)
    ("phospho-Foxo1, phospho-Akt and c-Myc" . SPARSER::COLLECTION)
    ("Foxo1 and Foxo3" . SPARSER::COLLECTION)
    ("PI3K, p38 or JNK" . SPARSER::COLLECTION)
    ("PDK1 and mTORC2" . SPARSER::COLLECTION)
    ("JNK and mTORC2" . SPARSER::COLLECTION)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("mTOR-Akt" . SPARSER::COLLECTION)
    ("mTOR, phospho-Akt and c-Myc" . SPARSER::COLLECTION)
    ("p38, JNK and PI3K" . SPARSER::COLLECTION)
    ("SB202190 and SP600125" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("PI3K (PTEN)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SB202190, LY294002 and SP600125" . SPARSER::COLLECTION)
    ("PD98059 (ERK inhibitor) or SP600125 (JNK inhibitor) 1 h"
     . SPARSER::COLLECTION)
    ("PI3K, p38 and JNK" . SPARSER::COLLECTION)
    ("PI3K/PDK1" . SPARSER::COLLECTION)
    ("Akt, ERK, p38, and JNK" . SPARSER::COLLECTION)
    ("Akt, ERK, p38, or JNK" . SPARSER::COLLECTION)
    ("metallothionein (MT) and glutathione (GSH)" . SPARSER::COLLECTION)
    ("the toxic metal ions" . SPARSER::MOLECULE)
    ("Foxo4 and Foxo6" . SPARSER::COLLECTION) ("Foxo6" . SPARSER::PROTEIN)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Foxo4 (AFX) and Foxo6" . SPARSER::COLLECTION)
    ("Foxo1 (FKHR), Foxo3 (FKHRL1), Foxo4 (AFX) and Foxo6"
     . SPARSER::COLLECTION)
    ("AFX" . SPARSER::PROTEIN) ("FKHR" . SPARSER::PROTEIN)
    ("endoribonuclease" . SPARSER::PROTEIN) ("TTP" . SPARSER::PROTEIN)
    ("tristetraprolin" . SPARSER::PROTEIN) ("ribonuclease" . SPARSER::PROTEIN)
    ("antigen" . SPARSER::PROTEIN) ("ERK and GSK-3β" . SPARSER::COLLECTION)
    ("PI3K-Akt-GSK-3β" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos and c-Myc" . SPARSER::COLLECTION)
    ("p38, JNK, ERK, PI3K and Akt" . SPARSER::COLLECTION)
    ("the metal-responsive transcription factor 1" . SPARSER::PROTEIN)
    ("The activated Akt phosphorylated Foxo1" . SPARSER::PROTEIN)
    ("PI3K, JNK and mTORC2" . SPARSER::COLLECTION)
    ("PI3K, p38, ERK and JNK" . SPARSER::COLLECTION)
    ("SGK1" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("lamin B1" . SPARSER::PROTEIN) ("NDRG1" . SPARSER::PROTEIN)
    ("SB202190" . SPARSER::DRUG) ("Foxo4" . SPARSER::PROTEIN)
    ("FKHRL1" . SPARSER::PROTEIN) ("Foxo3" . SPARSER::PROTEIN)
    ("CRD-BP" . SPARSER::PROTEIN) ("FBW7" . SPARSER::PROTEIN)
    ("MTF-1" . SPARSER::PROTEIN) ("transcription factor 1" . SPARSER::PROTEIN)
    ("Foxo1" . SPARSER::PROTEIN) ("Cd-" . SPARSER::PROTEIN)
    ("phospho-MEK, Erk, and p90RSK" . SPARSER::COLLECTION)
    ("ULK1 and FIP200" . SPARSER::COLLECTION)
    ("PLX4032 or CQ" . SPARSER::COLLECTION)
    ("PLX4032 or PLX4032" . SPARSER::COLLECTION)
    ("AMPK or its upstream kinases" . SPARSER::COLLECTION)
    ("MEK-Erk-p90RSK" . SPARSER::COLLECTION)
    ("Raptor (Ser792) and ULK1 (Ser757)" . SPARSER::COLLECTION)
    ("AMPK-ULK1" . SPARSER::COLLECTION) ("AMPK–ULK1" . SPARSER::COLLECTION)
    ("AMPK and ULK1" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("phospho-mTOR" . SPARSER::PROTEIN)
    ("PLX4032 or PLX4720 and CQ" . SPARSER::COLLECTION)
    ("PLX4720 and CQ" . SPARSER::COLLECTION)
    ("PLX4032 and CQ" . SPARSER::COLLECTION)
    ("Atg13 or Atg7" . SPARSER::COLLECTION) ("CQ" . SPARSER::PROTEIN)
    ("PLX4032 or PLX4720" . SPARSER::COLLECTION)
    ("RNAs (siRNAs) or a pharmacological inhibitor" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION) ("RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("p53, Beclin1, and Bcl-2" . SPARSER::COLLECTION)
    ("-mTOR" . SPARSER::COLLECTION) ("-AMP-activated" . SPARSER::COLLECTION)
    ("PI3K-Akt-mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("the unc-51-like kinase 1 (ULK1) and ULK2 and the subunits autophagy-related gene"
     . SPARSER::COLLECTION)
    ("ULK2 and the subunits autophagy-related gene" . SPARSER::COLLECTION)
    ("Atg13" . SPARSER::PROTEIN)
    ("the Food and Drug Administration" . SPARSER::COLLECTION)
    ("MEK-ERK-RSK" . SPARSER::COLLECTION) ("PLX4032 " . SPARSER::DRUG)
    ("as 2" . SPARSER::PROTEIN) ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c–nu" . SPARSER::PROTEIN) ("light chain 3" . SPARSER::PROTEIN)
    ("PLX4032" . SPARSER::DRUG) ("LKB1-AMPK" . SPARSER::PROTEIN)
    ("kinase-interacting protein" . SPARSER::PROTEIN)
    ("ULK2" . SPARSER::PROTEIN) ("unc-51-like kinase 1" . SPARSER::PROTEIN)
    ("53BP1/REV7" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 , or RAD51C" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, or RAD51" . SPARSER::COLLECTION)
    ("HR and shelterin" . SPARSER::COLLECTION)
    ("Brca2 and Trf1" . SPARSER::COLLECTION) ("Trf1" . SPARSER::PROTEIN)
    ("olaparib or IR" . SPARSER::COLLECTION)
    ("chromatin-associated RPA" . SPARSER::PROTEIN)
    ("53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("REV7 or 53BP1" . SPARSER::COLLECTION) ("intact Brca1" . SPARSER::PROTEIN)
    ("REV7 ( xref A; xref ) or 53BP1 ( xref B; xref )" . SPARSER::COLLECTION)
    ("a previously reported G4-stabilizing drug" . SPARSER::DRUG)
    ("Ligands" . SPARSER::LIGAND) ("H2AX and CHK1" . SPARSER::COLLECTION)
    ("aphidicolin" . SPARSER::PROTEIN) ("RAD51-" . SPARSER::PROTEIN)
    ("IdU" . SPARSER::DRUG)
    ("replication protein A (RPA) subnuclear foci" . SPARSER::PROTEIN)
    ("protein A (RPA)" . SPARSER::PROTEIN)
    ("RAD51 or BRCA2" . SPARSER::COLLECTION)
    ("telomeric FISH" . SPARSER::PROTEIN) ("Alkaline" . SPARSER::PROTEIN)
    ("BRCA2 or RAD51" . SPARSER::COLLECTION)
    ("PARP1 and γH2AX" . SPARSER::COLLECTION) ("HR-" . SPARSER::PROTEIN)
    ("Brca1 or 53BP1" . SPARSER::COLLECTION)
    ("Cre-treated Brca2  F/- MEFs" . SPARSER::PROTEIN)
    ("PDS or poly (ADP-ribose) polymerase 1 (PARP1) inhibitor olaparib"
     . SPARSER::DRUG)
    ("IF-FISH" . SPARSER::COLLECTION)
    ("Cre-treated Brca2  F/- and Rad51c  F/F MEFs" . SPARSER::PROTEIN)
    ("Brca2 or Rad51c" . SPARSER::COLLECTION) ("Rad51c" . SPARSER::PROTEIN)
    ("Brca2" . SPARSER::PROTEIN) ("RAD51C-" . SPARSER::PROTEIN)
    ("Doxycycline" . SPARSER::DRUG) ("RAD51C or BRCA2" . SPARSER::COLLECTION)
    ("BRCA2 and RAD51C" . SPARSER::COLLECTION) ("BRCA2-" . SPARSER::PROTEIN)
    ("BRCA2 and RAD51" . SPARSER::COLLECTION) ("duplex DNA" . SPARSER::DNA)
    ("FANCJ, PIF1, RECQ, BLM, and WRN" . SPARSER::COLLECTION)
    ("RECQ" . SPARSER::PROTEIN-FAMILY) ("FANCJ" . SPARSER::PROTEIN)
    ("Helicases" . SPARSER::PROTEIN)
    ("several other structure-specific antibodies" . SPARSER::ANTIBODY)
    ("a monovalent cation" . SPARSER::MOLECULE)
    ("homologous duplex DNA molecule" . SPARSER::MOLECULE)
    ("secondary DNA" . SPARSER::DNA)
    ("polymerases, helicases, and nucleases" . SPARSER::COLLECTION)
    ("polymerases" . SPARSER::PROTEIN) ("53BP1 or REV7" . SPARSER::COLLECTION)
    ("Pif1" . SPARSER::PROTEIN) ("pif1" . SPARSER::PROTEIN)
    ("S6B" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("G-to-C" . SPARSER::PROTEIN) ("REV1" . SPARSER::PROTEIN)
    ("PIF1" . SPARSER::PROTEIN) ("REV7" . SPARSER::PROTEIN)
    ("dNTP" . SPARSER::MOLECULE) ("dinucleotide" . SPARSER::MOLECULE)
    ("VE-821 and VX-970 and CHK1" . SPARSER::COLLECTION)
    ("VX-970 and CHK1" . SPARSER::COLLECTION)
    ("the ATR inhibitor VE-821 and the CHK1 inhibitor AZD7762"
     . SPARSER::COLLECTION)
    ("synergistic cytotoxic" . SPARSER::PROTEIN)
    ("VE-821, and AZD7762" . SPARSER::COLLECTION)
    ("CDK/CDC7" . SPARSER::COLLECTION) ("Roscovitine" . SPARSER::DRUG)
    ("CHK1 and the ATR inhibitor VE-821" . SPARSER::COLLECTION)
    ("SCH" . SPARSER::PROTEIN)
    ("one null CHK1 allele and one allele" . SPARSER::COLLECTION)
    ("CHK1 and CHK2" . SPARSER::COLLECTION) ("ATR-CHK1" . SPARSER::COLLECTION)
    ("BJ-hTERT" . SPARSER::PROTEIN-PAIR) ("p53 and RB" . SPARSER::COLLECTION)
    ("hTERT" . SPARSER::PROTEIN) ("cMYC" . SPARSER::PROTEIN)
    ("ATM and JNK" . SPARSER::COLLECTION)
    ("small molecule JNK (SR-3306) and ATM (KU-55933) inhibitors"
     . SPARSER::COLLECTION)
    ("the pan-nuclear γH2AX" . SPARSER::PROTEIN)
    ("UVA-induced pan-nuclear γH2AX" . SPARSER::PROTEIN)
    ("JNK and ATM" . SPARSER::COLLECTION)
    ("AZD7762 and VE-821" . SPARSER::COLLECTION)
    ("AZD7762 (30 or 60 nM) and 10 μM VE-821" . SPARSER::COLLECTION)
    ("pan-nuclear γH2AX and nuclear 53BP1" . SPARSER::COLLECTION)
    ("γH2AX foci or pan-nuclear γH2AX (a marker of widespread replication fork collapse)"
     . SPARSER::COLLECTION)
    ("pan-nuclear γH2AX" . SPARSER::PROTEIN)
    ("VE-821 or AZD7762" . SPARSER::COLLECTION)
    ("VE-821 and AZD7762" . SPARSER::COLLECTION)
    ("ATM or DNAPK" . SPARSER::COLLECTION)
    ("VE-821 and VX-970" . SPARSER::COLLECTION) ("DNAPK" . SPARSER::PROTEIN)
    ("γH2AX, and DNA" . SPARSER::COLLECTION)
    ("VX-970 and AZD7762" . SPARSER::COLLECTION)
    ("both the ATR inhibitor VE-821 and the CHK1 inhibitor AZD7762"
     . SPARSER::COLLECTION)
    ("compensatory DNA damage response proteins" . SPARSER::PROTEIN)
    ("ATM and p53" . SPARSER::COLLECTION)
    ("premature chromosome condensation" . SPARSER::PROTEIN-FAMILY)
    ("kinases, ATR and CHK1" . SPARSER::COLLECTION)
    ("ssDNA" . SPARSER::PROTEIN) ("ATR " . SPARSER::PROTEIN)
    ("α-Tocopherol" . SPARSER::MOLECULE) ("C–5" . SPARSER::PROTEIN)
    ("CDC7" . SPARSER::PROTEIN) ("VE-822" . SPARSER::DRUG)
    ("RASV12" . SPARSER::DRUG) ("H-RAS" . SPARSER::PROTEIN)
    ("B–1" . SPARSER::PROTEIN) ("A–S1" . SPARSER::PROTEIN)
    ("VX-970" . SPARSER::DRUG) ("AZD7762" . SPARSER::DRUG)
    ("HDACs and oncogenic BRAF" . SPARSER::COLLECTION)
    ("sclerostin" . SPARSER::PROTEIN) ("SOST" . SPARSER::PROTEIN)
    ("HDAC6 and SIRT2" . SPARSER::COLLECTION)
    ("gluconeogenic enzymes genes" . SPARSER::GENE)
    ("HDACs and SIRTs" . SPARSER::COLLECTION) ("fructose" . SPARSER::PROTEIN)
    ("FBP" . SPARSER::PROTEIN) ("Smurf" . SPARSER::PROTEIN)
    ("HDAC4 and HDAC5" . SPARSER::COLLECTION)
    ("RunX2 and PKM2" . SPARSER::COLLECTION) ("Istodax" . SPARSER::DRUG)
    ("Zolinza" . SPARSER::DRUG)
    ("hexamethylene bisacetamide (HMBA) and MS275" . SPARSER::COLLECTION)
    ("HMBA" . SPARSER::DRUG) ("shRNA and HDAC6" . SPARSER::COLLECTION)
    ("shRNA, and HDAC6" . SPARSER::COLLECTION)
    ("MMP9 and vimentin" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("Fan and Qin" . SPARSER::COLLECTION) ("Fan" . SPARSER::PROTEIN)
    ("the most efficient shRNA" . SPARSER::PROTEIN)
    ("reportedly available HDACis" . SPARSER::MOLECULE)
    ("PCI" . SPARSER::PROTEIN) ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HBI" . SPARSER::PROTEIN) ("CS" . SPARSER::PROTEIN)
    ("HDACis" . SPARSER::MOLECULE) ("entinostat" . SPARSER::DRUG)
    ("mocetinostat" . SPARSER::DRUG) ("multi-HDAC" . SPARSER::COLLECTION)
    ("HDAC5 or HDAC6" . SPARSER::COLLECTION)
    ("HDAC5 and HDAC6" . SPARSER::COLLECTION)
    ("panobinostat and vorinostat" . SPARSER::COLLECTION)
    ("panobinostat" . SPARSER::DRUG) ("N-myc" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("RunX2" . SPARSER::PROTEIN)
    ("hexamethylene bisacetamide" . SPARSER::DRUG) ("c-nu" . SPARSER::PROTEIN)
    ("Cathepsin-D" . SPARSER::PROTEIN)
    ("heat-shock protein 90" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("MS275" . SPARSER::DRUG) ("PXD101" . SPARSER::DRUG)
    ("ITF2357" . SPARSER::DRUG) ("LBH589" . SPARSER::DRUG)
    ("Plk1 kinase and the HR complex" . SPARSER::COLLECTION)
    ("PALB2, BRCA2 and Rad51" . SPARSER::COLLECTION)
    ("BRCA2 and Rad51" . SPARSER::COLLECTION)
    ("BRCA1-PALB2-BRCA2" . SPARSER::COLLECTION)
    ("CDK1 and Plk1" . SPARSER::COLLECTION)
    ("Plk1 and BRCA1" . SPARSER::COLLECTION) ("S1164/S1377" . SPARSER::PROTEIN)
    ("wtBRCA1" . SPARSER::PROTEIN) ("HA-BRCA1 S1164/S1377" . SPARSER::PROTEIN)
    ("HA-wtBRCA1" . SPARSER::COLLECTION)
    ("characteristic HA-BRCA1 foci" . SPARSER::PROTEIN)
    ("HA-BRCA1" . SPARSER::COLLECTION) ("GST-BRCA1" . SPARSER::COLLECTION)
    ("FAE" . SPARSER::PROTEIN) ("DTS" . SPARSER::PROTEIN)
    ("paclitaxel (PTX)" . SPARSER::DRUG)
    ("using immunoprecipitated endogenous Plk1 and recombinant BRCA1 protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("protein and BRCA1" . SPARSER::COLLECTION)
    ("casein" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1 and Plk1" . SPARSER::COLLECTION)
    ("Plk1-BRCA1" . SPARSER::COLLECTION)
    ("at least five large BRCA1 foci" . SPARSER::PROTEIN)
    ("larger foci" . SPARSER::PROTEIN)
    ("at least five detectable Rad51 foci" . SPARSER::PROTEIN)
    ("CLM" . SPARSER::PROTEIN)
    ("the I-SceI endonuclease and a second downstream modified GFP fragment"
     . SPARSER::COLLECTION)
    ("residual γH2AX foci" . SPARSER::PROTEIN) ("Pre" . SPARSER::PROTEIN)
    ("ATM, ATR and Chk2" . SPARSER::COLLECTION)
    ("efficiently form Rad51 foci" . SPARSER::PROTEIN)
    ("BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("the HR pathway form subnuclear foci" . SPARSER::PROTEIN)
    ("BRCA2, PALB2 and Rad51" . SPARSER::COLLECTION) ("DNA-end" . SPARSER::DNA)
    ("Rad51-ssDNA" . SPARSER::PROTEIN-PAIR)
    ("Mre11, Rad50 and Nbs1" . SPARSER::COLLECTION)
    ("RPA-Rad51" . SPARSER::COLLECTION) ("recombinase" . SPARSER::PROTEIN)
    ("CDK1-cyclin" . SPARSER::COLLECTION) ("Kap1" . SPARSER::PROTEIN)
    ("HSP60" . SPARSER::PROTEIN) ("RO-3306" . SPARSER::DRUG)
    ("pre-replicative complexes" . SPARSER::BIO-COMPLEX)
    ("Polo-like kinase" . SPARSER::PROTEIN)
    ("the mesenchymal phenotype prone" . SPARSER::PROTEIN-FAMILY)
    ("IL-6 and IL-4 receptor" . SPARSER::COLLECTION)
    ("TGF-β and IL-10" . SPARSER::COLLECTION)
    ("HDAC and macrophages" . SPARSER::COLLECTION)
    ("especially M2 macrophages" . SPARSER::PROTEIN)
    ("CD68 and Arginase1" . SPARSER::COLLECTION)
    ("macrophages, and IL-4 receptor" . SPARSER::COLLECTION)
    ("saha" . SPARSER::DRUG) ("p-HDAC3" . SPARSER::COLLECTION)
    ("media stimulated EMT" . SPARSER::PROTEIN)
    ("CD163 and Arginase1" . SPARSER::COLLECTION)
    ("macrophages, and EMT" . SPARSER::COLLECTION)
    ("Arginase" . SPARSER::PROTEIN)
    ("collagen and α-SMA" . SPARSER::COLLECTION) ("TSP" . SPARSER::PROTEIN)
    ("Cigarette" . SPARSER::DRUG) ("LSL-Kras" . SPARSER::COLLECTION)
    ("Pdx1-Cre" . SPARSER::COLLECTION) ("LSL" . SPARSER::PROTEIN)
    ("Cre" . SPARSER::PROTEIN) ("HDAC and IL-6" . SPARSER::COLLECTION)
    ("Zeb1" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("HDAC3 and IL-6" . SPARSER::COLLECTION)
    ("l -glutamine" . SPARSER::MOLECULE)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("Pdx1" . SPARSER::PROTEIN)
    ("Th2" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("interleukin-4" . SPARSER::PROTEIN) ("IL-4 receptor" . SPARSER::PROTEIN)
    ("profibrotic mediators" . SPARSER::PROTEIN)
    ("/COX-2 " . SPARSER::COLLECTION)
    ("TGFβ, IL-1β, TNFα and LPS" . SPARSER::COLLECTION)
    ("the proximal COX-2 promoter" . SPARSER::PROMOTER)
    ("transcription factor or co-stimulatory" . SPARSER::COLLECTION)
    ("Western blotting siRNA" . SPARSER::PROTEIN)
    ("mRNA (ANOVA)" . SPARSER::PROTEIN)
    ("CpG 2 and CpG3" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("Zebularine" . SPARSER::DRUG)
    ("inhibitor, 5AZA or HDAC" . SPARSER::COLLECTION)
    ("mature COX-2 mRNA" . SPARSER::PROTEIN)
    ("cyclooxygenase-2 ( COX-2 , PTGS2 ) and its downstream anti-fibrotic product prostaglandin (PG) E 2"
     . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("COX-2 and PGE 2" . SPARSER::COLLECTION)
    ("the fibroproliferative state" . SPARSER::BIO-STATE)
    ("COX- 2" . SPARSER::PROTEIN) ("C8orf4" . SPARSER::PROTEIN)
    ("PTGER2" . SPARSER::PROTEIN) ("CpG 2" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("EIF4A2" . SPARSER::PROTEIN)
    ("TGF-β 1" . SPARSER::PROTEIN) ("5-lipoxygenase" . SPARSER::PROTEIN)
    ("GM-CSF" . SPARSER::PROTEIN)
    ("Granulocyte-macrophage colony stimulating factor" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN) ("–3 " . SPARSER::PROTEIN)
    ("c8orf4 " . SPARSER::PROTEIN) ("E 2" . SPARSER::MOLECULE)
    ("COX-2 " . SPARSER::PROTEIN) ("c8orf4" . SPARSER::PROTEIN)
    ("TC-1" . SPARSER::PROTEIN)
    ("chromosome 8 open reading frame 4" . SPARSER::PROTEIN)
    ("mir145" . SPARSER::PROTEIN) ("Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("mesenchymal genes" . SPARSER::GENE)
    ("APC , CTNNB1 or KRAS" . SPARSER::COLLECTION)
    ("MYC and its related targets genes" . SPARSER::COLLECTION)
    ("a more aggressive oncogene such asKRAS mut" . SPARSER::PROTEIN)
    ("mut and transcription factor" . SPARSER::COLLECTION)
    ("VIM and SLUG" . SPARSER::COLLECTION) ("SLUG" . SPARSER::PROTEIN)
    ("LGR5 or KRAS" . SPARSER::COLLECTION) ("/KRAS" . SPARSER::COLLECTION)
    ("these spatiotemporal LGR5" . SPARSER::PROTEIN)
    ("/LGR5" . SPARSER::COLLECTION) ("miR145" . SPARSER::PROTEIN)
    ("lenti-miR145" . SPARSER::COLLECTION)
    ("pluripotency genes and suppression of human embryonic SC"
     . SPARSER::COLLECTION)
    ("systemic regulators" . SPARSER::REGULATOR) ("pCCL" . SPARSER::PROTEIN)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lenti-pCCL and lenti-KRAS mut (Figure xref )" . SPARSER::COLLECTION)
    ("lenti-pCCL" . SPARSER::COLLECTION) ("Lenti-" . SPARSER::PROTEIN)
    ("Lenti" . SPARSER::PROTEIN) ("SOX2, FGFR1 and LCK" . SPARSER::COLLECTION)
    ("LCK" . SPARSER::PROTEIN)
    ("factors enriched byKRAS mut" . SPARSER::PROTEIN)
    ("mut and LGR5" . SPARSER::COLLECTION)
    ("mut and lenti-" . SPARSER::COLLECTION) ("lenti-" . SPARSER::PROTEIN)
    ("lenti" . SPARSER::PROTEIN) ("lenti-KRAS" . SPARSER::COLLECTION)
    ("mut , LGR5, and pCCL" . SPARSER::COLLECTION)
    ("LGR5 and KRAS" . SPARSER::COLLECTION)
    ("MEK and AKT" . SPARSER::COLLECTION)
    ("APC or CTNNB1" . SPARSER::COLLECTION)
    ("lithium chloride" . SPARSER::DRUG) ("Lgr5" . SPARSER::PROTEIN)
    ("Foxn1" . SPARSER::PROTEIN) ("β-ACTIN" . SPARSER::PROTEIN)
    ("KLF4" . SPARSER::PROTEIN) ("LGR5" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor 5" . SPARSER::PROTEIN)
    ("miR-100-corresponding genes" . SPARSER::GENE)
    ("miR-100 correlative genes" . SPARSER::GENE)
    ("Paclitaxel" . SPARSER::DRUG) ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("rapamycin and paclitaxel" . SPARSER::COLLECTION)
    ("insulin-like growth factor (IGF)" . SPARSER::PROTEIN)
    ("PLK1 and SMARCA5" . SPARSER::COLLECTION)
    ("progesterone receptor (PR) and human epidermal growth factor receptor"
     . SPARSER::COLLECTION)
    ("ER-, PR- and HER2+" . SPARSER::COLLECTION)
    ("ER-, PR- and HER2-" . SPARSER::COLLECTION) ("ER-" . SPARSER::PROTEIN)
    ("micro RNA" . SPARSER::RNA) ("Luminal" . SPARSER::DRUG)
    ("17β-estradiol" . SPARSER::PROTEIN) ("Micro-RNAs" . SPARSER::MICRO-RNA)
    ("SMARCA5" . SPARSER::PROTEIN) ("SCD-protein" . SPARSER::COLLECTION)
    ("SCD-proteins" . SPARSER::COLLECTION) ("FMRP" . SPARSER::PROTEIN)
    ("neurotransmitter" . SPARSER::MOLECULE)
    ("Semaphorins, Netrins and Slit" . SPARSER::COLLECTION)
    ("Semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("synaptic proteins" . SPARSER::PROTEIN)
    ("VAMP2 and Synapsin-I" . SPARSER::COLLECTION)
    ("coatomer" . SPARSER::BIO-COMPLEX)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("novel possible ATM and ATR" . SPARSER::COLLECTION)
    ("DCC, ROBO2/3 and PLXNB2/3" . SPARSER::COLLECTION)
    ("NES, CTTNBP2, NF1 and MAP1B" . SPARSER::COLLECTION)
    ("DCC" . SPARSER::PROTEIN) ("GLI2 and GLI3" . SPARSER::COLLECTION)
    ("ARFGEF1, CKAP4, HERC1 and HIP1R" . SPARSER::COLLECTION)
    ("MYH6, MYO3A, MYO5C and MYH7" . SPARSER::COLLECTION)
    ("SPTBN5 and SPTBN1" . SPARSER::COLLECTION)
    ("CNN1, CNN2 and CNN3" . SPARSER::COLLECTION) ("RHOU" . SPARSER::PROTEIN)
    ("calponin" . SPARSER::PROTEIN) ("Spectrin" . SPARSER::PROTEIN)
    ("myosins" . SPARSER::PROTEIN-FAMILY) ("Examples" . SPARSER::EXAMPLE)
    ("ARF1/ARF3" . SPARSER::COLLECTION)
    ("SNARE proteins (STX17, STX4 and STX6) and the ESCRT-II complex (VPS36)"
     . SPARSER::COLLECTION)
    ("the Clathrin-associated adaptor protein complex" . SPARSER::BIO-COMPLEX)
    ("COG7, USO1, GOLGA5, GOLGA2, GOLGB1 and GCC1" . SPARSER::COLLECTION)
    ("AP1G1, AP2M1 and AP4M1" . SPARSER::COLLECTION)
    ("VPS52 and COPB2" . SPARSER::COLLECTION)
    ("SEC24B, SEC24D and SEC31B" . SPARSER::COLLECTION)
    ("STX17, STX4 and STX6" . SPARSER::COLLECTION) ("SNARE" . SPARSER::PROTEIN)
    ("Clathrin" . SPARSER::PROTEIN)
    ("condensin (NCAPD2) and a regulator" . SPARSER::COLLECTION)
    ("Other noteworthy putative targets" . SPARSER::TARGET-PROTEIN)
    ("DCLRE1a" . SPARSER::PROTEIN) ("rDNA" . SPARSER::PROTEIN)
    ("condensin" . SPARSER::PROTEIN-FAMILY) ("Shelterin" . SPARSER::PROTEIN)
    ("several centrosomal proteins" . SPARSER::PROTEIN)
    ("centromere proteins (CENPJ and CENPF) and key regulators"
     . SPARSER::COLLECTION)
    ("several kinesins (KIF15 and KIF11), centromere proteins (CENPJ and CENPF) and key regulators"
     . SPARSER::COLLECTION)
    ("KIF15 and KIF11" . SPARSER::COLLECTION)
    ("NUMA1 and SPAG5" . SPARSER::COLLECTION) ("CENPF" . SPARSER::PROTEIN)
    ("Fanconi Anemia (FANCM)" . SPARSER::PROTEIN) ("FANCM" . SPARSER::PROTEIN)
    ("WRN" . SPARSER::PROTEIN) ("holoenzyme" . SPARSER::PROTEIN)
    ("TFIIH" . SPARSER::PROTEIN) ("TFIID" . SPARSER::PROTEIN)
    ("response element (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("CREB1, EP300 and CREBBP" . SPARSER::COLLECTION)
    ("−3 and p  " . SPARSER::COLLECTION)
    ("at least one SCD" . SPARSER::PROTEIN)
    ("proteomic SCD" . SPARSER::PROTEIN) ("SCDs" . SPARSER::PROTEIN)
    ("possible ATM/ATR" . SPARSER::COLLECTION)
    ("serines and threonines" . SPARSER::COLLECTION)
    ("threonines" . SPARSER::AMINO-ACID)
    ("the possible ATM" . SPARSER::PROTEIN)
    ("a progressive cerebellar ataxia" . SPARSER::PROTEIN)
    ("Ataxia" . SPARSER::PROTEIN) ("ATM/ATR" . SPARSER::COLLECTION)
    ("SCD" . SPARSER::PROTEIN) ("TQ" . SPARSER::DRUG)
    ("Synapsin-I" . SPARSER::PROTEIN) ("VAMP2" . SPARSER::PROTEIN)
    ("MAP1B" . SPARSER::PROTEIN) ("CTTNBP2" . SPARSER::PROTEIN)
    ("PLXNB2" . SPARSER::PROTEIN) ("ROBO2" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("GLI3" . SPARSER::PROTEIN)
    ("GLI2" . SPARSER::PROTEIN) ("POU6F1" . SPARSER::PROTEIN)
    ("TBR1" . SPARSER::PROTEIN) ("brain-specific" . SPARSER::PROTEIN)
    ("CNN3" . SPARSER::PROTEIN) ("CNN2" . SPARSER::PROTEIN)
    ("CNN1" . SPARSER::PROTEIN) ("SPTBN1" . SPARSER::PROTEIN)
    ("SPTBN5" . SPARSER::PROTEIN) ("MYH7" . SPARSER::PROTEIN)
    ("MYO5C" . SPARSER::PROTEIN) ("MYO3" . SPARSER::PROTEIN)
    ("MYH6" . SPARSER::PROTEIN) ("HIP1R" . SPARSER::PROTEIN)
    ("HERC1" . SPARSER::PROTEIN) ("CKAP4" . SPARSER::PROTEIN)
    ("ARFGEF1" . SPARSER::PROTEIN) ("ARF3" . SPARSER::PROTEIN)
    ("ARF1" . SPARSER::PROTEIN) ("VPS36" . SPARSER::PROTEIN)
    ("ESCRT-II" . SPARSER::PROTEIN-FAMILY) ("STX6" . SPARSER::PROTEIN)
    ("STX4" . SPARSER::PROTEIN) ("STX17" . SPARSER::PROTEIN)
    ("SEC24D" . SPARSER::PROTEIN) ("SEC24B" . SPARSER::PROTEIN)
    ("COPB2" . SPARSER::PROTEIN) ("VPS52" . SPARSER::PROTEIN)
    ("AP4M1" . SPARSER::PROTEIN) ("AP2M1" . SPARSER::PROTEIN)
    ("AP1G1" . SPARSER::PROTEIN) ("GCC1" . SPARSER::PROTEIN)
    ("GOLGB1" . SPARSER::PROTEIN) ("GOLGA2" . SPARSER::PROTEIN)
    ("GOLGA5" . SPARSER::PROTEIN) ("USO1" . SPARSER::PROTEIN)
    ("COG7" . SPARSER::PROTEIN) ("TTF1" . SPARSER::PROTEIN)
    ("NCAPD2" . SPARSER::PROTEIN) ("TERF2IP" . SPARSER::PROTEIN)
    ("PCM1" . SPARSER::PROTEIN) ("SPAG5" . SPARSER::PROTEIN)
    ("NUMA1" . SPARSER::PROTEIN) ("KIF15" . SPARSER::PROTEIN)
    ("POLA1" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("CREB1" . SPARSER::PROTEIN) ("SMC1" . SPARSER::PROTEIN)
    ("ESCO1" . SPARSER::PROTEIN) ("Metformin" . SPARSER::DRUG)
    ("an antidiabetic drug" . SPARSER::DRUG)
    ("glucose or STAT3" . SPARSER::COLLECTION)
    ("glucose or reducing STAT3 activation" . SPARSER::COLLECTION)
    ("STAT3 and Src" . SPARSER::COLLECTION)
    ("Src and FAK" . SPARSER::COLLECTION)
    ("p-Src (Y419) and p-SFKs" . SPARSER::COLLECTION)
    ("wnt/β-catenin" . SPARSER::COLLECTION)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1, vimentin and MMP2" . SPARSER::COLLECTION)
    ("HG and STAT3" . SPARSER::COLLECTION)
    ("normal and high glucose" . SPARSER::PROTEIN)
    ("cyclin D1, MMP2, and vimentin" . SPARSER::COLLECTION)
    ("Stattic" . SPARSER::DRUG) ("Glucose" . SPARSER::PROTEIN)
    ("Rho " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytoplasmic STAT3 and cytoplasmic pSTAT3 (S727)" . SPARSER::COLLECTION)
    ("glucose (FBG)" . SPARSER::MOLECULE) ("dL" . SPARSER::MOLECULE)
    ("various histological types" . TYPE) ("p-AMPKα" . SPARSER::COLLECTION)
    ("Fgr" . SPARSER::PROTEIN) ("multiple cellular kinases" . SPARSER::KINASE)
    ("normal glucose (N; 5.56 mM) or high glucose (H; 25 mM)"
     . SPARSER::COLLECTION)
    ("tie" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fluke" . SPARSER::PROTEIN)
    ("glucose and STAT3" . SPARSER::COLLECTION)
    ("proteins, cyclin D1, vimentin and MMP2" . SPARSER::COLLECTION)
    ("normal glucose" . SPARSER::PROTEIN) ("phospho-kinase" . SPARSER::PROTEIN)
    ("Phospho-kinase" . SPARSER::PROTEIN) ("a 37 " . SPARSER::PROTEIN)
    ("p-Src" . SPARSER::PROTEIN) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("phospho-kinases" . SPARSER::PROTEIN) ("Nai" . SPARSER::MOLECULE)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("Miki" . SPARSER::PROTEIN) ("Lyn" . SPARSER::PROTEIN)
    ("Vav1 and Vav3" . SPARSER::COLLECTION)
    ("Rac1 and Rho" . SPARSER::COLLECTION) ("VAV" . SPARSER::PROTEIN)
    ("fostamatinib" . SPARSER::DRUG) ("SYK and VAV1" . SPARSER::COLLECTION)
    ("Calcium" . SPARSER::CALCIUM) ("LYN, SYK and VAV1" . SPARSER::COLLECTION)
    ("IgE and FcεRI" . SPARSER::COLLECTION)
    ("mediators and proteoglycans" . SPARSER::COLLECTION)
    ("IgE-antigen" . SPARSER::PROTEIN-PAIR)
    ("proteoglycans" . SPARSER::PROTEIN) ("IgE" . SPARSER::PROTEIN)
    ("RI" . SPARSER::MOLECULE)
    ("SYK (27.3 ± 8.3) and PTPN6 (2.0 ± 0.5)" . SPARSER::COLLECTION)
    ("LYN (2.2 ± 0.4), SYK (27.3 ± 8.3) and PTPN6 (2.0 ± 0.5)"
     . SPARSER::COLLECTION)
    ("SYK (13.1 ± 4.4) and PTPN6 (11.2 ± 4.9)" . SPARSER::COLLECTION)
    ("VAV1 (12.6 ± 5.0), LYN (3.7 ± 1.1), SYK (13.1 ± 4.4) and PTPN6 (11.2 ± 4.9)"
     . SPARSER::COLLECTION)
    ("SYK, LYN, PTPN6 and VAV1" . SPARSER::COLLECTION)
    ("CSF2RB, LCP2, LYN, PLCG2, PTPN6, PTPRC, SYK and VAV1"
     . SPARSER::COLLECTION)
    ("PTPRC" . SPARSER::PROTEIN)
    ("SMAD9, LYN, PTPN6, ZBTB16, SYK, PRKCB, SVIL, VAV1, BMPR1B and BTK"
     . SPARSER::COLLECTION)
    ("BTK" . SPARSER::PROTEIN) ("SVIL" . SPARSER::PROTEIN)
    ("PRKCB" . SPARSER::PROTEIN) ("Protein–protein" . SPARSER::COLLECTION)
    ("the FABP4 gene (fatty acid-binding protein 4) and a 3.3-fold down-regulation of the CNTN1 gene (contactin 1)"
     . SPARSER::COLLECTION)
    ("differentially expressed genes" . SPARSER::GENE)
    ("prognostic and therapeutic biomarkers" . SPARSER::MOLECULE)
    ("SYK, LYN and PTPN6" . SPARSER::COLLECTION)
    ("VAV1, SYK, LYN and PTPN6" . SPARSER::COLLECTION)
    ("Protein-protein" . SPARSER::COLLECTION) ("SYK" . SPARSER::PROTEIN)
    ("ATHs" . SPARSER::MOLECULE) ("ATH and MIT" . SPARSER::COLLECTION)
    ("ATH" . SPARSER::MOLECULE) ("delta–" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glycoprotein VI" . SPARSER::PROTEIN) ("Vav3" . SPARSER::PROTEIN)
    ("Vav1" . SPARSER::PROTEIN) ("α-chain" . SPARSER::PROTEIN)
    ("PLCG2" . SPARSER::PROTEIN) ("LCP2" . SPARSER::PROTEIN)
    ("CSF2RB" . SPARSER::PROTEIN) ("BMPR1B" . SPARSER::PROTEIN)
    ("ZBTB16" . SPARSER::PROTEIN) ("SMAD9" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("contactin 1" . SPARSER::PROTEIN)
    ("CNTN1" . SPARSER::PROTEIN)
    ("fatty acid-binding protein 4" . SPARSER::PROTEIN)
    ("FABP4" . SPARSER::PROTEIN) ("PTPN6" . SPARSER::PROTEIN)
    ("VAV1" . SPARSER::PROTEIN) ("the globular protein" . SPARSER::PROTEIN)
    ("these highly flexible IDPs" . SPARSER::PROTEIN)
    ("proteins or protein" . SPARSER::COLLECTION)
    ("globular proteins" . SPARSER::PROTEIN)
    ("Intrinsically Disorder Proteins" . SPARSER::PROTEIN)
    ("the secondary structure conformation" . SPARSER::BIO-CONFORMATION)
    ("Ile" . SPARSER::AMINO-ACID) ("amide" . SPARSER::MOLECULE)
    ("states and forms" . SPARSER::COLLECTION) ("Phe" . SPARSER::AMINO-ACID)
    ("Arg and Lys" . SPARSER::COLLECTION)
    ("TAZ2 and p53" . SPARSER::COLLECTION)
    ("previously reported NMR chemical" . SPARSER::MOLECULE)
    ("the p53TAD WT :TAZ2 complex and the same complex" . SPARSER::COLLECTION)
    (":TAZ2" . SPARSER::BIO-COMPLEX)
    ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID) ("pSer" . SPARSER::PROTEIN)
    ("the unphosphorylated state and the three phosphorylated states"
     . SPARSER::COLLECTION)
    ("TAZ2" . SPARSER::PROTEIN) ("p53-TAZ2" . SPARSER::PROTEIN-PAIR)
    ("Tetramers" . SPARSER::TETRAMER)
    ("interleukin-6 and type I" . SPARSER::COLLECTION)
    ("CREB Binding Protein (CBP)" . SPARSER::PROTEIN)
    ("MDM2 and MDMX" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("cofactors and inhibitors" . SPARSER::COLLECTION)
    ("proteins or DNA" . SPARSER::COLLECTION) ("IDP" . SPARSER::PROTEIN)
    ("IDPs" . SPARSER::PROTEIN) ("19A" . SPARSER::PROTEIN)
    ("CREB Binding" . SPARSER::PROTEIN-FAMILY) ("TAZ1" . SPARSER::PROTEIN)
    ("CREB Binding Protein" . SPARSER::PROTEIN)
    ("pure lysosomal fractions" . SPARSER::COMPONENT)
    ("the Ragulator-Rag amino acid sensing pathway and Guan’s"
     . SPARSER::AMINO-ACID)
    ("ER and mitochondria" . SPARSER::COLLECTION)
    ("peroxisome" . SPARSER::PROTEIN) ("Rheb and mTORC1" . SPARSER::COLLECTION)
    ("both the TSC complex and mTORC1" . SPARSER::COLLECTION)
    ("the immunoprecipitated TSC complex and the purified GTP-bound form of Rheb"
     . SPARSER::COLLECTION)
    ("TSC2 or Rheb" . SPARSER::COLLECTION)
    ("TSC2 and active" . SPARSER::COLLECTION)
    ("Rag, SLC38A9, and mTOR" . SPARSER::COLLECTION)
    ("TSC2 and Rheb" . SPARSER::COLLECTION)
    ("other amino acids such as leucine" . SPARSER::AMINO-ACID)
    ("the entire complement" . SPARSER::PROTEIN)
    ("growth factor and arginine" . SPARSER::COLLECTION)
    ("an essential amino acid" . SPARSER::AMINO-ACID)
    ("growth factors and amino acids" . SPARSER::COLLECTION)
    ("Growth factors and arginine" . SPARSER::COLLECTION)
    ("Leucine and arginine" . SPARSER::COLLECTION)
    ("Rheb-mTOR" . SPARSER::COLLECTION) ("Rheb and mTOR" . SPARSER::COLLECTION)
    ("Rheb and TSC2" . SPARSER::COLLECTION) ("GST-Rheb" . SPARSER::COLLECTION)
    ("Flag-Rheb" . SPARSER::COLLECTION)
    ("constitutively lysosomal TSC2" . SPARSER::PROTEIN)
    ("overexpressed Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lysosomal" . SPARSER::PROTEIN) ("Rheb-TSC2" . SPARSER::COLLECTION)
    ("TSC2-Rheb" . SPARSER::COLLECTION)
    ("GTP-nucleotide" . SPARSER::NUCLEOTIDE)
    ("a larger lysosomal protein complex" . SPARSER::BIO-COMPLEX)
    ("mTORC1 and Rag" . SPARSER::COLLECTION)
    ("arginine and growth factor" . SPARSER::COLLECTION)
    ("Rheb or Rag" . SPARSER::COLLECTION) ("proteins " . SPARSER::PROTEIN)
    ("arginine but not leucine" . SPARSER::AMINO-ACID)
    ("amino acids or arginine" . SPARSER::COLLECTION)
    ("Rab7-" . SPARSER::PROTEIN)
    ("growth factors or amino acids" . SPARSER::COLLECTION)
    ("leucine or complete amino acid withdrawal ( xref )"
     . SPARSER::COLLECTION)
    ("amino acid or leucine" . SPARSER::COLLECTION)
    ("GTPases/SLC38A9" . SPARSER::COLLECTION)
    ("constitutively active Rag heterodimer" . SPARSER::HETERODIMER)
    ("Lamp1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) and ULK1"
     . SPARSER::COLLECTION)
    ("arginine but not leucine or isoleucine" . SPARSER::COLLECTION)
    ("leucine or isoleucine" . SPARSER::COLLECTION)
    ("citrulline" . SPARSER::MOLECULE) ("arginase" . SPARSER::PROTEIN)
    ("RARs" . SPARSER::PROTEIN)
    ("arginine, leucine and glutamine" . SPARSER::COLLECTION)
    ("arginine, leucine, and glutamine" . SPARSER::COLLECTION)
    ("arginine and leucine" . SPARSER::COLLECTION)
    ("isoleucine and methionine" . SPARSER::COLLECTION)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("leucine, arginine, or glutamine" . SPARSER::COLLECTION)
    ("conditionally essential amino acids" . SPARSER::AMINO-ACID)
    ("tightly control Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the classical TSC regulators" . SPARSER::REGULATOR)
    ("TSC/Rheb" . SPARSER::COLLECTION)
    ("leucine and glutamine" . SPARSER::COLLECTION)
    ("Leucine and glutamine" . SPARSER::COLLECTION)
    ("Leucine" . SPARSER::AMINO-ACID)
    ("TSC1, TBC1D7, and TSC2" . SPARSER::COLLECTION)
    ("AMPK and growth factors" . SPARSER::COLLECTION)
    ("the membrane-associated Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("Rheb and the Rag GTPases" . SPARSER::COLLECTION)
    ("The two most proximal regulators" . SPARSER::REGULATOR)
    ("Rag" . SPARSER::PROTEIN) ("intra-" . SPARSER::PROTEIN)
    ("conserved proteins called mTORC1" . SPARSER::PROTEIN)
    ("TSC-Rheb" . SPARSER::COLLECTION)
    ("the TSC complex and interaction with its target small GTPase protein"
     . SPARSER::COLLECTION)
    ("Arginine" . SPARSER::AMINO-ACID) ("N-2" . SPARSER::PROTEIN)
    ("hepatocyte nuclear factor 4" . SPARSER::PROTEIN)
    ("Oncostatin M" . SPARSER::PROTEIN) ("BMP4" . SPARSER::PROTEIN)
    ("FGF4" . SPARSER::PROTEIN) ("Activin A" . SPARSER::MOLECULE)
    ("B chain" . SPARSER::PROTEIN) ("small G-Protein" . SPARSER::PROTEIN)
    ("Rap1GAP" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("pH 3" . SPARSER::MOLECULE) ("GTPγS" . SPARSER::PROTEIN)
    ("Rheb1" . SPARSER::PROTEIN) ("T-2" . SPARSER::PROTEIN)
    ("Rheb 1" . SPARSER::PROTEIN) ("HNF4α" . SPARSER::PROTEIN)
    ("Pax6" . SPARSER::PROTEIN) ("PMP70" . SPARSER::PROTEIN)
    ("H4A" . SPARSER::PROTEIN) ("alpha-tubulin" . SPARSER::PROTEIN)
    ("K+" . SPARSER::MOLECULE) ("Na+" . SPARSER::MOLECULE)
    ("FRAP1" . SPARSER::PROTEIN) ("K 5" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN) ("amino acid transporter" . SPARSER::PROTEIN)
    ("branched chain" . SPARSER::PROTEIN) ("p18" . SPARSER::PROTEIN)
    ("V-ATPase" . SPARSER::PROTEIN-FAMILY) ("ULK1" . SPARSER::PROTEIN)
    ("S6K1" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("arginyl-tRNA synthetase" . SPARSER::PROTEIN)
    ("SLC38A9" . SPARSER::PROTEIN) ("TBC1D7" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("preferably target AKT1 and AKT2" . SPARSER::COLLECTION)
    ("NFAT5 and S100A4" . SPARSER::COLLECTION)
    ("PI3K and AKT1" . SPARSER::COLLECTION) ("Src-FAK" . SPARSER::COLLECTION)
    ("AKT3 or any other AKT isoform" . SPARSER::COLLECTION)
    ("DTCs" . SPARSER::MOLECULE)
    ("several promigratory proteins" . SPARSER::PROTEIN)
    ("the promigratory protein S100A4" . SPARSER::PROTEIN)
    ("only one AKT isoform" . SPARSER::ISOFORM)
    ("only few AKT substrates" . SPARSER::SUBSTRATE)
    ("S100A4 and the metastatic state and prognosis" . SPARSER::COLLECTION)
    ("state and prognosis" . SPARSER::COLLECTION)
    ("downstream of AKT3 in the regulation of cancer cell migration and metastasis"
     . SPARSER::EFFECTOR)
    ("the three highly homologous AKT isoforms" . SPARSER::ISOFORM)
    ("AKT2 or AKT3" . SPARSER::COLLECTION) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("promigratory proteins" . SPARSER::PROTEIN)
    ("AKT1 and AKT3" . SPARSER::COLLECTION)
    ("chemotaxis and transwell" . SPARSER::COLLECTION)
    ("AKT1, AKT2 and AKT3" . SPARSER::COLLECTION) ("NFAT5" . SPARSER::PROTEIN)
    ("nuclear factor of activated T-cells 5" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("HSC-70" . SPARSER::PROTEIN) ("vO" . SPARSER::MOLECULE)
    ("the adjacent intron" . SPARSER::PROTEIN)
    ("associated structural variants" . SPARSER::VARIANT)
    ("acceptors" . SPARSER::MOLECULE)
    ("the SVA-E-positive (SVA-E[pos]) genotype" . SPARSER::PROTEIN)
    ("allele or haplotype" . SPARSER::COLLECTION)
    ("correctly splice CASP8 intron" . SPARSER::PROTEIN)
    ("SVA" . SPARSER::PROTEIN-FAMILY) ("Alu" . SPARSER::PROTEIN)
    ("N  c" . SPARSER::PROTEIN) ("Group B" . SPARSER::PROTEIN)
    ("Group A" . SPARSER::PROTEIN) ("CASP 8" . SPARSER::PROTEIN)
    ("SYNE2" . SPARSER::PROTEIN) ("chr2" . SPARSER::PROTEIN)
    ("procaspase-8" . SPARSER::PROTEIN) ("CASP8" . SPARSER::PROTEIN)
    ("PKM2 and p65" . SPARSER::COLLECTION) ("abrogated p65" . SPARSER::PROTEIN)
    ("NF-κB and its target gene VEGF" . SPARSER::COLLECTION)
    ("PKM2 and HIF-1α" . SPARSER::COLLECTION)
    ("abrogated p65/RelA" . SPARSER::COLLECTION)
    ("NF-κB and HIF-1α" . SPARSER::COLLECTION)
    ("both HIF-1α (Fig.  xref ) and NF-κB (Fig.  xref )" . SPARSER::COLLECTION)
    ("PKM2 or p65" . SPARSER::COLLECTION) ("p65/NF-κB" . SPARSER::COLLECTION)
    ("HIF-1α and VEGF-A" . SPARSER::COLLECTION)
    ("the tetrameric form" . SPARSER::FORM) ("IF-" . SPARSER::PROTEIN)
    ("GFP-PKM2" . SPARSER::COLLECTION)
    ("von Willebrand Factor (vWF) and desmin (Fig.  xref and Additional file xref : Figure S3)"
     . SPARSER::COLLECTION)
    ("vWF" . SPARSER::PROTEIN) ("iodide (PI)" . SPARSER::PROTEIN)
    ("HIF-1α and NF-κB" . SPARSER::COLLECTION)
    ("HIF-1α/p65" . SPARSER::COLLECTION) ("IGF-1/IGF-1R" . SPARSER::COLLECTION)
    ("-CACA-3" . SPARSER::COLLECTION) ("-ACGTG-3" . SPARSER::COLLECTION)
    ("somatostatin" . SPARSER::PROTEIN)
    ("muscle) and PKM2" . SPARSER::COLLECTION) ("PKM" . SPARSER::PROTEIN)
    ("PKL" . SPARSER::PROTEIN)
    ("pyruvate and one molecule" . SPARSER::COLLECTION)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("PEP" . SPARSER::DRUG) ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("pyruvate" . SPARSER::PROTEIN) ("TEM8" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("von Willebrand Factor" . SPARSER::PROTEIN)
    ("muscle)" . SPARSER::PROTEIN) ("VEGF-A" . SPARSER::PROTEIN)
    ("the precise biological target gene" . SPARSER::GENE)
    ("cyclins and cyclins-dependent kinases (CDKs)" . SPARSER::COLLECTION)
    ("cyclins and CDK" . SPARSER::COLLECTION)
    ("proto-oncogenes and tumour-suppressor genes[ xref ]"
     . SPARSER::COLLECTION)
    ("proto-oncogenes and tumour suppressor genes" . SPARSER::COLLECTION)
    ("new light" . SPARSER::PROTEIN)
    ("frequent loss of heterozygosity" . SPARSER::PROTEIN)
    ("proto-oncogenes and/or the inactivation of tumour-suppressor genes[ xref ]"
     . SPARSER::COLLECTION)
    ("heat shock protein 70" . SPARSER::PROTEIN)
    ("miR-106a" . SPARSER::MOLECULE)
    ("the main secretory cytokines" . SPARSER::PROTEIN)
    ("c-Myc/HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("wogonin, bortezomib or lenalidomide" . SPARSER::COLLECTION)
    ("lenalidomide-" . SPARSER::DRUG) ("bortezomib-" . SPARSER::DRUG)
    ("wogonin-" . SPARSER::DRUG)
    ("bortezomib or lenalidomide" . SPARSER::COLLECTION)
    ("lenalidomide" . SPARSER::DRUG) ("VEGF and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc or VEGF" . SPARSER::COLLECTION)
    ("c-Myc, HIF-1α, VHL and VEGF" . SPARSER::COLLECTION)
    ("Ubi" . SPARSER::PROTEIN) ("HA-Ubi" . SPARSER::COLLECTION)
    ("FLAG-SUMO1" . SPARSER::COLLECTION)
    ("HIF-1α and VHL" . SPARSER::COLLECTION)
    ("VHL and HIF-1α" . SPARSER::COLLECTION)
    ("hydroxyl-HIF-1α" . SPARSER::PROTEIN-PAIR)
    ("RPMI 8226" . SPARSER::PROTEIN)
    ("the most popular Chinese herbal remedy Huang-Qin" . SPARSER::COLLECTION)
    ("Huang-Qin" . SPARSER::COLLECTION) ("Qin" . SPARSER::PROTEIN)
    ("flavones" . SPARSER::DRUG) ("SUMO" . SPARSER::PROTEIN)
    ("PIASy" . SPARSER::PROTEIN) ("Elongin" . SPARSER::PROTEIN)
    ("a potent pro-angiogenic transcription factor" . SPARSER::PROTEIN)
    ("bFGF" . SPARSER::PROTEIN) ("c-Myc/VHL/HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α-VHL" . SPARSER::COLLECTION) ("wogonin" . SPARSER::DRUG)
    ("Wogonin" . SPARSER::DRUG) ("SUMO1" . SPARSER::PROTEIN)
    ("CUL2" . SPARSER::PROTEIN) ("MDC1 and ATM" . SPARSER::COLLECTION)
    ("PpoI" . SPARSER::PROTEIN) ("TERC" . SPARSER::PROTEIN)
    ("MDC1 and 53BP1 and γH2AX" . SPARSER::COLLECTION)
    ("the control cells exhibited PLA" . SPARSER::PROTEIN)
    ("MDC1-RNF8" . SPARSER::COLLECTION) ("RNF8 and MDC1" . SPARSER::COLLECTION)
    ("ATM and MDC1" . SPARSER::COLLECTION)
    ("TRiC, ATM and ATR" . SPARSER::COLLECTION)
    ("ATM or ATR" . SPARSER::COLLECTION)
    ("DNA-PK or PARP" . SPARSER::COLLECTION)
    ("MDC1, RNF8, RNF168, 53BP1 or RAD51" . SPARSER::COLLECTION)
    ("WRAP53β and γH2AX" . SPARSER::COLLECTION)
    ("TRiC" . SPARSER::HUMAN-PROTEIN-FAMILY) ("chaperonin" . SPARSER::PROTEIN)
    ("glycin" . SPARSER::MOLECULE) ("EGFP-WRAP53β" . SPARSER::COLLECTION)
    ("WRAP53β" . SPARSER::PROTEIN) ("WRAP53β-γH2AX" . SPARSER::COLLECTION)
    ("53BP1 and γH2AX" . SPARSER::COLLECTION)
    ("H2AX or MDC1" . SPARSER::COLLECTION) ("γH2AX-MDC1" . SPARSER::COLLECTION)
    ("γH2AX and MDC1" . SPARSER::COLLECTION)
    ("exactly overlapped γH2AX foci" . SPARSER::PROTEIN)
    ("MDC1 and γH2AX" . SPARSER::COLLECTION)
    ("immunofluorescent foci" . SPARSER::PROTEIN)
    ("MDC1 and RNF8" . SPARSER::COLLECTION)
    ("53BP1, BRCA1 and RAD51" . SPARSER::COLLECTION)
    ("several repeats approximately 40 amino acids" . SPARSER::AMINO-ACID)
    ("scaffolds" . SPARSER::SCAFFOLD) ("tryptophan" . SPARSER::AMINO-ACID)
    ("the most severe types" . TYPE) ("phenylindole" . SPARSER::MOLECULE)
    ("Bovine serum albumin" . SPARSER::PROTEIN) ("Bromo" . SPARSER::MOLECULE)
    ("per 1 " . SPARSER::PROTEIN) ("VE-821" . SPARSER::DRUG)
    ("NU7441" . SPARSER::MOLECULE) ("KU55933" . SPARSER::DRUG)
    ("telomerase RNA component" . SPARSER::RNA) ("TCP-1" . SPARSER::PROTEIN)
    ("TCP-1 Ring Complex" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("U-2" . SPARSER::PROTEIN) ("Ring Finger protein 168" . SPARSER::PROTEIN)
    ("Ring finger protein 8" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN)
    ("Mediator of DNA damage checkpoint 1" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("Cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("p53-binding protein 1" . SPARSER::PROTEIN) ("WRAP53" . SPARSER::PROTEIN)
    ("activators or inhibitors" . SPARSER::COLLECTION)
    ("SSO-NSE3" . SPARSER::COLLECTION) ("global pre-mRNA" . SPARSER::RNA)
    ("INS" . SPARSER::PROTEIN) ("ATM-BRCA2-CHEK2" . SPARSER::COLLECTION)
    ("meiotic" . SPARSER::DRUG) ("leaky A-T alleles" . SPARSER::ALLELE)
    ("adenine" . SPARSER::NUCLEOBASE)
    ("these results further support U2AF35" . SPARSER::PROTEIN)
    ("BCOR-RARA" . SPARSER::PROTEIN-PAIR)
    ("the longest isoform" . SPARSER::ISOFORM)
    ("PML-AML1" . SPARSER::COLLECTION) ("the last exon" . SPARSER::PROTEIN)
    ("the shortest PML isoform" . SPARSER::ISOFORM)
    ("at least two isoforms" . SPARSER::ISOFORM)
    ("the telomeres-protecting shelterin complex" . SPARSER::BIO-COMPLEX)
    ("TRF1 (exon 7+)/PIN2 (exon 7−) isoforms" . SPARSER::ISOFORM)
    ("/PIN2" . SPARSER::COLLECTION) ("shelterin" . SPARSER::PROTEIN)
    ("ACTR5, ACTL6A and RUVL2B" . SPARSER::COLLECTION)
    ("ACTR" . SPARSER::PROTEIN)
    ("SRSF1 and other SR proteins, EP300 , RPA2, BLM, FANCD2 and FANCI, PPP2R5C and PPP2R5D , and SMC3"
     . SPARSER::COLLECTION)
    ("RPS6, SRSF1 and other SR proteins, EP300 , RPA2, BLM, FANCD2 and FANCI, PPP2R5C and PPP2R5D , and SMC3"
     . SPARSER::COLLECTION)
    ("exon or gene" . SPARSER::COLLECTION)
    ("proteins, EP300 , RPA2, BLM, FANCD2 and FANCI, PPP2R5C and PPP2R5D , and SMC3"
     . SPARSER::COLLECTION)
    ("FANCI, PPP2R5C and PPP2R5D , and SMC3" . SPARSER::COLLECTION)
    ("PPP2R5D , and SMC3" . SPARSER::COLLECTION)
    ("RNF168 and the ATM interactor ATMIN" . SPARSER::COLLECTION)
    ("ATR and PRKDC" . SPARSER::COLLECTION) ("ATMIN" . SPARSER::PROTEIN)
    ("PRKDC" . SPARSER::PROTEIN) ("The last MRE11A exon" . SPARSER::PROTEIN)
    ("MRE11, RAD50 and NBN" . SPARSER::COLLECTION) ("NBN" . SPARSER::PROTEIN)
    ("cyclin B1 and B2 mRNAs" . SPARSER::COLLECTION)
    ("U2AF35 as well as cyclin B1-interacting protein (CCNB1IP1)"
     . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("isomerase" . SPARSER::ISOMERASE) ("cdc2/cyclin-B" . SPARSER::COLLECTION)
    ("CDC25B and CDC25C" . SPARSER::COLLECTION)
    ("CHEK2/CHEK1" . SPARSER::COLLECTION)
    ("exogenous CHEK2" . SPARSER::PROTEIN) ("SSO" . SPARSER::PROTEIN)
    ("CDC25A, CDC25B, CDC25C and TTK" . SPARSER::COLLECTION)
    ("AATF" . SPARSER::PROTEIN) ("STRAP" . SPARSER::PROTEIN)
    ("a key apical kinase" . SPARSER::KINASE) ("SSOs" . SPARSER::PROTEIN)
    ("TG " . SPARSER::PROTEIN) ("SSO-PEBP" . SPARSER::PROTEIN-PAIR)
    ("PEBP" . SPARSER::PROTEIN) ("NSE and PE SSOs" . SPARSER::COLLECTION)
    ("partially productive spliceosomes" . SPARSER::BIO-COMPLEX)
    ("spliceosomes" . SPARSER::BIO-COMPLEX)
    ("exogeneous CHEK2" . SPARSER::PROTEIN)
    ("PUF60 and hnRNP A1" . SPARSER::COLLECTION)
    ("PUF60 or hnRNP A1" . SPARSER::COLLECTION)
    ("several heterogeneous nuclear ribonucleoproteins" . SPARSER::PROTEIN)
    ("PUF60 and CAPERα" . SPARSER::COLLECTION)
    ("ribonucleoproteins" . SPARSER::PROTEIN) ("CAPER" . SPARSER::PROTEIN)
    ("AAG" . SPARSER::PROTEIN) ("thymine" . SPARSER::MOLECULE)
    ("U2AF35 ( xref ) and no other cryptic exon" . SPARSER::COLLECTION)
    ("adjacent introns" . SPARSER::PROTEIN)
    ("available U2AF heterodimers" . SPARSER::HETERODIMER)
    ("a U2AF-repressed nonsense-mediated decay (NMD) switch exon"
     . SPARSER::PROTEIN)
    ("SF3B1, ZRSR2, SF1, SF3A1, PRPF40B, and SRSF2" . SPARSER::COLLECTION)
    ("SF3A1" . SPARSER::PROTEIN) ("SF3B1" . SPARSER::PROTEIN)
    ("cryptic" . SPARSER::PROTEIN) ("U2AF1" . SPARSER::PROTEIN)
    ("U2AF65" . SPARSER::PROTEIN) ("U2AF2" . SPARSER::PROTEIN)
    ("PPT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Spliceosomes" . SPARSER::BIO-COMPLEX)
    ("small nuclear RNAs (snRNAs) and a large number" . SPARSER::COLLECTION)
    ("Introns" . SPARSER::PROTEIN) ("intronic variants" . SPARSER::VARIANT)
    ("U2AF35" . SPARSER::PROTEIN) ("PUF60 and hnRNPA1" . SPARSER::COLLECTION)
    ("NSE" . SPARSER::PROTEIN) ("a critical apical kinase" . SPARSER::KINASE)
    ("SAP155" . SPARSER::PROTEIN) ("RBM39" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("SMN2" . SPARSER::PROTEIN)
    ("CLASP1" . SPARSER::PROTEIN) ("NPM1" . SPARSER::PROTEIN)
    ("AML1" . SPARSER::PROTEIN) ("TIN2" . SPARSER::PROTEIN)
    ("TIF2" . SPARSER::PROTEIN) ("PIN2" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("TERF1" . SPARSER::PROTEIN)
    ("ACTL6A" . SPARSER::PROTEIN) ("INO80C" . SPARSER::PROTEIN)
    ("INO80" . SPARSER::PROTEIN) ("SMC3" . SPARSER::PROTEIN)
    ("PPP2R5D" . SPARSER::PROTEIN) ("SRSF1" . SPARSER::PROTEIN)
    ("ATM interactor" . SPARSER::PROTEIN) ("RNF168" . SPARSER::PROTEIN)
    ("kinase-like" . SPARSER::PROTEIN-FAMILY) ("RAD50" . SPARSER::PROTEIN)
    ("MRE11" . SPARSER::PROTEIN) ("IP1" . SPARSER::PROTEIN)
    ("PIN1" . SPARSER::PROTEIN) ("CHEK1" . SPARSER::PROTEIN)
    ("S178" . SPARSER::PROTEIN) ("CABIN1" . SPARSER::PROTEIN)
    ("TRIM28" . SPARSER::PROTEIN) ("CDC25B" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("NSE3" . SPARSER::PROTEIN)
    ("UPF1" . SPARSER::PROTEIN) ("PRPF40B" . SPARSER::PROTEIN)
    ("SF1" . SPARSER::PROTEIN) ("ZRSR2" . SPARSER::PROTEIN)
    ("SF3" . SPARSER::PROTEIN) ("U2 auxiliary factor" . SPARSER::PROTEIN)
    ("small nuclear RNAs" . SPARSER::RNA) ("CHEK2" . SPARSER::PROTEIN)
    ("NSE 3" . SPARSER::PROTEIN) ("hnRNPA1" . SPARSER::PROTEIN)
    ("PUF60" . SPARSER::PROTEIN) ("U2AF" . SPARSER::BIO-COMPLEX)
    ("MNNG-treated p21 −/−" . SPARSER::PROTEIN)
    ("p21-PARP-1" . SPARSER::COLLECTION) ("exp" . SPARSER::PROTEIN)
    ("GST-PARP-1" . SPARSER::COLLECTION) ("GSH-agarose" . SPARSER::DRUG)
    ("PARP-1 (FL)" . SPARSER::PROTEIN) ("p21-GFP" . SPARSER::COLLECTION)
    ("EF" . SPARSER::PROTEIN) ("XRCC1 and pol" . SPARSER::COLLECTION)
    ("auto-PARylated PARP-1" . SPARSER::PROTEIN)
    ("UV-light" . SPARSER::COLLECTION)
    ("nicked photoreactive DNA" . SPARSER::DNA)
    ("-deoxyribose" . SPARSER::MOLECULE) ("deoxyribose" . SPARSER::MOLECULE)
    ("The photoreactive substrates" . SPARSER::SUBSTRATE)
    ("proliferating cell nuclear antigen (PCNA) and APE1 [ xref ]"
     . SPARSER::COLLECTION)
    ("intra" . SPARSER::PROTEIN)
    ("DNA glycosylase and apurinic/apyrimidinic" . SPARSER::COLLECTION)
    ("p21 and PARP-1" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("model photoreactive BER substrates" . SPARSER::SUBSTRATE)
    ("p21 proteins" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("lyase activity" . SPARSER::PROTEIN) ("AC40" . SPARSER::PROTEIN)
    ("N-20" . SPARSER::PROTEIN) ("E-F" . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("APE1" . SPARSER::PROTEIN)
    ("endonuclease 1" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN) ("anti-PAR" . SPARSER::DRUG)
    ("alkylating agent" . SPARSER::MOLECULE) ("kinase (IKK)" . SPARSER::KINASE)
    ("Zeb-1 and Snail" . SPARSER::COLLECTION)
    ("the PI3K inhibitor LY294002 and the NF-κB inhibitor PDTC ( xref )"
     . SPARSER::COLLECTION)
    ("P38 or JNK" . SPARSER::COLLECTION) ("MAPK/ERK1" . SPARSER::COLLECTION)
    ("PDTC" . SPARSER::DRUG)
    ("inhibitor of NF-κB (IκB) and nuclear translocation of p65 ( xref )"
     . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("CSQT-2" . SPARSER::COLLECTION)
    ("PI3K/Akt/NF-κB/MMPs" . SPARSER::COLLECTION)
    ("PI3K/Akt/NF-κB" . SPARSER::COLLECTION)
    ("AFB1-K2" . SPARSER::PROTEIN-PAIR)
    ("phospho-serine/threonine" . SPARSER::COLLECTION)
    ("TTR" . SPARSER::PROTEIN) ("Zeb-1" . SPARSER::PROTEIN)
    ("FOXM1" . SPARSER::PROTEIN) ("JNK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular regulated protein kinase" . SPARSER::PROTEIN)
    ("mitomycin-C" . SPARSER::DRUG) ("P65" . SPARSER::PROTEIN)
    ("P-ERK1/2" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("EGFR, FGFR1, and c-Met" . SPARSER::COLLECTION)
    ("dominant-negative SHP2" . SPARSER::PROTEIN)
    ("c-Cbl and Spry2" . SPARSER::COLLECTION)
    ("EGFR, FGFR1, and HGFR" . SPARSER::COLLECTION) ("HGF-" . SPARSER::PROTEIN)
    ("FGFR and c-Met" . SPARSER::COLLECTION)
    ("c-Met and FGFR1" . SPARSER::COLLECTION)
    ("FGFR1 and c-Met" . SPARSER::COLLECTION) ("S5b" . SPARSER::PROTEIN)
    ("SHP2-" . SPARSER::PROTEIN) ("MCF-10A or HMLE" . SPARSER::COLLECTION)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("Representative IF" . SPARSER::PROTEIN)
    ("EGFR and SHP2" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("Ras, ERK1/2, and Akt" . SPARSER::COLLECTION)
    ("S1b and c" . SPARSER::COLLECTION)
    ("Tyr-phosphorylated receptors and adaptor proteins" . SPARSER::COLLECTION)
    ("HER1–HER4" . SPARSER::COLLECTION)
    ("EGFR2, EGFR3, and EGFR4" . SPARSER::COLLECTION)
    ("HGFR" . SPARSER::PROTEIN)
    ("c-Met and fibroblast growth factor receptor 1" . SPARSER::COLLECTION)
    ("inositol 3-kinase/Akt" . SPARSER::COLLECTION)
    ("Ras/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("SHP2 and EGFR" . SPARSER::COLLECTION)
    ("SHP2 and the epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("COS1" . SPARSER::PROTEIN) ("Spry2" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN) ("perinuclear region" . SPARSER::PROTEIN)
    ("target cell" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("inositol 3-kinase" . SPARSER::PROTEIN)
    ("FLAG-c-FOS" . SPARSER::COLLECTION) ("ACTB" . SPARSER::PROTEIN)
    ("oligo-dT" . SPARSER::COLLECTION) ("Trizol" . SPARSER::DRUG)
    ("HSS" . SPARSER::PROTEIN)
    ("-UUCUCCGAACGUGUCACGUTT-3" . SPARSER::COLLECTION)
    ("Ubc5c" . SPARSER::PROTEIN)
    ("complex and substrate" . SPARSER::COLLECTION)
    ("ROC1 and SKP1" . SPARSER::COLLECTION) ("MYC-KDM2B" . SPARSER::COLLECTION)
    ("MYC-CUL1" . SPARSER::COLLECTION)
    ("MYC (EQKLISEEDL) or HA (YPYDVPDYA) antigen peptides"
     . SPARSER::COLLECTION)
    ("protease inhibitors and phosphatase inhibitors" . SPARSER::COLLECTION)
    ("anti-c-MYC agarose (A7470, Sigma-Aldrich) or anti-HA Sepharose (sc-7392 AC, Santa Cruz)"
     . SPARSER::COLLECTION)
    ("Sepharose" . SPARSER::MOLECULE) ("DTT" . SPARSER::MOLECULE)
    ("LAS" . SPARSER::PROTEIN)
    ("a horseradish peroxidase (HRP)-conjugated secondary antibody"
     . SPARSER::PROTEIN)
    ("peroxidase (HRP)" . SPARSER::PROTEIN) ("HRP" . SPARSER::PROTEIN)
    ("nitrocellulose" . SPARSER::MOLECULE) ("Antibodies" . SPARSER::ANTIBODY)
    ("Fluor" . SPARSER::MOLECULE) ("Azide" . SPARSER::MOLECULE)
    ("Ascorbate" . SPARSER::MOLECULE) ("PFA" . SPARSER::MOLECULE)
    ("ethynyl" . SPARSER::MOLECULE)
    ("DNA or Lipofectamine" . SPARSER::COLLECTION) ("MAX" . SPARSER::PROTEIN)
    ("hygromycin" . SPARSER::MOLECULE) ("streptomycin" . SPARSER::DRUG)
    ("U0126 (S1102, Selleckchem) and SCH772984 (S7101, Selleckchem)"
     . SPARSER::COLLECTION)
    ("MG132 (C2211, Sigma-Aldrich), CHX (94271, AMRESCO), EGF (AF-100-15, PeproTech), U0126 (S1102, Selleckchem) and SCH772984 (S7101, Selleckchem)"
     . SPARSER::COLLECTION)
    ("AF" . SPARSER::PROTEIN) ("c-Jun-" . SPARSER::PROTEIN)
    ("KDM2B and KDM2A/FBXL11" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("ERK5 and ERK1/2" . SPARSER::COLLECTION)
    ("PKC-Ras-Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("MEK1/2 inhibitor U0126 and an ERK1/2 inhibitor" . SPARSER::COLLECTION)
    ("the classical MEK1/2 (the ERK1/2 activating kinases) inhibitor U0126"
     . SPARSER::DRUG)
    ("KDM2B and substrate" . SPARSER::COLLECTION)
    ("nearly all c-Fos" . SPARSER::PROTEIN)
    ("CUL1 or KDM2B" . SPARSER::COLLECTION)
    ("KDM2B and c-Fos" . SPARSER::COLLECTION)
    ("c-Fos and KDM2B" . SPARSER::COLLECTION) ("LRR" . SPARSER::PROTEIN)
    ("LRF" . SPARSER::PROTEIN) ("FLAG-KDM2B" . SPARSER::COLLECTION)
    ("SKP1, CUL1 and ROC1" . SPARSER::COLLECTION) ("ROC1" . SPARSER::PROTEIN)
    ("KDM2B-CUL1" . SPARSER::COLLECTION)
    ("KDM2B and CUL1" . SPARSER::COLLECTION)
    ("KDM2B or CUL1" . SPARSER::COLLECTION)
    ("SKP1 and CUL1" . SPARSER::COLLECTION)
    ("FLAG-c-Fos" . SPARSER::COLLECTION)
    ("an internal promoter" . SPARSER::PROMOTER)
    ("c-Jun or c-Fos" . SPARSER::COLLECTION)
    ("polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("KDM2B/FBXL10" . SPARSER::COLLECTION) ("LRRs" . SPARSER::PROTEIN)
    ("FBXL10, NDY1, JHDM1B and CxxC2" . SPARSER::COLLECTION)
    ("c-Fos and UBR1" . SPARSER::COLLECTION)
    ("a dimeric complex" . SPARSER::BIO-COMPLEX)
    ("ATF (activating transcription factor) and MAF (musculoaponeurotic fibrosarcoma) protein families"
     . SPARSER::COLLECTION)
    ("hetero-dimeric complexes" . SPARSER::BIO-COMPLEX)
    ("SCF/CRL1" . SPARSER::COLLECTION) ("CRL1/SCF" . SPARSER::COLLECTION)
    ("the polycomb repressive complex" . SPARSER::BIO-COMPLEX)
    ("Ubc5" . SPARSER::PROTEIN) ("Phospho-ERK" . SPARSER::PROTEIN)
    ("N-3" . SPARSER::PROTEIN) ("KDM2A" . SPARSER::PROTEIN)
    ("leucine rich repeats" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("matrix metallopeptidase 1" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("SCH772984" . SPARSER::DRUG)
    ("SKP2" . SPARSER::PROTEIN) ("JHDM1B" . SPARSER::PROTEIN)
    ("UBR1" . SPARSER::PROTEIN) ("Proto-oncogene c-Fos" . SPARSER::PROTEIN)
    ("musculoaponeurotic fibrosarcoma" . SPARSER::PROTEIN)
    ("CRL1" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("this protein's" . SPARSER::PROTEIN)
    ("ILK/AKT/mTOR" . SPARSER::COLLECTION) ("Tao" . SPARSER::DRUG)
    ("AKT/PI3K" . SPARSER::COLLECTION) ("mannose" . SPARSER::MOLECULE)
    ("these glycoproteins, CREG1," . SPARSER::PROTEIN)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SPEG" . SPARSER::MOLECULE)
    ("glycopeptides (SPEG)" . SPARSER::MOLECULE)
    ("KRAS or mutant" . SPARSER::COLLECTION)
    ("KRAS and CREG1" . SPARSER::COLLECTION)
    ("KRAS, CLPTM1, TMEM106B and CREG1" . SPARSER::COLLECTION)
    ("overexpressed N-linked glycoproteins" . SPARSER::PROTEIN)
    ("NRAS and β-actin" . SPARSER::COLLECTION)
    ("siRNA-KRAS" . SPARSER::COLLECTION)
    ("overexpressed glycoproteins" . SPARSER::PROTEIN)
    ("overexpressed glycopeptides" . SPARSER::MOLECULE)
    ("HBE4 and A549/HBE4" . SPARSER::COLLECTION)
    ("the respective glycopeptides" . SPARSER::MOLECULE)
    ("EGFR and CREG1" . SPARSER::COLLECTION)
    ("Neuroplastin" . SPARSER::PROTEIN)
    ("Myelin protein zero-like protein 2 and N-acetylglucosamine-6-sulfatase"
     . SPARSER::COLLECTION)
    ("CD166, CD276, and CD97" . SPARSER::COLLECTION)
    ("Tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("unique glycopeptides" . SPARSER::MOLECULE) ("TPP" . SPARSER::PROTEIN)
    ("EGFR or KRAS" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION)
    ("Overexpressed N-linked glycoproteins" . SPARSER::PROTEIN)
    ("KRAS or EGFR" . SPARSER::COLLECTION)
    ("Raf/ERK/MAPK" . SPARSER::COLLECTION) ("Biomarker" . SPARSER::MOLECULE)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS)"
     . SPARSER::COLLECTION)
    ("a novel candidate biomarker or therapeutic target" . SPARSER::COLLECTION)
    ("CREG" . SPARSER::PROTEIN)
    ("Proteomic profiling revealed 27 glycopeptides" . SPARSER::MOLECULE)
    ("glycopeptides" . SPARSER::MOLECULE) ("glycopeptide" . SPARSER::MOLECULE)
    ("differentially expressed glycoproteins" . SPARSER::PROTEIN)
    ("attractive biomarkers and therapeutic targets" . SPARSER::COLLECTION)
    ("attractive biomarkers" . SPARSER::MOLECULE)
    ("glycoproteins" . SPARSER::PROTEIN) ("IGF2R" . SPARSER::PROTEIN)
    ("insulin-like growth factor II receptor" . SPARSER::PROTEIN)
    ("Transmembrane protein" . SPARSER::PROTEIN)
    ("transmembrane protein 1" . SPARSER::PROTEIN) ("CD109" . SPARSER::PROTEIN)
    ("Myelin protein zero" . SPARSER::PROTEIN)
    ("Desmoglein 2" . SPARSER::PROTEIN) ("CD97" . SPARSER::PROTEIN)
    ("CD166" . SPARSER::PROTEIN) ("M/L" . SPARSER::PROTEIN)
    ("H - K" . SPARSER::PROTEIN) ("M - K" . SPARSER::PROTEIN)
    ("Colon cancer" . SPARSER::PROTEIN) ("HBE4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("SW480" . SPARSER::PROTEIN) ("Amino Acids" . SPARSER::AMINO-ACID)
    ("simultaneous mTOR" . SPARSER::PROTEIN)
    ("chloroquine and mTOR" . SPARSER::COLLECTION) ("CCL" . SPARSER::DRUG)
    ("pro-apoptotic transcription factor CHOP" . SPARSER::PROTEIN)
    ("CAM and GEF" . SPARSER::COLLECTION) ("VCP/p97" . SPARSER::COLLECTION)
    ("polyglutamine" . SPARSER::MOLECULE)
    ("AZM- and CAM-immobilized affinity chromatography ( xref )"
     . SPARSER::COLLECTION)
    ("AZM and CAM" . SPARSER::COLLECTION) ("AZM-" . SPARSER::MOLECULE)
    ("/p97" . SPARSER::COLLECTION)
    ("bafilomycin A 1 and concanamycin" . SPARSER::COLLECTION)
    ("concanamycin" . SPARSER::MOLECULE)
    ("vacuolar (V)-type ATPase activity" . SPARSER::PROTEIN) ("-type" . TYPE)
    ("AZM, CAM and EM900" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("swollen mitochondria" . SPARSER::PROTEIN)
    ("concomitant AZM or EM900" . SPARSER::COLLECTION)
    ("various pro-apoptotic genes" . SPARSER::GENE)
    ("a pro-apoptotic transcription factor" . SPARSER::PROTEIN)
    ("Bax and Bim" . SPARSER::COLLECTION)
    ("GRP78 and CHOP" . SPARSER::COLLECTION)
    ("GEF and macrolides" . SPARSER::COLLECTION)
    ("a macrolide alone or only lysosome inhibitors" . SPARSER::INHIBITOR)
    ("AZM and EM900 in PANC-1 cells" . SPARSER::COLLECTION)
    ("CAM and EM900" . SPARSER::COLLECTION)
    ("CAM or EM900" . SPARSER::COLLECTION)
    ("AZM or EM900" . SPARSER::COLLECTION)
    ("CAM, AZM and EM900" . SPARSER::COLLECTION)
    ("only lysosomal inhibitors" . SPARSER::INHIBITOR)
    ("GEF and lysosomal" . SPARSER::COLLECTION) ("pepstatin" . SPARSER::DRUG)
    ("ERL-treatment" . SPARSER::MOLECULE) ("ethanolamine" . SPARSER::DRUG)
    ("phosphatidyl" . SPARSER::MOLECULE) ("GEF and ERL" . SPARSER::COLLECTION)
    ("hydrochloride (ERL)" . SPARSER::MOLECULE)
    ("GEF and erlotinib" . SPARSER::COLLECTION) ("ERL" . SPARSER::MOLECULE)
    ("hydrochloride" . SPARSER::MOLECULE)
    ("a novel 12-membered EM900" . SPARSER::PROTEIN)
    ("CAM and AZM" . SPARSER::COLLECTION) ("GEF and CAM" . SPARSER::COLLECTION)
    ("a proapoptotic transcription factor" . SPARSER::PROTEIN)
    ("/GADD153" . SPARSER::COLLECTION) ("CHOP" . SPARSER::PROTEIN)
    ("bortezomib and CAM" . SPARSER::COLLECTION)
    ("gefitinib (GEF) and erlotinib (ERL)" . SPARSER::COLLECTION)
    ("Rubicon" . SPARSER::PROTEIN) ("EGFR-TK" . SPARSER::COLLECTION)
    ("TK" . SPARSER::PROTEIN)
    ("lysosomal hydrolytic enzymes" . SPARSER::ENZYME)
    ("proteins and organelle" . SPARSER::COLLECTION)
    ("‘chemosensitizers’" . SPARSER::DRUG) ("chemosensitizers" . SPARSER::DRUG)
    ("AZM and EM900" . SPARSER::COLLECTION) ("AZM" . SPARSER::MOLECULE)
    ("a novel 12-membered non-antibiotic macrolide" . SPARSER::MOLECULE)
    ("macrolide" . SPARSER::MOLECULE) ("EM" . SPARSER::PROTEIN)
    ("azithromycin" . SPARSER::MOLECULE) ("macrolides" . SPARSER::MOLECULE)
    ("gefitinib (GEF) and clarithromycin (CAM)" . SPARSER::COLLECTION)
    ("clarithromycin" . SPARSER::DRUG) ("GEF" . SPARSER::GEF)
    ("RIP1" . SPARSER::PROTEIN) ("p97" . SPARSER::PROTEIN)
    ("Valosin-containing protein" . SPARSER::PROTEIN)
    ("bafilomycin A 1" . SPARSER::DRUG) ("RIP-1" . SPARSER::PROTEIN)
    ("necrostatin-1" . SPARSER::MOLECULE) ("GRP78" . SPARSER::PROTEIN)
    ("D-3" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN) ("Necrostatin-1" . SPARSER::MOLECULE)
    ("GADD153" . SPARSER::PROTEIN)
    ("C/EBP homologous protein" . SPARSER::PROTEIN)
    ("LAPTM4B" . SPARSER::PROTEIN) ("Cav-1-MAPK" . SPARSER::COLLECTION)
    ("p-MAPK" . SPARSER::COLLECTION) ("HNF1A and ALB" . SPARSER::COLLECTION)
    ("AKT and MAPK" . SPARSER::COLLECTION) ("MEK/MAPK" . SPARSER::COLLECTION)
    ("ALB , CYP1A1 , HNF1A and HNF1B" . SPARSER::COLLECTION)
    ("Oct4 and Nanog" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("α-fetoprotein (AFP) and albumin (ALB)" . SPARSER::COLLECTION)
    ("proteins and genes" . SPARSER::COLLECTION) ("Von" . SPARSER::PROTEIN)
    ("CD34, CD45, CD71 and CD106" . SPARSER::COLLECTION)
    ("CD13 and CD90" . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase/MAPK" . SPARSER::COLLECTION)
    ("growth factor, p44/42MAPK, AKT and signal transducer and activator of transcription 3"
     . SPARSER::COLLECTION)
    ("cholesterol-rich caveolae lipid" . SPARSER::LIPID)
    ("regenerative medicine" . SPARSER::DRUG)
    ("mitogen-activated protein kinase kinase/MAPK" . SPARSER::COLLECTION)
    ("ALB and HNF1A" . SPARSER::COLLECTION)
    ("albumin (ALB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALB" . SPARSER::PROTEIN) ("albumin" . SPARSER::PROTEIN)
    ("vitamin C" . SPARSER::MOLECULE) ("CD106" . SPARSER::PROTEIN)
    ("CD71" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("Cav-1" . SPARSER::PROTEIN) ("Caveolin-1" . SPARSER::PROTEIN)
    ("Component" . SPARSER::COMPONENT) ("severe IGF-I" . SPARSER::PROTEIN)
    ("Independent Dynamical Fragments" . SPARSER::FRAGMENT)
    ("Fragments" . SPARSER::FRAGMENT)
    ("receptors KIT [ xref , xref ] and CSF-1R [ xref ]" . SPARSER::COLLECTION)
    ("an associated G-protein" . SPARSER::PROTEIN)
    ("ligand and protein" . SPARSER::COLLECTION)
    ("regulators of cellular tyrosine phosphorylation and mediators"
     . SPARSER::COLLECTION)
    ("cytoplasmic receptors ( i . e ., receptors tyrosine kinases) and signaling proteins ( i . e ., STATs)"
     . SPARSER::COLLECTION)
    ("STAT5a, and β-strand" . SPARSER::COLLECTION)
    ("kinase or phosphatase" . SPARSER::COLLECTION)
    ("peculiar proteins" . SPARSER::PROTEIN)
    ("kinases (PTK)" . SPARSER::PROTEIN)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("–STAT5a" . SPARSER::COLLECTION)
    ("the pockets form and their dimension" . SPARSER::COLLECTION)
    ("A-B" . SPARSER::PROTEIN) ("A - B and α7" . SPARSER::COLLECTION)
    ("lap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("A - B" . SPARSER::PROTEIN)
    ("successive CPs" . SPARSER::PROTEIN) ("CPs" . SPARSER::PROTEIN)
    ("an individual (p-STAT5b) IDS" . SPARSER::PROTEIN)
    ("CCD and its N-extremity" . SPARSER::COLLECTION)
    ("PDF" . SPARSER::PROTEIN) ("a tiny part" . SPARSER::COMPONENT)
    ("four (in STAT5b and p-STAT5b) discrete IDSs" . SPARSER::PROTEIN)
    ("S16, S18 and S19" . SPARSER::COLLECTION)
    ("S11-S14" . SPARSER::COLLECTION) ("IDS" . SPARSER::PROTEIN)
    ("almost all identified IDSs" . SPARSER::PROTEIN)
    ("S12-S14" . SPARSER::COLLECTION)
    ("The two last IDSs , S13 and S14" . SPARSER::COLLECTION)
    ("IDSs , S13 and S14" . SPARSER::COLLECTION) ("CDD" . SPARSER::PROTEIN)
    ("the rigid fragments" . SPARSER::FRAGMENT)
    ("S2 or S11" . SPARSER::COLLECTION) ("IDSs" . SPARSER::PROTEIN)
    ("PFD" . SPARSER::PROTEIN) ("intra-protein" . SPARSER::PROTEIN-PAIR)
    ("the STAT5 MD conformations and their secondary structure composition"
     . SPARSER::COLLECTION)
    ("the highly-correlated fragments" . SPARSER::FRAGMENT)
    ("The distal CCD and the N-extremity" . SPARSER::COLLECTION)
    ("The distal CCD" . SPARSER::PROTEIN)
    ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NMA and PCA" . SPARSER::COLLECTION)
    ("STAT5b and p-STAT5a" . SPARSER::COLLECTION)
    ("the distal CCD" . SPARSER::PROTEIN) ("NMA" . SPARSER::PROTEIN)
    ("monomeric STAT3 protein" . SPARSER::PROTEIN)
    ("STAT5a (1Y1U) and STAT3 (1BG1)" . SPARSER::COLLECTION)
    ("Mus" . SPARSER::PROTEIN) ("p-STAT5b" . SPARSER::COLLECTION)
    ("p-STAT5a" . SPARSER::COLLECTION)
    ("DNA or any other molecules" . SPARSER::COLLECTION)
    ("STAT5a/STAT5b" . SPARSER::COLLECTION)
    ("monomeric state" . SPARSER::BIO-STATE)
    ("the human monomeric STAT5 proteins" . SPARSER::PROTEIN)
    ("STAT2 (2KA6, 2KA4 [ xref ]) and STAT6 (1OJ5 [ xref ])"
     . SPARSER::COLLECTION)
    ("STAT1, STAT2 (2KA6, 2KA4 [ xref ]) and STAT6 (1OJ5 [ xref ])"
     . SPARSER::COLLECTION)
    ("STAT3 (1BG1 [ xref ], 3CWG [ xref ] and 4E68 [ xref ]) and STAT5a (1Y1U [ xref ])"
     . SPARSER::COLLECTION)
    ("STAT1 (1BF5 [ xref ]), STAT3 (1BG1 [ xref ], 3CWG [ xref ] and 4E68 [ xref ]) and STAT5a (1Y1U [ xref ])"
     . SPARSER::COLLECTION)
    ("BF" . SPARSER::MOLECULE) ("BG1" . SPARSER::PROTEIN)
    ("Bank (PDB)" . SPARSER::PROTEIN)
    ("STAT1, STAT2 and STAT6" . SPARSER::COLLECTION)
    ("STAT3, STAT4 and STAT5a" . SPARSER::COLLECTION)
    ("STAT5 and the protein" . SPARSER::COLLECTION)
    ("monomeric STAT5" . SPARSER::PROTEIN)
    ("dimers and tetramer" . SPARSER::COLLECTION)
    ("–monomer" . SPARSER::MONOMER)
    ("A particular tetrameric state" . SPARSER::BIO-STATE)
    ("monomers" . SPARSER::MONOMER) ("Fragment (CF)" . SPARSER::FRAGMENT)
    ("Trans" . SPARSER::PROTEIN-FAMILY) ("CCD" . SPARSER::PROTEIN)
    ("Fragment" . SPARSER::FRAGMENT) ("MPNs" . SPARSER::PROTEIN)
    ("Bcl-xL , cyclin D1/D2 or Myc" . SPARSER::COLLECTION)
    ("cofactors or co-repressors" . SPARSER::COLLECTION)
    ("isoforms–STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b and STAT6"
     . SPARSER::COLLECTION)
    ("STAT5a and STAT5b" . SPARSER::COLLECTION) ("STAT5a" . SPARSER::PROTEIN)
    ("N-6" . SPARSER::PROTEIN) ("TIP3" . SPARSER::PROTEIN)
    ("CSF-1R" . SPARSER::PROTEIN) ("p-Y" . SPARSER::PROTEIN)
    ("S21" . SPARSER::PROTEIN) ("S24" . SPARSER::PROTEIN)
    ("S23" . SPARSER::PROTEIN) ("S19" . SPARSER::PROTEIN)
    ("S18" . SPARSER::PROTEIN) ("S16" . SPARSER::PROTEIN)
    ("S17" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("S13" . SPARSER::PROTEIN) ("S12" . SPARSER::PROTEIN)
    ("S11" . SPARSER::PROTEIN) ("N-term" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("STAT5b" . SPARSER::PROTEIN)
    ("an irreversible EGFR-TKI" . SPARSER::PROTEIN)
    ("Afatinib" . SPARSER::DRUG)
    ("EGFR-TKI and EGFR-TKI" . SPARSER::COLLECTION)
    ("at least one EGFR-TKI" . SPARSER::PROTEIN)
    ("erlotinib or afatinib" . SPARSER::COLLECTION)
    ("erlotinib or 5 mg/kg" . SPARSER::COLLECTION)
    ("LMC, and AZD9291" . SPARSER::COLLECTION) ("SHO" . SPARSER::PROTEIN)
    ("afatinib and AZD9291" . SPARSER::COLLECTION)
    ("gefitinib, erlotinib, afatinib, and AZD9291" . SPARSER::COLLECTION)
    ("PC-9/ffluc" . SPARSER::PROTEIN)
    ("lung adenocarcinoma PC-9/ffluc" . SPARSER::PROTEIN)
    ("erlotinib and afatinib" . SPARSER::COLLECTION)
    ("AZD9291 and CO-1686" . SPARSER::COLLECTION)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("regressed LMC" . SPARSER::PROTEIN)
    ("afatinib or AZD9291" . SPARSER::COLLECTION) ("afatinib" . SPARSER::DRUG)
    ("LMC" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("CO-1686" . SPARSER::DRUG) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("AZD9291" . SPARSER::DRUG)
    ("overexpressed anti-apoptotic genes" . SPARSER::GENE)
    ("oncogene ( KRAS )" . SPARSER::ONCOGENE)
    ("Simultaneous gene" . SPARSER::GENE)
    ("BCLXL , FLIP , KRAS , MCL1L , XIAP and SURVIVIN" . SPARSER::COLLECTION)
    ("Their orthologous genes" . SPARSER::GENE)
    ("BCLXL, FLIP, MCL1L, SURVIVIN, XIAP , and KRAS" . SPARSER::COLLECTION)
    ("Survivin and Xiap" . SPARSER::COLLECTION) ("KRas" . SPARSER::PROTEIN)
    ("simultaneous gene" . SPARSER::GENE) ("SiRNA" . SPARSER::PROTEIN)
    ("Xiap and Survivin" . SPARSER::COLLECTION) ("Xiap" . SPARSER::PROTEIN)
    ("IAPs" . SPARSER::PROTEIN) ("Mcl1" . SPARSER::PROTEIN)
    ("Mcl" . SPARSER::PROTEIN) ("DISC" . SPARSER::BIO-COMPLEX)
    ("overexpressed decoy receptors" . SPARSER::RECEPTOR)
    ("BCLXL , FLIP , MCL1L , SURVIVIN and XIAP" . SPARSER::COLLECTION)
    ("SURVIVIN" . SPARSER::PROTEIN) ("FLIP" . SPARSER::PROTEIN)
    ("BCLXL" . SPARSER::PROTEIN) ("SiRNAs" . SPARSER::PROTEIN)
    ("Glo 3" . SPARSER::PROTEIN) ("KIF11" . SPARSER::PROTEIN)
    ("Caspases 3" . SPARSER::PROTEIN) ("1 L" . SPARSER::PROTEIN)
    ("variant and gene" . SPARSER::COLLECTION)
    ("only rs451360 GT genotype" . SPARSER::PROTEIN)
    ("the rs451360 GT or TT genotype" . SPARSER::COLLECTION)
    ("TG or GG" . SPARSER::COLLECTION) ("TG" . SPARSER::PROTEIN)
    ("AG or GG" . SPARSER::COLLECTION)
    ("TERT or CLPTM1L" . SPARSER::COLLECTION)
    ("micronutrient" . SPARSER::MOLECULE)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TERT and CLPTM1L" . SPARSER::COLLECTION)
    ("a potential TERT intronic promoter" . SPARSER::PROMOTER)
    ("TERT-CLPTM1L" . SPARSER::COLLECTION) ("CRR9" . SPARSER::PROTEIN)
    ("1 like" . SPARSER::PROTEIN) ("CLPTM1L" . SPARSER::PROTEIN)
    ("polyUb" . SPARSER::PROTEIN)
    ("Indeed Hsp90 inhibitors" . SPARSER::INHIBITOR)
    ("rapamycin and trastuzumab" . SPARSER::COLLECTION)
    ("Cbl and CHIP antibodies" . SPARSER::COLLECTION)
    ("p62/sequestosome-1" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("Chloroquine" . SPARSER::PROTEIN)
    ("the autophagic markers LC3-II" . SPARSER::PROTEIN)
    ("Ctr" . SPARSER::PROTEIN) ("Hsp90 and ER" . SPARSER::COLLECTION)
    ("sh-p130Cas" . SPARSER::COLLECTION)
    ("ErbB2 and p130Cas" . SPARSER::COLLECTION)
    ("anti-estrogen and adriamycin" . SPARSER::COLLECTION)
    ("p130Cas and ErbB2" . SPARSER::COLLECTION)
    ("MMTV-p130Cas" . SPARSER::COLLECTION)
    ("Receptor and integrins" . SPARSER::COLLECTION)
    ("Cbl and CHIP E3 ligases" . SPARSER::COLLECTION)
    ("Cbl" . SPARSER::PROTEIN) ("antibodies and kinase" . SPARSER::COLLECTION)
    ("Na3VO4" . SPARSER::MOLECULE) ("s 5A" . SPARSER::PROTEIN)
    ("Beclin-1" . SPARSER::PROTEIN) ("MHY1485" . SPARSER::DRUG)
    ("anti-estrogen" . SPARSER::DRUG) ("RKIP–NICD" . SPARSER::COLLECTION)
    ("Notch1 and NF-κB" . SPARSER::COLLECTION)
    ("NF-kB/Snail/YY1/RKIP" . SPARSER::COLLECTION)
    ("RKIP and vice versa" . SPARSER::COLLECTION)
    ("Snail and Yin" . SPARSER::COLLECTION)
    ("NF-κB/Snail/YY1/RKIP" . SPARSER::COLLECTION)
    ("Raf1/ERK" . SPARSER::COLLECTION) ("oxidase (LOX)" . SPARSER::PROTEIN)
    ("oxidase" . SPARSER::PROTEIN) ("snail or slug" . SPARSER::COLLECTION)
    ("ERK or GSK3β" . SPARSER::COLLECTION) ("EGFP-RKIP" . SPARSER::COLLECTION)
    ("barely observed full-length (FL) Notch1" . SPARSER::PROTEIN)
    ("NICD-" . SPARSER::PROTEIN) ("RKIP and Notch1" . SPARSER::COLLECTION)
    ("Snail, N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("N-cadherin, Snail, and vimentin" . SPARSER::COLLECTION)
    ("FLAG-RKIP" . SPARSER::COLLECTION) ("RKIP and NICD" . SPARSER::COLLECTION)
    ("pLK" . SPARSER::PROTEIN) ("NTM" . SPARSER::PROTEIN)
    ("110kDa" . SPARSER::PROTEIN)
    ("stably overexpressing FLAG-tagged RKIP proteins" . SPARSER::PROTEIN)
    ("overexpressing FLAG-tagged RKIP proteins" . SPARSER::PROTEIN)
    ("Snail-" . SPARSER::PROTEIN)
    ("mastermind-like protein (Maml) and C-promoting binding factor 1 (CBF1)/Suppressor"
     . SPARSER::COLLECTION)
    ("Slug or Snail" . SPARSER::COLLECTION) ("CSL" . SPARSER::PROTEIN)
    ("Suppressor" . SPARSER::SUPPRESSOR)
    ("a catalytic subunit (Presenilin-1 or Presenilin-2) and accessory subunits"
     . SPARSER::COLLECTION)
    ("accessory subunits" . SPARSER::PROTEIN)
    ("Presenilin-1 or Presenilin-2" . SPARSER::COLLECTION)
    ("Aph1, and Nicastrin" . SPARSER::COLLECTION)
    ("Nicastrin" . SPARSER::PROTEIN) ("Aph" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Presenilin" . SPARSER::PROTEIN) ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("NIK" . SPARSER::PROTEIN) ("MAPK, or MEK" . SPARSER::COLLECTION)
    ("/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("Raf/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("ZEB1/ZEB2" . SPARSER::COLLECTION)
    ("vimentin, N-cadherin, and Snail" . SPARSER::COLLECTION)
    ("Notch1 intracellular domain (NICD)" . SPARSER::PROTEIN)
    ("protein (RKIP)" . SPARSER::PROTEIN) ("RKIP" . SPARSER::PROTEIN)
    ("Jagged1" . SPARSER::PROTEIN) ("Raf1" . SPARSER::PROTEIN)
    ("Hif1α" . SPARSER::PROTEIN) ("CBF1" . SPARSER::PROTEIN)
    ("PEN2" . SPARSER::PROTEIN) ("Presenilin-2" . SPARSER::PROTEIN)
    ("Presenilin-1" . SPARSER::PROTEIN) ("TAK1" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("Notch1 intracellular domain" . SPARSER::PROTEIN)
    ("other key invasion-associated proteins" . SPARSER::PROTEIN)
    ("ROCK1 and target molecules" . SPARSER::COLLECTION)
    ("miRNA and hypoxia" . SPARSER::COLLECTION)
    ("a potential prognostic biomarker" . SPARSER::MOLECULE)
    ("the other completely different mature miRNA" . SPARSER::PROTEIN)
    ("the unique mature miRNA" . SPARSER::PROTEIN)
    ("a novel tumor-suppressive miRNA" . SPARSER::PROTEIN)
    ("these antineoplastic miRNAs" . SPARSER::PROTEIN)
    ("tumor-suppressive miRNAs" . SPARSER::PROTEIN)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("Y-27632 and ROCK1" . SPARSER::COLLECTION)
    ("RhoA/ROCK1" . SPARSER::COLLECTION) ("Rho-ROCK" . SPARSER::COLLECTION)
    ("HIF-1α and ROCK-1" . SPARSER::COLLECTION)
    ("RhoA/ROCK" . SPARSER::COLLECTION) ("byRhoA/ROCK" . SPARSER::COLLECTION)
    ("phalloidin" . SPARSER::MOLECULE)
    ("completely different mature miRNAs" . SPARSER::PROTEIN)
    ("all genomic miRNAs" . SPARSER::PROTEIN)
    ("a completely different mature miRNA" . SPARSER::PROTEIN)
    ("the unique mature miRNA form" . SPARSER::FORM) ("5p" . SPARSER::PROTEIN)
    ("miR-5p" . SPARSER::PROTEIN-PAIR) ("miR-3p" . SPARSER::COLLECTION)
    ("duplex hairpins" . SPARSER::PROTEIN-FAMILY)
    ("longer 70-nt pre-miRNAs" . SPARSER::RNA)
    ("Mature miRNAs" . SPARSER::PROTEIN)
    ("widespread hypoxia" . SPARSER::PROTEIN)
    ("Triton X -100" . SPARSER::MOLECULE) ("Cdc42" . SPARSER::PROTEIN)
    ("Rac1" . SPARSER::PROTEIN) ("miR-221" . SPARSER::PROTEIN)
    ("miR-10b" . SPARSER::MOLECULE) ("ROCK1 protein" . SPARSER::PROTEIN)
    ("ROCK-1" . SPARSER::PROTEIN) ("Pre-miRNAs" . SPARSER::RNA)
    ("RNase III" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("ROCK1" . SPARSER::PROTEIN)
    ("mammary carcinogen DMBA" . SPARSER::MOLECULE)
    ("BRCA-1 and ESR1" . SPARSER::COLLECTION)
    ("BRCA-1/AhR" . SPARSER::COLLECTION) ("AhR-ERα" . SPARSER::COLLECTION)
    ("AhR and ERα" . SPARSER::COLLECTION)
    ("higher basal AhR" . SPARSER::PROTEIN)
    ("AhR, and BRCA-1" . SPARSER::COLLECTION)
    ("AhR/CYP1B1" . SPARSER::COLLECTION)
    ("BRCA-1 and ER α" . SPARSER::COLLECTION)
    ("The ERα and the BRCA-1" . SPARSER::COLLECTION)
    ("a strong AhR agonist [ xref ] and mammary carcinogen [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("a strong AhR agonist" . SPARSER::AGONIST)
    ("DMBA-rat" . SPARSER::MOLECULE)
    ("repressive histone (H3K9me3) and DNA (CpG methylation)"
     . SPARSER::COLLECTION)
    ("repressive histone" . SPARSER::PROTEIN)
    ("AhR, DNMTs, and MBD-2" . SPARSER::COLLECTION)
    ("the AhR and various chromatin" . SPARSER::COLLECTION)
    ("BRCA-1 and AhR" . SPARSER::COLLECTION)
    ("Cdk4 (Fig.  xref ) and Ccnd1 (Fig.  xref )" . SPARSER::COLLECTION)
    ("Cdk4 and Ccnd1" . SPARSER::COLLECTION)
    ("the Cyp1a1 (repression) and Cyp1b1 (activation) target genes"
     . SPARSER::COLLECTION)
    ("Basal Cyp1a1" . SPARSER::PROTEIN)
    ("Cyp1a1 and C yp1b1" . SPARSER::COLLECTION) ("Cyp1a1" . SPARSER::PROTEIN)
    ("oligonucleotides, and Brca -1" . SPARSER::COLLECTION)
    ("DNMT-3a and -3b" . SPARSER::COLLECTION)
    ("methyl-transferase-1" . SPARSER::COLLECTION)
    ("the AhR and downstream gene" . SPARSER::COLLECTION)
    ("industrial xenobiotics" . SPARSER::MOLECULE)
    ("xenobiotics" . SPARSER::MOLECULE) ("Agonists" . SPARSER::AGONIST)
    ("higher proliferation markers Ccnd1 (cyclin D1) and Cdk4"
     . SPARSER::COLLECTION)
    ("Cyp1b1" . SPARSER::PROTEIN) ("Cyp" . SPARSER::PROTEIN)
    ("AhR and BRCA-1" . SPARSER::COLLECTION)
    ("BRCA-1 and ERα" . SPARSER::COLLECTION)
    ("mammary carcinogen 7,12-dimethyl-benzo(a)anthracene (DMBA)"
     . SPARSER::DRUG)
    ("anthracene (DMBA)" . SPARSER::DRUG)
    ("the aromatic hydrocarbon receptor" . SPARSER::RECEPTOR)
    ("ERS1" . SPARSER::PROTEIN) ("OH-" . SPARSER::MOLECULE)
    ("ER α" . SPARSER::PROTEIN) ("MBD-2" . SPARSER::PROTEIN)
    ("Brca -1" . SPARSER::PROTEIN) ("- 3" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG) ("MBD2" . SPARSER::PROTEIN)
    ("protein-2" . SPARSER::PROTEIN) ("DNMT-3a" . SPARSER::PROTEIN)
    ("DNMT-1" . SPARSER::PROTEIN) ("methyl-transferase" . SPARSER::PROTEIN)
    ("ESR1" . SPARSER::PROTEIN) ("CYP1A1" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("HER-2" . SPARSER::PROTEIN)
    ("α-naphthoflavone" . SPARSER::MOLECULE) ("Brca-1" . SPARSER::PROTEIN)
    ("BRCA-1" . SPARSER::PROTEIN) ("namely KRAS exon" . SPARSER::PROTEIN)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY) ("primary CRC" . SPARSER::PROTEIN)
    ("KRAS and PTEN" . SPARSER::COLLECTION) ("intact PTEN" . SPARSER::PROTEIN)
    ("KRAS , PTEN, BRAF , and PIK3CA" . SPARSER::COLLECTION)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("LMs" . SPARSER::MOLECULE)
    ("KRAS, BRAF , and PIK3CA" . SPARSER::COLLECTION)
    ("CEA" . SPARSER::PROTEIN) ("carcinoembryonic" . SPARSER::PROTEIN)
    ("LM" . SPARSER::MOLECULE) ("EGFR antibody" . SPARSER::PROTEIN)
    ("IC 1" . SPARSER::PROTEIN) ("IC1" . SPARSER::PROTEIN)
    ("a robust and sensitive biomarker" . SPARSER::MOLECULE)
    ("The quantitative biomarker" . SPARSER::MOLECULE)
    ("the frontal lobe" . SPARSER::PROTEIN)
    ("MRI and histopathology" . SPARSER::COLLECTION)
    ("CADASIL specific granular NOTCH3" . SPARSER::PROTEIN)
    ("a quantitative biomarker" . SPARSER::MOLECULE)
    ("cerebrovascular NOTCH3" . SPARSER::PROTEIN)
    ("Electron" . SPARSER::MOLECULE)
    ("Characteristic granular NOTCH3" . SPARSER::PROTEIN)
    ("big granular NOTCH3" . SPARSER::PROTEIN)
    ("The individual granular NOTCH3" . SPARSER::PROTEIN)
    ("granular NOTCH3" . SPARSER::PROTEIN) ("tgN" . SPARSER::PROTEIN)
    ("a relevant biomarker" . SPARSER::MOLECULE)
    ("increased vascular NOTCH3" . SPARSER::PROTEIN)
    ("an interesting therapeutic biomarker" . SPARSER::MOLECULE)
    ("mutated pre-mRNA" . SPARSER::RNA)
    ("transgenic models overexpressing human NOTCH3 from a cDNA construct [ xref – xref ] or rat Notch3 from a genomic construct [ xref ]"
     . SPARSER::COLLECTION)
    ("overexpressing human NOTCH3" . SPARSER::PROTEIN)
    ("a feasible biomarker" . SPARSER::MOLECULE)
    ("the archetypal c" . SPARSER::PROTEIN) ("NOTCH3 " . SPARSER::PROTEIN)
    ("CD68" . SPARSER::PROTEIN) ("BRD4" . SPARSER::PROTEIN)
    ("SYDE1" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("Autosomal Dominant" . SPARSER::PROTEIN)
    ("PAI-1 and VE-cadherin" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p120 catenin, β-catenin, α-catenin and actin" . SPARSER::COLLECTION)
    ("VE-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("solvent-" . SPARSER::MOLECULE) ("solvent" . SPARSER::MOLECULE)
    ("VE-cadherin-GFP" . SPARSER::COLLECTION)
    ("PAI-039 or TM5275" . SPARSER::COLLECTION)
    ("sVE-cadherin" . SPARSER::COLLECTION)
    ("β-catenin, α-catenin and p120 catenin" . SPARSER::COLLECTION)
    ("RhoA and Rho kinase" . SPARSER::COLLECTION)
    ("α-catenin, β-catenin and p120 catenin" . SPARSER::COLLECTION)
    ("TMR" . SPARSER::PROTEIN) ("vitronectin" . SPARSER::PROTEIN)
    ("tiplaxtinin" . SPARSER::DRUG) ("Plasmin" . SPARSER::PROTEIN)
    ("a serine protease and an inhibitor" . SPARSER::COLLECTION)
    ("uPA and tPA" . SPARSER::COLLECTION)
    ("PAI-039 and TM5275" . SPARSER::COLLECTION) ("fibrin" . SPARSER::PROTEIN)
    ("tPA" . SPARSER::PROTEIN) ("Y-27632" . SPARSER::MOLECULE)
    ("Rho kinase" . SPARSER::PROTEIN) ("pp120" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("BV6" . SPARSER::MOLECULE)
    ("TM5275" . SPARSER::DRUG) ("plasminogen activator" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("p120 catenin" . SPARSER::PROTEIN)
    ("Vascular Endothelial-cadherin" . SPARSER::PROTEIN)
    ("VE-cadherin" . SPARSER::PROTEIN) ("PAI-039" . SPARSER::DRUG)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("fork-associated proteins" . SPARSER::PROTEIN)
    ("protein-associated nascent strand DNA" . SPARSER::DNA)
    ("key replication fork–associated TRAIP substrates" . SPARSER::SUBSTRATE)
    ("poisons" . SPARSER::MOLECULE)
    ("more fork-associated proteins" . SPARSER::PROTEIN)
    ("helicase and polymerase" . SPARSER::COLLECTION)
    ("helicases" . SPARSER::PROTEIN) ("ATR–Chk1" . SPARSER::COLLECTION)
    ("TRAIP and/or PCNA" . SPARSER::COLLECTION)
    ("DNA damage–induced polη foci" . SPARSER::PROTEIN)
    ("the TRAIP WT and ΔPIP alleles" . SPARSER::COLLECTION)
    ("HU-" . SPARSER::DRUG) ("a weak promoter" . SPARSER::PROMOTER)
    ("stably overexpressed TRAIP" . SPARSER::PROTEIN)
    ("overexpressed TRAIP" . SPARSER::PROTEIN)
    ("Chk1 and H2AX" . SPARSER::COLLECTION) ("HU or MMC" . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG) ("–PCNA" . SPARSER::COLLECTION)
    ("CSPs" . SPARSER::PROTEIN)
    ("purified PCNA and a C-terminal TRAIP peptide (residues 447–469)"
     . SPARSER::COLLECTION)
    ("TRAIP–PCNA" . SPARSER::COLLECTION)
    ("considerable homology" . SPARSER::PROTEIN)
    ("the C-terminal 10 amino acids of TRAIP" . SPARSER::PROTEIN)
    ("TRAIP and replisome-associated PCNA" . SPARSER::COLLECTION)
    ("replisome-associated PCNA" . SPARSER::PROTEIN) ("NCC" . SPARSER::PROTEIN)
    ("broken DNA" . SPARSER::DNA) ("TRAIP and RPA" . SPARSER::COLLECTION)
    ("geminin" . SPARSER::PROTEIN) ("TRIP or RNF206" . SPARSER::COLLECTION)
    ("TRIP" . SPARSER::PROTEIN)
    ("PCNA and numerous effector proteins" . SPARSER::COLLECTION)
    ("impact PCNA and/or its partner proteins ( xref )" . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("polymerase and helicase" . SPARSER::COLLECTION)
    ("PIP" . SPARSER::PROTEIN) ("TRAIP" . SPARSER::PROTEIN)
    ("2-µl" . SPARSER::PROTEIN) ("ZRANB3" . SPARSER::PROTEIN)
    ("pS4" . SPARSER::PROTEIN) ("RPA34" . SPARSER::PROTEIN)
    ("RPA2" . SPARSER::PROTEIN) ("MCM6" . SPARSER::PROTEIN)
    ("B-2" . SPARSER::PROTEIN) ("G-4" . SPARSER::PROTEIN)
    ("CDT1" . SPARSER::PROTEIN) ("RO3306" . SPARSER::DRUG)
    ("RPA1" . SPARSER::PROTEIN) ("F–H" . SPARSER::PROTEIN)
    ("3 D" . SPARSER::PROTEIN-FAMILY) ("1 C" . SPARSER::PROTEIN)
    ("1 B" . SPARSER::PROTEIN) ("RNF206" . SPARSER::PROTEIN)
    ("Proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("the appropriate cofactors and DNA-modifying enzymes"
     . SPARSER::COLLECTION)
    ("the appropriate cofactors" . SPARSER::PROTEIN)
    ("p53-MDM2-p53" . SPARSER::COLLECTION)
    ("other angiogenic genes" . SPARSER::GENE)
    ("a secondary wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the E1a/Ras-transformed TAp73 −/− MEFs" . SPARSER::PROTEIN)
    ("these E1a/Ras-transformed TAp73 −/− MEFs" . SPARSER::PROTEIN)
    ("p73 and HIF1-α" . SPARSER::COLLECTION)
    ("p73 and Vegf-A" . SPARSER::COLLECTION)
    ("p73 AND Vegf-A" . SPARSER::COLLECTION)
    ("angiogenic genes" . SPARSER::GENE)
    ("long-term continued hypoxia" . SPARSER::PROTEIN)
    ("state and context" . SPARSER::COLLECTION) ("ON" . SPARSER::PROTEIN)
    ("a dominant-negative p73DD form" . SPARSER::FORM)
    ("angiogenic target genes" . SPARSER::GENE) ("Vegf" . SPARSER::PROTEIN)
    ("DMBA" . SPARSER::MOLECULE) ("anthracene" . SPARSER::DRUG)
    ("DNp" . SPARSER::DRUG)
    ("the master angiogenic regulator" . SPARSER::REGULATOR)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATF4" . SPARSER::PROTEIN)
    ("endothelial differentiation" . SPARSER::PROTEIN)
    ("SIAH1" . SPARSER::PROTEIN)
    ("12- O -tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("HIF1" . SPARSER::PROTEIN) ("Polymerase" . SPARSER::PROTEIN)
    ("phosphoinositide phospholipase C (PLC γ ) and signal transducer"
     . SPARSER::COLLECTION)
    ("‐kinase/protein kinase B" . SPARSER::COLLECTION)
    ("PD173074" . SPARSER::DRUG) ("5–2" . SPARSER::PROTEIN)
    ("immunoglobulin heavy locus" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TACC3" . SPARSER::PROTEIN) ("PLC γ" . SPARSER::PROTEIN-FAMILY)
    ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("the constitutively active promoter" . SPARSER::PROMOTER)
    ("IL-6, and leptin" . SPARSER::COLLECTION)
    ("IL-6 and leptin" . SPARSER::COLLECTION)
    ("IL-6R and ObR" . SPARSER::COLLECTION) ("ObR" . SPARSER::PROTEIN)
    ("HER2 and IGF1R" . SPARSER::COLLECTION)
    ("the obese patient sera’s" . SPARSER::PROTEIN)
    ("at least two promoters" . SPARSER::PROMOTER)
    ("OB and N patient sera ( xref )" . SPARSER::COLLECTION)
    ("the sera’s" . SPARSER::PROTEIN)
    ("a constitutively active promoter" . SPARSER::PROMOTER)
    ("ERB" . SPARSER::PROTEIN) ("sera, BCL2 and CCND1" . SPARSER::COLLECTION)
    ("BCL2 and CCND1" . SPARSER::COLLECTION)
    ("the anti-apoptotic BCL2 gene and the pro-proliferative CCND1 gene"
     . SPARSER::COLLECTION)
    ("the pro-proliferative CCND1 gene" . SPARSER::GENE)
    ("Bcl-2 and Cyclin D1" . SPARSER::COLLECTION)
    ("mRNA and ERβ" . SPARSER::COLLECTION)
    ("the predominant ER" . SPARSER::PROTEIN)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ERα-" . SPARSER::PROTEIN)
    ("HER2-" . SPARSER::PROTEIN)
    ("antagonist, and siRNA" . SPARSER::COLLECTION)
    ("Bcl-2 and cyclin D1" . SPARSER::COLLECTION) ("sera" . SPARSER::PROTEIN)
    ("MMTV-neu" . SPARSER::COLLECTION) ("OB" . SPARSER::PROTEIN)
    ("gp130" . SPARSER::PROTEIN) ("IL-6R" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN) ("ERβ1" . SPARSER::PROTEIN)
    ("1-C" . SPARSER::PROTEIN) ("ESR2" . SPARSER::PROTEIN)
    ("estrogen receptor beta" . SPARSER::PROTEIN)
    ("a very essential intracellular component" . SPARSER::COMPONENT)
    ("NLRs" . SPARSER::PROTEIN)
    ("growth factors, cytokines, and antigen" . SPARSER::COLLECTION)
    ("49 up-regulated genes and 5 down-regulated genes ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("simple columnar epithelium" . SPARSER::PROTEIN)
    ("normal stratified squamous epithelium" . SPARSER::PROTEIN)
    ("P53, P16, E-cadherin, and Cyclin D" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF)"
     . SPARSER::COLLECTION)
    ("LYN" . SPARSER::PROTEIN) ("nod" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dec 1" . SPARSER::PROTEIN) ("P16" . SPARSER::PROTEIN)
    ("a valuable diagnostic and prognostic biomarker" . SPARSER::MOLECULE)
    ("PI3k/Akt" . SPARSER::COLLECTION)
    ("novel cancer-related miRNAs and their functional targets"
     . SPARSER::COLLECTION)
    ("Cyclin D1 and p27" . SPARSER::COLLECTION) ("miR-519a" . SPARSER::PROTEIN)
    ("miR-519a-mut" . SPARSER::PROTEIN-PAIR) ("mut" . SPARSER::PROTEIN)
    ("PTEN-3" . SPARSER::COLLECTION)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("/p21" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors" . SPARSER::COLLECTION)
    ("a novel prognostic biomarker" . SPARSER::MOLECULE)
    ("phosphatidylinositol-3-OH" . SPARSER::PROTEIN-PAIR)
    ("PI3" . SPARSER::PROTEIN) ("bromo-deoxyuridine" . SPARSER::DRUG)
    ("RNA-binding protein" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("kinase/STAT3/SNAIL" . SPARSER::COLLECTION) ("SNAIL" . SPARSER::PROTEIN)
    ("aberrant E-cadherin" . SPARSER::PROTEIN)
    ("certain EMT-associated proteins" . SPARSER::PROTEIN)
    ("Exogenous IL-6" . SPARSER::PROTEIN) ("BEC" . SPARSER::MOLECULE)
    ("Pro-inflammatory cytokine IL-6" . SPARSER::PROTEIN)
    ("human intrahepatic (HI) BECs" . SPARSER::MOLECULE)
    ("intrahepatic BECs" . SPARSER::MOLECULE)
    ("an important pleiotropic cytokine" . SPARSER::PROTEIN)
    ("primary biliary cirrhosis" . SPARSER::PROTEIN)
    ("BECs" . SPARSER::MOLECULE)
    ("E-cadherin and vimentin" . SPARSER::COLLECTION)
    ("calcium-binding protein" . SPARSER::PROTEIN) ("TFF3" . SPARSER::PROTEIN)
    ("family 3" . SPARSER::PROTEIN) ("ROS-JNK" . SPARSER::COLLECTION)
    ("JNK1, JNK2 and JNK3" . SPARSER::COLLECTION)
    ("ROS-ASK1-JNK" . SPARSER::COLLECTION) ("ATB" . SPARSER::PROTEIN)
    ("ABT-737 and curcumin" . SPARSER::COLLECTION) ("Trypan" . SPARSER::DRUG)
    ("-c-Jun" . SPARSER::COLLECTION)
    ("-apoptosis signal-regulating kinase 1" . SPARSER::COLLECTION)
    ("certain traditional chemotherapeutic drugs and molecular-targeted drugs ( xref – xref )"
     . SPARSER::COLLECTION)
    ("certain traditional chemotherapeutic drugs" . SPARSER::DRUG)
    ("Bcl-2, Bcl-xL and Bcl-w" . SPARSER::COLLECTION)
    ("ROS-ASK1-c-Jun" . SPARSER::COLLECTION)
    ("curcumin and ABT-737" . SPARSER::COLLECTION) ("JNK3" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("ABT-737-" . SPARSER::DRUG) ("or 2 µ" . SPARSER::MOLECULE)
    ("PARP-1" . SPARSER::PROTEIN)
    ("Fluorescein Isothiocyanate" . SPARSER::MOLECULE)
    ("N -acetyl- l -cysteine" . SPARSER::MOLECULE)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("Bcl-w" . SPARSER::PROTEIN) ("BH4" . SPARSER::PROTEIN-FAMILY)
    ("BH2" . SPARSER::MOLECULE) ("BH1" . SPARSER::PROTEIN)
    ("Bcl-2-like" . SPARSER::PROTEIN) ("ABT-737" . SPARSER::DRUG)
    ("mTOR/MnSOD/ROS" . SPARSER::COLLECTION)
    ("mTOR, MnSOD and Akt" . SPARSER::COLLECTION)
    ("shRNA-Akt1" . SPARSER::COLLECTION) ("Akti" . SPARSER::PROTEIN)
    ("rapamycin and mTOR" . SPARSER::COLLECTION)
    ("rapamycin- or mTOR" . SPARSER::COLLECTION) ("rapamycin-" . SPARSER::DRUG)
    ("the last part" . SPARSER::COMPONENT) ("MnSOD/SOD2" . SPARSER::COLLECTION)
    ("mTOR and mitochondrial manganese superoxide dismutase (MnSOD)"
     . SPARSER::COLLECTION)
    ("mitochondrial manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("MnSOD" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("p53, E2F1, miR-34c and SCF" . SPARSER::COLLECTION)
    ("p53 and E2F1" . SPARSER::COLLECTION)
    ("p53, miR-34s , miR-449s and E2F1" . SPARSER::COLLECTION)
    ("E2F1, miR-34c and SCF" . SPARSER::COLLECTION)
    ("Akt and GSK3β" . SPARSER::COLLECTION) ("nicotine" . SPARSER::DRUG)
    ("Bcl2 , c-Myc and Myb" . SPARSER::COLLECTION)
    ("some previously identified miR-34c" . SPARSER::PROTEIN)
    ("E2F1 and E2F3" . SPARSER::COLLECTION)
    ("E2F1 and miR-34c" . SPARSER::COLLECTION)
    ("probably another bona fide target" . SPARSER::TARGET-PROTEIN)
    ("ICAT" . SPARSER::PROTEIN) ("Imatinib" . SPARSER::DRUG)
    ("Ras/MAPK" . SPARSER::COLLECTION)
    ("some other previously identified miR-34c" . SPARSER::PROTEIN)
    ("Myb , c-Myc , Bcl2 and MET" . SPARSER::COLLECTION)
    ("Myb" . SPARSER::PROTEIN) ("anti-E2F1 or anti-Sp1" . SPARSER::COLLECTION)
    ("E2F1 and Sp1" . SPARSER::COLLECTION)
    ("intragenetic miRNAs" . SPARSER::PROTEIN)
    ("pri-miR-34c" . SPARSER::COLLECTION)
    ("an intergenetic miRNA" . SPARSER::PROTEIN) ("inp53" . SPARSER::PROTEIN)
    ("adriamycin" . SPARSER::DRUG) ("RE2" . SPARSER::PROTEIN)
    ("KITLG" . SPARSER::PROTEIN)
    ("Snail1 , Bcl2 , E2F3 , Sirt1 and KIT" . SPARSER::COLLECTION)
    ("either oncogenes or tumour" . SPARSER::COLLECTION)
    ("E2F1-" . SPARSER::PROTEIN) ("PI3K/Akt-GSK3β" . SPARSER::COLLECTION)
    ("SCF/KIT" . SPARSER::COLLECTION) ("-SCF" . SPARSER::COLLECTION)
    ("DAC" . SPARSER::PROTEIN) ("miR-34c" . SPARSER::PROTEIN)
    ("pre-miR-34c" . SPARSER::COLLECTION)
    ("stem cell factor (SCF)" . SPARSER::PROTEIN)
    ("transcription factor E2F1" . SPARSER::PROTEIN)
    ("E2F1 " . SPARSER::PROTEIN) ("Site 2" . SPARSER::PROTEIN)
    ("A 3 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("2F1" . SPARSER::PROTEIN)
    ("pE2" . SPARSER::PROTEIN) ("Sirt1" . SPARSER::PROTEIN)
    ("Snail1" . SPARSER::PROTEIN) ("stem cell factor" . SPARSER::PROTEIN)
    ("ERE" . SPARSER::PROTEIN) ("Fulvestrant" . SPARSER::DRUG)
    ("a pure ERα antagonist" . SPARSER::MOLECULE)
    ("fulvestrant" . SPARSER::DRUG) ("ERE-luciferase" . SPARSER::PROTEIN-PAIR)
    ("TBCA" . SPARSER::PROTEIN) ("ERα and CK2α" . SPARSER::COLLECTION)
    ("either normal breast epithelium or the well-differentiated luminal"
     . SPARSER::COLLECTION)
    ("the well-differentiated luminal" . SPARSER::DRUG)
    ("indole" . SPARSER::DRUG)
    ("cell permeable inhibitor" . SPARSER::INHIBITOR)
    ("furan" . SPARSER::MOLECULE) ("CX" . SPARSER::PROTEIN-FAMILY)
    ("heterotetrameric serine kinase" . SPARSER::KINASE)
    ("The heterotetrameric protein kinase CK2" . SPARSER::PROTEIN)
    ("Tissue Type" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CNK2" . SPARSER::PROTEIN) ("definitely cause TSC" . SPARSER::PROTEIN)
    ("isoforms and variants" . SPARSER::COLLECTION)
    ("AKT and AMPK" . SPARSER::COLLECTION)
    ("infantile epilepsy" . SPARSER::PROTEIN)
    ("a definite TSC‐causing variant" . SPARSER::VARIANT)
    ("the same human adult and fetal tissue types" . TYPE)
    ("S4 and S5" . SPARSER::COLLECTION)
    ("no pathogenic variants" . SPARSER::VARIANT)
    ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pathogenic R611Q variant" . SPARSER::VARIANT)
    ("TSC1/S6K" . SPARSER::COLLECTION)
    ("the original wild‐type TSC2 protein" . SPARSER::PROTEIN)
    ("TSC1–TSC2" . SPARSER::COLLECTION)
    ("Tables S2 and S3" . SPARSER::COLLECTION)
    ("skeletal muscle and thyroid" . SPARSER::COLLECTION)
    ("Wilcoxon" . SPARSER::PROTEIN) ("One intronic variant" . SPARSER::VARIANT)
    ("any pathological variants" . SPARSER::VARIANT)
    ("both obviously truncating variants and fully confirmed missense variants"
     . SPARSER::COLLECTION)
    ("a further 300 variants" . SPARSER::VARIANT)
    ("Variants" . SPARSER::VARIANT)
    ("any apparently pathological variant" . SPARSER::VARIANT)
    ("definite TSC" . SPARSER::PROTEIN)
    ("either TSC1 (MIM #605284) or TSC2 (MIM #191092)" . SPARSER::COLLECTION)
    ("classical TSC" . SPARSER::PROTEIN)
    ("a pathogenic TSC1 or TSC2 variant" . SPARSER::VARIANT)
    ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("TSC1 and TSC2" . SPARSER::COLLECTION) ("1B" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("Amino acid" . SPARSER::AMINO-ACID)
    ("their metastatic foci" . SPARSER::PROTEIN)
    ("normal epithelium" . SPARSER::PROTEIN)
    ("contiguous E-cadherin molecules" . SPARSER::MOLECULE)
    ("catenins" . SPARSER::PROTEIN-FAMILY)
    ("transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("vimentin (Fig.  xref -h) and E-cadherin (Fig.  xref -e)"
     . SPARSER::COLLECTION)
    ("N-cadherin (Fig.  xref -g), vimentin (Fig.  xref -h) and E-cadherin (Fig.  xref -e)"
     . SPARSER::COLLECTION)
    ("N-cadherin (Fig.  xref -c) and vimentin (Fig.  xref -d)"
     . SPARSER::COLLECTION)
    ("group I (Fig.  xref –a) and group III (Fig.  xref -e)"
     . SPARSER::COLLECTION)
    ("group I (Fig.  xref –b,-c,-d) and group III (Fig.  xref –f,-g,-h)"
     . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("-c" . SPARSER::COLLECTION)
    ("group I and group III" . SPARSER::COLLECTION)
    ("HEY" . SPARSER::PROTEIN-FAMILY)
    ("valuable biomarkers" . SPARSER::MOLECULE)
    ("epithelial-mesenchymal transition (EMT)-related proteins"
     . SPARSER::PROTEIN)
    ("E-cadherin, N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("p120" . SPARSER::PROTEIN)
    ("epithelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("group III" . SPARSER::PROTEIN) ("group I" . SPARSER::PROTEIN)
    ("CoCl 2" . SPARSER::MOLECULE) ("Ras or PSD95" . SPARSER::COLLECTION)
    ("regulating dynamic palmitate" . SPARSER::PROTEIN)
    ("overexpressed ABHD17A" . SPARSER::PROTEIN)
    ("the singly-palmitoylated N-Ras" . SPARSER::PROTEIN)
    ("ABHD17A as well as APT1 and APT2" . SPARSER::COLLECTION)
    ("Hras" . SPARSER::PROTEIN) ("Ras and PSD95" . SPARSER::COLLECTION)
    ("elegant chemical" . SPARSER::MOLECULE)
    ("EGFP-N-Ras" . SPARSER::COLLECTION) ("PSD-95-GFP" . SPARSER::COLLECTION)
    ("ABHD17A, ABHD17B, ABHD17C and ABHD6" . SPARSER::COLLECTION)
    ("ABHD17A" . SPARSER::PROTEIN)
    ("mutant or N-terminal" . SPARSER::COLLECTION) ("Nras" . SPARSER::PROTEIN)
    ("letter" . SPARSER::MOLECULE)
    ("ABHD12 and monoacylglyerol" . SPARSER::COLLECTION)
    ("palmitoyl-proteins" . SPARSER::PROTEIN-PAIR)
    ("AMPA " . SPARSER::MOLECULE)
    ("the residual ABHD17 enzymes" . SPARSER::ENZYME)
    ("N-Ras or PSD95" . SPARSER::COLLECTION) ("Rab5-" . SPARSER::PROTEIN)
    ("ABHD6, PNPLA6, and FASN" . SPARSER::COLLECTION)
    ("ABHD6 and PNPLA6" . SPARSER::COLLECTION) ("RHC" . SPARSER::PROTEIN)
    ("Palmitate" . SPARSER::PROTEIN) ("CoA" . SPARSER::MOLECULE)
    ("FASN, PNPLA6, ABHD6, ABHD16A, and ABHD17A/B/C" . SPARSER::COLLECTION)
    ("FASN" . SPARSER::PROTEIN) ("FP-Rho" . SPARSER::COLLECTION)
    ("a competitive activity-based protein" . SPARSER::PROTEIN)
    ("FP-rho" . SPARSER::COLLECTION)
    ("fluorophosphonate-rhodamine" . SPARSER::PROTEIN-PAIR)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteases and mSHs" . SPARSER::COLLECTION)
    ("APT1 or APT2" . SPARSER::COLLECTION)
    ("N-Ras, PSD95, and N-HTT" . SPARSER::COLLECTION)
    ("APT1, APT2, and PPT1" . SPARSER::COLLECTION) ("BP" . SPARSER::PROTEIN)
    ("PSD95 or N-Ras" . SPARSER::COLLECTION)
    ("SPRED2, GOLIM4, and ITM2B" . SPARSER::COLLECTION)
    ("HTT" . SPARSER::PROTEIN) ("these neuronal proteins" . SPARSER::PROTEIN)
    ("GAD65 and PSD95" . SPARSER::COLLECTION) ("AHA" . SPARSER::MOLECULE)
    ("N-Ras and PSD95" . SPARSER::COLLECTION) ("mSHs" . SPARSER::PROTEIN)
    ("N-Ras and other proteins ( xref ; xref )" . SPARSER::COLLECTION)
    ("Asp-His-His-Cys" . SPARSER::COLLECTION)
    ("cysteines" . SPARSER::AMINO-ACID)
    ("the neuronal post-synaptic density protein PSD95" . SPARSER::PROTEIN)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("PSD95 and N-Ras" . SPARSER::COLLECTION)
    ("postsynaptic density protein 95 (PSD95) or N-Ras" . SPARSER::COLLECTION)
    ("palmitate and protein" . SPARSER::COLLECTION)
    ("Huntingtin" . SPARSER::PROTEIN) ("Only two enzymes" . SPARSER::ENZYME)
    ("APT1 and APT2" . SPARSER::COLLECTION)
    ("acyl-protein" . SPARSER::COLLECTION) ("palmitate" . SPARSER::PROTEIN)
    ("thioesterases" . SPARSER::PROTEIN-FAMILY) ("ABHD4" . SPARSER::PROTEIN)
    ("PSD-95" . SPARSER::PROTEIN) ("SP8" . SPARSER::PROTEIN)
    ("or 2 " . SPARSER::MOLECULE) ("palmitic acid" . SPARSER::MOLECULE)
    ("TX-100" . SPARSER::DRUG) ("H -1" . SPARSER::PROTEIN)
    ("ABHD12" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("ABHD6" . SPARSER::PROTEIN)
    ("PNPLA6" . SPARSER::PROTEIN) ("BK channel" . SPARSER::PROTEIN)
    ("PPT1" . SPARSER::PROTEIN) ("ITM2B" . SPARSER::PROTEIN)
    ("GOLIM4" . SPARSER::PROTEIN) ("SPRED2" . SPARSER::PROTEIN)
    ("GAD65" . SPARSER::PROTEIN) ("glutamate decarboxylase" . SPARSER::PROTEIN)
    ("SNAP25" . SPARSER::PROTEIN) ("β-lactone" . SPARSER::MOLECULE)
    ("post-synaptic density protein" . SPARSER::PROTEIN)
    ("N-Ras" . SPARSER::PROTEIN) ("PSD95" . SPARSER::PROTEIN)
    ("postsynaptic density protein 95" . SPARSER::PROTEIN)
    ("APT2" . SPARSER::PROTEIN) ("APT1" . SPARSER::PROTEIN)
    ("bind cytoskeletal components" . SPARSER::COMPONENT)
    ("LKB1 and/or Dyn2" . SPARSER::COLLECTION)
    ("the predominant dynamin" . SPARSER::PROTEIN)
    ("LKB1, Dyn2 and NRP-1" . SPARSER::COLLECTION)
    ("Dynamin2 (Dyn2) and NRP-1" . SPARSER::COLLECTION)
    ("LKB1, Dynamin2 (Dyn2) and NRP-1" . SPARSER::COLLECTION)
    ("NRP-1 and HGF" . SPARSER::COLLECTION)
    ("receptor and ligand" . SPARSER::COLLECTION)
    ("c-met and NRP-1" . SPARSER::COLLECTION)
    ("pro-metastatic NRP-1" . SPARSER::PROTEIN)
    ("matrigel or gelatin basement membrane matrix" . SPARSER::COLLECTION)
    ("NRP-1/NEDD9" . SPARSER::COLLECTION)
    ("LKB1 and NRP-1" . SPARSER::COLLECTION)
    ("AMPK and VEGFR2" . SPARSER::COLLECTION)
    ("NRP-1, VEGFR2, LKB1 and AMPK" . SPARSER::COLLECTION)
    ("NRP-1 and the other cytokines" . SPARSER::COLLECTION)
    ("VEGF and PDGF-BB" . SPARSER::COLLECTION)
    ("HGF and G-CSF" . SPARSER::COLLECTION)
    ("platelet endothelial cell adhesion molecule (PECAM-1) and VEGF"
     . SPARSER::COLLECTION)
    ("-BB" . SPARSER::MOLECULE) ("BB" . SPARSER::MOLECULE)
    ("follistatin" . SPARSER::PROTEIN)
    ("negligible or undetected NRP-1" . SPARSER::PROTEIN)
    ("clinically relevant biomarkers" . SPARSER::MOLECULE)
    ("kinase (AMPK)" . SPARSER::KINASE) ("defective NRP-1" . SPARSER::PROTEIN)
    ("several membrane-associated proteins" . SPARSER::PROTEIN)
    ("Prominent NRP-1" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR) and VEGF receptor"
     . SPARSER::COLLECTION)
    ("the respective receptors" . SPARSER::PROTEIN)
    ("semaphorins and VEGF" . SPARSER::COLLECTION)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("bevacizumab or Sunitinib" . SPARSER::COLLECTION)
    ("Sunitinib, Cediranib and Vatalanib" . SPARSER::COLLECTION)
    ("Vatalanib" . SPARSER::DRUG) ("Cediranib" . SPARSER::DRUG)
    ("Sunitinib" . SPARSER::DRUG) ("Bevacizumab" . SPARSER::DRUG)
    ("vascular endothelial growth factor (VEGF) and tyrosine kinases"
     . SPARSER::COLLECTION)
    ("bid" . SPARSER::PROTEIN) ("NRP-1 and NEDD9" . SPARSER::COLLECTION)
    ("a pro-metastatic protein" . SPARSER::PROTEIN)
    ("Tumoral NRP-1" . SPARSER::PROTEIN) ("c-peptide" . SPARSER::MOLECULE)
    ("cytochalasin-D" . SPARSER::DRUG) ("Dyn2" . SPARSER::PROTEIN)
    ("Dynamin2" . SPARSER::PROTEIN) ("c-met" . SPARSER::PROTEIN)
    ("LKB-1" . SPARSER::PROTEIN) ("PDGF-BB" . SPARSER::PROTEIN)
    ("PECAM-1" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("interleukin-8" . SPARSER::PROTEIN)
    ("G-CSF" . SPARSER::PROTEIN)
    ("granulocyte-colony stimulating factor" . SPARSER::PROTEIN)
    ("Ang-2" . SPARSER::PROTEIN) ("angiopoietin-2" . SPARSER::PROTEIN)
    ("Liver Kinase B1" . SPARSER::PROTEIN)
    ("growth-factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("co-receptor" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("neuropilin-1" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("single-pass" . SPARSER::PROTEIN-FAMILY) ("NRP-1" . SPARSER::PROTEIN)
    ("Neuropilin-1" . SPARSER::PROTEIN) ("PAH and AFB1" . SPARSER::COLLECTION)
    ("Vimentin and N-Cadherin" . SPARSER::COLLECTION)
    ("HBx-DNMTs-p16 INK4A" . SPARSER::COLLECTION) ("HBx" . SPARSER::PROTEIN)
    ("TSGs" . SPARSER::PROTEIN)
    ("especially benzo(a)pyrene" . SPARSER::PROTEIN)
    ("PAHs" . SPARSER::PROTEIN) ("RASSF1A and p16 INK4A" . SPARSER::COLLECTION)
    ("HCC and non-cancerous" . SPARSER::COLLECTION)
    ("DNMT1, DNMT3a and DNMT3b" . SPARSER::COLLECTION)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("TCF-8/ZEB1" . SPARSER::COLLECTION)
    ("proteins, PARP, and caspase-3" . SPARSER::COLLECTION)
    ("RASSF10-2" . SPARSER::COLLECTION) ("DNMTs" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("-deoxycytidine" . SPARSER::COLLECTION) ("dC" . SPARSER::MOLECULE)
    ("α-Fetoprotein (AFP)" . SPARSER::PROTEIN)
    ("JunD and PKA" . SPARSER::COLLECTION) ("JunD" . SPARSER::PROTEIN)
    ("tumor suppressor gene (TSG)" . SPARSER::PROTEIN)
    ("RASSF" . SPARSER::PROTEIN-FAMILY)
    ("the approximately 782,500 new HCC" . SPARSER::PROTEIN)
    ("Bax and Bad" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xl" . SPARSER::COLLECTION)
    ("E-Cadherin" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate" . SPARSER::MOLECULE)
    ("N-Cadherin" . SPARSER::PROTEIN) ("p16 INK4A" . SPARSER::PROTEIN)
    ("demethylase activity" . SPARSER::PROTEIN) ("TCF-8" . SPARSER::PROTEIN)
    ("ZO-1" . SPARSER::PROTEIN) ("DNMT3b" . SPARSER::PROTEIN)
    ("DNMT3a" . SPARSER::PROTEIN) ("α-Fetoprotein" . SPARSER::PROTEIN)
    ("RASSF10" . SPARSER::PROTEIN) ("family 10" . SPARSER::PROTEIN)
    ("Cai" . SPARSER::DRUG) ("c-Myc and MEF2C" . SPARSER::COLLECTION)
    ("MEF2C, c-Fos, Fra 1, Sap-1, c-Myc and NF-κB" . SPARSER::COLLECTION)
    ("Thr and Tyr" . SPARSER::COLLECTION)
    ("SATB1 and its homolog SATB2" . SPARSER::COLLECTION)
    ("SATB1 and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc (Figure xref & xref ) and MEF2C (Figure xref )"
     . SPARSER::COLLECTION)
    ("CTRL" . SPARSER::PROTEIN) ("exogenous c-Myc" . SPARSER::PROTEIN)
    ("Flag-Myc" . SPARSER::COLLECTION)
    ("SATB2 and c-Myc" . SPARSER::COLLECTION)
    ("SATB2/Myc" . SPARSER::COLLECTION) ("c-Myc-Max" . SPARSER::COLLECTION)
    ("Max" . SPARSER::PROTEIN) ("MIZ-1" . SPARSER::PROTEIN)
    ("GFP or GFP-SATB2" . SPARSER::COLLECTION)
    ("GFP-SATB2" . SPARSER::COLLECTION)
    ("DLD-1 and SW1080" . SPARSER::COLLECTION)
    ("MEK5/ERK5" . SPARSER::COLLECTION)
    ("ABL1, ERRB2, MMP2, E-CADHERIN, VEGFB, KISS1 and TGFB1"
     . SPARSER::COLLECTION)
    ("VEGFB" . SPARSER::PROTEIN) ("the most curable types" . TYPE)
    ("SATB1 and SATB2" . SPARSER::COLLECTION)
    ("matrix-associated proteins" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("Full-length" . SPARSER::PROTEIN)
    ("Sap-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fra 1" . SPARSER::PROTEIN)
    ("T–E" . SPARSER::PROTEIN) ("MEF2C" . SPARSER::PROTEIN)
    ("MEK5" . SPARSER::PROTEIN) ("KISS1" . SPARSER::PROTEIN)
    ("E-CADHERIN" . SPARSER::PROTEIN) ("ERRB2" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("SATB2" . SPARSER::PROTEIN) ("SATB1" . SPARSER::PROTEIN)
    ("Special AT-rich sequence-binding protein 1" . SPARSER::PROTEIN)
    ("the artificial W80A mutant" . SPARSER::MUTANT)
    ("VIII or MK-2206" . SPARSER::COLLECTION)
    ("MK-2206 or GSK690693" . SPARSER::COLLECTION)
    ("the previously validated Akt1 L52R, Q79K, and D323H mutants"
     . SPARSER::MUTANT)
    ("the Akt1 D323H and Akt2 W80C mutants" . SPARSER::COLLECTION)
    ("MK-2206 and GSK690693" . SPARSER::COLLECTION)
    ("VIII and MK-2206" . SPARSER::COLLECTION)
    ("inhibitors, such as MK-2206, and ATP-competitive kinase inhibitors"
     . SPARSER::COLLECTION)
    ("GSK690693, AZD5363, and GSK2141795" . SPARSER::COLLECTION)
    ("Akt and PRAS40" . SPARSER::COLLECTION)
    ("Akt1 or Akt2" . SPARSER::COLLECTION)
    ("Akt1 and Akt2" . SPARSER::COLLECTION)
    ("a homologous mutant" . SPARSER::MUTANT) ("chosen" . SPARSER::PROTEIN)
    ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("AKT1 or AKT2" . SPARSER::COLLECTION)
    ("recurrently mutated amino acids" . SPARSER::AMINO-ACID)
    ("allosteric inhibitors and ATP-competitive kinase inhibitors"
     . SPARSER::COLLECTION)
    ("AKT2 and AKT3" . SPARSER::COLLECTION)
    ("the highly homologous kinases AKT1 , AKT2 , or AKT3"
     . SPARSER::COLLECTION)
    ("AKT1 , AKT2 , or AKT3" . SPARSER::COLLECTION)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("Akt1 D323H and Akt2 W80C mutants" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP)
    ("twenty recurrent Akt mutants" . SPARSER::MUTANT)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK2141795" . SPARSER::DRUG) ("AZD5363" . SPARSER::DRUG)
    ("GSK690693" . SPARSER::DRUG) ("PRAS40" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("Akt3" . SPARSER::PROTEIN)
    ("C-Raf" . SPARSER::PROTEIN) ("B-Raf" . SPARSER::PROTEIN)
    ("MK-2206" . SPARSER::MOLECULE) ("Akt2" . SPARSER::PROTEIN)
    ("sorafenib and JAK" . SPARSER::COLLECTION) ("SHPs" . SPARSER::PROTEIN)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p-STAT5" . SPARSER::COLLECTION)
    ("p-JAK1" . SPARSER::COLLECTION) ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("PMF" . SPARSER::PROTEIN) ("PV" . SPARSER::PROTEIN)
    ("c-MYC, CCND1, and VEGF" . SPARSER::COLLECTION)
    ("receptors, which in turn recruit signal transducer and activator"
     . SPARSER::COLLECTION)
    ("JAK1, JAK2, JAK3, and TYK2" . SPARSER::COLLECTION)
    ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("interferon (IFN) and interleukin 6 (IL-6)" . SPARSER::COLLECTION)
    ("receptors, FGFR, VEGFR, and PDGFR" . SPARSER::COLLECTION)
    ("sunitinib and dovitinib" . SPARSER::COLLECTION)
    ("dovitinib" . SPARSER::DRUG)
    ("FGFR, VEGFR, and PDGFR" . SPARSER::COLLECTION)
    ("WNT/beta-catenin" . SPARSER::COLLECTION)
    ("WNT, FGFR, VEGFR, and PDGFR" . SPARSER::COLLECTION)
    ("VEGFR" . SPARSER::PROTEIN) ("sorafenib" . SPARSER::DRUG)
    ("Ruxolitinib" . SPARSER::DRUG) ("ruxolitinib" . SPARSER::DRUG)
    ("Activator" . SPARSER::ACTIVATOR) ("Reducing Agent" . SPARSER::MOLECULE)
    ("IL-3" . SPARSER::PROTEIN) ("JAK1 A" . SPARSER::PROTEIN)
    ("TYK2" . SPARSER::PROTEIN) ("JAK3" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("Janus Kinase 1" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN)
    ("NOTCH2 as well as SRC and STAT3" . SPARSER::COLLECTION)
    ("the predominant NOTCH receptor" . SPARSER::RECEPTOR)
    ("Chen" . SPARSER::PROTEIN)
    ("the pivotal molecular mediators" . SPARSER::PROTEIN)
    ("c-MET/PKCδ/SRC/STAT3/NOTCH2" . SPARSER::COLLECTION)
    ("p-PKCδ" . SPARSER::COLLECTION) ("PKCδ or NOTCH2" . SPARSER::COLLECTION)
    ("SRC, STAT3 and NOTCH2" . SPARSER::COLLECTION)
    ("EGFR or variant" . SPARSER::COLLECTION) ("EGFRvIII" . SPARSER::PROTEIN)
    ("c-MET and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("SRC/STAT3/NOTCH2" . SPARSER::COLLECTION)
    ("JAG1 or -2" . SPARSER::COLLECTION) ("GSI" . SPARSER::PROTEIN)
    ("receptors and ligands" . SPARSER::COLLECTION)
    ("PKCδ/SRC/STAT3" . SPARSER::COLLECTION)
    ("these mesenchymal signature proteins" . SPARSER::PROTEIN)
    ("CDH2, SNAI2, and ZEB1" . SPARSER::COLLECTION)
    ("p-STAT3" . SPARSER::COLLECTION) ("p-SRC" . SPARSER::COLLECTION)
    ("SRC or STAT3" . SPARSER::COLLECTION)
    ("NF-κB or the MAPKs ERK (extracellular signal-regulated kinase)"
     . SPARSER::COLLECTION)
    ("p38, or JNK" . SPARSER::COLLECTION)
    ("SRC and STAT" . SPARSER::COLLECTION) ("kappaB" . SPARSER::PROTEIN)
    ("SRC and STAT3" . SPARSER::COLLECTION)
    ("SNAI2, SNAI1, and ZEB1" . SPARSER::COLLECTION)
    ("VIM and their regulators SNAI2" . SPARSER::COLLECTION)
    ("the mesenchymal markers CDH2, VIM and their regulators SNAI2"
     . SPARSER::COLLECTION)
    ("the mesenchymal markers CDH2" . SPARSER::PROTEIN)
    ("SNAI2 or ZEB1" . SPARSER::COLLECTION)
    ("CDH2 and VIM" . SPARSER::COLLECTION)
    ("SNAI2 and ZEB1" . SPARSER::COLLECTION)
    ("the mesenchymal cell markers CDH2" . SPARSER::PROTEIN)
    ("SNAI1, SNAI2, ZEB1 and TWIST1" . SPARSER::COLLECTION)
    ("VIM" . SPARSER::PROTEIN) ("mesenchymal traits" . SPARSER::PROTEIN)
    ("protein (GFP)" . SPARSER::PROTEIN)
    ("PKCα, PKCβ, PKCζ, and PKCδ" . SPARSER::COLLECTION)
    ("SRC/STAT3/Notch2" . SPARSER::COLLECTION)
    ("c-MET/PKCδ" . SPARSER::COLLECTION) ("SRC/STAT3" . SPARSER::COLLECTION)
    ("PKCα, PKCβI, PKCβII and PKCγ" . SPARSER::COLLECTION)
    ("PKCδ, PKCε, PKCη and PKCθ" . SPARSER::COLLECTION)
    ("PKCζ, PKCι and PKCλ" . SPARSER::COLLECTION)
    ("growth factors and other membrane receptor ligands"
     . SPARSER::COLLECTION)
    ("the most aggressive form" . SPARSER::FORM)
    ("c-MET/PKCδ/SRC/STAT3" . SPARSER::COLLECTION)
    ("NOTCH-2" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("p-P38" . SPARSER::PROTEIN) ("JAG2" . SPARSER::PROTEIN)
    ("Jagged-2" . SPARSER::PROTEIN) ("Jagged-1" . SPARSER::PROTEIN)
    ("SNAI2" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("CDH2" . SPARSER::PROTEIN) ("U87" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN) ("PKCγ" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("NOTCH2" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE)
    ("tumor suppressive phosphatases" . SPARSER::PHOSPHATASE)
    ("Three highly homologous isoforms" . SPARSER::ISOFORM)
    ("metastatic FTC" . SPARSER::DRUG)
    ("Pten and Inpp4b" . SPARSER::COLLECTION)
    ("PTEN and INPP4B" . SPARSER::COLLECTION) ("FTC" . SPARSER::DRUG)
    ("Lipid" . SPARSER::LIPID) ("P 3 and PI" . SPARSER::COLLECTION)
    ("Phosphoinositide 3-kinase (PI3K) and AKT" . SPARSER::COLLECTION)
    ("SGK3" . SPARSER::PROTEIN) ("Inpp4b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inositol polyphosphate 4-phosphatase type II" . SPARSER::PROTEIN)
    ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bank" . SPARSER::PROTEIN)
    ("VA" . SPARSER::MOLECULE)
    ("mitochondrial telomerase activity" . SPARSER::PROTEIN)
    ("PTIO" . SPARSER::PROTEIN) ("FM" . SPARSER::PROTEIN)
    ("DAF" . SPARSER::PROTEIN) ("prostacyclins" . SPARSER::MOLECULE)
    ("ceramide and TERT" . SPARSER::COLLECTION)
    ("Ceramide" . SPARSER::MOLECULE) ("ceramide" . SPARSER::MOLECULE)
    ("c-PTIO" . SPARSER::COLLECTION)
    ("kinases or calcium" . SPARSER::COLLECTION)
    ("p-eNOS" . SPARSER::COLLECTION)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("RM" . SPARSER::MOLECULE)
    ("aka" . SPARSER::PROTEIN) ("TERT- or nuc" . SPARSER::COLLECTION)
    ("TERT-" . SPARSER::PROTEIN) ("mitoSox" . SPARSER::DRUG)
    ("mitoSOX" . SPARSER::DRUG) ("nuc" . SPARSER::PROTEIN)
    ("TERT-GFP" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("rotenone" . SPARSER::PROTEIN) ("vasodilator" . SPARSER::PROTEIN)
    ("ACh" . SPARSER::PROTEIN)
    ("mitochondrial hydrogen peroxide" . SPARSER::DRUG)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("TRPV4" . SPARSER::PROTEIN)
    ("Daf-2" . SPARSER::PROTEIN) ("HSP 27" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("1C" . SPARSER::PROTEIN)
    ("Mitotracker Red" . SPARSER::MOLECULE) ("Ku80" . SPARSER::PROTEIN)
    ("a 37" . SPARSER::PROTEIN) ("1–1" . SPARSER::PROTEIN)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ET-1" . SPARSER::PROTEIN) ("actinomycin D" . SPARSER::MOLECULE)
    ("Telomerase activity" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("L-arginine" . SPARSER::MOLECULE) ("L-NAME" . SPARSER::MOLECULE)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("KN, SM, and RAK" . SPARSER::COLLECTION)
    ("reagents and advice" . SPARSER::COLLECTION) ("KN" . SPARSER::PROTEIN)
    ("AC and RAK" . SPARSER::COLLECTION) ("AC" . SPARSER::PROTEIN)
    ("RAK" . SPARSER::PROTEIN) ("viable MTB" . SPARSER::PROTEIN)
    ("c-Jun and HDAC1" . SPARSER::COLLECTION) ("GTCA" . SPARSER::PROTEIN)
    ("bacterially-derived cAMP" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("regulating several immune-related genes" . SPARSER::GENE)
    ("IL-2, IL-6, IL-10, and TNF-α" . SPARSER::COLLECTION)
    ("cyclic-AMP response element-binding protein (CREB) and c-Jun"
     . SPARSER::COLLECTION)
    ("protein (CREB)" . SPARSER::PROTEIN) ("Saha" . SPARSER::DRUG)
    ("Protein kinase-A (PKA)" . SPARSER::PROTEIN)
    ("metabolically active virulent MTB" . SPARSER::PROTEIN)
    ("IL-12B and HDAC1" . SPARSER::COLLECTION)
    ("the key cytokine" . SPARSER::PROTEIN)
    ("regulating IL-12 or other genes" . SPARSER::COLLECTION)
    ("intestinal macrophages" . SPARSER::PROTEIN)
    ("The secreted Listerial virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("LntA" . SPARSER::PROTEIN)
    ("the bacterial AnkA protein" . SPARSER::PROTEIN)
    ("several bacterial genes" . SPARSER::GENE)
    ("heat-killed virulent MTB" . SPARSER::PROTEIN)
    ("CREB, c-Jun and HDAC1" . SPARSER::COLLECTION) ("BCG" . SPARSER::DRUG)
    ("CREB, c-JUN, and SOX-5" . SPARSER::COLLECTION)
    ("CREB and c-Jun" . SPARSER::COLLECTION)
    ("PKC, PKA, and PI-3K" . SPARSER::COLLECTION)
    ("MAPK-ERK" . SPARSER::COLLECTION) ("Mitogen" . SPARSER::MITOGEN)
    ("HDAC1 and IL-12p40" . SPARSER::COLLECTION)
    ("butyrate (SB)" . SPARSER::PROTEIN) ("butyrate" . SPARSER::PROTEIN)
    ("macrophages and macrophages" . SPARSER::COLLECTION)
    ("virulent MTB-infected macrophages" . SPARSER::PROTEIN)
    ("PI, HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("at least PKA, CREB, and c-Jun" . SPARSER::COLLECTION)
    ("PKA, CREB, and c-Jun" . SPARSER::COLLECTION)
    ("live virulent MTB" . SPARSER::PROTEIN)
    ("protein kinase-A (PKA)" . SPARSER::PROTEIN)
    ("live MTB-infected macrophages" . SPARSER::PROTEIN)
    ("immunologically relevant kinases" . SPARSER::KINASE)
    ("CREB, and c-Jun" . SPARSER::COLLECTION)
    ("virulent MTB" . SPARSER::PROTEIN) ("Rv" . SPARSER::MOLECULE)
    ("MTB" . SPARSER::PROTEIN) ("SOX5" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("cyclic-AMP" . SPARSER::MOLECULE) ("Protein kinase-A" . SPARSER::PROTEIN)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("IL-10" . SPARSER::PROTEIN) ("Sin3A" . SPARSER::PROTEIN)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY) ("SOX-5" . SPARSER::PROTEIN)
    ("Protein Kinase-A" . SPARSER::PROTEIN)
    ("Protein Kinase-C" . SPARSER::PROTEIN) ("IL- 12B" . SPARSER::PROTEIN)
    ("H10" . SPARSER::PROTEIN) ("p40)" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("IL-12p40" . SPARSER::PROTEIN)
    ("Histone-H3" . SPARSER::PROTEIN) ("K23" . SPARSER::PROTEIN)
    ("H3—K9" . SPARSER::PROTEIN) ("protein kinase-A" . SPARSER::PROTEIN)
    ("IL-12B" . SPARSER::PROTEIN) ("H37" . SPARSER::PROTEIN)
    ("Raf and ERK" . SPARSER::COLLECTION)
    ("arsenic trioxide (ATO)" . SPARSER::MOLECULE)
    ("HO-1, NQO1, GCLM, and ferritin" . SPARSER::COLLECTION)
    ("ATO" . SPARSER::PROTEIN) ("promyelocytic" . SPARSER::PROTEIN)
    ("RA" . SPARSER::PROTEIN) ("ATRA" . SPARSER::DRUG)
    ("another strong and selective Nrf2 inhibitor" . SPARSER::INHIBITOR)
    ("Another highly water-soluble micellar form" . SPARSER::FORM)
    ("HO-1, and xenobiotic" . SPARSER::COLLECTION) ("lycopene" . SPARSER::DRUG)
    ("multidrug-resistance-related proteins" . SPARSER::PROTEIN)
    ("bortezomib" . SPARSER::DRUG) ("NF-kB and AP-1" . SPARSER::COLLECTION)
    ("andrographolide" . SPARSER::DRUG) ("iron" . SPARSER::MOLECULE)
    ("ferritin" . SPARSER::PROTEIN) ("bilirubin" . SPARSER::MOLECULE)
    ("oxygenase" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("HO-1, GCLM, and NQO1" . SPARSER::COLLECTION) ("GSCs" . SPARSER::PROTEIN)
    ("MRP3 and GSTs" . SPARSER::COLLECTION)
    ("cisplatin, etoposide, and doxorubicin" . SPARSER::COLLECTION)
    ("GSTs" . SPARSER::PROTEIN) ("MRP4, and MRP5" . SPARSER::COLLECTION)
    ("Multidrug" . SPARSER::PROTEIN)
    ("two representative chemotherapeutic drugs" . SPARSER::DRUG)
    ("protein and sensitises" . SPARSER::COLLECTION)
    ("mitoxantrone and topotecan" . SPARSER::COLLECTION)
    ("topotecan" . SPARSER::DRUG) ("member A2" . SPARSER::PROTEIN)
    ("GSSG" . SPARSER::DRUG)
    ("Nrf2 and its dependent genes" . SPARSER::COLLECTION)
    ("etoposide, cisplatin, and doxorubicin" . SPARSER::COLLECTION)
    ("prolyl-hydrolase" . SPARSER::COLLECTION) ("hydrolase" . SPARSER::PROTEIN)
    ("metalloproteases" . SPARSER::PROTEIN) ("intron" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase, phosphogluconate dehydrogenase, transketolase, and transaldolase 1"
     . SPARSER::COLLECTION)
    ("NADPH and purine" . SPARSER::COLLECTION)
    ("transketolase" . SPARSER::PROTEIN)
    ("WTX, PALB2, and DPP3" . SPARSER::COLLECTION) ("DPP" . SPARSER::MOLECULE)
    ("WTX" . SPARSER::PROTEIN) ("Kelch/DRG" . SPARSER::COLLECTION)
    ("DRG" . SPARSER::PROTEIN)
    ("Nrf2 and loss-of-function" . SPARSER::COLLECTION)
    ("homozygotes" . SPARSER::PROTEIN) ("amine (BBN)" . SPARSER::MOLECULE)
    ("amine" . SPARSER::MOLECULE) ("cytoprotective genes" . SPARSER::GENE)
    ("electrophiles and ROS" . SPARSER::COLLECTION)
    ("BRAF and C-MYC" . SPARSER::COLLECTION)
    ("KRAS, or KRAS" . SPARSER::COLLECTION)
    ("response element (TRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("TRE" . SPARSER::PROTEIN) ("Keap1 and β -TrCP" . SPARSER::COLLECTION)
    ("cirrhosis" . SPARSER::PROTEIN) ("Hrd1" . SPARSER::PROTEIN)
    ("β -TrCP-Skp1-Cul1-Rbx1" . SPARSER::COLLECTION)
    ("inducers" . SPARSER::MOLECULE)
    ("broad complex, Tramtrack, and Bric-a-Brac" . SPARSER::COLLECTION)
    ("glycine" . SPARSER::AMINO-ACID)
    ("ARE-sequence" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Wang and coworkers" . SPARSER::COLLECTION)
    ("the dimeric β -transducin" . SPARSER::COLLECTION)
    ("-transducin" . SPARSER::COLLECTION) ("transducin" . SPARSER::PROTEIN)
    ("protein (CBP)" . SPARSER::PROTEIN)
    ("CREB-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cAMP response element binding protein-" . SPARSER::PROTEIN)
    ("RAC" . SPARSER::PROTEIN) ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a strong antioxidant" . SPARSER::PROTEIN)
    ("nearly 500 genes" . SPARSER::GENE)
    ("proteins, lipids, and DNA" . SPARSER::COLLECTION)
    ("Nrf2/HO-1" . SPARSER::COLLECTION) ("Nrf2 and HO-1" . SPARSER::COLLECTION)
    ("arsenic trioxide" . SPARSER::MOLECULE)
    ("retinoid X receptor" . SPARSER::PROTEIN) ("RAR α" . SPARSER::PROTEIN)
    ("HIF α" . SPARSER::PROTEIN) ("prostaglandin J2" . SPARSER::MOLECULE)
    ("carbon monoxide" . SPARSER::MOLECULE)
    ("Heme oxygenase 1" . SPARSER::PROTEIN) ("MRP5" . SPARSER::PROTEIN)
    ("MRP4" . SPARSER::PROTEIN) ("protein-3" . SPARSER::PROTEIN)
    ("member A" . SPARSER::PROTEIN) ("subfamily G" . SPARSER::PROTEIN)
    ("transaldolase 1" . SPARSER::PROTEIN) ("DJ-1" . SPARSER::PROTEIN)
    ("C-MYC" . SPARSER::PROTEIN) ("Cullin 1" . SPARSER::PROTEIN)
    ("Rbx1" . SPARSER::PROTEIN) ("GSK-3 β" . SPARSER::PROTEIN)
    ("sequestosome-1" . SPARSER::PROTEIN)
    ("tert-butylhydroquinone" . SPARSER::DRUG)
    ("Bric-a-Brac" . SPARSER::PROTEIN) ("broad complex" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("RXR α" . SPARSER::PROTEIN)
    ("retinoid X receptor alpha" . SPARSER::PROTEIN)
    ("β -TrCP" . SPARSER::PROTEIN)
    ("cAMP response element binding protein" . SPARSER::PROTEIN)
    ("CHD6" . SPARSER::PROTEIN) ("Neh2" . SPARSER::PROTEIN)
    ("Neh1" . SPARSER::PROTEIN) ("p45" . SPARSER::PROTEIN)
    ("the homologous repair (HR) arm" . SPARSER::PROTEIN)
    ("BK" . SPARSER::PROTEIN) ("stably replicating HPV8 genomes types" . TYPE)
    ("replicating HPV8 genomes types" . TYPE)
    ("high-risk viral proteins" . SPARSER::PROTEIN)
    ("some other viral protein" . SPARSER::PROTEIN)
    ("ATR and ATRIP" . SPARSER::COLLECTION)
    ("which binds ATR" . SPARSER::PROTEIN)
    ("ATRIP and claspin" . SPARSER::COLLECTION)
    ("p-STAT-5" . SPARSER::COLLECTION)
    ("GSK-3β and its downstream target Tip60" . SPARSER::COLLECTION)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("ATR kinase and its downstream effector" . SPARSER::COLLECTION)
    ("STAT-5 or control shRNAs" . SPARSER::COLLECTION)
    ("pimozide" . SPARSER::DRUG)
    ("ATR as well as CHK1 kinases" . SPARSER::COLLECTION)
    ("AKT, CDK4, and CDK6" . SPARSER::COLLECTION)
    ("CDK4, and CDK6" . SPARSER::COLLECTION)
    ("around nucleotide" . SPARSER::NUCLEOTIDE)
    ("Neither UCN01 nor CHK2i" . SPARSER::COLLECTION)
    ("p-ATM and ATM" . SPARSER::COLLECTION) ("p-CHK2" . SPARSER::COLLECTION)
    ("p-ATM as well as total ATM" . SPARSER::COLLECTION)
    ("PARP (poly ADP-ribose polymerase) or Bcl-XL" . SPARSER::COLLECTION)
    ("CHK1 or ATR" . SPARSER::COLLECTION) ("p-ATR" . SPARSER::COLLECTION)
    ("viral DNAs" . SPARSER::DNA) ("total and activated forms" . SPARSER::FORM)
    ("CHK1, BRCA 1, and MCM" . SPARSER::COLLECTION) ("MCM" . SPARSER::PROTEIN)
    ("ATR-interacting protein (ATRIP)" . SPARSER::PROTEIN)
    ("claspin" . SPARSER::PROTEIN) ("ATR/CHK1" . SPARSER::COLLECTION)
    ("ATR or CHK1" . SPARSER::COLLECTION) ("Nbs1" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN) ("IRF-8" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("UCN01" . SPARSER::DRUG)
    ("ATR-interacting protein" . SPARSER::PROTEIN)
    ("STAT-5" . SPARSER::PROTEIN)
    ("estrogen or androgen" . SPARSER::COLLECTION)
    ("neither Src nor p300" . SPARSER::COLLECTION)
    ("Src, HMGA2, and SMYD3" . SPARSER::COLLECTION)
    ("Src/p300" . SPARSER::COLLECTION)
    ("HMGA2 and/or SMYD3 gene promoters" . SPARSER::COLLECTION)
    ("dasatinib or p300" . SPARSER::COLLECTION)
    ("Src or p300" . SPARSER::COLLECTION)
    ("the irrelevant beta-actin promoter" . SPARSER::PROMOTER)
    ("either p300 or general phosphotyrosine" . SPARSER::COLLECTION)
    ("a classical NLS or NES fused" . SPARSER::PROTEIN)
    ("NES" . SPARSER::PROTEIN) ("pSrc" . SPARSER::PROTEIN)
    ("exogenous c-Src" . SPARSER::PROTEIN) ("Src-" . SPARSER::PROTEIN)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("membranous Src substrates" . SPARSER::SUBSTRATE)
    ("dasatinib" . SPARSER::DRUG) ("orthovanadate" . SPARSER::MOLECULE)
    ("grim19" . SPARSER::PROTEIN) ("lamin" . SPARSER::PROTEIN)
    ("calnexin" . SPARSER::PROTEIN)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("the insoluble cytoplasmic fraction" . SPARSER::COMPONENT)
    ("the two nucleoplasmic fractions" . SPARSER::COMPONENT)
    ("DNase/RNase" . SPARSER::COLLECTION) ("DNAse/RNAse" . SPARSER::COLLECTION)
    ("RNase" . SPARSER::PROTEIN) ("RNAse" . SPARSER::PROTEIN)
    ("DNAse and heparin" . SPARSER::COLLECTION) ("heparin" . SPARSER::PROTEIN)
    ("DNAse" . SPARSER::PROTEIN) ("normal MEFs" . SPARSER::PROTEIN)
    ("the pro-migratory genes HMGA2 and SMYD3" . SPARSER::COLLECTION)
    ("PDAC and MEF" . SPARSER::COLLECTION)
    ("modular protein" . SPARSER::PROTEIN)
    ("Src and Src-family" . SPARSER::COLLECTION) ("vSrc" . SPARSER::PROTEIN)
    ("Src-p300" . SPARSER::COLLECTION) ("Src and p300" . SPARSER::COLLECTION)
    ("HMGA2 and SMYD3" . SPARSER::COLLECTION) ("PDAC" . SPARSER::MOLECULE)
    ("SET and MYND" . SPARSER::COLLECTION) ("SET" . SPARSER::PROTEIN)
    ("HMGA" . SPARSER::PROTEIN-FAMILY) ("hook" . SPARSER::PROTEIN-FAMILY)
    ("PKIα" . SPARSER::PROTEIN) ("β-Tubulin" . SPARSER::PROTEIN)
    ("C20" . SPARSER::PROTEIN)
    ("phosphatidylinositide 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C646" . SPARSER::MOLECULE) ("v-Src" . SPARSER::PROTEIN)
    ("Sam68" . SPARSER::PROTEIN) ("SMYD3" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("the fibrous astrocytes" . SPARSER::PROTEIN)
    ("protoplasmic astrocytes" . SPARSER::PROTEIN)
    ("IL-34 and extracellular nucleotides [ xref , xref – xref ]"
     . SPARSER::COLLECTION)
    ("HSPB1, HSPB5, HSPB6 and HSPB8" . SPARSER::COLLECTION)
    ("some cells and shares structural homology" . SPARSER::PROTEIN)
    ("reactive astrocytes" . SPARSER::PROTEIN)
    ("HSPB1, HSPB5 and HSPB6" . SPARSER::COLLECTION)
    ("HSPB1 or HSPB5" . SPARSER::COLLECTION)
    ("HSPB1 and HSPB5" . SPARSER::COLLECTION)
    ("the GM and the adjacent WM" . SPARSER::COLLECTION)
    ("HSPB1 and HSPB6" . SPARSER::COLLECTION)
    ("active and inactive" . SPARSER::COLLECTION)
    ("Olig2 (Fig.  xref ) or HLA-DR (Fig.  xref )" . SPARSER::COLLECTION)
    ("HSPB1 and either Olig2 or HLA-DR" . SPARSER::COLLECTION)
    ("Olig2 or HLA-DR" . SPARSER::COLLECTION) ("GFAP" . SPARSER::PROTEIN)
    ("HSPB1 and HLA-DR" . SPARSER::COLLECTION)
    ("PLP and HLA-DR" . SPARSER::COLLECTION) ("PLP" . SPARSER::PROTEIN)
    ("HSPB1, HSPB5, HSPB6, HSPB8 and HSPB11" . SPARSER::COLLECTION)
    ("HSPB1 and HSPB8" . SPARSER::COLLECTION)
    ("a classical state" . SPARSER::BIO-STATE)
    ("receptor (TLR)" . SPARSER::RECEPTOR)
    ("microglia/macrophages" . SPARSER::COLLECTION)
    ("myelin" . SPARSER::PROTEIN) ("microglia" . SPARSER::PROTEIN)
    ("HSPB1, HSPB6 and HSPB8" . SPARSER::COLLECTION)
    ("HSPB1, HSPB6, HSPB8 and HSPB11" . SPARSER::COLLECTION)
    ("GM" . SPARSER::PROTEIN) ("alpha B-crystallin" . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("IL-34" . SPARSER::PROTEIN) ("6.3 " . SPARSER::PROTEIN)
    ("AF 3" . SPARSER::PROTEIN) ("Olig2" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("IgG2b" . SPARSER::BIO-COMPLEX) ("HLA-DR" . SPARSER::PROTEIN)
    ("EF1α" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("HSPB11" . SPARSER::PROTEIN) ("HSPB8" . SPARSER::PROTEIN)
    ("HSPB6" . SPARSER::PROTEIN) ("HSPB5" . SPARSER::PROTEIN)
    ("alpha B" . SPARSER::PROTEIN)
    ("superoxide and hydrogen peroxide" . SPARSER::COLLECTION)
    ("superoxide, nitric oxide and hydrogen peroxide" . SPARSER::COLLECTION)
    ("NADPH and superoxide" . SPARSER::COLLECTION)
    ("NADPH and glutathione" . SPARSER::COLLECTION)
    ("Redox" . SPARSER::PROTEIN) ("HSCARG-NF-κB" . SPARSER::COLLECTION)
    ("an essential regulator" . SPARSER::REGULATOR)
    ("TNF-α and antiviral genes" . SPARSER::COLLECTION)
    ("cytokine genes (such as IFN- α / β and TNF- α) and antiviral genes"
     . SPARSER::COLLECTION)
    ("cellular redox" . SPARSER::PROTEIN)
    ("G6PD and IDH1" . SPARSER::COLLECTION)
    ("the antiviral genes" . SPARSER::GENE)
    ("TNF- α [ xref ] and MX1 [ xref ]" . SPARSER::COLLECTION)
    ("TNF- α ( xref ) and MX1 ( xref ) genes" . SPARSER::COLLECTION)
    ("G6PD-" . SPARSER::PROTEIN)
    ("the antiviral genes TNF- α and MX1" . SPARSER::COLLECTION)
    ("Numerous antiviral genes" . SPARSER::GENE)
    ("the viral N gene" . SPARSER::GENE)
    ("Exogenous G6PD or isocitrate dehydrogenase" . SPARSER::PROTEIN)
    ("G6PD or isocitrate" . SPARSER::COLLECTION)
    ("antiviral genes" . SPARSER::GENE)
    ("MX1 and TNF- α" . SPARSER::COLLECTION)
    ("protein kinase R (PKR)" . SPARSER::PROTEIN)
    ("the antiviral state" . SPARSER::BIO-STATE)
    ("synthetase (OAS)" . SPARSER::PROTEIN) ("IFN" . SPARSER::DRUG)
    ("antiviral proteins" . SPARSER::PROTEIN)
    ("the principal antiviral cytokines" . SPARSER::PROTEIN)
    ("antiviral cytokines" . SPARSER::PROTEIN)
    ("IFNs and TNF-α" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN) ("IFNs" . SPARSER::DRUG)
    ("G6PD or IDH1" . SPARSER::COLLECTION) ("viral genes" . SPARSER::GENE)
    ("HSCARG" . SPARSER::PROTEIN) ("TNF- α and MX1" . SPARSER::COLLECTION)
    ("nitric oxide" . SPARSER::MOLECULE) ("interleukin-10" . SPARSER::PROTEIN)
    ("IFN- α" . SPARSER::PROTEIN) ("HSST3" . SPARSER::PROTEIN)
    ("Δ C" . SPARSER::PROTEIN) ("glucose-6-phosphate" . SPARSER::MOLECULE)
    ("NMRAL1" . SPARSER::PROTEIN) ("protein kinase R" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("NADP +" . SPARSER::MOLECULE)
    ("TNF- α" . SPARSER::PROTEIN) ("G6PD" . SPARSER::PROTEIN)
    ("Glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("REF" . SPARSER::PROTEIN) ("Light" . SPARSER::PROTEIN)
    ("hAHA1–FLAG" . SPARSER::COLLECTION) ("Da" . SPARSER::MOLECULE)
    ("STY" . SPARSER::PROTEIN) ("RP" . SPARSER::PROTEIN)
    ("was run" . SPARSER::PROTEIN-FAMILY) ("tip" . SPARSER::PROTEIN)
    ("MH" . SPARSER::MOLECULE) ("detergent" . SPARSER::MOLECULE)
    ("TFA" . SPARSER::PROTEIN) ("REV" . SPARSER::PROTEIN-FAMILY)
    ("PMSF" . SPARSER::MOLECULE) ("Mag-trypsin" . SPARSER::COLLECTION)
    ("Mag-Trypsin" . SPARSER::COLLECTION)
    ("Mag" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NaCl" . SPARSER::PROTEIN)
    ("Peptide" . SPARSER::PEPTIDE) ("Peptides" . SPARSER::PEPTIDE)
    ("grade-modified trypsin" . SPARSER::PROTEIN)
    ("enzyme–protein" . SPARSER::COLLECTION) ("tris" . SPARSER::MOLECULE)
    ("MOPS" . SPARSER::MOLECULE) ("hAha1–FLAG" . SPARSER::COLLECTION)
    ("Trypsin" . SPARSER::PROTEIN)
    ("intrinsic ATPase activity" . SPARSER::PROTEIN)
    ("an essential chaperone" . SPARSER::PROTEIN) ("hAHA1" . SPARSER::PROTEIN)
    ("AHA-1" . SPARSER::PROTEIN) ("HCO 3" . SPARSER::MOLECULE)
    ("hAha1" . SPARSER::PROTEIN) ("Aha1" . SPARSER::PROTEIN)
    ("Heat Shock Protein 90" . SPARSER::PROTEIN)
    ("metastatic CRCs" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("NRAS, BRAF, or PIK3CA" . SPARSER::COLLECTION)
    ("KRAS, NRAS, BRAF, and PIK3CA" . SPARSER::COLLECTION)
    ("BRAF, NRAS, and PIK3CA" . SPARSER::COLLECTION)
    ("chemotherapy-refractory metastatic CRC" . SPARSER::PROTEIN)
    ("the largest cohort" . SPARSER::MOLECULE)
    ("PIK3CA or NRAS" . SPARSER::COLLECTION)
    ("BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS or NRAS" . SPARSER::COLLECTION)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("the histological subtypes" . SPARSER::PROTEIN)
    ("EGFR-RAS-RAF" . SPARSER::COLLECTION)
    ("BRAF, NRAS, and components" . SPARSER::COLLECTION)
    ("genes and proto-oncogenes" . SPARSER::COLLECTION)
    ("PI3K-PTEN-AKT" . SPARSER::COLLECTION)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION)
    ("KRAS, NRAS, PIK3CA and BRAF" . SPARSER::COLLECTION)
    ("PIK3CA (exon 20) and BRAF (exon 15) genes" . SPARSER::COLLECTION)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("KRAS, NRAS, BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("RAS family" . SPARSER::PROTEIN) ("CDK5 and miR-21" . SPARSER::COLLECTION)
    ("Fak-Akt" . SPARSER::COLLECTION) ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTEN, PDCD4, TIMP3 and TMP1" . SPARSER::COLLECTION)
    ("ASH" . SPARSER::PROTEIN)
    ("targets-PTEN and sulfatase-1" . SPARSER::COLLECTION)
    ("sulfatase" . SPARSER::PROTEIN) ("IF and IHC" . SPARSER::COLLECTION)
    ("ADR" . SPARSER::PROTEIN)
    ("antisense oligonucleotide (asON) or a STAT3 inhibitor WP1066"
     . SPARSER::COLLECTION)
    ("STAT3, pSTAT3, CDK5, N-cadherin, vimentin and β-catenin"
     . SPARSER::COLLECTION)
    ("WP1066 and asON (Fig.  xref )" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("after WP1066 and asON exposure" . SPARSER::COLLECTION)
    ("MMP-2/MMP-9" . SPARSER::COLLECTION)
    ("WP1066, a specific STAT3 small-molecule inhibitor, and antisense oligonucleotide (asON)"
     . SPARSER::COLLECTION)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("MiR-21/CDK5" . SPARSER::COLLECTION)
    ("CDK5 and EMT" . SPARSER::COLLECTION)
    ("STAT3 and EMT" . SPARSER::COLLECTION)
    ("MiR-21 and CDK5" . SPARSER::COLLECTION)
    ("miR-21 (red) and CDK5" . SPARSER::COLLECTION)
    ("Cancer Committee (AJCC) Lip and Oral Cancer TNM" . SPARSER::COLLECTION)
    ("Lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK5 and EMT-related proteins" . SPARSER::COLLECTION)
    ("miR-21, CDK5 and EMT-related proteins" . SPARSER::COLLECTION)
    ("miR-21/CDK5" . SPARSER::COLLECTION)
    ("CDK5 and p35" . SPARSER::COLLECTION)
    ("CDK5, p35 and p25" . SPARSER::COLLECTION) ("MTC" . SPARSER::PROTEIN)
    ("The neuronal kinase CDK5" . SPARSER::PROTEIN) ("HBE" . SPARSER::PROTEIN)
    ("arsenite" . SPARSER::DRUG) ("CDK5/CDK5R1" . SPARSER::COLLECTION)
    ("CDK5/p35" . SPARSER::COLLECTION) ("asON-miR-21" . SPARSER::COLLECTION)
    ("miR-21 and CDK5" . SPARSER::COLLECTION) ("COX" . SPARSER::PROTEIN)
    ("miR-21, CDK5 and EMT" . SPARSER::COLLECTION)
    ("STAT3/miR-21" . SPARSER::COLLECTION)
    ("STAT3 and miR-21" . SPARSER::COLLECTION) ("TMP1" . SPARSER::PROTEIN)
    ("TIMP3" . SPARSER::PROTEIN) ("neuronal migration" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("hSulf-1" . SPARSER::PROTEIN)
    ("p160" . SPARSER::PROTEIN) ("P160" . SPARSER::PROTEIN)
    ("p25" . SPARSER::PROTEIN) ("MiR-21" . SPARSER::PROTEIN)
    ("chromosome17" . SPARSER::PROTEIN) ("p35)" . SPARSER::PROTEIN)
    ("CDK5R1" . SPARSER::PROTEIN) ("p35" . SPARSER::PROTEIN)
    ("WP1066" . SPARSER::DRUG) ("CDK5" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 5" . SPARSER::PROTEIN)
    ("p53 or K-Ras" . SPARSER::COLLECTION) ("RIP" . SPARSER::PROTEIN)
    ("PD98059 and SB203580" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("DUSP5 and MKP1" . SPARSER::COLLECTION)
    ("MKP1 and DUSP5" . SPARSER::COLLECTION) ("chelators" . SPARSER::MOLECULE)
    ("cDDP" . SPARSER::DRUG) ("MAPKs and protein" . SPARSER::COLLECTION)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("v-H-Ras" . SPARSER::COLLECTION)
    ("UV, chemo and radiotherapy" . SPARSER::COLLECTION)
    ("such p19ARF [ xref ] or pRb" . SPARSER::COLLECTION)
    ("Bax and Caspase-9" . SPARSER::COLLECTION) ("pRb" . SPARSER::PROTEIN)
    ("chemosensitizer" . SPARSER::DRUG)
    ("this adenoviral protein" . SPARSER::PROTEIN)
    ("the adenoviral protein" . SPARSER::PROTEIN)
    ("Ras or Myc" . SPARSER::COLLECTION) ("caspases 3" . SPARSER::PROTEIN)
    ("sh-RNA" . SPARSER::RNA) ("CA-3" . SPARSER::PROTEIN)
    ("envelope protein" . SPARSER::PROTEIN) ("PD098059" . SPARSER::DRUG)
    ("SB 203580" . SPARSER::DRUG) ("NF-kb" . SPARSER::PROTEIN)
    ("Caspase-9" . SPARSER::PROTEIN) ("p19ARF" . SPARSER::PROTEIN)
    ("MKP1" . SPARSER::PROTEIN)
    ("SP1 and NF-κB/p65 that might regulate solamargine-suppressed EP4 gene expression"
     . SPARSER::COLLECTION)
    ("SP1 and EP4" . SPARSER::COLLECTION) ("EP4 and SP1" . SPARSER::COLLECTION)
    ("a steroidal alkaloid glycoside" . SPARSER::MOLECULE)
    ("glycoside" . SPARSER::MOLECULE)
    ("new adjunctive therapeutics" . SPARSER::THERAPEUTICS)
    ("exogenous expressed p65" . SPARSER::PROTEIN)
    ("/EP4" . SPARSER::COLLECTION) ("NF-κB/p65" . SPARSER::COLLECTION)
    ("mRNA, protein and promoter" . SPARSER::COLLECTION)
    ("prostanoid" . SPARSER::MOLECULE)
    ("rapamycin (mTOR) dual inhibitor" . SPARSER::INHIBITOR)
    ("/protein kinase B" . SPARSER::COLLECTION)
    ("low-toxic topoisomerase II inhibitor epirubicin" . SPARSER::DRUG)
    ("epirubicin" . SPARSER::DRUG) ("the histological types" . TYPE)
    ("PI3-K/Akt" . SPARSER::COLLECTION) ("SP1 and p65" . SPARSER::COLLECTION)
    ("exogenous expressed SP1" . SPARSER::PROTEIN)
    ("exogenous expressed Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SP1 and NF-κB" . SPARSER::COLLECTION)
    ("SP1, p65, and EP4" . SPARSER::COLLECTION)
    ("Natural phytochemicals" . SPARSER::DRUG)
    ("NADPH oxidase 4" . SPARSER::PROTEIN) ("a 20 " . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("EGF-R" . SPARSER::PROTEIN)
    ("prostaglandin E2" . SPARSER::MOLECULE)
    ("a tumor suppressor gene and prostate-specific expressed NKX3.1"
     . SPARSER::COLLECTION)
    ("NKX3.1 and androgen receptor" . SPARSER::COLLECTION)
    ("chromatin or histone" . SPARSER::COLLECTION) ("Lind" . SPARSER::PROTEIN)
    ("both primary and metastatic PCa" . SPARSER::PROTEIN)
    ("metastatic PCa" . SPARSER::PROTEIN)
    ("PTEN, GAPDH, NKX3.1 and PSA" . SPARSER::COLLECTION)
    ("PSA" . SPARSER::PROTEIN) ("dF/dT" . SPARSER::COLLECTION)
    ("NKX3.1 and PCa" . SPARSER::COLLECTION) ("tensin" . SPARSER::PROTEIN)
    ("Homology" . SPARSER::PROTEIN) ("primary PCa" . SPARSER::PROTEIN)
    ("REST and SPSS" . SPARSER::COLLECTION)
    ("PTEN and NKX3.1" . SPARSER::COLLECTION) ("REST" . SPARSER::PROTEIN)
    ("NKX3.1 and PTEN" . SPARSER::COLLECTION)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("NKX3.1" . SPARSER::PROTEIN) ("histological types" . TYPE)
    ("the very classical metastasis suppressor" . SPARSER::SUPPRESSOR)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S100A4, and matrix" . SPARSER::COLLECTION)
    ("cyto-keratins" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("keratins" . SPARSER::PROTEIN) ("Snail or Slug" . SPARSER::COLLECTION)
    ("ER-α,BRCA1 and p21" . SPARSER::COLLECTION) ("IRS " . SPARSER::PROTEIN)
    ("MTA1-siRNA" . SPARSER::COLLECTION) ("-cadherin" . SPARSER::COLLECTION)
    ("MTA1-high group and MTA1-low group" . SPARSER::COLLECTION)
    ("IOD" . SPARSER::MOLECULE) ("varieties" . SPARSER::VARIETY)
    ("asbestos" . SPARSER::MOLECULE)
    ("MTA1 and E-cadherin" . SPARSER::COLLECTION) ("MPM" . SPARSER::MOLECULE)
    ("Metastasis-associated gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S100A4" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("Pax5" . SPARSER::PROTEIN) ("IRS 4" . SPARSER::PROTEIN)
    ("MTA1" . SPARSER::PROTEIN) ("homozygote" . SPARSER::PROTEIN)
    ("XX-genotype" . SPARSER::PROTEIN-PAIR)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("genes and relevant mutations" . SPARSER::COLLECTION)
    ("The complex and multifactorial nature" . SPARSER::COLLECTION)
    ("Han and Hui" . SPARSER::COLLECTION)
    ("ER- α and ER- β" . SPARSER::COLLECTION)
    ("a complex and multifactorial disease that has a relatively mild phenotype"
     . SPARSER::COLLECTION)
    ("Stata" . SPARSER::PROTEIN) ("estrogen receptor-" . SPARSER::PROTEIN)
    ("ER- β" . SPARSER::PROTEIN) ("its receptor" . SPARSER::PROTEIN)
    ("ER- α" . SPARSER::PROTEIN) ("fun" . SPARSER::PROTEIN)
    ("PCL" . SPARSER::PROTEIN) ("an accessory protein" . SPARSER::PROTEIN)
    ("developmental and neuronal regulator genes" . SPARSER::GENE)
    ("PCL3 and KDM7A" . SPARSER::COLLECTION)
    ("E-cadherin and KDM7A" . SPARSER::COLLECTION) ("CB" . SPARSER::PROTEIN)
    ("G9a, E-cadherin, PCL3 and KDM7A" . SPARSER::COLLECTION)
    ("KDM7A and PCL3" . SPARSER::COLLECTION)
    ("KDM6A and 6B" . SPARSER::COLLECTION)
    ("KDM7A, KDM6A and KDM6B" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN)
    ("MLL and SETD1A" . SPARSER::COLLECTION)
    ("accessory proteins" . SPARSER::PROTEIN)
    ("Tri- and di-methylation" . SPARSER::COLLECTION)
    ("Tri-" . SPARSER::PROTEIN) ("Tri" . SPARSER::PROTEIN)
    ("GEM" . SPARSER::PROTEIN) ("a key methyltransferase" . SPARSER::PROTEIN)
    ("JMJD2/MLL2" . SPARSER::COLLECTION) ("MLL" . SPARSER::PROTEIN)
    ("MLL4 and KDM6A" . SPARSER::COLLECTION) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("G9a and PRC2" . SPARSER::COLLECTION)
    ("G9a and polycomb repressive complex 2" . SPARSER::COLLECTION)
    ("B17" . SPARSER::PROTEIN) ("MLL1" . SPARSER::PROTEIN)
    ("KDM6B" . SPARSER::PROTEIN) ("SETD1A" . SPARSER::PROTEIN)
    ("JMJD2" . SPARSER::PROTEIN) ("JMJD2B" . SPARSER::PROTEIN)
    ("MLL4" . SPARSER::PROTEIN) ("m2" . SPARSER::MOLECULE)
    ("KDM7A" . SPARSER::PROTEIN) ("PCL3" . SPARSER::PROTEIN)
    ("polycomb repressive complex 2" . SPARSER::PROTEIN)
    ("G9a" . SPARSER::PROTEIN) ("EGFR or PI3K" . SPARSER::COLLECTION)
    ("EGFR, PI3K, Akt, PKC and Sp1" . SPARSER::COLLECTION)
    ("PI3K/PKCζ" . SPARSER::COLLECTION)
    ("Pal and co-workers" . SPARSER::COLLECTION) ("Pal" . SPARSER::PROTEIN)
    ("HIFα/VEGF" . SPARSER::COLLECTION) ("GSK3β/MYCN" . SPARSER::COLLECTION)
    ("MYCN" . SPARSER::PROTEIN)
    ("EGFR and downstream kinases" . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("LY294002 and API-1" . SPARSER::COLLECTION)
    ("glycogen synthase, and glycogen" . SPARSER::COLLECTION)
    ("the principal downstream effectors" . SPARSER::EFFECTOR)
    ("3-phosphoinositide-dependent protein kinases" . SPARSER::PROTEIN)
    ("PDK-1 and PDK-2" . SPARSER::COLLECTION)
    ("PI3K/Akt/Sp1" . SPARSER::COLLECTION)
    ("PKCζ and Akt" . SPARSER::COLLECTION)
    ("LY294002 or API-1" . SPARSER::COLLECTION) ("Mithramycin" . SPARSER::DRUG)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("diacylglycerol (DAG)" . SPARSER::DAG)
    ("classical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DAG" . SPARSER::DAG)
    ("diacylglycerol" . SPARSER::PROTEIN) ("Atypical PKCζ" . SPARSER::PROTEIN)
    ("functional EGFR" . SPARSER::PROTEIN) ("FBS or SF" . SPARSER::COLLECTION)
    ("either wild-type GSK3β (wtGSK3) or a constitutively active GSK3β mutant (GSK3 S9A )"
     . SPARSER::COLLECTION)
    ("neither rapamycin nor SB216763" . SPARSER::COLLECTION)
    ("the mTOR inhibitor rapamycin (2.5 nM) or the GSK3 inhibitor SB216763 (5 μM)"
     . SPARSER::COLLECTION)
    ("GSK3 and the mammalian target of rapamycin (mTOR)" . SPARSER::COLLECTION)
    ("At least 13 Akt substrates" . SPARSER::SUBSTRATE)
    ("t " . SPARSER::PROTEIN) ("GSK3 and mTOR" . SPARSER::COLLECTION)
    ("CaMKII" . SPARSER::PROTEIN) ("ecto-ATPases" . SPARSER::COLLECTION)
    ("ARL" . SPARSER::PROTEIN) ("ATPases" . SPARSER::PROTEIN)
    ("ecto" . SPARSER::PROTEIN) ("FBS (FBS)" . SPARSER::PROTEIN)
    ("SF" . SPARSER::PROTEIN)
    ("several glycolytic enzymes and larger intracellular glycogen"
     . SPARSER::COLLECTION)
    ("larger intracellular glycogen" . SPARSER::PROTEIN)
    ("glycogen" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("G-protein coupled P2Y receptors and ligand-gated P2X cation"
     . SPARSER::COLLECTION)
    ("purinergic receptors" . SPARSER::PROTEIN)
    ("Nucleotides" . SPARSER::NUCLEOTIDE)
    ("PI3K/Akt/PKCζ" . SPARSER::COLLECTION)
    ("atypical PKCζ" . SPARSER::PROTEIN)
    ("receptor (EGFR)" . SPARSER::RECEPTOR) ("P2rx7" . SPARSER::PROTEIN)
    ("purinergic P2X7 receptor" . SPARSER::RECEPTOR)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("GSK3S" . SPARSER::HUMAN-PROTEIN-FAMILY) ("U-0126" . SPARSER::MOLECULE)
    ("luteinizing hormone receptor" . SPARSER::PROTEIN)
    ("derived growth factor-D" . SPARSER::PROTEIN) ("HIFα" . SPARSER::PROTEIN)
    ("PDK-2" . SPARSER::PROTEIN) ("PDK-1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3,4,5-triphosphate" . SPARSER::PIP3)
    ("PKCι" . SPARSER::PROTEIN) ("GSK3 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SB216763" . SPARSER::DRUG) ("API-1" . SPARSER::PROTEIN)
    ("KN93" . SPARSER::MOLECULE) ("GF109203X" . SPARSER::DRUG)
    ("ecto-ATPase" . SPARSER::PROTEIN) ("NFATc1" . SPARSER::PROTEIN)
    ("Ca 2+ -calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("P2Y 1" . SPARSER::PROTEIN) ("P2X1" . SPARSER::PROTEIN)
    ("G-protein coupled" . SPARSER::PROTEIN) ("PKCζ" . SPARSER::PROTEIN)
    ("P2X7" . SPARSER::PROTEIN) ("NSun2-p27" . SPARSER::COLLECTION)
    ("HuR-" . SPARSER::PROTEIN) ("NSun2, HuR and CUGBP1" . SPARSER::COLLECTION)
    ("CDK1, p27, p16 or p53" . SPARSER::COLLECTION)
    ("p27, CDK1, and CDC25C" . SPARSER::COLLECTION)
    ("the protein marker senescence-associated (SA)-β-galactosidase"
     . SPARSER::COLLECTION)
    ("-β-galactosidase" . SPARSER::COLLECTION)
    ("overexpressed NSun2" . SPARSER::PROTEIN)
    ("CDK1 and CDC25C" . SPARSER::COLLECTION)
    ("NSun2 or NSun2" . SPARSER::COLLECTION)
    ("CDK1, p27, and CDC25C" . SPARSER::COLLECTION)
    ("CDK1 and p27" . SPARSER::COLLECTION)
    ("p53 and p16" . SPARSER::COLLECTION)
    ("NSun2 and p27" . SPARSER::COLLECTION)
    ("NSun2, CDK1, and CDC25C" . SPARSER::COLLECTION)
    ("p16 and p27" . SPARSER::COLLECTION)
    ("NSun2, p53, p16, CDK1, p27, CDC25C, and GAPDH" . SPARSER::COLLECTION)
    ("PDL" . SPARSER::MOLECULE)
    ("senescence-associated proteins p53, p16, CDK1, and CDC25C"
     . SPARSER::COLLECTION)
    ("p53, p16, CDK1, and CDC25C" . SPARSER::COLLECTION)
    ("UTR and pGL3-5" . SPARSER::COLLECTION)
    ("p27 mRNA or vice versa ( xref )" . SPARSER::COLLECTION)
    ("HuR or CUGBP1" . SPARSER::COLLECTION) ("polysome" . SPARSER::BIO-COMPLEX)
    ("the polysomal fraction" . SPARSER::COMPONENT)
    ("Luc and Luc-5" . SPARSER::COLLECTION)
    ("UTR, and Luc-5" . SPARSER::COLLECTION)
    ("UTR, or pGL3-5" . SPARSER::COLLECTION) ("pGL3-3" . SPARSER::COLLECTION)
    ("pGL3-CR" . SPARSER::COLLECTION)
    ("luciferase, and GAPDH" . SPARSER::COLLECTION)
    ("nonisotopic S-Adenosyl methionine (SAM) and NSun2" . SPARSER::COLLECTION)
    ("nonisotopic S-Adenosyl methionine (SAM)" . SPARSER::MOLECULE)
    ("methionine (SAM)" . SPARSER::MOLECULE) ("m6A" . SPARSER::PROTEIN)
    ("SAM" . SPARSER::MOLECULE) ("methionine" . SPARSER::AMINO-ACID)
    ("p27-3" . SPARSER::COLLECTION) ("p27-CR" . SPARSER::COLLECTION)
    ("bacterial tRNA" . SPARSER::PROTEIN) ("p16-CR" . SPARSER::COLLECTION)
    ("p53, p16, E2F3, Bak1, ErbB2, and CDK1" . SPARSER::COLLECTION)
    ("p16, p53, E2F3, and ErbB2" . SPARSER::COLLECTION)
    ("Misu" . SPARSER::PROTEIN) ("HuR and CUGBP1" . SPARSER::COLLECTION)
    ("HuR" . SPARSER::PROTEIN)
    ("FoxM1, FOXO1, and FOXO3a" . SPARSER::COLLECTION)
    ("a pivotal CDK inhibitor" . SPARSER::INHIBITOR)
    ("p27 and CDK1" . SPARSER::COLLECTION) ("C-G" . SPARSER::PROTEIN)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RNA-specific" . SPARSER::PROTEIN)
    ("CDC25C" . SPARSER::PROTEIN) ("pGL3-5" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOP2/Sun domain family" . SPARSER::PROTEIN) ("CUGBP1" . SPARSER::PROTEIN)
    ("FoxM1" . SPARSER::PROTEIN) ("p27KIP1" . SPARSER::PROTEIN)
    ("NSun2" . SPARSER::PROTEIN) ("tRNA methyltransferase" . SPARSER::PROTEIN)
    ("p27 KIP1" . SPARSER::PROTEIN) ("Polycomb-Polycomb" . SPARSER::COLLECTION)
    ("NANOG, OCT4 and SOX2" . SPARSER::COLLECTION)
    ("PRC1 or DPPA4" . SPARSER::COLLECTION)
    ("INK4A and INK4B" . SPARSER::COLLECTION)
    ("CCNB1 , CCND1 , E2F1 , and MTBP" . SPARSER::COLLECTION)
    ("MTBP" . SPARSER::PROTEIN)
    ("OCT4 , NANOG and REX-1" . SPARSER::COLLECTION)
    ("a modest fraction" . SPARSER::COMPONENT)
    ("the DPPA4 and the Polycomb protein L3MBTL2" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("Acinus" . SPARSER::PROTEIN)
    ("Scaffold" . SPARSER::SCAFFOLD) ("SAP" . SPARSER::PROTEIN)
    ("DPPA" . SPARSER::PROTEIN) ("PCGF4/PRC1" . SPARSER::COLLECTION)
    ("NANOG and DPPA4" . SPARSER::COLLECTION)
    ("DPPA4 and NANOG" . SPARSER::COLLECTION)
    ("DPPA4 or NANOG" . SPARSER::COLLECTION) ("AK" . SPARSER::PROTEIN)
    ("both protein ( xref ) and mRNA ( xref )" . SPARSER::COLLECTION)
    ("DPPA4, OCT4 and NANOG" . SPARSER::COLLECTION)
    ("relevant antibodies" . SPARSER::ANTIBODY)
    ("DPPA4, NANOG, OCT4 and BCOR" . SPARSER::COLLECTION)
    ("MEIS1 , MEIS2 and HOX" . SPARSER::COLLECTION)
    ("PCGF1 and the pluripotency factors DPPA4, NANOG, and OCT4"
     . SPARSER::COLLECTION)
    ("DPPA4, NANOG, and OCT4" . SPARSER::COLLECTION)
    ("PCGF1 and DPPA4" . SPARSER::COLLECTION)
    ("DPPA4 and OCT4" . SPARSER::COLLECTION)
    ("multiple distinct Polycomb" . SPARSER::PROTEIN)
    ("canonical PRC1" . SPARSER::PROTEIN)
    ("PCGF2, PCGF4, CSNK2A1, PHC1 and PHC2" . SPARSER::COLLECTION)
    ("PCGF1 and BCOR" . SPARSER::COLLECTION)
    ("PCGF1, BCOR, DPPA4 and NANOG" . SPARSER::COLLECTION)
    ("PCGF1, DPPA4 and NANOG" . SPARSER::COLLECTION)
    ("NANOG, OCT4, DPPA4, and BCOR" . SPARSER::COLLECTION)
    ("NANOG and OCT4" . SPARSER::COLLECTION) ("a dimeric form" . SPARSER::FORM)
    ("approximately 440 KDa" . SPARSER::PROTEIN)
    ("PCGF1, BCOR, KDM2B, RNF2, and RYBP" . SPARSER::COLLECTION)
    ("DPPA4 and BCOR" . SPARSER::COLLECTION)
    ("Gao and coworkers" . SPARSER::COLLECTION) ("Gao" . SPARSER::PROTEIN)
    ("TREx" . SPARSER::PROTEIN-FAMILY)
    ("a smaller complex" . SPARSER::BIO-COMPLEX) ("KDa" . SPARSER::PROTEIN)
    ("MDa" . SPARSER::DRUG)
    ("PCGF1, BCOR, RING1, DPPA4, PCGF4, CBX8, and EZH2" . SPARSER::COLLECTION)
    ("enzymes and substrates" . SPARSER::COLLECTION)
    ("DPPA4, NANOG, and SKP1" . SPARSER::COLLECTION)
    ("computationally predicted ionizable peptides" . SPARSER::PEPTIDE)
    ("Ion" . SPARSER::MOLECULE)
    ("the physical PCGF1-containing complex" . SPARSER::BIO-COMPLEX)
    ("protein and NANOG, DPPA4 or PATZ1" . SPARSER::COLLECTION)
    ("NANOG, DPPA4 or PATZ1" . SPARSER::COLLECTION)
    ("DPPA4 and PATZ1" . SPARSER::COLLECTION)
    ("protein and RNA binding" . SPARSER::COLLECTION)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN)
    ("lysates contained PCGF1 and the variant PCGF1/PRC1 complex components BCOR, RNF2, and RYBP"
     . SPARSER::COLLECTION)
    ("lysates contained PCGF1" . SPARSER::PROTEIN)
    ("acetonitrile" . SPARSER::MOLECULE)
    ("zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble peptides" . SPARSER::PEPTIDE) ("trypsin" . SPARSER::PROTEIN)
    ("pluripotency-associated proteins" . SPARSER::PROTEIN)
    ("PCGF1-PRC1" . SPARSER::COLLECTION) ("RYBP or YAF2" . SPARSER::COLLECTION)
    ("PHC" . SPARSER::PROTEIN) ("SCM" . SPARSER::PROTEIN-FAMILY)
    ("CBX" . SPARSER::PROTEIN)
    ("FLAG, HA, and poly-histidine" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID) ("PCGF1/PRC1" . SPARSER::COLLECTION)
    ("PCGF1, RING1, RNF2, RYBP, BCOR, SKP1, and KDM2B" . SPARSER::COLLECTION)
    ("‘variant’" . SPARSER::VARIANT) ("RYBP" . SPARSER::PROTEIN)
    ("PCGF2 and PCGF4" . SPARSER::COLLECTION)
    ("CBX2, CBX4, CBX6, CBX7 or CBX8" . SPARSER::COLLECTION)
    ("PHC1, PHC2, or PHC3" . SPARSER::COLLECTION)
    ("Polyhomeotic" . SPARSER::PROTEIN)
    ("RING1 (RING1A) or RNF2 (RING1B)" . SPARSER::COLLECTION)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("ubiquitin ligase and methyltransferase activity" . SPARSER::COLLECTION)
    ("DPPA4 and other subunits" . SPARSER::COLLECTION)
    ("demethylase" . SPARSER::PROTEIN) ("Repressor" . SPARSER::REPRESSOR)
    ("Polycomb" . SPARSER::PROTEIN) ("MS2" . SPARSER::PROTEIN)
    ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P19" . SPARSER::PROTEIN)
    ("INK4B" . SPARSER::PROTEIN) ("CCNB1" . SPARSER::PROTEIN)
    ("REX-1" . SPARSER::PROTEIN) ("L3MBTL2" . SPARSER::PROTEIN)
    ("MEIS2" . SPARSER::PROTEIN) ("MEIS1" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("HOXA9" . SPARSER::PROTEIN)
    ("DDB1" . SPARSER::PROTEIN) ("MRE11A" . SPARSER::PROTEIN)
    ("LETMD1" . SPARSER::PROTEIN) ("SASS6" . SPARSER::PROTEIN)
    ("ARID1B" . SPARSER::PROTEIN) ("SMARCC2" . SPARSER::PROTEIN)
    ("BMI1" . SPARSER::PROTEIN) ("YAF2" . SPARSER::PROTEIN)
    ("H3K27me3" . SPARSER::MOLECULE) ("FBXL10" . SPARSER::PROTEIN)
    ("H2BK" . SPARSER::PROTEIN) ("SKP1" . SPARSER::PROTEIN)
    ("PCGF4" . SPARSER::PROTEIN) ("PCGF2" . SPARSER::PROTEIN)
    ("PHC3" . SPARSER::PROTEIN) ("PHC2" . SPARSER::PROTEIN)
    ("PHC1" . SPARSER::PROTEIN) ("CBX8" . SPARSER::PROTEIN)
    ("CBX7" . SPARSER::PROTEIN) ("CBX6" . SPARSER::PROTEIN)
    ("CBX4" . SPARSER::PROTEIN) ("CBX2" . SPARSER::PROTEIN)
    ("RING1B" . SPARSER::PROTEIN) ("RNF2" . SPARSER::PROTEIN)
    ("RING1A" . SPARSER::PROTEIN) ("RING1" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("DPPA4" . SPARSER::PROTEIN) ("PATZ1" . SPARSER::PROTEIN)
    ("KDM2B" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("PCGF1" . SPARSER::PROTEIN) ("protein and CSNK2A2" . SPARSER::COLLECTION)
    ("FZD3 and FZD5" . SPARSER::COLLECTION)
    ("pre-miR-29" . SPARSER::COLLECTION) ("miR-29a/b1" . SPARSER::PROTEIN)
    ("DROSHA" . SPARSER::PROTEIN) ("mature miRNA" . SPARSER::PROTEIN)
    ("pri-miR-29a/b1" . SPARSER::COLLECTION) ("pri" . SPARSER::PROTEIN)
    ("subsequent pre-miR-29b2" . SPARSER::COLLECTION)
    ("pri-miR-29b2" . SPARSER::PROTEIN-PAIR)
    ("TGFβ and Wnt" . SPARSER::COLLECTION)
    ("SOX9 and growth factor" . SPARSER::COLLECTION)
    ("miR-29a" . SPARSER::PROTEIN) ("only two miRNA" . SPARSER::PROTEIN)
    ("COL1A1 and COL3A1" . SPARSER::COLLECTION)
    ("inhibitors or non-targeting" . SPARSER::COLLECTION)
    ("agonists" . SPARSER::AGONIST) ("IL-1 or LPS" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGFβ1 and LPS" . SPARSER::COLLECTION)
    ("pre-miR-29a and miR-29b1" . SPARSER::COLLECTION)
    ("pre-miR-29a" . SPARSER::PROTEIN-PAIR)
    ("the mature miR-29 family" . SPARSER::PROTEIN-FAMILY)
    ("pre-miR-29c" . SPARSER::COLLECTION)
    ("pre-miR-29b2" . SPARSER::COLLECTION)
    ("pri-miR-29b2/c" . SPARSER::COLLECTION)
    ("a catabolic cytokine" . SPARSER::PROTEIN) ("mature form" . SPARSER::FORM)
    ("the mature miR-29c-3p" . SPARSER::COLLECTION)
    ("mature miR-29b and miR-29c" . SPARSER::COLLECTION)
    ("miR-29b and miR-29c" . SPARSER::COLLECTION)
    ("miR-29b2/c" . SPARSER::COLLECTION) ("miR-29c-3p" . SPARSER::COLLECTION)
    ("NOF" . SPARSER::PROTEIN) ("DMM and sham" . SPARSER::COLLECTION)
    ("sham" . SPARSER::DRUG) ("miR-29-3p" . SPARSER::COLLECTION)
    ("miRNA and their putative mRNA" . SPARSER::COLLECTION)
    ("miR-29b2 and miR-29c" . SPARSER::COLLECTION)
    ("miR-29b (b1 and b2 which are identical mature miRNAs) and miR-29c"
     . SPARSER::COLLECTION)
    ("the mature microRNAs" . SPARSER::RNA)
    ("miRNA and mRNA" . SPARSER::COLLECTION)
    ("collagen and proteoglycan" . SPARSER::COLLECTION)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("a transcription factor and master regulator" . SPARSER::COLLECTION)
    ("Sry" . SPARSER::PROTEIN) ("2588 mature human miRNAs" . SPARSER::PROTEIN)
    ("typically 19–25 nucleotides" . SPARSER::NUCLEOTIDE)
    ("FZD3 , FZD5 , DVL3 , FRAT2 , and CK2A2" . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("primary chondrocytes" . SPARSER::PROTEIN) ("DMM" . SPARSER::DRUG)
    ("WIF-1" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("pre-miRNA" . SPARSER::RNA)
    ("Frizzled family receptor 5" . SPARSER::PROTEIN)
    ("Frequently Rearranged In Advanced T-Cell Lymphomas 2" . SPARSER::PROTEIN)
    ("alpha 2 polypeptide" . SPARSER::PROTEIN) ("CSNK2A2" . SPARSER::PROTEIN)
    ("COL3A1" . SPARSER::PROTEIN) ("Wnt3" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("ADAMTS4" . SPARSER::PROTEIN) ("Interleukin-1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("COL2A1" . SPARSER::PROTEIN) ("Wnt3a" . SPARSER::PROTEIN)
    ("Dnase I" . SPARSER::PROTEIN) ("JSH-23" . SPARSER::MOLECULE)
    ("TGF-β3" . SPARSER::PROTEIN) ("5–2 " . SPARSER::PROTEIN)
    ("miR-29b2" . SPARSER::PROTEIN) ("Sox9" . SPARSER::PROTEIN)
    ("CK2A2" . SPARSER::PROTEIN) ("FRAT2" . SPARSER::PROTEIN)
    ("DVL3" . SPARSER::PROTEIN) ("FZD5" . SPARSER::PROTEIN)
    ("FZD3" . SPARSER::PROTEIN) ("TGFβ1" . SPARSER::PROTEIN)
    ("SOX9" . SPARSER::PROTEIN)
    ("RPL26 and microRNA-27a" . SPARSER::COLLECTION)
    ("an RBP and a miRNA" . SPARSER::COLLECTION)
    ("RBPs and miRNAs" . SPARSER::COLLECTION) ("RBP" . SPARSER::PROTEIN)
    ("RLP" . SPARSER::PROTEIN)
    ("exogenous GFP-tagged RPL26" . SPARSER::PROTEIN)
    ("Six1 and RPL26" . SPARSER::COLLECTION)
    ("RPL26 and Six1" . SPARSER::COLLECTION) ("PDXs" . SPARSER::PROTEIN)
    ("a translational regulator" . SPARSER::REGULATOR)
    ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("Six1 and miR-27a" . SPARSER::COLLECTION)
    ("the more relevant miR" . SPARSER::PROTEIN)
    ("co-transfected parental MCF7" . SPARSER::PROTEIN)
    ("p53-UTR" . SPARSER::COLLECTION)
    ("p53, miR-27a and miR-26b" . SPARSER::COLLECTION)
    ("already known p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the exogenous GFP–p53" . SPARSER::COLLECTION)
    ("the exogenous p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous GFP–p53" . SPARSER::COLLECTION)
    ("GFP–p53" . SPARSER::COLLECTION)
    ("MCF12A-Ctrl and Six1" . SPARSER::COLLECTION)
    ("cisplatin, doxorubicin or paclitaxel" . SPARSER::COLLECTION)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("whereby siRNA KD" . SPARSER::PROTEIN)
    ("RKO-Ctrl and Six1" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("MCF7-Ctrl" . SPARSER::COLLECTION)
    ("which targets p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an efficient KD" . SPARSER::PROTEIN)
    ("p53 and p21 protein" . SPARSER::COLLECTION)
    ("HCT-shSix1-1" . SPARSER::COLLECTION)
    ("reduced p53 and its downstream target" . SPARSER::COLLECTION)
    ("MCF7-Six1" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("−1" . SPARSER::PROTEIN)
    ("protein and p21 protein and mRNA" . SPARSER::COLLECTION)
    ("p21 protein and mRNA" . SPARSER::COLLECTION)
    ("Six1 and p53" . SPARSER::COLLECTION)
    ("histologic subtypes" . SPARSER::PROTEIN)
    ("the mouse mammary epithelium" . SPARSER::PROTEIN)
    ("the developmental regulator Six1" . SPARSER::PROTEIN)
    ("an important developmental regulator" . SPARSER::REGULATOR)
    ("dsRNA" . SPARSER::RNA) ("RBPs" . SPARSER::PROTEIN)
    ("p53/MDM2" . SPARSER::COLLECTION) ("P53–MDM2" . SPARSER::COLLECTION)
    ("polyubiquitination and proteasomal" . SPARSER::COLLECTION)
    ("MDM2-" . SPARSER::PROTEIN) ("p53–MDM2" . SPARSER::COLLECTION)
    ("2–4 " . SPARSER::PROTEIN) ("tween 20" . SPARSER::MOLECULE)
    ("protein-G" . SPARSER::PROTEIN) ("AGO1–4" . SPARSER::PROTEIN)
    ("Runx1" . SPARSER::PROTEIN) ("JNJ26854165" . SPARSER::DRUG)
    ("p21 protein" . SPARSER::PROTEIN) ("Nutlin-3" . SPARSER::DRUG)
    ("VEGF-C" . SPARSER::PROTEIN) ("RPL26" . SPARSER::PROTEIN)
    ("ribosomal protein L26" . SPARSER::PROTEIN) ("Six1" . SPARSER::PROTEIN)
    ("TERT or TP53" . SPARSER::COLLECTION) ("TERT" . SPARSER::PROTEIN)
    ("PDGFD" . SPARSER::PROTEIN) ("malignant SFT" . SPARSER::PROTEIN)
    ("HPF" . SPARSER::PROTEIN) ("the malignant SFT" . SPARSER::PROTEIN)
    ("one undetermined cytosine and 17 bps" . SPARSER::COLLECTION)
    ("cytosine and 17 bps" . SPARSER::COLLECTION)
    ("an intact exon" . SPARSER::PROTEIN)
    ("the functionally equivalent NAB2ex6‐STAT6ex16 variant"
     . SPARSER::VARIANT)
    ("mature adipocytes" . SPARSER::PROTEIN)
    ("a malignant pleural SFT" . SPARSER::PROTEIN)
    ("an intrathoracic SFT" . SPARSER::PROTEIN)
    ("Some histologic variants" . SPARSER::VARIANT)
    ("an elaborate vasculature" . SPARSER::PROTEIN)
    ("spindly" . SPARSER::PROTEIN) ("SFT" . SPARSER::PROTEIN)
    ("the predominant fusion type" . TYPE) ("HPFs" . SPARSER::PROTEIN)
    ("NTRK1" . SPARSER::PROTEIN) ("EGF2" . SPARSER::PROTEIN)
    ("NAB1" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 6" . SPARSER::PROTEIN)
    ("2/3" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("three Caucasian cohorts" . SPARSER::MOLECULE)
    ("Spondyloepimetaphyseal dysplasia Pakistani type" . TYPE)
    ("synthetase" . SPARSER::PROTEIN) ("MIM" . SPARSER::PROTEIN)
    ("FHS" . SPARSER::PROTEIN) ("FGFR2 or PAPSS2" . SPARSER::COLLECTION)
    ("our previous cohort" . SPARSER::MOLECULE)
    ("MUC1, ATP2B1, DCDC5, TRPM6, SHROOM3 , and MDS1" . SPARSER::COLLECTION)
    ("an essential cation" . SPARSER::MOLECULE)
    ("FGFR2 and PAPSS2" . SPARSER::COLLECTION) ("Quad" . SPARSER::DRUG)
    ("fibroblast growth factor receptor family"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDS1" . SPARSER::PROTEIN) ("SHROOM3" . SPARSER::PROTEIN)
    ("TRPM6" . SPARSER::PROTEIN) ("ATP2B1" . SPARSER::PROTEIN)
    ("MUC1" . SPARSER::PROTEIN) ("PAPSS2" . SPARSER::PROTEIN)
    ("PDK1 and c-Jun" . SPARSER::COLLECTION)
    ("the dominant-negative c-Jun mutant TAM67" . SPARSER::PROTEIN)
    ("TAM67" . SPARSER::PROTEIN) ("TAM" . SPARSER::PROTEIN)
    ("atypical bronchial epithelium" . SPARSER::PROTEIN)
    ("fos and jun" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3-K, PKA, and JNK" . SPARSER::COLLECTION)
    ("EP4-betaArrestin1-c-Src" . SPARSER::COLLECTION)
    ("COX-2-MMTV" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("EP1 and EP4" . SPARSER::COLLECTION)
    ("seven transmembrane G protein" . SPARSER::PROTEIN)
    ("rhodopsin" . SPARSER::PROTEIN) ("chemotaxis" . SPARSER::PROTEIN)
    ("decorin and collagen" . SPARSER::COLLECTION)
    ("decorin" . SPARSER::PROTEIN) ("PDK1 or siRNA" . SPARSER::COLLECTION)
    ("PIK3CA/PTEN" . SPARSER::COLLECTION)
    ("phosphoinositide-3 kinase and various intracellular serine/threonine kinases"
     . SPARSER::COLLECTION)
    ("kinase, and protein" . SPARSER::COLLECTION)
    ("its receptors and its downstream targets" . SPARSER::COLLECTION)
    ("PGE 2 and its receptors play" . SPARSER::COLLECTION)
    ("the major prostaglandin" . SPARSER::PROTEIN)
    ("prostaglandin" . SPARSER::PROTEIN)
    ("siRNA or antagonist" . SPARSER::COLLECTION) ("AH" . SPARSER::MOLECULE)
    ("pPDK1 and PDK1" . SPARSER::COLLECTION) ("PDK1/Akt" . SPARSER::COLLECTION)
    ("kinase (SGK)" . SPARSER::KINASE) ("SGK" . SPARSER::PROTEIN)
    ("glucocorticoid" . SPARSER::PROTEIN) ("EP1" . SPARSER::PROTEIN)
    ("PG" . SPARSER::PROTEIN)
    ("PDK1 siRNA and a PDK1 inhibitor" . SPARSER::COLLECTION)
    ("PDK1 small interfering RNA (siRNA) and a PDK1 inhibitor"
     . SPARSER::COLLECTION)
    ("EP4 and EP4" . SPARSER::COLLECTION)
    ("c-Jun and PDK1" . SPARSER::COLLECTION)
    ("a bioactive eicosanoid" . SPARSER::MOLECULE) ("c-jun" . SPARSER::PROTEIN)
    ("PI3-K" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Src" . SPARSER::PROTEIN) ("betaArrestin1" . SPARSER::PROTEIN)
    ("EP3 receptor" . SPARSER::PROTEIN) ("EP3" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKBα" . SPARSER::PROTEIN)
    ("phosphoinositide-dependent protein kinase-1" . SPARSER::PROTEIN)
    ("PGE2" . SPARSER::DRUG) ("C-Jun" . SPARSER::PROTEIN)
    ("pGL 2" . SPARSER::PROTEIN) ("1–2 " . SPARSER::PROTEIN)
    ("pPDK1" . SPARSER::PROTEIN) ("oxytocin receptor" . SPARSER::PROTEIN)
    ("OSU-03012" . SPARSER::DRUG) ("EGF 1" . SPARSER::PROTEIN)
    ("EP4 receptor" . SPARSER::PROTEIN) ("AKT / protein" . SPARSER::PROTEIN)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("protein kinase-1" . SPARSER::PROTEIN) ("EP4" . SPARSER::PROTEIN)
    ("EP2" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("the multifunctional ubiquitin-protein ligase E3 complex"
     . SPARSER::BIO-COMPLEX)
    ("p16, cyclin E, and cyclin B1" . SPARSER::COLLECTION)
    ("E2F/DP-1" . SPARSER::COLLECTION) ("the target" . SPARSER::TARGET-PROTEIN)
    ("CUL4A and TFDP1" . SPARSER::COLLECTION)
    ("IRS2 and CUL4A" . SPARSER::COLLECTION) ("SNU1079" . SPARSER::PROTEIN)
    ("SNU1079-IRS2" . SPARSER::COLLECTION) ("c-erbB-2" . SPARSER::COLLECTION)
    ("B-Raf proto-oncogene , serine/threonine kinase ( BRAF )"
     . SPARSER::PROTEIN)
    ("dehydrogenase" . SPARSER::PROTEIN) ("isocitrate" . SPARSER::PROTEIN)
    ("CUL4A , IRS2 , and TFDP1" . SPARSER::COLLECTION)
    ("ubiquitin-protein ligase" . SPARSER::PROTEIN)
    ("cullin family" . SPARSER::PROTEIN-FAMILY) ("DP-1" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("CDC16" . SPARSER::PROTEIN) ("cell division cycle 16" . SPARSER::PROTEIN)
    ("B-Raf proto-oncogene , serine/threonine kinase" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("TFDP1" . SPARSER::PROTEIN)
    ("transcription factor Dp-1" . SPARSER::PROTEIN)
    ("IRS2" . SPARSER::PROTEIN)
    ("insulin receptor substrate 2" . SPARSER::PROTEIN)
    ("CUL4A" . SPARSER::PROTEIN) ("cullin 4A" . SPARSER::PROTEIN)
    ("a diagnostic and prognostic biomarker" . SPARSER::MOLECULE)
    ("IRS" . SPARSER::PROTEIN) ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("MiR-1225-5p" . SPARSER::PROTEIN) ("MiR-361-5p" . SPARSER::PROTEIN)
    ("tumorigenic miRNA" . SPARSER::PROTEIN)
    ("differentially expressed miRNAs" . SPARSER::PROTEIN)
    ("Ccnd1 and c-Myc" . SPARSER::COLLECTION) ("Ccnd1" . SPARSER::PROTEIN)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("the western blot" . SPARSER::PROTEIN)
    ("IRS1 and miR-1225-5p" . SPARSER::COLLECTION)
    ("miR-1225-5p and IRS1" . SPARSER::COLLECTION)
    ("ETV1, IRS1, FUS and CSK" . SPARSER::COLLECTION)
    ("CSK" . SPARSER::PROTEIN)
    ("haematoxylin and eosin staining" . SPARSER::COLLECTION)
    ("haematoxylin" . SPARSER::MOLECULE)
    ("mature miR-1225-5p" . SPARSER::PROTEIN) ("primary GC" . SPARSER::PROTEIN)
    ("miR-1225-5p" . SPARSER::PROTEIN) ("miR-361-5p" . SPARSER::PROTEIN)
    ("hsa-miR-361-5p and hsa-miR-214" . SPARSER::COLLECTION)
    ("hsa-miR-1225-5p" . SPARSER::COLLECTION)
    ("hsa-miR-361-5p" . SPARSER::COLLECTION) ("gastrin" . SPARSER::PROTEIN)
    ("whose GC" . SPARSER::PROTEIN)
    ("IRS1 and β-catenin" . SPARSER::COLLECTION)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("previously reported small intestinal NETs or pancreatic NETs"
     . SPARSER::COLLECTION)
    ("previously reported small intestinal NETs"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGFR2 , MEN1 , HOOK3 , EZH2 , MLF1 , CARD11 , VHL , NONO , and SMAD1"
     . SPARSER::COLLECTION)
    ("NONO" . SPARSER::PROTEIN) ("at least one gene" . SPARSER::GENE)
    ("TSC2 or PTEN" . SPARSER::COLLECTION)
    ("DAXX and ATRX" . SPARSER::COLLECTION)
    ("larger patient cohort" . SPARSER::MOLECULE)
    ("transcription factor, and DNA" . SPARSER::COLLECTION)
    ("at least one cancer-related gene" . SPARSER::GENE)
    ("RB1 , ATM , and TP53BP1" . SPARSER::COLLECTION)
    ("PDGFR" . SPARSER::PROTEIN)
    ("pancreatic NETs and small intestinal NETs" . SPARSER::COLLECTION)
    ("small intestinal NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytokine-cytokine" . SPARSER::COLLECTION) ("hsa" . SPARSER::PROTEIN)
    ("MCL1, DNMT3A, MLJ1, MYD88, NOTCH1, HRAS, AKT1, TSC2, CREBBP, MARK3, CDH1, TP53, RARA , and BCL2"
     . SPARSER::COLLECTION)
    ("RARA" . SPARSER::PROTEIN) ("CREBBP" . SPARSER::PROTEIN)
    ("small intestinal NET" . SPARSER::PROTEIN)
    ("rectal NETs and G3 NETs" . SPARSER::COLLECTION)
    ("rectal NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("capecitabine and oxaliplatin" . SPARSER::COLLECTION)
    ("capecitabine" . SPARSER::DRUG)
    ("chromogranin, synaptophysin, and CD56" . SPARSER::COLLECTION)
    ("chromogranin" . SPARSER::PROTEIN) ("one primary NET" . SPARSER::PROTEIN)
    ("ATR , PARP2 , RBBP8 , and RIF1" . SPARSER::COLLECTION)
    ("PIK3/Akt/mTOR" . SPARSER::COLLECTION)
    ("48 small intestinal NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("50 small intestinal NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Small intestinal NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEN1 , DAXX , ATRX, TSC , and PTEN" . SPARSER::COLLECTION)
    ("TSC" . SPARSER::PROTEIN) ("ATRX" . SPARSER::PROTEIN)
    ("DAXX" . SPARSER::PROTEIN)
    ("well-differentiated pancreatic NET" . SPARSER::PROTEIN)
    ("PI3K-Akt-mTOR" . SPARSER::COLLECTION)
    ("multi-tyrosine kinase" . SPARSER::COLLECTION)
    ("everolimus" . SPARSER::DRUG) ("sunitinib" . SPARSER::DRUG)
    ("UK" . SPARSER::PROTEIN) ("GEP-NET" . SPARSER::COLLECTION)
    ("NET" . SPARSER::PROTEIN) ("SPEN" . SPARSER::PROTEIN)
    ("pazopanib" . SPARSER::DRUG) ("GEP-NETs" . SPARSER::COLLECTION)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GEP" . SPARSER::PROTEIN)
    ("SMAD1" . SPARSER::PROTEIN) ("CARD11" . SPARSER::PROTEIN)
    ("MLF1" . SPARSER::PROTEIN) ("HOOK3" . SPARSER::PROTEIN)
    ("TP53BP1" . SPARSER::PROTEIN) ("MAPKAPK5" . SPARSER::PROTEIN)
    ("MARK3" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("MYD88" . SPARSER::PROTEIN) ("DNMT3A" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("RIF1" . SPARSER::PROTEIN)
    ("RBBP8" . SPARSER::PROTEIN) ("MEN1" . SPARSER::PROTEIN)
    ("TBC1" . SPARSER::PROTEIN) ("SMARCB1" . SPARSER::PROTEIN)
    ("RASA1" . SPARSER::PROTEIN) ("KDM6A" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("the ovarian surface epithelium" . SPARSER::PROTEIN)
    ("ovarian cancer 3D" . SPARSER::PROTEIN-FAMILY)
    ("Tenascin" . SPARSER::PROTEIN)
    ("Matrigel and Collagen" . SPARSER::COLLECTION)
    ("E-cadherin and TGFβ2" . SPARSER::COLLECTION)
    ("miR200b" . SPARSER::PROTEIN) ("MMP2 and ZEB1" . SPARSER::COLLECTION)
    ("Matrigel and collagen" . SPARSER::COLLECTION)
    ("E-cadherin and TGFβ" . SPARSER::COLLECTION)
    ("TCF8/ZEB1" . SPARSER::COLLECTION)
    ("E-cadherin/TGFβ" . SPARSER::COLLECTION) ("Collagen" . SPARSER::PROTEIN)
    ("more intense E-cadherin" . SPARSER::PROTEIN)
    ("The OVCA433 ovarian cancer 3D" . SPARSER::PROTEIN-FAMILY)
    ("overexpressed protein" . SPARSER::PROTEIN) ("TAF" . SPARSER::PROTEIN)
    ("very weak E-cadherin" . SPARSER::PROTEIN)
    ("β-catenin and collagen" . SPARSER::COLLECTION)
    ("intense β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("TAFs" . SPARSER::PROTEIN) ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("different ovarian tumor types" . TYPE)
    ("transforming growth factor beta pathway genes and high levels of E-cadherin and microRNA200 (miR200) expression"
     . SPARSER::COLLECTION)
    ("E-cadherin and microRNA200" . SPARSER::COLLECTION)
    ("laminin" . SPARSER::PROTEIN) ("tenascin" . SPARSER::PROTEIN)
    ("OSE" . SPARSER::PROTEIN) ("cyclophilin A" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("collagen-I" . SPARSER::PROTEIN)
    ("phenol red" . SPARSER::DRUG) ("p36" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN) ("CD151" . SPARSER::PROTEIN)
    ("TCF8" . SPARSER::PROTEIN) ("TGFβ2" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular matrix protein" . SPARSER::PROTEIN)
    ("intact EEPD1" . SPARSER::PROTEIN)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("Exo1/BLM/RPA" . SPARSER::COLLECTION) ("ATR/Chk1" . SPARSER::COLLECTION)
    ("RPA/ATRIP" . SPARSER::COLLECTION) ("EEPD1/Exo1" . SPARSER::COLLECTION)
    ("Exo1 and EEPD1" . SPARSER::COLLECTION)
    ("EXO1-BLM-RPA" . SPARSER::COLLECTION) ("Rif1/53BP1" . SPARSER::COLLECTION)
    ("BRCA1/CtIP" . SPARSER::COLLECTION) ("pol" . SPARSER::PROTEIN)
    ("toxic recombination intermediates form" . SPARSER::FORM)
    ("EEPD1, Exo1, and BLM" . SPARSER::COLLECTION)
    ("Exo1, RPA32, and BLM" . SPARSER::COLLECTION)
    ("replisome" . SPARSER::PROTEIN) ("Dna2 and EEPD1" . SPARSER::COLLECTION)
    ("EEPD1 and CtiP" . SPARSER::COLLECTION) ("CtiP" . SPARSER::PROTEIN)
    ("EEPD1, CtIP, Exo1, and Dna2" . SPARSER::COLLECTION)
    ("CtIP or Dna2" . SPARSER::COLLECTION)
    ("CtIP and Dna2" . SPARSER::COLLECTION)
    ("CtIP, Exo1, and Dna2" . SPARSER::COLLECTION)
    ("alkaline" . SPARSER::PROTEIN)
    ("BRCA1, 53BP1, and NBS1" . SPARSER::COLLECTION)
    ("NBS1 and BRCA1" . SPARSER::COLLECTION)
    ("Mre11-Rad50-NBS1" . SPARSER::COLLECTION)
    ("NBS1, 53BP1 and BRCA1" . SPARSER::COLLECTION) ("Foci" . SPARSER::PROTEIN)
    ("ATR (3-fold) and Chk1 (11-fold)" . SPARSER::COLLECTION)
    ("RPA32, gamma-H2Ax, and RAD51" . SPARSER::COLLECTION)
    ("RPA, H2Ax, and Chk1" . SPARSER::COLLECTION) ("H2Ax" . SPARSER::PROTEIN)
    ("Components" . SPARSER::COMPONENT) ("Exo1 and CtIP" . SPARSER::COLLECTION)
    ("EEPD1 and CtIP" . SPARSER::COLLECTION)
    ("EEPD1 and Exo1" . SPARSER::COLLECTION)
    ("Exo1 or CtIP" . SPARSER::COLLECTION)
    ("both a transduced restriction enzyme (I-SceI) and exogenous IR"
     . SPARSER::COLLECTION)
    ("exogenous IR" . SPARSER::PROTEIN) ("Exo1/BLM" . SPARSER::COLLECTION)
    ("MluI" . SPARSER::PROTEIN) ("HR-MluI" . SPARSER::PROTEIN-PAIR)
    ("EGFP" . SPARSER::PROTEIN) ("genotoxins" . SPARSER::MOLECULE)
    ("olaparib" . SPARSER::DRUG) ("less efficient SS" . SPARSER::PROTEIN)
    ("EEP" . SPARSER::PROTEIN) ("carboxy" . SPARSER::MOLECULE)
    ("poison" . SPARSER::MOLECULE) ("apex" . SPARSER::PROTEIN)
    ("ATR and Chk1" . SPARSER::COLLECTION)
    ("RPA, gamma-H2Ax, and RAD51" . SPARSER::COLLECTION)
    ("NBS1, 53BP1, and BRCA1" . SPARSER::COLLECTION)
    ("exonuclease" . SPARSER::PROTEIN) ("CtIP and Mre11" . SPARSER::COLLECTION)
    ("Dna2 and Exo1" . SPARSER::COLLECTION) ("CtIP" . SPARSER::PROTEIN)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("DS" . SPARSER::PROTEIN)
    ("Gen1 or Mus81" . SPARSER::COLLECTION) ("Slx4" . SPARSER::PROTEIN)
    ("Gen1" . SPARSER::PROTEIN) ("Gen" . SPARSER::PROTEIN)
    ("BRCA2/RAD51" . SPARSER::COLLECTION) ("PriA" . SPARSER::PROTEIN)
    ("the previously uncharacterized EEPD1 protein" . SPARSER::PROTEIN)
    ("Exo1 and BLM" . SPARSER::COLLECTION) ("BLM" . SPARSER::PROTEIN)
    ("ATR and CHK1" . SPARSER::COLLECTION)
    ("gamma-H2AX, RAD51 and phospho-RPA32" . SPARSER::COLLECTION)
    ("the previously uncharacterized Exonuclease/Endonuclease/Phosphatase Domain-1 (EEPD1) protein"
     . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("Endonuclease" . SPARSER::PROTEIN)
    ("Exonuclease" . SPARSER::PROTEIN) ("Streptavidin-agarose" . SPARSER::DRUG)
    ("Alpha-" . SPARSER::PROTEIN) ("DNA2" . SPARSER::PROTEIN)
    ("Rif1" . SPARSER::PROTEIN) ("endonuclease activity" . SPARSER::PROTEIN)
    ("RNF8" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("I-SceI" . SPARSER::PROTEIN) ("D-N" . SPARSER::PROTEIN)
    ("VP-16" . SPARSER::PROTEIN) ("Dna2" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN)
    ("tumor suppressor p53-binding protein 1" . SPARSER::PROTEIN)
    ("exonuclease activity" . SPARSER::PROTEIN) ("Mus81" . SPARSER::PROTEIN)
    ("Exo1" . SPARSER::PROTEIN) ("RPA32" . SPARSER::PROTEIN)
    ("EEPD1" . SPARSER::PROTEIN)
    ("cell cycle genes and ETS transcription factors" . SPARSER::COLLECTION)
    ("RAS/MAPK" . SPARSER::COLLECTION) ("introns" . SPARSER::PROTEIN)
    ("Ras/Mapk" . SPARSER::COLLECTION) ("Mapk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERG or ETV1" . SPARSER::COLLECTION)
    ("ERG, ETV1, and ETV4" . SPARSER::COLLECTION)
    ("ETV1 and ETV5" . SPARSER::COLLECTION)
    ("those non-coding RNA’s" . SPARSER::RNA)
    ("snoRNA and other non-coding RNAs ( xref )" . SPARSER::COLLECTION)
    ("the 28S rRNA or 5S rRNA genes ( xref )" . SPARSER::COLLECTION)
    ("snoRNA" . SPARSER::RNA) ("snRNA" . SPARSER::RNA)
    ("tRNA" . SPARSER::PROTEIN) ("these only InR mRNA" . SPARSER::PROTEIN)
    ("Yki" . SPARSER::PROTEIN)
    ("probable growth regulatory genes" . SPARSER::GENE)
    ("rRNA, tRNAs and snRNAs" . SPARSER::COLLECTION)
    ("rRNA" . SPARSER::PROTEIN) ("Hpo" . SPARSER::PROTEIN)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ISCs and EBs" . SPARSER::COLLECTION) ("lncRNAs" . SPARSER::RNA)
    ("rRNAs" . SPARSER::RNA) ("tRNAs" . SPARSER::PROTEIN)
    ("snRNAs" . SPARSER::PROTEIN) ("dormant ISCs" . SPARSER::PROTEIN)
    ("EGFR, RAS, RAF, MEK, and MAPK" . SPARSER::COLLECTION)
    ("Rhomboid" . SPARSER::PROTEIN-FAMILY) ("Yan" . SPARSER::PROTEIN)
    ("pntP2 homozygous mutant ISCs" . SPARSER::PROTEIN)
    ("ISC" . SPARSER::PROTEIN)
    ("homozygous pnt null mutant ISCs" . SPARSER::PROTEIN)
    ("proliferating ISCs" . SPARSER::PROTEIN) ("gene-" . SPARSER::GENE)
    ("regulators and genes" . SPARSER::COLLECTION) ("Dpn" . SPARSER::MOLECULE)
    ("methylase" . SPARSER::PROTEIN) ("TaDa" . SPARSER::PROTEIN)
    ("a genome-wide mapping" . SPARSER::PROTEIN)
    ("argos" . SPARSER::PROTEIN-FAMILY) ("hkb" . SPARSER::PROTEIN)
    ("ETV1, ETV4 and ETV5" . SPARSER::COLLECTION)
    ("punctate" . SPARSER::PROTEIN) ("cic , Egfr or cic" . SPARSER::COLLECTION)
    ("Cic or Cic" . SPARSER::COLLECTION) ("UAS-flp" . SPARSER::COLLECTION)
    ("Cd2" . SPARSER::PROTEIN) ("Gal4" . SPARSER::PROTEIN)
    ("flp" . SPARSER::PROTEIN) ("cic and cic" . SPARSER::COLLECTION)
    ("cic or cic" . SPARSER::COLLECTION) ("UAS-cic-HA" . SPARSER::COLLECTION)
    ("-HA" . SPARSER::COLLECTION) ("UAS-cic" . SPARSER::COLLECTION)
    ("UAS-CD8-GFP" . SPARSER::COLLECTION) ("EB" . SPARSER::PROTEIN-FAMILY)
    ("UAS-GFP" . SPARSER::COLLECTION) ("Dl" . SPARSER::MOLECULE)
    ("YFP-" . SPARSER::PROTEIN) ("YFP" . SPARSER::PROTEIN)
    ("Gal80" . SPARSER::PROTEIN) ("cic" . SPARSER::PROTEIN)
    ("Gal" . SPARSER::PROTEIN) ("RAS, BRAF, or CIC" . SPARSER::COLLECTION)
    ("EGFR, RAS or BRAF" . SPARSER::COLLECTION)
    ("CIC:importin" . SPARSER::BIO-COMPLEX) ("GFP-CIC" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Egfr or Ras" . SPARSER::COLLECTION)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION) ("orthologs" . SPARSER::PROTEIN)
    ("Drosophila eye and wing imaginal discs, embryos, and ovaries"
     . SPARSER::COLLECTION)
    ("discs, embryos, and ovaries" . SPARSER::COLLECTION)
    ("/Ras/MAPK" . SPARSER::COLLECTION) ("discs" . SPARSER::BIO-COMPLEX)
    ("CyclinD" . SPARSER::PROTEIN) ("Egfr" . SPARSER::PROTEIN)
    ("Apc" . SPARSER::PROTEIN) ("Lrig" . SPARSER::PROTEIN-FAMILY)
    ("ECC" . SPARSER::MOLECULE) ("enteric" . SPARSER::PROTEIN)
    ("EBs and ISCs" . SPARSER::COLLECTION) ("absorptive" . SPARSER::PROTEIN)
    ("EBs" . SPARSER::PROTEIN)
    ("EGFR and its downstream effectors" . SPARSER::COLLECTION)
    ("CIC" . SPARSER::PROTEIN) ("CycE" . SPARSER::PROTEIN)
    ("EGFR/Ras/MAPK" . SPARSER::COLLECTION) ("that Cic’s" . SPARSER::PROTEIN)
    ("an essential downstream effector" . SPARSER::EFFECTOR)
    ("EGFR/Ras" . SPARSER::COLLECTION) ("Cic" . SPARSER::PROTEIN)
    ("Capicua" . SPARSER::PROTEIN) ("ISCs" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD2" . SPARSER::PROTEIN) ("Src42A" . SPARSER::PROTEIN)
    ("S6K" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("ETS2" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("ETV5" . SPARSER::PROTEIN) ("ETV4" . SPARSER::PROTEIN)
    ("ETV1" . SPARSER::PROTEIN) ("PEA3" . SPARSER::PROTEIN)
    ("PH3" . SPARSER::PROTEIN) ("spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("KPNA3" . SPARSER::PROTEIN) ("Ets21C" . SPARSER::PROTEIN)
    ("HMG-box" . SPARSER::PROTEIN)
    ("ATM, ATR, and BRCA1" . SPARSER::COLLECTION)
    ("DDR and DNA" . SPARSER::COLLECTION)
    ("at least one checkpoint protein" . SPARSER::PROTEIN)
    ("combined HDAC inhibitor and cytotoxic chemotherapy"
     . SPARSER::COLLECTION)
    ("Mdm2-survivin" . SPARSER::COLLECTION)
    ("heterochromatin and BRCA1" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("Sin3/HDAC" . SPARSER::COLLECTION) ("euchromatin" . SPARSER::BIO-COMPLEX)
    ("cisplatin and HDAC2" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("ATR, and Rad51" . SPARSER::COLLECTION)
    ("HDAC3, HDAC4, and HDAC8" . SPARSER::COLLECTION)
    ("HDAC2 and all three HP1 proteins" . SPARSER::COLLECTION)
    ("HDAC and HP1" . SPARSER::COLLECTION)
    ("HDAC2 , HP1α , HP1β , and HP1γ" . SPARSER::COLLECTION)
    ("HDAC2, HP1α, HP1β, and HP1γ" . SPARSER::COLLECTION)
    ("IF" . SPARSER::PROTEIN) ("HP1α and HP1β" . SPARSER::COLLECTION)
    ("PEO1 and PEO4 cells 24h" . SPARSER::COLLECTION)
    ("HDAC1, HDAC3, and HDAC4" . SPARSER::COLLECTION)
    ("Haematoxylin and eosin (H&E) staining" . SPARSER::COLLECTION)
    ("Haematoxylin" . SPARSER::MOLECULE) ("Carboplatin" . SPARSER::DRUG)
    ("ASM" . SPARSER::PROTEIN) ("HP" . SPARSER::PROTEIN)
    ("centric heterochromatin" . SPARSER::PROTEIN)
    ("HP1α, HP1β, and HP1γ" . SPARSER::COLLECTION)
    ("HATs or HDACs" . SPARSER::COLLECTION)
    ("HAT and HDAC" . SPARSER::COLLECTION)
    ("histones and other proteins [ xref , xref ]" . SPARSER::COLLECTION)
    ("structural homology" . SPARSER::PROTEIN)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN) ("HAT" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("HDAC2 and HP1" . SPARSER::COLLECTION) ("HOX" . SPARSER::PROTEIN)
    ("carboplatin" . SPARSER::DRUG) ("PEO1" . SPARSER::PROTEIN)
    ("OV" . SPARSER::MOLECULE) ("RNAse A" . SPARSER::PROTEIN)
    ("type IX" . SPARSER::PROTEIN) ("sulforhodamine B" . SPARSER::MOLECULE)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("A 15" . SPARSER::PROTEIN)
    ("Alpha-tubulin" . SPARSER::PROTEIN) ("Tween20" . SPARSER::MOLECULE)
    ("HP1 gamma" . SPARSER::PROTEIN) ("HP1 beta" . SPARSER::PROTEIN)
    ("HP1 alpha" . SPARSER::PROTEIN) ("BCA-1" . SPARSER::PROTEIN)
    ("k16" . SPARSER::PROTEIN) ("k56" . SPARSER::PROTEIN)
    ("FK228" . SPARSER::DRUG) ("TP53INP1" . SPARSER::PROTEIN)
    ("N-MYC" . SPARSER::PROTEIN) ("Sin3" . SPARSER::PROTEIN)
    ("Mi-2" . SPARSER::PROTEIN) ("HP1γ" . SPARSER::PROTEIN)
    ("HP1β" . SPARSER::PROTEIN) ("HP1α" . SPARSER::PROTEIN)
    ("NAD+" . SPARSER::MOLECULE) ("HDAC 4" . SPARSER::PROTEIN)
    ("HDAC 1" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("HP1" . SPARSER::PROTEIN) ("heterochromatin protein 1" . SPARSER::PROTEIN)
    ("gene and rs9456497" . SPARSER::COLLECTION)
    ("siRNA or lncRNA" . SPARSER::COLLECTION) ("lncRNA" . SPARSER::RNA)
    ("exon-intron" . SPARSER::PROTEIN-PAIR) ("etc" . SPARSER::PROTEIN)
    ("FOXO3 and AKT1" . SPARSER::COLLECTION)
    ("AKT1 and rs9456497" . SPARSER::COLLECTION) ("Allele" . SPARSER::ALLELE)
    ("FOXO3 , AKT1 and IGF-2R" . SPARSER::COLLECTION)
    ("hemoglobin" . SPARSER::MOLECULE)
    ("AKT1 and IGF-2R" . SPARSER::COLLECTION) ("Suh" . SPARSER::PROTEIN)
    ("FOXO3 and FOXO1A" . SPARSER::COLLECTION)
    ("longevity-associated genes" . SPARSER::GENE)
    ("FOXO3 as well as GGTCGG and GGTCAG" . SPARSER::COLLECTION)
    ("FOXO3, AKT1 and IGF-2R" . SPARSER::COLLECTION)
    ("HbA1" . SPARSER::PROTEIN) ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("Y Chromosome" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("E-2" . SPARSER::PROTEIN) ("Y chromosome" . SPARSER::PROTEIN)
    ("INS1" . SPARSER::PROTEIN) ("FOXO1A" . SPARSER::PROTEIN)
    ("IGF-2R" . SPARSER::PROTEIN)
    ("catalase, peroxidase, and superoxide" . SPARSER::COLLECTION)
    ("peroxidase" . SPARSER::PROTEIN)
    ("caspase-3, caspase-9, Bax, and Bcl-2" . SPARSER::COLLECTION)
    ("Bax and Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-XL, and Mcl-1" . SPARSER::COLLECTION)
    ("Bax, Bak, and Bad" . SPARSER::COLLECTION) ("Bak" . SPARSER::PROTEIN)
    ("protein and RNA" . SPARSER::COLLECTION)
    ("Bcl-2, Bax, caspase-3, and caspase-9" . SPARSER::COLLECTION)
    ("proapoptotic Bax, caspase-3, and caspase-9" . SPARSER::COLLECTION)
    ("antiapoptotic Bcl-2" . SPARSER::PROTEIN)
    ("Bax, caspase-3, and caspase-9" . SPARSER::COLLECTION)
    ("annexin V/PI" . SPARSER::COLLECTION)
    ("stress-activated p38 mitogen-activated protein kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-3 and caspase-9" . SPARSER::COLLECTION)
    ("Bcl-XL" . SPARSER::PROTEIN) ("P-p38" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H 2 DCFDA" . SPARSER::DRUG)
    ("display hyperactive Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PEITC and rapamycin" . SPARSER::COLLECTION) ("PEITC" . SPARSER::DRUG)
    ("Complexes" . SPARSER::BIO-COMPLEX) ("Excessive ROS" . SPARSER::PROTEIN)
    ("proteins, nucleic acids, and intracellular membranes"
     . SPARSER::COLLECTION)
    ("electron" . SPARSER::MOLECULE)
    ("Bad, Tsc2, Gsk3, and Foxos" . SPARSER::COLLECTION)
    ("Tsc2" . SPARSER::PROTEIN) ("shRNA and siRNA" . SPARSER::COLLECTION)
    ("NAC and PEG-catalase" . SPARSER::COLLECTION)
    ("PEG-catalase" . SPARSER::COLLECTION)
    ("NAC and catalase" . SPARSER::COLLECTION)
    ("DCFH-DA or DHE" . SPARSER::COLLECTION) ("DHE" . SPARSER::DRUG)
    ("ROS, and Akt" . SPARSER::COLLECTION)
    ("SOD2 and catalase" . SPARSER::COLLECTION)
    ("p38, JNK, and ERK" . SPARSER::COLLECTION)
    ("NF- κ B, MAPK, and Akt" . SPARSER::COLLECTION)
    ("all of the four genes and one" . SPARSER::COLLECTION)
    ("receptors, and MAPK" . SPARSER::COLLECTION)
    ("PI3 K/Akt" . SPARSER::COLLECTION)
    ("condensation and DNA" . SPARSER::COLLECTION)
    ("the hyperactive Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cellular adenosine triphosphate (ATP) and Ca 2+ levels"
     . SPARSER::COLLECTION)
    ("cellular adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("glutathione, thioredoxin, SOD2, catalase, and peroxidases"
     . SPARSER::COLLECTION)
    ("Foxos" . SPARSER::PROTEIN-FAMILY)
    ("Akt or protein kinase B" . SPARSER::COLLECTION)
    ("ASK1-p38/JNK" . SPARSER::COLLECTION) ("FADD" . SPARSER::PROTEIN)
    ("receptor (TNFR)" . SPARSER::RECEPTOR)
    ("tumor necrosis factor (TNF)" . SPARSER::PROTEIN)
    ("TNFR" . SPARSER::PROTEIN) ("TNF" . SPARSER::PROTEIN)
    ("a new naturally occurring anthraquinone compound" . SPARSER::DRUG)
    ("naphthoquinone" . SPARSER::MOLECULE) ("Plumbagin" . SPARSER::DRUG)
    ("Juglone" . SPARSER::DRUG) ("a traditional medicine" . SPARSER::DRUG)
    ("Akt/Foxo" . SPARSER::COLLECTION) ("Foxo" . SPARSER::PROTEIN-FAMILY)
    ("N -acetyl-L-cysteine and catalase" . SPARSER::COLLECTION)
    ("HG" . SPARSER::MOLECULE) ("aims" . SPARSER::PROTEIN)
    ("Gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-3" . SPARSER::PROTEIN) ("PI3 K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-p38" . SPARSER::PROTEIN) ("ASK1" . SPARSER::PROTEIN)
    ("c -Jun" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anthraquinone compound" . SPARSER::DRUG)
    ("Cytochrome c" . SPARSER::PROTEIN)
    ("N -acetyl-L-cysteine" . SPARSER::MOLECULE) ("Foxo3a" . SPARSER::PROTEIN)
    ("Antioxidant" . SPARSER::PROTEIN)
    ("p62 and Ad-mRFP-GFP-LC3" . SPARSER::COLLECTION)
    ("excessive ROS" . SPARSER::PROTEIN)
    ("first used exogenous H 2 O 2" . SPARSER::DRUG)
    ("lower intracellular ROS" . SPARSER::PROTEIN)
    ("oxidant-antioxidant" . SPARSER::COLLECTION)
    ("oxidant" . SPARSER::PROTEIN) ("Ub" . SPARSER::PROTEIN)
    ("siRNA and NC" . SPARSER::COLLECTION)
    ("both fluorescent proteins" . SPARSER::PROTEIN)
    ("GFP and RFP" . SPARSER::COLLECTION)
    ("the acid-sensitive green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("RFP" . SPARSER::PROTEIN) ("LC3-II and p62" . SPARSER::COLLECTION)
    ("Beclin1, and CQ" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase and CQ" . SPARSER::COLLECTION)
    ("Nrf2, Beclin1, and LC3-II" . SPARSER::COLLECTION)
    ("Nrf2 and autophagic related proteins" . SPARSER::COLLECTION)
    ("autophagic related proteins" . SPARSER::PROTEIN)
    ("exogenous H 2 O 2" . SPARSER::DRUG)
    ("the optimal H 2 O 2" . SPARSER::DRUG)
    ("Beclin1 and LC3-II" . SPARSER::COLLECTION)
    ("Beclin1 and LC3" . SPARSER::COLLECTION)
    ("autophagic inhibitor" . SPARSER::INHIBITOR) ("Atg7" . SPARSER::PROTEIN)
    ("Atg17" . SPARSER::PROTEIN) ("Atg1" . SPARSER::PROTEIN)
    ("Atg" . SPARSER::DRUG) ("chloroquine" . SPARSER::PROTEIN)
    ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("antioxidant response elements (AREs) or electrophile response elements (EpREs)"
     . SPARSER::COLLECTION)
    ("electrophile" . SPARSER::MOLECULE)
    ("Nrf2 and Keap1" . SPARSER::COLLECTION)
    ("long-lived proteins" . SPARSER::PROTEIN)
    ("exogenous hydrogen peroxide" . SPARSER::DRUG) ("S3B" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("LC3-II" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("LC3" . SPARSER::PROTEIN) ("Beclin1" . SPARSER::PROTEIN)
    ("PANC-1" . SPARSER::PROTEIN) ("FIP200" . SPARSER::PROTEIN)
    ("P62" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein1" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN) ("Ubc8" . SPARSER::PROTEIN)
    ("RLIM" . SPARSER::PROTEIN) ("Ubc" . SPARSER::PROTEIN)
    ("conjugase" . SPARSER::PROTEIN) ("SCF-Skp2" . SPARSER::COLLECTION)
    ("isopeptidase" . SPARSER::PROTEIN)
    ("chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("Cdh1" . SPARSER::PROTEIN) ("CDK2/CDK1" . SPARSER::COLLECTION)
    ("Skp2 and p27 Kip1" . SPARSER::COLLECTION)
    ("p27 Kip1 and many other proteins" . SPARSER::COLLECTION)
    ("proteasome inhibitor slightly increases Skp2" . SPARSER::PROTEIN)
    ("treatment very scarce Skp2 protein can" . SPARSER::PROTEIN)
    ("KPC" . SPARSER::PROTEIN) ("Ds-CDK4/6" . SPARSER::COLLECTION)
    ("cyclin/CDK" . SPARSER::COLLECTION)
    ("histones or nonhistone" . SPARSER::COLLECTION)
    ("proteins, and estrogen and androgen" . SPARSER::COLLECTION)
    ("estrogen and androgen" . SPARSER::COLLECTION)
    ("belinostat" . SPARSER::DRUG)
    ("vorinostat and romidepsin" . SPARSER::COLLECTION)
    ("migraine" . SPARSER::PROTEIN) ("type and stage" . SPARSER::COLLECTION)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("essentially such isoform" . SPARSER::ISOFORM)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Akt1 and CDK2" . SPARSER::COLLECTION)
    ("p27 Kip1 and Skp2" . SPARSER::COLLECTION)
    ("a megakaryoblastic leukemia" . SPARSER::PROTEIN)
    ("JURL-MK1" . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("both unmodified p27 Kip1 and its polyubiquitinated isoforms"
     . SPARSER::COLLECTION)
    ("Cdh" . SPARSER::PROTEIN) ("a clear elongation" . SPARSER::PROTEIN)
    ("a key CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EPN and K562 cells" . SPARSER::COLLECTION)
    ("EPN, HeLa, HT29, and Caco2" . SPARSER::COLLECTION)
    ("p21 Cip1 and p57 Kip2" . SPARSER::COLLECTION) ("EPN" . SPARSER::MOLECULE)
    ("NAM and splitomicin" . SPARSER::COLLECTION)
    ("splitomicin" . SPARSER::DRUG) ("NAM" . SPARSER::PROTEIN-FAMILY)
    ("p21 Cip1 , p27 Kip1 , and p57 Kip2" . SPARSER::COLLECTION)
    ("mitogen" . SPARSER::MITOGEN) ("CKIs" . SPARSER::PROTEIN)
    ("the molecule and its concentration" . SPARSER::COLLECTION)
    ("epilepsy" . SPARSER::PROTEIN) ("VPA" . SPARSER::PROTEIN)
    ("apicidin" . SPARSER::DRUG) ("romidepsin" . SPARSER::DRUG)
    ("trichostatin" . SPARSER::MOLECULE)
    ("the first natural hydroxamate" . SPARSER::MOLECULE)
    ("hydroxamate" . SPARSER::MOLECULE) ("Trichostatin" . SPARSER::MOLECULE)
    ("hydroxamates" . SPARSER::MOLECULE)
    ("more efficacious and stable HDACIs" . SPARSER::MOLECULE)
    ("cellular glutathione" . SPARSER::DRUG)
    ("colonic mucosal epithelium" . SPARSER::PROTEIN)
    ("phenylbutyrate" . SPARSER::DRUG) ("DNA-repair" . SPARSER::DNA)
    ("HDAC1, HDAC2, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("HDAC4, HDAC5, HDAC6, HDAC7, HDAC9, and HDAC10" . SPARSER::COLLECTION)
    ("acetyltransferases and histone" . SPARSER::COLLECTION)
    ("lysine and arginine" . SPARSER::COLLECTION)
    ("arginine" . SPARSER::AMINO-ACID) ("Skp2-SCF" . SPARSER::COLLECTION)
    ("inhibitor (CKI)" . SPARSER::INHIBITOR) ("UBP43" . SPARSER::PROTEIN)
    ("ISG15" . SPARSER::PROTEIN) ("Smad 4" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("Cks1" . SPARSER::PROTEIN) ("GATA-1" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("MK1" . SPARSER::PROTEIN)
    ("β -lactone" . SPARSER::MOLECULE)
    ("N-acetyl-leucyl-leucyl-norleucinal" . SPARSER::MOLECULE)
    ("p57 Kip2" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("valproic acid" . SPARSER::MOLECULE)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("butyric acid" . SPARSER::MOLECULE) ("short chain" . SPARSER::PROTEIN)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC11" . SPARSER::PROTEIN)
    ("HDAC10" . SPARSER::PROTEIN) ("HDAC9" . SPARSER::PROTEIN)
    ("HDAC7" . SPARSER::PROTEIN) ("HDAC5" . SPARSER::PROTEIN)
    ("RPD3" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("Histone deacetylase" . SPARSER::PROTEIN)
    ("chrysin, apigenin, luteolin, and trigonelline" . SPARSER::COLLECTION)
    ("trigonelline" . SPARSER::DRUG) ("luteolin" . SPARSER::DRUG)
    ("apigenin" . SPARSER::DRUG) ("chrysin" . SPARSER::DRUG)
    ("the naturally occurring alkaloid brusatol" . SPARSER::DRUG)
    ("brusatol" . SPARSER::DRUG) ("alkaloid" . SPARSER::MOLECULE)
    ("KEAP1-NRF2" . SPARSER::COLLECTION)
    ("HO-1 and GPX2" . SPARSER::COLLECTION)
    ("MRP2 and BCRP" . SPARSER::COLLECTION)
    ("NRF2 and target genes" . SPARSER::COLLECTION)
    ("NQO1 and GCLM" . SPARSER::COLLECTION)
    ("GCLC, GPX2/3, and TXNRD1" . SPARSER::COLLECTION)
    ("NRF2 and BCRP" . SPARSER::COLLECTION)
    ("NRF2, AhR, and SP1" . SPARSER::COLLECTION)
    ("mithramycin" . SPARSER::DRUG) ("AhR" . SPARSER::PROTEIN)
    ("SOD1 and GPX1/2" . SPARSER::COLLECTION)
    ("CD133 and OCT-4" . SPARSER::COLLECTION)
    ("nrf2 , gclc , and xCT" . SPARSER::COLLECTION)
    ("GCLC, NQO-1, and HO-1" . SPARSER::COLLECTION) ("GCLC" . SPARSER::PROTEIN)
    ("LPS" . SPARSER::PROTEIN) ("ERK-NRF2" . SPARSER::COLLECTION)
    ("protoporphyrin" . SPARSER::DRUG) ("cobalt" . SPARSER::MOLECULE)
    ("prosurvival cytokines" . SPARSER::PROTEIN)
    ("erythroid-lymphoid" . SPARSER::COLLECTION)
    ("erythroid" . SPARSER::PROTEIN)
    ("sulforaphane and t" . SPARSER::COLLECTION)
    ("sulforaphane" . SPARSER::DRUG)
    ("peroxiredoxin 1 and NQO1" . SPARSER::COLLECTION)
    ("exogenous ROS" . SPARSER::PROTEIN)
    ("the intestinal epithelium" . SPARSER::PROTEIN)
    ("gclc" . SPARSER::PROTEIN) ("taxol" . SPARSER::DRUG)
    ("KRAS and c-MYC" . SPARSER::COLLECTION)
    ("NRF2 and its target genes" . SPARSER::COLLECTION)
    ("cisplatin, doxorubicin, and 5-fluorouracil" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID) ("purine" . SPARSER::DRUG)
    ("pentose" . SPARSER::MOLECULE) ("ERT" . SPARSER::PROTEIN)
    ("DLG and ETGE" . SPARSER::COLLECTION)
    ("protein and KEAP1" . SPARSER::COLLECTION)
    ("KEAP1 or NRF2" . SPARSER::COLLECTION) ("BBN" . SPARSER::MOLECULE)
    ("toxic chemicals" . SPARSER::MOLECULE)
    ("p21 and p62" . SPARSER::COLLECTION) ("kinase (PERK)" . SPARSER::KINASE)
    ("PI3K, and protein" . SPARSER::COLLECTION) ("PERK" . SPARSER::PROTEIN)
    ("Cys" . SPARSER::AMINO-ACID)
    ("ROS or electrophiles" . SPARSER::COLLECTION)
    ("electrophiles" . SPARSER::MOLECULE) ("DLG" . SPARSER::PROTEIN)
    ("human MRP3 [ xref ] and BCRP genes [ xref ]" . SPARSER::COLLECTION)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("MDR1, BCRP, and MRP2" . SPARSER::COLLECTION) ("SFN" . SPARSER::PROTEIN)
    ("Sulforaphane" . SPARSER::PROTEIN)
    ("MDR1, MRP2/3, and BCRP" . SPARSER::COLLECTION)
    ("oltipraz" . SPARSER::DRUG) ("Mrp1" . SPARSER::PROTEIN)
    ("G6PDH and 6-phosphogluconate dehydrogenase" . SPARSER::COLLECTION)
    ("GSR and TXNRD" . SPARSER::COLLECTION) ("thiols" . SPARSER::MOLECULE)
    ("GPX and GSH" . SPARSER::COLLECTION) ("GSR" . SPARSER::PROTEIN)
    ("GPX" . SPARSER::PROTEIN) ("divergent genes" . SPARSER::GENE)
    ("isothiocyanate" . SPARSER::MOLECULE) ("xenobiotic" . SPARSER::MOLECULE)
    ("NQO1 and GST" . SPARSER::COLLECTION) ("CNC" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY) ("t-" . SPARSER::PROTEIN)
    ("gsta2" . SPARSER::PROTEIN) ("/CD44" . SPARSER::COLLECTION)
    ("PI3K or mTOR" . SPARSER::COLLECTION)
    ("transforming growth factor-" . SPARSER::PROTEIN)
    ("siRNA or sulfasalazine" . SPARSER::COLLECTION)
    ("sulfasalazine" . SPARSER::DRUG) ("xCT" . SPARSER::PROTEIN)
    ("cystine" . SPARSER::MOLECULE) ("CD44 and CD13" . SPARSER::COLLECTION)
    ("BSO" . SPARSER::DRUG)
    ("glutamate cysteine ligase (GCLM, the rate-limiting enzyme of GSH synthesis) and FoxO1"
     . SPARSER::COLLECTION)
    ("the modulatory subunit" . SPARSER::FRAGMENT) ("GCLM" . SPARSER::PROTEIN)
    ("HIF1 α and HIF2 α" . SPARSER::COLLECTION)
    ("OCT4, SOX2, and NANOG" . SPARSER::COLLECTION)
    ("FoxO/ATM" . SPARSER::COLLECTION) ("/AKT" . SPARSER::COLLECTION)
    ("normal HSCs" . SPARSER::PROTEIN)
    ("ATM and the FoxO protein" . SPARSER::COLLECTION)
    ("foxo4" . SPARSER::PROTEIN) ("foxo3a" . SPARSER::PROTEIN)
    ("foxo" . SPARSER::PROTEIN-FAMILY)
    ("GSH biosynthetic enzymes" . SPARSER::ENZYME)
    ("FoxO1 and FoxO3" . SPARSER::COLLECTION)
    ("FoxO1, FoxO3, FoxO4, and FoxO6" . SPARSER::COLLECTION)
    ("ray" . SPARSER::PROTEIN) ("N -acetylcysteine (NAC)" . SPARSER::DRUG)
    ("NAC" . SPARSER::PROTEIN) ("atm" . SPARSER::PROTEIN)
    ("AMPK-mTOR" . SPARSER::COLLECTION) ("MSC" . SPARSER::PROTEIN)
    ("NOX" . SPARSER::PROTEIN) ("MSCs" . SPARSER::PROTEIN)
    ("a cell-permeable ROS" . SPARSER::PROTEIN)
    ("diacetate (DCFDA)" . SPARSER::MOLECULE)
    ("NOTCH1 and BCRP" . SPARSER::COLLECTION) ("DCFDA" . SPARSER::DRUG)
    ("diacetate" . SPARSER::MOLECULE)
    ("GSH and thioredoxin" . SPARSER::COLLECTION) ("TXN" . SPARSER::PROTEIN)
    ("thioredoxin" . SPARSER::PROTEIN) ("HSCs" . SPARSER::PROTEIN)
    ("multidrug resistance-associated proteins" . SPARSER::PROTEIN)
    ("OCT4 and NANOG" . SPARSER::COLLECTION) ("SRY" . SPARSER::PROTEIN)
    ("NANOG" . SPARSER::PROTEIN) ("octamer" . SPARSER::PROTEIN)
    ("/CD38" . SPARSER::COLLECTION) ("TICs" . SPARSER::PROTEIN)
    ("NF-E2-" . SPARSER::PROTEIN) ("cellular ROS" . SPARSER::PROTEIN)
    ("mitochondrial ROS" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oxygen and water" . SPARSER::COLLECTION)
    ("catalase or glutathione peroxidases" . SPARSER::COLLECTION)
    ("GPXs" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("cellular macromolecules" . SPARSER::MOLECULE)
    ("highly proactive molecules" . SPARSER::MOLECULE)
    ("ataxia telangiectasia mutated (ATM) and forkhead box O3 (FoxO3)"
     . SPARSER::COLLECTION)
    ("GPX2" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("OCT-4" . SPARSER::PROTEIN) ("heme oxygenase 1" . SPARSER::PROTEIN)
    ("hydrogen sulfide" . SPARSER::MOLECULE)
    ("fumarate hydratase" . SPARSER::PROTEIN) ("HIF-1 α" . SPARSER::PROTEIN)
    ("N-butyl-N-(4-hydroxybutyl)nitrosamine" . SPARSER::MOLECULE)
    ("linker protein" . SPARSER::PROTEIN) ("D-L" . SPARSER::PROTEIN)
    ("D-X" . SPARSER::PROTEIN) ("E-T" . SPARSER::PROTEIN)
    ("CUL3" . SPARSER::PROTEIN) ("Cullin 3" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("MRP3" . SPARSER::PROTEIN) ("KEAP1" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN)
    ("phosphogluconate dehydrogenase" . SPARSER::PROTEIN)
    ("peroxiredoxin 1" . SPARSER::PROTEIN) ("TXNRD1" . SPARSER::PROTEIN)
    ("thioredoxin reductase 1" . SPARSER::PROTEIN) ("TXN1" . SPARSER::PROTEIN)
    ("thioredoxin 1" . SPARSER::PROTEIN) ("nrf2" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD13" . SPARSER::PROTEIN)
    ("PRDX4" . SPARSER::PROTEIN) ("peroxiredoxin 4" . SPARSER::PROTEIN)
    ("GPX3" . SPARSER::PROTEIN) ("HIF2 α" . SPARSER::PROTEIN)
    ("hif1α" . SPARSER::PROTEIN) ("HIF1 α" . SPARSER::PROTEIN)
    ("akt1" . SPARSER::PROTEIN) ("foxo3" . SPARSER::PROTEIN)
    ("foxo1" . SPARSER::PROTEIN) ("FoxO4" . SPARSER::PROTEIN)
    ("G6PDH" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("N -acetylcysteine" . SPARSER::DRUG)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NOX4" . SPARSER::PROTEIN) ("GPX1" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("ATP-binding cassette transporter" . SPARSER::PROTEIN)
    ("β -catenin" . SPARSER::PROTEIN)
    ("sex determining region Y" . SPARSER::PROTEIN)
    ("Nanog homeobox" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("transcription factor 4" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("factor 2" . SPARSER::PROTEIN)
    ("NF-E2" . SPARSER::PROTEIN) ("erythroid 2" . SPARSER::PROTEIN)
    ("NOX1" . SPARSER::PROTEIN)
    ("glutathione peroxidases" . SPARSER::PROTEIN-FAMILY)
    ("hydroxyl radical" . SPARSER::MOLECULE) ("NRF2" . SPARSER::PROTEIN)
    ("nuclear factor-erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("forkhead box O3" . SPARSER::PROTEIN)
    ("N-SH2-associated proteins" . SPARSER::PROTEIN)
    ("FAK and SRC-family" . SPARSER::COLLECTION)
    ("membrane-associated protein substrates" . SPARSER::SUBSTRATE)
    ("FA-associated proteins" . SPARSER::PROTEIN)
    ("SRC or SRCY527F" . SPARSER::COLLECTION)
    ("kinases and phosphoatases" . SPARSER::COLLECTION)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("medium-sized FAs (0.5 ~ 2 μm 2 ) and small FAs (<0.5 μm 2 )"
     . SPARSER::COLLECTION)
    ("Paxillin" . SPARSER::PROTEIN)
    ("phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("the mobile and immobile fractions" . SPARSER::COMPONENT)
    ("FRAP" . SPARSER::PROTEIN) ("SRCY527F" . SPARSER::PROTEIN)
    ("SRCY527F-GFP" . SPARSER::COLLECTION)
    ("SRCY527F-GFP (open-conformation constitutively active SRC) and SRCY527FΔSH2-GFP (open-conformation constitutively active SRC without SH2 domain)"
     . SPARSER::COLLECTION)
    ("SRC-GFP" . SPARSER::COLLECTION) ("c-SRC" . SPARSER::COLLECTION)
    ("/FYN" . SPARSER::COLLECTION) ("FAK or SRC" . SPARSER::COLLECTION)
    ("especially large FAs (>2 μm 2 ) and medium-sized FAs (0.5 ~ 2 μm 2 )"
     . SPARSER::COLLECTION)
    ("FAs, especially large FAs (>2 μm 2 ) and medium-sized FAs (0.5 ~ 2 μm 2 )"
     . SPARSER::COLLECTION)
    ("GFP-SHP1" . SPARSER::COLLECTION) ("SRC or FAK" . SPARSER::COLLECTION)
    ("SRC and FAK" . SPARSER::COLLECTION) ("the protein’s" . SPARSER::PROTEIN)
    ("SRC and SHP2" . SPARSER::COLLECTION)
    ("Cy5-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("SRC(SH2) and SHP2(NSH2)" . SPARSER::COLLECTION)
    ("mApple-paxillin" . SPARSER::COLLECTION)
    ("GFP-SHP2" . SPARSER::COLLECTION) ("GFP-SRC" . SPARSER::COLLECTION)
    ("pGFP" . SPARSER::PROTEIN)
    ("pGFP-SHP2(NSH2) or pGFP-SHP2(CSH2)" . SPARSER::COLLECTION)
    ("pGFP-SRC(SH2), pGFP-SHP1(NSH2), pGFP-SHP1(CSH2), pGFP-SHP2(NSH2) or pGFP-SHP2(CSH2)"
     . SPARSER::COLLECTION)
    ("a fluorescent protein" . SPARSER::PROTEIN) ("GFPs" . SPARSER::PROTEIN)
    ("pGFP-SHP2" . SPARSER::COLLECTION) ("pGFP-SHP1" . SPARSER::COLLECTION)
    ("pGFP-SRC" . SPARSER::COLLECTION)
    ("SRC and N-SH2 domain" . SPARSER::COLLECTION)
    ("kinase and phosphatases" . SPARSER::COLLECTION)
    ("SRC and FAs" . SPARSER::COLLECTION) ("Fyn" . SPARSER::PROTEIN)
    ("ROCKII" . SPARSER::PROTEIN) ("SHP1 and SHP2" . SPARSER::COLLECTION)
    ("PTPase" . SPARSER::PROTEIN) ("FAK or p130Cas" . SPARSER::COLLECTION)
    ("proteins, SRC, SHP1 and SHP2" . SPARSER::COLLECTION)
    ("Src-homologue-2" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("FAs and the SRC_SH2 domain" . SPARSER::COLLECTION)
    ("FAs and the SHP2_N-SH2 domains" . SPARSER::COLLECTION)
    ("paxillin and FAK" . SPARSER::COLLECTION) ("paxillin" . SPARSER::PROTEIN)
    ("kinase (FAK)" . SPARSER::KINASE)
    ("these enzymes transiently target FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("SRC, SHP1 and SHP2" . SPARSER::COLLECTION)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("5–2 " . SPARSER::PROTEIN)
    ("SRC 1" . SPARSER::PROTEIN) ("SU6656" . SPARSER::PROTEIN)
    ("receptor protein-tyrosine kinases"
     . SPARSER::RECEPTOR-PROTEIN-TYROSINE-KINASE)
    ("CSH2" . SPARSER::PROTEIN) ("SRC kinase" . SPARSER::PROTEIN)
    ("α-actinin" . SPARSER::PROTEIN) ("C-SH2" . SPARSER::PROTEIN)
    ("p130Cas" . SPARSER::PROTEIN) ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("SHP1" . SPARSER::PROTEIN) ("exogenous ethanol" . SPARSER::PROTEIN)
    ("FA and mental retardation/central" . SPARSER::COLLECTION)
    ("a crucial aa" . SPARSER::MOLECULE)
    ("ATP- or ADP-binding status ( xref right panel)" . SPARSER::COLLECTION)
    ("ATP-" . SPARSER::ATP) ("The mutated aa" . SPARSER::MOLECULE)
    ("a helical nucleoprotein filament" . SPARSER::PROTEIN-FAMILY)
    ("Filaments" . SPARSER::PROTEIN-FAMILY)
    ("Ca 2+ and ATP" . SPARSER::COLLECTION)
    ("RAD51 and ssDNA" . SPARSER::COLLECTION)
    ("a somewhat lower baseline ATPase activity" . SPARSER::PROTEIN)
    ("RAD51 and RAD51 A293T" . SPARSER::COLLECTION)
    ("MMC and hydroxyurea" . SPARSER::COLLECTION)
    ("RAD51 , CASC5 and DNAJ17" . SPARSER::COLLECTION)
    ("the cross-linking agents MMC ( xref ) and CPT ( xref )"
     . SPARSER::COLLECTION)
    ("aa" . SPARSER::MOLECULE) ("BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("only one candidate gene" . SPARSER::GENE) ("PRR" . SPARSER::PROTEIN)
    ("KU" . SPARSER::DRUG) ("adenosine" . SPARSER::PROTEIN)
    ("CPT" . SPARSER::PROTEIN) ("camptothecin" . SPARSER::DRUG)
    ("linkers" . SPARSER::LINKER) ("the typical FA" . SPARSER::PROTEIN)
    ("duplex DNA and search" . SPARSER::COLLECTION)
    ("DNA and search" . SPARSER::COLLECTION)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION) ("FANCA" . SPARSER::PROTEIN)
    ("multi" . SPARSER::PROTEIN) ("FANCI" . SPARSER::PROTEIN)
    ("FA/BRCA" . SPARSER::COLLECTION) ("DEB or MMC" . SPARSER::COLLECTION)
    ("DEB" . SPARSER::MOLECULE) ("diepoxybutane" . SPARSER::MOLECULE)
    ("MMC" . SPARSER::PROTEIN)
    ("microcephaly and mental retardation" . SPARSER::COLLECTION)
    ("the homologous recombination DNA repair gene RAD51" . SPARSER::PROTEIN)
    ("Ala" . SPARSER::AMINO-ACID) ("Fanconi" . SPARSER::PROTEIN-FAMILY)
    ("32P" . SPARSER::|32P|) ("SK3" . SPARSER::PROTEIN)
    ("H-10" . SPARSER::PROTEIN) ("cRAD51" . SPARSER::PROTEIN)
    ("CASC5" . SPARSER::PROTEIN) ("RAD51 A" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("S–G2" . SPARSER::PROTEIN)
    ("FA-S" . SPARSER::PROTEIN) ("SLX4" . SPARSER::PROTEIN)
    ("RAD51C" . SPARSER::PROTEIN) ("PALB2" . SPARSER::PROTEIN)
    ("BRIP1" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("FANCD1" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("X-linked" . SPARSER::PROTEIN) ("vorinostat and B" . SPARSER::COLLECTION)
    ("DNMT" . SPARSER::PROTEIN)
    ("cyclin E, cyclin A2, and cyclin B1" . SPARSER::COLLECTION)
    ("cyclin D1 or antisense" . SPARSER::COLLECTION)
    ("MAPK and p70S6" . SPARSER::COLLECTION) ("PDE" . SPARSER::PROTEIN)
    ("epoxide" . SPARSER::MOLECULE) ("diol" . SPARSER::MOLECULE)
    ("the carcinogenic component" . SPARSER::COMPONENT)
    ("histone acetyltransferases (HATs) and HDACs" . SPARSER::COLLECTION)
    ("HATs" . SPARSER::PROTEIN) ("acetyltransferases" . SPARSER::PROTEIN)
    ("/Akt/mTOR/eIF4E-BP" . SPARSER::COLLECTION)
    ("RFS and protein" . SPARSER::COLLECTION)
    ("Wilcoxon-rank" . SPARSER::PROTEIN-PAIR)
    ("Ets or AP-1" . SPARSER::COLLECTION)
    ("promoter, and benzo" . SPARSER::COLLECTION)
    ("ERKs/cyclin D1" . SPARSER::COLLECTION)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2F, and Oct-1" . SPARSER::COLLECTION)
    ("siRNA and vorinostat" . SPARSER::COLLECTION)
    ("vorinostat or cyclin D1" . SPARSER::COLLECTION)
    ("poor RFS" . SPARSER::PROTEIN)
    ("cyclin A2, cyclin E, and p16" . SPARSER::COLLECTION)
    ("cyclin D1 and other proteins" . SPARSER::COLLECTION)
    ("cyclin A2 (Spearman’s rank correlation coefficient [ r  s ] = 0.38, P  < 0.0001) and p16 ( r  s  = 0.32, P  = 0.0003)"
     . SPARSER::COLLECTION)
    ("cyclin A2 ( P  < 0.0001) and cyclin E ( P  = 0.003)"
     . SPARSER::COLLECTION)
    ("cyclin A2, cyclin D1, and cyclin E" . SPARSER::COLLECTION)
    ("Representative examples" . SPARSER::EXAMPLE)
    ("the United States Food and Drug Administration (FDA)"
     . SPARSER::COLLECTION)
    ("suberoylanilide hydroxamic acid (SAHA)" . SPARSER::DRUG)
    ("HDACI" . SPARSER::MOLECULE) ("HDACIs" . SPARSER::MOLECULE)
    ("receptor and non-receptor tyrosine kinases, and vascular endothelial"
     . SPARSER::COLLECTION)
    ("the associated drugs" . SPARSER::DRUG)
    ("vinorelbine or etoposide" . SPARSER::COLLECTION)
    ("pyrene" . SPARSER::PROTEIN) ("Vorinostat" . SPARSER::DRUG)
    ("cyclin A2, cyclin D1, cyclin E, and p16" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin A2, cyclin E, and p16" . SPARSER::COLLECTION)
    ("identifying prognostic biomarkers" . SPARSER::MOLECULE)
    ("vorinostat" . SPARSER::DRUG) ("D-H" . SPARSER::PROTEIN)
    ("lys9" . SPARSER::PROTEIN) ("4E-BP" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("– 2" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("ERCC1, CD3EAP and PPP1R13L" . SPARSER::COLLECTION)
    ("PPP1R13L and CD3EAP" . SPARSER::COLLECTION)
    ("CBP and the XRCC1 polymorphisms" . SPARSER::COLLECTION)
    ("a valid biomarker" . SPARSER::MOLECULE) ("Trp" . SPARSER::AMINO-ACID)
    ("Gln" . SPARSER::AMINO-ACID)
    ("a central scaffolding protein" . SPARSER::PROTEIN)
    ("CBP and polymorphism" . SPARSER::COLLECTION)
    ("PPP1R13L, CD3EAP and ERCC1" . SPARSER::COLLECTION)
    ("AGT" . SPARSER::PROTEIN)
    ("XRCC1, XPC, XPF, PPP1R13L, CD3EAP and ERCC1" . SPARSER::COLLECTION)
    ("CBP and XPC and XPF" . SPARSER::COLLECTION)
    ("XPC and XPF" . SPARSER::COLLECTION)
    ("genotype and CT+TT" . SPARSER::COLLECTION)
    ("the XPB rs4150441 GA genotype (OR = 1.729; 95% CI: 1.000–2.992; P = 0.049) and the GA+AA genotypes (OR = 1.716; 95% CI: 1.015–2.900; P = 0.043)"
     . SPARSER::COLLECTION)
    ("adj" . SPARSER::DRUG) ("some valid biomarkers" . SPARSER::MOLECULE)
    ("This exceptional type" . TYPE) ("nucleoprotein" . SPARSER::PROTEIN)
    ("ERCC1, CD3EAP, and PPP1R13L" . SPARSER::COLLECTION)
    ("PPP1R13L (protein phosphatase 1, regulatory subunit 13 like) and CD3EAP (CD3e molecule, epsilon-associated protein)"
     . SPARSER::COLLECTION)
    ("ERCC1 and ERCC2" . SPARSER::COLLECTION) ("epsilon" . SPARSER::PROTEIN)
    ("XRCC1 and ERCC1" . SPARSER::COLLECTION) ("ADPRT" . SPARSER::PROTEIN)
    ("macromolecules" . SPARSER::MOLECULE)
    ("quinones and reactive oxygen species (ROS) [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("quinones" . SPARSER::MOLECULE)
    ("a commonly used industrial chemical" . SPARSER::MOLECULE)
    ("valid biomarkers" . SPARSER::MOLECULE)
    ("XPC (Xeroderma pigmentosum group C) and XPF (Xeroderma pigmentosum group F)"
     . SPARSER::COLLECTION)
    ("XPF" . SPARSER::PROTEIN) ("XPC" . SPARSER::PROTEIN)
    ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("poisoning (CBP)" . SPARSER::MOLECULE) ("poisoning" . SPARSER::MOLECULE)
    ("Exonuclease-I" . SPARSER::PROTEIN) ("DNA-polymerase" . SPARSER::PROTEIN)
    ("RNA polymerase I" . SPARSER::PROTEIN) ("ERCC2" . SPARSER::PROTEIN)
    ("group F" . SPARSER::PROTEIN) ("group C" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("protein phosphatase 1" . SPARSER::PROTEIN)
    ("PPP1R13L" . SPARSER::PROTEIN)
    ("epsilon associated protein" . SPARSER::PROTEIN)
    ("CD3e molecule" . SPARSER::PROTEIN) ("CD3EAP" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("HIF-1α and its target genes" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("PLD-PH" . SPARSER::COLLECTION)
    ("transferrin receptor, EGFR and angiotensin II" . SPARSER::COLLECTION)
    ("HIF-1α and PLD1" . SPARSER::COLLECTION)
    ("PLD1 or PLD1-PH" . SPARSER::COLLECTION) ("Dynamin" . SPARSER::PROTEIN)
    ("intact PLD1" . SPARSER::PROTEIN)
    ("HIF-1α and PHD2" . SPARSER::COLLECTION)
    ("HIF-1α, PHD2 and VHL" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION)
    ("HIF-1α and EGF" . SPARSER::COLLECTION) ("Rab7" . SPARSER::PROTEIN)
    ("GFP–Rab5" . SPARSER::COLLECTION) ("GFP–Rab7" . SPARSER::COLLECTION)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLD1 or lipase-inactive" . SPARSER::COLLECTION)
    ("lipase" . SPARSER::PROTEIN) ("Rabs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rhodamine-EGF" . SPARSER::COLLECTION) ("rhodamine" . SPARSER::PROTEIN)
    ("the early endosomal resident protein" . SPARSER::PROTEIN)
    ("PLD, PLD1 and PLD2" . SPARSER::COLLECTION) ("dynamin" . SPARSER::PROTEIN)
    ("triphosphatases" . SPARSER::PROTEIN) ("guanosine" . SPARSER::MOLECULE)
    ("phox" . SPARSER::PROTEIN) ("PA" . SPARSER::PROTEIN)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors or downstream effectors" . SPARSER::COLLECTION)
    ("PLD1 and HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α, PHD and VHL" . SPARSER::COLLECTION)
    ("/von Hippel–Lindau" . SPARSER::COLLECTION)
    ("HIF-1α and PLD" . SPARSER::COLLECTION) ("PLD" . SPARSER::PROTEIN)
    ("transferrin receptor" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("rabaptin5" . SPARSER::PROTEIN)
    ("Rabaptin-5" . SPARSER::PROTEIN) ("RABEP1" . SPARSER::PROTEIN)
    ("N 2" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("pleckstrin homology" . SPARSER::PROTEIN) ("PLD2" . SPARSER::PROTEIN)
    ("Phospholipase D" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLD1-PH" . SPARSER::PROTEIN) ("rabaptin-5" . SPARSER::PROTEIN)
    ("Rab5" . SPARSER::PROTEIN) ("lipase activity" . SPARSER::PROTEIN)
    ("PLD1" . SPARSER::PROTEIN) ("von Hippel–Lindau" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN)
    ("phospholipase D" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("PARP inhibitors or androgen receptor inhibitors" . SPARSER::COLLECTION)
    ("mTOR inhibitors, PARP inhibitors or androgen receptor inhibitors"
     . SPARSER::COLLECTION)
    ("MAGI3 and AKT3" . SPARSER::COLLECTION)
    ("only one EGFR gene" . SPARSER::GENE) ("CISH" . SPARSER::PROTEIN)
    ("EE" . SPARSER::PROTEIN) ("SBR-EE" . SPARSER::COLLECTION)
    ("normal or deleted EGFR or chromosome 7 polysomy ( p  = 0.043, Fig.  xref )"
     . SPARSER::COLLECTION)
    ("normal or deleted EGFR" . SPARSER::PROTEIN)
    ("the most common histological type" . TYPE) ("SBR" . SPARSER::PROTEIN)
    ("uPA/PAI-1" . SPARSER::COLLECTION) ("uPA" . SPARSER::PROTEIN)
    ("PI3K/PTEN" . SPARSER::COLLECTION)
    ("PIK3CA and PTEN" . SPARSER::COLLECTION) ("-PI3K" . SPARSER::COLLECTION)
    ("EGFR/PI3K/PTEN" . SPARSER::COLLECTION) ("AKT3" . SPARSER::PROTEIN)
    ("MAGI3" . SPARSER::PROTEIN) ("INPP4B" . SPARSER::PROTEIN)
    ("RAS-GTP" . SPARSER::PROTEIN) ("p110 alpha" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN) ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("Cell membrane" . SPARSER::PROTEIN) ("RTK or Wnt" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("ErbB2" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("SchA" . SPARSER::PROTEIN)
    ("mesenchymal fibronectin and α5β1 integrin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibronectin and α5β1" . SPARSER::COLLECTION)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("MAPK and Akt-mTOR" . SPARSER::COLLECTION)
    ("Akt or mTOR" . SPARSER::COLLECTION)
    ("the membrane-associated metalloprotease TACE" . SPARSER::PROTEIN)
    ("TACE" . SPARSER::PROTEIN) ("metalloprotease" . SPARSER::PROTEIN)
    ("High glucose and insulin" . SPARSER::COLLECTION)
    ("TβRI and clathrin" . SPARSER::COLLECTION)
    ("The dual specificity kinase TGF-β receptors" . SPARSER::RECEPTOR)
    ("receptor-associated Tyr kinases" . SPARSER::PROTEIN)
    ("autocrine TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cholesterol-rich lipid" . SPARSER::LIPID)
    ("Smad and Erk" . SPARSER::COLLECTION) ("RTK" . SPARSER::PROTEIN)
    ("Ser and Tyr" . SPARSER::COLLECTION)
    ("clathrin/EEA1" . SPARSER::COLLECTION)
    ("clathrin and EEA1" . SPARSER::COLLECTION)
    ("TβRI and caveolin 1" . SPARSER::COLLECTION)
    ("both TβRII and Flag-tagged TβRI" . SPARSER::COLLECTION)
    ("β2-adaptin, and p52ShcA" . SPARSER::COLLECTION)
    ("ShcA and Smad3" . SPARSER::COLLECTION) ("glutathione" . SPARSER::DRUG)
    ("GST-Smad3" . SPARSER::COLLECTION)
    ("Smad3 and ShcA" . SPARSER::COLLECTION)
    ("Smad3-TβRI" . SPARSER::COLLECTION)
    ("the major TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TβRI or TβRII" . SPARSER::COLLECTION)
    ("TβRI and TβRII" . SPARSER::COLLECTION)
    ("high glucose or insulin" . SPARSER::COLLECTION)
    ("TβRII and TβRI" . SPARSER::COLLECTION)
    ("fibronectin, N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("Smad7 and PAI-1" . SPARSER::COLLECTION)
    ("Smad7 or PAI-1" . SPARSER::COLLECTION)
    ("Smad2 or Smad3" . SPARSER::COLLECTION)
    ("epithelial E-cadherin and actin" . SPARSER::COLLECTION)
    ("E-cadherin and actin" . SPARSER::COLLECTION)
    ("mesenchymal fibronectin, vimentin, and N-cadherin" . SPARSER::COLLECTION)
    ("cortical actin" . SPARSER::PROTEIN)
    ("fibronectin, vimentin, and N-cadherin" . SPARSER::COLLECTION)
    ("SB431542 or LY2109761" . SPARSER::COLLECTION)
    ("TGF-β/activin" . SPARSER::COLLECTION) ("activin" . SPARSER::PROTEIN)
    ("fibronectin, vimentin or E-cadherin" . SPARSER::COLLECTION)
    ("MEK1/2-Erk" . SPARSER::COLLECTION)
    ("fibronectin or vimentin" . SPARSER::COLLECTION)
    ("Partial" . SPARSER::PROTEIN) ("DiI" . SPARSER::MOLECULE)
    ("acini" . SPARSER::PROTEIN)
    ("fibronectin, N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("prominent fibronectin" . SPARSER::PROTEIN)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("keratinocytes" . SPARSER::PROTEIN)
    ("These cells underwent EMT" . SPARSER::PROTEIN) ("ZEB" . SPARSER::PROTEIN)
    ("Snail" . SPARSER::PROTEIN)
    ("other dual specificity kinases" . SPARSER::PROTEIN)
    ("Ser/Thr" . SPARSER::COLLECTION)
    ("Erk, c-Jun N-terminal kinase (JNK), and p38 MAPK signaling"
     . SPARSER::COLLECTION)
    ("PI3K-Akt-TOR" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("Smad2 and/or Smad3" . SPARSER::COLLECTION) ("trimers" . SPARSER::TRIMER)
    ("Sers" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β and TGF-β-related proteins" . SPARSER::COLLECTION)
    ("two type II and two type I receptor kinases" . SPARSER::COLLECTION)
    ("serine (Ser) and threonine (Thr) phosphorylation" . SPARSER::COLLECTION)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("membrane-associated Tyr kinases" . SPARSER::PROTEIN)
    ("p66, p52, and p46" . SPARSER::COLLECTION)
    ("Ras/Erk" . SPARSER::COLLECTION)
    ("membrane-associated receptors" . SPARSER::PROTEIN)
    ("receptors and integrins" . SPARSER::COLLECTION)
    ("RTKs" . SPARSER::PROTEIN) ("Shc" . SPARSER::PROTEIN)
    ("the predominant ShcA isoform" . SPARSER::ISOFORM)
    ("ShcA and Tyr" . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION)
    ("heteromeric receptor" . SPARSER::RECEPTOR)
    ("clathrin" . SPARSER::PROTEIN) ("caveolin" . SPARSER::PROTEIN)
    ("MAPK and Akt" . SPARSER::COLLECTION) ("TGF-β/Smad" . SPARSER::COLLECTION)
    ("ShcA" . SPARSER::PROTEIN) ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPL19" . SPARSER::PROTEIN) ("90K" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN) ("βR1" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("clathrin heavy chain" . SPARSER::PROTEIN)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("Akt-mTOR" . SPARSER::PROTEIN) ("Dab2" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("caveolin 1" . SPARSER::PROTEIN) ("β2-adaptin" . SPARSER::PROTEIN)
    ("TGF-β1" . SPARSER::PROTEIN) ("TβRII" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("Smad7" . SPARSER::PROTEIN)
    ("LY2109761" . SPARSER::DRUG) ("SB431542" . SPARSER::DRUG)
    ("CD49f" . SPARSER::PROTEIN) ("Smad4" . SPARSER::PROTEIN)
    ("TβRI" . SPARSER::PROTEIN) ("p46" . SPARSER::PROTEIN)
    ("p66" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("Smad3" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("ERβ and PAM50" . SPARSER::COLLECTION)
    ("proteins and ER" . SPARSER::COLLECTION)
    ("ER and HER" . SPARSER::COLLECTION)
    ("the most prognostic genes" . SPARSER::GENE)
    ("an antiproliferative molecule" . SPARSER::MOLECULE)
    ("NRG1 or other ligands" . SPARSER::COLLECTION)
    ("HER2 and HER2" . SPARSER::COLLECTION)
    ("HB-EGF and amphiregulin" . SPARSER::COLLECTION)
    ("amphiregulin" . SPARSER::PROTEIN) ("ERβ-HER2/HER3" . SPARSER::COLLECTION)
    ("HER3, and NRG1" . SPARSER::COLLECTION)
    ("ERBB2/HER2" . SPARSER::COLLECTION)
    ("MYC, CCNE1, and HER2" . SPARSER::COLLECTION)
    ("ER and PGR" . SPARSER::COLLECTION)
    ("ER, PGR, and HER2" . SPARSER::COLLECTION)
    ("MKI67, ANLN, EXO1 , and NDC80" . SPARSER::COLLECTION)
    ("MKI67 , ANLN, NDC80 , and EXO1" . SPARSER::COLLECTION)
    ("Cohorts" . SPARSER::MOLECULE) ("histologic types" . TYPE)
    ("CCNE1, MYC, and HER2" . SPARSER::COLLECTION)
    ("reliable antibodies" . SPARSER::ANTIBODY)
    ("HER2 , CCNE1 , and MYC" . SPARSER::COLLECTION)
    ("EGFR/HER1" . SPARSER::COLLECTION)
    ("β-estradiol, AKT, MAPK, ERK1/2, and JNK" . SPARSER::COLLECTION)
    ("ERBB/HER" . SPARSER::COLLECTION) ("ERBB" . SPARSER::PROTEIN)
    ("ER, and NRG1" . SPARSER::COLLECTION) ("Letrozole" . SPARSER::DRUG)
    ("bazedoxifene" . SPARSER::DRUG) ("MYC and PGR" . SPARSER::COLLECTION)
    ("HER3/HER4" . SPARSER::COLLECTION) ("letrozole" . SPARSER::DRUG)
    ("HER2 or HER3" . SPARSER::COLLECTION) ("neuregulin" . SPARSER::PROTEIN)
    ("HER2/HER3" . SPARSER::COLLECTION) ("Neuregulin" . SPARSER::PROTEIN)
    ("the entire cohort" . SPARSER::MOLECULE) ("Cohort" . SPARSER::MOLECULE)
    ("GRB7 , MIA, MYC, FGFR4, CXXC5 , and FOXC1" . SPARSER::COLLECTION)
    ("GRB7, MYC, MIA, CXXC5, PGR, FGFR4 , and FOXC1" . SPARSER::COLLECTION)
    ("PGR" . SPARSER::PROTEIN) ("MIA" . SPARSER::PROTEIN)
    ("cohort 1 using only seven PAM50 genes" . SPARSER::GENE)
    ("ERβ-1" . SPARSER::COLLECTION) ("progesterone" . SPARSER::PROTEIN)
    ("antiestrogens" . SPARSER::DRUG) ("ER and HER2" . SPARSER::COLLECTION)
    ("ERβ and HER2" . SPARSER::COLLECTION)
    ("ER and progesterone receptor" . SPARSER::COLLECTION)
    ("ERβ and other proteins" . SPARSER::COLLECTION)
    ("HB-EGF" . SPARSER::PROTEIN) ("HR 3" . SPARSER::PROTEIN)
    ("EXO1" . SPARSER::PROTEIN) ("NDC80" . SPARSER::PROTEIN)
    ("MKI67" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("NRG1" . SPARSER::PROTEIN) ("NRG-1" . SPARSER::PROTEIN)
    ("HOXB4" . SPARSER::PROTEIN) ("GRB7" . SPARSER::PROTEIN)
    ("PC2" . SPARSER::PROTEIN) ("FOXC1" . SPARSER::PROTEIN)
    ("β-estradiol" . SPARSER::MOLECULE) ("neuregulin-1" . SPARSER::PROTEIN)
    ("ERβ" . SPARSER::PROTEIN) ("RB-E2F1" . SPARSER::COLLECTION)
    ("RB" . SPARSER::PROTEIN) ("OGT, USP7 and MLL5" . SPARSER::COLLECTION)
    ("USP7 or OGT" . SPARSER::COLLECTION)
    ("MLL5 and OGT" . SPARSER::COLLECTION)
    ("USP7 and MLL5" . SPARSER::COLLECTION)
    ("USP7 and OGT" . SPARSER::COLLECTION)
    ("rabbit anti-OGT" . SPARSER::ANTIBODY)
    ("proteins, and MLL5, OGT and USP7" . SPARSER::COLLECTION)
    ("OGT and USP72" . SPARSER::COLLECTION) ("USP" . SPARSER::PROTEIN)
    ("Western Blot" . SPARSER::PROTEIN) ("Blot" . SPARSER::PROTEIN)
    ("MLL5, OGT, and USP7" . SPARSER::COLLECTION)
    ("OGT and TRAF" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION)
    ("USP7 and V5-tagged" . SPARSER::COLLECTION)
    ("C223S mutant USP7 and His-tagged ubiquitin" . SPARSER::COLLECTION)
    ("UBL" . SPARSER::PROTEIN) ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("HAUSP" . SPARSER::PROTEIN)
    ("deubiquitinases and MLL5" . SPARSER::COLLECTION)
    ("deubiquitinases, USP7 and USP10" . SPARSER::COLLECTION)
    ("ubiquitin and His" . SPARSER::COLLECTION) ("NTA" . SPARSER::MOLECULE)
    ("ShRNA" . SPARSER::PROTEIN)
    ("Cyclin E and several CDKIs" . SPARSER::COLLECTION)
    ("p27, p21, p16 and p19" . SPARSER::COLLECTION)
    ("OGT and MLL5" . SPARSER::COLLECTION) ("MLL5-OGT" . SPARSER::COLLECTION)
    ("deubiquitinase and histone" . SPARSER::COLLECTION)
    ("OGT or USP7" . SPARSER::COLLECTION)
    ("ubiquitin-proteasomal" . SPARSER::COLLECTION)
    ("tumor suppressor p53 and its E3 ubiquitin ligase" . SPARSER::COLLECTION)
    ("E1, E2 and E3" . SPARSER::COLLECTION)
    ("OGT and OGA" . SPARSER::COLLECTION) ("OGA" . SPARSER::PROTEIN)
    ("nutrient" . SPARSER::MOLECULE)
    ("the immediate donor substrate" . SPARSER::SUBSTRATE)
    ("UDP-GlcNAc" . SPARSER::MOLECULE) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("uridine" . SPARSER::PROTEIN) ("HBP" . SPARSER::PROTEIN)
    ("hexosamine" . SPARSER::MOLECULE) ("E6 and E7" . SPARSER::COLLECTION)
    ("Mll5" . SPARSER::PROTEIN) ("protein and histone 3" . SPARSER::COLLECTION)
    ("OGT and USP7" . SPARSER::COLLECTION)
    ("a stable ternary complex" . SPARSER::BIO-COMPLEX)
    ("MLL5, OGT and USP7" . SPARSER::COLLECTION)
    ("a novel MLL5-associated protein" . SPARSER::PROTEIN)
    ("OGT" . SPARSER::PROTEIN) ("K4" . SPARSER::PROTEIN)
    ("group H" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("USP10" . SPARSER::PROTEIN) ("Sh-RNAs" . SPARSER::RNA)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("p19" . SPARSER::PROTEIN)
    ("IP2" . SPARSER::PROTEIN) ("PRK5" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("N-Acetylglucosamine" . SPARSER::MOLECULE)
    ("beta-Actin" . SPARSER::PROTEIN) ("O-GlcNAcase" . SPARSER::PROTEIN)
    ("UDP-" . SPARSER::PROTEIN) ("N-acetylglucosamine" . SPARSER::MOLECULE)
    ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY) ("USP7" . SPARSER::PROTEIN)
    ("O-GlcNAc" . SPARSER::PROTEIN) ("MLL5" . SPARSER::PROTEIN)
    ("Macrophages" . SPARSER::PROTEIN)
    ("growth factors (e.g. EGF, LIF) and NFκB" . SPARSER::COLLECTION)
    ("other inflammatory cytokines" . SPARSER::PROTEIN)
    ("LIF" . SPARSER::PROTEIN) ("IL-6 and TNFα" . SPARSER::COLLECTION)
    ("IFNγ, IL-6 and TNFα" . SPARSER::COLLECTION)
    ("Inflammatory cytokines and macrophages" . SPARSER::COLLECTION)
    ("Possible upstream activators" . SPARSER::ACTIVATOR)
    ("cytokines and macrophages" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("STAT1-STAT3" . SPARSER::COLLECTION)
    ("the inflammation-associated transcription factors STAT1, STAT3 and NFκB"
     . SPARSER::COLLECTION)
    ("homodimer" . SPARSER::HOMODIMER) ("p50-p50" . SPARSER::COLLECTION)
    ("RelA-p50" . SPARSER::COLLECTION) ("homodimers" . SPARSER::HOMODIMER)
    ("NFKB1 nor rs11820062" . SPARSER::COLLECTION)
    ("another nearby gene or several genes" . SPARSER::COLLECTION)
    ("NFKB1 (rs12509403) and RELA (rs11820062)" . SPARSER::COLLECTION)
    ("STAT1 , STAT3 , or genes" . SPARSER::COLLECTION)
    ("RELA or NFKB1" . SPARSER::COLLECTION) ("eGFR" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN) ("Macrophage" . SPARSER::PROTEIN)
    ("neutrophils" . SPARSER::PROTEIN)
    ("macrophages and transcription factor" . SPARSER::COLLECTION)
    ("TYROBP" . SPARSER::PROTEIN)
    ("interstitial macrophages" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN)
    ("many inflammatory cytokines" . SPARSER::PROTEIN)
    ("macrophage" . SPARSER::PROTEIN)
    ("the EMT transcription factor TWIST1 and the mesenchymal marker vimentin ( xref )"
     . SPARSER::COLLECTION)
    ("the mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("VEGFA" . SPARSER::PROTEIN)
    ("cytokine or growth factor" . SPARSER::COLLECTION)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("IL-6, IFNγ or TNFα" . SPARSER::COLLECTION)
    ("IFNγ, IL6 and TNFα" . SPARSER::COLLECTION) ("CFI" . SPARSER::PROTEIN)
    ("CEBPD" . SPARSER::PROTEIN) ("interferon" . SPARSER::PROTEIN)
    ("IL-6 (r = 0.36, p = 0.02) and TNFα (r = 0.46, p < 10 −10 )"
     . SPARSER::COLLECTION)
    ("IFNγ (r = 0.64, p < 10 −5 ), IL-6 (r = 0.36, p = 0.02) and TNFα (r = 0.46, p < 10 −10 )"
     . SPARSER::COLLECTION)
    ("32 IL-6-regulated genes and 230 TNFα-regulated genes ( xref )"
     . SPARSER::COLLECTION)
    ("48 IFNγ-regulated genes, 32 IL-6-regulated genes and 230 TNFα-regulated genes ( xref )"
     . SPARSER::COLLECTION)
    ("IFNγ, IL-6, or TNFα" . SPARSER::COLLECTION)
    ("IFNγ, IL-6, and TNFα" . SPARSER::COLLECTION)
    ("the three inflammatory cytokines" . SPARSER::PROTEIN)
    ("these inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6, IFNγ, or TNFα" . SPARSER::COLLECTION)
    ("IL-6, IFNγ and TNFα" . SPARSER::COLLECTION) ("NFKBIE" . SPARSER::PROTEIN)
    ("NFKBIA" . SPARSER::PROTEIN) ("LTB" . SPARSER::PROTEIN)
    ("NAMPT" . SPARSER::PROTEIN) ("NNMT" . SPARSER::PROTEIN)
    ("PML" . SPARSER::PROTEIN)
    ("transcription factor and differentially" . SPARSER::COLLECTION)
    ("IFNγ, IL-6 or TNFα" . SPARSER::COLLECTION)
    ("STAT3 or RelA" . SPARSER::COLLECTION)
    ("STAT1, STAT3 and RelA" . SPARSER::COLLECTION)
    ("STAT1 (1.23-fold increase, p = 0.006, Student’s t-test) and STAT3 (1.2-fold increase, p = 0.008, Student’s t-test)"
     . SPARSER::COLLECTION)
    ("p65/RelA" . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("Inducers" . SPARSER::MOLECULE)
    ("cytokines or growth factors" . SPARSER::COLLECTION)
    ("STAT1 and STAT3" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("STAT" . SPARSER::PROTEIN)
    ("the orthologous genes" . SPARSER::GENE)
    ("NFκB and its target genes" . SPARSER::COLLECTION)
    ("STAT1, STAT3 or NFκB" . SPARSER::COLLECTION)
    ("STAT3 (2.1-fold enriched, p = 3 x 10 −10 ) and NFκB (3.4-fold-enriched, p = 7.6 x 10 −17 )"
     . SPARSER::COLLECTION)
    ("STAT1 (4.4-fold-enriched, p = 1.3 x 10 −5 ), STAT3 (2.1-fold enriched, p = 3 x 10 −10 ) and NFκB (3.4-fold-enriched, p = 7.6 x 10 −17 )"
     . SPARSER::COLLECTION)
    ("STAT1, STAT3, and NFκB" . SPARSER::COLLECTION)
    ("p16/INK4A" . SPARSER::COLLECTION) ("hyaline" . SPARSER::PROTEIN)
    ("GFR" . SPARSER::PROTEIN) ("STAT1, STAT3 and NFκB" . SPARSER::COLLECTION)
    ("RELA and NFKB1" . SPARSER::COLLECTION) ("RELA" . SPARSER::PROTEIN)
    ("the inflammation-associated transcription factors NFκB, STAT1 and STAT3"
     . SPARSER::COLLECTION)
    ("NFκB, STAT1 and STAT3" . SPARSER::COLLECTION)
    ("genome-wide maps" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("BCLAF1" . SPARSER::PROTEIN)
    ("BCL11A" . SPARSER::PROTEIN) ("IKZF1" . SPARSER::PROTEIN)
    ("EBF1" . SPARSER::PROTEIN) ("PU1" . SPARSER::PROTEIN)
    ("TAF1" . SPARSER::PROTEIN) ("RAD21" . SPARSER::PROTEIN)
    ("CCR2" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("CD163" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("TNFAIP3" . SPARSER::PROTEIN)
    ("CCL20" . SPARSER::PROTEIN) ("CXCL2" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("IL23A" . SPARSER::PROTEIN)
    ("IL32" . SPARSER::PROTEIN) ("IL18BP" . SPARSER::PROTEIN)
    ("GBP2" . SPARSER::PROTEIN) ("GBP1" . SPARSER::PROTEIN)
    ("IRF1" . SPARSER::PROTEIN) ("TRAF3" . SPARSER::PROTEIN)
    ("TNFRSF1A" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("BIRC3" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("TAP1" . SPARSER::PROTEIN)
    ("HLA-E" . SPARSER::PROTEIN) ("MX1" . SPARSER::PROTEIN)
    ("BAK1" . SPARSER::PROTEIN) ("S3I-201" . SPARSER::MOLECULE)
    ("HK-2" . SPARSER::PROTEIN) ("IL-1" . SPARSER::PROTEIN)
    ("interleukin-1 beta" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("NFKB1" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("IFNγ" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("available inhibitors" . SPARSER::INHIBITOR)
    ("BRAF, MEK1/2 and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("BEZ235 or AZD8055" . SPARSER::COLLECTION) ("Shi" . SPARSER::PROTEIN)
    ("MEK and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("The latter two genes" . SPARSER::GENE)
    ("the anti-apoptotic gene Bcl-2 and the mTOR interactor 4EBP1 (Figure xref )"
     . SPARSER::COLLECTION)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY) ("RSK" . SPARSER::PROTEIN)
    ("“PI3K/AKT" . SPARSER::COLLECTION) ("IPA" . SPARSER::MOLECULE)
    ("BRAF and PI3K/mTOR co-targeting" . SPARSER::COLLECTION)
    ("fmk" . SPARSER::PROTEIN) ("livin/ML-IAP" . SPARSER::COLLECTION)
    ("c-IAP1" . SPARSER::COLLECTION) ("livin" . SPARSER::PROTEIN)
    ("annexin-V/PI" . SPARSER::COLLECTION)
    ("AZD6244 and BEZ235" . SPARSER::COLLECTION) ("FA" . SPARSER::PROTEIN)
    ("AZD6244 and PLX4720" . SPARSER::COLLECTION)
    ("at most drug" . SPARSER::DRUG)
    ("MEK1/2 and/or PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("lo" . SPARSER::PROTEIN) ("PTEN, MDM4 and MDM2" . SPARSER::COLLECTION)
    ("AZD6244, PLX4720, BEZ235 and AZD8055" . SPARSER::COLLECTION)
    ("a BRAF and a MEK inhibitor" . SPARSER::COLLECTION)
    ("dual mTORC1/2 (AZD8055) inhibitors" . SPARSER::INHIBITOR)
    ("dual PI3K/mTOR" . SPARSER::COLLECTION)
    ("MEK1/2 and PI3K/mTOR inhibitors" . SPARSER::COLLECTION)
    ("the MEK1/2- and the PI3K/mTOR-specific inhibitors" . SPARSER::COLLECTION)
    ("dual mTORC1/2-specific inhibitors" . SPARSER::INHIBITOR)
    ("BRAFV600E-" . SPARSER::PROTEIN)
    ("a dual PI3K/mTOR (BEZ235) inhibitor" . SPARSER::INHIBITOR)
    ("BRAF and/or MEK inhibitors" . SPARSER::COLLECTION)
    ("MITF" . SPARSER::PROTEIN) ("BRAF and MEK" . SPARSER::COLLECTION)
    ("Selumetinib" . SPARSER::DRUG) ("Trametinib" . SPARSER::DRUG)
    ("BRAF inhibitors and experience tumor progression" . SPARSER::COLLECTION)
    ("Inhibitors" . SPARSER::INHIBITOR)
    ("a MEK1/2 and a PI3K/mTOR inhibitor" . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION)
    ("MEK1/2 and PI3K/mTOR co-targeting" . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("MEK1/2-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BRAFV" . SPARSER::PROTEIN)
    ("m1" . SPARSER::MOLECULE) ("Caspase 7" . SPARSER::PROTEIN)
    ("Caspase-3" . SPARSER::PROTEIN) ("PDGFRβ" . SPARSER::PROTEIN)
    ("−3" . SPARSER::PROTEIN) ("LEF-1" . SPARSER::PROTEIN)
    ("β catenin" . SPARSER::PROTEIN) ("z-VAD-fmk" . SPARSER::DRUG)
    ("ML-IAP" . SPARSER::PROTEIN) ("IAP1" . SPARSER::PROTEIN)
    ("annexin-V" . SPARSER::PROTEIN) ("pS6" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("AZD8055" . SPARSER::DRUG)
    ("PLX4720" . SPARSER::DRUG) ("mTORC1" . SPARSER::PROTEIN)
    ("BEZ235" . SPARSER::DRUG) ("AZD6244" . SPARSER::DRUG)
    ("similarly diverse A-T" . SPARSER::PROTEIN)
    ("two mutated alleles" . SPARSER::ALLELE)
    ("the paternal allele" . SPARSER::ALLELE)
    ("Relatively few mRNAs" . SPARSER::PROTEIN)
    ("entirely ATM −/−" . SPARSER::PROTEIN)
    ("the mutated allele" . SPARSER::ALLELE) ("reverted c" . SPARSER::PROTEIN)
    ("PCR-amplified genomic DNA from iPSC from various cell lines or passage numbers"
     . SPARSER::COLLECTION)
    ("receptor ( TCR )" . SPARSER::RECEPTOR)
    ("P4 and P10" . SPARSER::COLLECTION)
    ("occasional pATM and γH2A" . SPARSER::COLLECTION)
    ("functional ATM" . SPARSER::PROTEIN)
    ("pATM and γH2A" . SPARSER::COLLECTION)
    ("phospho-ATM (pATM) and γH2A" . SPARSER::COLLECTION)
    ("pATM" . SPARSER::PROTEIN)
    ("CAR3, Q1SA, Q3SA, or Q3SC" . SPARSER::COLLECTION)
    ("the maternal allele" . SPARSER::ALLELE) ("p " . SPARSER::PROTEIN)
    ("the ATM western blot" . SPARSER::PROTEIN)
    ("the diagnostic genotype" . SPARSER::PROTEIN)
    ("CAR3 and Q3SC" . SPARSER::COLLECTION) ("puncta" . SPARSER::PROTEIN)
    ("KU-55933 (KU)" . SPARSER::DRUG) ("XR" . SPARSER::PROTEIN)
    ("CAR3 and Q1SA" . SPARSER::COLLECTION)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CAR" . SPARSER::PROTEIN)
    ("ataxia" . SPARSER::PROTEIN) ("CHK2 and H2A" . SPARSER::COLLECTION)
    ("H11" . SPARSER::PROTEIN) ("Oct-4" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("A–4" . SPARSER::PROTEIN) ("P20" . SPARSER::PROTEIN)
    ("TCRβ" . SPARSER::PROTEIN) ("CAR4" . SPARSER::PROTEIN)
    ("P10" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CAR3" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("TRA-1" . SPARSER::PROTEIN) ("Oct4" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("TET1" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("A-T" . SPARSER::PROTEIN) ("PI3K/p-AKT" . SPARSER::COLLECTION)
    ("lenvi-NC" . SPARSER::COLLECTION) ("miR-126 or NC" . SPARSER::COLLECTION)
    ("PC-3" . SPARSER::PROTEIN) ("miR-126 and pik3r2" . SPARSER::COLLECTION)
    ("Micro (mi)RNAs" . SPARSER::RNA)
    ("efficient diagnostic and prognostic biomarkers" . SPARSER::MOLECULE)
    ("mortality-associated cancer types" . TYPE)
    ("a novel therapeutic biomarker" . SPARSER::MOLECULE)
    ("PCa" . SPARSER::PROTEIN) ("MiR-126" . SPARSER::PROTEIN)
    ("Pik3r2" . SPARSER::PROTEIN) ("pik3r2" . SPARSER::PROTEIN)
    ("miR-126" . SPARSER::PROTEIN)
    ("DPYD , TYMP , DHFR , FPGS , ERCC1 and VEGF" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("BRAF" . SPARSER::PROTEIN)
    ("EGFR and human epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("TYMP and GGH" . SPARSER::COLLECTION) ("UFT" . SPARSER::DRUG)
    ("tegafur" . SPARSER::DRUG) ("uracil" . SPARSER::DRUG)
    ("TYMS , TYMP , DHFR and ERCC1" . SPARSER::COLLECTION)
    ("TYMS , DHFR and ERCC1" . SPARSER::COLLECTION)
    ("TYMS , TYMP , DHFR , and ERCC1" . SPARSER::COLLECTION)
    ("FPGS , GGH , TOP1 and ERCC1" . SPARSER::COLLECTION)
    ("TYMS , DPYD and TYMP" . SPARSER::COLLECTION)
    ("DHFR , VEGF and EGFR" . SPARSER::COLLECTION)
    ("TOP1 (1.17-fold; p<0.0001) and EGFR (1.15-fold; p=0.006) genes"
     . SPARSER::COLLECTION)
    ("ERCC1 (1.08-fold; p=0.084) and VEGF (1.07-fold; p=0.191)"
     . SPARSER::COLLECTION)
    ("left-sided colon cancer" . SPARSER::PROTEIN)
    ("right-sided colon cancer" . SPARSER::PROTEIN)
    ("GGH and TOP1" . SPARSER::COLLECTION)
    ("FPGS and ERCC1" . SPARSER::COLLECTION)
    ("T4a and T4b" . SPARSER::COLLECTION) ("AI" . SPARSER::PROTEIN)
    ("SE" . SPARSER::PROTEIN) ("SS" . SPARSER::PROTEIN)
    ("MP" . SPARSER::PROTEIN)
    ("TYMS , DPYD , TYMP , DHFR , FPGS , GGH , TOP1 , ERCC1 , VEGF and EGFR"
     . SPARSER::COLLECTION)
    ("VEGF and EGFR" . SPARSER::COLLECTION)
    ("TOP1 and ERCC1" . SPARSER::COLLECTION)
    ("Topoisomerase" . SPARSER::PROTEIN) ("FPGS and GGH" . SPARSER::COLLECTION)
    ("polyglutamate" . SPARSER::MOLECULE)
    ("tetrahydrofolate" . SPARSER::MOLECULE)
    ("dihydrofolate" . SPARSER::PROTEIN)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("Leucovorin" . SPARSER::DRUG)
    ("TYMS, DPYD and TYMP" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("TYMS and 5,10-methylene-THF" . SPARSER::COLLECTION)
    ("Thymidylate synthase (TYMS)" . SPARSER::PROTEIN)
    ("THF" . SPARSER::MOLECULE)
    ("methylenetetrahydrofolate" . SPARSER::MOLECULE)
    ("irinotecan and oxaliplatin" . SPARSER::COLLECTION)
    ("5-FU and leucovorin" . SPARSER::COLLECTION)
    ("leucovorin" . SPARSER::DRUG) ("TYMS and DPYD" . SPARSER::COLLECTION)
    ("GGH and EGFR" . SPARSER::COLLECTION)
    ("DHFR , FPGS , TOP1 and ERCC1" . SPARSER::COLLECTION)
    ("DPYD and TYMP" . SPARSER::COLLECTION)
    ("TYMS and DHFR" . SPARSER::COLLECTION)
    ("dihydropyrimidine dehydrogenase ( DPYD ) and thymidine phosphorylase ( TYMP )"
     . SPARSER::COLLECTION)
    ("folylpolyglutamate synthase ( FPGS ) and gamma-glutamyl hydrolase ( GGH )"
     . SPARSER::COLLECTION)
    ("biologic agent-related vascular endothelial growth factor ( VEGF ) and epidermal growth factor receptor ( EGFR )"
     . SPARSER::COLLECTION)
    ("growth factor ( VEGF )" . SPARSER::GROWTH-FACTOR)
    ("dihydrofolate reductase ( DHFR )" . SPARSER::PROTEIN)
    ("thymidylate synthase ( TYMS )" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("GGH" . SPARSER::PROTEIN)
    ("FPGS" . SPARSER::PROTEIN) ("DHFR" . SPARSER::PROTEIN)
    ("folate" . SPARSER::MOLECULE) ("TYMP" . SPARSER::PROTEIN)
    ("DPYD" . SPARSER::PROTEIN) ("TYMS" . SPARSER::PROTEIN)
    ("anti- EGFR" . SPARSER::PROTEIN) ("Colon Cancer" . SPARSER::PROTEIN)
    ("T4a" . SPARSER::PROTEIN) ("Dihydrofolate reductase" . SPARSER::PROTEIN)
    ("Thymidine phosphorylase" . SPARSER::PROTEIN)
    ("Dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE)
    ("Thymidylate synthase" . SPARSER::PROTEIN) ("TOP1" . SPARSER::PROTEIN)
    ("gamma-glutamyl hydrolase" . SPARSER::PROTEIN)
    ("folylpolyglutamate synthase" . SPARSER::PROTEIN)
    ("dihydrofolate reductase" . SPARSER::PROTEIN)
    ("thymidine phosphorylase" . SPARSER::PROTEIN)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("lysosomal" . SPARSER::PROTEIN)
    ("p53 (KBM5) or those not expressing p53 (K562)" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("caspase-9, caspase-3 and PARP" . SPARSER::COLLECTION)
    ("annexin V and 7-AAD" . SPARSER::COLLECTION)
    ("butein and cycloheximide" . SPARSER::COLLECTION)
    ("p53 and its downstream effectors" . SPARSER::COLLECTION)
    ("p21 and MDM2" . SPARSER::COLLECTION) ("CDK/cyclin" . SPARSER::COLLECTION)
    ("CDK2 and cyclin D" . SPARSER::COLLECTION)
    ("chalcones" . SPARSER::MOLECULE) ("Butein" . SPARSER::DRUG)
    ("BCR" . SPARSER::PROTEIN) ("ABL" . SPARSER::PROTEIN)
    ("certain cyclins and the p53-downstream targets" . SPARSER::COLLECTION)
    ("MDM2 and p21" . SPARSER::COLLECTION) ("butein" . SPARSER::DRUG)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("Bcr - Abl" . SPARSER::PROTEIN)
    ("p110α and PI3K" . SPARSER::COLLECTION)
    ("miR-21 and p85α" . SPARSER::COLLECTION)
    ("ER or HER2" . SPARSER::COLLECTION)
    ("protein and miR-21" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("the mesenchymal markers N-cadherin, vimentin, FSP1, snail and slug"
     . SPARSER::COLLECTION)
    ("N-cadherin, vimentin, FSP1, snail and slug" . SPARSER::COLLECTION)
    ("slug" . SPARSER::PROTEIN) ("snail" . SPARSER::PROTEIN)
    ("miR-21 and the predicted target gene" . SPARSER::COLLECTION)
    ("miR-21 and PIK3R1" . SPARSER::COLLECTION) ("PITA" . SPARSER::PROTEIN)
    ("overexpressed miRNAs" . SPARSER::PROTEIN) ("AK3" . SPARSER::PROTEIN)
    ("STAT3" . SPARSER::PROTEIN) ("NFKB2" . SPARSER::PROTEIN)
    ("snail 1" . SPARSER::PROTEIN) ("FSP1" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN) ("catalytic subunit" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("regulatory subunit 1" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ROS and oncogene" . SPARSER::COLLECTION) ("Tyr" . SPARSER::AMINO-ACID)
    ("One relevant example" . SPARSER::EXAMPLE) ("ARF" . SPARSER::PROTEIN)
    ("their associated genes and protein products" . SPARSER::COLLECTION)
    ("transducers and/or effectors" . SPARSER::COLLECTION)
    ("their associated genes" . SPARSER::GENE)
    ("ATM and its targets KAP1 and ITCH" . SPARSER::COLLECTION)
    ("KAP1 and ITCH" . SPARSER::COLLECTION)
    ("IR, UVC and UH" . SPARSER::COLLECTION)
    ("IR or UVC or HU" . SPARSER::COLLECTION)
    ("IR or UVC or HU and GST" . SPARSER::COLLECTION)
    ("UVC or HU and GST" . SPARSER::COLLECTION)
    ("HU and GST" . SPARSER::COLLECTION) ("efficient DDR" . SPARSER::PROTEIN)
    ("WWOX and p-ATM" . SPARSER::COLLECTION)
    ("UVC and HU" . SPARSER::COLLECTION)
    ("the mutated form WWOXK274R (line 5 vs. 6) or WWOXWFPA (line 9 vs. 10)"
     . SPARSER::COLLECTION)
    ("WWOXK274R" . SPARSER::PROTEIN)
    ("GST-WWOXK274R or GST-WWOXWFPA" . SPARSER::COLLECTION)
    ("GST-WWOXK274R" . SPARSER::PROTEIN-PAIR)
    ("GST-WWOX" . SPARSER::COLLECTION) ("HA-Ubiquitin" . SPARSER::COLLECTION)
    ("Ubiquitin" . SPARSER::PROTEIN) ("UVC or HU" . SPARSER::COLLECTION)
    ("GAPDH and Lamin A/C" . SPARSER::COLLECTION)
    ("intact WWOX" . SPARSER::PROTEIN)
    ("parental KO-MEFs" . SPARSER::COLLECTION)
    ("MEFs and KO-Ad-WWOX-infected" . SPARSER::COLLECTION)
    ("Adenoviral vector (Ad)-WWOX" . SPARSER::COLLECTION)
    ("-WWOX" . SPARSER::COLLECTION) ("KD" . SPARSER::PROTEIN)
    ("KO" . SPARSER::PROTEIN) ("KO-MEFs" . SPARSER::COLLECTION)
    ("Wwox" . SPARSER::PROTEIN) ("UVC" . SPARSER::PROTEIN)
    ("new MCF7" . SPARSER::PROTEIN) ("MCF7-shWWOX" . SPARSER::PROTEIN-PAIR)
    ("SSBs (UVC)" . SPARSER::PROTEIN) ("a mutated form" . SPARSER::FORM)
    ("WWOX or WWOXK274R" . SPARSER::COLLECTION)
    ("Lysine" . SPARSER::AMINO-ACID) ("p-CHK1" . SPARSER::COLLECTION)
    ("MCF7-WWOX" . SPARSER::COLLECTION) ("WWOX and SSBs" . SPARSER::COLLECTION)
    ("HU or APH" . SPARSER::COLLECTION)
    ("APH or HU or UVC" . SPARSER::COLLECTION)
    ("HU, and APH" . SPARSER::COLLECTION) ("fragile genes" . SPARSER::GENE)
    ("46kDa" . SPARSER::PROTEIN) ("CFS" . SPARSER::PROTEIN)
    ("oxidoreductase (WWOX)" . SPARSER::PROTEIN)
    ("ATM and ATR" . SPARSER::COLLECTION)
    ("Ataxia Telangiectasia and Rad3-related protein (ATR)" . SPARSER::PROTEIN)
    ("Aphidicolin (APH)" . SPARSER::MOLECULE)
    ("Hydroxyurea (HU)" . SPARSER::DRUG) ("APH" . SPARSER::PROTEIN)
    ("Aphidicolin" . SPARSER::PROTEIN) ("iii" . SPARSER::PROTEIN)
    ("Hydroxyurea" . SPARSER::DRUG) ("CPDs" . SPARSER::PROTEIN)
    ("cyclobutane" . SPARSER::MOLECULE) ("UVR" . SPARSER::PROTEIN-FAMILY)
    ("H2AX, KAP1, and CHK2" . SPARSER::COLLECTION)
    ("DNA single- and double-strand" . SPARSER::COLLECTION)
    ("ITCH" . SPARSER::PROTEIN) ("lysine" . SPARSER::AMINO-ACID)
    ("oxidoreductase" . SPARSER::PROTEIN) ("WWOX" . SPARSER::PROTEIN)
    ("KAP-1" . SPARSER::PROTEIN) ("Histone H2A.X" . SPARSER::PROTEIN)
    ("FRA3B" . SPARSER::PROTEIN) ("KU-55933" . SPARSER::DRUG)
    ("p-ATM" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("Lamin A/C" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("γ-H2AX" . SPARSER::PROTEIN) ("WOX1" . SPARSER::PROTEIN)
    ("short-chain dehydrogenase/reductase" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("Serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("ataxia telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("ER-α and Dlx3" . SPARSER::COLLECTION)
    ("ER-α and Runx2 or Stat5" . SPARSER::COLLECTION)
    ("Runx2 or Stat5" . SPARSER::COLLECTION) ("ERs" . SPARSER::PROTEIN)
    ("response elements (HRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("estrogen and ER-α" . SPARSER::COLLECTION) ("retinoid" . SPARSER::PROTEIN)
    ("DAPA" . SPARSER::PROTEIN-FAMILY)
    ("Dlx3 and ER-α-FL or ER-α-ΔLBD" . SPARSER::COLLECTION)
    ("ER-α-ΔLBD" . SPARSER::PROTEIN) ("HA-ER-α-ΔLBD" . SPARSER::COLLECTION)
    ("ER-α-" . SPARSER::PROTEIN) ("ERE-Luc" . SPARSER::COLLECTION)
    ("DRE-Luc" . SPARSER::COLLECTION) ("GFP-Dlx3" . SPARSER::COLLECTION)
    ("HA-ER-α" . SPARSER::COLLECTION) ("Myc-Dlx3" . SPARSER::COLLECTION)
    ("Luc" . SPARSER::PROTEIN) ("ALP-Luc and BSP-Luc" . SPARSER::COLLECTION)
    ("BSP-Luc" . SPARSER::COLLECTION) ("ALP-Luc" . SPARSER::COLLECTION)
    ("ALP and BSP" . SPARSER::COLLECTION)
    ("BSP, and COL1A1 and co-transfection" . SPARSER::COLLECTION)
    ("COL1A1 and co-transfection" . SPARSER::COLLECTION)
    ("BSP" . SPARSER::PROTEIN) ("osteogenic marker genes" . SPARSER::GENE)
    ("ALP" . SPARSER::PROTEIN) ("Dlx3 and ER-α" . SPARSER::COLLECTION)
    ("Hormone" . SPARSER::MOLECULE) ("Estrogen" . SPARSER::MOLECULE)
    ("chondrocytes" . SPARSER::PROTEIN) ("Dlx5 and Dlx6" . SPARSER::COLLECTION)
    ("mesenchymal condensation" . SPARSER::PROTEIN-FAMILY)
    ("Dll" . SPARSER::PROTEIN) ("estradiol" . SPARSER::PROTEIN)
    ("AF-2" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN) ("GATA4" . SPARSER::PROTEIN)
    ("AC-3" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("C-3" . SPARSER::PROTEIN) ("B-5" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN) ("BMP-2" . SPARSER::PROTEIN)
    ("Runx2" . SPARSER::PROTEIN) ("ER-β" . SPARSER::PROTEIN)
    ("Dlx5" . SPARSER::PROTEIN) ("Dlx2" . SPARSER::PROTEIN)
    ("BMP2" . SPARSER::PROTEIN) ("Dlx3" . SPARSER::PROTEIN)
    ("ER-α" . SPARSER::PROTEIN) ("Estrogen receptor" . SPARSER::PROTEIN)
    ("efficient biomarkers" . SPARSER::MOLECULE)
    ("GC and COX-2" . SPARSER::COLLECTION)
    ("DNA and hypermethylation" . SPARSER::COLLECTION)
    ("azacytidine" . SPARSER::DRUG) ("deoxycytidine" . SPARSER::PROTEIN)
    ("aza" . SPARSER::DRUG)
    ("Further validation using 31 GC" . SPARSER::PROTEIN)
    ("foci or non-lymphocytic" . SPARSER::COLLECTION)
    ("SP1 and AP-2" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("EBP" . SPARSER::PROTEIN) ("SP1" . SPARSER::PROTEIN)
    ("CDH1 , p16 , APC , COX-2 , RUNX3 , and hMLH1" . SPARSER::COLLECTION)
    ("pre- and post-GC" . SPARSER::COLLECTION) ("pre-" . SPARSER::PROTEIN)
    ("DYS" . SPARSER::PROTEIN) ("pre" . SPARSER::PROTEIN)
    ("74 pre-GC and 95 post-GC" . SPARSER::COLLECTION)
    ("pre-GC" . SPARSER::COLLECTION) ("GCs" . SPARSER::PROTEIN)
    ("DNA and risk" . SPARSER::COLLECTION) ("Ets-1" . SPARSER::PROTEIN)
    ("AP-2" . SPARSER::PROTEIN) ("set 2 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("promyelocytic leukemia" . SPARSER::PROTEIN) ("K 2" . SPARSER::PROTEIN)
    ("Cyclooxygenase 2" . SPARSER::PROTEIN) ("hMLH1" . SPARSER::PROTEIN)
    ("RUNX3" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("our Belgian cohort" . SPARSER::MOLECULE)
    ("GR" . SPARSER::PROTEIN)
    ("the anteromedial temporal lobes" . SPARSER::PROTEIN)
    ("the temporal and parietal lobes" . SPARSER::PROTEIN)
    ("the parietal lobes and the cerebellum ( xref )" . SPARSER::COLLECTION)
    ("the parietal lobes" . SPARSER::PROTEIN)
    ("the anterior temporal lobes" . SPARSER::PROTEIN)
    ("MAPT and GRN" . SPARSER::COLLECTION)
    ("the Belgian FTD cohort" . SPARSER::MOLECULE)
    ("TDP-43 and p62" . SPARSER::COLLECTION)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("TBK1 and C9orf72" . SPARSER::COLLECTION)
    ("the Belgian patient cohort" . SPARSER::MOLECULE)
    ("C9orf72 and GRN" . SPARSER::COLLECTION) ("Genotype" . SPARSER::PROTEIN)
    ("iii–vi" . SPARSER::PROTEIN-PAIR) ("TDP-43-" . SPARSER::PROTEIN)
    ("vi" . SPARSER::PROTEIN)
    ("the hippocampal dentate gyrus" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN) ("dentate" . SPARSER::PROTEIN)
    ("dystrophic" . SPARSER::PROTEIN)
    ("tau and phospho-tau" . SPARSER::COLLECTION) ("CSF" . SPARSER::PROTEIN)
    ("amyloid" . SPARSER::PROTEIN) ("FDG" . SPARSER::PROTEIN)
    ("his" . SPARSER::AMINO-ACID) ("pyridostigmine" . SPARSER::DRUG)
    ("a rapidly progressive ALS" . SPARSER::PROTEIN) ("arm" . SPARSER::PROTEIN)
    ("pure ALS" . SPARSER::PROTEIN)
    ("a rapidly progressive form" . SPARSER::FORM)
    ("bulbar ALS" . SPARSER::PROTEIN) ("State" . SPARSER::BIO-STATE)
    ("the frontal variant" . SPARSER::VARIANT)
    ("Families" . SPARSER::PROTEIN-FAMILY)
    ("FTD-ALS or ALS" . SPARSER::COLLECTION) ("FTLD" . SPARSER::PROTEIN)
    ("the Belgian patient cohorts" . SPARSER::MOLECULE)
    ("the Belgian FTD and ALS patient cohort" . SPARSER::MOLECULE)
    ("a Belgian cohort" . SPARSER::MOLECULE)
    ("optineurin ( OPTN ) ( xref ; xref ) and p62 ( SQSTM1 )"
     . SPARSER::COLLECTION)
    ("optineurin ( OPTN )" . SPARSER::PROTEIN) ("OPTN" . SPARSER::PROTEIN)
    ("optineurin" . SPARSER::PROTEIN) ("TDP-43 or FUS" . SPARSER::COLLECTION)
    ("Mendelian inherited forms" . SPARSER::FORM)
    ("GRN , MAPT or C9orf72" . SPARSER::COLLECTION)
    ("VCP or CHMP2B" . SPARSER::COLLECTION) ("VCP" . SPARSER::PROTEIN)
    ("FTLD-FUS" . SPARSER::PROTEIN-PAIR) ("FTLD-tau" . SPARSER::PROTEIN-PAIR)
    ("FUS" . SPARSER::PROTEIN) ("tau" . SPARSER::PROTEIN)
    ("MAPT" . SPARSER::PROTEIN) ("TDP" . SPARSER::TDP)
    ("TARDBP" . SPARSER::PROTEIN)
    ("a language variant or primary progressive aphasia (PPA)"
     . SPARSER::COLLECTION)
    ("a behavioural variant" . SPARSER::VARIANT) ("PPA" . SPARSER::PROTEIN)
    ("the temporal lobes" . SPARSER::PROTEIN)
    ("TBK1 , C9orf72 and GRN" . SPARSER::COLLECTION)
    ("behavioural variant" . SPARSER::VARIANT)
    ("currently known causal genes" . SPARSER::GENE)
    ("the behavioural variant" . SPARSER::VARIANT)
    ("GRN or C9orf72" . SPARSER::COLLECTION) ("GRN" . SPARSER::PROTEIN)
    ("Van" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("C9orf7" . SPARSER::PROTEIN) ("C 9orf72" . SPARSER::PROTEIN)
    ("AT8" . SPARSER::PROTEIN) ("β-amyloid" . SPARSER::MOLECULE)
    ("PARK2" . SPARSER::PROTEIN) ("LRRK2" . SPARSER::PROTEIN)
    ("SOD1" . SPARSER::PROTEIN) ("PSEN2" . SPARSER::PROTEIN)
    ("PSEN1" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("TANK-binding kinase 1" . SPARSER::PROTEIN)
    ("CHMP2B" . SPARSER::PROTEIN) ("RNA binding protein" . SPARSER::PROTEIN)
    ("microtubule associated protein tau" . SPARSER::PROTEIN)
    ("TAR DNA binding protein 43" . SPARSER::PROTEIN)
    ("type B" . SPARSER::PROTEIN) ("TDP-43" . SPARSER::PROTEIN)
    ("C9orf72" . SPARSER::PROTEIN)
    ("several chromatin-associated proteins" . SPARSER::PROTEIN)
    ("the mature CDH1 mRNA" . SPARSER::PROTEIN)
    ("chromatin opening and faster rate of transcriptional elongation"
     . SPARSER::COLLECTION)
    ("slower transcriptional elongation" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("CDH1 and 1054 del 83" . SPARSER::COLLECTION)
    ("mRNA/protein" . SPARSER::COLLECTION)
    ("a calcium-dependent transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN)
    ("MGC80-3 and human gastric mucosal epithelial cell line GES-1"
     . SPARSER::PROTEIN)
    ("TSA or DNA" . SPARSER::COLLECTION) ("lysines" . SPARSER::AMINO-ACID)
    ("tri" . SPARSER::PROTEIN)
    ("the human gastric mucosal epithelial cell line GES-1" . SPARSER::PROTEIN)
    ("the normal CDH1" . SPARSER::PROTEIN) ("PTC" . SPARSER::PROTEIN)
    ("HDGC" . SPARSER::PROTEIN)
    ("human gastric mucosal epithelial cell line GES-1" . SPARSER::PROTEIN)
    ("TSA, or siRNA" . SPARSER::COLLECTION) ("TSA" . SPARSER::PROTEIN)
    ("AZA" . SPARSER::DRUG) ("methyltransferase" . SPARSER::PROTEIN)
    ("bisulphite" . SPARSER::MOLECULE) ("RNA binding" . SPARSER::PROTEIN)
    ("site 2" . SPARSER::PROTEIN) ("MS-275" . SPARSER::DRUG)
    ("pre-mRNAs" . SPARSER::RNA) ("site 1" . SPARSER::PROTEIN)
    ("H3K4" . SPARSER::PROTEIN) ("pre-mRNA" . SPARSER::RNA)
    ("SRSF2" . SPARSER::PROTEIN) ("SETD2" . SPARSER::PROTEIN)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("K16" . SPARSER::PROTEIN)
    ("GES-1" . SPARSER::PROTEIN) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("hnRNP A1 and MAZ" . SPARSER::COLLECTION)
    ("These unusual DNA" . SPARSER::DNA)
    ("unbroken oligonucleotide" . SPARSER::MOLECULE)
    ("PEI" . SPARSER::MOLECULE)
    ("β2-microglobulin and hypoxanthine" . SPARSER::COLLECTION)
    ("hypoxanthine" . SPARSER::DRUG) ("–dRFU/dT" . SPARSER::COLLECTION)
    ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY) (":hnRNP A1" . SPARSER::BIO-COMPLEX)
    ("an extended rigid rod" . SPARSER::PROTEIN)
    ("the duplex conformation" . SPARSER::BIO-CONFORMATION)
    ("rod" . SPARSER::PROTEIN) ("protein and DNA" . SPARSER::COLLECTION)
    ("an unspecific protein" . SPARSER::PROTEIN) ("BSA" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN) ("-mutant" . SPARSER::MUTANT)
    ("heterogeneous ribonuclear proteins" . SPARSER::PROTEIN)
    ("hnRNP" . SPARSER::PROTEIN) ("TAMRA" . SPARSER::MOLECULE)
    ("Variant" . SPARSER::VARIANT) ("mer" . SPARSER::PROTEIN)
    ("ODN" . SPARSER::PROTEIN) ("polyacrylamide" . SPARSER::DRUG)
    ("TA" . SPARSER::PROTEIN) ("mH" . SPARSER::MOLECULE)
    ("pKa" . SPARSER::PROTEIN) ("lactate" . SPARSER::MOLECULE)
    ("Tris" . SPARSER::MOLECULE)
    ("other relevant oncogenes" . SPARSER::ONCOGENE)
    ("CMYC" . SPARSER::PROTEIN) ("CKIT" . SPARSER::PROTEIN)
    ("cytosines" . SPARSER::NUCLEOBASE)
    ("an essential protein" . SPARSER::PROTEIN)
    ("a 21-k D GTP-ase conveying" . SPARSER::NUCLEOTIDE)
    ("a 21-k D GTP-ase" . SPARSER::NUCLEOTIDE)
    ("21-k D GTP-ase" . SPARSER::NUCLEOTIDE)
    ("D GTP-ase" . SPARSER::NUCLEOTIDE) ("GTP-ase" . SPARSER::NUCLEOTIDE)
    ("Chromatin" . SPARSER::PROTEIN) ("PEG" . SPARSER::PROTEIN)
    ("hras -1 and hras -2" . SPARSER::COLLECTION) ("PAGE 1" . SPARSER::PROTEIN)
    ("H /R" . SPARSER::PROTEIN) ("hras- 1" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("hnRNP K" . SPARSER::PROTEIN) ("S 5" . SPARSER::MOLECULE)
    ("β2-microglobulin" . SPARSER::PROTEIN) ("S 4" . SPARSER::PROTEIN-FAMILY)
    ("UP1" . SPARSER::PROTEIN) ("S 2" . SPARSER::MOLECULE)
    ("HnRNP A1" . SPARSER::PROTEIN) ("CD-" . SPARSER::PROTEIN)
    ("hnRNP A1" . SPARSER::PROTEIN) ("hras -2" . SPARSER::PROTEIN)
    ("hras -1" . SPARSER::PROTEIN) ("MAPL/PI3K" . SPARSER::COLLECTION)
    ("MAPL" . SPARSER::PROTEIN)
    ("mutant SHP2 (SHP2 D61G) and the scaffolding protein Gab1 [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("Gab1-ERK" . SPARSER::COLLECTION) ("Gab2 and SHP2" . SPARSER::COLLECTION)
    ("SHP2 and Gab1" . SPARSER::COLLECTION)
    ("Gab1 and SHP2" . SPARSER::COLLECTION)
    ("mutant SHP2 (SHP2 D61G) and the scaffolding protein Gab1"
     . SPARSER::COLLECTION)
    ("ERK and Akt" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("LY294002 and SB203580" . SPARSER::COLLECTION)
    ("p-Erk" . SPARSER::COLLECTION) ("Erk and AKT" . SPARSER::COLLECTION)
    ("Ras-Erk" . SPARSER::COLLECTION) ("SHP2SHP2" . SPARSER::PROTEIN)
    ("FN" . SPARSER::PROTEIN) ("MAPK-PI3K" . SPARSER::COLLECTION)
    ("growth factor/cytokine" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("Ras and other effectors [ xref , xref ]" . SPARSER::COLLECTION)
    ("Src homologous protein phosphotyrosyl phosphatase 2" . SPARSER::PROTEIN)
    ("Gab1 and mutant" . SPARSER::COLLECTION) ("Ras-ErK" . SPARSER::COLLECTION)
    ("ErK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Gab1-Ras-Erk" . SPARSER::COLLECTION)
    ("trypsin inhibitor" . SPARSER::PROTEIN) ("Gab2" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Gab1" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("CARP1 and CARP2" . SPARSER::COLLECTION)
    ("Mdm2 null MEFs" . SPARSER::PROTEIN)
    ("parental wild-type MEFs" . SPARSER::PROTEIN)
    ("mouse Ube4b null MEFs" . SPARSER::PROTEIN)
    ("Hdm2 and p53S15" . SPARSER::COLLECTION)
    ("polyubiquitinate" . SPARSER::PROTEIN)
    ("polyubiquitin" . SPARSER::PROTEIN) ("RPMI" . SPARSER::PROTEIN)
    ("Hdm2, UBE4B, Pirh2, or Cop1" . SPARSER::COLLECTION)
    ("wild-type p53 and various p53 mutants" . SPARSER::COLLECTION)
    ("Hdm2 or UBE4B or Pirh2 or Cop1" . SPARSER::COLLECTION)
    ("UBE4B or Pirh2 or Cop1" . SPARSER::COLLECTION)
    ("Pirh2 or Cop1" . SPARSER::COLLECTION)
    ("p53S15 and p53S392" . SPARSER::COLLECTION)
    ("p53S15, p53S392, or p53-2S" . SPARSER::COLLECTION)
    ("p53S15, p53S392 and p53-2S" . SPARSER::COLLECTION)
    ("p53- or p53S15A- or p53" . SPARSER::COLLECTION)
    ("p53S15A- or p53" . SPARSER::COLLECTION)
    ("UBE4B-p53S392A" . SPARSER::COLLECTION)
    ("UBE4B-p53S15A" . SPARSER::COLLECTION)
    ("p53S15A and p53S392A" . SPARSER::COLLECTION)
    ("Flag-UBE4B" . SPARSER::COLLECTION) ("p53- or p53" . SPARSER::COLLECTION)
    ("wt-p53 or p53S15A or p53S392A or p53-2A" . SPARSER::COLLECTION)
    ("p53S15A or p53S392A or p53-2A" . SPARSER::COLLECTION)
    ("p53S392A or p53-2A" . SPARSER::COLLECTION)
    ("p53- or p53S15A-" . SPARSER::COLLECTION)
    ("p53S15A-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 or p53" . SPARSER::COLLECTION)
    ("a substrate for UBE4B or Hdm2-dependent ubiquitination in vitro"
     . SPARSER::COLLECTION)
    ("p53(S392A) and p53(2A)" . SPARSER::COLLECTION)
    ("E1 and E2" . SPARSER::COLLECTION) ("GST-p53" . SPARSER::COLLECTION)
    ("E3 and E4" . SPARSER::COLLECTION)
    ("wt-p53 and p53" . SPARSER::COLLECTION)
    ("ubiquitin and p53, p53S15A, p53S392A, p53-2A, UBE4B or Hdm2"
     . SPARSER::COLLECTION)
    ("p53, p53S15A, p53S392A, p53-2A, UBE4B or Hdm2" . SPARSER::COLLECTION)
    ("wt-p53 or p53" . SPARSER::COLLECTION)
    ("p53 variants and UBE4B or Hdm2 in H1299 cells" . SPARSER::COLLECTION)
    ("Serines" . SPARSER::AMINO-ACID)
    ("phospho-p53(S15) and phospho-p53(S392)" . SPARSER::COLLECTION)
    ("p53 or p53S15A or p53S392A" . SPARSER::COLLECTION)
    ("p53S15A or p53S392A" . SPARSER::COLLECTION)
    ("UBE4B or Hdm2" . SPARSER::COLLECTION)
    ("p53 or p53S15 or p53S392" . SPARSER::COLLECTION)
    ("p53S15 or p53S392" . SPARSER::COLLECTION) ("p53S15" . SPARSER::PROTEIN)
    ("Ube4b null MEFs" . SPARSER::PROTEIN)
    ("p53 and phospho-p53S15" . SPARSER::COLLECTION)
    ("p53, Hdm2 and Cop1" . SPARSER::COLLECTION)
    ("ligases and p53" . SPARSER::COLLECTION)
    ("Hdm2 and UBE4B" . SPARSER::COLLECTION)
    ("p53(S15) and p53(S392)" . SPARSER::COLLECTION)
    ("UBE4B-p53" . SPARSER::COLLECTION) ("Hdm2-p53" . SPARSER::COLLECTION)
    ("p-p53" . SPARSER::COLLECTION) ("specific-antibody" . SPARSER::PROTEIN)
    ("IPs" . SPARSER::PROTEIN) ("Hdm2 and p53" . SPARSER::COLLECTION)
    ("evaluated using western blot and the nucleus (N)-specific marker Oct-1 antibody or cytoplasm (C)-specific marker tubulin antibody [ xref ]"
     . SPARSER::COLLECTION)
    ("the nucleus (N)-specific marker Oct-1 antibody or cytoplasm (C)-specific marker tubulin antibody [ xref ]"
     . SPARSER::COLLECTION)
    ("evaluated using western blot" . SPARSER::PROTEIN)
    ("p53 and UBE4B" . SPARSER::COLLECTION) ("rays" . SPARSER::PROTEIN)
    ("p53-Hdm2" . SPARSER::COLLECTION) ("IR and UV" . SPARSER::COLLECTION)
    ("Cop1 and CHIP trigger" . SPARSER::COLLECTION)
    ("Pirh2, Cop1 and CHIP trigger" . SPARSER::COLLECTION)
    ("Polyubiquitination" . SPARSER::PROTEIN) ("Ube4b" . SPARSER::PROTEIN)
    ("p53S15A, p53S392A, and p53-2A" . SPARSER::COLLECTION)
    ("UBE4B and Hdm2" . SPARSER::COLLECTION) ("serines" . SPARSER::AMINO-ACID)
    ("β-gal" . SPARSER::PROTEIN) ("CA5" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("CARP2" . SPARSER::PROTEIN)
    ("CARP1" . SPARSER::PROTEIN) ("ligase activity" . SPARSER::PROTEIN)
    ("UbcH5b" . SPARSER::PROTEIN) ("Oct-1" . SPARSER::PROTEIN)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("UFD2" . SPARSER::PROTEIN)
    ("S15A" . SPARSER::PROTEIN) ("p53-2" . SPARSER::PROTEIN)
    ("p53S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cop1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Pirh2" . SPARSER::PROTEIN)
    ("Hdm2" . SPARSER::PROTEIN) ("UBE4B" . SPARSER::PROTEIN)
    ("SSB or DSB" . SPARSER::COLLECTION)
    ("a larger polymer" . SPARSER::MOLECULE)
    ("SSBs or DSBs" . SPARSER::COLLECTION)
    ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("strong DNA or DNA–protein complex adsorption" . SPARSER::COLLECTION)
    ("strong DNA" . SPARSER::DNA) ("Spermidine" . SPARSER::MOLECULE)
    ("putrescine or spermidine" . SPARSER::COLLECTION)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("PARP1 and SSB" . SPARSER::COLLECTION)
    ("PARP2 or PARP1" . SPARSER::COLLECTION)
    ("the auto-PARylated protein" . SPARSER::PROTEIN)
    ("PARP2 and PARP1" . SPARSER::COLLECTION)
    ("gap- or flap-containing DNA" . SPARSER::COLLECTION)
    ("a preferential substrate" . SPARSER::SUBSTRATE)
    ("gap-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins and DNA" . SPARSER::COLLECTION)
    ("gap or flap" . SPARSER::COLLECTION) ("flap" . SPARSER::PROTEIN)
    ("PARP1 or PARP2" . SPARSER::COLLECTION)
    ("PARP2 and DNA" . SPARSER::COLLECTION)
    ("around 3.5 nM PARPs" . SPARSER::MOLECULE)
    ("Representative AFM" . SPARSER::PROTEIN)
    ("putrescine (Pu 2+ ) or spermidine (Spd 3+ )" . SPARSER::COLLECTION)
    ("multivalent cations" . SPARSER::MOLECULE)
    ("glutaraldehyde" . SPARSER::MOLECULE) ("spermidine" . SPARSER::MOLECULE)
    ("–DNA" . SPARSER::DNA) ("polyamines" . SPARSER::MOLECULE)
    ("polymer" . SPARSER::MOLECULE) ("SSB and DSB" . SPARSER::COLLECTION)
    ("DNAs" . SPARSER::DNA) ("SSB" . SPARSER::PROTEIN)
    ("putrescine" . SPARSER::MOLECULE) ("polymers" . SPARSER::MOLECULE)
    ("PARP2 and the DNA" . SPARSER::COLLECTION) ("PARPs" . SPARSER::MOLECULE)
    ("DNA and DSBs" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("SSBs and DSBs" . SPARSER::COLLECTION) ("AFM" . SPARSER::PROTEIN)
    ("SSBs" . SPARSER::PROTEIN) ("PARP1 and PARP2" . SPARSER::COLLECTION)
    ("ADP-ribosyl" . SPARSER::MOLECULE) ("cm −1" . SPARSER::PROTEIN)
    ("M −1" . SPARSER::PROTEIN) ("PARP-2" . SPARSER::PROTEIN)
    ("N-hydroxysuccinimide" . SPARSER::DRUG) ("1 D" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE) ("PARP2" . SPARSER::PROTEIN)
    ("antagonists" . SPARSER::MOLECULE) ("pyrimidine" . SPARSER::DRUG)
    ("Fluoropyrimidine" . SPARSER::DRUG) ("MAPK/ERK" . SPARSER::COLLECTION)
    ("KSR" . SPARSER::PROTEIN)
    ("both an active kinase and a scaffolding protein" . SPARSER::COLLECTION)
    ("Raf, MEK, and ERK" . SPARSER::COLLECTION)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("genes and oncogenes" . SPARSER::COLLECTION)
    ("KSR1 and p-ERK1/2" . SPARSER::COLLECTION) ("MVD" . SPARSER::PROTEIN)
    ("miR-497 directly targets KSR1" . SPARSER::PROTEIN)
    ("Mut" . SPARSER::PROTEIN) ("puromycin" . SPARSER::DRUG)
    ("a potential new biomarker" . SPARSER::MOLECULE)
    ("IGF-IR, eIF4E, SMURF1, Bcl2 and cyclin E1" . SPARSER::COLLECTION)
    ("both oncogenes and tumor-suppressor genes" . SPARSER::COLLECTION)
    ("-UTRs" . SPARSER::COLLECTION) ("UTRs" . SPARSER::PROTEIN)
    ("fluorouracil" . SPARSER::DRUG) ("MiR" . SPARSER::PROTEIN)
    ("Housekeeping gene" . SPARSER::PROTEIN) ("S-1" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("SMURF1" . SPARSER::PROTEIN) ("KSR1" . SPARSER::PROTEIN)
    ("kinase suppressor of ras 1" . SPARSER::PROTEIN)
    ("the heterogeneous Lum" . SPARSER::PROTEIN)
    ("the latter subtypes" . SPARSER::PROTEIN)
    ("PR and HER2" . SPARSER::COLLECTION)
    ("low PR and high Ki67" . SPARSER::COLLECTION) ("HER" . SPARSER::PROTEIN)
    ("Wnt-β-catenin" . SPARSER::COLLECTION)
    ("receptor and neuroendocrine" . SPARSER::COLLECTION)
    ("ER and Ki67" . SPARSER::COLLECTION)
    ("ER, Ki67, P63, CG, SYN and SOX2" . SPARSER::COLLECTION)
    ("CG ( p = 0.003) and SYN ( p = 0.030)" . SPARSER::COLLECTION)
    ("SYN ( p = 0.001) and SOX2 ( p = 0.013)" . SPARSER::COLLECTION)
    ("high Ki67 ( p < 0.001), p-cadherin ( p = 0.011), CG ( p = 0.007), SYN ( p = 0.001) and SOX2 ( p = 0.013)"
     . SPARSER::COLLECTION)
    ("PR, EGFR, HER2, c-kit, CK5/6, CK14 and P-cadherin" . SPARSER::COLLECTION)
    ("CG and SYN" . SPARSER::COLLECTION) ("SYN" . SPARSER::PROTEIN)
    ("Lum" . SPARSER::PROTEIN)
    ("subtypes and biomarkers" . SPARSER::COLLECTION)
    ("Representative FGFR1" . SPARSER::PROTEIN)
    ("gene or protein" . SPARSER::COLLECTION)
    ("a therapeutic target and prognostic biomarker" . SPARSER::COLLECTION)
    ("prognostic biomarker" . SPARSER::MOLECULE)
    ("the mammary epithelium" . SPARSER::PROTEIN)
    ("an important tumor biomarker and adverse prognostic factor"
     . SPARSER::COLLECTION)
    ("heterogeneous luminal" . SPARSER::DRUG)
    ("synaptophysin" . SPARSER::PROTEIN) ("p63" . SPARSER::PROTEIN)
    ("Chr8" . SPARSER::PROTEIN) ("chr8" . SPARSER::PROTEIN)
    ("P-cadherin" . SPARSER::PROTEIN) ("CK14" . SPARSER::PROTEIN)
    ("CK5" . SPARSER::PROTEIN) ("c-kit" . SPARSER::PROTEIN)
    ("P63" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("p-cadherin" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("ERG" . SPARSER::PROTEIN)
    ("HER2 and/or MYC (like PTEN deletions in our study)"
     . SPARSER::COLLECTION)
    ("AKT/PTEN" . SPARSER::COLLECTION) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("epithelium" . SPARSER::PROTEIN)
    ("FISH [ xref ] or array CGH [ xref ]" . SPARSER::COLLECTION)
    ("CGH" . SPARSER::PROTEIN) ("HER2 , MYC , and CCND1" . SPARSER::COLLECTION)
    ("HER2 , MYC , or CCND1" . SPARSER::COLLECTION)
    ("PTEN and HER2" . SPARSER::COLLECTION)
    ("PTEN and MYC" . SPARSER::COLLECTION)
    ("PTEN and CCND1" . SPARSER::COLLECTION)
    ("interpretable PTEN FISH" . SPARSER::PROTEIN)
    ("HER2 and MYC" . SPARSER::COLLECTION)
    ("HER2 , CCND1 and MYC" . SPARSER::COLLECTION) ("Type" . TYPE)
    ("a historical cohort" . SPARSER::MOLECULE)
    ("MYC and HER2" . SPARSER::COLLECTION)
    ("a relevant fraction" . SPARSER::COMPONENT)
    ("MYC , HER2 , CCND1 and PTEN" . SPARSER::COLLECTION)
    ("MYC ( p = 0.0430) and HER2 ( p = 0.0065)" . SPARSER::COLLECTION)
    ("PTEN/AKT" . SPARSER::COLLECTION) ("ER/PR" . SPARSER::COLLECTION)
    ("no special type" . TYPE) ("PIK3" . SPARSER::PROTEIN)
    ("sulfate" . SPARSER::MOLECULE) ("dextran" . SPARSER::DEXTRAN)
    ("common mechanical and chemical cues" . SPARSER::PROTEIN-FAMILY)
    ("a critical non-cell-autonomous regulator" . SPARSER::REGULATOR)
    ("IL6 and SRF" . SPARSER::COLLECTION) ("SRF and IL6" . SPARSER::COLLECTION)
    ("verteporfin" . SPARSER::DRUG) ("exogenous TEAD" . SPARSER::PROTEIN)
    ("TEAD and SRF" . SPARSER::COLLECTION)
    ("TEAD and CTGF" . SPARSER::COLLECTION)
    ("SRF and YAP co-overexpression" . SPARSER::COLLECTION)
    ("MaSC signature genes and MaSC-like properties" . SPARSER::COLLECTION)
    ("IL6 and MaSC-like" . SPARSER::COLLECTION)
    ("YAP/TAZ and SRF" . SPARSER::COLLECTION)
    ("SRF and YAP/TAZ" . SPARSER::COLLECTION)
    ("TAZ (WWTR1) and IL6" . SPARSER::COLLECTION)
    ("claudin" . SPARSER::PROTEIN)
    ("SRF, YAP/TAZ and IL6" . SPARSER::COLLECTION) ("SRF-" . SPARSER::PROTEIN)
    ("SRF or IL6" . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("BALB/c" . SPARSER::COLLECTION)
    ("YAP/TAZ or SRF" . SPARSER::COLLECTION)
    ("YAP/TAZ- or SRF-depleted MCF-10A H-Ras G12V" . SPARSER::COLLECTION)
    ("YAP/TAZ-" . SPARSER::PROTEIN) ("SRF–YAP/TAZ–IL6" . SPARSER::COLLECTION)
    ("YAP/TAZ" . SPARSER::PROTEIN) ("MRTF" . SPARSER::PROTEIN)
    ("previously known SRF–MRTF target genes" . SPARSER::GENE)
    ("SRF–MRTF" . SPARSER::COLLECTION) ("myocardin" . SPARSER::PROTEIN)
    ("exogenous TEAD4" . SPARSER::PROTEIN)
    ("IL6 , CTGF, PCDH7 , THBS1 , PPP2R2B , ETS1 and DLL1"
     . SPARSER::COLLECTION)
    ("CArG" . SPARSER::PROTEIN) ("mapping" . SPARSER::PROTEIN)
    ("IL6 and DLL1" . SPARSER::COLLECTION)
    ("CYR61 and ANKRD1" . SPARSER::COLLECTION)
    ("ETS1 and DLL1" . SPARSER::COLLECTION)
    ("representative MaSC genes" . SPARSER::GENE)
    ("TCF4/LEF1-β-catenin" . SPARSER::COLLECTION)
    ("RK and ΔC" . SPARSER::COLLECTION) ("RK" . SPARSER::PROTEIN)
    ("CTGF, CYR61 and ANKRD1" . SPARSER::COLLECTION)
    ("representative MaSC signature genes" . SPARSER::GENE)
    ("IL6 and CTGF" . SPARSER::COLLECTION) ("TEAD" . SPARSER::PROTEIN)
    ("extracellular IL6" . SPARSER::PROTEIN) ("IL6-JAK" . SPARSER::COLLECTION)
    ("nonsecretable mutant IL6" . SPARSER::PROTEIN)
    ("an IL6-neutralizing antibody and an inhibitor" . SPARSER::COLLECTION)
    ("JAK" . SPARSER::PROTEIN) ("/CD24" . SPARSER::COLLECTION)
    ("Lo" . SPARSER::PROTEIN) ("homologue" . SPARSER::PROTEIN)
    ("MaSCs" . SPARSER::PROTEIN) ("CTGF and CYR61" . SPARSER::COLLECTION)
    ("inducer" . SPARSER::MOLECULE)
    ("the previously documented YAP signature genes" . SPARSER::GENE)
    ("the first universal transcriptional target" . SPARSER::TARGET-PROTEIN)
    ("numerous mammary stem cell (MaSC) signature genes" . SPARSER::GENE)
    ("mitogens and matrix-stiffness" . SPARSER::COLLECTION)
    ("LATS" . SPARSER::PROTEIN) ("IL6 and stemness" . SPARSER::COLLECTION)
    ("SRF–YAP/TAZ" . SPARSER::PROTEIN-PAIR)
    ("interleukin (IL)" . SPARSER::PROTEIN)
    ("mammary stem cell (MaSC) signature-gene promoters" . SPARSER::PROMOTER)
    ("interleukin" . SPARSER::PROTEIN) ("MaSC" . SPARSER::PROTEIN)
    ("SRF–IL6" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("effector and oncoprotein" . SPARSER::COLLECTION)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("hypoxanthine phosphoribosyltransferase 1" . SPARSER::PROTEIN)
    ("N-cadherin" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("1–4" . SPARSER::PROTEIN) ("ALDH1" . SPARSER::PROTEIN)
    ("B-27" . SPARSER::PROTEIN) ("ALDH1A1" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN) ("H-Ras" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("TEAD4" . SPARSER::PROTEIN)
    ("PPP2R2B" . SPARSER::PROTEIN) ("PCDH7" . SPARSER::PROTEIN)
    ("NEDD9" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("DLL1" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("thrombospondin 1" . SPARSER::PROTEIN) ("THBS1" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("TCF4" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN) ("ΔC" . SPARSER::PROTEIN)
    ("TEAD2" . SPARSER::PROTEIN) ("ANKRD1" . SPARSER::PROTEIN)
    ("TEAD1" . SPARSER::PROTEIN) ("signal peptide" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("CYR61" . SPARSER::PROTEIN)
    ("CXCL1" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("heat-shock protein" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("4-OHT" . SPARSER::DRUG) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("YAP 2" . SPARSER::PROTEIN) ("putative oncogene" . SPARSER::PROTEIN)
    ("serum response factor" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("an exploratory cohort" . SPARSER::MOLECULE) ("ATAC" . SPARSER::PROTEIN)
    ("MIB-1 and SP6" . SPARSER::COLLECTION)
    ("ROR, and IHC4" . SPARSER::COLLECTION)
    ("TP53 mutation (HR = 1.53, 95% CI = 1.07–2.19) independently predicted shorter RFS"
     . SPARSER::PROTEIN)
    ("both of the IHC4 high risk group (HR = 1.90, 95% CI = 1.32–2.73) and TP53 mutation (HR = 1.63, 95% CI = 1.14–2.32) independently predicted shorter RFS ( xref )"
     . SPARSER::COLLECTION)
    ("TP53 mutation (HR = 1.63, 95% CI = 1.14–2.32) independently predicted shorter RFS"
     . SPARSER::PROTEIN)
    ("shorter RFS" . SPARSER::PROTEIN) ("RFS" . SPARSER::PROTEIN)
    ("Mutant" . SPARSER::MUTANT) ("PIK3CA and TP53" . SPARSER::COLLECTION)
    ("ROR, or IHC4" . SPARSER::COLLECTION)
    ("ROR and IHC4" . SPARSER::COLLECTION) ("ROR" . SPARSER::PROTEIN-FAMILY)
    ("PgR" . SPARSER::PROTEIN) ("Adjuvant" . SPARSER::DRUG)
    ("HR " . SPARSER::PROTEIN)
    ("Breast Cancer International Consortium (METABRIC) cohort"
     . SPARSER::MOLECULE)
    ("SP6" . SPARSER::PROTEIN) ("N3" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("F11" . SPARSER::PROTEIN)
    ("acute leukemia" . SPARSER::PROTEIN)
    ("CCND3, XBP1, CLIC1, TTK, MRPL12, ATAD2 and MAPK6" . SPARSER::COLLECTION)
    ("TTK" . SPARSER::PROTEIN) ("CCND3, BCL2L1 and PIM2" . SPARSER::COLLECTION)
    ("MAPK or JAK-STAT" . SPARSER::COLLECTION)
    ("UPF2, UPF3 and PPP2R5C" . SPARSER::COLLECTION)
    ("UPF2, UPF3, SMG1 and PPP2R5C" . SPARSER::COLLECTION)
    ("three isogenic K562 mutant" . SPARSER::MUTANT) ("PB" . SPARSER::PROTEIN)
    ("kw" . SPARSER::MOLECULE)
    ("Sorafenib and Quizartinib" . SPARSER::COLLECTION)
    ("Quizartinib" . SPARSER::DRUG) ("Sorafenib" . SPARSER::DRUG)
    ("CCK8 and CFSE" . SPARSER::COLLECTION) ("wt/ITD" . SPARSER::COLLECTION)
    ("FLT3-wt/wt" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("CFSE" . SPARSER::DRUG) ("THP-1" . SPARSER::PROTEIN)
    ("Akt, Erk and Stat5" . SPARSER::COLLECTION)
    ("bcr/abl" . SPARSER::COLLECTION) ("abl" . SPARSER::PROTEIN)
    ("bcr" . SPARSER::PROTEIN) ("ligand (FL)" . SPARSER::MOLECULE)
    ("the isogenic mutant" . SPARSER::MUTANT)
    ("Target" . SPARSER::TARGET-PROTEIN)
    ("DNA and Sanger" . SPARSER::COLLECTION) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("isogenic leukemia" . SPARSER::PROTEIN)
    ("artificial fusion proteins" . SPARSER::PROTEIN)
    ("Acute leukemia (AL)" . SPARSER::PROTEIN)
    ("Differentially" . SPARSER::PROTEIN) ("Blast2" . SPARSER::PROTEIN)
    ("DNase-I" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Abl" . SPARSER::PROTEIN) ("anti–" . SPARSER::ANTIBODY)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("Erk1" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN) ("−2 " . SPARSER::PROTEIN)
    ("MAPK6" . SPARSER::PROTEIN) ("ATAD2" . SPARSER::PROTEIN)
    ("MRPL12" . SPARSER::PROTEIN) ("CLIC1" . SPARSER::PROTEIN)
    ("XBP1" . SPARSER::PROTEIN) ("JAK-STAT" . SPARSER::PROTEIN)
    ("PIM2" . SPARSER::PROTEIN) ("BCL2L1" . SPARSER::PROTEIN)
    ("CCND3" . SPARSER::PROTEIN) ("PPP2R5C" . SPARSER::PROTEIN)
    ("SMG1" . SPARSER::PROTEIN) ("UPF3" . SPARSER::PROTEIN)
    ("UPF2" . SPARSER::PROTEIN) ("CD45 " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AC220" . SPARSER::DRUG) ("FLT3 " . SPARSER::PROTEIN)
    ("wt/wt" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("nuclease activity" . SPARSER::PROTEIN)
    ("a 15" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN) ("t" . SPARSER::PROTEIN)
    ("at least a 20" . SPARSER::PROTEIN) ("paraformaldehyde" . SPARSER::DRUG)
    ("formalin" . SPARSER::MOLECULE) ("Bank" . SPARSER::PROTEIN)
    ("Comparative Medicine" . SPARSER::DRUG) ("Aldrich" . SPARSER::PROTEIN)
    ("Sigma-Aldrich" . SPARSER::COLLECTION) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("sterile" . SPARSER::PROTEIN-FAMILY) ("robust ECM" . SPARSER::PROTEIN)
    ("LXR/APOE" . SPARSER::COLLECTION)
    ("individual fibrotic enzymes" . SPARSER::ENZYME)
    ("RNA and protein" . SPARSER::COLLECTION)
    ("certain fibrotic disease states" . SPARSER::BIO-STATE)
    ("an environmental trigger" . SPARSER::PROTEIN)
    ("a severe form" . SPARSER::FORM) ("a new light" . SPARSER::PROTEIN)
    ("other YAP/TAZ-associated miRNAs" . SPARSER::PROTEIN)
    ("only unique miRNAs" . SPARSER::PROTEIN)
    ("an even more complex" . SPARSER::BIO-COMPLEX)
    ("a relevant fibrotic gene" . SPARSER::GENE)
    ("both fibrotic gene" . SPARSER::GENE) ("ApoE" . SPARSER::PROTEIN)
    ("LXR" . SPARSER::PROTEIN) ("CTGF" . SPARSER::PROTEIN)
    ("Lox" . SPARSER::PROTEIN) ("Lrp8 and Pparγ" . SPARSER::COLLECTION)
    ("miR-NC" . SPARSER::COLLECTION) ("MiRNA" . SPARSER::PROTEIN)
    ("desmin" . SPARSER::PROTEIN) ("vimentin" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("miRNA and protein" . SPARSER::COLLECTION)
    ("apolipoprotein E (APOE) and the apolipoprotein E receptor LRP8"
     . SPARSER::COLLECTION)
    ("the associated factors peroxisome proliferator-activated receptor gamma (PPARγ), apolipoprotein E (APOE) and the apolipoprotein E receptor LRP8"
     . SPARSER::COLLECTION)
    ("the associated factors peroxisome proliferator-activated receptor gamma"
     . SPARSER::PROTEIN)
    ("Pparγ and Lrp8" . SPARSER::COLLECTION) ("Lrp8" . SPARSER::PROTEIN)
    ("PPARY-APOE-LRP8" . SPARSER::COLLECTION) ("APOE" . SPARSER::PROTEIN)
    ("fibrotic gene" . SPARSER::GENE) ("a distinct cohort" . SPARSER::MOLECULE)
    ("the fibrotic component" . SPARSER::COMPONENT) ("Rank" . SPARSER::PROTEIN)
    ("well-connected first-degree interactors" . SPARSER::PROTEIN)
    ("interactors" . SPARSER::PROTEIN)
    ("other fibrotic states" . SPARSER::BIO-STATE)
    ("fibrotic genes" . SPARSER::GENE)
    ("fibrosis-relevant genes" . SPARSER::GENE)
    ("a global miRNA regulator" . SPARSER::REGULATOR)
    ("those dominant miRNAs" . SPARSER::PROTEIN)
    ("individual miRNA families often control multiple target genes and phenotypes"
     . SPARSER::COLLECTION)
    ("genes and phenotypes" . SPARSER::COLLECTION)
    ("cues and microRNA" . SPARSER::COLLECTION)
    ("extracellular mechanical cues" . SPARSER::PROTEIN-FAMILY)
    ("cues" . SPARSER::PROTEIN-FAMILY) ("coactivators" . SPARSER::PROTEIN)
    ("LOX" . SPARSER::PROTEIN) ("the pulmonary vasculature" . SPARSER::PROTEIN)
    ("the mechanosensitive microRNA-130/301 family" . SPARSER::PROTEIN-FAMILY)
    ("PH" . SPARSER::PROTEIN) ("TAZ" . SPARSER::PROTEIN)
    ("ECM" . SPARSER::PROTEIN) ("tissue type" . SPARSER::PROTEIN)
    ("non-selective" . SPARSER::PROTEIN) ("miR-21" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("GW3965" . SPARSER::DRUG)
    ("Yap1" . SPARSER::PROTEIN) ("α–SMA" . SPARSER::PROTEIN)
    ("Pparγ" . SPARSER::PROTEIN) ("apolipoprotein E" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("LRP8" . SPARSER::PROTEIN) ("Yes Associated Protein 1" . SPARSER::PROTEIN)
    ("lysyl oxidase" . SPARSER::PROTEIN)
    ("the largest human genes" . SPARSER::GENE) ("Triptorelin" . SPARSER::DRUG)
    ("GH" . SPARSER::PROTEIN) ("dopa" . SPARSER::MOLECULE)
    ("FSH " . SPARSER::DRUG) ("dl" . SPARSER::MOLECULE)
    ("glial" . SPARSER::PROTEIN) ("Drosophila" . SPARSER::PROTEIN)
    ("Neurofibromin" . SPARSER::PROTEIN)
    ("amino acids (AA)" . SPARSER::AMINO-ACID) ("GRD" . SPARSER::PROTEIN)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("seizures" . SPARSER::PROTEIN)
    ("iris" . SPARSER::PROTEIN) ("Lisch" . SPARSER::PROTEIN)
    ("neurofibromin" . SPARSER::PROTEIN) ("growth hormone" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("proteins or mRNAs" . SPARSER::COLLECTION)
    ("RRM1 and TS" . SPARSER::COLLECTION) ("TUBB3-mRNA" . SPARSER::COLLECTION)
    ("BRCA1, p53R2, and TUBB3" . SPARSER::COLLECTION)
    ("BRCA1, RRM1, and TUBB3" . SPARSER::COLLECTION)
    ("BRCA1 and RRM1" . SPARSER::COLLECTION) ("TC-NER" . SPARSER::COLLECTION)
    ("TC" . SPARSER::PROTEIN)
    ("nonfunctional ERCC1 isoforms" . SPARSER::ISOFORM)
    ("protein and gene" . SPARSER::COLLECTION) ("dTMP" . SPARSER::MOLECULE)
    ("deoxythymidine" . SPARSER::MOLECULE) ("dUMP" . SPARSER::DUMP)
    ("dNTPs" . SPARSER::MOLECULE)
    ("pathological TNM, TS, and ERCC1" . SPARSER::COLLECTION)
    ("TNM, TS, and ERCC1" . SPARSER::COLLECTION)
    ("ERCC1, BRAC1, RRM1, RRM2, P53R2, TUBB3, and TS" . SPARSER::COLLECTION)
    ("pathological TNM, and TS" . SPARSER::COLLECTION)
    ("TNM, and TS" . SPARSER::COLLECTION)
    ("male (52.7%) and 156 (47.3%)" . SPARSER::COLLECTION)
    ("only pathological TNM" . SPARSER::MOLECULE)
    ("TUBB3 and TS" . SPARSER::COLLECTION)
    ("RRM1 ( r = 0.29, p < 0.01) and TS ( r = 0.47, p < 0.05)"
     . SPARSER::COLLECTION)
    ("TS and TUBB3" . SPARSER::COLLECTION) ("histological type" . TYPE)
    ("RRM1, p53R2, TUBB3, and BRCA1" . SPARSER::COLLECTION)
    ("RRM2 (HR = 2.26; 95% CI = 1.08–4.74; p = 0.031) and TS (HR = 2.93; 95% CI = 1.16–7.42; p = 0.023)"
     . SPARSER::COLLECTION)
    ("BRCA1-" . SPARSER::PROTEIN) ("Pathological TNM" . SPARSER::MOLECULE)
    ("only subunit p53R2" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION)
    ("an essential enzyme" . SPARSER::ENZYME) ("tubulins" . SPARSER::PROTEIN)
    ("α -tubulin and β -tubulin" . SPARSER::COLLECTION)
    ("RRM2 and RRM1" . SPARSER::COLLECTION)
    ("eukaryotic RR" . SPARSER::MOLECULE)
    ("RRM2 or p53R2" . SPARSER::COLLECTION)
    ("subunits, RRM1, RRM2, and p53R2" . SPARSER::COLLECTION)
    ("deoxyribonucleotides" . SPARSER::MOLECULE)
    ("ribonucleotides" . SPARSER::MOLECULE) ("RR" . SPARSER::MOLECULE)
    ("AQUA" . SPARSER::MOLECULE) ("NER" . SPARSER::PROTEIN)
    ("ERCC1, BRCA1, RRM1, RRM2, and p53R2" . SPARSER::COLLECTION)
    ("IA and IB" . SPARSER::COLLECTION) ("IIB" . SPARSER::PROTEIN)
    ("IB" . SPARSER::DRUG) ("IA" . SPARSER::MOLECULE)
    ("RRM2, TS, and ERCC1" . SPARSER::COLLECTION)
    ("RRM2 and TS" . SPARSER::COLLECTION)
    ("thymidylate synthase (TS)" . SPARSER::PROTEIN)
    ("RRM1 and RRM2" . SPARSER::COLLECTION) ("p53R2" . SPARSER::PROTEIN)
    ("TS" . SPARSER::PROTEIN) ("ribonucleotide" . SPARSER::MOLECULE)
    ("P53R2" . SPARSER::PROTEIN) ("beta -glucuronidase" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("beta -2-microglobulin" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("α -tubulin" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-9" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("TUBB3" . SPARSER::PROTEIN)
    ("beta -tubulin" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN) ("RRM2" . SPARSER::PROTEIN)
    ("RRM1" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tubulin or microtubule-associated proteins" . SPARSER::COLLECTION)
    ("The different mitotic HDAC3-AKAP95-HA95 complex" . SPARSER::BIO-COMPLEX)
    ("FLAG-HDAC3" . SPARSER::COLLECTION)
    ("HDAC3-AKAP95-HA95" . SPARSER::COLLECTION)
    ("the mitotic HDAC3 complex" . SPARSER::BIO-COMPLEX)
    ("HDAC3 and N-CoR" . SPARSER::COLLECTION)
    ("the microtubule-associated proteins" . SPARSER::PROTEIN)
    ("tubulin" . SPARSER::PROTEIN)
    ("polar microtubules or microtubule-associated proteins"
     . SPARSER::COLLECTION)
    ("microtubule-associated proteins" . SPARSER::PROTEIN)
    ("HDAC6 and SirT2" . SPARSER::COLLECTION)
    ("the presumptive microtubule-localized HDAC3-H1.3 complex"
     . SPARSER::BIO-COMPLEX)
    ("revealed at least four potentially additional proteins"
     . SPARSER::PROTEIN)
    ("the mitotic and late G 2 phase complex components" . SPARSER::COMPONENT)
    ("the polar microtubule motor protein Eg5" . SPARSER::PROTEIN)
    ("the mitotic kinase CDK1" . SPARSER::PROTEIN)
    ("tetrameric CK2 protein" . SPARSER::PROTEIN)
    ("Saccharomyces" . SPARSER::PROTEIN)
    ("a different HDAC or a different HDAC3 complex" . SPARSER::COLLECTION)
    ("The mitotic HDAC3-H1.3 complex" . SPARSER::BIO-COMPLEX)
    ("The late G 2 phase complex" . SPARSER::BIO-COMPLEX)
    ("mitotic condensation" . SPARSER::PROTEIN-FAMILY)
    ("Linker" . SPARSER::LINKER) ("heterochromatin" . SPARSER::PROTEIN)
    ("HDAC3 and linker" . SPARSER::COLLECTION)
    ("at Least Seven Proteins" . SPARSER::PROTEIN)
    ("the polar microtubules" . SPARSER::PROTEIN)
    ("HDAC3 or H1.3" . SPARSER::COLLECTION)
    ("the mitotic kinesin family" . SPARSER::PROTEIN)
    ("a specific polar microtubule motor protein" . SPARSER::PROTEIN)
    ("Eg5" . SPARSER::PROTEIN) ("polar microtubules" . SPARSER::PROTEIN)
    ("anti-HDAC3 and anti-histone" . SPARSER::COLLECTION)
    ("nonspecific scrambled siRNA" . SPARSER::PROTEIN)
    ("CK2α/CK2α" . SPARSER::COLLECTION) ("tetramer" . SPARSER::TETRAMER)
    ("the mitotic H1.3-HDAC3 complex" . SPARSER::BIO-COMPLEX)
    ("Cdc2-cyclin" . SPARSER::COLLECTION)
    ("the mitotic complex" . SPARSER::BIO-COMPLEX)
    ("the late G 2 phase complex" . SPARSER::BIO-COMPLEX)
    ("SMRT or N-CoR" . SPARSER::COLLECTION)
    ("HDAC3-SMRT" . SPARSER::COLLECTION)
    ("HDAC3, or phospho-histone" . SPARSER::COLLECTION)
    ("agarose" . SPARSER::MOLECULE) ("Sephadex" . SPARSER::DRUG)
    ("Complex" . SPARSER::BIO-COMPLEX) ("H1.3 or HDAC3" . SPARSER::COLLECTION)
    ("histone H1.3 ( xref  F ), phospho-histone H1 ( xref  G ), and HDAC3 ( xref  H ) proteins"
     . SPARSER::COLLECTION)
    ("phospho-histone" . SPARSER::PROTEIN) ("H1.3-HDAC3" . SPARSER::COLLECTION)
    ("anti H1.3 antibody ( xref  H ) or anti HDAC3 antibody ( xref  I )"
     . SPARSER::COLLECTION)
    ("H1.3 and HDAC3" . SPARSER::COLLECTION) ("anti" . SPARSER::PROTEIN)
    ("HDAC3 ( xref  H ) or H1.3 ( xref  I )" . SPARSER::COLLECTION)
    ("FITC" . SPARSER::MOLECULE) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE)
    ("HDAC3 and histone" . SPARSER::COLLECTION)
    ("anti-HDAC8 antibody and vice versa" . SPARSER::COLLECTION)
    ("HDAC3, HDAC8, and histone" . SPARSER::COLLECTION)
    ("HDAC3 and HDAC8" . SPARSER::COLLECTION)
    ("HDACs and Histone" . SPARSER::COLLECTION)
    ("at least four additional proteins" . SPARSER::PROTEIN)
    ("SMRT and N-CoR" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN)
    ("HDAC3 and the linker histone subtype H1.3" . SPARSER::COLLECTION)
    ("deacetylases and histone" . SPARSER::COLLECTION)
    ("SirT1" . SPARSER::PROTEIN) ("HDACs and H1s" . SPARSER::COLLECTION)
    ("an architectural protein" . SPARSER::PROTEIN)
    ("functional HDAC3" . SPARSER::PROTEIN) ("acetyl" . SPARSER::MOLECULE)
    ("the mitotic chromatin" . SPARSER::PROTEIN)
    ("HDAC3 and H1.3" . SPARSER::COLLECTION)
    ("CK2α and CK2α" . SPARSER::COLLECTION)
    ("mitotic complexes" . SPARSER::BIO-COMPLEX)
    ("silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) and nuclear receptor corepressor 1 (N-CoR)"
     . SPARSER::COLLECTION)
    ("HDAC3-H1.3" . SPARSER::COLLECTION) ("SMRT" . SPARSER::PROTEIN)
    ("HDACs and linker" . SPARSER::COLLECTION) ("HA95" . SPARSER::PROTEIN)
    ("AKAP95" . SPARSER::PROTEIN)
    ("A-kinase anchor protein" . SPARSER::PROTEIN) ("SirT2" . SPARSER::PROTEIN)
    ("MEF2" . SPARSER::PROTEIN) ("GATA-2" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("TBLR1" . SPARSER::PROTEIN)
    ("TBL1" . SPARSER::PROTEIN) ("G 2 /M" . SPARSER::PROTEIN)
    ("kinesin family" . SPARSER::PROTEIN) ("B–D" . SPARSER::PROTEIN)
    ("CK2 α" . SPARSER::PROTEIN) ("Cdc2" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE) ("A–F" . SPARSER::PROTEIN)
    ("H1.4" . SPARSER::PROTEIN) ("H1.2" . SPARSER::PROTEIN)
    ("A–C" . SPARSER::PROTEIN) ("HDAC8" . SPARSER::PROTEIN)
    ("Histone Deacetylase 3" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("Histone Deacetylase" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("HD2" . SPARSER::PROTEIN) ("K5" . SPARSER::PROTEIN)
    ("H1.5" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("anti-Histone" . SPARSER::PROTEIN)
    ("deacetylase activity" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("CK2α" . SPARSER::PROTEIN) ("casein kinase 2" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("N-CoR" . SPARSER::PROTEIN)
    ("nuclear receptor corepressor 1" . SPARSER::PROTEIN)
    ("silencing mediator of retinoic acid and thyroid hormone receptor"
     . SPARSER::PROTEIN)
    ("H1.3" . SPARSER::PROTEIN) ("Histone deacetylase 3" . SPARSER::PROTEIN)
    ("TLK1 or another protein" . SPARSER::COLLECTION)
    ("Chk1-Rad9A" . SPARSER::COLLECTION) ("Rad9A-Chk1" . SPARSER::COLLECTION)
    ("ATM, 53BP1, NBS1, BRCA1, FANCD2, and RAD51" . SPARSER::COLLECTION)
    ("UCN-01 or Chk1" . SPARSER::COLLECTION)
    ("the kinases Wee1 [ xref , xref ] and Myt1 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("protein or proteins" . SPARSER::COLLECTION) ("BrdU" . SPARSER::DRUG)
    ("Rad9A around 62 kDa" . SPARSER::PROTEIN)
    ("MG132 and BLEO" . SPARSER::COLLECTION)
    ("DMSO or MG132" . SPARSER::COLLECTION)
    ("CHX and MG132" . SPARSER::COLLECTION)
    ("Cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("Cycloheximide" . SPARSER::PROTEIN) ("antibiotic" . SPARSER::DRUG)
    ("Brca1 and Claspin" . SPARSER::COLLECTION) ("UPP" . SPARSER::PROTEIN)
    ("Rad9A or Chk1" . SPARSER::COLLECTION)
    ("Rad9A and Chk1" . SPARSER::COLLECTION)
    ("Rad9A or ubiquitin" . SPARSER::COLLECTION)
    ("UCN-01 and BLEO" . SPARSER::COLLECTION)
    ("Rad9A, Chk1 or Chk1" . SPARSER::COLLECTION)
    ("ATR-Chk1-Cdc25A" . SPARSER::COLLECTION)
    ("Hus1 or Rad1" . SPARSER::COLLECTION)
    ("Rad1 and Hus1" . SPARSER::COLLECTION)
    ("ubiquitin, Rad9A or Rad9A" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN) ("Bleomycin" . SPARSER::DRUG)
    ("Claspin and SCFβ-TrCP" . SPARSER::COLLECTION)
    ("bleomycin (BLEO)" . SPARSER::DRUG) ("BLEO" . SPARSER::DRUG)
    ("Rad9A and TopBp1" . SPARSER::COLLECTION)
    ("Chk1 and Rad9A" . SPARSER::COLLECTION) ("SQ" . SPARSER::MOLECULE)
    ("Rad9A-TopBp1-ATR-Chk1" . SPARSER::COLLECTION)
    ("Claspin" . SPARSER::PROTEIN) ("ATR-ATRIP" . SPARSER::COLLECTION)
    ("ATRIP" . SPARSER::PROTEIN)
    ("Rad9A, Rad1, and Hus1" . SPARSER::COLLECTION)
    ("trimer" . SPARSER::TRIMER)
    ("mediators, transducers and effectors" . SPARSER::COLLECTION)
    ("UCN-01 or siRNA" . SPARSER::COLLECTION)
    ("polyubiquitinated, and Rad9A" . SPARSER::COLLECTION)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("bleomycin" . SPARSER::DRUG)
    ("Rad9A" . SPARSER::PROTEIN) ("TLK1" . SPARSER::PROTEIN)
    ("DU145" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("NBS1" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("B/Cdk1" . SPARSER::PROTEIN) ("Myt1" . SPARSER::PROTEIN)
    ("Wee1" . SPARSER::PROTEIN) ("Cdc25B" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("Plk1" . SPARSER::PROTEIN)
    ("RNase A" . SPARSER::PROTEIN) ("RNase-A" . SPARSER::PROTEIN)
    ("N-Ethylmaleimide" . SPARSER::MOLECULE)
    ("N-ethylmaleimide" . SPARSER::MOLECULE) ("per 1" . SPARSER::PROTEIN)
    ("TWEEN 20" . SPARSER::MOLECULE) ("HUS1" . SPARSER::PROTEIN)
    ("Cdc25C" . SPARSER::PROTEIN) ("hRad9" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("TopBp1" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("β-TrCP" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("Rad17–RFC" . SPARSER::BIO-COMPLEX) ("Hus1" . SPARSER::PROTEIN)
    ("Rad1" . SPARSER::PROTEIN) ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("UCN-01" . SPARSER::DRUG) ("TopBP1" . SPARSER::PROTEIN)
    ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DR and NPDR" . SPARSER::COLLECTION)
    ("allele and genotypes" . SPARSER::COLLECTION)
    ("DR and its clinical subgroups NPDR and PDR" . SPARSER::COLLECTION)
    ("characteristic serine protease activator Tissue Plasminogen Activator (t-PA) and its inhibitor PAI-1"
     . SPARSER::COLLECTION)
    ("characteristic serine protease activator Tissue Plasminogen Activator"
     . SPARSER::PROTEIN)
    ("plasminogen" . SPARSER::PROTEIN)
    ("the more severe proliferative form PDR" . SPARSER::MOLECULE)
    ("the less severe form" . SPARSER::FORM)
    ("the more severe form" . SPARSER::FORM)
    ("an angiogenic growth factor" . SPARSER::GROWTH-FACTOR)
    ("epithelium-derived growth factors" . SPARSER::PROTEIN-PAIR)
    ("ACE, ACE2 and Angiotensin II" . SPARSER::COLLECTION)
    ("the homozygous DD risk genotype" . SPARSER::PROTEIN)
    ("heterozygous ID genotype" . SPARSER::PROTEIN)
    ("NPDR and PDR" . SPARSER::COLLECTION)
    ("angiotensinogen" . SPARSER::PROTEIN) ("renin" . SPARSER::PROTEIN)
    ("its sub-clinical types" . TYPE)
    ("DR (OR 1.87 [95%CI = 1.043–3.36], p = 0.00883) and the sub-clinical class NPDR (OR 2.25 [95%CI = 1.098–4.62], p = 0.00584)"
     . SPARSER::COLLECTION)
    ("the sub-clinical class NPDR" . SPARSER::MOLECULE)
    ("the sub-clinical classes" . CLASS)
    ("ACE and PAI-1" . SPARSER::COLLECTION) ("Pima" . SPARSER::DRUG)
    ("plasmin" . SPARSER::PROTEIN)
    ("converting enzyme (ACE)" . SPARSER::PROTEIN)
    ("Angiotensin" . SPARSER::PROTEIN)
    ("moderate and severe nonproliferative DR (NPDR)" . SPARSER::MOLECULE)
    ("PDR" . SPARSER::MOLECULE) ("hyperglycemia" . SPARSER::PROTEIN)
    ("the retinal vasculature" . SPARSER::PROTEIN)
    ("proliferative DR (PDR)" . SPARSER::MOLECULE)
    ("the severe form" . SPARSER::FORM) ("NPDR" . SPARSER::MOLECULE)
    ("its sub-clinical class non-proliferative DR (NPDR)" . SPARSER::MOLECULE)
    ("DR (NPDR)" . SPARSER::MOLECULE) ("PAI" . SPARSER::PROTEIN)
    ("angiotensin converting enzyme ( ACE ) and plasminogen activator inhibitor-1 ( PAI-1 ) gene polymorphisms"
     . SPARSER::COLLECTION)
    ("its sub-clinical classes" . CLASS)
    ("converting enzyme ( ACE )" . SPARSER::PROTEIN) ("ACE" . SPARSER::PROTEIN)
    ("angiotensin" . SPARSER::PROTEIN) ("PPARγ" . SPARSER::PROTEIN)
    ("t-PA" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AT1" . SPARSER::PROTEIN) ("Angiotensin II" . SPARSER::PROTEIN)
    ("ACE2" . SPARSER::PROTEIN) ("Plasminogen Activator" . SPARSER::PROTEIN)
    ("PAI -1" . SPARSER::PROTEIN) ("angiotensin II" . SPARSER::PROTEIN)
    ("PAI - 1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN)
    ("our four nominal HDL-cholesterol" . SPARSER::MOLECULE)
    ("enhancers" . SPARSER::PROTEIN) ("mere" . SPARSER::PROTEIN-FAMILY)
    ("IL-6, TNF-α, or MCP-1" . SPARSER::COLLECTION) ("CRP" . SPARSER::PROTEIN)
    ("PLTP" . SPARSER::PROTEIN) ("LCAT" . SPARSER::PROTEIN)
    ("acyltransferase" . SPARSER::PROTEIN) ("CETP" . SPARSER::PROTEIN)
    ("cigarette" . SPARSER::DRUG) ("Lipids" . SPARSER::LIPID)
    ("apoA1" . SPARSER::PROTEIN) ("apoA" . SPARSER::PROTEIN)
    ("apolipoprotein" . SPARSER::MOLECULE) ("LDL" . SPARSER::PROTEIN)
    ("ezetimibe" . SPARSER::DRUG) ("statins" . SPARSER::DRUG)
    ("adipokine and cytokine" . SPARSER::COLLECTION)
    ("Family" . SPARSER::PROTEIN-FAMILY)
    ("cytokine and adipokine" . SPARSER::COLLECTION)
    ("the only class-I B kinase" . SPARSER::KINASE)
    ("p87 or p101" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases and the GTPase Ras (e.g., PI3Kα)"
     . SPARSER::COLLECTION)
    ("heterotrimeric G-proteins and Rho-family GTPases" . SPARSER::GTPASE)
    ("G-proteins and Rho-family" . SPARSER::COLLECTION)
    ("PIK3CA , PIK3CB , PIK3CG , and PIK3CD" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::PROTEIN) ("Class" . CLASS)
    ("PI3Kγ and HDL" . SPARSER::COLLECTION) ("HDL" . SPARSER::PROTEIN)
    ("hyperinsulinaemic-euglycaemic clamps" . SPARSER::PROTEIN-FAMILY)
    ("clamps" . SPARSER::PROTEIN-FAMILY)
    ("adipokine/cytokine" . SPARSER::COLLECTION)
    ("adipokine" . SPARSER::PROTEIN-FAMILY) ("leukocytes" . SPARSER::PROTEIN)
    ("SRB1" . SPARSER::PROTEIN) ("m²" . SPARSER::MOLECULE)
    ("ribosomal protein S13" . SPARSER::PROTEIN) ("RPS13" . SPARSER::PROTEIN)
    ("SCARB1" . SPARSER::PROTEIN)
    ("lecithin-cholesterol acyltransferase" . SPARSER::PROTEIN)
    ("phospholipid transfer protein" . SPARSER::PROTEIN)
    ("cholesteryl ester transfer protein" . SPARSER::PROTEIN)
    ("PRKAR2B" . SPARSER::PROTEIN) ("C-Peptide" . SPARSER::MOLECULE)
    ("Apolipoprotein A1" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN)
    ("glucose oxidase" . SPARSER::PROTEIN) ("C-peptide" . SPARSER::MOLECULE)
    ("MCP-1" . SPARSER::PROTEIN)
    ("monocyte chemoattractant protein 1" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("IL-6" . SPARSER::PROTEIN) ("interleukin 6" . SPARSER::PROTEIN)
    ("p101" . SPARSER::PROTEIN) ("p87" . SPARSER::PROTEIN)
    ("Akt/protein" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("PI3Kβ" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("PI3Kα" . SPARSER::PROTEIN) ("PIK3CD" . SPARSER::PROTEIN)
    ("PIK3CB" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("PI3Ks" . SPARSER::PROTEIN) ("Phosphoinositide 3" . SPARSER::PROTEIN)
    ("HDL-cholesterol" . SPARSER::MOLECULE) ("PIK3CG" . SPARSER::PROTEIN)
    ("β-cell" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("PI3Kγ" . SPARSER::PROTEIN)
    ("Phosphoinositide 3-kinase" . SPARSER::PROTEIN) ("APE" . SPARSER::PROTEIN)
    ("centromeres" . SPARSER::PROTEIN) ("anchor" . SPARSER::ANCHOR)
    ("Knl1 and Borealin" . SPARSER::COLLECTION)
    ("Mad1, Bub3, Incenp, Cdc20, H2A, and Bub1" . SPARSER::COLLECTION)
    ("Incenp" . SPARSER::PROTEIN)
    ("its physiologically relevant substrates" . SPARSER::SUBSTRATE)
    ("the longer constructs form" . SPARSER::FORM)
    ("significantly more active" . SPARSER::ACTIVE)
    ("Bub1:Bub3/BubR1:Bub3" . SPARSER::BIO-COMPLEX)
    ("Bub3, Knl1, and BubR1" . SPARSER::COLLECTION)
    ("Gly" . SPARSER::AMINO-ACID)
    ("a stoichiometric component" . SPARSER::COMPONENT)
    ("Bub1:Bub3-BubR1:Bub3" . SPARSER::BIO-COMPLEX)
    ("Met-Glu-Leu-Thr (MELT)" . SPARSER::COLLECTION)
    ("Met-Glu-Leu-Thr" . SPARSER::COLLECTION) ("MELT" . SPARSER::DRUG)
    ("Leu" . SPARSER::AMINO-ACID) ("Glu" . SPARSER::AMINO-ACID)
    ("Met" . SPARSER::AMINO-ACID)
    ("Bub1:Bub3 (150 kDa) and BubR1:Bub3 (144 kDa)" . SPARSER::COLLECTION)
    ("a distinctly worse substrate" . SPARSER::SUBSTRATE)
    ("GST-H2A" . SPARSER::COLLECTION) ("kinase (PKA)" . SPARSER::KINASE)
    ("Knl1, and Bub1" . SPARSER::COLLECTION)
    ("Substrates" . SPARSER::SUBSTRATE)
    ("Potential substrates" . SPARSER::SUBSTRATE)
    ("reagent" . SPARSER::MOLECULE) ("SDS" . SPARSER::PROTEIN)
    ("mant-ATPγS" . SPARSER::PROTEIN-PAIR)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("sit" . SPARSER::HUMAN-PROTEIN-FAMILY) ("lobes" . SPARSER::PROTEIN)
    ("a larger C-terminal lobe" . SPARSER::PROTEIN)
    ("the eukaryotic protein kinase family" . SPARSER::PROTEIN-FAMILY)
    ("the previously reported unphosphorylated Bub1 kinase and P-S969-Bub1 kinase"
     . SPARSER::COLLECTION)
    ("the previously reported unphosphorylated Bub1 kinase" . SPARSER::KINASE)
    ("P-S969" . SPARSER::PROTEIN) ("P-S969-Bub1" . SPARSER::COLLECTION)
    ("ADP and a second Mg 2+ ion [ xref ]" . SPARSER::COLLECTION)
    ("CENP-A or H3-nucleosomes" . SPARSER::COLLECTION)
    ("mixing Bub1 kinase" . SPARSER::KINASE)
    ("the dephosphorylated forms of Bub1 kinase and either CENP-A- or H3-containing nucleosomes or free DNA"
     . SPARSER::COLLECTION)
    ("Bub1 kinase and either CENP-A- or H3-containing nucleosomes"
     . SPARSER::COLLECTION)
    ("its centromeric variant CENP-A" . SPARSER::PROTEIN)
    ("H2A or H2A" . SPARSER::COLLECTION)
    ("H2A and Borealin" . SPARSER::COLLECTION)
    ("recombinant histone H2A or the Bor:Sur complex" . SPARSER::COLLECTION)
    ("ADP-Glo" . SPARSER::COLLECTION) ("TM" . SPARSER::PROTEIN)
    ("Glo" . SPARSER::PROTEIN) ("ADP" . SPARSER::PROTEIN)
    ("kinase and Bub1:Bub3" . SPARSER::COLLECTION)
    ("kinase and BubR1:Bub3" . SPARSER::COLLECTION)
    ("BubR1 kinase or the BubR1:Bub3 complex" . SPARSER::COLLECTION)
    ("Borealin:Survivin" . SPARSER::BIO-COMPLEX) ("Sur" . SPARSER::PROTEIN)
    ("Survivin" . SPARSER::PROTEIN) ("Borealin" . SPARSER::PROTEIN)
    ("MBP" . SPARSER::PROTEIN) ("kinase and BubR1" . SPARSER::COLLECTION)
    ("-ATP" . SPARSER::ATP) ("analog" . SPARSER::ANALOG)
    ("asparagine" . SPARSER::AMINO-ACID)
    ("BubR1 and Bub1" . SPARSER::COLLECTION)
    ("kinase and Bub1" . SPARSER::COLLECTION) ("PDB" . SPARSER::MOLECULE)
    ("TPR" . SPARSER::PROTEIN)
    ("Shugoshin and protein phosphatase 2A" . SPARSER::COLLECTION)
    ("Shugoshin" . SPARSER::PROTEIN)
    ("Mad1, Mad2, BubR1, Bub3 and Cdc20" . SPARSER::COLLECTION)
    ("Mad" . SPARSER::PROTEIN)
    ("the mitotic checkpoint complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("complex (MCC)" . SPARSER::BIO-COMPLEX) ("LECA" . SPARSER::PROTEIN)
    ("Knl1" . SPARSER::PROTEIN)
    ("Bub1:Bub3 and BubR1:Bub3" . SPARSER::COLLECTION)
    ("BubR1:Bub3" . SPARSER::BIO-COMPLEX) ("Bub1:Bub3" . SPARSER::BIO-COMPLEX)
    ("Bub1 and BubR1" . SPARSER::COLLECTION) ("paralogs" . SPARSER::PROTEIN)
    ("SAC" . SPARSER::PROTEIN) ("CCP4" . SPARSER::PROTEIN)
    ("KI1" . SPARSER::PROTEIN) ("S . cerevisiae" . SPARSER::PROTEIN)
    ("Kinase activity" . SPARSER::PROTEIN) ("Mps1" . SPARSER::PROTEIN)
    ("A-G" . SPARSER::PROTEIN) ("A-N" . SPARSER::PROTEIN)
    ("ID 1" . SPARSER::PROTEIN) ("cAMP-dependent" . SPARSER::PROTEIN)
    ("ATPγS" . SPARSER::PROTEIN) ("ID 3" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("CENP-A" . SPARSER::PROTEIN)
    ("P-S" . SPARSER::PROTEIN) ("ID 4" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN) ("KLF-4 and JUN-D" . SPARSER::COLLECTION)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and CXCR4" . SPARSER::COLLECTION)
    ("several potential novel targets" . SPARSER::TARGET-PROTEIN)
    ("BCL2 , MYC , CCND1 and CXCR4" . SPARSER::COLLECTION)
    ("Slug and other regulators" . SPARSER::COLLECTION)
    ("Slug" . SPARSER::PROTEIN) ("osteopontin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NPC" . SPARSER::MOLECULE) ("its dominant-negative forms" . SPARSER::FORM)
    ("pro-apoptotic protein" . SPARSER::PROTEIN)
    ("p27 and p21" . SPARSER::COLLECTION)
    ("antiapoptotic protein (Bcl2) and MMP7" . SPARSER::COLLECTION)
    ("cyclins (D1 and E1), antiapoptotic protein (Bcl2) and MMP7"
     . SPARSER::COLLECTION)
    ("MMP7 , ICAM1 , VEGF , MYC, ADM and CXCR4" . SPARSER::COLLECTION)
    ("ADM" . SPARSER::PROTEIN) ("BCL2 and MCL1" . SPARSER::COLLECTION)
    ("cell-cycle-associated genes" . SPARSER::GENE)
    ("CCND1 , CCNE1 and PCNA" . SPARSER::COLLECTION)
    ("CDKN1A/p21" . SPARSER::COLLECTION) ("CDKN1B/p27" . SPARSER::COLLECTION)
    ("subline" . SPARSER::PROTEIN)
    ("BxPC3-MYB and MiaPaCa-NT-Scr" . SPARSER::COLLECTION)
    ("BxPC3-Neo and MiaPaCa-shMYB" . SPARSER::COLLECTION)
    ("BxPC3-Neo, MiaPaCa-shMYB and Panc1-shMYB" . SPARSER::COLLECTION)
    ("BxPC3-MYB, MiaPaCa-NT-Scr and Panc1-NT-Scr" . SPARSER::COLLECTION)
    ("Neo" . SPARSER::PROTEIN) ("transfectants" . SPARSER::PROTEIN)
    ("human acute myelogenous leukemia" . SPARSER::PROTEIN)
    ("MYB/c-MYB" . SPARSER::COLLECTION) ("PCs" . SPARSER::PROTEIN)
    ("respective biomarkers" . SPARSER::MOLECULE)
    ("MYB and other cellular proteins" . SPARSER::COLLECTION)
    ("PC" . SPARSER::PROTEIN) ("MYB" . SPARSER::PROTEIN)
    ("KLF-4" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("actinomycin-D" . SPARSER::MOLECULE) ("pGL4" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("c-MYB" . SPARSER::PROTEIN) ("v- Myb" . SPARSER::PROTEIN)
    ("OTUD3 and TOP2A" . SPARSER::COLLECTION)
    ("PTEN and OTUD3" . SPARSER::COLLECTION)
    ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("potential mediators" . SPARSER::PROTEIN)
    ("both exogenous PTEN and the phosphatase dead PTEN mutant"
     . SPARSER::COLLECTION)
    ("both exogenous PTEN" . SPARSER::PROTEIN)
    ("PTEN or PTEN" . SPARSER::COLLECTION)
    ("the translational inhibitor CHX" . SPARSER::PROTEIN)
    ("TOP2A and PTEN" . SPARSER::COLLECTION) ("Asp" . SPARSER::AMINO-ACID)
    ("PTP" . SPARSER::PROTEIN) ("PTEN/TOP2A" . SPARSER::COLLECTION)
    ("ectopic PTEN ( xref , supplementary Fig. 5c lane 1 vs lane 3) or TOP2A ( xref )"
     . SPARSER::COLLECTION)
    ("Pten or Top2a" . SPARSER::COLLECTION)
    ("exogenous Pten" . SPARSER::PROTEIN)
    ("PTEN or TOP2A" . SPARSER::COLLECTION)
    ("the control group and the PTEN group (Supplementary Form 1)"
     . SPARSER::COLLECTION)
    ("Form" . SPARSER::FORM) ("Pten and p53" . SPARSER::COLLECTION)
    ("Pten/p53" . SPARSER::COLLECTION)
    ("PTEN, or partial" . SPARSER::COLLECTION) ("MEFs" . SPARSER::PROTEIN)
    ("chromatin bound protein" . SPARSER::PROTEIN) ("Top2a" . SPARSER::PROTEIN)
    ("DNase" . SPARSER::PROTEIN) ("PTEN and TOP2A" . SPARSER::COLLECTION)
    ("Pten ΔC" . SPARSER::PROTEIN) ("DLD" . SPARSER::PROTEIN)
    ("Pten  +/+ and Pten  −/− cells" . SPARSER::COLLECTION)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the fraction of Pten  +/+ and Pten  −/− cells" . SPARSER::COLLECTION)
    ("MEF" . SPARSER::PROTEIN)
    ("PTEN  +/+ and PTEN  −/− cells" . SPARSER::COLLECTION)
    ("PICH and CREST" . SPARSER::COLLECTION)
    ("sister centromeric DNA" . SPARSER::DNA) ("1b" . SPARSER::PROTEIN)
    ("Pten" . SPARSER::PROTEIN) ("previously nuclear PTEN" . SPARSER::PROTEIN)
    ("PICH" . SPARSER::PROTEIN) ("centromeric DNA" . SPARSER::DNA)
    ("TOP2A and TOP2B" . SPARSER::COLLECTION) ("bis-" . SPARSER::PROTEIN)
    ("ICRF" . SPARSER::PROTEIN) ("bis" . SPARSER::PROTEIN)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("topoisomerase" . SPARSER::PROTEIN) ("S-protein" . SPARSER::PROTEIN)
    ("DNase I" . SPARSER::PROTEIN) ("S-tag" . SPARSER::PROTEIN)
    ("3d" . SPARSER::PROTEIN-FAMILY) ("MDC1" . SPARSER::PROTEIN)
    ("TOP2B" . SPARSER::PROTEIN) ("ICRF-193" . SPARSER::DRUG)
    ("PIP3" . SPARSER::PIP3) ("protein phosphatase" . SPARSER::PROTEIN)
    ("OTUD3" . SPARSER::PROTEIN) ("TOP2A" . SPARSER::PROTEIN)
    ("TOP2" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::PROTEIN)
    ("cetuximab and lapatinib" . SPARSER::COLLECTION)
    ("lapatinib or trastuzumab" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ECD" . SPARSER::PROTEIN)
    ("KRAS, NRAS, MET, FLT3, EGFR, and MAP2K1" . SPARSER::COLLECTION)
    ("MET" . SPARSER::PROTEIN)
    ("fluoropyrimidine, oxaliplatin, irinotecan, and bevacizumab"
     . SPARSER::COLLECTION)
    ("bevacizumab" . SPARSER::DRUG) ("irinotecan" . SPARSER::DRUG)
    ("oxaliplatin" . SPARSER::DRUG) ("fluoropyrimidine" . SPARSER::DRUG)
    ("histologically confirmed metastatic CRC" . SPARSER::PROTEIN)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("lapatinib" . SPARSER::DRUG) ("KRAS and NRAS" . SPARSER::COLLECTION)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("metastatic CRC" . SPARSER::PROTEIN)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("mCRC" . SPARSER::PROTEIN) ("EFTUD2" . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("NP40" . SPARSER::MOLECULE)
    ("ADAM10" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN) ("Anti-EGFR" . SPARSER::PROTEIN)
    ("the targeted organic cation transporters" . SPARSER::PROTEIN)
    ("OCT1 and OCT2" . SPARSER::COLLECTION)
    ("catecholamines" . SPARSER::MOLECULE)
    ("these organic cation transporters" . SPARSER::PROTEIN)
    ("OCT1, OCT2, MATE1 and MATE2-K" . SPARSER::COLLECTION)
    ("organic anion-transporting polypeptide (OATP) 1B1 ( SLCO1B1 ) and OATP1B3 ( SLCO1B3 )"
     . SPARSER::COLLECTION)
    ("OATP" . SPARSER::PROTEIN) ("Cis" . SPARSER::PROTEIN)
    ("ondansetron" . SPARSER::DRUG)
    ("OCT1, MATE1 and MATE2-K" . SPARSER::COLLECTION)
    ("metformin" . SPARSER::DRUG) ("MATE1 and MATE-2K" . SPARSER::COLLECTION)
    ("MATE1-" . SPARSER::PROTEIN) ("salt" . SPARSER::MOLECULE)
    ("XI" . SPARSER::PROTEIN) ("MATE1 and MATE2-K" . SPARSER::COLLECTION)
    ("max" . SPARSER::PROTEIN) ("EC" . SPARSER::PROTEIN)
    ("HEK-MATE2-K" . SPARSER::COLLECTION) ("HEK-MATE1" . SPARSER::COLLECTION)
    ("HEK-OCT2" . SPARSER::COLLECTION) ("amitriptyline" . SPARSER::DRUG)
    ("organic cation transporters" . SPARSER::PROTEIN)
    ("OCT2, MATE1 and MATE2-K" . SPARSER::COLLECTION)
    ("Av and Vv" . SPARSER::COLLECTION) ("Vi" . SPARSER::PROTEIN)
    ("Av" . SPARSER::MOLECULE) ("van" . SPARSER::PROTEIN)
    ("WHIM" . SPARSER::PROTEIN) ("3D-WHIM" . SPARSER::COLLECTION)
    ("BIM-XI" . SPARSER::COLLECTION) ("BIM-VIII" . SPARSER::COLLECTION)
    ("BIM-VII" . SPARSER::COLLECTION) ("BIM-VI" . SPARSER::PROTEIN-PAIR)
    ("VIII" . SPARSER::PROTEIN) ("VII" . SPARSER::PROTEIN)
    ("analogs" . SPARSER::ANALOG)
    ("Ro 31–8220 or verapamil" . SPARSER::COLLECTION) ("DAPI" . SPARSER::DRUG)
    ("verapamil and other OCT inhibitors" . SPARSER::COLLECTION)
    ("ester" . SPARSER::MOLECULE) ("Staurosporine" . SPARSER::DRUG)
    ("various structurally-divergent pan-PKC inhibitors" . SPARSER::INHIBITOR)
    ("Gö 6983, staurosporine and chelerythrine" . SPARSER::COLLECTION)
    ("Lck" . SPARSER::PROTEIN) ("CaMK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HEK-NTCP" . SPARSER::COLLECTION) ("taurocholate" . SPARSER::MOLECULE)
    ("NTCP" . SPARSER::PROTEIN) ("HEK-OCT1" . SPARSER::COLLECTION)
    ("verapamil" . SPARSER::DRUG) ("HEK" . SPARSER::PROTEIN)
    ("organic cations" . SPARSER::MOLECULE)
    ("the solute carrier (SLC) organic cation transporter (OCT)"
     . SPARSER::PROTEIN)
    ("BCRP" . SPARSER::PROTEIN)
    ("the ABC transporters P-glycoprotein ( ABCB1 ) and multidrug resistance-associated protein (MRP)"
     . SPARSER::COLLECTION)
    ("MRP" . SPARSER::PROTEIN)
    ("phospholipase C and c-Jun" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("CDC2 histone H1 kinase [ xref ] and glycogen synthase kinase-3 [ xref ]"
     . SPARSER::COLLECTION)
    ("the p90 ribosomal S6 kinase [ xref ], p70 ribosomal S6 kinase [ xref , xref ], CDC2 histone H1 kinase [ xref ] and glycogen synthase kinase-3 [ xref ]"
     . SPARSER::COLLECTION)
    ("p70 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("the p90 ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("RSK1, RSK2 and RSK3" . SPARSER::COLLECTION)
    ("β2 and γ PKC isoforms [ xref ]" . SPARSER::COLLECTION)
    ("atypical ι and ζ PKC isoforms" . SPARSER::ISOFORM)
    ("this lipophilic chemical" . SPARSER::MOLECULE)
    ("platelets" . SPARSER::PROTEIN)
    ("OCT1 and other organic cation transporters" . SPARSER::COLLECTION)
    ("protein (MATE)" . SPARSER::PROTEIN)
    ("other organic cation transporters" . SPARSER::PROTEIN)
    ("multidrug and toxin" . SPARSER::COLLECTION)
    ("multidrug" . SPARSER::PROTEIN) ("transporters" . SPARSER::PROTEIN)
    ("staurosporine and chelerythrine" . SPARSER::COLLECTION)
    ("tetraethylammonium" . SPARSER::MOLECULE)
    ("chelerythrine" . SPARSER::DRUG)
    ("the solute carrier organic cation transporter (OCT)" . SPARSER::PROTEIN)
    ("transporter (OCT)" . SPARSER::PROTEIN) ("OCT" . SPARSER::PROTEIN)
    ("cation" . SPARSER::MOLECULE) ("transporter" . SPARSER::PROTEIN)
    ("BIMs" . SPARSER::PROTEIN) ("SLCO1B3" . SPARSER::PROTEIN)
    ("OATP1B3" . SPARSER::PROTEIN) ("SLCO1B1" . SPARSER::PROTEIN)
    ("1B1" . SPARSER::PROTEIN)
    ("organic anion-transporting polypeptide" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("MRP2" . SPARSER::PROTEIN)
    ("Oct1" . SPARSER::PROTEIN) ("Ro 31–8425" . SPARSER::DRUG)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP2" . SPARSER::DRUG) ("Src kinase" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("a 3D" . SPARSER::PROTEIN) ("Ro 31-8220" . SPARSER::DRUG)
    ("D-glucose" . SPARSER::MOLECULE) ("MgSO 4" . SPARSER::DRUG)
    ("hOCT2" . SPARSER::PROTEIN) ("hOCT1" . SPARSER::PROTEIN)
    ("SLC10A1" . SPARSER::PROTEIN) ("MATE1" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("KN62" . SPARSER::DRUG) ("Gö 6983" . SPARSER::DRUG)
    ("cyclosporin A" . SPARSER::MOLECULE)
    ("transporter activity" . SPARSER::PROTEIN) ("SLC22A2" . SPARSER::PROTEIN)
    ("SLC47A2" . SPARSER::PROTEIN) ("SLC47A1" . SPARSER::PROTEIN)
    ("SLC22A1" . SPARSER::PROTEIN) ("ABCG2" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN)
    ("multidrug resistance-associated protein" . SPARSER::PROTEIN)
    ("ABCB1" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("GF 109203X" . SPARSER::DRUG) ("voltage-dependent" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("CDC2" . SPARSER::PROTEIN) ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("p90" . SPARSER::PROTEIN) ("RSK3" . SPARSER::PROTEIN)
    ("RSK2" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("phosphatase-1" . SPARSER::PROTEIN) ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("OCT2" . SPARSER::PROTEIN) ("MATE2-K" . SPARSER::PROTEIN)
    ("LY 333531" . SPARSER::DRUG) ("OCT1" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("ATP-binding cassette" . SPARSER::PROTEIN) ("Ro 31–8220" . SPARSER::DRUG)
    ("nanoparticles, liposomes, micelles, and phospholipid"
     . SPARSER::COLLECTION)
    ("phospholipid" . SPARSER::PHOSPHOLIPID) ("liposomes" . SPARSER::PROTEIN)
    ("nanoparticles" . SPARSER::MOLECULE) ("p38 and ERK" . SPARSER::COLLECTION)
    ("AdipoR1 and AdipoR2" . SPARSER::COLLECTION)
    ("AdipoR2" . SPARSER::PROTEIN) ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prostatic" . SPARSER::PROTEIN) ("TN" . SPARSER::PROTEIN)
    ("circulatory adiponectin" . SPARSER::PROTEIN)
    ("adipocytokines" . SPARSER::PROTEIN-FAMILY)
    ("MMP-9, NF-κB, and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("antimetastatic proteins" . SPARSER::PROTEIN)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("herbal medicine" . SPARSER::DRUG) ("medicine" . SPARSER::DRUG)
    ("group (DMSO)" . SPARSER::MOLECULE) ("DMSO" . SPARSER::MOLECULE)
    ("adiponectin and MMPs" . SPARSER::COLLECTION)
    ("monomer and dimer" . SPARSER::COLLECTION)
    ("monomer, dimer, and multimer" . SPARSER::COLLECTION)
    ("p38–MAPK" . SPARSER::COLLECTION)
    ("adiponectin receptor 1 and receptor" . SPARSER::COLLECTION)
    ("adiponectin, adiponectin receptor 1, and adiponectin receptor 2"
     . SPARSER::COLLECTION)
    ("siRNA, and adiponectin receptor 2" . SPARSER::COLLECTION)
    ("Matrigel" . SPARSER::PROTEIN)
    ("curcumin and adiponectin" . SPARSER::COLLECTION)
    ("adiponectin receptor 1 and adiponectin receptor 2" . SPARSER::COLLECTION)
    ("MTT" . SPARSER::MOLECULE)
    ("adiponectin and adiponectin" . SPARSER::COLLECTION)
    ("Cytotoxic" . SPARSER::PROTEIN)
    ("adiponectin and adiponectin receptor 1" . SPARSER::COLLECTION)
    ("receptors, and MMPs" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor, AMPK, p38, and NF-κB" . SPARSER::COLLECTION)
    ("ROCK/IP10/matrix metalloproteinase" . SPARSER::COLLECTION)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("polypeptide" . SPARSER::PROTEIN)
    ("adiponectin and leptin" . SPARSER::COLLECTION)
    ("leptin" . SPARSER::PROTEIN) ("adipokines" . SPARSER::PROTEIN-FAMILY)
    ("NF-κB/MMP" . SPARSER::COLLECTION)
    ("adiponectin and curcumin" . SPARSER::COLLECTION)
    ("adiponectin" . SPARSER::PROTEIN)
    ("the principal curcuminoid" . SPARSER::DRUG)
    ("curcuminoid" . SPARSER::DRUG) ("diferuloylmethane" . SPARSER::DRUG)
    ("Curcumin" . SPARSER::DRUG) ("Adiponectin" . SPARSER::PROTEIN)
    ("endocrine" . SPARSER::PROTEIN) ("pP38" . SPARSER::PROTEIN)
    ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p50" . SPARSER::PROTEIN)
    ("AdipoR1" . SPARSER::PROTEIN) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("MMP-9" . SPARSER::PROTEIN) ("F-10" . SPARSER::PROTEIN)
    ("MMP-1" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("SB203580" . SPARSER::DRUG)
    ("PD98059" . SPARSER::MOLECULE)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adiponectin receptor 2" . SPARSER::PROTEIN) ("Rac-1" . SPARSER::PROTEIN)
    ("beta1" . SPARSER::PROTEIN) ("IP10" . SPARSER::PROTEIN)
    ("adiponectin receptor 1" . SPARSER::PROTEIN)
    ("both cellular and viral TFII-I" . SPARSER::PROTEIN)
    ("the multifunctional transcription factor TFII-I" . SPARSER::PROTEIN)
    ("viral TFII-I" . SPARSER::PROTEIN) ("cellular TFII-I" . SPARSER::PROTEIN)
    ("a cytomegaloviral protein" . SPARSER::PROTEIN)
    ("MdmX" . SPARSER::PROTEIN) ("GFP-Sp1" . SPARSER::COLLECTION)
    ("YY1, E2F1, TAFII250 or Sp1" . SPARSER::COLLECTION)
    ("p53 and TFII-I" . SPARSER::COLLECTION)
    ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("TAFII250, YY1, KAP1, E2F1, and HIF1α" . SPARSER::COLLECTION)
    ("the Williams-Beuren syndrome–associated transcription factor TFII-I"
     . SPARSER::PROTEIN)
    ("receptor, ETS and SRE" . SPARSER::COLLECTION)
    ("CREB/ATF" . SPARSER::COLLECTION) ("NF-κB/rel" . SPARSER::COLLECTION)
    ("SRE" . SPARSER::PROTEIN) ("ETS" . SPARSER::PROTEIN)
    ("rel" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("Mdm2-Sp1" . SPARSER::COLLECTION) ("TFII-I and Sp1" . SPARSER::COLLECTION)
    ("mixtures" . SPARSER::MOLECULE) ("TFII-I or Mdm2" . SPARSER::COLLECTION)
    ("viral promoters" . SPARSER::PROMOTER)
    ("GST-TFII-I" . SPARSER::COLLECTION)
    ("siRNAs or siRNAs" . SPARSER::COLLECTION)
    ("exogenous TFII-I" . SPARSER::PROTEIN)
    ("the full-length CMV promoter or its shorter deletion mutants [ xref ]"
     . SPARSER::COLLECTION)
    ("its shorter deletion mutants" . SPARSER::MUTANT)
    ("bacterial β-galactosidase" . SPARSER::PROTEIN)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("LacZ" . SPARSER::PROTEIN) ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteasomes" . SPARSER::PROTEIN)
    ("GST and a GST-tagged TFII-I mutant" . SPARSER::COLLECTION)
    ("exogenous Mdm2" . SPARSER::PROTEIN)
    ("anti-Mdm2 and anti-TFII-I" . SPARSER::COLLECTION)
    ("TFII-I and Mdm2" . SPARSER::COLLECTION)
    ("p53, TAFII250, YY1, KAP1, E2F1, and HIF1α" . SPARSER::COLLECTION)
    ("Mdm2 and TFII-I" . SPARSER::COLLECTION)
    ("the frequently used immediate-early promoter" . SPARSER::PROMOTER)
    ("GTF2i" . SPARSER::PROTEIN)
    ("p53 and a critical negative regulator" . SPARSER::COLLECTION)
    ("hypoxia or DNA" . SPARSER::COLLECTION)
    ("tumor suppressors ATM (ataxia telangiectasia mutated) and p53 [ xref ]"
     . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the epidermal growth factor (EGF) and the platelet-derived growth factor (PDGF) [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("c-fos and cyclin D1" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("repressor" . SPARSER::REPRESSOR) ("polycomb" . SPARSER::PROTEIN)
    ("repressors" . SPARSER::REPRESSOR)
    ("a classical HLH protein" . SPARSER::PROTEIN)
    ("protein and E-box" . SPARSER::COLLECTION) ("USF" . SPARSER::PROTEIN)
    ("craniofacial malformations" . SPARSER::PROTEIN)
    ("Gtf2ird1 or Gtf2i" . SPARSER::COLLECTION) ("Gtf2i" . SPARSER::PROTEIN)
    ("Gtf2ird1" . SPARSER::PROTEIN)
    ("GTF2I , GTF2IRD1 and GTF2IRD2" . SPARSER::COLLECTION)
    ("the immediate-early promoter" . SPARSER::PROMOTER)
    ("TFII-I and a negative regulator" . SPARSER::COLLECTION)
    ("Williams-Beuren syndrome-associated transcription factor TFII-I"
     . SPARSER::PROTEIN)
    ("mitogens" . SPARSER::MITOGEN) ("type 5" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("pp71" . SPARSER::PROTEIN)
    ("p14" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("KAP1" . SPARSER::PROTEIN) ("TAFII250" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("α Tubulin" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("CO 3" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("U3" . SPARSER::PROTEIN)
    ("USP48" . SPARSER::PROTEIN) ("1A" . SPARSER::PROTEIN)
    ("elongation factor" . SPARSER::PROTEIN) ("c- fos" . SPARSER::PROTEIN)
    ("Mdm4" . SPARSER::PROTEIN) ("double minute 2" . SPARSER::PROTEIN)
    ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-fos" . SPARSER::PROTEIN) ("HDAC3" . SPARSER::PROTEIN)
    ("GTF2IRD1" . SPARSER::PROTEIN) ("GTF2I" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("TFII-I" . SPARSER::PROTEIN)
    ("Williams-Beuren syndrome" . SPARSER::PROTEIN)
    ("an equimolar mixture" . SPARSER::MOLECULE) ("LNA" . SPARSER::PROTEIN)
    ("complete melting" . SPARSER::DRUG) ("melt" . SPARSER::DRUG)
    ("nucleotides (AAGA)" . SPARSER::NUCLEOTIDE)
    ("the dimeric form" . SPARSER::FORM) ("a monomeric form" . SPARSER::FORM)
    ("KCl" . SPARSER::MOLECULE)
    ("at least three guanines" . SPARSER::NUCLEOBASE) ("melts" . SPARSER::DRUG)
    ("Melting" . SPARSER::DRUG)
    ("the mutated oligonucleotides" . SPARSER::MOLECULE)
    ("thymines" . SPARSER::MOLECULE) ("TGT" . SPARSER::PROTEIN)
    ("G1:G10:G1:G10" . SPARSER::COLLECTION)
    ("both hydrogen-bond acceptor and donor" . SPARSER::COLLECTION)
    ("acceptor" . SPARSER::MOLECULE) ("Imino" . SPARSER::MOLECULE)
    ("syn" . SPARSER::PROTEIN) ("monomeric form" . SPARSER::FORM)
    ("a shorter oligonucleotide" . SPARSER::MOLECULE)
    ("mixture" . SPARSER::MOLECULE)
    ("G1-G10 and G22-C30" . SPARSER::COLLECTION)
    ("guanines" . SPARSER::NUCLEOBASE) ("Oligonucleotides" . SPARSER::MOLECULE)
    ("sharp" . SPARSER::PROTEIN) ("chemical" . SPARSER::MOLECULE)
    ("imino" . SPARSER::MOLECULE) ("An aqueous K + ion" . SPARSER::MOLECULE)
    ("AG" . SPARSER::PROTEIN) ("GGC" . SPARSER::PROTEIN)
    ("AGA" . SPARSER::PROTEIN) ("GGA" . SPARSER::MOLECULE)
    ("GAG" . SPARSER::PROTEIN) ("GAA" . SPARSER::PROTEIN)
    ("GCG" . SPARSER::PROTEIN)
    ("Myc-associated zinc finger protein (MAZ)" . SPARSER::PROTEIN)
    ("GGG" . SPARSER::MOLECULE)
    ("usually planar aromatic molecules" . SPARSER::MOLECULE)
    ("Continuous or interrupted guanine" . SPARSER::PROTEIN)
    ("propeller" . SPARSER::PROTEIN-FAMILY) ("runs" . SPARSER::PROTEIN-FAMILY)
    ("HRAS, KRAS and NRAS" . SPARSER::COLLECTION) ("NRAS" . SPARSER::PROTEIN)
    ("complemented" . SPARSER::PROTEIN)
    ("a crucial transcription factor" . SPARSER::PROTEIN)
    ("MAZ" . SPARSER::PROTEIN) ("NHE" . SPARSER::PROTEIN)
    ("A11" . SPARSER::PROTEIN) ("G10" . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN)
    ("Myc-associated zinc finger protein" . SPARSER::PROTEIN)
    ("ras family" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTEIN)
    ("BCL2 and Mcl-1" . SPARSER::COLLECTION)
    ("A variant genotype (A allele) or BAX -248G" . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG) ("2–4 adverse alleles" . SPARSER::ALLELE)
    ("0–1 adverse alleles" . SPARSER::ALLELE)
    ("2 adverse alleles" . SPARSER::ALLELE)
    ("adverse allele" . SPARSER::ALLELE) ("adverse alleles" . SPARSER::ALLELE)
    ("genotypes" . SPARSER::PROTEIN)
    ("AA or CA+AA genotype" . SPARSER::COLLECTION)
    ("AA or GA+AA genotype" . SPARSER::COLLECTION) ("CR" . SPARSER::PROTEIN)
    ("Genotypes" . SPARSER::PROTEIN)
    ("cisplatin or pemetrexed" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG) ("vinorelbine" . SPARSER::DRUG)
    ("docetaxel" . SPARSER::DRUG) ("Taxol" . SPARSER::DRUG)
    ("TP" . SPARSER::PROTEIN) ("BCL2-" . SPARSER::PROTEIN)
    ("CG" . SPARSER::PROTEIN)
    ("1 and 91 (38.7%) never smoked tobacco and 76 (32.3%) patients"
     . SPARSER::COLLECTION)
    ("PS " . SPARSER::PROTEIN) ("PS" . SPARSER::PROTEIN)
    ("38 (16.2%) stage IIIB and 154 (65.5%) stage IV disease"
     . SPARSER::COLLECTION)
    ("IIIB" . SPARSER::DRUG) ("BCL2 and BAX" . SPARSER::COLLECTION)
    ("Bcl-2 and/or BAX" . SPARSER::COLLECTION)
    ("the pro-apoptotic B-cell lymphoma 2-associated X protein ( BAX )"
     . SPARSER::PROTEIN)
    ("protein ( BAX )" . SPARSER::PROTEIN) ("Platinum" . SPARSER::MOLECULE)
    ("alleles" . SPARSER::ALLELE) ("Mcl-1" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("OR 2" . SPARSER::MOLECULE) ("HR 2" . SPARSER::PROTEIN)
    ("HR 1" . SPARSER::PROTEIN-FAMILY) ("OR 1" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("cyclosome" . SPARSER::PROTEIN)
    ("CDK1 or a non-kinase" . SPARSER::COLLECTION)
    ("mitotic kinases" . SPARSER::KINASE) ("ajuba" . SPARSER::PROTEIN)
    ("dimer" . SPARSER::DIMER) ("which deposits NuMA" . SPARSER::PROTEIN)
    ("p34/cdc2" . SPARSER::COLLECTION) ("Kif2c/MCAK" . SPARSER::COLLECTION)
    ("Kif2a" . SPARSER::PROTEIN) ("MCAK" . SPARSER::PROTEIN)
    ("Kinases" . SPARSER::PROTEIN) ("NuMA and dynein" . SPARSER::COLLECTION)
    ("Kif2b or Dynein" . SPARSER::COLLECTION) ("Dynein" . SPARSER::PROTEIN)
    ("mutant CEP170 ( xref , upper panel) or NuMA ( xref , lower panel)"
     . SPARSER::COLLECTION)
    ("CEP170 or NuMA" . SPARSER::COLLECTION)
    ("alanine and threonine" . SPARSER::COLLECTION)
    ("valine" . SPARSER::AMINO-ACID) ("penetratin" . SPARSER::DRUG)
    ("PLK1-GST" . SPARSER::COLLECTION)
    ("PLK1, or CEP170" . SPARSER::COLLECTION) ("Histone" . SPARSER::PROTEIN)
    ("a 13 amino-acid peptide" . SPARSER::PEPTIDE)
    ("CEP170 and Kif2b" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kinesins and dyneins" . SPARSER::COLLECTION)
    ("dyneins" . SPARSER::PROTEIN) ("kinesins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBK1 or a non-targeting control shRNA" . SPARSER::COLLECTION)
    ("nocodazole" . SPARSER::DRUG)
    ("anti-phosphoSerine or anti-phosphoThreonine antibody and subsequent western blot"
     . SPARSER::COLLECTION)
    ("subsequent western blot" . SPARSER::PROTEIN)
    ("phospho-CEP170 and phospho-NuMA" . SPARSER::COLLECTION)
    ("phosphoThreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phosphoSerine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("GST-NuMA" . SPARSER::COLLECTION) ("sepharose" . SPARSER::MOLECULE)
    ("only one antibody or a normal IgG ( xref )" . SPARSER::COLLECTION)
    ("a normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only one antibody" . SPARSER::ANTIBODY)
    ("TBK1 and CEP170" . SPARSER::COLLECTION)
    ("TBK1 and NuMA" . SPARSER::COLLECTION)
    ("distinct foci" . SPARSER::PROTEIN) ("circular DNA" . SPARSER::DNA)
    ("secondary antibodies" . SPARSER::ANTIBODY)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein–protein" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("the minus-end-directed molecular motor protein dynein"
     . SPARSER::PROTEIN)
    ("phosphoprotein" . SPARSER::PROTEIN)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("HU and BX795" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("2 mM hydroxyurea (HU) or TBK1 inhibitor BX795" . SPARSER::COLLECTION)
    ("hydroxyurea (HU)" . SPARSER::DRUG) ("hydroxyurea" . SPARSER::DRUG)
    ("supernumerary centrosomes" . SPARSER::PROTEIN)
    ("GFP-tagged alpha tubulin and mCherry-tagged histone H2B"
     . SPARSER::COLLECTION)
    ("a mitotic state" . SPARSER::BIO-STATE)
    ("BX795 or MRT67307" . SPARSER::COLLECTION)
    ("Supernumerary centrosomes" . SPARSER::PROTEIN)
    ("TBK1 and TBK1" . SPARSER::COLLECTION)
    ("a well-established mitotic kinase" . SPARSER::KINASE)
    ("a lentiviral small-hairpin RNA" . SPARSER::RNA)
    ("fractions" . SPARSER::COMPONENT)
    ("centrosomal fraction" . SPARSER::COMPONENT)
    ("γ-tubulin, phospho-PLK1, PLK1 and CEP170" . SPARSER::COLLECTION)
    ("Fraction" . SPARSER::COMPONENT) ("sucrose" . SPARSER::MOLECULE)
    ("mitotic kinase PLK1" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("tracheobronchial" . SPARSER::PROTEIN) ("pS" . SPARSER::PROTEIN)
    ("the mitotic kinase PLK1" . SPARSER::PROTEIN)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Rel and BCL-XL" . SPARSER::COLLECTION) ("Sec5" . SPARSER::PROTEIN)
    ("exocyst" . SPARSER::BIO-COMPLEX) ("RalB" . SPARSER::PROTEIN)
    ("TLR and RIG1" . SPARSER::COLLECTION)
    ("IRF3 and IRF7" . SPARSER::COLLECTION)
    ("genes and interferons" . SPARSER::COLLECTION)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("Serine" . SPARSER::AMINO-ACID)
    ("IKK" . SPARSER::PROTEIN)
    ("the centrosomal protein CEP170 and the mitotic apparatus protein NuMa"
     . SPARSER::COLLECTION)
    ("the mitotic apparatus protein NuMa" . SPARSER::PROTEIN)
    ("NuMa" . SPARSER::PROTEIN) ("TBK1–CEP170" . SPARSER::COLLECTION)
    ("dynein" . SPARSER::PROTEIN)
    ("the mitotic apparatus protein NuMA" . SPARSER::PROTEIN)
    ("the centrosomal protein CEP170" . SPARSER::PROTEIN)
    ("CEP170 and NuMA" . SPARSER::COLLECTION) ("NuMA" . SPARSER::PROTEIN)
    ("cytochalasin D" . SPARSER::DRUG) ("Alpha Tubulin" . SPARSER::PROTEIN)
    ("MRm3" . SPARSER::PROTEIN) ("H2B" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("min −1" . SPARSER::PROTEIN)
    ("MnCl 2" . SPARSER::DRUG) ("SP5" . SPARSER::PROTEIN)
    ("γ Tubulin" . SPARSER::PROTEIN) ("Alpha tubulin" . SPARSER::PROTEIN)
    ("Monoclonal antibody" . SPARSER::DRUG) ("g protein" . SPARSER::PROTEIN)
    ("Nonidet P-40" . SPARSER::DRUG) ("PLK-1" . SPARSER::PROTEIN)
    ("IKKβ" . SPARSER::PROTEIN) ("cdc2" . SPARSER::PROTEIN)
    ("p34" . SPARSER::PROTEIN) ("Kif2c" . SPARSER::PROTEIN)
    ("NEK2" . SPARSER::PROTEIN) ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MRT67307" . SPARSER::DRUG) ("BX795" . SPARSER::DRUG)
    ("S10" . SPARSER::PROTEIN) ("pH3" . SPARSER::MOLECULE)
    ("alpha tubulin" . SPARSER::PROTEIN)
    ("microtubule-associated protein" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("BCL-XL" . SPARSER::PROTEIN)
    ("c-Rel" . SPARSER::PROTEIN) ("K-Ras" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("RIG1" . SPARSER::PROTEIN) ("TANK binding kinase 1" . SPARSER::PROTEIN)
    ("Kif2b" . SPARSER::PROTEIN) ("CEP170" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("TANK Binding Kinase 1" . SPARSER::PROTEIN)
    ("SIRT1 and AMD" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("resveratrol" . SPARSER::PROTEIN) ("ELN" . SPARSER::PROTEIN)
    ("ARMS" . SPARSER::PROTEIN) ("CFH" . SPARSER::PROTEIN)
    ("complement" . SPARSER::PROTEIN)
    ("both neovascular AMD and atrophy AMD group ( P  = 0.030 and P  = 0.007, respectively)"
     . SPARSER::COLLECTION)
    ("both neovascular AMD" . SPARSER::PROTEIN)
    ("gene, and rs4746720" . SPARSER::COLLECTION)
    ("SIRT" . SPARSER::PROTEIN-FAMILY) ("atrophic AMD" . SPARSER::PROTEIN)
    ("neovascular AMD" . SPARSER::PROTEIN)
    ("gene and rs4746720" . SPARSER::COLLECTION)
    ("SIRT1–SIRT7" . SPARSER::COLLECTION) ("RPE" . SPARSER::PROTEIN)
    ("Lys" . SPARSER::AMINO-ACID) ("retinas" . SPARSER::DRUG)
    ("sirtuins (SIRT)" . SPARSER::PROTEIN-FAMILY)
    ("deacetylases" . SPARSER::PROTEIN) ("NAD" . SPARSER::MOLECULE)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("proteins and lipids" . SPARSER::COLLECTION) ("CNV" . SPARSER::VARIANT)
    ("AMD" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("SKIV2L" . SPARSER::PROTEIN) ("Exonuclease I" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("Mg 2+" . SPARSER::MOLECULE) ("SIRT7" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN) ("PC1/ENPP1" . SPARSER::COLLECTION)
    ("PC1" . SPARSER::PROTEIN) ("DDR1 and IR" . SPARSER::COLLECTION)
    ("DDR1 and other components" . SPARSER::COLLECTION)
    ("AKT, IGF-BP2, IGF-BP5 and IR" . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("IGF-IR/AKT" . SPARSER::COLLECTION)
    ("IGF-I and hypoxia" . SPARSER::COLLECTION) ("ILK" . SPARSER::PROTEIN)
    ("integrin" . SPARSER::PROTEIN)
    ("DDR1 and miR-199a-5p" . SPARSER::COLLECTION)
    ("myr-AKT or IGF-II" . SPARSER::COLLECTION) ("-UTR" . SPARSER::COLLECTION)
    ("MiRNAs" . SPARSER::PROTEIN)
    ("the ERK1/2 and the mTOR/p70S6K" . SPARSER::COLLECTION)
    ("DDR1–IGF-IR" . SPARSER::COLLECTION)
    ("miR-199a-5p and DDR1" . SPARSER::COLLECTION)
    ("DDR1 and IGF-I or IGF-II" . SPARSER::COLLECTION)
    ("IGF-I or IGF-II" . SPARSER::COLLECTION)
    ("IGF-IR and IGFBP2" . SPARSER::COLLECTION)
    ("AKT, INSR or IGFBP5" . SPARSER::COLLECTION)
    ("DDR1 and INSR" . SPARSER::COLLECTION)
    ("IGF-IR, IGFBP2, IGFBP5 and AKT" . SPARSER::COLLECTION)
    ("the homologous receptors insulin receptor" . SPARSER::PROTEIN)
    ("INSR or IR" . SPARSER::COLLECTION) ("INSR" . SPARSER::PROTEIN)
    ("IGFs and AKT" . SPARSER::COLLECTION) ("biologic" . SPARSER::DRUG)
    ("myr-AKT or autocrine IGF-II" . SPARSER::COLLECTION)
    ("either myr-AKT or autocrine IGF-II" . SPARSER::COLLECTION)
    ("AKT and ERK1/2" . SPARSER::COLLECTION)
    ("IGF-IR and AKT" . SPARSER::COLLECTION)
    ("IGF-I and/or IGF-II [ xref ]" . SPARSER::COLLECTION)
    ("autocrine IGF-II" . SPARSER::PROTEIN) ("CAFs" . SPARSER::PROTEIN)
    ("DDR1 protein (Figure xref ) and DDR1 mRNA (Figure xref )"
     . SPARSER::COLLECTION)
    ("an active form of AKT (myr-AKT) or a control empty vector"
     . SPARSER::COLLECTION)
    ("myr" . SPARSER::MOLECULE) ("UTR" . SPARSER::PROTEIN)
    ("UTR–luciferase" . SPARSER::PROTEIN-PAIR)
    ("MEK1 and mTOR" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION)
    ("DDR1 protein (Figure xref ) and mRNA (Figure xref )"
     . SPARSER::COLLECTION)
    ("a regulatory miR" . SPARSER::PROTEIN)
    ("myristoylated" . SPARSER::PROTEIN) ("Kinase" . SPARSER::KINASE)
    ("DDR1 and the insulin receptor [ xref ]" . SPARSER::COLLECTION)
    ("translational elongation" . SPARSER::PROTEIN)
    ("DDR1 and IGF-IR" . SPARSER::COLLECTION)
    ("IGF-IR and DDR1" . SPARSER::COLLECTION) ("PTB" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("DDRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DDR1 and DDR2" . SPARSER::COLLECTION)
    ("IGF-IR and IR-A" . SPARSER::COLLECTION)
    ("IGF-I and IGF-II" . SPARSER::COLLECTION)
    ("the type I IGF-I receptor (IGF-IR) and the homolog insulin receptor (IR)"
     . SPARSER::COLLECTION)
    ("insulin receptor (IR)" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("IGF" . SPARSER::PROTEIN) ("IGFs" . SPARSER::PROTEIN)
    ("p70/mTOR" . SPARSER::COLLECTION) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("DDR1-IGF-IR" . SPARSER::COLLECTION) ("IGFBP4" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("anti-ERK" . SPARSER::PROTEIN) ("C-20" . SPARSER::PROTEIN)
    ("Actinomycin D" . SPARSER::MOLECULE) ("AKT 1" . SPARSER::PROTEIN)
    ("LY 294002" . SPARSER::MOLECULE) ("PI3 kinase" . SPARSER::PROTEIN)
    ("NVP-AEW541" . SPARSER::DRUG) ("ENPP1" . SPARSER::PROTEIN)
    ("IGF-BP5" . SPARSER::PROTEIN) ("IGF-BP2" . SPARSER::PROTEIN)
    ("IGFBP1" . SPARSER::PROTEIN) ("IGFBP5" . SPARSER::PROTEIN)
    ("IGFBP2" . SPARSER::PROTEIN) ("TORC1" . SPARSER::PROTEIN)
    ("MiR-199a-5p" . SPARSER::MOLECULE) ("IGF-1" . SPARSER::PROTEIN)
    ("PKC ζ" . SPARSER::PROTEIN) ("inhibitor1" . SPARSER::PROTEIN)
    ("LY-294002" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src-homology" . SPARSER::PROTEIN) ("DDR2" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("IGF-I receptor" . SPARSER::PROTEIN) ("IGF-II" . SPARSER::PROTEIN)
    ("miR-199a-5p" . SPARSER::MOLECULE) ("p70" . SPARSER::PROTEIN)
    ("IGF-I" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN) ("collagen receptor" . SPARSER::PROTEIN)
    ("DDR1" . SPARSER::PROTEIN)
    ("Discoidin Domain Receptor 1" . SPARSER::PROTEIN)
    ("HLA" . SPARSER::PROTEIN) ("MHC" . SPARSER::PROTEIN)
    ("viral proteins" . SPARSER::PROTEIN)
    ("These included 5 TP53 mutant MCPyV-negative MCCs and 13 TP53 wild-type MCCs (2 MCPyV-negative MCCs and 11 MCPyV-positive MCCs)"
     . SPARSER::COLLECTION)
    ("FDA" . SPARSER::PROTEIN) ("SAHA" . SPARSER::DRUG)
    ("HDAC" . SPARSER::PROTEIN)
    ("HDAC6 inhibitors and HSP90 inhibitors target mutant p53"
     . SPARSER::COLLECTION)
    ("Hsp70/Hsp90" . SPARSER::COLLECTION) ("GOF" . SPARSER::PROTEIN)
    ("TP53 and RB1" . SPARSER::COLLECTION)
    ("MCPyV small and large T antigens" . SPARSER::MOLECULE)
    ("ligases" . SPARSER::LIGASE) ("survivin" . SPARSER::PROTEIN)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("a previous cohort" . SPARSER::MOLECULE)
    ("TP53 and no SSNVs or SCNVs" . SPARSER::COLLECTION)
    ("UV light" . SPARSER::PROTEIN) ("UV" . SPARSER::PROTEIN)
    ("ultraviolet light (UV)" . SPARSER::PROTEIN)
    ("mismatch" . SPARSER::PROTEIN) ("MCCs and MCC-His" . SPARSER::COLLECTION)
    ("His" . SPARSER::AMINO-ACID) ("a smaller cohort" . SPARSER::MOLECULE)
    ("viral DNA" . SPARSER::DNA) ("HIs" . SPARSER::AMINO-ACID)
    ("MCC-LOs" . SPARSER::COLLECTION) ("LOs" . SPARSER::PROTEIN)
    ("MCC-LO and MCC-HI" . SPARSER::COLLECTION)
    ("MCC-LO" . SPARSER::PROTEIN-PAIR)
    ("Somatic single nucleotide variants (SSNVs) and somatic copy number variants (SCNVs)"
     . SPARSER::COLLECTION)
    ("gold" . SPARSER::MOLECULE) ("PIK3CA and AKT1" . SPARSER::COLLECTION)
    ("the small and large T antigens" . SPARSER::MOLECULE)
    ("two viral oncogenes" . SPARSER::ONCOGENE)
    ("HRAS, KRAS, PIK3CA, PTEN , and TSC1" . SPARSER::COLLECTION)
    ("Notch1 and Notch2" . SPARSER::COLLECTION) ("HRAS" . SPARSER::PROTEIN)
    ("RB1 and TP53" . SPARSER::COLLECTION)
    ("ASXL1, MLL2 , and MLL3" . SPARSER::COLLECTION)
    ("MAP3K1 and TRAF7" . SPARSER::COLLECTION)
    ("ATM, MSH2 , and BRCA1" . SPARSER::COLLECTION)
    ("DNA-damage" . SPARSER::DNA) ("MCCs" . SPARSER::PROTEIN)
    ("MCC" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("thyroid peroxidase" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN) ("E-4" . SPARSER::PROTEIN)
    ("Hsp70" . SPARSER::PROTEIN) ("PI-3-K" . SPARSER::PROTEIN)
    ("small T antigen" . SPARSER::PROTEIN) ("PRUNE2" . SPARSER::PROTEIN)
    ("PI-3-kinase" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("E-5" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("T antigens" . SPARSER::MOLECULE)
    ("Notch2" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("TRAF7" . SPARSER::PROTEIN)
    ("MAP3K1" . SPARSER::PROTEIN) ("MLL3" . SPARSER::PROTEIN)
    ("MLL2" . SPARSER::PROTEIN) ("ASXL1" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("RB1" . SPARSER::PROTEIN)
    ("Medicine" . SPARSER::DRUG)
    ("pharmacologically inhibiting residual enzyme" . SPARSER::ENZYME)
    ("CAMP" . SPARSER::PROTEIN) ("dietary vitamin D3" . SPARSER::MOLECULE)
    ("catabolism" . SPARSER::PROTEIN) ("CTA091, or 25D3" . SPARSER::COLLECTION)
    ("CTA" . SPARSER::PROTEIN) ("Ketoconazole" . SPARSER::DRUG)
    ("at least one allele" . SPARSER::ALLELE) ("Cel" . SPARSER::PROTEIN)
    ("calcium" . SPARSER::CALCIUM) ("pg" . SPARSER::MOLECULE)
    ("Dietary vitamin D3" . SPARSER::MOLECULE)
    ("VDR and CYP24A1" . SPARSER::COLLECTION) ("Exon" . SPARSER::PROTEIN)
    ("mos" . SPARSER::PROTEIN) ("Ligand" . SPARSER::LIGAND)
    ("receptor (VDR)" . SPARSER::RECEPTOR) ("States" . SPARSER::BIO-STATE)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("VDR" . SPARSER::PROTEIN) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MgCl2" . SPARSER::MOLECULE) ("CEL-I" . SPARSER::PROTEIN)
    ("Vitamin D" . SPARSER::MOLECULE) ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP10" . SPARSER::PROTEIN)
    ("dual specificity phosphatase 10" . SPARSER::PROTEIN)
    ("cathelicidin antimicrobial peptide" . SPARSER::PROTEIN)
    ("CYP24A1" . SPARSER::PROTEIN) ("Vitamin D3" . SPARSER::MOLECULE)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vitamin D3" . SPARSER::MOLECULE) ("zinc finger" . SPARSER::PROTEIN)
    ("1,25-dihydroxyvitamin D" . SPARSER::MOLECULE)
    ("CYP27B1" . SPARSER::PROTEIN) ("vitamin D" . SPARSER::MOLECULE)
    ("Erlotinib and Geffitinib" . SPARSER::COLLECTION)
    ("DNA-PK [ xref ] and ERCC1 [ xref ]" . SPARSER::COLLECTION)
    ("Jak-Stat3" . SPARSER::COLLECTION) ("mTORC2-NF-κB" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cisplatin and hyperthermia" . SPARSER::COLLECTION)
    ("PARP" . SPARSER::PROTEIN) ("BAX" . SPARSER::PROTEIN)
    ("BIM" . SPARSER::PROTEIN) ("ATR and ATM" . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN)
    ("HC-treated group and H-, NC- or Mock-treated" . SPARSER::COLLECTION)
    ("group and H-, NC- or Mock-treated" . SPARSER::COLLECTION)
    ("NC-" . SPARSER::PROTEIN) ("HC and NC" . SPARSER::COLLECTION)
    ("PBS" . SPARSER::PROTEIN) ("PI/annexin V" . SPARSER::COLLECTION)
    ("condensation" . SPARSER::PROTEIN-FAMILY)
    ("NC and HC" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("China Food and Drug Administration (CFDA) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("taking icotinib" . SPARSER::DRUG) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE) ("icotinib" . SPARSER::DRUG)
    ("systemic gemcitabine" . SPARSER::DRUG) ("gemcitabine" . SPARSER::DRUG)
    ("left upper lobe" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("predictive biomarkers" . SPARSER::MOLECULE) ("cisplatin" . SPARSER::DRUG)
    ("HC" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("FoxO3a" . SPARSER::PROTEIN) ("S15" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("L-glutamine" . SPARSER::MOLECULE)
    ("ERCC1" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("BCL-2" . SPARSER::PROTEIN) ("Bim-1" . SPARSER::PROTEIN)
    ("FoxO3" . SPARSER::PROTEIN) ("annexin V" . SPARSER::PROTEIN)
    ("M1a" . SPARSER::MOLECULE) ("miRNA and RNA" . SPARSER::COLLECTION)
    ("an adequate biomarker" . SPARSER::MOLECULE)
    ("maternal FN1" . SPARSER::PROTEIN)
    ("altered maternal FN1" . SPARSER::PROTEIN)
    ("placental derived protein and DNAm" . SPARSER::COLLECTION)
    ("protein and DNAm" . SPARSER::COLLECTION) ("mask" . SPARSER::PROTEIN)
    ("/PAPPA" . SPARSER::COLLECTION) ("INHA and FN1" . SPARSER::COLLECTION)
    ("INHA and PAPPA" . SPARSER::COLLECTION) ("SD" . SPARSER::PROTEIN)
    ("a larger cohort" . SPARSER::MOLECULE) ("Bisulfite" . SPARSER::MOLECULE)
    ("INHBA ( ∆β = −0.16, FDR < 0.05) and PAPPA ( ∆β = −0.074, FDR < 0.05)"
     . SPARSER::COLLECTION)
    ("PAPPA and INBHA" . SPARSER::COLLECTION)
    ("DNAm, mRNA or protein" . SPARSER::COLLECTION)
    ("pregnancy associated plasma protein A (PAPPA) and placental growth factor (PlGF)"
     . SPARSER::COLLECTION)
    ("placental growth factor" . SPARSER::GROWTH-FACTOR)
    ("PlGF" . SPARSER::PROTEIN) ("proteinuria" . SPARSER::PROTEIN)
    ("INHA/FN1" . SPARSER::COLLECTION) ("INHBA and FN1" . SPARSER::COLLECTION)
    ("INHA" . SPARSER::PROTEIN) ("DNAm and gene" . SPARSER::COLLECTION)
    ("INHBA and PAPPA" . SPARSER::COLLECTION) ("PAPPA" . SPARSER::PROTEIN)
    ("INHBA" . SPARSER::PROTEIN) ("p " . SPARSER::PROTEIN)
    ("Fibronectin" . SPARSER::PROTEIN) ("a protein’s" . SPARSER::PROTEIN)
    ("placental DNAm" . SPARSER::PROTEIN)
    ("DNAm and protein" . SPARSER::COLLECTION) ("DNAm" . SPARSER::PROTEIN)
    ("v19" . SPARSER::PROTEIN) ("Inhibin alpha" . SPARSER::PROTEIN)
    ("of Pregnancy" . SPARSER::PROTEIN) ("PAPPA2" . SPARSER::PROTEIN)
    ("pregnancy associated plasma protein A" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN) ("FN1" . SPARSER::PROTEIN)
    ("p-" . SPARSER::PROTEIN)
    ("both mTOR and specific MMPs" . SPARSER::COLLECTION)
    ("MMP9 and MMP7" . SPARSER::COLLECTION)
    ("both mTOR and the MMPs" . SPARSER::COLLECTION)
    ("mTOR and MMP" . SPARSER::COLLECTION)
    ("both the respective MMPs and mTOR" . SPARSER::COLLECTION)
    ("MMPs and mTOR" . SPARSER::COLLECTION) ("Rapamycin" . SPARSER::DRUG)
    ("nodal" . SPARSER::PROTEIN)
    ("mTOR and MMP2 or MMP7" . SPARSER::COLLECTION)
    ("MMP2 or MMP7" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("IL" . SPARSER::PROTEIN) ("MMP2 , MMP7 and MMP9" . SPARSER::COLLECTION)
    ("MMP2, MMP7, and MMP9" . SPARSER::COLLECTION)
    ("MMP2, MMP7 and MMP9" . SPARSER::COLLECTION)
    ("MMP2 and MMP7" . SPARSER::COLLECTION)
    ("the Western blot" . SPARSER::PROTEIN) ("rapamycin" . SPARSER::DRUG)
    ("MMP" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("P70S6K" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("MMP7" . SPARSER::PROTEIN) ("HER2/MAPK/MMP9" . SPARSER::COLLECTION)
    ("proteins and MMP9" . SPARSER::COLLECTION) ("Cho" . SPARSER::PROTEIN)
    ("HER2 and RAF, MEK, ERK, and JNK" . SPARSER::COLLECTION)
    ("RAF, MEK, ERK, and JNK" . SPARSER::COLLECTION)
    ("RAF1, MEK1, ERK1/2, and JNK" . SPARSER::COLLECTION)
    ("JNK and jnk" . SPARSER::COLLECTION)
    ("the predominant downstream target" . SPARSER::TARGET-PROTEIN)
    ("ERK, and BRACs" . SPARSER::COLLECTION)
    ("MEK1 and mek1" . SPARSER::COLLECTION) ("mek1" . SPARSER::PROTEIN)
    ("S/T-dual specificity protein kinase" . SPARSER::KINASE)
    ("substances" . SPARSER::SUBSTANCE)
    ("RAF1, and raf1" . SPARSER::COLLECTION) ("MEK/JNK" . SPARSER::COLLECTION)
    ("GTP-" . SPARSER::NUCLEOTIDE)
    ("guanosine triphosphate-" . SPARSER::MOLECULE)
    ("RAS/RAF/MEK/JNK" . SPARSER::COLLECTION)
    ("HER2/Neu" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("peonidin-3-glucose" . SPARSER::COLLECTION) ("cyanidin" . SPARSER::DRUG)
    ("MMP9 and JNK" . SPARSER::COLLECTION)
    ("HER2, ERK, and JNK" . SPARSER::COLLECTION)
    ("their respective siRNAs" . SPARSER::PROTEIN)
    ("RAF1, MEK, and JNK1/2" . SPARSER::COLLECTION)
    ("p-JNK protein" . SPARSER::COLLECTION) ("p-MEK" . SPARSER::COLLECTION)
    ("p-RAF" . SPARSER::COLLECTION)
    ("RAF1, MEK1/2, ERK1/2, and JNK" . SPARSER::COLLECTION)
    ("HER2 as well as RAF1, MEK, or JNK" . SPARSER::COLLECTION)
    ("RAF1, MEK, or JNK" . SPARSER::COLLECTION)
    ("HER2 and RAF1, MEK, and JNK" . SPARSER::COLLECTION)
    ("RAF1, MEK, and JNK" . SPARSER::COLLECTION)
    ("HER2 and RAF/MAPK proteins" . SPARSER::COLLECTION)
    ("MEK1/2, ERK1/2, JNK, and RAF1" . SPARSER::COLLECTION)
    ("raf1 , mek , and jnk" . SPARSER::COLLECTION) ("raf1" . SPARSER::PROTEIN)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION) ("-siRNA" . SPARSER::COLLECTION)
    ("RAF/MAPK" . SPARSER::COLLECTION) ("MCF-10A" . SPARSER::PROTEIN)
    ("natural phytochemicals" . SPARSER::DRUG)
    ("Anthocyanins" . SPARSER::MOLECULE) ("/protein" . SPARSER::COLLECTION)
    ("/Akt" . SPARSER::COLLECTION) ("HER2/neu" . SPARSER::COLLECTION)
    ("PKA" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("neu" . SPARSER::PROTEIN)
    ("a particularly aggressive form" . SPARSER::FORM)
    ("siRNAs" . SPARSER::PROTEIN) ("RAF, MEK, or JNK" . SPARSER::COLLECTION)
    ("RAF, MEK, and JNK" . SPARSER::COLLECTION)
    ("raf , mek , and jnk" . SPARSER::COLLECTION)
    ("jnk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kinase (JNK)" . SPARSER::KINASE)
    ("anthocyanins" . SPARSER::MOLECULE) ("RAS/RAF/MAPK" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("JNK protein" . SPARSER::PROTEIN)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("L-15" . SPARSER::PROTEIN)
    ("SP600125" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("ZM336372" . SPARSER::DRUG) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-ERK" . SPARSER::PROTEIN) ("p-MEK1" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 1" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-RAS" . SPARSER::PROTEIN)
    ("Mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogen-activated protein kinase kinase kinase" . SPARSER::PROTEIN)
    ("a potential and effective therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the redundant ROS" . SPARSER::PROTEIN)
    ("both cytoplasmic and nuclear Nrf2 protein and the Nrf2 downstream antioxidative genes"
     . SPARSER::COLLECTION)
    ("the Nrf2 downstream antioxidative genes" . SPARSER::GENE)
    ("the downstream target antioxidative genes" . SPARSER::GENE)
    ("protein-Keap1" . SPARSER::COLLECTION)
    ("Nrf2/Keap1" . SPARSER::COLLECTION) ("LDH and MDA" . SPARSER::COLLECTION)
    ("MPTP" . SPARSER::PROTEIN) ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("an indirect part" . SPARSER::COMPONENT)
    ("Apaf-1 and subsequently activated caspase-9" . SPARSER::COLLECTION)
    ("media" . SPARSER::PROTEIN) ("Nrf2-ARE-driven genes" . SPARSER::GENE)
    ("the antioxidative molecules" . SPARSER::MOLECULE)
    ("no significant cytotoxic and 100  μ M PQ" . SPARSER::COLLECTION)
    ("Several antioxidative enzymes" . SPARSER::ENZYME)
    ("ROS or other exogenous toxicant" . SPARSER::COLLECTION)
    ("enzymes [ xref ] and antioxidative proteins [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("antioxidative proteins" . SPARSER::PROTEIN)
    ("kelch-like ECH-associated protein" . SPARSER::PROTEIN)
    ("Nrf2-Keap1" . SPARSER::COLLECTION)
    ("apoptotic protease activating factor-1 (Apaf-1) and adenosine triphosphate (ATP)"
     . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("hydrogen peroxide, superoxide anion, and hydroxyl radicals"
     . SPARSER::COLLECTION)
    ("NADPH" . SPARSER::PROTEIN) ("dopamine" . SPARSER::PROTEIN)
    ("its structural homology" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN)
    ("Agricultural chemicals" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("PKC and CKII" . SPARSER::COLLECTION) ("CKII" . SPARSER::PROTEIN)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("MDA and LDH" . SPARSER::COLLECTION) ("LDH" . SPARSER::PROTEIN)
    ("PQ" . SPARSER::MOLECULE) ("Paraquat" . SPARSER::MOLECULE)
    ("neurotoxins" . SPARSER::PROTEIN) ("H 2 O 2" . SPARSER::DRUG)
    ("β -tubulin" . SPARSER::PROTEIN) ("NQO-1" . SPARSER::PROTEIN)
    ("β -actin" . SPARSER::PROTEIN) ("anti- β" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN) ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("Keap1" . SPARSER::PROTEIN) ("adenosine triphosphate" . SPARSER::MOLECULE)
    ("Apaf-1" . SPARSER::PROTEIN)
    ("apoptotic protease activating factor-1" . SPARSER::PROTEIN)
    ("reducing agent" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("hydroxyl radicals" . SPARSER::MOLECULE)
    ("superoxide anion" . SPARSER::MOLECULE) ("NQO1" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN)
    ("EJ-GFP and DR-GFP" . SPARSER::COLLECTION)
    ("toxin and I-" . SPARSER::COLLECTION)
    ("the reporter gene plasmidial DNA" . SPARSER::DNA)
    ("endonuclease" . SPARSER::PROTEIN) ("DR" . SPARSER::MOLECULE)
    ("RhoA, RhoB, and RhoC" . SPARSER::COLLECTION) ("RhoC" . SPARSER::PROTEIN)
    ("RhoB" . SPARSER::PROTEIN)
    ("both Chk1 (Ser345) and Chk2 (Thr-68)" . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION) ("OTM" . SPARSER::PROTEIN)
    ("PI" . SPARSER::PROTEIN) ("RhoA" . SPARSER::PROTEIN)
    ("FBS" . SPARSER::PROTEIN) ("monolayers" . SPARSER::PROTEIN)
    ("GDP and Rho" . SPARSER::COLLECTION)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GEFs" . SPARSER::GEF)
    ("an active form (Rho-GTP) and an inactive form (Rho-GDP)"
     . SPARSER::COLLECTION)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("actin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("toxin" . SPARSER::MOLECULE)
    ("Chk1/Chk2" . SPARSER::COLLECTION) ("α -Tubulin" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("K 4" . SPARSER::PROTEIN)
    ("K 3" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("18 h" . SPARSER::PROTEIN) ("β -galactosidase" . SPARSER::PROTEIN)
    ("Na 3 Vo 4" . SPARSER::MOLECULE) ("CCL-2" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("GTPase activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("H2A" . SPARSER::PROTEIN) ("Chk2" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN)
    ("ethanol and acetaldehyde" . SPARSER::COLLECTION)
    ("p38/ERK" . SPARSER::COLLECTION) ("p38/ERKs" . SPARSER::COLLECTION)
    ("Akt-CREB" . SPARSER::COLLECTION)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE) ("JNKs" . SPARSER::PROTEIN)
    ("Bcl-2-associated death protein" . SPARSER::PROTEIN)
    ("Bad" . SPARSER::PROTEIN) ("examples" . SPARSER::EXAMPLE)
    ("protein kinase B (PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proapoptotic protein Bax and antiapoptotic proteins, Bcl-2 and Bcl-xL"
     . SPARSER::COLLECTION)
    ("Mitochondria" . SPARSER::PROTEIN) ("ROS and MDA" . SPARSER::COLLECTION)
    ("lipid" . SPARSER::LIPID) ("lipids" . SPARSER::LIPID)
    ("GSH" . SPARSER::DRUG) ("tripeptide" . SPARSER::MOLECULE)
    ("p38MAPK/ERK/JNK" . SPARSER::COLLECTION)
    ("Akt/CREB" . SPARSER::COLLECTION)
    ("proapoptic protein Bax" . SPARSER::PROTEIN)
    ("Proapoptotic protein Bax and antiapoptotic proteins, Bcl-2 and Bcl-xL"
     . SPARSER::COLLECTION)
    ("proteins, Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Akt and CREB" . SPARSER::COLLECTION)
    ("Akt (a serine/threonine kinase or protein kinase, PKB) and cyclic AMP-responsive element binding protein (CREB)"
     . SPARSER::COLLECTION)
    ("kinase or protein" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("superoxide" . SPARSER::MOLECULE) ("redox" . SPARSER::PROTEIN)
    ("ROS" . SPARSER::PROTEIN) ("astrocytes" . SPARSER::PROTEIN)
    ("FAS" . SPARSER::PROTEIN) ("malformations" . SPARSER::PROTEIN)
    ("CA1" . SPARSER::PROTEIN) ("defective ALDH2" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase (ALDH)" . SPARSER::PROTEIN)
    ("ALDH" . SPARSER::PROTEIN) ("smoke" . SPARSER::MOLECULE)
    ("tobacco" . SPARSER::DRUG)
    ("Catalase and cytochrome p450" . SPARSER::COLLECTION)
    ("Catalase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p44/p42MAPK" . SPARSER::COLLECTION)
    ("activated Akt and cyclic AMP-responsive element binding protein (CREB)"
     . SPARSER::COLLECTION)
    ("element binding protein (CREB)" . SPARSER::PROTEIN)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AMP" . SPARSER::AMP)
    ("proapoptotic Bax" . SPARSER::PROTEIN)
    ("antiapoptotic Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION) ("SH-SY5Y" . SPARSER::PROTEIN)
    ("acetaldehyde" . SPARSER::MOLECULE)
    ("the most toxic metabolite" . SPARSER::MOLECULE)
    ("ethanol" . SPARSER::PROTEIN) ("Acetaldehyde" . SPARSER::MOLECULE)
    ("alcohol" . SPARSER::DRUG) ("GSK3 β" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("caspase 9" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cell membrane" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN) ("Ac-DEVD-pNA" . SPARSER::DRUG)
    ("p42 MAPK" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("Caspase 3" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("SOD2" . SPARSER::PROTEIN)
    ("ALDH2" . SPARSER::PROTEIN) ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("cytochrome p450" . SPARSER::PROTEIN-FAMILY)
    ("alcohol dehydrogenase" . SPARSER::PROTEIN) ("p42MAPK" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("element binding protein" . SPARSER::PROTEIN)
    ("Notch1, Bcl-2, cyclin D1, HIF1α and VEGF" . SPARSER::COLLECTION)
    ("Proteins" . SPARSER::PROTEIN) ("Akt and mTOR" . SPARSER::COLLECTION)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("cyclin D1 and -B1" . SPARSER::COLLECTION)
    ("cell cycle-associated proteins cyclin D1 and cyclin B1"
     . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin B1" . SPARSER::COLLECTION)
    ("quercetin and curcumin" . SPARSER::COLLECTION)
    ("curcumin" . SPARSER::DRUG) ("wine" . SPARSER::MOLECULE)
    ("AKT/mTOR/p70S6K1" . SPARSER::COLLECTION)
    ("HIF1α/VEGF" . SPARSER::COLLECTION) ("etoposide-" . SPARSER::PROTEIN)
    ("mitoxantrone" . SPARSER::DRUG) ("integrins" . SPARSER::PROTEIN)
    ("fibronectin" . SPARSER::PROTEIN)
    ("quercetin and shHSP27 reduced the expression of cyclin B1 ( xref )"
     . SPARSER::COLLECTION)
    ("the first cell cycle-associated protein" . SPARSER::PROTEIN)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-2/Bax" . SPARSER::COLLECTION) ("a homologous gene" . SPARSER::GENE)
    ("heterodimer" . SPARSER::HETERODIMER)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION) ("p-AKT" . SPARSER::COLLECTION)
    ("quercetin and/or shHSP27" . SPARSER::COLLECTION)
    ("specifically target HSP27" . SPARSER::PROTEIN)
    ("functionally associated proteins" . SPARSER::PROTEIN)
    ("Leukemia" . SPARSER::PROTEIN) ("eicosanoid" . SPARSER::MOLECULE)
    ("substance" . SPARSER::SUBSTANCE) ("flavone" . SPARSER::DRUG)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("angiogenesis-associated proteins HIF1α and VEGF" . SPARSER::COLLECTION)
    ("HIF1α and VEGF" . SPARSER::COLLECTION) ("NR" . SPARSER::PROTEIN)
    ("quercetin" . SPARSER::MOLECULE) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("p70S6K1" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("Gag-Pol" . SPARSER::PROTEIN)
    ("HSPB1" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("β-catenin" . SPARSER::PROTEIN) ("Notch 1" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("TMA" . SPARSER::MOLECULE) ("mRNA or protein" . SPARSER::COLLECTION)
    ("HRM" . SPARSER::PROTEIN-FAMILY)
    ("RASSF1A or RASSF1C" . SPARSER::COLLECTION) ("at least 37 types" . TYPE)
    ("RalGDS/AF-6" . SPARSER::COLLECTION) ("transducers" . SPARSER::PROTEIN)
    ("RalGDS" . SPARSER::PROTEIN) ("AF-6" . SPARSER::PROTEIN)
    ("FHIT ( xref ) and RASSF1 ( xref )" . SPARSER::COLLECTION)
    ("VHL ( xref ), FHIT ( xref ) and RASSF1 ( xref )" . SPARSER::COLLECTION)
    ("genes (TSG)" . SPARSER::GENE) ("FHIT" . SPARSER::PROTEIN)
    ("TSG" . SPARSER::PROTEIN) ("radical" . SPARSER::MOLECULE)
    ("TNM" . SPARSER::MOLECULE) ("melting" . SPARSER::DRUG)
    ("RASSF1A and RASSF1C" . SPARSER::COLLECTION) ("TNM 1" . SPARSER::PROTEIN)
    ("TNM 3" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("N2" . SPARSER::PROTEIN) ("T1-4" . SPARSER::PROTEIN)
    ("T1-2" . SPARSER::PROTEIN) ("s 2" . SPARSER::MOLECULE)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("ddH 2" . SPARSER::PROTEIN)
    ("family member 1" . SPARSER::PROTEIN) ("RASSF1A" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("c -myc and SMARCAL1" . SPARSER::COLLECTION)
    ("SMARCAL1 and BRG1" . SPARSER::COLLECTION)
    ("ATPase activity and the protein" . SPARSER::COLLECTION)
    ("histones" . SPARSER::PROTEIN)
    ("nucleosomes and BRG1" . SPARSER::COLLECTION)
    ("Nucleolin" . SPARSER::PROTEIN)
    ("SMARCAL1 and c -myc" . SPARSER::COLLECTION)
    ("brg1 , SMARCAL1 , and c-myc" . SPARSER::COLLECTION)
    ("cereberal ischemia" . SPARSER::PROTEIN) ("ischemia" . SPARSER::PROTEIN)
    ("SMARCAL1 and c-MYC" . SPARSER::COLLECTION) ("EDTA" . SPARSER::MOLECULE)
    ("ions" . SPARSER::MOLECULE) ("monovalent cations" . SPARSER::MOLECULE)
    ("cations" . SPARSER::MOLECULE) ("DNA and ATP" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("weaker" . SPARSER::PROTEIN)
    ("the bovine homolog of human SMARCAL1" . SPARSER::PROTEIN)
    ("guanine and L" . SPARSER::COLLECTION)
    ("micrococcal nuclease" . SPARSER::PROTEIN)
    ("nucleosome" . SPARSER::PROTEIN) ("nuclease" . SPARSER::PROTEIN)
    ("-promoter" . SPARSER::PROMOTER)
    ("SMARCAL1 and RPA" . SPARSER::COLLECTION)
    ("BRG1 or SMARCAL1" . SPARSER::COLLECTION)
    ("both brg1 ( xref ) as well as c- myc" . SPARSER::COLLECTION)
    ("c -myc and brg1" . SPARSER::COLLECTION) ("brg1" . SPARSER::PROTEIN)
    ("Sh" . SPARSER::PROTEIN-FAMILY)
    ("c- kit and c -myc" . SPARSER::COLLECTION) ("PMA" . SPARSER::PROTEIN)
    ("phorbol" . SPARSER::DRUG)
    ("BRG1 and RNA polymerase II" . SPARSER::COLLECTION)
    ("BRG1 and SMARCAL1" . SPARSER::COLLECTION) ("GC" . SPARSER::PROTEIN)
    ("leucine" . SPARSER::AMINO-ACID) ("globin" . SPARSER::PROTEIN)
    ("fish" . SPARSER::PROTEIN) ("helicase" . SPARSER::PROTEIN)
    ("RPA" . SPARSER::PROTEIN) ("c- myc and c -kit" . SPARSER::COLLECTION)
    ("histone" . SPARSER::PROTEIN) ("nucleosomes" . SPARSER::PROTEIN)
    ("chromatin" . SPARSER::PROTEIN)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("the bovine homolog of SMARCAL1" . SPARSER::PROTEIN)
    ("ATPase" . SPARSER::PROTEIN) ("BRG1 and RNAPII" . SPARSER::COLLECTION)
    ("BRG1, SMARCAL1 and RNAPII" . SPARSER::COLLECTION)
    ("SWI2/SNF2" . SPARSER::COLLECTION) ("Dual-luciferase" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("NaHCO 3" . SPARSER::DRUG)
    ("Rpb1" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("sodium bicarbonate" . SPARSER::DRUG)
    ("ATPase activity" . SPARSER::PROTEIN)
    ("spondyloepiphyseal dysplasia" . SPARSER::PROTEIN)
    ("a 11 " . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("pGL3" . SPARSER::PROTEIN) ("c- kit" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("E1" . SPARSER::MOLECULE)
    ("gata1" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("autosomal recessive" . SPARSER::PROTEIN) ("c -kit" . SPARSER::PROTEIN)
    ("ATP-dependent chromatin remodeling protein" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN) ("c -myc" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("c- myc" . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN) ("SNF2" . SPARSER::PROTEIN)
    ("SWI2" . SPARSER::PROTEIN) ("SMARCAL1" . SPARSER::PROTEIN)
    ("FGFR1 and CDK" . SPARSER::COLLECTION)
    ("CDK4/6 or CDK2" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("CDK1 and cyclin B1" . SPARSER::COLLECTION)
    ("CDK2, cyclin E and cyclin" . SPARSER::COLLECTION)
    ("CDK4 and cyclin D1" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("Flag-FGFR1" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("multiple cell cycle-associated genes" . SPARSER::GENE)
    ("Genes and Genomes" . SPARSER::COLLECTION) ("Genes" . SPARSER::GENE)
    ("ponatinib" . SPARSER::DRUG) ("tumori-genesis" . SPARSER::COLLECTION)
    ("genesis" . SPARSER::PROTEIN) ("FGFs" . SPARSER::PROTEIN)
    ("monomer" . SPARSER::MONOMER) ("FGFR" . SPARSER::PROTEIN)
    ("FGFR1, FGFR2, FGFR3 and FGFR4" . SPARSER::COLLECTION)
    ("Ig" . SPARSER::MOLECULE) ("FGFRs" . SPARSER::PROTEIN)
    ("CDK4/6" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("FGFR3" . SPARSER::PROTEIN) ("FGFR2" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("cyclin-dependent kinase 1" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("antioxidant" . SPARSER::PROTEIN) ("EGCG and ECG" . SPARSER::COLLECTION)
    ("ERK1/2, JNK or p38" . SPARSER::COLLECTION)
    ("MEK/ERK" . SPARSER::COLLECTION) ("PI 3 K/AKT" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("ERK and p38" . SPARSER::COLLECTION)
    ("vascular remodeling-related genes" . SPARSER::GENE)
    ("JNK and p38" . SPARSER::COLLECTION)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("threonine and tyrosine" . SPARSER::COLLECTION)
    ("tyrosine" . SPARSER::AMINO-ACID) ("MAPKs" . SPARSER::PROTEIN)
    ("NICD, c-Myc, HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION) ("CBP" . SPARSER::PROTEIN)
    ("mastermind" . SPARSER::PROTEIN-FAMILY)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("Akt and c-Myc" . SPARSER::COLLECTION)
    ("Akt or c-Myc" . SPARSER::COLLECTION)
    ("blot and luciferase" . SPARSER::COLLECTION)
    ("Akt/c-Myc/HIF-1α" . SPARSER::COLLECTION)
    ("c-Myc/HIF-1α" . SPARSER::COLLECTION)
    ("phenanthrene-quinone" . SPARSER::PROTEIN) ("quinone" . SPARSER::PROTEIN)
    ("phenanthrene" . SPARSER::DRUG) ("derivative" . SPARSER::DERIVATIVE)
    ("Tanshinone" . SPARSER::DRUG)
    ("HIF-1α and mTOR/p70S6K/4E-BP1" . SPARSER::COLLECTION)
    ("Silibinin" . SPARSER::DRUG) ("flavonol" . SPARSER::MOLECULE)
    ("Quercetin" . SPARSER::MOLECULE)
    ("Akt, mTOR, p70S6K, and 4E-BP1" . SPARSER::COLLECTION)
    ("ribosomal proteins" . SPARSER::PROTEIN) ("elongation" . SPARSER::PROTEIN)
    ("Active" . SPARSER::ACTIVE) ("p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("cytokines" . SPARSER::PROTEIN) ("HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("the heterodimeric transcription factor HIF-1" . SPARSER::PROTEIN)
    ("ECG or EGCG" . SPARSER::COLLECTION)
    ("ECG and EGCG" . SPARSER::COLLECTION)
    ("VEGF and basic fibroblast growth factor" . SPARSER::COLLECTION)
    ("food" . SPARSER::MOLECULE) ("p-FoxO1" . SPARSER::COLLECTION)
    ("p-ERK1/2" . SPARSER::PROTEIN)
    ("Notch-1/c-Myc/HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("Akt/c-Myc/HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("HIF-1α promoter and VEGF promoter ( xref , and xref )"
     . SPARSER::COLLECTION)
    ("c-Myc promoter, HIF-1α promoter and VEGF promoter ( xref , and xref )"
     . SPARSER::COLLECTION)
    ("Akt or NICD" . SPARSER::COLLECTION) ("Luciferase" . SPARSER::PROTEIN)
    ("NICD" . SPARSER::PROTEIN) ("c-Myc and HIF-1α" . SPARSER::COLLECTION)
    ("Notch-1/c-myc" . SPARSER::COLLECTION) ("Akt/c-myc" . SPARSER::COLLECTION)
    ("VEGF promoter and HIF-1α promoter ( xref )" . SPARSER::COLLECTION)
    ("Akt, mTOR, p70S6K or 4E-BP1" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN)
    ("Akt, mTOR, p70S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("p" . SPARSER::PROTEIN)
    ("PTEN, p-Akt, Akt, p-mTOR, mTOR, p-p70S6K, p70S6K, p-4E-BP1 and 4E-BP1"
     . SPARSER::COLLECTION)
    ("p-4E-BP1" . SPARSER::COLLECTION) ("p-mTOR" . SPARSER::COLLECTION)
    ("PI 3 K/Akt" . SPARSER::COLLECTION) ("CAM" . SPARSER::PROTEIN)
    ("Solution" . SPARSER::MOLECULE) ("VEGF and HIF-1α" . SPARSER::COLLECTION)
    ("Notch-1/c-Myc" . SPARSER::COLLECTION) ("Part" . SPARSER::COMPONENT)
    ("ECG" . SPARSER::DRUG) ("Theaflavins" . SPARSER::DRUG)
    ("catechin" . SPARSER::MOLECULE)
    ("thearubigin and other oligomers ( xref )" . SPARSER::COLLECTION)
    ("oligomeric flavanols" . SPARSER::MOLECULE)
    ("oligomers" . SPARSER::MOLECULE) ("thearubigin" . SPARSER::DRUG)
    ("theaflavins" . SPARSER::DRUG) ("flavanols" . SPARSER::MOLECULE)
    ("subunits, HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("subunits" . SPARSER::PROTEIN)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("molecules and growth factors" . SPARSER::COLLECTION)
    ("vasculature" . SPARSER::PROTEIN)
    ("c-Myc, HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("Akt/c-Myc" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("-epigallocatechin-3-gallate" . SPARSER::DRUG) ("EGCG" . SPARSER::DRUG)
    ("Theaflavin" . SPARSER::DRUG) ("AMP-activated" . SPARSER::PROTEIN)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("Lag-1" . SPARSER::PROTEIN)
    ("CBF-1" . SPARSER::PROTEIN) ("γ-secretase" . SPARSER::PROTEIN)
    ("VEGFR-2" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("Notch-1 intracellular domain" . SPARSER::PROTEIN)
    ("RPS6" . SPARSER::PROTEIN) ("PI 3 K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-galactosidase" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBE1" . SPARSER::PROTEIN) ("HIF1alpha" . SPARSER::PROTEIN)
    ("PHAS-I" . SPARSER::PROTEIN) ("RPS6KB1" . SPARSER::PROTEIN)
    ("delta4" . SPARSER::PROTEIN) ("p-ERK1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FoxO1" . SPARSER::PROTEIN) ("Forkhead Box O1" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("t-butyl" . SPARSER::MOLECULE) ("F-12" . SPARSER::PROTEIN)
    ("tea polyphenols" . SPARSER::MOLECULE) ("HIF-1" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("anti-angiogenic" . SPARSER::DRUG) ("Notch-1" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("epicatechin gallate" . SPARSER::DRUG) ("antisense" . SPARSER::PROTEIN)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin B2, cyclin B1, cyclin D1, cdc25a and cdk1" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("two different biological states" . SPARSER::BIO-STATE)
    ("genes or pathways" . SPARSER::COLLECTION)
    ("cdc25a and GAPDH" . SPARSER::COLLECTION) ("GAPDH" . SPARSER::PROTEIN)
    ("AFP" . SPARSER::PROTEIN) ("aflatoxin" . SPARSER::MOLECULE)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("the amino sugar" . SPARSER::MOLECULE) ("thyroid" . SPARSER::PROTEIN)
    ("sugar" . SPARSER::MOLECULE) ("solution" . SPARSER::MOLECULE)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("Cdc25a" . SPARSER::PROTEIN) ("cdc25a" . SPARSER::PROTEIN)
    ("HCC" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("Cyclin B1" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("cyclin family" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cdk1" . SPARSER::PROTEIN) ("cyclin B2" . SPARSER::PROTEIN)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("α-fetoprotein" . SPARSER::PROTEIN) ("Cdc25" . SPARSER::PROTEIN)
    ("cdc25" . SPARSER::PROTEIN)
    ("platinum and taxane or doxorubicin" . SPARSER::COLLECTION)
    ("taxane or doxorubicin" . SPARSER::COLLECTION) ("taxane" . SPARSER::DRUG)
    ("proteins and CCNE1" . SPARSER::COLLECTION)
    ("PTEN, HER2, p53, MLH1 and ARID1A" . SPARSER::COLLECTION)
    ("PTEN , p53 and ARID1A" . SPARSER::COLLECTION)
    ("Notch1-JAG1" . SPARSER::COLLECTION) ("oncoproteins" . SPARSER::PROTEIN)
    ("oncoprotein" . SPARSER::PROTEIN) ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-MYC and CCNE1" . SPARSER::COLLECTION)
    ("cancer-associated substrates" . SPARSER::SUBSTRATE)
    ("Cyclin E-CDK2" . SPARSER::COLLECTION) ("FISH" . SPARSER::PROTEIN)
    ("PTEN, p53, HER2, MLH1 and ARID1A" . SPARSER::COLLECTION)
    ("PTEN, p53, HER2, MLH1 or ARID1A" . SPARSER::COLLECTION)
    ("which targets CCNE1" . SPARSER::PROTEIN) ("log-rank" . SPARSER::PROTEIN)
    ("rank" . SPARSER::PROTEIN)
    ("the humanized antibodies trastuzumab (Herceptin) and matuzumab"
     . SPARSER::COLLECTION)
    ("ERBB2 and EGFR" . SPARSER::COLLECTION) ("matuzumab" . SPARSER::DRUG)
    ("Herceptin" . SPARSER::DRUG) ("trastuzumab" . SPARSER::DRUG)
    ("c-myc, ERBB2, EGFR , AKT2 , CCND1 and CCNE1" . SPARSER::COLLECTION)
    ("ubiquitin" . SPARSER::PROTEIN) ("SCF" . SPARSER::PROTEIN)
    ("cyclin E-FBXW7" . SPARSER::COLLECTION)
    ("K-ras and/or PIK3CA ( xref – xref )" . SPARSER::COLLECTION)
    ("MSI" . SPARSER::PROTEIN)
    ("p53, HER2, MLH1 and ARID1A" . SPARSER::COLLECTION)
    ("MLH1" . SPARSER::PROTEIN) ("JAG1" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("FBXW7 protein" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("O18" . SPARSER::PROTEIN)
    ("K18" . SPARSER::PROTEIN) ("Chr2" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("CCND1" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("c-myc" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("Skp1" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("PIK3CA" . SPARSER::PROTEIN)
    ("K-ras" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ARID1A" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN) ("WD repeat domain" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("linker" . SPARSER::LINKER) ("scaffold" . SPARSER::SCAFFOLD)
    ("PLK1 and APC/C" . SPARSER::COLLECTION)
    ("PLK1 and PP2A" . SPARSER::COLLECTION)
    ("securin and cyclin B1" . SPARSER::COLLECTION)
    ("securin" . SPARSER::PROTEIN)
    ("the centrosomal PCNT and CEP215" . SPARSER::COLLECTION)
    ("CEP215 and PCNT" . SPARSER::COLLECTION)
    ("PCNT or CEP215" . SPARSER::COLLECTION) ("PCNT-" . SPARSER::PROTEIN)
    ("centrin-2 and C-NAP1" . SPARSER::COLLECTION)
    ("the centrosomal PCNT" . SPARSER::PROTEIN)
    ("phospho-antibody" . SPARSER::PROTEIN)
    ("the phospho-mimetic PCNT sensor protein" . SPARSER::PROTEIN)
    ("-GFP-PACT" . SPARSER::COLLECTION)
    ("FLAG-mCherry-PCNT" . SPARSER::COLLECTION) ("PACT" . SPARSER::PROTEIN)
    ("mCherry" . SPARSER::PROTEIN)
    ("the phospho-mimetic PCNT mutant" . SPARSER::MUTANT)
    ("-Myc" . SPARSER::COLLECTION) ("FLAG-PCNT" . SPARSER::COLLECTION)
    ("FLAG-PCNT-Myc" . SPARSER::COLLECTION) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("C-NAP1 and CEP135" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("PCNT and CEP215" . SPARSER::COLLECTION)
    ("centrosomal CEP192 and γ-tubulin" . SPARSER::COLLECTION)
    ("CEP192 and γ-tubulin" . SPARSER::COLLECTION)
    ("a mitotic kinase" . SPARSER::KINASE) ("Pericentrin" . SPARSER::PROTEIN)
    ("microcephaly" . SPARSER::PROTEIN) ("microtubules" . SPARSER::PROTEIN)
    ("PCM" . SPARSER::PROTEIN) ("Separase" . SPARSER::PROTEIN)
    ("PCNT" . SPARSER::PROTEIN) ("separase" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("CS6" . SPARSER::PROTEIN)
    ("Protein A" . SPARSER::PROTEIN) ("MgCl 2" . SPARSER::MOLECULE)
    ("IB 1" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("A-3" . SPARSER::PROTEIN) ("GAG-3" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("D -Myc" . SPARSER::PROTEIN) ("CEP135" . SPARSER::PROTEIN)
    ("C-NAP1" . SPARSER::PROTEIN) ("centrin-2" . SPARSER::PROTEIN)
    ("CEP215" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("CEP192" . SPARSER::PROTEIN) ("ZM447439" . SPARSER::DRUG)
    ("BI2536" . SPARSER::DRUG) ("membrane-bound" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN)
    ("no currently available population-based disease-free cohorts"
     . SPARSER::MOLECULE)
    ("genotype" . SPARSER::PROTEIN) ("CYP1B1-genotype" . SPARSER::PROTEIN-PAIR)
    ("complete RV" . SPARSER::MOLECULE) ("CYP" . SPARSER::PROTEIN)
    ("Testosterone" . SPARSER::MOLECULE) ("Androgen" . SPARSER::PROTEIN)
    ("E2 and androgens" . SPARSER::COLLECTION) ("Male" . SPARSER::MOLECULE)
    ("heritable PAH" . SPARSER::PROTEIN)
    ("this healthy cohort" . SPARSER::MOLECULE)
    ("CYP1B1 and the androgen receptor" . SPARSER::COLLECTION)
    ("androgens and RV" . SPARSER::COLLECTION)
    ("respective LV" . SPARSER::MOLECULE)
    ("Urinary E2 metabolites" . SPARSER::MOLECULE)
    ("metabolites and RVEF" . SPARSER::COLLECTION)
    ("hormone therapy and left ventricular ejection fraction"
     . SPARSER::COMPONENT)
    ("creatinine" . SPARSER::PROTEIN)
    ("Urinary E2 metabolites and RV" . SPARSER::COLLECTION)
    ("metabolites and RV" . SPARSER::COLLECTION)
    ("top three principal components and hormone therapy (Bonferroni-corrected p=0.02)"
     . SPARSER::COLLECTION)
    ("top three principal components" . SPARSER::COMPONENT)
    ("MESA" . SPARSER::PROTEIN)
    ("higher RVEF and lower RV mass and RVEDV" . SPARSER::COLLECTION)
    ("OHE" . SPARSER::MOLECULE) ("multi-ethnic cohort" . SPARSER::MOLECULE)
    ("androgens" . SPARSER::DRUG) ("LV" . SPARSER::MOLECULE)
    ("possible therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("CYP1B1 and aromatase" . SPARSER::COLLECTION)
    ("aromatase" . SPARSER::PROTEIN) ("1b1" . SPARSER::PROTEIN)
    ("PAH" . SPARSER::PROTEIN) ("testosterone and RVEF" . SPARSER::COLLECTION)
    ("androgen" . SPARSER::MOLECULE)
    ("significantly higher RVEF" . SPARSER::COMPONENT)
    ("metabolite" . SPARSER::MOLECULE)
    ("AA (global p<7.2×10 −6 ) and white (global p=0.05) women"
     . SPARSER::COLLECTION)
    ("RVEF" . SPARSER::COMPONENT) ("fraction (RVEF)" . SPARSER::COMPONENT)
    ("AA" . SPARSER::MOLECULE)
    ("cytochrome P4501B1 (CYP1B1) and serum testosterone"
     . SPARSER::COLLECTION)
    ("Urinary oestradiol (E2) metabolites" . SPARSER::MOLECULE)
    ("testosterone" . SPARSER::MOLECULE) ("cytochrome" . SPARSER::PROTEIN)
    ("metabolites" . SPARSER::MOLECULE) ("oestradiol" . SPARSER::MOLECULE)
    ("RV" . SPARSER::MOLECULE) ("Androgen-receptor" . SPARSER::PROTEIN)
    ("GPR30" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Androgen receptor" . SPARSER::PROTEIN)
    ("bone morphogenetic protein receptor type 2" . SPARSER::PROTEIN)
    ("high-density lipoprotein" . SPARSER::PROTEIN)
    ("o-methyltransferase" . SPARSER::PROTEIN) ("1A1" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("androgen receptor" . SPARSER::PROTEIN)
    ("Cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY) ("CYP1B1" . SPARSER::PROTEIN)
    ("P4501B1" . SPARSER::PROTEIN) ("E2" . SPARSER::MOLECULE)
    ("potential biomarkers" . SPARSER::MOLECULE)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("cis" . SPARSER::PROTEIN)
    ("HIPK" . SPARSER::PROTEIN-FAMILY)
    ("CLOCK and BMAL1" . SPARSER::COLLECTION)
    ("FTO, GCK, HNF1A and HNF1B, PPAR γ, PTEN , and TCF7L2"
     . SPARSER::COLLECTION)
    ("HNF1B, PPAR γ, PTEN , and TCF7L2" . SPARSER::COLLECTION)
    ("PTEN" . SPARSER::PROTEIN) ("GCK" . SPARSER::PROTEIN)
    ("FTO" . SPARSER::PROTEIN) ("CLOCK" . SPARSER::PROTEIN)
    ("a strong developmental component" . SPARSER::COMPONENT)
    ("JNK and MAPK" . SPARSER::COLLECTION) ("macrophages" . SPARSER::PROTEIN)
    ("MAPK" . SPARSER::PROTEIN) ("JNK" . SPARSER::PROTEIN)
    ("cJun" . SPARSER::PROTEIN) ("Argonaute" . SPARSER::PROTEIN-FAMILY)
    ("LKB1 and AMPK" . SPARSER::COLLECTION) ("AMPK" . SPARSER::PROTEIN)
    ("skeletal muscle" . SPARSER::PROTEIN) ("fat" . SPARSER::PROTEIN)
    ("glucose" . SPARSER::MOLECULE) ("MEST , and PEG10" . SPARSER::COLLECTION)
    ("MEST" . SPARSER::PROTEIN)
    ("PIWIL4, TAOK3 , and FYN" . SPARSER::COLLECTION)
    ("ion" . SPARSER::MOLECULE) ("FYN CpGs1" . SPARSER::PROTEIN)
    ("TAOK3 and PIWIL4" . SPARSER::COLLECTION)
    ("PIWIL4, FYN , and TAOK3" . SPARSER::COLLECTION)
    ("cytosine" . SPARSER::MOLECULE) ("PIWIL4 and TAOK3" . SPARSER::COLLECTION)
    ("CpG2" . SPARSER::PROTEIN) ("hg" . SPARSER::MOLECULE)
    ("contiguous CpGs" . SPARSER::PROTEIN)
    ("-methylguanine-DNA methyltransferase ( MGMT )" . SPARSER::COLLECTION)
    ("mir-125b , and aurora Kinase A" . SPARSER::COLLECTION)
    ("-methylguanine-DNA methyltransferase" . SPARSER::COLLECTION)
    ("SRC" . SPARSER::PROTEIN) ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AURKA" . SPARSER::PROTEIN) ("piwi" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MGMT" . SPARSER::PROTEIN)
    ("differentially methylated CpGs" . SPARSER::PROTEIN)
    ("CpGs" . SPARSER::PROTEIN) ("male" . SPARSER::MOLECULE)
    ("potential epigenetic biomarkers" . SPARSER::MOLECULE)
    ("traits" . SPARSER::PROTEIN) ("– 1" . SPARSER::PROTEIN)
    ("PIWIL4 ( P = 0.003) and TAOK3 ( P = 0.001)" . SPARSER::COLLECTION)
    ("FYN, PIWIL4 , and TAOK3" . SPARSER::COLLECTION)
    ("FYN" . SPARSER::PROTEIN) ("bisulfite" . SPARSER::MOLECULE)
    ("GTPase" . SPARSER::GTPASE) ("80 unique genes" . SPARSER::GENE)
    ("differentially" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("MD 1" . SPARSER::PROTEIN) ("DNA polymerase" . SPARSER::PROTEIN)
    ("CD4" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NOTCH4" . SPARSER::PROTEIN)
    ("TRIM3" . SPARSER::PROTEIN) ("TCF7L2" . SPARSER::PROTEIN)
    ("PPAR γ" . SPARSER::PROTEIN) ("HNF1B" . SPARSER::PROTEIN)
    ("HNF1A" . SPARSER::PROTEIN) ("Type 2" . SPARSER::PROTEIN)
    ("BMAL1" . SPARSER::PROTEIN) ("HIF3A" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NH 2" . SPARSER::MOLECULE) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 INK4a" . SPARSER::PROTEIN) ("p16  INK4a" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fatty acid" . SPARSER::MOLECULE)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PEG10" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("CpG1" . SPARSER::PROTEIN) ("RAB1A" . SPARSER::PROTEIN)
    ("Rab1A" . SPARSER::PROTEIN) ("SPON2" . SPARSER::PROTEIN)
    ("spondin2" . SPARSER::PROTEIN) ("aurora Kinase A" . SPARSER::PROTEIN)
    ("mir-125b" . SPARSER::MOLECULE) ("TAO kinase 3" . SPARSER::PROTEIN)
    ("methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("X chromosome" . SPARSER::PROTEIN) ("CpG3" . SPARSER::PROTEIN)
    ("TAOK3" . SPARSER::PROTEIN) ("PIWIL4" . SPARSER::PROTEIN)
    ("Phosphatases" . SPARSER::PHOSPHATASE) ("CBL" . SPARSER::PROTEIN)
    ("EGFR and TGFa" . SPARSER::COLLECTION) ("TGFa" . SPARSER::PROTEIN)
    ("Promoter" . SPARSER::PROMOTER) ("ligands" . SPARSER::LIGAND)
    ("cetuximab" . SPARSER::DRUG)
    ("a clinically available EGFR inhibitor" . SPARSER::INHIBITOR)
    ("Cetuximab" . SPARSER::DRUG) ("Erlotinib" . SPARSER::DRUG)
    ("cohort" . SPARSER::MOLECULE) ("reagents" . SPARSER::MOLECULE)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MRI" . SPARSER::PROTEIN)
    ("Oncogene" . SPARSER::ONCOGENE) ("western blot" . SPARSER::PROTEIN)
    ("TetO-" . SPARSER::PROTEIN) ("TetO" . SPARSER::PROTEIN)
    ("Dr" . SPARSER::MOLECULE) ("EGFR and ERK" . SPARSER::COLLECTION)
    ("Kras" . SPARSER::PROTEIN) ("PC-9" . SPARSER::PROTEIN)
    ("overexpressed wt-EGFR mimicked mutant EGFRs" . SPARSER::PROTEIN)
    ("EGFRs" . SPARSER::PROTEIN) ("Phopho-EGFR" . SPARSER::COLLECTION)
    ("P-Erk, and P-Akt" . SPARSER::COLLECTION)
    ("EGFR, Akt, and Erk" . SPARSER::COLLECTION)
    ("Raf-Mek-Erk" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("transgene" . SPARSER::PROTEIN)
    ("Tet" . SPARSER::PROTEIN) ("KIT" . SPARSER::PROTEIN)
    ("KRAS" . SPARSER::PROTEIN)
    ("EGFR as well as other candidate oncogenes" . SPARSER::COLLECTION)
    ("thoroughly all the hot" . SPARSER::PROTEIN) ("hot" . SPARSER::PROTEIN)
    ("exon" . SPARSER::PROTEIN) ("Gefitinib" . SPARSER::DRUG)
    ("partial" . SPARSER::PROTEIN) ("Wang" . SPARSER::PROTEIN)
    ("the predictive biomarkers" . SPARSER::MOLECULE)
    ("biomarkers" . SPARSER::MOLECULE) ("NCCN" . SPARSER::MOLECULE)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("HER3/erbB-3" . SPARSER::COLLECTION) ("HER2/erbB-2" . SPARSER::COLLECTION)
    ("EGFR/erbB-1" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the major pathological type" . TYPE) ("Wt-EGFR" . SPARSER::COLLECTION)
    ("EGFR-TKIs" . SPARSER::COLLECTION) ("TKIs" . SPARSER::PROTEIN)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("wt-EGFR" . SPARSER::COLLECTION)
    ("TKI" . SPARSER::PROTEIN) ("EGFR" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("CC10" . SPARSER::PROTEIN) ("C-cbl" . SPARSER::PROTEIN)
    ("P-Erk" . SPARSER::PROTEIN) ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("HER4" . SPARSER::PROTEIN) ("erbB-3" . SPARSER::PROTEIN)
    ("erbB-2" . SPARSER::PROTEIN) ("erbB-1" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("TCF/LEF" . SPARSER::COLLECTION)
    ("LEF" . SPARSER::PROTEIN)
    ("DKK-1, DVL-1 and Wnt10A" . SPARSER::COLLECTION)
    ("prognostic metastasis genes" . SPARSER::GENE)
    ("E-cadherin or Vimentin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("smaller tumor foci" . SPARSER::PROTEIN)
    ("matrigel" . SPARSER::PROTEIN) ("metastatic foci" . SPARSER::PROTEIN)
    ("DDR" . SPARSER::PROTEIN)
    ("Wnt pathway components and the transcriptional activity of beta-catenin"
     . SPARSER::COLLECTION)
    ("FOP" . SPARSER::PROTEIN) ("Wnt10A and DVL1" . SPARSER::COLLECTION)
    ("Wnt10A, SMAD3, DKK1 and DVL1" . SPARSER::COLLECTION)
    ("BAMBI, ROCK2 and PLCB4" . SPARSER::COLLECTION)
    ("BAMBI" . SPARSER::PROTEIN) ("NMF" . SPARSER::DRUG)
    ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("an available inhibitor" . SPARSER::INHIBITOR)
    ("water" . SPARSER::MOLECULE) ("doxycycline" . SPARSER::DRUG)
    ("tet" . SPARSER::PROTEIN)
    ("established metastatic foci" . SPARSER::PROTEIN)
    ("smaller foci" . SPARSER::PROTEIN) ("NSG" . SPARSER::PROTEIN-FAMILY)
    ("NOD" . SPARSER::PROTEIN) ("CRC" . SPARSER::PROTEIN)
    ("FAK and EZH2" . SPARSER::COLLECTION) ("FAK" . SPARSER::PROTEIN)
    ("AXL" . SPARSER::PROTEIN) ("MMPs" . SPARSER::PROTEIN)
    ("heterodimers" . SPARSER::HETERODIMER) ("TCF" . SPARSER::PROTEIN)
    ("Fos and FosB" . SPARSER::COLLECTION) ("FosB" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("Ras/Raf/MEK/ERK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Fos, c-Jun and Fra-1" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR)
    ("ATF and MAF protein families" . SPARSER::COLLECTION)
    ("Fos (c-FOS, FOSB, Fra-1, Fra-2), Jun (c-JUN, JUNB, JUND), ATF and MAF protein families"
     . SPARSER::COLLECTION)
    ("ATF" . SPARSER::PROTEIN) ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOSB" . SPARSER::PROTEIN) ("dimers" . SPARSER::DIMER)
    ("foci" . SPARSER::PROTEIN) ("anoikis" . SPARSER::PROTEIN)
    ("EMT" . SPARSER::PROTEIN) ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AP-1" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("beta-actin" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("beta-glycerophosphate" . SPARSER::DRUG)
    ("P40" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("Beta-catenin" . SPARSER::PROTEIN) ("For 3" . SPARSER::PROTEIN)
    ("1-2" . SPARSER::PROTEIN) ("Wnt receptor" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("DVL-1" . SPARSER::PROTEIN)
    ("DKK-1" . SPARSER::PROTEIN)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("PLCB4" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("DVL1" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("Wnt10A" . SPARSER::PROTEIN)
    ("FOSL1" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("DLD-1" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("ADORA2B" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN) ("Fra-2" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN) ("Activator Protein 1" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN) ("antigen-1" . SPARSER::PROTEIN)
    ("Fra-1" . SPARSER::PROTEIN)
    ("iASPP (anti-apoptotic) and ASPP2 (pro-apoptotic)" . SPARSER::COLLECTION)
    ("iASPP-p53" . SPARSER::COLLECTION)
    ("other inflammatory-related genes" . SPARSER::GENE)
    ("Arg" . SPARSER::AMINO-ACID) ("Pro" . SPARSER::AMINO-ACID)
    ("ankyrin" . SPARSER::PROTEIN) ("cyclin B1/CDK1" . SPARSER::COLLECTION)
    ("iASPP(92-828) and iASPP(295-828)" . SPARSER::COLLECTION)
    ("osteoclasts" . SPARSER::PROTEIN) ("XIAP" . SPARSER::PROTEIN)
    ("Caspases and iASPP" . SPARSER::COLLECTION) ("elegans" . SPARSER::PROTEIN)
    ("Caspases" . SPARSER::PROTEIN)
    ("a more potent inhibitor of p53 and RelA/p65" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FL-iASPP, iASPP(295-828) and iASPP(92-828)" . SPARSER::COLLECTION)
    ("iASPP(295-828) and iASPP(92-828)" . SPARSER::COLLECTION)
    ("FL-iASPP and the 80kDa iASPP fragment" . SPARSER::COLLECTION)
    ("cytosolic caspases and the stable 80kDa iASPP fragment"
     . SPARSER::COLLECTION)
    ("both iASPP(92-828) and iASPP(295-828)" . SPARSER::COLLECTION)
    ("Truncated V5-tagged iASPP mutants" . SPARSER::MUTANT)
    ("cytochrome c and dATP" . SPARSER::COLLECTION)
    ("a potential caspase-3 substrate" . SPARSER::SUBSTRATE)
    ("FMK" . SPARSER::PROTEIN) ("iASPP-" . SPARSER::PROTEIN)
    ("approximately 95, 80, 30, and 5 kDa" . SPARSER::PROTEIN)
    ("FL-iASPP and iASPP" . SPARSER::COLLECTION)
    ("Activated cleaved caspase-3 and the 80kDa iASPP fragment"
     . SPARSER::COLLECTION)
    ("endogenous iASPP (protein in the cell free cytosol) or exogenous iASPP ( in vitro translated iASPP added into cell free system)"
     . SPARSER::COLLECTION)
    ("exogenous iASPP" . SPARSER::PROTEIN) ("dATP" . SPARSER::DATP)
    ("staurosporine-" . SPARSER::DRUG) ("staurosporine" . SPARSER::DRUG)
    ("Jurkat" . SPARSER::PROTEIN)
    ("p65 and mutant p53 [ xref ]" . SPARSER::COLLECTION)
    ("a potential substrate" . SPARSER::SUBSTRATE) ("Fas" . SPARSER::PROTEIN)
    ("specific proteins [ xref ] and the cleaved fragments"
     . SPARSER::COLLECTION)
    ("fragments" . SPARSER::FRAGMENT)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cysteine" . SPARSER::AMINO-ACID) ("Ankyrin" . SPARSER::PROTEIN)
    ("oligomer" . SPARSER::MOLECULE)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("iASPP-RelA/p65" . SPARSER::COLLECTION)
    ("leukemia" . SPARSER::PROTEIN) ("ASPP1 and ASPP2" . SPARSER::COLLECTION)
    ("p53 and RelA/p65" . SPARSER::COLLECTION)
    ("Protein (ASPP)" . SPARSER::PROTEIN)
    ("ASPP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Proline" . SPARSER::AMINO-ACID)
    ("etoposide" . SPARSER::PROTEIN) ("doxorubicin" . SPARSER::PROTEIN)
    ("example" . SPARSER::EXAMPLE) ("p53 or RelA/p65" . SPARSER::COLLECTION)
    ("80kDa" . SPARSER::PROTEIN) ("fragment" . SPARSER::FRAGMENT)
    ("kDa" . SPARSER::PROTEIN) ("Caspase" . SPARSER::PROTEIN)
    ("iASPP" . SPARSER::PROTEIN) ("RelA/p65" . SPARSER::COLLECTION)
    ("RelA" . SPARSER::PROTEIN)
    ("the inflammatory mediator NF-kB and the tumour suppressor protein p53"
     . SPARSER::COLLECTION)
    ("protein A" . SPARSER::PROTEIN) ("or 2" . SPARSER::MOLECULE)
    ("monoclonal antibody" . SPARSER::DRUG)
    ("penicillin G" . SPARSER::MOLECULE) ("L-Glutamine" . SPARSER::MOLECULE)
    ("Caspase 4" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis protein" . SPARSER::PROTEIN)
    ("PIG3" . SPARSER::PROTEIN) ("gene 3" . SPARSER::PROTEIN)
    ("aspartic acids" . SPARSER::AMINO-ACID)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1-4" . SPARSER::PROTEIN)
    ("caspase-3" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("z-VAD-FMK" . SPARSER::DRUG) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("p73" . SPARSER::PROTEIN) ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ICAM1" . SPARSER::PROTEIN) ("type 1" . SPARSER::PROTEIN)
    ("ASPP2" . SPARSER::PROTEIN) ("ASPP1" . SPARSER::PROTEIN)
    ("Ankyrin repeat" . SPARSER::PROTEIN) ("p65" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("VEGF and EIF4EBP1" . SPARSER::COLLECTION)
    ("PAPB-1" . SPARSER::COLLECTION) ("PAPB" . SPARSER::PROTEIN)
    ("HER2 and HER3" . SPARSER::COLLECTION) ("ligand" . SPARSER::MOLECULE)
    ("chemokine" . SPARSER::PROTEIN) ("isoform" . SPARSER::ISOFORM)
    ("eIF4EBP1" . SPARSER::PROTEIN) ("AKT/mTOR" . SPARSER::COLLECTION)
    ("eIF" . SPARSER::PROTEIN)
    ("miR-125a, miR-125b, and EIF4EBP1" . SPARSER::COLLECTION)
    ("mTOR and VEGF" . SPARSER::COLLECTION) ("mTOR" . SPARSER::PROTEIN)
    ("EIF4EBP1 and VEGF" . SPARSER::COLLECTION) ("VEGF" . SPARSER::PROTEIN)
    ("miR-125a- and miR-125b-mimic-treated" . SPARSER::COLLECTION)
    ("miR-125a-" . SPARSER::PROTEIN)
    ("a miR-125a inhibitor, a miR-125b inhibitor, or a negative control"
     . SPARSER::COLLECTION)
    ("miR-125a or miR-125b" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION) ("HGS" . SPARSER::PROTEIN)
    ("miR-125a and miR-125b, and EIF4EBP1" . SPARSER::COLLECTION)
    ("miR-125b, and EIF4EBP1" . SPARSER::COLLECTION)
    ("aberrantly-expressed miRNAs—whether over-expressed tumorigenic miRNAs"
     . SPARSER::PROTEIN)
    ("at least one miRNA" . SPARSER::PROTEIN)
    ("an intrinsic barrier" . SPARSER::PROTEIN)
    ("Akt and Ras" . SPARSER::COLLECTION) ("barrier" . SPARSER::PROTEIN)
    ("posttranscriptional regulators" . SPARSER::REGULATOR)
    ("miR-125a and miR-125b" . SPARSER::COLLECTION)
    ("luciferase" . SPARSER::PROTEIN) ("miRNA" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("4EBP1" . SPARSER::PROTEIN)
    ("Anti-β" . SPARSER::PROTEIN) ("anti-VEGF" . SPARSER::DRUG)
    ("4E-BP1" . SPARSER::PROTEIN) ("NP 40" . SPARSER::MOLECULE)
    ("sodium chloride" . SPARSER::DRUG) ("U6" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("IGF2" . SPARSER::PROTEIN) ("eIF4EBP" . SPARSER::PROTEIN-FAMILY)
    ("EIF4EBP" . SPARSER::PROTEIN-FAMILY) ("E-cadherin" . SPARSER::PROTEIN)
    ("full-length" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EIF4E" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("miR-125b" . SPARSER::MOLECULE) ("miR-125a" . SPARSER::PROTEIN)
    ("EIF4EBP1" . SPARSER::PROTEIN) ("theG" . SPARSER::PROTEIN)
    ("only one SNPin RASGRF1" . SPARSER::PROTEIN)
    ("a strong candidate gene" . SPARSER::GENE)
    ("choroidal retinoic acid" . SPARSER::MOLECULE)
    ("receptors and retinoic acid" . SPARSER::COLLECTION)
    ("muscarinic" . SPARSER::PROTEIN) ("GDP/GTP" . SPARSER::PROTEIN-PAIR)
    ("GTPases" . SPARSER::GTPASE) ("GTP" . SPARSER::NUCLEOTIDE)
    ("GDP" . SPARSER::NUCLEOTIDE) ("retina" . SPARSER::DRUG)
    ("NOS" . SPARSER::PROTEIN) ("cohorts" . SPARSER::MOLECULE)
    ("light" . SPARSER::PROTEIN) ("Han" . SPARSER::PROTEIN)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("guanine" . SPARSER::PROTEIN)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LUM" . SPARSER::PROTEIN)
    ("lumican" . SPARSER::PROTEIN) ("collagen" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("GT" . SPARSER::PROTEIN)
    ("variants" . SPARSER::VARIANT) ("allele" . SPARSER::ALLELE)
    ("seven" . SPARSER::PROTEIN) ("Biologic" . SPARSER::DRUG)
    ("retinoic acid" . SPARSER::MOLECULE) ("Ras family" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR) ("GRF1" . SPARSER::PROTEIN)
    ("CDC25L" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("GJD2" . SPARSER::PROTEIN)
    ("gap junction protein delta 2" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PAX6" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("transforming growth factor beta 1" . SPARSER::PROTEIN)
    ("RASGRF1" . SPARSER::PROTEIN) ("GnRHR/ERK" . SPARSER::COLLECTION)
    ("even two (equally probable) states" . SPARSER::BIO-STATE)
    ("mGnRHR or XGnRHR" . SPARSER::COLLECTION) ("mGnRHR" . SPARSER::PROTEIN)
    ("HA-mGnRHR" . SPARSER::PROTEIN-PAIR)
    ("HA and ppERK" . SPARSER::COLLECTION)
    ("the functional GnRHR" . SPARSER::PROTEIN)
    ("GnRH and GnRH" . SPARSER::COLLECTION)
    ("mammalian GnRHR (hGnRHR and mGnRHR) that do not desensitize and non-mammalian GnRHR (XGnRHR)"
     . SPARSER::COLLECTION)
    ("schematic form" . SPARSER::FORM) ("maps" . SPARSER::PROTEIN)
    ("under-expressing GnRHR" . SPARSER::PROTEIN)
    ("cytokine and growth factor" . SPARSER::COLLECTION)
    ("cytokine" . SPARSER::PROTEIN)
    ("Ca 2+ effectors (including NFAT) as well as PKCs and their effectors (including ERK)"
     . SPARSER::COLLECTION)
    ("PKCs and their effectors (including ERK)" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ionomycin, and MI" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("HA" . SPARSER::PROTEIN) ("HA-GnRHR and ppERK" . SPARSER::COLLECTION)
    ("HA-GnRHR" . SPARSER::COLLECTION) ("CHX" . SPARSER::PROTEIN)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN) ("Protein" . SPARSER::PROTEIN)
    ("myc and R53A/R54A" . SPARSER::COLLECTION) ("myc" . SPARSER::PROTEIN)
    ("the GnRH and K52R ERK2" . SPARSER::COLLECTION)
    ("ERK2-GFP" . SPARSER::COLLECTION) ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("run" . SPARSER::PROTEIN-FAMILY) ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NFAT1c-EFP" . SPARSER::COLLECTION) ("EFP" . SPARSER::PROTEIN)
    ("c" . SPARSER::PROTEIN) ("PLC/PKC/ERK" . SPARSER::COLLECTION)
    ("more reliable hormone" . SPARSER::MOLECULE)
    ("zsGREEN" . SPARSER::PROTEIN) ("Egr1-zsGREEN" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR) ("Effector" . SPARSER::EFFECTOR)
    ("Egr1" . SPARSER::PROTEIN) ("PDBu" . SPARSER::MOLECULE)
    ("activator" . SPARSER::ACTIVATOR) ("GnRH and ppERK" . SPARSER::COLLECTION)
    ("ERK and NFAT" . SPARSER::COLLECTION)
    ("arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("agonist" . SPARSER::AGONIST)
    ("arrestins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("COOH" . SPARSER::MOLECULE)
    ("PKC" . SPARSER::PROTEIN) ("PLC" . SPARSER::PROTEIN)
    ("neuropeptide" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("effectors" . SPARSER::EFFECTOR)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EGF" . SPARSER::PROTEIN)
    ("Raf or son-of-sevenless (SOS)" . SPARSER::COLLECTION)
    ("dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("Raf or son-of-sevenless" . SPARSER::COLLECTION)
    ("DUSPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatases" . SPARSER::PHOSPHATASE) ("son" . SPARSER::PROTEIN)
    ("NFκB and ATF-2" . SPARSER::COLLECTION) ("GnRHRs" . SPARSER::PROTEIN)
    ("DUSP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("inactive" . SPARSER::INACTIVE)
    ("NFAT" . SPARSER::PROTEIN) ("GnRHR" . SPARSER::PROTEIN)
    ("GnRH" . SPARSER::PROTEIN) ("gonadotropin" . SPARSER::PROTEIN)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("−2" . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("NFAT1" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("Ca 2+" . SPARSER::CALCIUM-ION) ("phospholipase C" . SPARSER::PROTEIN)
    ("gonadotropin-releasing hormone receptor" . SPARSER::PROTEIN)
    ("G-proteins" . SPARSER::PROTEIN) ("ATF-2" . SPARSER::PROTEIN)
    ("NFκB" . SPARSER::PROTEIN) ("DUSP5" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PHD1 and Cep192" . SPARSER::COLLECTION)
    ("either wild-type PHD1 or the unphosphorylatable S130A PHD1 mutant"
     . SPARSER::COLLECTION)
    ("the unphosphorylatable S130A PHD1 mutant" . SPARSER::MUTANT)
    ("centrosomes" . SPARSER::PROTEIN)
    ("the centrosomal protein Cep192" . SPARSER::PROTEIN)
    ("cofactor" . SPARSER::MOLECULE) ("PHD2 and PHD3" . SPARSER::COLLECTION)
    ("HIF and Cep192" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("either Cep192 or the ubiquitin ligase Skp2" . SPARSER::COLLECTION)
    ("the ubiquitin ligase Skp2" . SPARSER::PROTEIN) ("Skp" . SPARSER::PROTEIN)
    ("S130 and HIF1α" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("centrosomal components" . SPARSER::COMPONENT)
    ("pericentrin" . SPARSER::PROTEIN) ("PHD1-S130A–GFP" . SPARSER::COLLECTION)
    ("PHD1-S130D–GFP" . SPARSER::COLLECTION) ("S130A" . SPARSER::PROTEIN)
    ("PHD1-S130A" . SPARSER::COLLECTION) ("S130D" . SPARSER::PROTEIN)
    ("PHD1-S130D" . SPARSER::COLLECTION)
    ("exogenous wild-type PHD1" . SPARSER::PROTEIN)
    ("endogenous PHD1 and only expressing GFP" . SPARSER::COLLECTION)
    ("particular S130" . SPARSER::PROTEIN)
    ("HIF1α and PHD1" . SPARSER::COLLECTION)
    ("Normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MG132 or hypoxia" . SPARSER::COLLECTION)
    ("cycloheximide" . SPARSER::PROTEIN) ("PHD1–HIFα" . SPARSER::PROTEIN-PAIR)
    ("double-thymidine" . SPARSER::PROTEIN)
    ("BNIP3, CAIX and Glut3" . SPARSER::COLLECTION)
    ("PHD2, PHD3 and CAIX" . SPARSER::COLLECTION) ("CAIX" . SPARSER::PROTEIN)
    ("DFX and DMOG" . SPARSER::COLLECTION)
    ("anti-hydroxy-HIF1α" . SPARSER::COLLECTION) ("DMOG" . SPARSER::DRUG)
    ("DFX" . SPARSER::PROTEIN) ("proteasomal" . SPARSER::PROTEIN)
    ("HIF1α and HIF2α" . SPARSER::COLLECTION)
    ("the wild-type PHD1 and the two mutants" . SPARSER::COLLECTION)
    ("GST–PHD1" . SPARSER::COLLECTION) ("GST" . SPARSER::PROTEIN)
    ("enzyme" . SPARSER::ENZYME) ("Myc and E2F1" . SPARSER::COLLECTION)
    ("the mutants, led to an increase in PHD1 phosphorylation"
     . SPARSER::MUTANT)
    ("E2F1 and Src" . SPARSER::COLLECTION) ("Src" . SPARSER::PROTEIN)
    ("the oncogene Myc and two mutant derivatives" . SPARSER::COLLECTION)
    ("derivatives" . SPARSER::DERIVATIVE) ("mutant" . SPARSER::MUTANT)
    ("Myc" . SPARSER::PROTEIN) ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("MAPK3 and MAPK1" . SPARSER::COLLECTION)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("thymidine" . SPARSER::PROTEIN)
    ("oncogenes" . SPARSER::ONCOGENE) ("CDK1–cyclin-B" . SPARSER::COLLECTION)
    ("CDK2 and CDK1" . SPARSER::COLLECTION)
    ("PHD1 and CDK2" . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("aspartate" . SPARSER::PROTEIN)
    ("alanine" . SPARSER::AMINO-ACID) ("mutants" . SPARSER::MUTANT)
    ("Antibody" . SPARSER::PROTEIN)
    ("the region around S130" . SPARSER::PROTEIN)
    ("peptide" . SPARSER::PEPTIDE)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("antibodies" . SPARSER::ANTIBODY) ("peptides" . SPARSER::PEPTIDE)
    ("PHD1–GFP" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("map" . SPARSER::PROTEIN)
    ("the key centrosomal component Cep192" . SPARSER::PROTEIN)
    ("PKM2 and HCLK2" . SPARSER::COLLECTION)
    ("their regulatory cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 (also known as CDKN1A) and p27 (also known as CDKN1B)"
     . SPARSER::COLLECTION)
    ("their regulatory cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine/threonine" . SPARSER::COLLECTION) ("kinases" . SPARSER::KINASE)
    ("states" . SPARSER::BIO-STATE)
    ("a transcriptionally active complex" . SPARSER::BIO-COMPLEX)
    ("PHD" . SPARSER::PROTEIN) ("ligase" . SPARSER::LIGASE)
    ("VHL" . SPARSER::PROTEIN) ("PHD1 and/or PHD3" . SPARSER::COLLECTION)
    ("PHD1 and PHD3" . SPARSER::COLLECTION)
    ("PHD1, PHD2 and PHD3" . SPARSER::COLLECTION)
    ("EGLN2, EGLN1 and EGLN3" . SPARSER::COLLECTION)
    ("cofactors" . SPARSER::PROTEIN) ("enzymes" . SPARSER::ENZYME)
    ("proline" . SPARSER::AMINO-ACID) ("normoxia" . SPARSER::PROTEIN)
    ("ODD" . SPARSER::PROTEIN) ("bHLH" . SPARSER::PROTEIN)
    ("the currently known isoforms" . SPARSER::ISOFORM)
    ("isoforms" . SPARSER::ISOFORM)
    ("an oxygen-labile HIFα subunit and the constitutively expressed HIF1β subunit (also known as ARNT)"
     . SPARSER::COLLECTION)
    ("ARNT" . SPARSER::PROTEIN) ("subunit" . SPARSER::FRAGMENT)
    ("labile" . SPARSER::PROTEIN) ("HIFs" . SPARSER::PROTEIN)
    ("Hypoxia" . SPARSER::PROTEIN) ("ATP" . SPARSER::ATP)
    ("HIF1α and Cep192" . SPARSER::COLLECTION) ("mediators" . SPARSER::PROTEIN)
    ("PHD1 and HIF1α" . SPARSER::COLLECTION) ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("CDK2, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("the crucial centrosomal protein Cep192" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("hypoxia" . SPARSER::PROTEIN)
    ("PHDs" . SPARSER::PROTEIN) ("prolyl" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("l −1" . SPARSER::PROTEIN)
    ("phospho-ERK" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("NBP1" . SPARSER::PROTEIN) ("GLUT3" . SPARSER::PROTEIN)
    ("HK2" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("PA1" . SPARSER::PROTEIN) ("HIF-2α" . SPARSER::PROTEIN)
    ("phospho-threonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("N1" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE)
    ("peptidyl-prolyl cis-trans isomerase" . SPARSER::PROTEIN)
    ("FKBP38" . SPARSER::PROTEIN) ("Siah-2" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SLC2A3" . SPARSER::PROTEIN)
    ("Glut3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BNIP3" . SPARSER::PROTEIN)
    ("CA9" . SPARSER::PROTEIN) ("MG132" . SPARSER::PROTEIN)
    ("2–4" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN) ("MAPK1" . SPARSER::PROTEIN)
    ("MAPK3" . SPARSER::PROTEIN) ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK2" . SPARSER::PROTEIN) ("ERK1" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("Growth factors" . SPARSER::GROWTH-FACTOR)
    ("cyclin-B" . SPARSER::PROTEIN-FAMILY) ("CDK1" . SPARSER::PROTEIN)
    ("HCLK2" . SPARSER::PROTEIN) ("PKM2" . SPARSER::PROTEIN)
    ("FOXO3A" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("CDKN1A" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("von Hippel-Lindau" . SPARSER::PROTEIN) ("HIF2α" . SPARSER::PROTEIN)
    ("EGLN3" . SPARSER::PROTEIN) ("EGLN1" . SPARSER::PROTEIN)
    ("PHD3" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("amino acid" . SPARSER::AMINO-ACID)
    ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("basic helix-loop-helix" . SPARSER::PROTEIN) ("HIF3α" . SPARSER::PROTEIN)
    ("EPAS1" . SPARSER::PROTEIN) ("HIF2a" . SPARSER::PROTEIN)
    ("HIF1β" . SPARSER::PROTEIN) ("HIF1α" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN) ("S130" . SPARSER::PROTEIN)
    ("CDK6" . SPARSER::PROTEIN) ("CDK2" . SPARSER::PROTEIN)
    ("Cep192" . SPARSER::PROTEIN) ("EGLN2" . SPARSER::PROTEIN)
    ("PHD1" . SPARSER::PROTEIN) ("a predictive biomarker" . SPARSER::MOLECULE)
    ("HDAC6 and proteasome inhibitors [ xref ]" . SPARSER::COLLECTION)
    ("taxanes" . SPARSER::DRUG)
    ("BRMS1 [ xref ] or c-Raf and AKT [ xref ]" . SPARSER::COLLECTION)
    ("c-Raf and AKT" . SPARSER::COLLECTION) ("c-Raf" . SPARSER::PROTEIN-PAIR)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("substrate" . SPARSER::SUBSTRATE)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("defective mitochondria" . SPARSER::PROTEIN) ("mito" . SPARSER::DRUG)
    ("pro" . SPARSER::AMINO-ACID) ("EnR" . SPARSER::PROTEIN)
    ("an essential component" . SPARSER::COMPONENT)
    ("chaperone" . SPARSER::PROTEIN) ("chaperones" . SPARSER::PROTEIN)
    ("polypeptides" . SPARSER::PEPTIDE) ("substrates" . SPARSER::SUBSTRATE)
    ("ER–PR" . SPARSER::COLLECTION) ("PAM" . SPARSER::PROTEIN)
    ("S3b" . SPARSER::PROTEIN) ("HR" . SPARSER::PROTEIN)
    ("S3a" . SPARSER::PROTEIN) ("canonical HDAC6" . SPARSER::PROTEIN)
    ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("protein or mRNA" . SPARSER::COLLECTION) ("variant" . SPARSER::VARIANT)
    ("both cells lines (as demonstrated by accumulation of acetylated α-tubulin) all these selective HDAC6 inhibitors"
     . SPARSER::INHIBITOR)
    ("HDACs" . SPARSER::PROTEIN)
    ("a commonly used chemotherapeutic drug" . SPARSER::DRUG)
    ("paclitaxel" . SPARSER::DRUG) ("PDX" . SPARSER::PROTEIN)
    ("Ac-α-tubulin" . SPARSER::COLLECTION) ("cytometry" . SPARSER::PROTEIN)
    ("AAD" . SPARSER::MOLECULE) ("MDA" . SPARSER::DRUG)
    ("Our genome-wide lentiviral shRNA" . SPARSER::PROTEIN)
    ("NCT01997840, NCT01323751 and NCT02189343" . SPARSER::COLLECTION)
    ("NCT" . SPARSER::PROTEIN)
    ("clinically relevant pharmacological inhibitors" . SPARSER::INHIBITOR)
    ("HDAC6 (Fig.  xref ) and HDAC6" . SPARSER::COLLECTION)
    ("GO" . SPARSER::PROTEIN) ("Gene" . SPARSER::GENE)
    ("GSEA" . SPARSER::PROTEIN) ("FC" . SPARSER::PROTEIN)
    ("general essential genes" . SPARSER::GENE)
    ("spliceosome" . SPARSER::BIO-COMPLEX) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("essential genes" . SPARSER::GENE) ("QC" . SPARSER::PROTEIN)
    ("approximately 18,500 human genes" . SPARSER::GENE)
    ("containing approximately 58,000 different shRNAs" . SPARSER::RNA)
    ("shRNA-miRs" . SPARSER::COLLECTION) ("shRNAs" . SPARSER::RNA)
    ("miRs" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("lymphoid" . SPARSER::PROTEIN) ("IIb" . SPARSER::DRUG) ("class" . CLASS)
    ("basal subtypes" . SPARSER::PROTEIN) ("luminal" . SPARSER::DRUG)
    ("oncogene" . SPARSER::ONCOGENE) ("BRMS1" . SPARSER::PROTEIN)
    ("breast cancer metastasis suppressor 1" . SPARSER::PROTEIN)
    ("HIF-1 alpha" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p11" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("S1b" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("Annexin-V" . SPARSER::PROTEIN)
    ("β-actin" . SPARSER::PROTEIN) ("histone deacetylase" . SPARSER::PROTEIN)
    ("histone deacetylase 6" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("-2" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC6" . SPARSER::PROTEIN) ("PI3K/Akt/FOXO" . SPARSER::COLLECTION)
    ("FOXO3a and its downstream molecule" . SPARSER::COLLECTION)
    ("FOXO3a protein and their target genes p27Kip1" . SPARSER::COLLECTION)
    ("tamoxifen" . SPARSER::MOLECULE)
    ("FOXO3a and vernodalin" . SPARSER::COLLECTION)
    ("cyclinD1, p21Cip and p27Kip1" . SPARSER::COLLECTION)
    ("FOXO3a/PI3K/Akt" . SPARSER::COLLECTION)
    ("p21Cip1 and p27Kip1" . SPARSER::COLLECTION)
    ("effector" . SPARSER::EFFECTOR)
    ("an attractive molecular target" . SPARSER::TARGET-PROTEIN)
    ("p-PI3K" . SPARSER::COLLECTION) ("GSK" . SPARSER::PROTEIN)
    ("PI3K or Akt" . SPARSER::COLLECTION)
    ("Bcl-xL and Bcl-2" . SPARSER::COLLECTION)
    ("mitochondria" . SPARSER::PROTEIN) ("caspases" . SPARSER::PROTEIN)
    ("Bax" . SPARSER::PROTEIN) ("CDKIs" . SPARSER::DRUG)
    ("CDK-cyclin" . SPARSER::COLLECTION) ("p21 and p27" . SPARSER::COLLECTION)
    ("FOXO3a and other important cell cycle molecules" . SPARSER::COLLECTION)
    ("pro-apoptotic genes" . SPARSER::GENE)
    ("Bim and p27Kip1" . SPARSER::COLLECTION)
    ("FOXO3a and p27Kip1" . SPARSER::COLLECTION)
    ("FOXO3a and total FOXO3a protein" . SPARSER::COLLECTION)
    ("PCNA and Ki-67" . SPARSER::COLLECTION)
    ("Ki67 and PCNA" . SPARSER::COLLECTION) ("IV" . SPARSER::PROTEIN)
    ("Tamoxifen" . SPARSER::MOLECULE) ("II" . SPARSER::PROTEIN)
    ("Group" . SPARSER::MOLECULE) ("hepatocytes" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE) ("Akt and PI3K" . SPARSER::COLLECTION)
    ("p21cip1/waf1" . SPARSER::COLLECTION)
    ("a FOXO3a-specific siRNA or control siRNA" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("Figure S2 and Additional file xref" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("p21Cip1/waf1" . SPARSER::COLLECTION)
    ("p27Kip1 and p21" . SPARSER::COLLECTION) ("Cip" . SPARSER::PROTEIN)
    ("cyclins and/or CDKs" . SPARSER::COLLECTION)
    ("cyclin/cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("CDKs" . SPARSER::PROTEIN) ("genistein" . SPARSER::PROTEIN)
    ("phytochemicals" . SPARSER::DRUG)
    ("FOXO3 and its downstream target molecules" . SPARSER::COLLECTION)
    ("sesquiterpene" . SPARSER::MOLECULE) ("cytotoxic" . SPARSER::PROTEIN)
    ("caspase" . SPARSER::PROTEIN) ("kappa" . SPARSER::PROTEIN-FAMILY)
    ("chloroform" . SPARSER::MOLECULE)
    ("KIP1 (also known as p27) and WAF1 (also known as CIP1 or p21)"
     . SPARSER::COLLECTION)
    ("CIP1 or p21" . SPARSER::COLLECTION) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("regulators" . SPARSER::REGULATOR)
    ("cyclin-dependent kinases (CDK) and their inhibitors (CDKI) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("cyclins, cyclin-dependent kinases (CDK) and their inhibitors (CDKI) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("inhibitors (CDKI)" . SPARSER::INHIBITOR) ("CDKI" . SPARSER::DRUG)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chemotherapeutic drugs" . SPARSER::DRUG) ("variety" . SPARSER::VARIETY)
    ("cyclin-CDK" . SPARSER::COLLECTION) ("complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CKI" . SPARSER::PROTEIN)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("threonine/serine" . SPARSER::COLLECTION) ("Ser" . SPARSER::AMINO-ACID)
    ("Thr" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("threonine" . SPARSER::AMINO-ACID)
    ("FOXO1, FOXO3, FOXO4 and FOXO6" . SPARSER::COLLECTION)
    ("forkhead" . SPARSER::PROTEIN) ("antioxidants" . SPARSER::DRUG)
    ("chemo-therapeutic drugs" . SPARSER::DRUG)
    ("the chemo-therapeutic drugs" . SPARSER::DRUG)
    ("estrogen" . SPARSER::MOLECULE) ("parts" . SPARSER::COMPONENT)
    ("PCNA and Ki67" . SPARSER::COLLECTION)
    ("FOXO3a/PI3K-Akt" . SPARSER::COLLECTION)
    ("p21Waf1/cip1" . SPARSER::COLLECTION) ("cip" . SPARSER::PROTEIN)
    ("FOXO" . SPARSER::PROTEIN-FAMILY) ("p-FOXO3a" . SPARSER::COLLECTION)
    ("LA" . SPARSER::PROTEIN) ("PCNA" . SPARSER::PROTEIN)
    ("Western blot" . SPARSER::PROTEIN) ("targets" . SPARSER::TARGET-PROTEIN)
    ("siRNA" . SPARSER::PROTEIN) ("RNA" . SPARSER::RNA)
    ("PI3K, FOXO3a, Bim, p27kip1, cyclinD1, and cyclinE" . SPARSER::COLLECTION)
    ("p-Akt" . SPARSER::COLLECTION) ("blot" . SPARSER::PROTEIN)
    ("cyclinE" . SPARSER::PROTEIN-FAMILY) ("Bim" . SPARSER::PROTEIN)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Vernodalin" . SPARSER::DRUG)
    ("vernodalin" . SPARSER::DRUG) ("LY294002" . SPARSER::MOLECULE)
    ("GSK-3β" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("Anti-" . SPARSER::ANTIBODY) ("Group V" . SPARSER::PROTEIN)
    ("Group I" . SPARSER::PROTEIN) ("H–E" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("p21cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S2" . SPARSER::MOLECULE)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tween 20" . SPARSER::MOLECULE) ("Group III" . SPARSER::PROTEIN)
    ("-3 " . SPARSER::PROTEIN) ("GSK-3α" . SPARSER::PROTEIN)
    ("GSK-3" . SPARSER::PROTEIN)
    ("Glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("anti-β" . SPARSER::PROTEIN) ("LaminB1" . SPARSER::PROTEIN)
    ("waf1" . SPARSER::PROTEIN) ("p21Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NP-40" . SPARSER::DRUG) ("serum albumin" . SPARSER::PROTEIN)
    ("Triton X-100" . SPARSER::MOLECULE) ("CO 2" . SPARSER::PROTEIN)
    ("CA-9" . SPARSER::PROTEIN) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("anti-oxidant" . SPARSER::DRUG) ("anti-diabetic" . SPARSER::DRUG)
    ("anti-microbial" . SPARSER::DRUG) ("anti-viral" . SPARSER::DRUG)
    ("CIP1" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN) ("KIP1" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-2" . SPARSER::PROTEIN) ("Ser-315" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY) ("PI3K-Akt" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("p21" . SPARSER::PROTEIN)
    ("p27Kip1" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("kinase activity" . SPARSER::PROTEIN) ("cyclinD1" . SPARSER::PROTEIN)
    ("p27kip1" . SPARSER::PROTEIN) ("FOXO3a" . SPARSER::PROTEIN)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rep" . SPARSER::PROTEIN)
    ("a useful predictive or diagnostic biomarker" . SPARSER::MOLECULE)
    ("antibody" . SPARSER::ANTIBODY)
    ("a potential biomarker" . SPARSER::MOLECULE) ("DSS" . SPARSER::PROTEIN)
    ("adjuvant" . SPARSER::DRUG)
    ("poly adeno-sine diphosphate-ribose polymerase-1 (PARP1) inhibitors and platinum-derived drugs"
     . SPARSER::COLLECTION)
    ("drugs" . SPARSER::DRUG) ("platinum" . SPARSER::MOLECULE)
    ("polymerase" . SPARSER::PROTEIN) ("-1" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("traditional hormone" . SPARSER::MOLECULE)
    ("ER and PR" . SPARSER::COLLECTION)
    ("a reliable biomarker" . SPARSER::MOLECULE)
    ("receptors" . SPARSER::PROTEIN) ("hormone" . SPARSER::MOLECULE)
    ("–1" . SPARSER::PROTEIN) ("MSP" . SPARSER::PROTEIN)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::RECEPTOR) ("met" . SPARSER::AMINO-ACID)
    ("prone" . SPARSER::PROTEIN-FAMILY)
    ("especially tumor suppressor genes" . SPARSER::GENE)
    ("suppressor" . SPARSER::SUPPRESSOR) ("promoters" . SPARSER::PROMOTER)
    ("group" . SPARSER::MOLECULE)
    ("a useful predictive or prognostic biomarker" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE) ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER" . SPARSER::PROTEIN) ("CpG" . SPARSER::PROTEIN)
    ("a classic tumor suppressor gene" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN) ("BRCA 1" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("innovative microRNA-based therapeutics" . SPARSER::THERAPEUTICS)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("MDM2-p53mRNA" . SPARSER::COLLECTION)
    ("mRNA or microRNA" . SPARSER::COLLECTION)
    ("MDM2 protein and p53" . SPARSER::COLLECTION)
    ("protein-mRNA" . SPARSER::COLLECTION) ("miR-34a-" . SPARSER::MOLECULE)
    ("mRNA-MDM2 protein" . SPARSER::COLLECTION)
    ("protein-MDM2" . SPARSER::COLLECTION)
    ("a transcription factor and a microRNA" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT)
    ("oscillatory p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("versa" . SPARSER::PROTEIN) ("neocarzinostatin (NCS)" . SPARSER::PROTEIN)
    ("NCS" . SPARSER::PROTEIN) ("neocarzinostatin" . SPARSER::PROTEIN)
    ("p53-mdm2" . SPARSER::COLLECTION) ("molecules" . SPARSER::MOLECULE)
    ("a stably integrated fluorescent reporter Venus fused" . SPARSER::PROTEIN)
    ("promoter" . SPARSER::PROMOTER) ("metallothionein" . SPARSER::PROTEIN)
    ("fused" . SPARSER::PROTEIN) ("fraction" . SPARSER::COMPONENT)
    ("types" . TYPE) ("miR-34a and miR-29" . SPARSER::COLLECTION)
    ("mRNAs" . SPARSER::PROTEIN) ("state" . SPARSER::BIO-STATE)
    ("inhibitor" . SPARSER::INHIBITOR)
    ("miR-34a and miR-29a" . SPARSER::COLLECTION)
    ("the mathematical model inhibitors" . SPARSER::INHIBITOR)
    ("radiomimetic drug" . SPARSER::DRUG)
    ("p53 and MDM2" . SPARSER::COLLECTION) ("drug" . SPARSER::DRUG)
    ("another oscillatory transcription factor" . SPARSER::PROTEIN)
    ("damped" . SPARSER::MOLECULE) ("ATM, p53 and Wip1" . SPARSER::COLLECTION)
    ("microRNAs and intermediate proteins" . SPARSER::COLLECTION)
    ("kinase" . SPARSER::KINASE) ("ATM" . SPARSER::PROTEIN)
    ("active" . SPARSER::ACTIVE) ("molecule" . SPARSER::MOLECULE)
    ("its associated target proteins" . SPARSER::PROTEIN)
    ("SIRT1 and YY1" . SPARSER::COLLECTION)
    ("miR-34a, and CDC42 and Wip1" . SPARSER::COLLECTION)
    ("CDC42 and Wip1" . SPARSER::COLLECTION) ("proteins" . SPARSER::PROTEIN)
    ("target" . SPARSER::TARGET-PROTEIN) ("component" . SPARSER::COMPONENT)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("phosphatase" . SPARSER::PHOSPHATASE)
    ("miR-29b, and miR-29c" . SPARSER::COLLECTION)
    ("p53, miR-34a, YY1 and MDM2" . SPARSER::COLLECTION)
    ("a ubiquitous transcription factor" . SPARSER::PROTEIN)
    ("Yin" . SPARSER::PROTEIN) ("antagonist" . SPARSER::MOLECULE)
    ("regulator" . SPARSER::REGULATOR)
    ("p53 and miR-34a" . SPARSER::COLLECTION)
    ("protein and mRNA" . SPARSER::COLLECTION) ("mRNA" . SPARSER::PROTEIN)
    ("family" . SPARSER::PROTEIN-FAMILY) ("part" . SPARSER::COMPONENT)
    ("miRNAs" . SPARSER::PROTEIN) ("MicroRNA" . SPARSER::RNA)
    ("inhibitors" . SPARSER::INHIBITOR)
    ("approximately 22 nucleotides" . SPARSER::NUCLEOTIDE)
    ("genes" . SPARSER::GENE) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("RNAs" . SPARSER::RNA) ("MicroRNAs" . SPARSER::RNA)
    ("the p53 protein and its negative regulator MDM2 [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("protein" . SPARSER::PROTEIN) ("trigger" . SPARSER::PROTEIN)
    ("gene" . SPARSER::GENE) ("type" . TYPE) ("complex" . SPARSER::BIO-COMPLEX)
    ("forms" . SPARSER::FORM) ("form" . SPARSER::FORM)
    ("MCF7" . SPARSER::PROTEIN) ("DNA" . SPARSER::DNA)
    ("p53-MDM2" . SPARSER::COLLECTION) ("miR" . SPARSER::PROTEIN)
    ("around p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("microRNA" . SPARSER::RNA)
    ("classes" . CLASS) ("p53 and microRNAs" . SPARSER::COLLECTION)
    ("microRNAs" . SPARSER::RNA) ("De-" . SPARSER::MOLECULE)
    ("de-" . SPARSER::MOLECULE) ("CO2" . SPARSER::PROTEIN)
    ("G 418" . SPARSER::MOLECULE) ("MDM2 protein" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("mdm2" . SPARSER::PROTEIN)
    ("single-stranded RNA" . SPARSER::RNA) ("NF-kB" . SPARSER::PROTEIN)
    ("Rho family" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("Wip1" . SPARSER::PROTEIN) ("miR-29c" . SPARSER::PROTEIN)
    ("miR-29b" . SPARSER::MOLECULE) ("protein can" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    (NIL . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("MDM2" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY)))